Citrus Sinensis ID: 002580
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 905 | 2.2.26 [Sep-21-2011] | |||||||
| O48963 | 996 | Phototropin-1 OS=Arabidop | yes | no | 0.963 | 0.875 | 0.713 | 0.0 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | yes | no | 0.883 | 0.868 | 0.608 | 0.0 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | yes | no | 0.883 | 0.868 | 0.607 | 0.0 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.783 | 0.774 | 0.606 | 0.0 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.753 | 0.751 | 0.637 | 0.0 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.247 | 0.367 | 0.421 | 5e-53 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.296 | 0.455 | 0.395 | 1e-52 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.296 | 0.455 | 0.395 | 2e-52 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.247 | 0.239 | 0.413 | 8e-52 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.215 | 0.371 | 0.475 | 8e-49 |
| >sp|O48963|PHOT1_ARATH Phototropin-1 OS=Arabidopsis thaliana GN=PHOT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1242 bits (3214), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 649/910 (71%), Positives = 736/910 (80%), Gaps = 38/910 (4%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 63
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 64 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 119
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 120 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 177
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 178 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 235
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 236 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 295
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 296 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 355
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 356 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 415
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 416 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 473
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 474 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 533
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 534 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 593
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 594 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 653
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 654 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 714 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 834 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILV 888
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAP +S +T + L IL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 889 SKKFMEFQPF 898
+ + PF
Sbjct: 883 YEMLYGYTPF 892
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Required for blue-light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to low rate of blue light. Mediates also rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under low rate but not under high rate blue light. Contributes to the chloroplast accumulation but seems to be not required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1058 bits (2737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 547/899 (60%), Positives = 661/899 (73%), Gaps = 99/899 (11%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 67
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 68 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 127
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 128 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 186
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
K P+F AEPMRASNSFVGTEEYIAP ++ +T + L IL+ + + PF
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPF 821
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1057 bits (2734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 546/899 (60%), Positives = 662/899 (73%), Gaps = 99/899 (11%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 67
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 68 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 127
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 128 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 186
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
K P+F AEPMRASNSFVGTEEYIAP ++ +T + L IL+ + + PF
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPF 821
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 903 bits (2334), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/755 (60%), Positives = 551/755 (72%), Gaps = 46/755 (6%)
Query: 119 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMS 178
++ +R AEWGL + V SG D + K + S N +
Sbjct: 62 DSAKITERTAEWGL------------SAVKPDSGDDGISFKLSSEVERSKN-MSRRSSEE 108
Query: 179 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 238
+ PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGR
Sbjct: 109 STSSESGAFPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGR 168
Query: 239 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 298
NCRFLQG TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +K
Sbjct: 169 NCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIK 228
Query: 299 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS-LSE 357
FIGMQVEVSK+TEG DK LRPNGL +SLIRYDARQKE A S+TE+VQ ++ +S + E
Sbjct: 229 FIGMQVEVSKYTEGVNDKALRPNGLSKSLIRYDARQKEKALDSITEVVQTIRHRKSQVQE 288
Query: 358 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 417
S + +++ S P P R + R S+ K +
Sbjct: 289 SVSNDTMVKPD----------------SSTTPTPGRQT----------RQSDEASKSFRT 322
Query: 418 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDD--ERPDSVDDKVRQKEMRKGI 475
GR S G K +S+++ E+ + ME ++ S + + DS D R++++R+GI
Sbjct: 323 PGRVS--TPTGSKLKSSNNR--HEDLLRMEPEELMLSTEVIGQRDSWDLSDRERDIRQGI 378
Query: 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 535
DLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD AT
Sbjct: 379 DLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDQAT 438
Query: 536 VRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595
V+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EP
Sbjct: 439 VQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEP 498
Query: 596 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPP 655
L+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK V+P PH K+S
Sbjct: 499 LQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHNKESTS 558
Query: 656 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 715
WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AMKAM+K +MLNRNK
Sbjct: 559 WKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMMLNRNK 618
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF LLDRQP K+L ED+
Sbjct: 619 AHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDS 678
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS +T+C PQL++P
Sbjct: 679 ARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQLIIPAA 738
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K+RR K Q P F+AEP SNSFVGTEEYIAP
Sbjct: 739 PSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAP 773
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 885 bits (2287), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/689 (63%), Positives = 521/689 (75%), Gaps = 7/689 (1%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY+ +EVVGRNCRFLQG
Sbjct: 86 LPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGYSPREVVGRNCRFLQGP 145
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+DD GKV+KFIGMQVEV
Sbjct: 146 DTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIRDDNGKVIKFIGMQVEV 205
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTN----RP 362
SK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K+PR + P
Sbjct: 206 SKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVKQPRGARAPADAALLTP 265
Query: 363 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 422
P + ++ A G S + R+S + +K SGR S
Sbjct: 266 PKMSDADKMAAMSPVVAPGTPSGGGGGAGSFKSPLWDLKKEESRLSRLASGRK--SGRSS 323
Query: 423 FMGL-IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTL 481
MG IG++S E ER DS + R+K++R+GIDLATTL
Sbjct: 324 LMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDSWERAEREKDIRQGIDLATTL 383
Query: 482 ERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRA 541
ERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGRNCRFLQGPETD TV KIR
Sbjct: 384 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCRFLQGPETDQGTVDKIRE 443
Query: 542 AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIP 601
AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EPLRN +
Sbjct: 444 AIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLS 503
Query: 602 EATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQK 661
E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS V PKPH++++P W AI+K
Sbjct: 504 ENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEK 563
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 721
+ GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FAMKAMDK VMLNRNKVHRAC
Sbjct: 564 ATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVMLNRNKVHRACI 623
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF +LDRQP K+ +E+ RFYAA
Sbjct: 624 EREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAA 683
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
EVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS LT+ KP ++ +T+ K+RR
Sbjct: 684 EVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHVIKNSTSLKRRR 743
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ P F++EP SNSFVGTEEYIAP
Sbjct: 744 SQEFLPPTFVSEPSTPSNSFVGTEEYIAP 772
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 5e-53, Method: Compositional matrix adjust.
Identities = 115/273 (42%), Positives = 150/273 (54%), Gaps = 49/273 (17%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KPH+ + W+AIQ + + ++HFR +K LG GD GSV+L EL G+ FAMK M+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
K + NR K+ RA EREIL LDHPF+P LY F+T+ CL+ ++CPGG+L L RQ
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
P K E AVRFY AEV+++LEYLH GIIYRDLKPENVL++ +GH+ L+DFDLS S
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 827 KPQLLLPTTNEKKRRH-------------------------------------------- 842
P L+ + N + +
Sbjct: 382 SPTLVKSSNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKN 441
Query: 843 --KGQQNPV--FMAEPMRA-SNSFVGTEEYIAP 870
Q P+ +AEP A S SFVGT EY+AP
Sbjct: 442 DMHNQVTPLPELIAEPTNARSMSFVGTHEYLAP 474
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 127/321 (39%), Positives = 169/321 (52%), Gaps = 53/321 (16%)
Query: 603 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 660
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 720
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 831
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 832 --------------------------LPTT---------NEKKRRHKGQQN------PVF 850
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 851 MAEPMRA-SNSFVGTEEYIAP 870
+AEP A S SFVGT EY+AP
Sbjct: 422 IAEPSDARSMSFVGTHEYLAP 442
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 127/321 (39%), Positives = 169/321 (52%), Gaps = 53/321 (16%)
Query: 603 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 660
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 720
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 831
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 832 --------------------------LPTT---------NEKKRRHKGQQN------PVF 850
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 851 MAEPMRA-SNSFVGTEEYIAP 870
+AEP A S SFVGT EY+AP
Sbjct: 422 IAEPSDARSMSFVGTHEYLAP 442
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 8e-52, Method: Compositional matrix adjust.
Identities = 115/278 (41%), Positives = 151/278 (54%), Gaps = 54/278 (19%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KPH W+AI+ I + L+HF +K LG GD G+V+L EL G+ FA+K MD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
+ R K RA AEREIL MLDHPF+P LYA F + CL+ +YCPGG+L +L +Q
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 821
+ E A RFY AE+++ALEYLH GIIYRDLKPEN+L++ +GH+ LTDFDLS
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 822 -------------------------------CLT--SCKPQLLLP--TTNEKKRR----- 841
C+T SC+ P ++N+++ R
Sbjct: 691 NPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRG 750
Query: 842 --------HKGQQNPVFMAEPMRA-SNSFVGTEEYIAP 870
H + P +AEP A SNSFVGT EY+AP
Sbjct: 751 DHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAP 788
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (497), Expect = 8e-49, Method: Compositional matrix adjust.
Identities = 95/200 (47%), Positives = 136/200 (68%), Gaps = 5/200 (2%)
Query: 647 KPHRKDSPPWKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMK 703
KPH+ + W+A+ ++ G + L+HFR +K LGSGD GSV+L ++ GS + ++AMK
Sbjct: 59 KPHKANQVAWEAMARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIRGSPETAFYAMK 118
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763
+DK + + K+ RA E++IL MLDHPF P LYA+F+ + L+ +YCPGG+L+ +
Sbjct: 119 VVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAVR 178
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
RQP+K + RFYAAE +VALEYLH GI+YRDLKPENVL++ +GHV L+DFDLS
Sbjct: 179 LRQPSKRFTISSTRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSFK 238
Query: 824 TSCKPQLLLPTTNEKKRRHK 843
PQ L + N++ R H+
Sbjct: 239 CDVVPQFL--SDNDRDRGHQ 256
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 905 | ||||||
| 225435157 | 1004 | PREDICTED: phototropin-1-like [Vitis vin | 0.979 | 0.882 | 0.768 | 0.0 | |
| 297746173 | 958 | unnamed protein product [Vitis vinifera] | 0.937 | 0.885 | 0.755 | 0.0 | |
| 224055599 | 977 | predicted protein [Populus trichocarpa] | 0.953 | 0.883 | 0.755 | 0.0 | |
| 255582071 | 1006 | serine/threonine protein kinase, putativ | 0.976 | 0.878 | 0.757 | 0.0 | |
| 401782496 | 1028 | phototropin 1 [Fragaria x ananassa] | 0.961 | 0.846 | 0.732 | 0.0 | |
| 60099454 | 976 | phototropin [Phaseolus vulgaris] | 0.946 | 0.878 | 0.714 | 0.0 | |
| 356542583 | 977 | PREDICTED: phototropin-1-like [Glycine m | 0.948 | 0.878 | 0.719 | 0.0 | |
| 350535803 | 1018 | phototropin-1 [Solanum lycopersicum] gi| | 0.959 | 0.852 | 0.708 | 0.0 | |
| 449460993 | 952 | PREDICTED: phototropin-1-like [Cucumis s | 0.855 | 0.813 | 0.787 | 0.0 | |
| 15231245 | 996 | non-specific serine/threonine protein ki | 0.963 | 0.875 | 0.713 | 0.0 |
| >gi|225435157|ref|XP_002281752.1| PREDICTED: phototropin-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1392 bits (3602), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 700/911 (76%), Positives = 783/911 (85%), Gaps = 25/911 (2%)
Query: 1 MREMDQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQR 60
M D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R
Sbjct: 1 MEASDDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPR 55
Query: 61 ESPEPEHA-KLNSKSSR-AEEITSWMALKDPAPQ------KPSLPPLIQKMTNDQEKSTV 112
+PE E + +L+SKS R A+EITSWMALK+P+P + S+ P + ++K T
Sbjct: 56 GTPEREGSPELSSKSGRSADEITSWMALKEPSPAPPLPLAQKSVSPAFNVQDDTRQKPTR 115
Query: 113 TKQLSGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVR 172
QLSGE AAQRAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVR
Sbjct: 116 KTQLSGEVDNAAQRAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVR 175
Query: 173 SSGEMSDEGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 230
SSGEMSDEGG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGY
Sbjct: 176 SSGEMSDEGGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGY 235
Query: 231 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 290
TSKEV+GRNCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIK
Sbjct: 236 TSKEVIGRNCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIK 295
Query: 291 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 350
D+ G VLKFIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+K
Sbjct: 296 DENGNVLKFIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVK 355
Query: 351 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 410
KPRSLSES++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+
Sbjct: 356 KPRSLSESSDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISEL 412
Query: 411 PEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKE 470
PEKK +KS R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+E
Sbjct: 413 PEKKPRKSSRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQRE 468
Query: 471 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 530
MR+GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 469 MRRGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 528
Query: 531 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590
TDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS
Sbjct: 529 TDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 588
Query: 591 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 650
EH+EPL N IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHR
Sbjct: 589 EHVEPLHNCIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHR 648
Query: 651 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 710
K+S WKAIQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VM
Sbjct: 649 KESSAWKAIQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVM 708
Query: 711 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKV
Sbjct: 709 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKV 768
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
LKEDAVRFYAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQL
Sbjct: 769 LKEDAVRFYAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQL 828
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-IL 887
L+P TNEKKR+HKGQQNP+FMAEPMRASNSFVGTEEYIAP ++ +T + L IL
Sbjct: 829 LMPNTNEKKRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 888
Query: 888 VSKKFMEFQPF 898
+ + + PF
Sbjct: 889 LYEMLYGYTPF 899
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746173|emb|CBI16229.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1353 bits (3501), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 682/903 (75%), Positives = 757/903 (83%), Gaps = 55/903 (6%)
Query: 1 MREMDQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQR 60
M D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R
Sbjct: 1 MEASDDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPR 55
Query: 61 ESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEA 120
S A+EITSWMALK+P+ +KS
Sbjct: 56 RS--------------ADEITSWMALKEPS---------PAPPLPLAQKS---------- 82
Query: 121 GAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDE 180
RAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGEMSDE
Sbjct: 83 -----RAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGEMSDE 137
Query: 181 GG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 238
GG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GR
Sbjct: 138 GGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGR 197
Query: 239 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 298
NCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G VLK
Sbjct: 198 NCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENGNVLK 257
Query: 299 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSES 358
FIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRSLSES
Sbjct: 258 FIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRSLSES 317
Query: 359 TNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKS 418
++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK +KS
Sbjct: 318 SDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKKPRKS 374
Query: 419 GRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLA 478
R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+GIDLA
Sbjct: 375 SRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRGIDLA 430
Query: 479 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRK 538
TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRK
Sbjct: 431 TTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRK 490
Query: 539 IRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 598
IR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EPL N
Sbjct: 491 IREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPLHN 550
Query: 599 SIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKA 658
IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S WKA
Sbjct: 551 CIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESSAWKA 610
Query: 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
IQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRNKVHR
Sbjct: 611 IQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRNKVHR 670
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
ACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKEDAVRF
Sbjct: 671 ACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKEDAVRF 730
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
YAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P TNEK
Sbjct: 731 YAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPNTNEK 790
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEF 895
KR+HKGQQNP+FMAEPMRASNSFVGTEEYIAP ++ +T + L IL+ + +
Sbjct: 791 KRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGY 850
Query: 896 QPF 898
PF
Sbjct: 851 TPF 853
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055599|ref|XP_002298559.1| predicted protein [Populus trichocarpa] gi|222845817|gb|EEE83364.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1333 bits (3450), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 684/905 (75%), Positives = 758/905 (83%), Gaps = 42/905 (4%)
Query: 4 MDQSEKSPKQSSKACESPLSRDSRGSLEVFNPST-FSTRPTNPVFRP-QPTWQTWMEQ-- 59
M+ ++KS KQSS PL RDSRGSLEVFNPS+ + RPTNP FR PTW++W++
Sbjct: 1 MEATDKSSKQSSGNV-PPLPRDSRGSLEVFNPSSAYLNRPTNPAFRSSNPTWKSWVDSSA 59
Query: 60 RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 119
+ PEPE A + TSWMALKDP +KP +QLSGE
Sbjct: 60 KNEPEPEEAPIT---------TSWMALKDP--KKPK------------------QQLSGE 90
Query: 120 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSD 179
G A +RAAEWGLVLKTD ETGKPQ V RTSGGDDPN KPGTSRR+SNNSVR+SGE+SD
Sbjct: 91 IGVATKRAAEWGLVLKTDDETGKPQGVSVRTSGGDDPNAKPGTSRRDSNNSVRNSGELSD 150
Query: 180 EGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 237
+GG +PRVS+ +++ALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+G
Sbjct: 151 DGGTSNNSNIPRVSEDIRNALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIG 210
Query: 238 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 297
RNCRFLQGAGTDPEDVAKIRE L+ +YCGRLLNYKKDG+PFWNLLTIAPIKDD GKVL
Sbjct: 211 RNCRFLQGAGTDPEDVAKIREALRGEGTYCGRLLNYKKDGSPFWNLLTIAPIKDDSGKVL 270
Query: 298 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 357
KFIGM VEVSKHTEG+KDK LRPNGLP SLIRYDARQKEMATSSVTELVQA+ +PR+LSE
Sbjct: 271 KFIGMLVEVSKHTEGSKDKTLRPNGLPGSLIRYDARQKEMATSSVTELVQAVNRPRALSE 330
Query: 358 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 417
STNRP ++RKSEGG E ER GA+GRR SENV P RRNS+ G R SMQRISE+PEKK +K
Sbjct: 331 STNRP-LMRKSEGGGEGERKGAIGRRNSENVAPNRRNSHRG-TRNSMQRISELPEKKPRK 388
Query: 418 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDL 477
S R SFMGL+ + + S D+ + + + D + DD R DS+DDKVR+KEMRKGIDL
Sbjct: 389 SSRLSFMGLMRKSTHSNDESFDVGITLDDDFESDDDDDDARLDSLDDKVRKKEMRKGIDL 448
Query: 478 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 537
ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR
Sbjct: 449 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 508
Query: 538 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597
KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EP
Sbjct: 509 KIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPRT 568
Query: 598 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 657
NSIPEATA ESE+LVKQTAENV++A +ELPDAN+ PEDLWANHSKVV+PKPHRKDSP WK
Sbjct: 569 NSIPEATAIESEQLVKQTAENVDDAARELPDANMRPEDLWANHSKVVYPKPHRKDSPSWK 628
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
AIQKIL+SGEQ+ L+HFRP+KPLGSGDTGSVHLVEL G+GQ+FAMK MDK MLNRNKVH
Sbjct: 629 AIQKILESGEQLGLKHFRPVKPLGSGDTGSVHLVELYGTGQFFAMKTMDKAAMLNRNKVH 688
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 777
RACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQP KVLKEDAVR
Sbjct: 689 RACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPKKVLKEDAVR 748
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
FYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTSCKPQLL+P+TNE
Sbjct: 749 FYAAEVVIALEYLHCQGIIYRDLKPENVLLQSNGHVALTDFDLSCLTSCKPQLLIPSTNE 808
Query: 838 KKRRHKGQQN-PVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFM 893
KKR K QQ PVFMAEPMRASNSFVGTEEYIAP ++ +T + L IL+ +
Sbjct: 809 KKRHRKHQQAPPVFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLY 868
Query: 894 EFQPF 898
+ PF
Sbjct: 869 GYTPF 873
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582071|ref|XP_002531832.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223528528|gb|EEF30552.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1325 bits (3428), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 694/916 (75%), Positives = 774/916 (84%), Gaps = 32/916 (3%)
Query: 1 MREMDQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPT-NPVFRPQPTWQTWMEQ 59
M +S S KQS +PL RD RGSLEVFNPS+ S+ + N +RP W+TW+E+
Sbjct: 1 MEPTGRSSSSNKQSPPVI-TPLPRDPRGSLEVFNPSSTSSTRSTNLAYRPNTNWKTWVEK 59
Query: 60 -RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLI-----QKMTNDQEKSTVT 113
+ P + KS RAEE T+WMA+KDPAP P+LP L Q + NDQ+K+ T
Sbjct: 60 PHDGPNTQSP---PKSGRAEEATTWMAIKDPAPS-PTLPLLSSPSHSQLIGNDQDKNPAT 115
Query: 114 KQLSGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPN-GKPGTSRRNSNNSVR 172
+LSGEA AA+RAAEWGLVLK +T+ GKPQ V R+SGGD+PN KPGTSRRNSNNSV+
Sbjct: 116 -ELSGEAEMAARRAAEWGLVLKPETQEGKPQVGV-RSSGGDEPNSNKPGTSRRNSNNSVQ 173
Query: 173 SSG-EMS-DEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG 229
SSG ++S D+GGKE KG+PRVS+ +K+ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG
Sbjct: 174 SSGGDLSEDDGGKENKGIPRVSEDIKNALSTFQQTFVVSDATKPDYPIMYASAGFFKMTG 233
Query: 230 YTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPI 289
YTSKEV+GRNCRFLQGA TDPEDVAKIRE LQ+ SYCGRLLNYKKDGTPFWNLLTI+PI
Sbjct: 234 YTSKEVIGRNCRFLQGADTDPEDVAKIREALQSENSYCGRLLNYKKDGTPFWNLLTISPI 293
Query: 290 KDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAM 349
KD+ GKVLK+IGMQVEVSK TEG+KDKMLRPNGLPESLIRYDARQKEMATSSVTELVQA+
Sbjct: 294 KDESGKVLKYIGMQVEVSKFTEGSKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAV 353
Query: 350 KKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISE 409
K+PRSLSE+T+RP ++RKSE G E+ER GALGRR SENVP RRNS GG R SMQ I+E
Sbjct: 354 KRPRSLSEATSRP-LMRKSESGGEDERKGALGRRNSENVPSNRRNSLGG-ARNSMQSINE 411
Query: 410 VPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE------RPDSVD 463
+PEKK +KS R SFMGL+ +KS + + DSF++ +I+ GDDD DDE RP+SVD
Sbjct: 412 LPEKKPRKSIRLSFMGLM-KKSSTQSNADSFDDALILNGDDDDVDDDEESEIDERPNSVD 470
Query: 464 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 523
DKVR+KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC
Sbjct: 471 DKVRKKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 530
Query: 524 RFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 583
RFLQGPETDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI
Sbjct: 531 RFLQGPETDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 590
Query: 584 GVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV 643
GVQLDGSEH+EP N IPE TA+ESEKLVKQTAENV+EAV+ELPDAN PEDLWANHSK
Sbjct: 591 GVQLDGSEHVEPRSNCIPEETAQESEKLVKQTAENVDEAVRELPDANSKPEDLWANHSKA 650
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
VH KPHRKD+P WKAIQKILD GE I L+HFRP+KPLGSGDTGSVHLVEL G+ +FAMK
Sbjct: 651 VHAKPHRKDTPSWKAIQKILDDGEPIGLKHFRPVKPLGSGDTGSVHLVELSGTDHHFAMK 710
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763
AMDK VMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYC GGELF+LL
Sbjct: 711 AMDKNVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCSGGELFMLL 770
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
DRQPTKVLKEDA RFYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ +GHVSLTDFDLSCL
Sbjct: 771 DRQPTKVLKEDAARFYAAEVVIALEYLHCQGIIYRDLKPENVLLQSSGHVSLTDFDLSCL 830
Query: 824 TSCKPQLLLPTTNEKKR-RHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAYTRMTRY 882
TSCKPQLL+PT +EKK+ R QQ+P+FMAEPMRASNSFVGTEEYIAPV F + T
Sbjct: 831 TSCKPQLLIPTVDEKKKHRKHHQQDPIFMAEPMRASNSFVGTEEYIAPVLIFHFIFATG- 889
Query: 883 NYLILVSKKFMEFQPF 898
IL+ + + PF
Sbjct: 890 ---ILLYEMLYGYTPF 902
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|401782496|dbj|BAM36551.1| phototropin 1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 1300 bits (3364), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 671/916 (73%), Positives = 745/916 (81%), Gaps = 46/916 (5%)
Query: 21 PLSRDSRGSLEVFNPSTFSTRPTNPV-FRPQ--PTWQTWMEQRES-----PEPEHAKLNS 72
PL RDSRGSLE+FNPS STRP +P FR TW+TW++ R++ S
Sbjct: 16 PLPRDSRGSLEIFNPS--STRPASPPPFRQSKPATWKTWLDPRDTLNPKPDPSPPPIPAS 73
Query: 73 KSSRAE-EITSWMALKD----------PAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAG 121
KS R + ITSWMALKD P+ Q PP IQ+ + V + + E G
Sbjct: 74 KSGRDDGTITSWMALKDFPPTPPPPSKPSKQSQQAPPYIQQQQTIS--AAVNDKSTPEHG 131
Query: 122 AAAQRAAEWGLVLKTDTETGKPQAVVARTSGG-DDPNGKPGTSRRNSNNSVRSSGEMSDE 180
AAQRAAEWGLVLKTDTETGKPQ V R SGG +DP+ KPGTSRRNSNNSVRSSGE+SD+
Sbjct: 132 DAAQRAAEWGLVLKTDTETGKPQGVTTRNSGGPEDPSHKPGTSRRNSNNSVRSSGELSDD 191
Query: 181 GGKEKG----LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV 236
GG G PRVS+ +K+ LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+
Sbjct: 192 GGGGGGIGKGFPRVSEDLKNVLSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVI 251
Query: 237 GRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKV 296
GRNCRFLQGA TDPEDVA++RE L SYCGRLLNYKKDGTPFWNLLTIAPIKD+ GKV
Sbjct: 252 GRNCRFLQGADTDPEDVAQLREALAKNTSYCGRLLNYKKDGTPFWNLLTIAPIKDETGKV 311
Query: 297 LKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLS 356
LKFIGMQVEVSKHTEG+KDKMLRPNGLPESLIRYDARQKE AT SVTELVQA+++PRSLS
Sbjct: 312 LKFIGMQVEVSKHTEGSKDKMLRPNGLPESLIRYDARQKEKATHSVTELVQAVRRPRSLS 371
Query: 357 ESTNRPPIIRKSEGGVEEER---------AGALGRRKSENVPPPRRNSYGGGCRTSMQRI 407
ESTNRP RKS GG E + +L RR SE+V PPRRNS G SM I
Sbjct: 372 ESTNRP--FRKSGGGGRGEEVIEAHARPSSESLPRRNSESVAPPRRNSLGD-ANFSMHSI 428
Query: 408 SEVPEKKKQKSGRRSFMGLIGRKSQSTD--DHDSFENEIIMEGDDDYESDDERPDSVDDK 465
EVPEKK++K RRSFMG++ +KSQ+ + D D+F+ E D +DERP S+DDK
Sbjct: 429 KEVPEKKQKKPRRRSFMGIM-KKSQTQNQLDDDTFDEFGASEDVRDDSDNDERPMSLDDK 487
Query: 466 VRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 525
VR+KEMRKG+DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF
Sbjct: 488 VRKKEMRKGMDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 547
Query: 526 LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
LQGPETDPATV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGV
Sbjct: 548 LQGPETDPATVKKIREAIDNQTEVTVQLINYTKSGKKFWNVFHLQPMRDQKGEVQYFIGV 607
Query: 586 QLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVH 645
QLDGS+H+EPL+NSIPE A+ESEKLVK+TA NV+EA +ELPDAN+ PEDLW NHSKVVH
Sbjct: 608 QLDGSQHIEPLQNSIPEVAAKESEKLVKETAVNVDEAARELPDANMKPEDLWMNHSKVVH 667
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
PKPHRKDSPPW AIQKILDSGEQI L+HF+PIKPLGSGDTGSVHLV+LCG+ QYFAMKAM
Sbjct: 668 PKPHRKDSPPWIAIQKILDSGEQIGLKHFKPIKPLGSGDTGSVHLVQLCGTDQYFAMKAM 727
Query: 706 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR 765
DK +MLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDY PGGELFLLLD
Sbjct: 728 DKNIMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYYPGGELFLLLDT 787
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
QPTKVLKE++VRFY AEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTS
Sbjct: 788 QPTKVLKENSVRFYVAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVTLTDFDLSCLTS 847
Query: 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYN 883
CKPQLLLPT NEKKR HK Q +P+FMAEPMRASNSFVGTEEYIAP ++ ++ +
Sbjct: 848 CKPQLLLPTINEKKRHHKRQHDPIFMAEPMRASNSFVGTEEYIAPEIITGAGHSSAVDWW 907
Query: 884 YL-ILVSKKFMEFQPF 898
L IL+ + + PF
Sbjct: 908 ALGILIYEMLYGYTPF 923
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60099454|dbj|BAD89966.1| phototropin [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 1265 bits (3274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/886 (71%), Positives = 722/886 (81%), Gaps = 29/886 (3%)
Query: 24 RDSRGSLEVFNPSTFSTRPTNPVFRP---QPTWQTWMEQRESPEPEHAKLNSKSSRAEEI 80
RD RGSLEVFNPS+ S PV P Q TW+TW++ R +PE + + +E+
Sbjct: 6 RDQRGSLEVFNPSSSSYSNEKPVISPLRTQSTWKTWVDSRVEEQPEKQQ---RGGGPDEV 62
Query: 81 T--SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDT 138
T SWMALKD P PS Q + V + E G AA+RAAEWGLVLKTDT
Sbjct: 63 TATSWMALKDSTPPPPS-----------QTLAAVLGEPPAEVGNAAKRAAEWGLVLKTDT 111
Query: 139 ETGKPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKD 196
ETGKPQ V +TSGG++P K G SRR+S NSVRSSGE SD+G + +G +PRVS+ ++D
Sbjct: 112 ETGKPQGVAVQTSGGEEPGVKVTGGSRRDSGNSVRSSGESSDDGREYRGGIPRVSEDLRD 171
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
ALS FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKI
Sbjct: 172 ALSAFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKI 231
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 316
RE LQ GQ+YCGRLLNYKKDGTPFWNLLTIAPIKD +G+VLKFIGMQVEVSKHTEG K+
Sbjct: 232 REALQTGQTYCGRLLNYKKDGTPFWNLLTIAPIKDHDGRVLKFIGMQVEVSKHTEGNKEN 291
Query: 317 MLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEER 376
MLRPNGLPESLIRYDARQKE A SSV+EL+ A+++PR+LSES RP I + + G ++++
Sbjct: 292 MLRPNGLPESLIRYDARQKEKANSSVSELLLAVRRPRALSESGGRPLIRKSASGDDDQDK 351
Query: 377 AGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDD 436
RRKSE+V RR S+ G RTSM++I+E+PE K + S RRSFMG I RK+QS
Sbjct: 352 PEKSSRRKSESVASFRRKSHAGD-RTSMEKITEIPENKHKTSRRRSFMGFI-RKNQSK-- 407
Query: 437 HDSFENEIIMEGDDDYESDD-ERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRL 495
SF +E ++EG + +D ER S D KV++KE RKG+DLATTLERIEKNFVITDPRL
Sbjct: 408 FGSFNDEAVIEGSSESSDEDGERSGSFDGKVQRKEKRKGLDLATTLERIEKNFVITDPRL 467
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555
PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AID QTDVTVQLIN
Sbjct: 468 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDTQTDVTVQLIN 527
Query: 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQT 615
YTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E EKLVK T
Sbjct: 528 YTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIAENTAKEGEKLVKDT 587
Query: 616 AENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFR 675
AENV++A++ELPDANL PEDLW NHSKVVHPKPHR+D WKAIQKIL+SGEQI L HF+
Sbjct: 588 AENVDDALRELPDANLKPEDLWMNHSKVVHPKPHRRDEAAWKAIQKILESGEQIGLNHFK 647
Query: 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
P+KPLGSGDTGSV+LVEL +GQYFAMKAM+KG+MLNRNKVHRAC EREILDMLDHPF+P
Sbjct: 648 PVKPLGSGDTGSVYLVELGETGQYFAMKAMEKGIMLNRNKVHRACTEREILDMLDHPFLP 707
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
ALYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGI
Sbjct: 708 ALYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGI 767
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
IYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P+ NEKK+ KG Q P+FMAEPM
Sbjct: 768 IYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPSINEKKKAQKGHQPPIFMAEPM 827
Query: 856 RASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
RASNSFVGTEEYIAP ++ ++ + L IL+ + F + PF
Sbjct: 828 RASNSFVGTEEYIAPEIITGSGHSSAVDWWALGILLYEMFFGYTPF 873
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542583|ref|XP_003539746.1| PREDICTED: phototropin-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1260 bits (3260), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/885 (71%), Positives = 732/885 (82%), Gaps = 27/885 (3%)
Query: 24 RDSRGSLEVFNPST-FST-RPTNPVFRPQPTWQTWMEQRESPEPEHAKLNSKSSRAEEIT 81
RD RGSLEVFNPS+ +ST + N R Q TW+TW++ E PE + + ++ T
Sbjct: 6 RDQRGSLEVFNPSSSYSTEKSVNSPVRVQSTWKTWID--ELPEQQQQQQCGGTNEVT-AT 62
Query: 82 SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDTETG 141
SWMALKD AP PP + + + + V GE G AA+RAAEWGLVLKTDTETG
Sbjct: 63 SWMALKDSAPP----PPTLAAVLGESLSAAV-----GEVGNAAKRAAEWGLVLKTDTETG 113
Query: 142 KPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKDALS 199
KPQ V RTSGG++P+ K G SRR+S+NSVRSSGE SD+G + +G +PRVS+ ++DALS
Sbjct: 114 KPQGVKVRTSGGEEPSAKVTGGSRRDSSNSVRSSGESSDDGREYRGGIPRVSEDLRDALS 173
Query: 200 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRET 259
FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKIRE
Sbjct: 174 AFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKIREA 233
Query: 260 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 319
LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD+G+VLKFIGMQVEVSKHTEGAK+KMLR
Sbjct: 234 LQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDDGRVLKFIGMQVEVSKHTEGAKEKMLR 293
Query: 320 PNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGG--VEEERA 377
PNGLPESLIRYDARQKE A S+V+EL+ A+++PR+LSES RP +I+KS G +++
Sbjct: 294 PNGLPESLIRYDARQKEKANSTVSELLLAVRRPRALSESAGRP-MIKKSASGDDAQDKPP 352
Query: 378 GALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDH 437
RRKSE+V RR S+ G R+SM+RI+E+PEKK + S RRSFMG I RKSQS +
Sbjct: 353 EKSSRRKSESVASFRRKSHAGD-RSSMERITELPEKKHKSSRRRSFMGFI-RKSQS--NF 408
Query: 438 DSFENEIIMEGDDDYESDDE-RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLP 496
SF +E ++E + +D+ RP+S D KV++KE RKG+DLATTLERIEKNFVITDPRLP
Sbjct: 409 GSFNDEAVVENSSESSDEDDERPESFDGKVQKKEKRKGLDLATTLERIEKNFVITDPRLP 468
Query: 497 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556
DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AIDNQTDVTVQLINY
Sbjct: 469 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDNQTDVTVQLINY 528
Query: 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTA 616
TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I + TA+E E+LVK TA
Sbjct: 529 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIADDTAKEGEQLVKDTA 588
Query: 617 ENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRP 676
ENV++A++ELPDAN+ PEDLW NHSKVVHPKPHR+D WKAIQ+IL+SGEQI L HFRP
Sbjct: 589 ENVDDALRELPDANMKPEDLWMNHSKVVHPKPHRRDEAAWKAIQQILNSGEQIGLNHFRP 648
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+KPLGSGDTGSV+LVEL +G YFAMKAM+KGVMLNRNKVHRAC EREILDMLDHPF+PA
Sbjct: 649 VKPLGSGDTGSVYLVELGETGHYFAMKAMEKGVMLNRNKVHRACTEREILDMLDHPFLPA 708
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGII
Sbjct: 709 LYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGII 768
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P NEKK+ KG P+FMAEPMR
Sbjct: 769 YRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPVINEKKKAQKGPHAPIFMAEPMR 828
Query: 857 ASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
ASNSFVGTEEYIAP ++ +T + L IL+ + F + PF
Sbjct: 829 ASNSFVGTEEYIAPEIITGSGHTSAVDWWALGILLYEMFYGYTPF 873
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350535803|ref|NP_001234214.1| phototropin-1 [Solanum lycopersicum] gi|151176133|gb|ABN42185.2| phototropin-1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1258 bits (3254), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 645/911 (70%), Positives = 727/911 (79%), Gaps = 43/911 (4%)
Query: 21 PLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWM-----------------EQRESP 63
PL RD RGSLEVFNPST+S+R TNPVFR QP+W+ W EQ P
Sbjct: 13 PLPRDPRGSLEVFNPSTYSSRSTNPVFRSQPSWKNWTAADPITRSTIPETEEKTEQIAIP 72
Query: 64 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAA 123
+ K+N + W L+ Q+ L L++ + +K E GAA
Sbjct: 73 QIRVTKMNKSL-----LHGWQLLR---LQRNWLLRLLKNQLPVVRRFN-SKAAVDEVGAA 123
Query: 124 AQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEG-G 182
AQRAAEWGLVLKTD ETGK Q V RTSG DD NGK TSRR+S NS RSSGE SD+G G
Sbjct: 124 AQRAAEWGLVLKTDDETGKLQGVKVRTSG-DDTNGKTETSRRDSGNSGRSSGEFSDDGAG 182
Query: 183 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 242
KE+G+PRVS+ ++DALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 183 KERGIPRVSEDLRDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 242
Query: 243 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 302
+QG+GTDPEDVA IRE LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD GKVLKFIGM
Sbjct: 243 MQGSGTDPEDVATIREALQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDAGKVLKFIGM 302
Query: 303 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPR---SLSEST 359
QVEVSKHTEG+K+K +RPNGLPESLIRYD RQKEMA++SV EL++ +K PR +LSEST
Sbjct: 303 QVEVSKHTEGSKEKTVRPNGLPESLIRYDVRQKEMASNSVNELLEEIKNPRRARALSEST 362
Query: 360 N-RPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSM--QRISEVPEKKKQ 416
N RP +RKSEG E+ + N P RR+S+ G T+M ++I+EVPEKK +
Sbjct: 363 NNRPTFMRKSEGDQVEQDKQDTHKLNLVNKAPARRHSHAGTRTTTMKMEKINEVPEKKPK 422
Query: 417 KSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDE---RPDSVDDKVRQKE 470
KS R SFMG++ +K ST FE + M+ DDD + + + RP SVDDKVR+KE
Sbjct: 423 KSARLSFMGIMKKKRSSTTMTTDDDDFEARMTMDNDDDDDDESDNDGRPVSVDDKVRKKE 482
Query: 471 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 530
MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 483 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 542
Query: 531 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590
TDPATV+KIR AIDNQTDVTVQLINYTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS
Sbjct: 543 TDPATVKKIRQAIDNQTDVTVQLINYTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 602
Query: 591 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 650
+H+EPL+NSIPE A ES KL+K+TA NV+EAV+ELPDAN PEDLW NHSKVV PKPHR
Sbjct: 603 QHVEPLQNSIPEDKATESAKLIKETAGNVDEAVRELPDANSKPEDLWRNHSKVVQPKPHR 662
Query: 651 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 710
KDSP WKAIQKIL+SGE I L+HF+PIKPLGSGDTGSVHLVELCG+ Q+FAMKAMDK +M
Sbjct: 663 KDSPSWKAIQKILESGEPIGLKHFKPIKPLGSGDTGSVHLVELCGTDQHFAMKAMDKSIM 722
Query: 711 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQ TKV
Sbjct: 723 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQQTKV 782
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
LKEDA RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ GHVSLTDFDLSCLTSCKPQL
Sbjct: 783 LKEDAARFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSGGHVSLTDFDLSCLTSCKPQL 842
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-IL 887
L+P NEKK+ KGQ NP+FMAEPMRASNSFVGTEEYIAP ++ +T + L IL
Sbjct: 843 LVPEINEKKKHQKGQHNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 902
Query: 888 VSKKFMEFQPF 898
+ + + PF
Sbjct: 903 LYEMLYGYTPF 913
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460993|ref|XP_004148228.1| PREDICTED: phototropin-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1256 bits (3249), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 633/804 (78%), Positives = 688/804 (85%), Gaps = 30/804 (3%)
Query: 119 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSG-EM 177
E G+AA RAAEWGLVLKTDTETGKPQ V RTSGGD+PN K SRR SNNSVRSSG EM
Sbjct: 49 EVGSAALRAAEWGLVLKTDTETGKPQGVGVRTSGGDEPNTKQENSRRTSNNSVRSSGDEM 108
Query: 178 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 237
S+EGG+E+G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+G
Sbjct: 109 SEEGGRERGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIG 168
Query: 238 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 297
RNCRFLQGA TDPEDVAKIRE LQ G SYCGRLLNYKKDGTPFWNLLTI+PIKDD+GKVL
Sbjct: 169 RNCRFLQGADTDPEDVAKIREALQAGTSYCGRLLNYKKDGTPFWNLLTISPIKDDDGKVL 228
Query: 298 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 357
K IGMQVEVSKHTEG KDKM+RPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRSLSE
Sbjct: 229 KLIGMQVEVSKHTEGFKDKMVRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRSLSE 288
Query: 358 --------STNRPPIIRKSEGGVEEERAG----------ALGRRKSENVPPPRRNSYGGG 399
S NR + RKS GG G + RRKSE+ P GG
Sbjct: 289 YRPRALSESMNRR-LFRKSGGGGGGGEGGGKDEKDKLEPTMVRRKSESAAAPAGRRSQGG 347
Query: 400 CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE-- 457
R SMQRI+EVP+KK +KS RSFMG++ RKSQS + +SF+ I EG DD D+
Sbjct: 348 SRRSMQRINEVPDKKPKKSSHRSFMGIM-RKSQSNVE-ESFD---IEEGSDDENESDDDV 402
Query: 458 RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 517
RPDSVDDKVRQ+EMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE
Sbjct: 403 RPDSVDDKVRQREMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 462
Query: 518 ILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 577
ILGRNCRFLQGPETD TV+KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG
Sbjct: 463 ILGRNCRFLQGPETDRTTVKKIRDAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 522
Query: 578 EVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW 637
EVQYFIGVQLDGS+H+EPL N I E+TA+E EKL+K+TAENV+ A +ELPDANLTPEDLW
Sbjct: 523 EVQYFIGVQLDGSQHVEPLSNCIAESTAKEGEKLIKETAENVDLAARELPDANLTPEDLW 582
Query: 638 ANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG 697
ANHSK+V PKPHRKDSP W+AIQKILD GEQI L+HF+P+KPLGSGDTGSVHLVELCG+
Sbjct: 583 ANHSKLVQPKPHRKDSPSWQAIQKILDGGEQIGLKHFKPVKPLGSGDTGSVHLVELCGTD 642
Query: 698 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757
QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDYCPGG
Sbjct: 643 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYCPGG 702
Query: 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
ELFLLLDRQPTKV+KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTD
Sbjct: 703 ELFLLLDRQPTKVIKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVALTD 762
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFA 875
FDLSCLTSCKPQLLLP NEKK++ K QQ P+FMAEPMRASNSFVGTEEYIAP ++
Sbjct: 763 FDLSCLTSCKPQLLLPAANEKKKQSKTQQTPIFMAEPMRASNSFVGTEEYIAPEIITGAG 822
Query: 876 YTRMTRYNYL-ILVSKKFMEFQPF 898
+T + L IL+ + + PF
Sbjct: 823 HTSAVDWWALGILLYEMLYGYTPF 846
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231245|ref|NP_190164.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|79314333|ref|NP_001030814.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|25090817|sp|O48963.1|PHOT1_ARATH RecName: Full=Phototropin-1; AltName: Full=Non-phototropic hypocotyl protein 1; AltName: Full=Root phototropism protein 1 gi|13430612|gb|AAK25928.1|AF360218_1 putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|2832241|gb|AAC01753.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|7019644|emb|CAB75791.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|14532876|gb|AAK64120.1| putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|332644551|gb|AEE78072.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|332644552|gb|AEE78073.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1242 bits (3214), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 649/910 (71%), Positives = 736/910 (80%), Gaps = 38/910 (4%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 63
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 64 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 119
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 120 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 177
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 178 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 235
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 236 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 295
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 296 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 355
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 356 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 415
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 416 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 473
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 474 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 533
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 534 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 593
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 594 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 653
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 654 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 714 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 834 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILV 888
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAP +S +T + L IL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 889 SKKFMEFQPF 898
+ + PF
Sbjct: 883 YEMLYGYTPF 892
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 905 | ||||||
| TAIR|locus:2102674 | 996 | PHOT1 "phototropin 1" [Arabido | 0.962 | 0.874 | 0.694 | 0.0 | |
| UNIPROTKB|Q8H935 | 963 | Vfphot1a "Phototropin" [Vicia | 0.931 | 0.875 | 0.652 | 1.4e-302 | |
| UNIPROTKB|Q2QYY8 | 921 | PHOT1A "Phototropin-1A" [Oryza | 0.767 | 0.754 | 0.681 | 9.3e-266 | |
| UNIPROTKB|Q2RBR1 | 921 | PHOT1B "Phototropin-1B" [Oryza | 0.767 | 0.754 | 0.680 | 1.9e-265 | |
| TAIR|locus:2155821 | 915 | PHOT2 "phototropin 2" [Arabido | 0.560 | 0.554 | 0.623 | 9e-239 | |
| UNIPROTKB|Q9ST27 | 907 | PHOT2 "Phototropin-2" [Oryza s | 0.762 | 0.760 | 0.620 | 3.3e-230 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.234 | 0.302 | 0.483 | 4.5e-58 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.218 | 0.396 | 0.505 | 6e-56 | |
| TAIR|locus:2087785 | 577 | AGC1.5 "AGC kinase 1.5" [Arabi | 0.259 | 0.407 | 0.433 | 1.8e-55 | |
| TAIR|locus:2032785 | 499 | RSH3 "root hair specific 3" [A | 0.204 | 0.370 | 0.513 | 1.3e-53 |
| TAIR|locus:2102674 PHOT1 "phototropin 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3089 (1092.4 bits), Expect = 0., P = 0.
Identities = 633/911 (69%), Positives = 713/911 (78%)
Query: 8 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 63
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 64 EPEHAKLNSKSSRAE-EI---TSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSXX 119
P+ S R++ EI TSWMALKDP+P+ I K T EK Q S
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPET------ISKKTITAEKP----QKSAV 111
Query: 120 XXXXXXXXXXWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTXXXXXXXXXXXXGEM 177
WGLVLKTDT+TGKPQ V R SGG +DPNGK T GEM
Sbjct: 112 AAEQRAAE--WGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 178 SD---EGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 234
SD GG+ G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKE
Sbjct: 170 SDGDVPGGRS-GIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKE 228
Query: 235 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 294
VVGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ G
Sbjct: 229 VVGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESG 288
Query: 295 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 354
KVLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+
Sbjct: 289 KVLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRA 348
Query: 355 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 414
LSESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 349 LSESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKK 405
Query: 415 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMR 472
+KS SFMG I +KS+S D+ S ++ I SVDDKVRQKEMR
Sbjct: 406 SRKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMR 461
Query: 473 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 532
KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 462 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 521
Query: 533 PATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H
Sbjct: 522 LTTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKH 581
Query: 593 LEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKD 652
+EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKD
Sbjct: 582 VEPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKD 641
Query: 653 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 712
SPPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLN
Sbjct: 642 SPPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLN 701
Query: 713 RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 772
RNKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLK
Sbjct: 702 RNKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLK 761
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
EDAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+
Sbjct: 762 EDAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLI 821
Query: 833 PTTNEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-IL 887
P+ +EKK++ K QQ P+FMAEPMRASNSFVGTEEYIAP +S +T + L IL
Sbjct: 822 PSIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGIL 881
Query: 888 VSKKFMEFQPF 898
+ + + PF
Sbjct: 882 MYEMLYGYTPF 892
|
|
| UNIPROTKB|Q8H935 Vfphot1a "Phototropin" [Vicia faba (taxid:3906)] | Back alignment and assigned GO terms |
|---|
Score = 2797 (989.7 bits), Expect = 1.4e-302, Sum P(2) = 1.4e-302
Identities = 572/877 (65%), Positives = 653/877 (74%)
Query: 35 PSTFSTRPTNPVFRPQPTWQTWMEQ-RESPEPEHAKLNSKSSRAEEITSWM--ALKDPAP 91
P T R + VF P + +P P ++ SSR E + D P
Sbjct: 3 PFTRDHRGSLEVFNPSSSETNGTPNPNPNPNPSNSWNTGTSSRGTEAPPLRDSIISDEVP 62
Query: 92 QKPSLPPLIQKMTNDQEKSTVTKQLSXXXXXXXXXXXXWGLVLKTDTETGKPQAVVARTS 151
S L K T KS + ++ WGLVLKTD+ETGKPQ V R S
Sbjct: 63 TATSWMAL--KETTPSPKSGESGSVAEQRAAE------WGLVLKTDSETGKPQGVGVRGS 114
Query: 152 GGDDPNGKPGTXXXXXXXXXXXXGEMSDEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDA 210
GG G GE SD+G + +G+PRVS+ ++DALS FQQTFVVSDA
Sbjct: 115 GGG------GGSRRDSNNSVRSSGESSDDGREGGRGIPRVSEDLRDALSAFQQTFVVSDA 168
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270
TKPDYPIMYASAGFF MTGYTSKEV+GRNCRF+QGA TDP DVAKIRE L G SYCGRL
Sbjct: 169 TKPDYPIMYASAGFFSMTGYTSKEVIGRNCRFMQGADTDPNDVAKIREALAAGTSYCGRL 228
Query: 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRY 330
LNYKKDGT FWNLLTIAPIKD+ GK+LK IGMQVEVSKHTEG K+KMLRPNGLPESLIRY
Sbjct: 229 LNYKKDGTTFWNLLTIAPIKDEHGKILKLIGMQVEVSKHTEGTKEKMLRPNGLPESLIRY 288
Query: 331 DARQKEMATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEE----RAGALGRRKS 385
DARQKE A SSVTELV+A+ K+PRSLSES NR P +K G + + + R+
Sbjct: 289 DARQKEKANSSVTELVEAVSKRPRSLSESANRLPFNKKPTNGSNDHATPPNSESSSRKSG 348
Query: 386 ENVPPPRRNSYGG-GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEI 444
+ RR S+ G G SM I+E+PE KS RRSFMG + RKS S ++ F +E
Sbjct: 349 STLRSFRRKSHSGAGNSNSMHPITELPENNN-KSRRRSFMGFM-RKSLSNNER--FNHEQ 404
Query: 445 IMXXXXXXXXXXXXXXSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 504
++ + +++E RKG DLATTLERIEKNFVITDPRLPDNPIIFAS
Sbjct: 405 VIDRNSSEDEDRLDSFDEQNIAQKREKRKGFDLATTLERIEKNFVITDPRLPDNPIIFAS 464
Query: 505 DSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564
DSFLELTEYSREEILGRNCRFLQGPETDPATV+KIR AIDNQT+VTVQLINYTK+GKKFW
Sbjct: 465 DSFLELTEYSREEILGRNCRFLQGPETDPATVKKIRYAIDNQTEVTVQLINYTKTGKKFW 524
Query: 565 NLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVK 624
NLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E E LVK+TAENV++A++
Sbjct: 525 NLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNGIAEDTAKEGENLVKKTAENVDDALR 584
Query: 625 ELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGD 684
ELPDAN+ PEDLW NHSKVVHPKPHR++ W+AIQKI++SGEQI L+HF+PIKPLGSGD
Sbjct: 585 ELPDANMKPEDLWMNHSKVVHPKPHRREDSAWRAIQKIMESGEQIGLKHFKPIKPLGSGD 644
Query: 685 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744
TGSVHLVELCG+ +FAMKAMDKGVM NRNKVHRAC EREILDMLDHPF+PALYASFQTK
Sbjct: 645 TGSVHLVELCGTDHHFAMKAMDKGVMPNRNKVHRACTEREILDMLDHPFLPALYASFQTK 704
Query: 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804
TH+CLITDYCPGGELF+LLDRQP KVLKEDAVRFYA EVVVALEYLHCQGIIYRDLKPEN
Sbjct: 705 THICLITDYCPGGELFMLLDRQPAKVLKEDAVRFYATEVVVALEYLHCQGIIYRDLKPEN 764
Query: 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 864
VLLQ GHVSLTDFDLSCLTSCKP+L++P+TN+KK KGQ P+FMAEPMRASNSFVGT
Sbjct: 765 VLLQSTGHVSLTDFDLSCLTSCKPELIVPSTNDKK---KGQHGPIFMAEPMRASNSFVGT 821
Query: 865 EEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
EEYIAP ++ +T + L IL+ + F + PF
Sbjct: 822 EEYIAPEIITGSGHTCAVDWWALGILLYEMFYGYTPF 858
|
|
| UNIPROTKB|Q2QYY8 PHOT1A "Phototropin-1A" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2502 (885.8 bits), Expect = 9.3e-266, Sum P(2) = 9.3e-266
Identities = 490/719 (68%), Positives = 580/719 (80%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
K P+F AEPMRASNSFVGTEEYIAP ++ +T + L IL+ + + PF
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPF 821
|
|
| UNIPROTKB|Q2RBR1 PHOT1B "Phototropin-1B" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2499 (884.8 bits), Expect = 1.9e-265, Sum P(2) = 1.9e-265
Identities = 489/719 (68%), Positives = 581/719 (80%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 307 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 366
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 367 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 424
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 425 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 482
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 483 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 542
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 543 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 602
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 662
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
K P+F AEPMRASNSFVGTEEYIAP ++ +T + L IL+ + + PF
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPF 821
|
|
| TAIR|locus:2155821 PHOT2 "phototropin 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1638 (581.7 bits), Expect = 9.0e-239, Sum P(3) = 9.0e-239
Identities = 329/528 (62%), Positives = 392/528 (74%)
Query: 348 AMKKPRSLSESTNRPPIIRKSEGGVEEERAG-ALGRRKSENVPPPRRNSYGGGCRTSMQR 406
A +K ++L T IR + V+E + + + S P P R + R
Sbjct: 262 ARQKEKALDSITEVVQTIRHRKSQVQESVSNDTMVKPDSSTTPTPGRQT----------R 311
Query: 407 ISEVPEKKKQKSGRRSFMGLIGRKSQSTDD-HDSF---ENEIIMXXXXXXXXXXXXXXSV 462
S+ K + GR S G K +S+++ H+ E E +M S
Sbjct: 312 QSDEASKSFRTPGRVSTP--TGSKLKSSNNRHEDLLRMEPEELMLSTEVIGQRD----SW 365
Query: 463 DDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN 522
D R++++R+GIDLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRN
Sbjct: 366 DLSDRERDIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRN 425
Query: 523 CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYF 582
CRFLQGPETD ATV+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYF
Sbjct: 426 CRFLQGPETDQATVQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYF 485
Query: 583 IGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSK 642
IGVQLDGS+H+EPL+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK
Sbjct: 486 IGVQLDGSDHVEPLQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSK 545
Query: 643 VVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAM 702
V+P PH K+S WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AM
Sbjct: 546 PVYPLPHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAM 605
Query: 703 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
KAM+K +MLNRNK HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF L
Sbjct: 606 KAMEKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFAL 665
Query: 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
LDRQP K+L ED+ RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS
Sbjct: 666 LDRQPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSF 725
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+T+C PQL++P K+RR K Q P F+AEP SNSFVGTEEYIAP
Sbjct: 726 MTTCTPQLIIPAAPSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAP 773
|
|
| UNIPROTKB|Q9ST27 PHOT2 "Phototropin-2" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2221 (786.9 bits), Expect = 3.3e-230, P = 3.3e-230
Identities = 440/709 (62%), Positives = 531/709 (74%)
Query: 175 GEMSDEGG----KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 230
G+ S +GG LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY
Sbjct: 70 GKSSVDGGVGRASHDSLPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGY 129
Query: 231 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 290
+ +EVVGRNCRFLQG TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+
Sbjct: 130 SPREVVGRNCRFLQGPDTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIR 189
Query: 291 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 350
DD GKV+KFIGMQVEVSK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K
Sbjct: 190 DDNGKVIKFIGMQVEVSKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVK 249
Query: 351 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 410
+PR + + + ++ A+ S V P + GGG + + ++
Sbjct: 250 QPRGARAPADAALLTPPKMS--DADKMAAM----SPVVAPGTPSGGGGGAGSFKSPLWDL 303
Query: 411 PEKKKQ--------KSGRRSFMGL-IGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXXS 461
+++ + KSGR S MG IG++S E S
Sbjct: 304 KKEESRLSRLASGRKSGRSSLMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDS 363
Query: 462 VDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR 521
+ R+K++R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGR
Sbjct: 364 WERAEREKDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGR 423
Query: 522 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 581
NCRFLQGPETD TV KIR AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QY
Sbjct: 424 NCRFLQGPETDQGTVDKIREAIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQY 483
Query: 582 FIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHS 641
FIGVQLDGS+H+EPLRN + E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS
Sbjct: 484 FIGVQLDGSDHVEPLRNRLSENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHS 543
Query: 642 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 701
V PKPH++++P W AI+K + GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FA
Sbjct: 544 MRVSPKPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFA 603
Query: 702 MKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 761
MKAMDK VMLNRNKVHRAC EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF
Sbjct: 604 MKAMDKSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFA 663
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+LDRQP K+ +E+ RFYAAEVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS
Sbjct: 664 VLDRQPMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLS 723
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
LT+ KP ++ +T+ K+RR + P F++EP SNSFVGTEEYIAP
Sbjct: 724 FLTTSKPHVIKNSTSLKRRRSQEFLPPTFVSEPSTPSNSFVGTEEYIAP 772
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 4.5e-58, Sum P(3) = 4.5e-58
Identities = 103/213 (48%), Positives = 142/213 (66%)
Query: 629 ANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSV 688
+ L+ + W+N + + KPH+ + P WKAI I + + HF+ +K LG GD GSV
Sbjct: 264 SGLSDDSNWSNITGSAN-KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSV 322
Query: 689 HLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748
+L EL G+ YFAMK MDK + +R K+ RA EREIL +LDHPF+P LY F+T C
Sbjct: 323 YLSELSGTRCYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSC 382
Query: 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 808
L+ +YCPGG+L L RQP K E A RFYAAEV++ALEYLH G++YRDLKPENVL++
Sbjct: 383 LVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVR 442
Query: 809 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+GH+ L+DFDLS + P L+ ++++ +R
Sbjct: 443 DDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKR 475
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 6.0e-56, Sum P(2) = 6.0e-56
Identities = 101/200 (50%), Positives = 138/200 (69%)
Query: 638 ANHSKVVHP-KPHRKDSPPWKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCG 695
AN +V P KPH+ + W AIQ + S E + L HFR +K LG GD GSV+L EL
Sbjct: 76 ANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELRE 135
Query: 696 SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755
G +FAMK MDKG+++ R K+ RA EREIL +LDHPF+P LY+ F+T+ CL+ ++C
Sbjct: 136 MGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCS 195
Query: 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815
GG+L +L +QP K E A RFYA+EV++ALEYLH G++YRDLKPENV+++ +GH+ L
Sbjct: 196 GGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIML 255
Query: 816 TDFDLSCLTSCKPQLLLPTT 835
+DFDLS + P L+ T+
Sbjct: 256 SDFDLSLQSFVSPTLIQSTS 275
|
|
| TAIR|locus:2087785 AGC1.5 "AGC kinase 1.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 1.8e-55, Sum P(3) = 1.8e-55
Identities = 107/247 (43%), Positives = 147/247 (59%)
Query: 592 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDL--WANHSKVVHP--- 646
H +P + +P T+E +A N + + PD P +A +V P
Sbjct: 101 HYDP-KKIVPLTTSET----YSPSARNHHHHRTKSPDKKRAPRHNGDYAYGDNLVGPSAQ 155
Query: 647 --KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
KPH W AI I G QI L +FR +K LG GD GSV+L +L G+ FAMK
Sbjct: 156 PFKPHTGGDVRWDAINSIASKGPQIGLDNFRLLKRLGYGDIGSVYLADLRGTNAVFAMKV 215
Query: 705 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 764
MDK + +RNK+ RA EREIL +LDHPF+P LY+ F+T CL+ ++C GG L L
Sbjct: 216 MDKASLASRNKLLRAQTEREILSLLDHPFLPTLYSYFETDKFYCLVMEFCSGGNLHSLRQ 275
Query: 765 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
+QP++ E+A RFYA+EV++ALEYLH G++YRDLKPEN+L++ GH+ L+DFDLS
Sbjct: 276 KQPSRRFTEEAARFYASEVLLALEYLHMLGVVYRDLKPENILVRDEGHIMLSDFDLSLRC 335
Query: 825 SCKPQLL 831
+ P L+
Sbjct: 336 TFNPTLV 342
|
|
| TAIR|locus:2032785 RSH3 "root hair specific 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 1.3e-53, Sum P(2) = 1.3e-53
Identities = 96/187 (51%), Positives = 127/187 (67%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKA 704
KPH W A+ + G ++ + FR +K LG GD GSV+LVEL G+ YFAMK
Sbjct: 86 KPHTGGDIRWDAVNSLKSRGIKLGISDFRVLKRLGYGDIGSVYLVELKGANPTTYFAMKV 145
Query: 705 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 764
MDK +++RNK+ RA EREIL LDHPF+P LY+ F+T CL+ ++C GG L+ L
Sbjct: 146 MDKASLVSRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCSGGNLYSLRQ 205
Query: 765 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
+QP K EDA RF+A+EV++ALEYLH GI+YRDLKPENVL++ +GH+ L+DFDLS
Sbjct: 206 KQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRC 265
Query: 825 SCKPQLL 831
S P L+
Sbjct: 266 SVNPTLV 272
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q2QYY8 | PHT1A_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6084 | 0.8839 | 0.8686 | yes | no |
| Q2RBR1 | PHT1B_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6073 | 0.8839 | 0.8686 | yes | no |
| O48963 | PHOT1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7131 | 0.9635 | 0.8755 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.I.2683.1 | hypothetical protein (971 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 905 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-105 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-59 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-53 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-48 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-46 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-42 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-40 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-40 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 6e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-39 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 1e-38 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-37 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-37 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-37 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-37 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 1e-36 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-36 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-36 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-35 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-35 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-35 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-33 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-33 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-33 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-33 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-32 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 3e-31 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 7e-31 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 2e-30 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-30 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-29 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-29 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-29 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-29 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-29 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-28 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-28 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-28 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-28 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-28 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-27 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-27 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-26 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 3e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-25 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-25 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-24 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-23 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-22 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-22 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-12 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 1e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-10 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-09 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-09 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 7e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-09 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-08 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 1e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-07 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 3e-07 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-06 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-06 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-06 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 5e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-05 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 2e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.001 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 0.002 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.002 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.003 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.004 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 329 bits (845), Expect = e-105
Identities = 113/201 (56%), Positives = 140/201 (69%), Gaps = 2/201 (0%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+HF+ IK LG GD G V LV L G+G+ FA+K +DK M+ RNKV R E+EIL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
PF+P LYASFQT+T++CL+ DYCPGGELF LL RQP K L E+ RFYAAEV++ALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT--TNEKKRRHKGQQNPV 849
GI+YRDLKPEN+LL +GH+ L+DFDLS + +P + ++ +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
F EP SNSFVGTEEYIAP
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAP 201
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 9e-59
Identities = 78/191 (40%), Positives = 106/191 (55%), Gaps = 29/191 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V LV +G+ +AMK + K ++ R +V ER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+FQT+ + L+ +Y PGGELF L ++ E+ RFYAAE+V+ALEYLH GIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKPEN+LL +GH+ LTDF L+ +E R N
Sbjct: 119 LKPENILLDADGHIKLTDFGLAK--------------------------ELSSEGSRT-N 151
Query: 860 SFVGTEEYIAP 870
+F GT EY+AP
Sbjct: 152 TFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 32/197 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++ LG G G V+L +G+ A+K + K + + R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ LY F+ + + L+ +YC GG+LF LL ++ L ED RFY +++ ALEYLH +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GI++RDLKPEN+LL +GHV L DF L+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLAR---------------------------QLDP 149
Query: 854 PMRASNSFVGTEEYIAP 870
+ +FVGT EY+AP
Sbjct: 150 GEKL-TTFVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 7e-48
Identities = 74/191 (38%), Positives = 106/191 (55%), Gaps = 21/191 (10%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+ G G V L + +G +A+K + K M+ +N+V + ER+IL P+V LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
SFQ K ++ L+ +Y PGG+L LL+ L ED R Y AE+V+ALEYLH GII+RD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKP+N+L+ NGH+ LTDF LS + + Q+ L ++ +R
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR------------------ 160
Query: 860 SFVGTEEYIAP 870
VGT +YIAP
Sbjct: 161 -IVGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 9e-48
Identities = 67/147 (45%), Positives = 93/147 (63%), Gaps = 2/147 (1%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
F IK LG+G G V LV GSG+Y+A+K + K ++ +V E+ IL + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
PF+ LY SFQ +++ L+ +Y PGGELF L + + E RFYAA+VV+ALEYLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDF 818
I+YRDLKPEN+LL +G++ +TDF
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-46
Identities = 69/201 (34%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP 732
F+ K +G G +V L + + + +A+K +DK ++ KV E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ LY +FQ + ++ + +Y P GEL + + + L E RFYAAE+++ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHS 120
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL---TSCKPQLLLPTTNEKKRRHKGQQNPV 849
+GII+RDLKPEN+LL + H+ +TDF + + S TN + K ++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF- 179
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
SFVGT EY++P
Sbjct: 180 ---------ASFVGTAEYVSP 191
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 81/206 (39%), Positives = 112/206 (54%), Gaps = 18/206 (8%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK +G G G V LV +GQ +AMK + K M+ RN++ AER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ LY SFQ + H+ L+ +Y PGG+L LL R+ V E+ RFY AE+V+AL+ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS---------CLTSCKPQLLLPTTNEKKRRHKG 844
G I+RD+KP+N+L+ +GH+ L DF L LL N RR
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAP 870
+Q V +NS VGT +YIAP
Sbjct: 181 KQRRVR-------ANSTVGTPDYIAP 199
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 67/197 (34%), Positives = 94/197 (47%), Gaps = 30/197 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++ LGSG G+V+ + G+G+ A+K + K K A E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L +F+ K H+ L+ +YC GG+LF L R L ED + A +++ LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GII+RDLKPEN+LL NG V + DF L+ L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---------------------- 155
Query: 854 PMRASNSFVGTEEYIAP 870
+FVGT Y+AP
Sbjct: 156 -----TTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 71/192 (36%), Positives = 102/192 (53%), Gaps = 32/192 (16%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V LV++ + FA+K + K ++ + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 740 SFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+F+ K ++ ++ +YC GGEL+ +L DR + E RFY A VV+A EYLH +GIIYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLKPEN+LL NG+V L DF + K K +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFG--------------FAKKLKSGQK--------------T 149
Query: 859 NSFVGTEEYIAP 870
+F GT EY+AP
Sbjct: 150 WTFCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-40
Identities = 80/203 (39%), Positives = 113/203 (55%), Gaps = 26/203 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK + +G G+V+LV + Q FAMK ++K ++ RN++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +++ SF+TK H+C++ +Y GG+ LL L D R Y AE V+ALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNY 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN------EKKRRHKGQQN 847
GI++RDLKP+N+L+ GH+ LTDF LS K L+ TTN EK R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMSLTTNLYEGHIEKDTRE----- 170
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
F+ GT EYIAP
Sbjct: 171 --FL------DKQVCGTPEYIAP 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-39
Identities = 60/144 (41%), Positives = 84/144 (58%), Gaps = 3/144 (2%)
Query: 449 DDDYESDDERPDSVDD--KVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDS 506
R SVD+ + R I A +E ++TDP PDNPI+FA+ +
Sbjct: 3 SPPEPRPHGRAPSVDESAAGDVSDHRSDIFFAA-VETTRMPMIVTDPNQPDNPIVFANRA 61
Query: 507 FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 566
FLE+T Y+ EEI+G NCRFLQGPETD ATV ++R AI + ++ +++NY K G FWN
Sbjct: 62 FLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEILNYRKDGSSFWNA 121
Query: 567 FHLQPMRDQKGEVQYFIGVQLDGS 590
+ P+ + G++ YF G QLD S
Sbjct: 122 LFVSPVYNDAGDLVYFFGSQLDVS 145
|
Length = 540 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 66/198 (33%), Positives = 102/198 (51%), Gaps = 30/198 (15%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
HF ++ +G G G V +V+ + + FAMK M+K + + V ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L+ SFQ + ++ L+ D GG+L L ++ E+ V+F+ E+V+ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GII+RD+KP+N+LL GHV +TDF+++
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT----------------------------KV 150
Query: 853 EPMRASNSFVGTEEYIAP 870
P + S GT Y+AP
Sbjct: 151 TPDTLTTSTSGTPGYMAP 168
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 64/192 (33%), Positives = 89/192 (46%), Gaps = 31/192 (16%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G+V+L +G+ A+K + K + + + E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
F+ + H+ L+ +YC GG L LL K L ED + +++ LEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 800 LKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
LKPEN+LL NG V L DF LS +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSK---------------------------LLTSDKSLL 150
Query: 859 NSFVGTEEYIAP 870
+ VGT Y+AP
Sbjct: 151 KTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-38
Identities = 56/125 (44%), Positives = 76/125 (60%)
Query: 467 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 526
R G +E+ ITDP PD PI+ A+ +FL+LT Y+ EE++GRNCRFL
Sbjct: 35 RDFRGASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFL 94
Query: 527 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQ 586
QG TDP V KIRAAI + ++ V+L+NY K G+ FWN HL P+ + G + YF G Q
Sbjct: 95 QGAATDPIAVAKIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQ 154
Query: 587 LDGSE 591
D ++
Sbjct: 155 WDVTD 159
|
Length = 361 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 80/198 (40%), Positives = 109/198 (55%), Gaps = 33/198 (16%)
Query: 677 IKPLGSGDTGSVHLVE-LCGS--GQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHP 732
+K LG G G V V + G+ G+ FAMK + K ++ N+ AER IL+ + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L +FQT + LI +Y GGELF+ L+R+ + ED FY +E+ +ALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
QGIIYRDLKPEN+LL GHV LTDF L CK + H+G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL-----CKESI-----------HEGT------- 155
Query: 853 EPMRASNSFVGTEEYIAP 870
+++F GT EY+AP
Sbjct: 156 ----VTHTFCGTIEYMAP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 74/210 (35%), Positives = 108/210 (51%), Gaps = 35/210 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--- 730
FR + LG G G V L E +G+ +A+KA+ KG ++ R++V E+ I + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HPF+ L+A FQT+ HVC + +Y GG+L + + V E FYAA VV+ L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H I+YRDLK +N+LL G V + DF L CK
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEG--------------------- 151
Query: 851 MAEPMRASNSFVGTEEYIAP--VSDFAYTR 878
M R S +F GT E++AP +++ +YTR
Sbjct: 152 MGFGDRTS-TFCGTPEFLAPEVLTETSYTR 180
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 72/196 (36%), Positives = 106/196 (54%), Gaps = 36/196 (18%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML--DHPFV 734
+KP+ G GSV+L + +G YFA+K + K M+ +N+V AER I+ M+ + P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM-MIQGESPYV 59
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
LY SFQ+K ++ L+ +Y GG+ L+ + L ED + Y AEVV+ +E LH +G
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 854
II+RD+KPEN+L+ GH+ LTDF LS G +N
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS--------------------RNGLENK------ 151
Query: 855 MRASNSFVGTEEYIAP 870
FVGT +Y+AP
Sbjct: 152 -----KFVGTPDYLAP 162
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 5e-37
Identities = 78/214 (36%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK +G G G V LV+ +G +AMK + K ML + +V AER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V LY SFQ + ++ LI +Y PGG++ LL ++ T E+ RFY AE ++A++ +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR---HKGQQNPVF 850
G I+RD+KP+N+LL GH+ L+DF L C L E R F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGL-----CTG-LKKSHRTEFYRILSHALPSNFLDF 174
Query: 851 MAEPM----RASN----------SFVGTEEYIAP 870
+++PM +A S VGT +YIAP
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAP 208
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 52/113 (46%), Positives = 72/113 (63%), Gaps = 3/113 (2%)
Query: 198 LSTFQQT---FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVA 254
+QT ++D +PD PI+ A+ F +TGY ++EVVGRNCRFLQGA TDP VA
Sbjct: 46 EQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVA 105
Query: 255 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
KIR + + LLNY+KDG PFWN L + P+ ++G++L F G Q +V+
Sbjct: 106 KIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVT 158
|
Length = 361 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 69/194 (35%), Positives = 101/194 (52%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
K LG G G V L EL G+ + +A+K + K V+L + V E+ +L + HPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L++ FQTK + + +Y GG+L + R E RFYAAE+V+ L++LH +GII
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +NVLL GH+ + DF + CK +L T
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVT--------------------- 152
Query: 857 ASNSFVGTEEYIAP 870
+++F GT +YIAP
Sbjct: 153 -TSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-36
Identities = 74/193 (38%), Positives = 101/193 (52%), Gaps = 29/193 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RDLK EN++L +GH+ +TDF L CK + T
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGISDGAT---------------------- 151
Query: 858 SNSFVGTEEYIAP 870
+F GT EY+AP
Sbjct: 152 MKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 74/194 (38%), Positives = 100/194 (51%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L + G+++A+K + K +L + + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GHV LTDF L CK + E +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGI----------------------EHSK 151
Query: 857 ASNSFVGTEEYIAP 870
+++F GT EY+AP
Sbjct: 152 TTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 78/203 (38%), Positives = 106/203 (52%), Gaps = 35/203 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDML 729
F ++ LG+G G V LV G +G+ +AMK + K ++ + K ER++L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 730 DH-PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVAL 787
PF+ L+ +FQT T + LI DY GGELF L R+ E VR Y AE+V+AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
++LH GIIYRD+K EN+LL GHV LTDF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS-------------------------- 152
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
F+AE + SF GT EY+AP
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 81/226 (35%), Positives = 116/226 (51%), Gaps = 36/226 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPA 736
+G G G V+ V + + +AMK + K ++ + +V ER IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L SFQT + + L+TDY GGELF L Q ED +FY AE+V+ALE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GH++L DF LS K L T N+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-----KANL---TDNK------------------- 151
Query: 857 ASNSFVGTEEYIAP---VSDFAYTRMTRYNYL-ILVSKKFMEFQPF 898
+N+F GT EY+AP + + YT+ + L +LV + + PF
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 71/193 (36%), Positives = 105/193 (54%), Gaps = 29/193 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
+FQT +C + +Y GGELF L R+ +V E+ RFY AE+V ALEYLH + ++Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RD+K EN++L +GH+ +TDF L CK + ++ +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL-----CKEGI----SDGATMK---------------- 153
Query: 858 SNSFVGTEEYIAP 870
+F GT EY+AP
Sbjct: 154 --TFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-35
Identities = 77/228 (33%), Positives = 109/228 (47%), Gaps = 46/228 (20%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F IK +G G G V LV + +AMK + K +L RN+ AER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+V LY SFQ K ++ + DY PGG++ LL R + +ED RFY AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDL------------------------------SC 822
G I+RD+KP+N+L+ +GH+ LTDF L S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ C+ + L +RR K Q ++S VGT YIAP
Sbjct: 180 IDRCRLKPL-------ERRRKRQHQRC-------LAHSLVGTPNYIAP 213
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 736
K LG G G V L EL G+ ++FA+KA+ K V+L + V ER +L + +HPF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ +FQTK H+ + +Y GG+L + Q + E RFYAAE++ L++LH +GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +NVLL +GH+ + DF + CK +
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGK--------------------- 152
Query: 857 ASNSFVGTEEYIAP 870
+++F GT +YIAP
Sbjct: 153 -ASTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 79/197 (40%), Positives = 112/197 (56%), Gaps = 33/197 (16%)
Query: 677 IKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+K LG G G V LV ++ G +GQ +AMK + K + R++V R ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V+FY AE+ +AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GIIYRDLKPEN+LL GH+ LTDF LS +EKK
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS---------KESIDHEKK-------------- 154
Query: 854 PMRASNSFVGTEEYIAP 870
+ SF GT EY+AP
Sbjct: 155 ----AYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-33
Identities = 76/194 (39%), Positives = 100/194 (51%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L + G ++A+K + K +L + + + AER +L L HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + DY GGELF L R+ + E RFYAAEV A+ YLH II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GHV LTDF L CK + EP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGV----------------------EPEE 151
Query: 857 ASNSFVGTEEYIAP 870
+++F GT EY+AP
Sbjct: 152 TTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 65/169 (38%), Positives = 93/169 (55%), Gaps = 15/169 (8%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709
+ D+ WK L F + LG+G G V + + G+G+Y+A+K + K
Sbjct: 9 KPDTSSWK-------------LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE 55
Query: 710 MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 769
+L +V E+ IL L HPF+ + SFQ + V + ++ GGELF L R+ +
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGR 114
Query: 770 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
D +FY AE+V+A EYLH + IIYRDLKPEN+LL GHV +TDF
Sbjct: 115 -FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDF 162
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 56/147 (38%), Positives = 82/147 (55%), Gaps = 2/147 (1%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
IK +G+G G VHLV S Y+A+K M ++ + E+ +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
PF+ L+ + + + ++ +Y PGGELF L + + FYA+E+V ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ I+YRDLKPEN+LL GH+ LTDF
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 82/218 (37%), Positives = 114/218 (52%), Gaps = 31/218 (14%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV SG+Y+AMK + K V++ +++V E +L HPF+ +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
SFQTK +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
RDLK EN++L +GH+ +TDF L CK + T +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGITDAATMK-------------------- 153
Query: 858 SNSFVGTEEYIAP--VSDFAYTRMTRYNYLILVSKKFM 893
+F GT EY+AP + D Y R + L +V + M
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-32
Identities = 75/218 (34%), Positives = 113/218 (51%), Gaps = 24/218 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F +K +G G G V LV+ +G+ +AMK + K M ++++ AER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +LY SFQ ++ LI ++ PGG+L +L + T ED RFY AE V+A+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-----LTSCKPQLLLPTTNEKKRRHKGQQNP 848
G I+RD+KP+N+L+ GH+ L+DF LS S Q LL K R + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL-QGKSNKNRIDNRNSV 179
Query: 849 VFMAEPMRASN----------------SFVGTEEYIAP 870
+ + S+ S VGT +YIAP
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAP 217
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 75/202 (37%), Positives = 107/202 (52%), Gaps = 33/202 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNK-VHRACAEREILDML 729
F +K LG+G G V LV +G+ +AMK + K ++ + K V ER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 730 -DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
PF+ L+ +FQT+ + LI DY GGE+F L ++ ED VRFY+ E+++ALE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+LH GI+YRD+K EN+LL GHV LTDF LS
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS--------------------------K 153
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
F++E + SF GT EY+AP
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 34/202 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLD 730
+ IK +G G G V+LV G+ + +K +D + N ++ R A E IL L+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALE 788
HP + Y SF+ K +C++ +Y GG+L + +Q + E+ + + ++ +AL+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH + I++RD+KP+N+ L NG V L DF +S K +
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---------------------KVLSST 156
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
V +A + VGT Y++P
Sbjct: 157 VDLA------KTVVGTPYYLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 81/219 (36%), Positives = 117/219 (53%), Gaps = 32/219 (14%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GII 796
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH + ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK EN++L +GH+ +TDF L CK +G ++ M
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL-----CK---------------EGIKDGATM----- 153
Query: 857 ASNSFVGTEEYIAP--VSDFAYTRMTRYNYLILVSKKFM 893
+F GT EY+AP + D Y R + L +V + M
Sbjct: 154 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-31
Identities = 52/123 (42%), Positives = 73/123 (59%), Gaps = 5/123 (4%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
I D LPD P+I+ +D+F +T YS +E+LGRNCRFLQG +T+ V ++R AID +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 549 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEES 608
+V+L NY K G FWN + P+RD+ G V +++G Q D +E R A E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTE-----RKEAELALQRER 276
Query: 609 EKL 611
KL
Sbjct: 277 RKL 279
|
Length = 665 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 68/194 (35%), Positives = 103/194 (53%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
K LG G G V L EL G+ Q+FA+KA+ K V+L + V E+ +L + +HPF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LY +FQTK ++ + +Y GG+L + Q FYAAE++ L++LH +GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +N+LL +GH+ + DF + CK +L + K
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM-----CKENML----GDAK----------------- 152
Query: 857 ASNSFVGTEEYIAP 870
+ +F GT +YIAP
Sbjct: 153 -TCTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 7e-31
Identities = 48/106 (45%), Positives = 73/106 (68%)
Query: 206 VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 265
++DAT PD P++Y + F ++TGY+ EV+GRNCRFLQG T+ E VA++RE + +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 266 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
L NY+KDG+ FWN + IAPI+D++G V ++G Q +V++ E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267
|
Length = 665 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 49/118 (41%), Positives = 79/118 (66%)
Query: 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 250
SDI A+ T + +V+D +PD PI++A+ F +MTGY ++E++G NCRFLQG TD
Sbjct: 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDR 88
Query: 251 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
VA++R+ + + +LNY+KDG+ FWN L ++P+ +D G ++ F G Q++VS+
Sbjct: 89 ATVAEVRDAIAERREIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSR 146
|
Length = 540 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 74/194 (38%), Positives = 99/194 (51%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L + G+ +A+K + K ++LNR + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + D+ GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GHV LTDF L CK + T
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDT--------------------- 152
Query: 857 ASNSFVGTEEYIAP 870
+ +F GT EY+AP
Sbjct: 153 -TTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 32/198 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F+ + +G G G V L + +G+ A+K M K ++ N+V ER+IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
++ L +FQ ++ L +Y PGG+ LL+ VL ED RFY AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
G I+RDLKPEN L+ +GH+ LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS------------------------------K 149
Query: 853 EPMRASNSFVGTEEYIAP 870
+ +NS VG+ +Y+AP
Sbjct: 150 GIVTYANSVVGSPDYMAP 167
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 70/194 (36%), Positives = 98/194 (50%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 736
K LG G G V L EL G+ + +A+K + K V+L + V E+ IL + HPF+ A
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ FQTK + + +Y GG+L + Q ++ E RFYAAEV +AL +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLK +N+LL GH L DF + CK +L
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM-----CKEGIL----------------------NGV 151
Query: 857 ASNSFVGTEEYIAP 870
+ +F GT +YIAP
Sbjct: 152 TTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 66/191 (34%), Positives = 98/191 (51%), Gaps = 27/191 (14%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V +V +G +AMK M K V+L + V ER+IL + + P++P L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+FQ K ++ L+ +Y PGG+L LL+R + ED +FY AE+V+A+ +H G ++RD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
+KPENVL+ GH+ L DF + + A M S
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--------------------------ANKMVNSK 161
Query: 860 SFVGTEEYIAP 870
VGT +YIAP
Sbjct: 162 LPVGTPDYIAP 172
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 39/104 (37%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
++ DP D I++A+D+ L L Y+REE+LG++ R L GP D V ++R A+ N
Sbjct: 1 ILVLDP---DGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+V V+L K G+ F L P+RD+ GEV +G+ D +E
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 78/203 (38%), Positives = 111/203 (54%), Gaps = 33/203 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDM 728
+F +K LG+G G V LV ++ G SG+ +AMK + K ++ + K ER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 729 LDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ PF+ L+ +FQT T + LI DY GGELF L ++ + KE V+ Y+ E+V+AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLAL 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
E+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------------------------- 152
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
F + + + SF GT EY+AP
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 71/199 (35%), Positives = 108/199 (54%), Gaps = 31/199 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC--AEREILDMLDH 731
F +K +G G G V +V++ +GQ +AMK ++K ML R + AC ER++L D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET--ACFREERDVLVNGDR 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVH 119
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
G ++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLR-------------------------LL 153
Query: 852 AEPMRASNSFVGTEEYIAP 870
A+ SN VGT +YI+P
Sbjct: 154 ADGTVQSNVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 70/194 (36%), Positives = 97/194 (50%), Gaps = 30/194 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
K +G G G V L +++A+K + K +L + + +ER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKPEN+LL GH+ LTDF L CK + E
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL-----CKENI----------------------EHNG 151
Query: 857 ASNSFVGTEEYIAP 870
+++F GT EY+AP
Sbjct: 152 TTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-29
Identities = 60/154 (38%), Positives = 92/154 (59%), Gaps = 2/154 (1%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ F +KP+ G G V+L + + +A+K + K M+N+N VH+ AER+ L +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
PF+ LY S Q+ +V L+ +Y GG++ LL E+ Y +EV +AL+YL
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYL 120
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824
H GII+RDLKP+N+L+ GH+ LTDF LS +T
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-29
Identities = 64/147 (43%), Positives = 89/147 (60%), Gaps = 2/147 (1%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK LG G G V L + +AMK + K +LNRN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V LY SFQ K ++ + DY PGG++ LL R +V E RFY AE+ +A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDL 820
G I+RD+KP+N+L+ +GH+ LTDF L
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 50/143 (34%), Positives = 80/143 (55%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V ++ +G+ +A K +DK + R A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+F+TK +CL+ GG+L + E FYAA+++ LE+LH + I+YRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 800 LKPENVLLQGNGHVSLTDFDLSC 822
LKPENVLL +G+V ++D L+
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 73/195 (37%), Positives = 107/195 (54%), Gaps = 32/195 (16%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
K LG G G V L EL G G+YFA+KA+ K V+L + V E+ +L + ++PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 737 LYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
LY +FQTK H+ + ++ GG+L F + D+ + + FYAAE+V L++LH +GI
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR---ATFYAAEIVCGLQFLHSKGI 117
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
IYRDLK +NV+L +GH+ + DF + CK + G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVF------------GDN--------- 151
Query: 856 RASNSFVGTEEYIAP 870
RAS +F GT +YIAP
Sbjct: 152 RAS-TFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 63/147 (42%), Positives = 87/147 (59%), Gaps = 2/147 (1%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK LG G G V L + +AMK + K +L RN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V LY SFQ K ++ + DY PGG++ LL R + ED RFY AE+ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDL 820
G I+RD+KP+N+L+ +GH+ LTDF L
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 76/211 (36%), Positives = 113/211 (53%), Gaps = 22/211 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+A +FY AE V+A++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNEKK 839
G I+RD+KP+N+LL GHV L+DF L LT P N K+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ ++N +A S VGT +YIAP
Sbjct: 181 KAETWKKNRRQLAY------STVGTPDYIAP 205
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-28
Identities = 58/162 (35%), Positives = 91/162 (56%), Gaps = 5/162 (3%)
Query: 657 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
KA +KI ++ + F IK +G G G V LV S Q +AMK + K M+ R+
Sbjct: 30 KAAEKITKL--RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 717 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 776
ER+I+ + ++ L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWA 144
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
RFY AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 74/213 (34%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+ +FY AE V+A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNE 837
G I+RD+KP+N+LL GHV L+DF L L P N
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K++ ++N +A S VGT +YIAP
Sbjct: 179 KRKAETWKRNRRQLA------FSTVGTPDYIAP 205
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 68/192 (35%), Positives = 97/192 (50%), Gaps = 30/192 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738
LG G G V L L SG+ +A+K + K V+L + V E+ IL + +HPF+ LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
FQT + + ++ GG+L + Q ++ E RFYAAE+ AL +LH +GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL GH L DF + CK + G + +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGI-----------FNG-----------KTT 153
Query: 859 NSFVGTEEYIAP 870
++F GT +YIAP
Sbjct: 154 STFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 31/201 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V V + + +A+K + K +++R++V AER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
SFQ+ + L+ + GGELF L R+ RFY AE++ ALE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LKPEN+LL GH++L DF L CK L ++ K +N
Sbjct: 119 LKPENILLDYQGHIALCDFGL-----CK----LNMKDDDK------------------TN 151
Query: 860 SFVGTEEYIAP--VSDFAYTR 878
+F GT EY+AP + YT+
Sbjct: 152 TFCGTPEYLAPELLLGHGYTK 172
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 30/198 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 732
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGM-----CKENIFGGKT----------------- 157
Query: 853 EPMRASNSFVGTEEYIAP 870
+ +F GT +YIAP
Sbjct: 158 -----TRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 30/192 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738
+G G V LVEL + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ FQT++ + + ++ GG+L + RQ + L E+ RFY+AE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL GH+ LTD+ + CK + P +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGI----------------------RPGDTT 153
Query: 859 NSFVGTEEYIAP 870
++F GT YIAP
Sbjct: 154 STFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLD 730
+ + LG G GSV+L +G+ A+K+++ L+ + A E IL L
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEALEREIRILSSLQ 57
Query: 731 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
HP + Y S + + + + +Y GG L LL + L E +R Y +++ L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLA 115
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH GI++RD+K N+L+ +G V L DF + KR +
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA-----------------KRLGDIETGE 158
Query: 849 VFMAEPMRASNSFVGTEEYIAP--VSDFAYTR 878
+ S GT ++AP + Y R
Sbjct: 159 --------GTGSVRGTPYWMAPEVIRGEEYGR 182
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 37/104 (35%), Positives = 66/104 (63%), Gaps = 3/104 (2%)
Query: 205 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 264
+V D PD I+YA+ ++ GYT +E++G++ R L G G D E VA++RE L+NG
Sbjct: 1 ILVLD---PDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 265 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
L +KDG PF L++ +P++D++G+V+ +G+ ++++
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 7e-26
Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 27/201 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+R ++ LG G G V+L + A+K + K + +V R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 733 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYL 790
+ LY FQ + + L+ +Y GG L LL + K L E F A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 791 HCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
H +GII+RD+KPEN+LL +G V L DF L+ L +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP---------------------DPG 156
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
+ ++ VGT Y+AP
Sbjct: 157 STSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-25
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 32/198 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F ++ +G G G V+ +G+ A+K + + K+ E +IL HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ Y S+ K + ++ ++C GG L LL + L E + + E++ LEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS 116
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
GII+RD+K N+LL +G V L DF LS QL
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA------QL---------------------- 148
Query: 853 EPMRASNSFVGTEEYIAP 870
+A N+ VGT ++AP
Sbjct: 149 SDTKARNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-25
Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 30/192 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALY 738
+G G V LV L + Q +AMK + K ++ + + E+ + + +PF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ FQT + + L+ +Y GG+L + RQ + L E+ RFYAAE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL +GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGL----------------------GPGDTT 153
Query: 859 NSFVGTEEYIAP 870
++F GT YIAP
Sbjct: 154 STFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-25
Identities = 58/150 (38%), Positives = 89/150 (59%), Gaps = 2/150 (1%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F IK +G G G V +V++ + + +AMK ++K ML R + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A+ +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
++RD+KP+NVLL NGH+ L DF SCL
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCL 150
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 30/198 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 732
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ V L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GIIYRDLK +NV+L GH+ + DF + CK ++ T
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVT----------------- 157
Query: 853 EPMRASNSFVGTEEYIAP 870
+ +F GT +YIAP
Sbjct: 158 -----TRTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 64/192 (33%), Positives = 100/192 (52%), Gaps = 30/192 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738
+G G V LV L + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
DLK +NVLL GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTT 153
Query: 859 NSFVGTEEYIAP 870
++F GT YIAP
Sbjct: 154 STFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 61/187 (32%), Positives = 101/187 (54%), Gaps = 9/187 (4%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDK 707
+KDS K ++ ++ + F I+ LG+G G V L + + A+K +K
Sbjct: 12 KKDSDSTKEPKR----KNKMKYEDFNFIRTLGTGSFGRVILATY-KNEDFPPVAIKRFEK 66
Query: 708 GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 767
++ + +V +ER+IL+ ++HPF LY SF+ ++++ L+ ++ GGE F L R
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN- 125
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
K D FYAA++V+ EYL I+YRDLKPEN+LL +G + +TDF + + +
Sbjct: 126 -KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 828 PQLLLPT 834
L T
Sbjct: 185 TYTLCGT 191
|
Length = 340 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 56/162 (34%), Positives = 93/162 (57%), Gaps = 5/162 (3%)
Query: 657 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
K ++KI Q+ + + +K +G G G V LV S + +AMK + K M+ R+
Sbjct: 30 KIVRKI--RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 717 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 776
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWA 144
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+FY AEVV+AL+ +H G+I+RD+KP+N+LL +GH+ L DF
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/194 (32%), Positives = 96/194 (49%), Gaps = 34/194 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 736
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ +F T + I D GG+L L + V E +RFYAAE+++ LE++H + ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPH-------------- 153
Query: 857 ASNSFVGTEEYIAP 870
AS VGT Y+AP
Sbjct: 154 AS---VGTHGYMAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 65/199 (32%), Positives = 105/199 (52%), Gaps = 27/199 (13%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F +K +G G G V +V+L + + FAMK ++K ML R + ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
++RD+KP+N+L+ NGH+ L DF SCL M
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLK-------------------------LM 153
Query: 852 AEPMRASNSFVGTEEYIAP 870
+ S+ VGT +YI+P
Sbjct: 154 EDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 49/142 (34%), Positives = 83/142 (58%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V V++ +G+ +A K +DK + ++ A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+F++KTH+CL+ GG+L + + L+ + V Y+A++ + +LH I+YRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 800 LKPENVLLQGNGHVSLTDFDLS 821
+KPENVLL G+ L+D L+
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 51/148 (34%), Positives = 82/148 (55%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +L +++TK +CL+ GG+L + E+ FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I+YRDLKPEN+LL GH+ ++D L+
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 50/148 (33%), Positives = 82/148 (55%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V L +++TK +CL+ GG+L + +E+ FYAAE++ LE LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+YRDLKPEN+LL GH+ ++D L+
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 51/146 (34%), Positives = 82/146 (56%), Gaps = 5/146 (3%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 736
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ +F T +C I D GG+L L + V E +RFYA E+++ LE++H + ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSC 822
YRDLKP N+LL +GHV ++D L+C
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLAC 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-22
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 30/198 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 732
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENMWDGVT----------------- 157
Query: 853 EPMRASNSFVGTEEYIAP 870
+ +F GT +YIAP
Sbjct: 158 -----TKTFCGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 3e-22
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 31/212 (14%)
Query: 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
I KI D ++ + + +K +G G G V LV + + +AMK + K M+ R+
Sbjct: 32 INKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RF
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARF 146
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
Y AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+ K
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNK----------- 194
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
E M ++ VGT +YI+P
Sbjct: 195 --------------EGMVRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 5e-21
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V ++ +G+ +A K ++K + R A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 740 SFQTKTHVCLITDYCPGGEL----FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
+FQTKT +CL+ GG+L + + + P E FY A+++ LE+LH + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
IYRDLKPENVLL +G+V ++D L+ + L K + + G P FMA +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLA--------VELKDGQSKTKGYAG--TPGFMAPEL 168
Query: 856 RASNSFVGTEEYIAPVSDFA 875
+ EEY V FA
Sbjct: 169 ------LQGEEYDFSVDYFA 182
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-21
Identities = 51/148 (34%), Positives = 83/148 (56%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +L +++TK +CL+ GG+L + +E FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I+YRDLKPEN+LL +GH+ ++D L+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 45/140 (32%), Positives = 73/140 (52%), Gaps = 5/140 (3%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-EREILDMLDHPFVPALY 738
+G G G V+ +G+ A+K + + N K + A E ++L++L HP + Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
+ V + +YC GG L LL+ ++L E +R Y +++ L YLH GI++R
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 799 DLKPENVLLQGNGHVSLTDF 818
D+KP N+ L NG + L DF
Sbjct: 124 DIKPANIFLDHNGVIKLGDF 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 45/150 (30%), Positives = 81/150 (54%), Gaps = 3/150 (2%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F+ +K LG G GSV+ V+ Q++A+K +D G M ++ + A E IL ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPN 60
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLH 791
+ + +F +C++ +Y P G+L + ++ K++ E + +++ L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
Q I++RDLK N+LL N V + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 50/148 (33%), Positives = 79/148 (53%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
FR + LG G G V ++ +G+ +A K ++K + R A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +L +++TK +CL+ GG+L + E FYAAE+ LE L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I+YRDLKPEN+LL GH+ ++D L+
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 32/199 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+K LG G +G V+ V +G+ +A+K + + + E + L + P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+V Y +F + + ++ +Y GG L LL + + E + + A +++ L+YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHT 117
Query: 793 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ II+RD+KP N+L+ G V + DF +S +L T ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQC------------ 157
Query: 852 AEPMRASNSFVGTEEYIAP 870
N+FVGT Y++P
Sbjct: 158 -------NTFVGTVTYMSP 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
A++ I+ G+ L ++ ++ +G G +G V+ +G+ A+K M L +
Sbjct: 7 ALKDIVSEGDPREL--YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKE 60
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 777
E I+ HP + Y S+ + ++ +Y GG L ++ + + + E +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIA 119
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+ EV+ LEYLH Q +I+RD+K +N+LL +G V L DF + QL T E
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA------QL----TKE 169
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K +R NS VGT ++AP
Sbjct: 170 KSKR-----------------NSVVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ LG+G++G V V +G+ A+K + + K + E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNS 58
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P++ Y +F + + +Y GG L +L + E + A V+ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLH 117
Query: 792 CQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ II+RD+KP N+L+ G + L DF +S
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LD 730
+ I+ +G G T V+ + + A+K +D L + + +E+ M +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCN 57
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 789
HP V Y SF + L+ Y GG L ++ P L E + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH G I+RD+K N+LL +G V + DF +S L +K R
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS------LADGGDRTRKVRK------- 164
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
+FVGT ++AP
Sbjct: 165 ----------TFVGTPCWMAP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC-AEREILDMLDHPFVPALY 738
+G G G V+ +G + A+K + + + + ++ E ++L L HP +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798
S +T + +I +Y G L ++ + E V Y +V+ L YLH QG+I+R
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 799 DLKPENVLLQGNGHVSLTDFDLS 821
D+K N+L +G V L DF ++
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA 146
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 60/199 (30%), Positives = 88/199 (44%), Gaps = 36/199 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
F ++ +G G G V+ + Q A+K +D L + ++EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P++ Y SF + + +I +YC GG LL L E + F EV++ LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+G I+RD+K N+LL G V L DF +S QL T+ KR
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS------GQL---TSTMSKR----------- 155
Query: 852 AEPMRASNSFVGTEEYIAP 870
N+FVGT ++AP
Sbjct: 156 -------NTFVGTPFWMAP 167
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 30/192 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V V + +AMK +D M NR + A E +L LD ++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV-RFYAAEVVVALEYLHCQGIIYR 798
SF K + ++ +Y G+L LL Q + L ED V RF+ ++++ L +LH + I++R
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGLAHLHSKKILHR 125
Query: 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 858
D+K N+ L +V + D ++ +LL TN +
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVA-------KLLSDNTN--------------------FA 158
Query: 859 NSFVGTEEYIAP 870
N+ VGT Y++P
Sbjct: 159 NTIVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREI--LDMLDHPFV 734
LGSG GSV+ G +FA+K + + + + + E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVS---LADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
+ + + ++ + + PGG L LL + E +R Y ++++ LEYLH +
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLS 821
++RD+K N+L+ NG V L DF ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 31/191 (16%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ + +G + A K + + ++ E +IL HP + LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
++ + + ++ ++C GG L ++ + + L E +R+ +++ AL +LH +I+RD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
LK N+LL +G V L DF +S + ++R
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK----------NKSTLQKRD----------------- 161
Query: 860 SFVGTEEYIAP 870
+F+GT ++AP
Sbjct: 162 TFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 49/153 (32%), Positives = 86/153 (56%), Gaps = 7/153 (4%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPAL 737
LG G G+V+LV+ + +K + + + LN N+ +A E ++L LDHP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
+ASF + C+IT+YC G +L L+ + K L E+ V + ++++ + Y+H + I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLT--SC 826
++RDLK +N+ L+ N + + DF +S L SC
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSC 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 734
+ +G G G V+ +G+ A+K + ++ A REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNHPNI 60
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
L F+ K + L+ ++ L+ DRQ + L E ++ Y +++ L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDL 820
I++RDLKPEN+L+ G + L DF L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 47/194 (24%), Positives = 90/194 (46%), Gaps = 29/194 (14%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
++ +G G G LV+ S Q +AMK + + + + V + E +L + HP + A
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
SF+ H+ ++ +YC GG+L + Q K+ ED + + ++ + ++++H + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
+RD+K +N+ L NG V L DF + L + P
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARL---------------------------LTSPGA 155
Query: 857 ASNSFVGTEEYIAP 870
+ ++VGT Y+ P
Sbjct: 156 YACTYVGTPYYVPP 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 37/145 (25%), Positives = 79/145 (54%), Gaps = 1/145 (0%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K +G G G LV+ G+ + +K ++ M + + + E +L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
SF+ ++ ++ DYC GG+L+ ++ Q + ED + + ++ +AL+++H + I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLS 821
+RD+K +N+ L +G + L DF ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 33/197 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ LG G GSV+ +GQ A+K V+ + E IL D P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQEIIKEISILKQCDSPY 59
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ Y S+ T + ++ +YC G + ++ + K L E+ + + + LEYLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
I+RD+K N+LL G L DF +S GQ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----------------------GQLT-----D 151
Query: 854 PMRASNSFVGTEEYIAP 870
M N+ +GT ++AP
Sbjct: 152 TMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ I+ +G G G VHL + +K + M +++ A E ++L +L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPN 60
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ Y +F + ++ +Y PGG L + ++ +L ED + + ++++AL ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 794 GIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCK 827
I++RDLK +N+LL + H V + DF +S + S K
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
++ +G G G+V V G+ K +D G M + K + +E IL L HP +
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 737 LYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC 792
Y ++ + ++ +YC GG+L L+ + + K ++E+ + ++++AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 793 QG-----IIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++RDLKP N+ L N +V L DF L+
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHR-ACAEREILDML 729
H+ PI+ LG G G L K ++ L R K R A E IL +L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN----LTRLSEKERRDALNEIVILSLL 56
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
HP + A Y F + + +Y GG L+ + RQ ++ +E+ V +Y ++V A+ Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+H GI++RD+K N+ L G + L DF +S
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 52/212 (24%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDML- 729
F ++ +G G G V+ +GQ A+K MD E EI ++L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILR 57
Query: 730 ---DHPFVPALYASFQTKTHVC------LITDYCPGGELFLLLD--RQPTKVLKEDAVRF 778
+HP + Y +F K L+ + C GG + L+ R+ K LKE+ + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
E + L YLH +I+RD+K +N+LL N V L DF +S L +T +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDSTLGR 169
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ N+F+GT ++AP
Sbjct: 170 R-------------------NTFIGTPYWMAP 182
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 39/204 (19%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREILDM 728
+ + I+ +GSG G V+ +G+ A+K ++ G + E +L
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKE 56
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVA 786
HP + A + S+ + + ++ +YC GG L + R P L E + + E +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKG 113
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
L YLH G I+RD+K N+LL +G V L DF +S QL T KR
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------QL---TATIAKR------ 158
Query: 847 NPVFMAEPMRASNSFVGTEEYIAP 870
SF+GT ++AP
Sbjct: 159 ------------KSFIGTPYWMAP 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 731
K LG G G V+ L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
P + L + + ++ +Y PGG+L +L +P ++ D + F A ++ +EY
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSF-ALQIARGMEY 118
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
L + I+RDL N L+ N V ++DF LS
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 41/148 (27%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
+ IK +G G G ++L + ++ +K +D M + K +++E+ L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMKH 58
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + +ASFQ + ++ +YC GG+L ++RQ + ED + + ++ + L+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 792 CQGIIYRDLKPENVLLQGNGHVS-LTDF 818
+ I++RD+K +N+ L NG V+ L DF
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 42/133 (31%), Positives = 69/133 (51%), Gaps = 14/133 (10%)
Query: 688 VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKT 745
V LV + Q F +K + K +R + L ++ H P + L+ ++
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSRER----------LTIIPHCVPNMVCLHKYIVSED 58
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
V L+ + GG+L+ + + + E+ V+ +AAE+VVAL+ LH +GI+ RDL P N+
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 806 LLQGNGHVSLTDF 818
LL GH+ LT F
Sbjct: 117 LLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 658 AIQKILDSGEQ-INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A+Q ++D G+ L +F I G G TG V + +G+ A+K MD R +
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQ 58
Query: 717 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
R E++ M D HP + +Y+S+ + ++ ++ GG L D + E+
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 115
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ V+ AL +LH QG+I+RD+K +++LL +G V L+DF
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
I LG G G V+ + +G A K ++ + ++ E EIL +HP++
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVK 73
Query: 737 LYASFQTKTHVCLITDYCPGGE---LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L +F + ++ ++CPGG + L LDR L E ++ +++ AL+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
II+RDLK NVLL +G + L DF +S
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 8/103 (7%)
Query: 723 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE--LFLLLDRQPTKVLKEDAVRF 778
REI L L HP + L T+ + L+ +YC + L LD++P L + ++
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP-LSPNLIKS 102
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ L Y H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-13
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLD 730
++ IK LG G GSV+L +G+ A+K M K RE + + +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L F+ + + +Y G L+ L+ + K E +R +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
H G +RDLKPEN+L+ G V + DF L+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 32/229 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD-KGVMLNRNKVHRA---CAEREI--LDMLDHPF 733
+GSG GSV+L SG+ A+K ++ V + R+ REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ S H+ + +Y PGG + LL+ +E VR + +++ L YLH +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
GII+RD+K N+L+ G + ++DF +S +L + + K +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS------KKLEANSLSTKTNGAR---------- 169
Query: 854 PMRASNSFVGTEEYIAP--VSDFAYTRMTR-YNYLILVSKKFMEFQPFP 899
S G+ ++AP V +YTR ++ LV + PFP
Sbjct: 170 -----PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 39/202 (19%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDM 728
++ ++ +G G G+V+ + +G+ A+K ++ L+ + +RE+ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQ 58
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
P + Y S+ + +I +Y GG + L+ P + E + EV+VAL+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALK 115
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
Y+H G+I+RD+K N+L+ G+V L DF ++ L N KR
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------NQNSSKR-------- 158
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
++FVGT ++AP
Sbjct: 159 ----------STFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 39/153 (25%), Positives = 61/153 (39%), Gaps = 15/153 (9%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV----MLNRNKVHRACAE--REILDM-- 728
K LG G G V+ G + L E E M
Sbjct: 4 GKKLGEGAFGEVYK------GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L HP + L + ++T+Y PGG+L L + K+ +D ++ A ++ +E
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGME 116
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YL + ++RDL N L+ N V ++DF LS
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 23/158 (14%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA------CAEREI-- 725
+ I +G G G V+ +G+ A+K + ++ A REI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKL 51
Query: 726 LDMLDHPFVPALY---ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
L L HP + L S + + ++ +Y +L LLD K E ++ Y +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGS-IYMVFEYMDH-DLTGLLDSPEVK-FTESQIKCYMKQ 108
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
++ L+YLH GI++RD+K N+L+ +G + L DF L
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 44/148 (29%), Positives = 80/148 (54%), Gaps = 6/148 (4%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 734
++ +G G G V LV G+ + +K ++ + N ++ R AE+E +L L HP +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 735 PALYASFQTKTHVCLIT-DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
A S++ + + I +C GG+L+ L Q K+L E+ V + ++ +AL+YLH +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I++RDLK +NV L + + D ++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIA 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 731
K LG G G V+ +L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
P V L + + ++ +Y GG+L +L R+ L + +A ++ +EY
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
L + I+RDL N L+ N V ++DF LS
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 31/92 (33%), Positives = 56/92 (60%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+YA+ F ++TGYT +E++G+N L T PE + +L + + G+LLN +KD
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
G + LT+AP+ ++ G+ F+GM ++++
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 50/152 (32%), Positives = 71/152 (46%), Gaps = 18/152 (11%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G GSV L +G FA+K + D L + + E EI P++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCKSPYIVKY 64
Query: 738 YASF--QTKTHVCLITDYCPGGELFLLLDRQPTKVLK------EDAVRFYAAEVVVALEY 789
Y +F ++ + + + +YC GG L D KV K E + A V+ L Y
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
LH + II+RD+KP N+LL G V L DF +S
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 3/146 (2%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G G V + +G+ A+K + L ++A E + L HP+V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
F + L+ +Y P +L D + + L E V+ Y ++ + Y+H GI++RD
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 800 LKPENVLLQGNGHVSLTDFDLSCLTS 825
LKP N+L+ +G + + DF L+ L S
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFS 150
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 49/144 (34%), Positives = 75/144 (52%), Gaps = 4/144 (2%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G+ GSV+ V +G AMK + + L+ +K ++ E +IL P++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 740 SFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIY 797
+F + V + +Y G L L T+ + ED +R VV L++L + II+
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 798 RDLKPENVLLQGNGHVSLTDFDLS 821
RD+KP NVL+ GNG V L DF +S
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD- 730
+ F I+ +GSG G V+ +G+ A+K V+ A ++EI+ M D
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDC 63
Query: 731 -HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
H + A + S+ + + + ++C GG L + T L E + + + E + L Y
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYY 121
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
LH +G ++RD+K N+LL NGHV L DF +S
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 9/153 (5%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ I LG+G+ GSV V+ +G A K + G + K + E +I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRS 62
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALEY 789
P++ + Y +F + ++C+ ++ G L DR K + + + A VV L Y
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 790 LH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L+ I++RD+KP N+L+ G + L DF +S
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMK-------AMDKGVMLNRNKVHRACAEREILDMLDHP 732
+G G G V+L +G+ A+K + ++ V +E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 733 FVPALYASFQTK-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+ Y F+T ++ + +Y PGG + L R + +E VRF+ +V+ L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+GI++RDLK +N+L+ +G ++DF +S
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 12/166 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML 729
+ P+ +G G G+V+ SG + A+K++ V N + + R A + L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAF 59
Query: 730 DHPFVPALY---ASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
DHP + L A+ +T +T V L+ ++ +L LD+ P L + ++ + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
L++LH I++RDLKPEN+L+ G V L DF L+ + SC+ L
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 20/159 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREI--LDMLD 730
+ K LG G V+ +G+ A+K + G ++ A REI L L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELK 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV------- 783
HP + L F K+++ L+ ++ D + KV+K+ ++ A++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------DLE--KVIKDKSIVLTPADIKSYMLMT 111
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
+ LEYLH I++RDLKP N+L+ +G + L DF L+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
++ D D I++A+ + +L YS EE++G++ L PE ++ +
Sbjct: 5 VIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGE 61
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
VT+++ K G W L L P+RD+ GEV +GV D
Sbjct: 62 PVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDMLDHPFV 734
+G G G+V+ +G++ A+K + V L+ + + REI L+ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTL-REIALLKQLESFEHPNI 63
Query: 735 PALYASFQTK-----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
L + L+ ++ +L L + P L + ++ +++ +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDL-------SCLTSC 826
LH I++RDLKP+N+L+ +G V + DF L LTS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 38/118 (32%), Positives = 61/118 (51%), Gaps = 4/118 (3%)
Query: 714 NKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVL 771
++ + A RE+ L L H + L +F+ K + L+ +Y L LL+ P L
Sbjct: 40 DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-L 97
Query: 772 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
DAVR Y +++ A+ Y H II+RD+KPEN+L+ +G + L DF + +P
Sbjct: 98 PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 12/144 (8%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKA--MDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G+ G+V+ + + A+K +D V L + + +E EIL D P++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM----SELEILYKCDSPYIIGF 64
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
Y +F + + + T++ GG L + + P VL AV VV L YL I++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAV-----AVVKGLTYLWSLKILH 118
Query: 798 RDLKPENVLLQGNGHVSLTDFDLS 821
RD+KP N+L+ G V L DF +S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 35/95 (36%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
M D+P LY S T LI DY G+LF LL ++ L E V+ ++V AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEAL 122
Query: 788 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLS 821
LH II+ D+K ENVL + + L D+ L
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 14/164 (8%)
Query: 658 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A+Q ++D G+ + L +F I G G TG V + + SG+ A+K MD R +
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQ 59
Query: 717 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 116
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ V+ AL LH QG+I+RD+K +++LL +G V L+DF
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 734 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ Y +F K+ + L+ ++C G + L+ LKED + + E++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L +LH +I+RD+K +NVLL N V L DF +S
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 658 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A++ ++D G+ + L+++ I G G TG V + SG+ A+K MD R +
Sbjct: 9 ALRMVVDQGDPRSLLENYIKI---GEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQ 60
Query: 717 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
R E++ M D H V +Y S+ + ++ ++ GG L ++ + L E+
Sbjct: 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEE 117
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ V+ AL YLH QG+I+RD+K +++LL +G V L+DF
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 6e-11
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 12/154 (7%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G G V+ +L G A+K + + + + E ++ L HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 735 PALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF-----YAAEVVVAL 787
L + + L+ +Y GG+L +L R ++ + +A ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
EYL + ++RDL N L+ + V ++DF LS
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L +F+ K +G G V+ G+ A+K + M++ E ++L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 788
HP V ASF + ++ + G+L ++ ++ +++ E + Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
++H + I++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
A++S VGT Y++P
Sbjct: 162 --------AAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 673 HFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNR--NKVHRACAER 723
H + IK LG G G V ELC +G+ A+K LN + HR+ ER
Sbjct: 5 HLKFIKQLGEGHFGKV---ELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFER 55
Query: 724 EILDM--LDHPFVPAL--YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
EI + LDH + + LI +Y P G L L R ++ + + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF- 114
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++++ ++YL Q I+RDL N+L++ V ++DF L+
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 42/202 (20%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 732
F + LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR---ELKVLHECNSP 59
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEY 789
++ Y +F + + + ++ GG L +L R P +L + ++ V+ L Y
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI-----AVLRGLTY 114
Query: 790 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 149
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
+ + M +NSFVGT Y++P
Sbjct: 150 --LIDSM--ANSFVGTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 729
++ + P+GSG G V +G+ A+K + + ++ +H R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHM 71
Query: 730 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
DH F PA +S + V L+T G +L ++ Q L +D ++F
Sbjct: 72 DHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVY 125
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
+++ L+Y+H GII+RDLKP N+ + + + + DF L+ T
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 29/202 (14%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L +FR K +G G V+ G A+K + +++ E ++L L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 788
HP V YASF + ++ + G+L ++ ++ +++ E V Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
A++S VGT Y++P
Sbjct: 162 --------AAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 1/142 (0%)
Query: 681 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 740
D VHL + + A+K ++ ++ + E L HP + S
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 741 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800
F + + +++ G LL + L E A+ F +V+ AL+Y+H +G I+R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 801 KPENVLLQGNGHVSLTDFDLSC 822
K ++LL G+G V L+ S
Sbjct: 128 KASHILLSGDGKVVLSGLRYSV 149
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 4/146 (2%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LG G G V+L +G+ A+K + D + +V+ E ++L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
Y + + + +Y PGG + L + L E R Y +++ +EYLH I
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLS 821
++RD+K N+L G+V L DF S
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGAS 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
A+Q ++ G+ ++ +G G TG V + +G+ A+K MD R +
Sbjct: 10 ALQLVVSPGDP--REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQR 62
Query: 718 RACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQ 119
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ V+ AL YLH QG+I+RD+K +++LL +G + L+DF
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDF 162
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILD 727
+ + +G G +G+V+ +GQ A+K M+ K +++N V R I++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
LD S+ + ++ +Y GG L D + E + E + AL
Sbjct: 81 YLD---------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
E+LH +I+RD+K +N+LL +G V LTDF
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 53/229 (23%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
P P S + +L + +GSG G+V+ V +G+ +A+K +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 706 ----DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 761
+ V R ++ C E EIL ++HP V + F + ++ ++ GG L
Sbjct: 108 YGNHEDTV---RRQI---CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-- 159
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ T + E + A +++ + YLH + I++RD+KP N+L+ +V + DF +S
Sbjct: 160 ----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ +A+ M NS VGT Y++P
Sbjct: 216 RI---------------------------LAQTMDPCNSSVGTIAYMSP 237
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
I LG G G V+ + +G A K +D + ++ E +IL DHP +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVK 66
Query: 737 LYASFQTKTHVCLITDYCPGGEL---FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L +F + ++ ++ ++C GG + L L+R L E +R + + AL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
II+RDLK N+L +G + L DF +S T +RR
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA----------KNTRTIQRR------------ 160
Query: 854 PMRASNSFVGTEEYIAP 870
+SF+GT ++AP
Sbjct: 161 -----DSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E +L D P+V Y S+ T + +I +Y GG LL+ P L E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILR 108
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
E++ L+YLH + I+RD+K NVLL +G V L DF ++
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 11/146 (7%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 734
+ +G G G V +GQ A+K K V + V + A REI L L HP +
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLL--LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
L F+ K + L+ +YC + +L L++ P V E ++ + + A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNFCHK 118
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDF 818
I+RD+KPEN+L+ G + L DF
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 36/199 (18%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 732
F I LG+G+ G V V+ SG A K + + RN++ R E ++L + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
++ Y +F + + + ++ GG L +L + K + E+ + + V+ L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 793 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ I++RD+KP N+L+ G + L DF +S GQ +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ-----L 154
Query: 852 AEPMRASNSFVGTEEYIAP 870
+ M +NSFVGT Y++P
Sbjct: 155 IDSM--ANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 734 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ Y +F K + L+ ++C G + L+ LKE+ + + E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L +LH +I+RD+K +NVLL N V L DF +S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 6/145 (4%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K LGSG G VHL + G A+K + +G M + + A +++ L HP +
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEA----KVMMKLSHPNLVQ 63
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LY + + ++T+Y G L L + L + + ++V A+EYL G I
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLS 821
+RDL N L+ + V ++DF L+
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 45/160 (28%), Positives = 68/160 (42%), Gaps = 24/160 (15%)
Query: 674 FRPIKPLGSGDTGSVH----LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-- 727
IK LGSG G+V+ + E A+K + R + A +EILD
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-------REETSPK-ANKEILDEA 60
Query: 728 ----MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA 781
+DHP V L + LIT P G L LD R + + +
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL---LDYVRNHKDNIGSQYLLNWCV 116
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + YL + +++RDL NVL++ HV +TDF L+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 680 LGSGDTGSVHLVELCGSGQ-YFAMK-------AMDKGVMLNRNKVHRACAEREIL-DMLD 730
LGSG G V+ V +GQ A+K A K + +E I+ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 731 HPFVPALYASFQTKTHVCLITDY---CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
HP + Y +F + ++ D P GE F L ++ + E+ + ++V+AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLAL 126
Query: 788 EYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLS 821
YLH + I++RDL P N++L + V++TDF L+
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-09
Identities = 27/94 (28%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN----GQSYCGRLLN 272
I+YA+ ++ GY+ +E++G++ L PED ++RE L+N G+ +
Sbjct: 14 ILYANPAAEQLLGYSPEELIGKSLLDL----IHPEDREELRERLENLLSGGEPVTLEVRL 69
Query: 273 YKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
+KDG+ W L+++ PI+D+ G+V+ +G+ ++
Sbjct: 70 RRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRDI 103
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G G G V+ + + A+K +D + +++ E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ Y S+ T + +I +Y GG LL P L+E + E++ L+YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I+RD+K NVLL G V L DF ++
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-08
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-----NGQSYCGRLL 271
I+Y S F ++ GYT +E+ +L PED ++R LQ G+ Y G
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDL--VHPEDRERVRRALQEFSLKKGEPYSGEYR 58
Query: 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 301
+KDG W PI+D+ GK ++ IG
Sbjct: 59 IRRKDGEYRWVEARGRPIRDENGKPVRVIG 88
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 22/96 (22%), Positives = 42/96 (43%), Gaps = 2/96 (2%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 558
I++ + +F E+ YS EE++GRN L E +I ++ + + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 559 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594
G + W + P+R G +G+ D +E +
Sbjct: 85 DGSEIWVEVSVSPIRTN-GGELGVVGIVRDITERKQ 119
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 3e-08
Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 29/164 (17%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLD 730
+ +KP+GSG G V +G+ A+K K + + + R E ++L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 731 HP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVR 777
H P F V ++T+ + D + P + L +D ++
Sbjct: 58 HENIIGLLDILRPPSPEDFND---VYIVTEL-------METDLHKVIKSP-QPLTDDHIQ 106
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ +++ L+YLH +I+RDLKP N+L+ N + + DF L+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 28/179 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 733
+G G +G+V+ +GQ A++ M+ K +++N V R I++ LD
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
S+ + ++ +Y GG L D + E + E + ALE+LH
Sbjct: 85 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K +N+LL +G V LTDF T E+ +R P +MA
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKRSTMVGTPYWMA 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 3/100 (3%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E +L D P+V Y S+ T + +I +Y GG LL P E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLK 108
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
E++ L+YLH + I+RD+K NVLL G V L DF ++
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 36/191 (18%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 735
I+ +G G G V+ V G A+K +D + AE IL L +HP V
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDR----QPTKVLK----------EDAVRFYAA 781
Y F D GG+L+L+L+ T+++K E + +
Sbjct: 83 KFYGMFYK-------ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ L++LH II+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR 185
Query: 842 HKGQQNPVFMA 852
+ P +MA
Sbjct: 186 NTSVGTPFWMA 196
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 44/202 (21%), Positives = 84/202 (41%), Gaps = 29/202 (14%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L +F+ K +G G V+ + A+K + M++ E ++L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 788
HP V SF + ++ + G+L ++ ++ +++ E V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
++H + +++RD+KP NV + G V L D L
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG--------------------------- 153
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
F + A++S VGT Y++P
Sbjct: 154 RFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 38/148 (25%), Positives = 73/148 (49%), Gaps = 4/148 (2%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++ LG G +V+ + +G+ A+K + + A E +L L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHAN 64
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ TK + L+ +Y +L +D+ P L + V+ + +++ L Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR 122
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I++RDLKP+N+L+ G + L DF L+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 7e-08
Identities = 20/53 (37%), Positives = 34/53 (64%)
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+L++ R+ +++ AL+Y+H +I+RDLKP N+LL + V L DF L+
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 12/151 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG--VMLNRNKVHRACAEREILDMLDH 731
++PI+ +GSG G V SG+ A+K + V + R E +IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKH 63
Query: 732 PFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ A+ + V ++ D ++ QP L E+ +R++ +++ L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGL 120
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+Y+H +I+RDLKP N+L+ + + + DF
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 730
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 731 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
H + Y + + + + +Y PGG + L + L E+ R Y +++ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YLH I++RD+K N+L G+V L DF S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 35/200 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYL 790
P + + L+ +YC G +L + ++P L+E + + L YL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H I+RD+K N+LL G V L DF + L S
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------------------------- 166
Query: 851 MAEPMRASNSFVGTEEYIAP 870
+NSFVGT ++AP
Sbjct: 167 ------PANSFVGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 27/189 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELC------GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
++ + I+ LG G G V L C G+G+ A+K + + + + + ++EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL--YCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEI 57
Query: 726 --LDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
L L H + S Q + LI +Y P G L D P L + +A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQ 114
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ + YLH Q I+RDL NVLL + V + DF L+ +P +E R
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHEYYRV 166
Query: 842 HKGQQNPVF 850
+ +PVF
Sbjct: 167 REDGDSPVF 175
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 28/179 (15%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 733
+G G +G+V+ +GQ A+K M+ K +++N V R I++ LD
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
S+ + ++ +Y GG L D + E + E + AL++LH
Sbjct: 84 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K +N+LL +G V LTDF T E+ +R P +MA
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKRSTMVGTPYWMA 183
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 28/168 (16%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---D 730
++ + +G G V + +G+Y+A+K M K + + + REI +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD----------RQPTKVLKEDAVRFYA 780
HP + L + L +F L+D ++P L E V+ Y
Sbjct: 57 HPNILRLIEVLFDRKTGRLAL-------VFELMDMNLYELIKGRKRP---LPEKRVKSYM 106
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
+++ +L+++H GI +RD+KPEN+L++ + + L DF KP
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP 153
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 727
IN +K LGSG G VHL + Q A+KA+++G M + + A +++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEGAMSEEDFIEEA----KVMM 54
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + LY + + ++T++ G L L RQ L +D + +V +
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGM 113
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
EYL I+RDL N L+ G V ++DF ++
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 670 NLQH-FRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREIL 726
N QH + I+ +GSG G V+ +G+ A+K ++ G + ++EI
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-------SLIQQEIF 58
Query: 727 DMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
+ + H + A + S+ ++ + + +YC GG L + T L E + + E +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETL 116
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L YLH +G ++RD+K N+LL NG V L DF ++
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-07
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 550 TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
TV+ K G W L P+RD+ GEV+ +GV D +E
Sbjct: 1 TVEYRLRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDITE 42
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAER-EILDMLDHPFVPA 736
LG G G+V+ L GQ A+K +D +L K + E ++L L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ + + ++ PGG + +L+R L E Y +++ + YLH ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 797 YRDLKPENVLLQGNGHVSLTDF 818
+RD+K NV+L NG + L DF
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDF 146
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 30/188 (15%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML-DH 731
I+ +G G G V V +G A+K +D +H AE IL L DH
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDP--------IHDIDEEIEAEYNILKALSDH 74
Query: 732 PFVPALYASFQTKT-----HVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVV 784
P V Y + K + L+ + C GG + L+ + + ++E + + E +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ L++LH I+RD+K N+LL G V L DF +S QL T+ + RR+
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRRNTS 184
Query: 845 QQNPVFMA 852
P +MA
Sbjct: 185 VGTPFWMA 192
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 16/172 (9%)
Query: 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LD 727
L+ + + LG G G V+ +G+ A+K K +M N A REI L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILK 62
Query: 728 MLDHPFVPAL------YASFQTKTHVC--LITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
L HP V L + ++T Y +L LL+ K L E ++ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK-LTESQIKCY 120
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQL 830
+++ + YLH I++RD+K N+L+ G + + DF L+ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 22/155 (14%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G G V E SG A+K + + + E I+ LDH +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK--EAAIMHSLDHENL 58
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF--------YAAEVVVA 786
LY T + ++T+ P G L LDR L++DA+ YA ++
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSL---LDR-----LRKDALGHFLISTLCDYAVQIANG 109
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ YL + I+RDL N+LL + V + DF L
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 36/143 (25%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRAC-AEREILDMLDHPFVPA 736
LG+G S + +G A+K + + + +V A E ++ L+HP +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
+ + +H L ++ GG + LL + KE + Y +++ L YLH II
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 797 YRDLKPENVLLQGNGH-VSLTDF 818
+RD+K N+L+ G + + DF
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADF 148
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 25/57 (43%), Positives = 34/57 (59%), Gaps = 1/57 (1%)
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ ED + A +V ALEYLH + +I+RD+KP NVL+ NG V L DF +S
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 48/157 (30%), Positives = 71/157 (45%), Gaps = 21/157 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LGSG TG+V + G+ FA+K +D M + +RA AE L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 740 SFQTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE-------VV 784
F K + L+ DY G+L RQ K + F E V+
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+A+ ++H + +I+RD+K N+LL NG V L DF S
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 38/116 (32%), Positives = 55/116 (47%), Gaps = 6/116 (5%)
Query: 723 REI--LDMLDHPFVPALYASFQTK--THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
REI L L HP + L K + L+ +YC +L LLD PT E V+
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKC 112
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
+++ L+YLH II+RDLK N+LL G + + DF L+ + + P
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 26/92 (28%), Positives = 51/92 (55%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 559
I++A+D+F +T Y++EEI+G+N L T P + + ++ Q +L+N K
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 560 GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
G+ + + P+ ++ GE +F+G+ D +E
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 52.2 bits (123), Expect = 3e-07
Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 535
L LE + D D I++A+ + EL YS EE LGR L PE +
Sbjct: 113 RLRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERR 169
Query: 536 VRK--IRAAIDNQTDVTVQLINYTKSGKK-FWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ A + ++ K G++ W L + P+RD GE+ +G+ D +E
Sbjct: 170 ELELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDD-GEIVGVVGIARDITE 227
|
Length = 232 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 49/198 (24%), Positives = 76/198 (38%), Gaps = 35/198 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G G G+V+ + + A+K M + K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ + L+ +YC G LL + ++P + ++ AV A + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLHS 133
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K N+LL G V L DF A
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFG-------------------------------SA 162
Query: 853 EPMRASNSFVGTEEYIAP 870
M +N FVGT ++AP
Sbjct: 163 SIMAPANXFVGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 726
F+ ++ +G G G V+ +G+ A+K + +GV + A REI L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--------PSTAIREISLL 53
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
L+HP + L T+ + L+ ++ +L +D P + ++ Y +++
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L + H +++RDLKP+N+L+ G + L DF L+
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 42/202 (20%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 732
F I LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEY 789
++ Y +F + + + ++ GG L +L + P ++L + ++ V+ L Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIKGLTY 118
Query: 790 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 153
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
+ + M +NSFVGT Y++P
Sbjct: 154 --LIDSM--ANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F ++ +G G G+V+ + + A+K M + K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 143
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K N+LL G V L DF + + S
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------------------------- 176
Query: 853 EPMRASNSFVGTEEYIAP 870
+NSFVGT ++AP
Sbjct: 177 ----PANSFVGTPYWMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 40/165 (24%), Positives = 82/165 (49%), Gaps = 15/165 (9%)
Query: 672 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI 725
Q + + +G G G V +L G++ A+K + ++G+ L+ R A
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRH 57
Query: 726 LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
L+ +HP V L+ + +T + L+ ++ +L LD+ P + + ++
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
+++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 6/139 (4%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G +G+V +GQ A+K ++ + + K E ++ L +P +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
SF + ++ +Y GG L D + E + E + ALE+LH +I+RD
Sbjct: 84 SFLVGDELFVVMEYLAGGSL---TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 800 LKPENVLLQGNGHVSLTDF 818
+K +NVLL +G V LTDF
Sbjct: 141 IKSDNVLLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 8/154 (5%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 727
I+ + +K LG+G G V + GQY A+K + +G M + A +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSEDEFIEEA----KVMM 54
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H + LY + + ++T+Y G L L R+ K + + +V +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGM 113
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YL + I+RDL N L+ G V ++DF LS
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 21/48 (43%), Positives = 31/48 (64%)
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
L E VR Y +++ +E+ H II+RD+KPEN+L+ +G V L DF
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 42/201 (20%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+H + I+ LG G+ GSV ELC +G+ A+K + + R E E
Sbjct: 4 RHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIE 57
Query: 725 ILDMLDHPFVPALYASFQTKTHVC---------LITDYCPGGELFLLLDRQPTKVLKEDA 775
IL L H + Y VC L+ +Y P G L L + ++ D
Sbjct: 58 ILKSLQHDNI-VKYKG------VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DH 107
Query: 776 VRF--YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
+ YA+++ +EYL + ++RDL N+L++ V + DF L+ +LP
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT--------KVLP 159
Query: 834 TTNEKKRRHKGQQNPVFMAEP 854
E + + ++P+F P
Sbjct: 160 QDKEYYKVREPGESPIFWYAP 180
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 17/156 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 726
+ I+ +G G G V+ +GQ AMK + ++GV + A REI L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV--------PSTAIREISLL 53
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVV 785
L HP + L ++ + LI ++ +L LD P + + + V+ Y +++
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ + H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 45/146 (30%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALY 738
+GSG G V+ + +G A+K M + N+ + R + +++ D P++ Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 739 ASFQTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYL-HCQGI 795
F T + V I L LL R P + ED + +V AL YL G+
Sbjct: 81 GYFITDSDV-FICMELMSTCLDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLS 821
I+RD+KP N+LL +G+V L DF +S
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 6/152 (3%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDH 731
+R K LG G G V+L +G+ A K + D +V E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 732 PFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
+ Y + + + + +Y PGG + L + L E R Y +++ + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSY 121
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
LH I++RD+K N+L G+V L DF S
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 23/165 (13%)
Query: 680 LGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACA----------EREI 725
LG G G VHL E G ++ F++ +L K+ R A E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAV------- 776
+ L P + L A T +C+IT+Y G+L FL K D V
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
F A ++ ++YL ++RDL N L+ N + + DF +S
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 49/194 (25%), Positives = 78/194 (40%), Gaps = 34/194 (17%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ + A+K + + +H E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
S + + PGG L LL + P K E + FY +++ L+YLH I++
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 798 RDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 856
RD+K +NVL+ +G V ++DF S +R G NP
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS------------------KRLAG-INPC------- 165
Query: 857 ASNSFVGTEEYIAP 870
+ +F GT +Y+AP
Sbjct: 166 -TETFTGTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPG--GELFLLLDRQPTKVLKEDAVRFY 779
E +L L HP V AL CL+ P +L+ L + + L V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARL-RPLGLAQVTAV 265
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
A +++ A++Y+H +GII+RD+K ENVL+ G + L DF +C
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308
|
Length = 461 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 48/198 (24%), Positives = 77/198 (38%), Gaps = 35/198 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F + +G G G+V+ + + A+K M K E + L L HP
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 139
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+I+RD+K N+LL G V L DF + +S
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------------------------- 172
Query: 853 EPMRASNSFVGTEEYIAP 870
+NSFVGT ++AP
Sbjct: 173 ----PANSFVGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 22/186 (11%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDML 729
F+ IK LGSG G+V+ G+ A+K + + NK E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVAL 787
D+P V L T T V LIT P G LLD R+ + + + ++ +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
YL + +++RDL NVL++ HV +TDF L+ L +EK+ +G +
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---------GADEKEYHAEGGKV 173
Query: 848 PV-FMA 852
P+ +MA
Sbjct: 174 PIKWMA 179
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-06
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 15/107 (14%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLI-----TD-YCPGGELFLLLDRQPTKVLKEDA 775
E IL ++HP + L +F CLI TD YC L ++ + A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC------YLAAKRNIAICDILA 186
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
+ V+ A++YLH II+RD+K EN+ + G V L DF +C
Sbjct: 187 IE---RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230
|
Length = 391 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 275
I+Y +A ++ G + +EV+G++ L D E +R+ L G+ G ++++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 276 DGTPFWNLLTIAPIKDDEGKVLKFIGM 302
DG P + +P++D G+V F+G+
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 6/153 (3%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
IN + + +G G+ G V L + GQ A+K + + AE ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKD----DSTAAQAFLAEASVMTT 56
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L HP + L + ++T+Y G L L + V+ +A +V +E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YL + ++RDL NVL+ + ++DF L+
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.1 bits (115), Expect = 3e-06
Identities = 19/97 (19%), Positives = 41/97 (42%), Gaps = 2/97 (2%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ--NGQSYCGRL 270
D I+YA+ ++ GY+ +E +GR L + ++ L G
Sbjct: 130 EDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEY 189
Query: 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+KDG +L+ D+G+++ +G+ +++
Sbjct: 190 RVRRKDGERVRWILSRISPVRDDGEIVGVVGIARDIT 226
|
Length = 232 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 23/90 (25%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 558
I++ + + EL SREE++G++ L + D +R A+ + +++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 559 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
G+ P+RD GEV+ F+GV D
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGVLRD 112
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 729
+ ++ + P+GSG GSV Q A+K + + ++ +H R E +L +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHM 71
Query: 730 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
H F PA S + V L+T+ G +L ++ Q L ++ V+F
Sbjct: 72 KHENVIGLLDVFTPA--TSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIY 125
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ L+Y+H GII+RDLKP NV + + + + DF L+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 37/151 (24%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDH 731
F+ ++ LG G +V+ +G+ A+K + L+ + + A REI M L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE----IHLDAEEGTPSTAIREISLMKELKH 57
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYL 790
+ L+ T+ + L+ +Y +L +D L + V+ + +++ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
H +++RDLKP+N+L+ G + L DF L+
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 16/156 (10%)
Query: 680 LGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
LG G+ GSV +L GS Q A+K M K + + + + E + DHP V
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 737 LYA-SFQTKTHVCL-----ITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVV 785
L S +++ L I + G+L FLL+ R +P + + VRF ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIAS 124
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+EYL + I+RDL N +L N V + DF LS
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 19/147 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ ++PLG G G V + A+K K V+ + V A E +I+ LDH
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 734 VPALY-------------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
+ +Y T+ + I +L +L++ P L E+ R +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFM 120
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLL 807
+++ L+Y+H +++RDLKP NV +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFI 147
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
P +P+G G G V V G+ A+K M V N R E ++L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 734 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
V P F+ + ++T+ +++ QP L D V+ + +++
Sbjct: 61 VLSALDILQPPHIDPFE---EIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQILR 114
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L+YLH GI++RD+KP N+L+ N + + DF L+
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 42/255 (16%)
Query: 615 TAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK--DSPPWKAIQKILDSGEQINLQ 672
+AE +N+ K P T E+ + + + P+ ++K D P + + + + E
Sbjct: 12 SAELLNQYAKYFPHVLFTSEEAFEKYCADLDPEAYKKCVDLPEGEEVPESNNPRE----- 66
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREILDMLDH 731
H + L + + V GS K + K VMLN + A +E L DH
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDH 124
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED--------AVRFYAAEV 783
+ + F++ + LI +Y GG+L ++Q + LKE + FY ++
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDL----NKQIKQRLKEHLPFQEYEVGLLFY--QI 178
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS---------------CLTSCKP 828
V+AL+ +H + +++RDLK N+ L G + L DF S C T P
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT---P 235
Query: 829 QLLLPTTNEKKRRHK 843
L P E+KR K
Sbjct: 236 YYLAPELWERKRYSK 250
|
Length = 478 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 16/158 (10%)
Query: 678 KPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G+ GSV +L GS A+K M K + +++ +E + DHP V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 735 PALY------ASFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEV 783
L +S Q +I + G+L FLL R P K+ + ++F ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDI 122
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +EYL + I+RDL N +L+ + V + DF LS
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 23/174 (13%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLN-RNKVHRACA 721
+I L R ++ LG G G V+ EL G S A+K + + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 767
E E++ L HP + L + C++ +Y G+L FL+ D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L A ++ +EYL ++RDL N L+ V ++DF LS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 22/94 (23%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 275
I+Y + F ++ GY+++E++GRN L E +I L+ + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 276 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
DG+ W ++++PI G L +G+ ++++
Sbjct: 85 DGSEIWVEVSVSPI-RTNGGELGVVGIVRDITER 117
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 10/148 (6%)
Query: 678 KPLGSGDTGSVHL-VELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
K LG G+ GSV V L SG+ A+K + + + K E ++ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 735 PALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
L + + + L+ + P G L L R+ V ++ A +V + + YL +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQVAMGMAYLESK 114
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++RDL NVLL ++DF +S
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMK-----AMDKGVMLNRNKVHRACAEREI--L 726
++ ++ +G G G V+ +G+ A+K D+GV + A REI L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV--------PSTAIREISLL 52
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
L+HP + L ++ + L+ ++ +L +D P L ++ Y +++
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
+ Y H +++RDLKP+N+L+ G + L DF L
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 27/172 (15%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ PIKP+G G G V + + + A+K + NR R E ++L LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 734 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFY 779
V P +F V ++ + L+D + ++ L +D +++
Sbjct: 66 VIAIKDIMPPPHREAFND---VYIVYE---------LMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
+++ L+Y+H +++RDLKP N+LL N + + DF L+ TS K +
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734
+ L G G V + G Q +KA+ G R E +IL + H +
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EIDILKTISHRAI 148
Query: 735 PALYASFQTKTHVCLITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
L +++ K+ VC++ C +LF +DR L++ ++ AL YLH
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQ--AITIQRRLLEALAYLHG 203
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC-LTSC--KPQ 829
+GII+RD+K EN+ L + L DF +C L + PQ
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
|
Length = 392 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 17/151 (11%)
Query: 684 DTGSVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
D S+ L+ G+GQ+ A+K + G M AE +I+ L
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + LYA + + ++T+ G L L + LK + AA+V + YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
Q I+RDL NVL+ N + DF L+
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLDH 731
++ + P+GSG GSV +G A+K + + ++ +H R E +L + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKH 75
Query: 732 P--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
F PA S + V L+T + G +L ++ Q L +D V+F ++
Sbjct: 76 ENVIGLLDVFTPA--RSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQI 129
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ L+Y+H II+RDLKP N+ + + + + DF L+
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDK--GVMLNRNKVHRACAEREILDMLDHPFV 734
++P+G G G V +GQ A+K + K + + +R E ++L L H +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKHLRHENI 71
Query: 735 PALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+L F + +T+ G +L LL +P L++ ++++ +++ L+Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSA 127
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
G+++RDLKP N+L+ N + + DF L+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRKI--RAAIDNQTDVTVQLIN 555
II+ S F E+ Y+ EE+ +L PE D VR+ ++ + +
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDLVHPE-DRERVRRALQEFSLKKGEPYSGEYRI 59
Query: 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
K G+ W +P+RD+ G+ IGV
Sbjct: 60 RRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 2e-05
Identities = 11/36 (30%), Positives = 25/36 (69%)
Query: 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+KDG+ W L++ +PI+D++G+V +G+ +++
Sbjct: 6 LRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDIT 41
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 8/154 (5%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+N++ + ++ +G G+ G V L G Y K K + N AE ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML------GDYRGNKVAVKCIK-NDATAQAFLAEASVMTQ 55
Query: 729 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H V L + K + ++T+Y G L L + VL D + ++ +V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
EYL ++RDL NVL+ + ++DF L+
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+R +K +GSG G+V +G A+K + + + RA E +L + H
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHEN 75
Query: 734 VPALYASFQTKTHVCLITDY---CP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
V L F + D+ P G +L L+ + L ED ++F +++ L+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQMLKGLK 132
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
Y+H GII+RDLKP N+ + + + + DF L+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAM----DKGVMLNRNKVHRACAEREILDMLDHP 732
++ LG G +V+ +GQ A+K + ++GV A E +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT------AIREASLLKGLKHA 63
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ L+ TK + + +Y +L + + P L VR + +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHG 121
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
Q I++RDLKP+N+L+ G + L DF L+
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 1/54 (1%)
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
V+ E+ + A V AL YL + II+RD+KP N+LL NG++ L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 730
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 731 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
H + Y + + + + ++ PGG + L + L E+ R Y +++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YLH I++RD+K N+L G+V L DF S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 39/152 (25%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--LDML 729
++ +G G G+V + + + A+K + D+GV + A REI L L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--------ALREICLLKEL 56
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
H + LY + + L+ +YC +L D + + V+ + +++ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAF 114
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
H +++RDLKP+N+L+ NG + L DF L+
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 2/97 (2%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E ++L L + L +F+ + + L+ +Y + LL+ P V + VR Y
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKVRSYIY 107
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+++ A+ + H I++RD+KPEN+L+ N + L DF
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 36/172 (20%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA---MDKGVML---------NRNKVHRA 719
Q R + LG G G VHL E G ++ A + V++ + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 720 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP--TKVLKEDAVR 777
E +I+ L +P + L + +C+IT+Y G+L L ++ + + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 778 --------FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ A ++ ++YL ++RDL N L+ + + + DF +S
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 37/145 (25%), Positives = 65/145 (44%), Gaps = 6/145 (4%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K LG+G G V + A+K++ +G M AE ++ L HP +
Sbjct: 11 VKKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVR 65
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LYA T+ + +IT+Y G L L L + + AA++ + ++ + I
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLS 821
+RDL+ N+L+ + DF L+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 26/101 (25%), Positives = 49/101 (48%), Gaps = 1/101 (0%)
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
+E IL DHP + L + + ++ + PGG+ L ++ ++ + V+F A
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-A 99
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ + YL + I+RDL N L+ N + ++DF +S
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 35/142 (24%), Positives = 59/142 (41%), Gaps = 4/142 (2%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ A+K + + M +V E ++ + HP + L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+ +IT++ G L L + + + + A ++ A+EYL + I+RD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 800 LKPENVLLQGNGHVSLTDFDLS 821
L N L+ N V + DF LS
Sbjct: 130 LAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 17/148 (11%)
Query: 687 SVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
S+ L G+GQ+ A+K + G M E +I+ L H
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ LYA + + ++T+Y G L L K L+ + AA++ + YL +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
I+RDL N+L+ N + DF L+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 42/170 (24%), Positives = 83/170 (48%), Gaps = 15/170 (8%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+ ++ +KP+GSG G V G A+K + + N+ RA E +L ++
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN 78
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFL---LLDRQPTKV----LKEDAVRFYAAEV 783
H + +L F + + D ++L L+D +V L + + + ++
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQD------VYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833
+ +++LH GII+RDLKP N++++ + + + DF L+ T+C ++ P
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMMTP 181
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 29/165 (17%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDH 731
+ + +G G G V + Q A+K K +M N + A RE IL +L H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQLLKH 70
Query: 732 PFVPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
V L +T K L+ ++C + +L V+F +E+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFC---------EHDLAGLLSNKNVKFTLSEI 121
Query: 784 -------VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ L Y+H I++RD+K N+L+ +G + L DF L+
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAEREI 725
I+ ++ +GSG G V L G A+K + +G M + + A ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWL----GYWLEKRKVAIKTIREGAMSEEDFIEEA----QV 52
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ L HP + LY ++ +CL+ ++ G L L Q K +E + +V
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE-TLLGMCLDVCE 111
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ YL +I+RDL N L+ N V ++DF ++
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 31/181 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK---AMDKGVML-----------NRNKVH 717
H + LG G G VHL E+ ++ + KG L N+N +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FL----LLDRQ----- 766
E +IL L P + L + +C+IT+Y G+L FL L D++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 767 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
+ ++ A ++ ++YL ++RDL N L+ N + + DF +
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 821 S 821
S
Sbjct: 185 S 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 33/121 (27%), Positives = 52/121 (42%), Gaps = 26/121 (21%)
Query: 730 DHPFVPALYASFQTKTHVC-----------LITDYCPGGELFLLLDRQPTKVLKE----- 773
D P A F+ +T +C L + P G LF + + P + L+E
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD 73
Query: 774 ------DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 824
+ R +V+ AL H QGI++RDLKP+N+++ G H + DF + L
Sbjct: 74 GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 825 S 825
Sbjct: 133 P 133
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+I + + +K LG+G G V + S + A+K + G M V E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMK 56
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVA 786
L H + LYA + + +IT+Y G L L KVL + F +A++
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEG 115
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ Y+ + I+RDL+ NVL+ + + DF L+
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 39/157 (24%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 728
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 72
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 784
++H + +L F + + D EL +D +V L + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL---MDANLCQVIQMELDHERMSYLLYQML 129
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 39/157 (24%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 728
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 79
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 784
++H + L F + + D EL +D +V L + + + +++
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL---MDANLCQVIQMELDHERMSYLLYQML 136
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 34/145 (23%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ IK L G G V + G +K KG L E +L ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V + + + C++ + +L+ L ++ + + A+ ++ L YLH Q
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ-ILEGLRYLHAQ 176
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDF 818
II+RD+K EN+ + V + D
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A E +L L H + L+ TK + L+ +Y +L +D L VR
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRL 107
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFV 734
IK L G T V+L+ + +K R E IL +L V
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK--INPSREKGADRER---EVAILQLLARKGLPV 55
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
P + AS ++ L+ ++ G L + + + + ++ AE++ L L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLV 109
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
+ + DL P N+L+ + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+Q + I+ +G G G V+L + A+K + + + N R E +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA------- 781
HP + +Y+ V Y G L LL Q + KE A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
++ +EY+H +G+++RDLKP+N+LL G V + D+ + + + LL ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE--- 177
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
M VGT +Y+AP
Sbjct: 178 ------RNICYSSMTIPGKIVGTPDYMAP 200
|
Length = 932 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 17/170 (10%)
Query: 672 QHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRA----CA 721
+ + LG G G V +G+ A+K + V +R V
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 722 EREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRF 778
RE+ M + H + L + + L+ D +L ++DR K+ L E V+
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR---KIRLTESQVKC 123
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
+++ L LH ++RDL P N+ + G + DF L+ P
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP 173
|
Length = 335 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 677 IKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 729
I+ LG G G V ELC +G+ A+K++ N + E EIL L
Sbjct: 9 IRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL 63
Query: 730 DHPFVPALYASFQTK---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
H + Y T+ + LI ++ P G L L R K+ + ++ YA ++
Sbjct: 64 YHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKG 121
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++YL + ++RDL NVL++ V + DF L+
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 15/157 (9%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LG G+ GSV +L A+K M K + R+++ +E + DHP V
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 736 ALYA-SFQTKTH-----VCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVV 784
L QT +I + G+L FLL R P + + V+F ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIA 122
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+EYL + I+RDL N +L N +V + DF LS
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 50/220 (22%), Positives = 83/220 (37%), Gaps = 64/220 (29%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMK----AMDKGVMLNRNKVHRACAEREIL 726
+ IK LG G G V + + A+K K ++ R A RE+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-------ALREL- 52
Query: 727 DMLDHPFVPALYASFQTKTH---VCL----ITDYCPGGELFL---LLDRQPTKVLK---- 772
L F + H CL I EL+L L++ ++++
Sbjct: 53 -KLLRHF----------RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP 101
Query: 773 -EDA-VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
DA + + +++ L+Y+H +++RDLKP N+L+ + + + DF L+ S P
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-- 159
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+N FM E +V T Y AP
Sbjct: 160 --------------GENAGFMTE-------YVATRWYRAP 178
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-----CAEREILDML-DH 731
K LG+G G V VE G + M V + + H + +E +I+ L +H
Sbjct: 41 KTLGAGAFGKV--VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+ L + + +IT+YC G+L L R+ L + + ++ +V + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 792 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLS 821
+ I+RDL NVLL +G + + DF L+
Sbjct: 159 SKNCIHRDLAARNVLLT-HGKIVKICDFGLA 188
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 18/54 (33%), Positives = 35/54 (64%)
Query: 768 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
T+ L D ++++ +++ L+Y+H +++RDLKP N+LL N + + DF L+
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 8/148 (5%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
IK LG+G G V + G+ + A+K + G M + + A +I+ L H +
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEA----QIMKKLRHDKLVQ 65
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
LYA ++ + ++T+Y G L L + LK + AA+V + Y+ I
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 797 YRDLKPENVLLQGNGHV-SLTDFDLSCL 823
+RDL+ N+L+ G+G V + DF L+ L
Sbjct: 125 HRDLRSANILV-GDGLVCKIADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 1/100 (1%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E EIL DHP + L K + ++ + PGG L L R+ L + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSL 100
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +EYL + I+RDL N L+ N + ++DF +S
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 2/146 (1%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 736
+K +GSG GSV +G+ A+K + + + RA E +L + H V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIG 78
Query: 737 LYASFQTKTHVCLITD-YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
L F + D Y + L + L ED V++ +++ L+Y+H GI
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLS 821
I+RDLKP N+ + + + + DF L+
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 14/148 (9%)
Query: 680 LGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRAC-----AEREILDMLDHPF 733
LGSG+ G V G Y K +D + + +N+ ++ E EI+ LD+P+
Sbjct: 3 LGSGNFGCVK------KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ + + + + L+ + GG L L + ++ + V +V + ++YL +
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-QVSMGMKYLEGK 114
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++RDL NVLL + ++DF LS
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 8/101 (7%)
Query: 719 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 770
AC E +L L HP V AL F + V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ 104
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811
L V+ +++ + YLH +++RDLKP N+L+ G G
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A E +L L H + L+ T+ + L+ +Y +L LD ++ V+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKI 107
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++ L Y H + I++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 28/110 (25%), Positives = 52/110 (47%), Gaps = 16/110 (14%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE----- 773
A E +L L H + L+ T+ + L+ +Y LD+ + L +
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY---------LDKDLKQYLDDCGNSI 101
Query: 774 --DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
V+ + +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 38/164 (23%), Positives = 58/164 (35%), Gaps = 23/164 (14%)
Query: 677 IKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDML 729
+ LG G G V L E + A+K + K N R R E E+L
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER---EAELLTNF 65
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGEL------------FLLLDRQPTKVLKEDAVR 777
H + Y ++ +Y G+L FL P L +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
A ++ + YL Q ++RDL N L+ + V + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 2/101 (1%)
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
E I+ DHP + L T+ V ++ + P GEL L L ++ Y+
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ AL YL + ++RD+ NVL+ V L DF LS
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 19/160 (11%)
Query: 678 KPLGSGDTGSVHLVE---LCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ LG G G V L E LC A+K + R HR E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 733 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKEDAVRFYAA 781
+ Y + ++ +Y G+L L+ + L + + A
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + YL Q ++RDL N L+ N V + DF +S
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 17/37 (45%), Positives = 26/37 (70%)
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+V+ L LH GI++RD+KPEN+L+ +G V + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 1/44 (2%)
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDF 818
V+ Y+ ++ AL Y+H + I +RDLKP+N+L+ N H + L DF
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 36/144 (25%), Positives = 66/144 (45%), Gaps = 6/144 (4%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V + G+ + A+K + G M + A +++ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEA----QVMKKLRHEKLVQLYA 68
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
++ + ++T+Y G L L + K L+ + AA++ + Y+ ++RD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 800 LKPENVLLQGNGHVSLTDFDLSCL 823
L+ N+L+ N + DF L+ L
Sbjct: 128 LRAANILVGENLVCKVADFGLARL 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 12/156 (7%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM----- 728
+ +K LGSG G+V+ G+ + K +L N +A +EILD
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK--VLRENTSPKA--NKEILDEAYVMA 64
Query: 729 -LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ P+V L T T V L+T P G L + ++ +D + + ++ +
Sbjct: 65 GVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGM 122
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
YL +++RDL NVL++ HV +TDF L+ L
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 729 LDHPFVPALYA--SFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
+DH +P Y SF+ + L E+F + + K++K +
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK-----D 134
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
++ LEY+H GI + D+KPEN+++ GN + D+
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
|
Length = 294 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 8/101 (7%)
Query: 719 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 770
AC E +L L HP V +L F V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 104
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811
L V+ +++ + YLH +++RDLKP N+L+ G G
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A E +L L H + L+ T + L+ +Y +L +D ++ V+
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKI 108
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 15/49 (30%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 265
I+YA+ ++ GY+ +E++G++ L PED +++E LQ S
Sbjct: 23 ILYANPAAEELLGYSPEELIGKSLLEL----IHPEDRERVQEALQRLLS 67
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 28/100 (28%), Positives = 45/100 (45%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E + L L H + +L+A V +IT+ G L L +VL ++ A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+V + YL Q I+RDL N+L+ + + DF L+
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 8/154 (5%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE----REILDML 729
+ +K LGSG G+V+ G+ + K +LN +A E I+ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASM 66
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
DHP + L + T + L+T P G L + + + + + ++ + Y
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMY 124
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
L + +++RDL NVL++ HV +TDF L+ L
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 42/165 (25%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 728
L+ ++ +KP+GSG G V +GQ A+K + + +N H A RE++ M
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKL 71
Query: 729 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAV 776
++H F P S + V L+ + L+D +V L + +
Sbjct: 72 VNHKNIIGLLNVFTPQ--KSLEEFQDVYLVME---------LMDANLCQVIQMDLDHERM 120
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 14/159 (8%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDML 729
R +K LGSG G+VH G + K + R + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 730 DHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
DH ++ L AS Q L+T P G L + RQ L + + ++
Sbjct: 67 DHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIA 119
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
+ YL +++R+L N+LL+ + V + DF ++ L
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 17/51 (33%), Positives = 30/51 (58%)
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
ED ++ + +++ L Y H + ++RD+K N+LL G + L DF L+ L
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 16/51 (31%), Positives = 32/51 (62%)
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L + +F+ +++ AL+Y+H + +RDLKP+N+L + + + DF L+
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 905 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.98 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.98 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.9 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.86 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.52 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.5 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.49 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.48 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.44 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.4 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.4 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.39 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.38 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.37 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.36 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.3 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.2 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.18 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.15 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.14 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.07 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.06 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.84 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.83 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.83 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.8 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.72 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.7 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.69 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.67 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.66 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.57 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.55 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.54 | |
| PRK11388 | 638 | DNA-binding transcriptional regulator DhaR; Provis | 98.53 | |
| COG2202 | 232 | AtoS FOG: PAS/PAC domain [Signal transduction mech | 98.46 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=364.11 Aligned_cols=205 Identities=40% Similarity=0.636 Sum_probs=187.7
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
....++|++++.||+|+||+||.++.+.|++.||+|++++.......+......|..+|..++||+||+++..|++.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35578999999999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+|++|+.||.|+.+|.++ +.|++..++.++..|+.||.|||++|||||||||+||||+.+|+++|+|||+|+..-.
T Consensus 101 ylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999999875 4599999999999999999999999999999999999999999999999999975221
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
....+.++|||+.|||||++.+ +..+|.||||+++|+|++|.+||...
T Consensus 178 --------------------------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 178 --------------------------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred --------------------------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 1223456899999999999994 45899999999999999999999753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=361.63 Aligned_cols=199 Identities=25% Similarity=0.407 Sum_probs=180.5
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+.+.||+|+|++||+|+++.++..||||.+.+..+ .....+.+..|+.+|+.++|||||.+++++.+++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999987644 666778889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC------CcEEEEeccCcccc
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN------GHVSLTDFDLSCLT 824 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~------~~vkL~DFG~s~~~ 824 (905)
||||.||+|.+|+++.+ .+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999999998864 59999999999999999999999999999999999999764 46899999999876
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .....+.||+|.|||||++. ...|+|+||+|++||++++|+.||..
T Consensus 166 ~~----------------------------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 166 QP----------------------------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred Cc----------------------------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 51 22345789999999999996 34599999999999999999999973
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=375.47 Aligned_cols=201 Identities=26% Similarity=0.414 Sum_probs=186.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
..|...+.||+|+|+.||.+++..+|..||+|++.+..+......+.+.+|+++.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888889999999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|+|..++|..++++. +.+++.+++.+++||+.||.|||+++|+|||||..|+||+++.++||+|||+|+.+..+
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~---- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD---- 171 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc----
Confidence 999999999999864 56999999999999999999999999999999999999999999999999999876522
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.....+.||||.|+|||++.. ...+||||+|||||.|++|++||+..
T Consensus 172 -----------------------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 172 -----------------------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred -----------------------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 234567899999999999993 56999999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=360.84 Aligned_cols=203 Identities=29% Similarity=0.426 Sum_probs=179.8
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++++..... ......+.+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3568999999999999999999999999999999999875433 223445679999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC---CcEEEEeccCcc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSC 822 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~---~~vkL~DFG~s~ 822 (905)
+.||||||++||+|++.+-.+ +.+.+.....+++|++.||.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999999875 458888889999999999999999999999999999999766 689999999998
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CC-CchHHHHHHHHHHHHhCCC
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YT-RMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~-~sDiwSlGvil~elltg~~ 896 (905)
..+ ......++||||.|.|||++.. ++ +.|+|||||+||-+++|.+
T Consensus 328 ~~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p 379 (475)
T KOG0615|consen 328 VSG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP 379 (475)
T ss_pred ccc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence 754 2335678999999999999983 33 8899999999999999999
Q ss_pred Cchhhh
Q 002580 897 PFPILC 902 (905)
Q Consensus 897 PF~~~~ 902 (905)
||..-.
T Consensus 380 PFS~~~ 385 (475)
T KOG0615|consen 380 PFSEEY 385 (475)
T ss_pred Cccccc
Confidence 997643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.25 Aligned_cols=201 Identities=39% Similarity=0.691 Sum_probs=186.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
...++|++++.||.|+||.|.+++.+.+|..||+|++++.........+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45789999999999999999999999999999999999987777778889999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
|||||++||.|+.++++. ++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+...
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999885 459999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
..+.+.||||.|+|||++.. ..++|-||||+++|||+.|.+||..-
T Consensus 196 ---------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 196 ---------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ---------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 12457899999999999983 45889999999999999999999753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=359.41 Aligned_cols=217 Identities=34% Similarity=0.525 Sum_probs=191.6
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCe
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 746 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 746 (905)
.....+|.+++.||.|+|++|++|+++.+++.||||++.+..+.....+..+.+|..+|.+| .||.|++||..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34577999999999999999999999999999999999998888888888999999999999 89999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
+|+|+||+++|+|.++|++. +.|++..++.++.+|+.||+|||++|||||||||+||||+.+|++||+|||.|+.+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999999886 4599999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...... ++..-........+|+||..|.+||++.. ...+|+|+||||||.|+.|.+||..
T Consensus 227 ~~~~~~--------------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra 289 (604)
T KOG0592|consen 227 SQKSQE--------------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA 289 (604)
T ss_pred hhcccc--------------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc
Confidence 433211 11111111122367999999999999994 5699999999999999999999964
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.46 Aligned_cols=257 Identities=46% Similarity=0.768 Sum_probs=216.8
Q ss_pred CCCCCCCCCchhhHHhhc-CccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHH
Q 002580 646 PKPHRKDSPPWKAIQKIL-DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724 (905)
Q Consensus 646 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~ 724 (905)
..||......|..+.... ..+..+..++|++++.||+|.-|+||+|....++..+|+|++.+..+...+...+.+.|.+
T Consensus 50 ~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~e 129 (459)
T KOG0610|consen 50 NKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTERE 129 (459)
T ss_pred CCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHH
Confidence 467777777888777655 4667788999999999999999999999999999999999999998888889999999999
Q ss_pred HHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCC
Q 002580 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (905)
Q Consensus 725 il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~N 804 (905)
||+.++||+++.||..|+.+.+.|++||||+||+|+.++++++.+.|++..++.++..++.||+|||-.|||+|||||+|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCCCCcc----------------------hhhhcccc-C-----CCCcccccc-cc
Q 002580 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT----------------------NEKKRRHK-G-----QQNPVFMAE-PM 855 (905)
Q Consensus 805 ILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~----------------------~~~~~~~~-~-----~~~~~~~~~-~~ 855 (905)
|||.++|++.|+||.++..+...+....... .....+.+ . ...|-.+++ ..
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9999999999999999987754343332111 00000000 0 011112223 34
Q ss_pred cccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhhh
Q 002580 856 RASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPILC 902 (905)
Q Consensus 856 ~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~~ 902 (905)
....+++||.+|+|||++.| ..+.|.|+||++||||++|..||...-
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~ 339 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN 339 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence 66778999999999999995 348999999999999999999997543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=359.70 Aligned_cols=231 Identities=34% Similarity=0.552 Sum_probs=191.2
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.+..++|.+++.||+|+||.||+|+.+.||..||+|++++..+...+++..+..|..+|...++|+||++|..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 56788999999999999999999999999999999999999888899999999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
||||||++||++..+|.+. ..+++..++.++.+++.||..||+.|+|||||||+|+|||..|++||+|||+|.-+.+.
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999999875 45999999999999999999999999999999999999999999999999999655432
Q ss_pred CCCCC-----------Ccchhhhccc-----cC----CCCcccccccccccccccCCccccccccccC---CCCchHHHH
Q 002580 828 PQLLL-----------PTTNEKKRRH-----KG----QQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNY 884 (905)
Q Consensus 828 ~~~~~-----------~~~~~~~~~~-----~~----~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSl 884 (905)
..... .......... .. .....|....-....+.+|||.|||||++.+ ...+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 21110 0000000000 00 0000011111223446799999999999994 348999999
Q ss_pred HHHHHHHHhCCCCchh
Q 002580 885 LILVSKKFMEFQPFPI 900 (905)
Q Consensus 885 Gvil~elltg~~PF~~ 900 (905)
||||||||.|.+||..
T Consensus 375 G~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCS 390 (550)
T ss_pred HHHHHHHHhCCCCCCC
Confidence 9999999999999963
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=338.16 Aligned_cols=201 Identities=27% Similarity=0.439 Sum_probs=181.8
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
..+..++.+.++.||+|..|+||+|.++.|++.+|+|++.. ..+....+++.+|+++++.++|||||.+|+.|..++.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 44566788999999999999999999999999999999953 3456677899999999999999999999999999984
Q ss_pred -EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 747 -VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 747 -~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
++|+||||.+|+|..++... +++++.....|+.+|++||.|||+ ++||||||||+|||++..|.+||||||.|..+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 99999999999999999875 559999999999999999999996 89999999999999999999999999999765
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
..+ ...+++||..|||||-+.+ ..++||||||++|+|+.+|++||..
T Consensus 230 vnS-----------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 230 VNS-----------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred hhh-----------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 321 2457899999999999996 3499999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.38 Aligned_cols=203 Identities=27% Similarity=0.438 Sum_probs=179.8
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCe-E
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-SFQTKTH-V 747 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~-~~~~~~~-~ 747 (905)
...+|++++.||.|+||.||++.+..+|..+|.|.++-. ..+....+....|+.+|++|+|||||++|+ .|..++. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 456899999999999999999999999999999999844 556777888999999999999999999998 5555554 9
Q ss_pred EEEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 748 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC--QG--IIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~gL~~LH~--~g--IvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
+||||||.+|+|..+++. ...+.+++..+++++.|++.||.+||+ .. |+||||||.||+|+.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999874 345679999999999999999999999 44 999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
+.+..... ...+++|||.||+||.+.. +.+|||||+||++|||+.-++||
T Consensus 176 r~l~s~~t---------------------------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 176 RFLSSKTT---------------------------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred hHhcchhH---------------------------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 88653322 3457899999999999984 45999999999999999999999
Q ss_pred hh
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 229 ~g 230 (375)
T KOG0591|consen 229 YG 230 (375)
T ss_pred cc
Confidence 64
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.14 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=175.4
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+.|+.+.++|+|+||.||+|+++.||+.||||.+... ..++...+-.++|+++|++++|+|+|.++.+|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 5789999999999999999999999999999998754 334555667789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||+. ++.+-+.+.+. .++...+..++.|++.|+.|||+++++||||||+||||+.+|.+||||||+|+.+..
T Consensus 81 E~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~----- 153 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA----- 153 (396)
T ss_pred eecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-----
Confidence 99954 55555665543 489999999999999999999999999999999999999999999999999987652
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCCCchhh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
+...-+.++.|.+|.|||.+.|. ...||||+||++.||++|.+.|+.-
T Consensus 154 ----------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 154 ----------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred ----------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 22234568999999999999973 4889999999999999999999854
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=346.19 Aligned_cols=203 Identities=37% Similarity=0.680 Sum_probs=184.6
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 745 (905)
..+..++|.++++||+|.||+|+++..+.+++.||||++++..+...++++..+.|..|+... +||++++++.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 367889999999999999999999999999999999999999998999999999999999887 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
++|+||||+.||++..+.+ ...|++..++.|+..|+.||.|||++||||||||.+|||+|.+|.+||+|||+|+..-
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999543332 3569999999999999999999999999999999999999999999999999996521
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
..+..+.++||||.|||||++.+ +.+.|-|||||+||+|+.|..||+
T Consensus 520 ---------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 520 ---------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred ---------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 12346778999999999999994 348899999999999999999997
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.70 Aligned_cols=200 Identities=27% Similarity=0.461 Sum_probs=185.7
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
..+|++.+.||+|+||.|-++.....|+.||||.+.+..+.+..+.-.+.+|++||..|+||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999999999999999999999888889999999999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||..+|.|++|+...+ .+++.+++.+++||+.|+.|||.++++|||||.+|||+|.++++||+|||++-...
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~----- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA----- 204 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-----
Confidence 99999999999998864 49999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....++|||+|-|.+||++.|. +..|.||||++||.|++|..||..
T Consensus 205 -----------------------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 205 -----------------------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred -----------------------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 22345789999999999999963 489999999999999999999964
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=336.32 Aligned_cols=203 Identities=31% Similarity=0.515 Sum_probs=179.1
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCH--HHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLD-HPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 745 (905)
...+.|.+.+.||+|+||+|+.|.+..++..||+|++.+...... .....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 446799999999999999999999999999999998876522211 33456678999999998 999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEeccCcccc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 824 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG~s~~~ 824 (905)
.+|+|||||.||+|++++.. .+++.+..+..++.||+.|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999988 3569999999999999999999999999999999999999999 99999999999764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---C--CCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---Y--TRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~--~~sDiwSlGvil~elltg~~PF~ 899 (905)
. .......++|||+.|+|||++.+ | .++|+||||++||.|++|+.||.
T Consensus 172 ~---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 P---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred C---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 2 01223457899999999999994 3 48999999999999999999997
Q ss_pred h
Q 002580 900 I 900 (905)
Q Consensus 900 ~ 900 (905)
.
T Consensus 225 d 225 (370)
T KOG0583|consen 225 D 225 (370)
T ss_pred C
Confidence 5
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=339.35 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=183.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+-|++++.||.|+.|.|-+|++..||+..|||++.+...........+.+|+-+|+.+.||||+.+|++|.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 56799999999999999999999999999999999987555666677889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
+||++||.|++++-+. +++++.++.+++.||+.|+.|||..+||||||||+|+||+..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~----- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV----- 163 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-----
Confidence 9999999999999875 559999999999999999999999999999999999999999999999999996532
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
+.....+.||+|.|.|||++.| ..++||||+|||||-|++|++||..
T Consensus 164 -----------------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 164 -----------------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred -----------------------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 3344567899999999999996 3599999999999999999999963
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=330.62 Aligned_cols=204 Identities=24% Similarity=0.303 Sum_probs=177.4
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T 745 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~ 745 (905)
+...+.|+.+++||+|+||.||+|++..||+.||+|.+.... ..........+||.||++|+||||+++.+..... +
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 445678999999999999999999999999999999998653 2345566778999999999999999999988876 7
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+|||+|||+ .+|.-++... .-.|++.++..|++||+.||.|||++||+|||||.+|||||.+|.+||+|||+|++..
T Consensus 192 siYlVFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 192 SIYLVFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred eEEEEEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 8999999994 5888887653 3459999999999999999999999999999999999999999999999999998755
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.... ...+..+-|.+|.|||.+.| ....|+||+||||.||++|++.|+.
T Consensus 270 ~~~~--------------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 270 PSGS--------------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred CCCC--------------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 3221 12345688999999999996 3489999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=332.75 Aligned_cols=198 Identities=30% Similarity=0.436 Sum_probs=178.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.+.. ....+.+.+.+|++|++.++||||+.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57999999999999999999999999999999998763 35567788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||.| +|+.++.... .++++.+..|+.+++.||.|||+++|+|||+||.|||+...|.+|+||||+++..+..
T Consensus 81 e~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~---- 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN---- 153 (808)
T ss_pred hhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC----
Confidence 99976 9999998864 4999999999999999999999999999999999999999999999999999765421
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
....+..-|||.|||||.+.+ ...+|.||+||++||++.|++||..
T Consensus 154 -----------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 154 -----------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred -----------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 122345679999999999995 4489999999999999999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.86 Aligned_cols=206 Identities=27% Similarity=0.417 Sum_probs=177.7
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeE-EEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~-vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
..++.....+.+.||.|+||+||++.+. |.. +|+|++......... ...|.+|+.+|.+++|||||++++++....
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4456667777888999999999999994 445 999999876444333 778999999999999999999999999887
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeCCCCCCCEEEcCCC-cEEEEeccCcc
Q 002580 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNG-HVSLTDFDLSC 822 (905)
Q Consensus 746 -~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g-IvHrDLKp~NILl~~~~-~vkL~DFG~s~ 822 (905)
..+|||||+++|+|.+++.......++...+..|+.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 7999999999999999998754567999999999999999999999999 99999999999999998 99999999997
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCC
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~P 897 (905)
...... .......||+.|||||++.+ +.++|+||||++||||+||..|
T Consensus 193 ~~~~~~---------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 193 EKVISK---------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred eecccc---------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 643211 11233689999999999992 4599999999999999999999
Q ss_pred chhhh
Q 002580 898 FPILC 902 (905)
Q Consensus 898 F~~~~ 902 (905)
|+...
T Consensus 246 f~~~~ 250 (362)
T KOG0192|consen 246 FEDLA 250 (362)
T ss_pred CCCCC
Confidence 98653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.09 Aligned_cols=209 Identities=30% Similarity=0.431 Sum_probs=173.9
Q ss_pred cccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccC-----------HHHHHHHHHHHHHHHhCCCCCc
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------RNKVHRACAEREILDMLDHPFV 734 (905)
Q Consensus 666 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~h~nI 734 (905)
.....+++|++++.||+|.||.|-+|++..+++.||||++.+..... ....+...+|+.+|++|.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34456789999999999999999999999999999999998753221 1224678999999999999999
Q ss_pred ceEEEEEEeC--CeEEEEEeccCCCCHHHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC
Q 002580 735 PALYASFQTK--THVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (905)
Q Consensus 735 v~l~~~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~~~-l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~ 811 (905)
|+|+.+..+. +.+|||+|||..|.+...- ..+. +++.++++|+++++.||.|||.+|||||||||+|+||+++|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999998764 6899999999988775332 2344 89999999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-------CCCchHHHH
Q 002580 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-------YTRMTRYNY 884 (905)
Q Consensus 812 ~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~sDiwSl 884 (905)
++||+|||.+......... .........+|||.|+|||.+.+ ..+.||||+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~----------------------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDE----------------------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred cEEeeccceeeecccCCcc----------------------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 9999999999765422110 01112233689999999999985 238899999
Q ss_pred HHHHHHHHhCCCCch
Q 002580 885 LILVSKKFMEFQPFP 899 (905)
Q Consensus 885 Gvil~elltg~~PF~ 899 (905)
||+||.|++|+.||-
T Consensus 306 GVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 306 GVTLYCLLFGQLPFF 320 (576)
T ss_pred hhhHHHhhhccCCcc
Confidence 999999999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.54 Aligned_cols=202 Identities=24% Similarity=0.399 Sum_probs=178.7
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT- 745 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~- 745 (905)
.+..++|.++++||.|+||.||+|+...++..||||.+++... ..++. .-++|+..|++|+ ||||+++.+++.+.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 3457899999999999999999999999999999999988744 33332 2358999999998 999999999999887
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+|+||||| ..+|+++++.+ ...|++..++.|+.||++||+|+|.+|+.||||||+|||+.....+||+|||+|+.+.
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 999999999 68999999877 6789999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
+.+- -+.++.|.+|.|||++.. +.+.|+||+|||++|+++-++.|+..
T Consensus 162 SkpP----------------------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 162 SKPP----------------------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred cCCC----------------------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 3321 246789999999999983 34999999999999999999999754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.39 Aligned_cols=211 Identities=24% Similarity=0.387 Sum_probs=185.0
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
.....+.+.|++...||.|..++||+|++..++..||||++..... ......+.+|+..++.++||||++++.+|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 4456778899999999999999999999999999999999986533 23478899999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|+||.||.+|++.++++......+++..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999999876667999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc----CC-CCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF----AY-TRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~----~~-~~sDiwSlGvil~elltg~~PF~ 899 (905)
..... + .......++||+.|||||++. || .|+||||||++.+||.+|..||.
T Consensus 177 ~~~G~--------R---------------~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 177 FDSGD--------R---------------QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred cccCc--------e---------------eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 32110 0 001126789999999999965 44 49999999999999999999996
Q ss_pred h
Q 002580 900 I 900 (905)
Q Consensus 900 ~ 900 (905)
.
T Consensus 234 k 234 (516)
T KOG0582|consen 234 K 234 (516)
T ss_pred c
Confidence 4
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.15 Aligned_cols=205 Identities=29% Similarity=0.425 Sum_probs=188.0
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.+..++|.+.+.||.|-||.||+++...++-.+|+|++.+..+......+++.+|++|-..|+||||+++|++|.+...+
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 45678999999999999999999999999999999999988766666678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+++||..+|+|+..|...+.+.+++..+..++.|++.||.|||.++++||||||+|+|++..|.+||+|||++...+
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999999997777889999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.....+.|||..|.+||+..+ ....|+|++|++.||++.|.+||+..
T Consensus 176 ---------------------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 176 ---------------------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred ---------------------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 223457899999999999995 55899999999999999999999854
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=305.32 Aligned_cols=207 Identities=35% Similarity=0.611 Sum_probs=188.6
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
....+.+++|..+++||+|.||+|-+|+.+.+++.||+|++++..+...+.+.....|-.+|+.++||++..+-..|+..
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 34467789999999999999999999999999999999999999888888999999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
+.+|+||||..||.|+-++.+. ..|++..++.+...|+.||.|||+++||+||||.+|+|+|.+|++||+|||+|+--
T Consensus 241 drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999999998774 55999999999999999999999999999999999999999999999999999642
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
. .......++||||.|+|||++.. ..+.|-|.+||+||||++|+.||..
T Consensus 319 I---------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 319 I---------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred c---------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 1 12334678999999999999983 3488999999999999999999964
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=293.65 Aligned_cols=200 Identities=23% Similarity=0.363 Sum_probs=174.7
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.+|...+.||+|.||.||+|++..||+.||||.++.....+ .......+|++.|+.++|+||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47888999999999999999999999999999998764322 22345789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+ ..+|...++.. ...++...+..++.++++||+|||++.|+||||||.|+||+++|.+||+|||+++.......
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 999 56999998764 45699999999999999999999999999999999999999999999999999988653322
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.....+-|.+|.|||.+.| .+..|+||.||++.||+.|.+-|+..
T Consensus 157 -------------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 157 -------------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred -------------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 1122378999999999996 34889999999999999999888753
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=323.79 Aligned_cols=227 Identities=31% Similarity=0.513 Sum_probs=178.4
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||+|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999764 459999999999999999999999999999999999999999999999999987643211100
Q ss_pred CCcc-hh---hhccccCC----CCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTT-NE---KKRRHKGQ----QNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~-~~---~~~~~~~~----~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.... .. ........ ....+...........+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 0000 00 00000000 000000001111235689999999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=313.15 Aligned_cols=202 Identities=29% Similarity=0.423 Sum_probs=174.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--eEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVC 748 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~ 748 (905)
..+|...+.||+|+||.||++.+..+|..+|+|.+... +....+.+.+|+.+|.+++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34688899999999999999999999999999998754 2222677899999999999999999999755444 699
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEEEeccCccccCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL~DFG~s~~~~~~ 827 (905)
++|||+++|+|.+++.+.+. .+++..++.+.+||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999999998765 6999999999999999999999999999999999999999 799999999999765420
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc-C-CC--CchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF-A-YT--RMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~-~~--~sDiwSlGvil~elltg~~PF~~ 900 (905)
. ........+.||+.|||||++. + .. ++|||||||++.||+||..||..
T Consensus 172 ~------------------------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 172 G------------------------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred c------------------------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 0 0112334678999999999999 4 23 89999999999999999999976
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=319.09 Aligned_cols=200 Identities=35% Similarity=0.616 Sum_probs=177.1
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 44679999999999999999999999999999999998654434445677889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999999765 3589999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 171 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 171 ----------------------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred ----------------------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 1123579999999999984 4589999999999999999999953
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.99 Aligned_cols=201 Identities=19% Similarity=0.239 Sum_probs=174.6
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 747 (905)
..+.|+.+..|++|+||.||+|+++.|++.||+|.++... ......-...+|+.+|.+++|||||.+-.+.... +.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4568999999999999999999999999999999997653 1222334567899999999999999999887743 579
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
||||||| ..+|..++...+ .+|...++..++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 153 y~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 153 YIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999 469999998764 56999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
....+..+-|.+|.|||.+.| ++..|+||+|||+.||+++++.|+.
T Consensus 231 ---------------------------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G 280 (419)
T KOG0663|consen 231 ---------------------------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG 280 (419)
T ss_pred ---------------------------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence 223345678999999999995 5699999999999999999999964
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=322.89 Aligned_cols=193 Identities=26% Similarity=0.427 Sum_probs=173.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCCe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H-----PFVPALYASFQTKTH 746 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----~nIv~l~~~~~~~~~ 746 (905)
+|.+++.||+|+||.|.+|.+..|++.||||++++. .....+...|+.+|..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999864 445667788999999996 4 389999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC--CcEEEEeccCcccc
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLT 824 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~--~~vkL~DFG~s~~~ 824 (905)
+|||+|++ +.+|+++++.+....++...++.|+.||+.||.+||..||||+||||+||||..- ..+||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 7899999999888889999999999999999999999999999999999999653 47999999999874
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. ....++.+..|.|||++.| .++.||||||||+.||++|.+.|+.
T Consensus 342 ~q------------------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQ------------------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CC------------------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 31 1226788999999999996 4599999999999999999888864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=321.91 Aligned_cols=227 Identities=32% Similarity=0.537 Sum_probs=177.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654334455567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||+|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999764 359999999999999999999999999999999999999999999999999987543211100
Q ss_pred CCcchhh-----------hccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCC
Q 002580 832 LPTTNEK-----------KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 832 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~P 897 (905)
....... ...........+...........+||+.|+|||++.. +.++|+|||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 0000000 0000000000000000011224579999999999874 4589999999999999999999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 239 f~~ 241 (364)
T cd05599 239 FCS 241 (364)
T ss_pred CCC
Confidence 953
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=311.88 Aligned_cols=197 Identities=34% Similarity=0.581 Sum_probs=173.7
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997653333345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999999764 3589999999999999999999999999999999999999999999999999864321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 154 -------------------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred -------------------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1123478999999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=321.35 Aligned_cols=226 Identities=34% Similarity=0.491 Sum_probs=177.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|.+++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987655455566788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
||+|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999999764 3589999999999999999999999999999999999999999999999999864321110000
Q ss_pred Ccch--------hhhc------------cccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHH
Q 002580 833 PTTN--------EKKR------------RHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVS 889 (905)
Q Consensus 833 ~~~~--------~~~~------------~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ 889 (905)
.... .... .....................+||+.|+|||++.+ ..++|+|||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0000 0000 00000000000000111235689999999999873 45899999999999
Q ss_pred HHHhCCCCchh
Q 002580 890 KKFMEFQPFPI 900 (905)
Q Consensus 890 elltg~~PF~~ 900 (905)
+|++|..||..
T Consensus 240 elltG~~Pf~~ 250 (381)
T cd05626 240 EMLVGQPPFLA 250 (381)
T ss_pred HHHhCCCCCcC
Confidence 99999999953
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=322.82 Aligned_cols=227 Identities=33% Similarity=0.499 Sum_probs=176.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999987653333445567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|..........
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999985432110000
Q ss_pred CCcchhhhc--------cc--------cCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH
Q 002580 832 LPTTNEKKR--------RH--------KGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 832 ~~~~~~~~~--------~~--------~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell 892 (905)
......... .. ...................+||+.|+|||++.+ ..++|+|||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000000000 00 000000000001112235689999999999974 45899999999999999
Q ss_pred hCCCCchh
Q 002580 893 MEFQPFPI 900 (905)
Q Consensus 893 tg~~PF~~ 900 (905)
+|+.||..
T Consensus 239 ~G~~Pf~~ 246 (376)
T cd05598 239 VGQPPFLA 246 (376)
T ss_pred hCCCCCCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.84 Aligned_cols=200 Identities=27% Similarity=0.442 Sum_probs=176.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccc-----cCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-----LNRNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~-----~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 744 (905)
...|...+.||.|..+.|..|.++.+|..+|+|++..... ....-.+...+|+.||+++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4578889999999999999999999999999999875321 1123345667899999998 799999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+++|+|+|+.|.|++++... -.++++..+.|++|++.|+.|||.++||||||||+|||++++.++||+|||+++.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999874 45999999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---------CCCchHHHHHHHHHHHHhCC
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---------YTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---------~~~sDiwSlGvil~elltg~ 895 (905)
. ++......||||+|+|||.+.+ +...|+|++|++||.|+.|.
T Consensus 174 ~----------------------------~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 E----------------------------PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred C----------------------------CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 4 2233457899999999999982 23789999999999999999
Q ss_pred CCchh
Q 002580 896 QPFPI 900 (905)
Q Consensus 896 ~PF~~ 900 (905)
+||-.
T Consensus 226 pPFwH 230 (411)
T KOG0599|consen 226 PPFWH 230 (411)
T ss_pred CchhH
Confidence 99964
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=321.05 Aligned_cols=226 Identities=33% Similarity=0.502 Sum_probs=176.8
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|.+++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++|+||++++++|.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999986544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
||++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999999764 3589999999999999999999999999999999999999999999999999854321110000
Q ss_pred Ccchhhhc-cccC----CCCc---------------ccccccccccccccCCccccccccccC---CCCchHHHHHHHHH
Q 002580 833 PTTNEKKR-RHKG----QQNP---------------VFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVS 889 (905)
Q Consensus 833 ~~~~~~~~-~~~~----~~~~---------------~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ 889 (905)
.......+ .... ...+ .............+||+.|+|||++.+ ..++|+|||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00000000 0000 0000 000000111234689999999999874 45999999999999
Q ss_pred HHHhCCCCchh
Q 002580 890 KKFMEFQPFPI 900 (905)
Q Consensus 890 elltg~~PF~~ 900 (905)
+|++|+.||..
T Consensus 240 elltG~~Pf~~ 250 (382)
T cd05625 240 EMLVGQPPFLA 250 (382)
T ss_pred HHHhCCCCCCC
Confidence 99999999963
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.70 Aligned_cols=226 Identities=32% Similarity=0.526 Sum_probs=175.7
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+++.||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987654334455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||+|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999986432110000
Q ss_pred -----CCcchhhhc----cccCCC-----------CcccccccccccccccCCccccccccccC---CCCchHHHHHHHH
Q 002580 832 -----LPTTNEKKR----RHKGQQ-----------NPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILV 888 (905)
Q Consensus 832 -----~~~~~~~~~----~~~~~~-----------~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil 888 (905)
......... ...... ...+...........+||+.|+|||++.+ ..++|+|||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 000000000 000000 00000000001123679999999999874 4589999999999
Q ss_pred HHHHhCCCCch
Q 002580 889 SKKFMEFQPFP 899 (905)
Q Consensus 889 ~elltg~~PF~ 899 (905)
|+|++|..||.
T Consensus 239 ~elltG~~Pf~ 249 (377)
T cd05629 239 FECLIGWPPFC 249 (377)
T ss_pred hhhhcCCCCCC
Confidence 99999999995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.54 Aligned_cols=201 Identities=32% Similarity=0.602 Sum_probs=176.1
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCC-eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~-~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
.+..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 356779999999999999999999976654 6899999876544444556678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999775 4589999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 184 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 184 ------------------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred ------------------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 1124579999999999874 4589999999999999999999964
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.54 Aligned_cols=206 Identities=24% Similarity=0.415 Sum_probs=181.2
Q ss_pred HHhhcCccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEE
Q 002580 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY 738 (905)
Q Consensus 659 ~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~ 738 (905)
++.+...+++ ...|.....||+|+.|.||.+....+++.||+|.+... .....+.+.+|+.+|+..+|+|||.++
T Consensus 262 l~~v~~~~dP--~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~---~Q~~keLilnEi~Vm~~~~H~NiVnfl 336 (550)
T KOG0578|consen 262 LKRVVSQGDP--RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR---KQPKKELLLNEILVMRDLHHPNIVNFL 336 (550)
T ss_pred hheeccCCCh--hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec---cCCchhhhHHHHHHHHhccchHHHHHH
Confidence 3344445554 34788999999999999999999999999999999865 334456788999999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEec
Q 002580 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 739 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DF 818 (905)
+.|...+.+|+||||++||+|.+.+... .+++.++..|++.++.||+|||.+||+|||||.+|||++.+|.+||+||
T Consensus 337 ~Sylv~deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 337 DSYLVGDELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred HHhcccceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeee
Confidence 9999999999999999999999998763 4999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCC
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~ 895 (905)
|+|..+.... ....+.+|||.|||||+... .++.||||||+|++||+-|.
T Consensus 414 GFcaqi~~~~---------------------------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 414 GFCAQISEEQ---------------------------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred eeeecccccc---------------------------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 9997754221 13357799999999999985 67999999999999999999
Q ss_pred CCch
Q 002580 896 QPFP 899 (905)
Q Consensus 896 ~PF~ 899 (905)
+||-
T Consensus 467 PPYl 470 (550)
T KOG0578|consen 467 PPYL 470 (550)
T ss_pred CCcc
Confidence 9984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=321.32 Aligned_cols=203 Identities=30% Similarity=0.514 Sum_probs=176.3
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44678999999999999999999999999999999997644334444566788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
+|||||+|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999653 48899999999999999999999999999999999999999999999999986542110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||+||+|++|..||..
T Consensus 197 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred --------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 011235679999999999863 3589999999999999999999953
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.03 Aligned_cols=200 Identities=30% Similarity=0.458 Sum_probs=173.3
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++++.+++..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37888999999999999999999999999999876544333444567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|..++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998886554456899999999999999999999999999999999999999999999999998653211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......||+.|+|||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 156 -----------------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred -----------------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 01123468999999999974 4589999999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.74 Aligned_cols=197 Identities=34% Similarity=0.540 Sum_probs=175.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998764444445667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999764 3589999999999999999999999999999999999999999999999999864321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 154 -------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred -------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 1234579999999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.17 Aligned_cols=202 Identities=25% Similarity=0.372 Sum_probs=174.7
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKT---- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~---- 745 (905)
...|..++.||+|+||+||+|+...+|+.||+|.+..... .........+|+.+|+.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4568888999999999999999999999999999986532 1223456789999999999999 999999998877
Q ss_pred --eEEEEEeccCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 746 --HVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 746 --~~~lV~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
.+++|+||+ ..+|..++..... ..++...++.++.||+.||+|||+++|+||||||.||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 6899999987653 35788899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~P 897 (905)
+.... +.......++|..|.|||++.|. +..|+||+||+++||++++..
T Consensus 168 ra~~i---------------------------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFSI---------------------------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhcC---------------------------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 75431 22224456899999999999963 589999999999999999999
Q ss_pred chhh
Q 002580 898 FPIL 901 (905)
Q Consensus 898 F~~~ 901 (905)
|+..
T Consensus 221 FpG~ 224 (323)
T KOG0594|consen 221 FPGD 224 (323)
T ss_pred CCCC
Confidence 9754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=318.94 Aligned_cols=204 Identities=30% Similarity=0.513 Sum_probs=177.0
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999764333444556678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+|||||+|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999998753 3889999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
. .......+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred C--------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 0 011234679999999999863 3589999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=312.99 Aligned_cols=193 Identities=38% Similarity=0.644 Sum_probs=169.3
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998754444555667889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------
Confidence 999998764 45899999999999999999999999999999999999999999999999998542100
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 196 (323)
T cd05571 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred -----------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence 011234679999999999974 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=317.90 Aligned_cols=204 Identities=31% Similarity=0.495 Sum_probs=176.3
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.+..++|.+.+.||+|+||.||+|.+..++..||+|++.+...........+..|+.+++.++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35567999999999999999999999999999999999765333444455678899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+|||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998653 4889999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
. .......+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred C--------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 0 011234579999999999863 3489999999999999999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=338.21 Aligned_cols=206 Identities=32% Similarity=0.500 Sum_probs=186.8
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
++..++|.+++.||+|+||.|.+++++.|++.||+|++++-.+..+.....|..|.++|...+.+-|++++..|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 56678999999999999999999999999999999999987676777888999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+|||||+||+|..++.+.. ++++..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.|-....
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~- 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA- 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-
Confidence 99999999999999998754 699999999999999999999999999999999999999999999999999865442
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.....+...+|||.|++||++.. ...+|.||+||++|||++|..||+
T Consensus 228 -------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 228 -------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred -------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 22335567799999999999981 348899999999999999999997
Q ss_pred hh
Q 002580 900 IL 901 (905)
Q Consensus 900 ~~ 901 (905)
..
T Consensus 283 ad 284 (1317)
T KOG0612|consen 283 AD 284 (1317)
T ss_pred HH
Confidence 53
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=316.52 Aligned_cols=227 Identities=31% Similarity=0.520 Sum_probs=177.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++|+||++++++|.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444455677888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||+|++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999999764 348999999999999999999999999999999999999999999999999987543211100
Q ss_pred CC------cchhhhcc--ccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LP------TTNEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. ........ ........+...........+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 00 00000000 0000000000001112235689999999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=310.17 Aligned_cols=202 Identities=27% Similarity=0.398 Sum_probs=182.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 748 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 748 (905)
....|.+.+.||.|.||.||.|..+.||+.+|+|++++...........+.+|+.+|+++. ||||+.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3568999999999999999999999999999999999887666667788999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC----CCcEEEEeccCcccc
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFDLSCLT 824 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~----~~~vkL~DFG~s~~~ 824 (905)
+|||+|.||.|++.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+.. ++.+|++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999999876 2999999999999999999999999999999999999953 357999999999775
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.. .......+||+.|+|||++.. ....|+||+|+++|.|++|..||...
T Consensus 190 ~~----------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 190 KP----------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred cC----------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 42 123456799999999999993 45999999999999999999999765
Q ss_pred h
Q 002580 902 C 902 (905)
Q Consensus 902 ~ 902 (905)
.
T Consensus 242 ~ 242 (382)
T KOG0032|consen 242 T 242 (382)
T ss_pred C
Confidence 4
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=308.53 Aligned_cols=193 Identities=37% Similarity=0.655 Sum_probs=168.6
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||+|+||.||++.+..+|..||+|++.+...........+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998764444455667788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--------- 149 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------- 149 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC---------
Confidence 999988764 358999999999999999999999999999999999999999999999999985421100
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 196 (323)
T cd05595 150 ------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (323)
T ss_pred ------------------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence 11224579999999999974 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=308.84 Aligned_cols=193 Identities=39% Similarity=0.657 Sum_probs=169.3
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998765445556677889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999988764 45899999999999999999999999999999999999999999999999998542110
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~ 196 (328)
T cd05593 149 -----------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 196 (328)
T ss_pred -----------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence 011234579999999999874 468999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.97 Aligned_cols=201 Identities=22% Similarity=0.333 Sum_probs=175.9
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CC
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KT 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-----~~ 745 (905)
...|..++.||.|+||.|+.+.+..+|..||+|.+... +.+....++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566689999999999999999999999999998754 4566778899999999999999999999999875 35
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+|+|+|+| +.+|...++.+ ..+++..+..+++||+.||+|+|+.+|+||||||+|+|++.+..+||||||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 799999999 78999999875 349999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. ......+.++.|.+|.|||++.. +...||||+|||+.||++|++.|+.
T Consensus 177 ~~-------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 177 KF-------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred cc-------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 22 01123467889999999999983 4588999999999999999999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=309.89 Aligned_cols=202 Identities=34% Similarity=0.510 Sum_probs=174.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998643334445667888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++|++|.+++.+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999999753 24589999999999999999999999999999999999999999999999999855321110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......+||+.|+|||++.. ..++|+|||||++|+|++|+.||..
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 ------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ------------------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 01123469999999999862 3489999999999999999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=306.24 Aligned_cols=192 Identities=35% Similarity=0.574 Sum_probs=168.3
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..++||||++++++|...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999865444455667788999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~ 839 (905)
.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9999764 45899999999999999999999999999999999999999999999999998642211
Q ss_pred ccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 147 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 147 ---------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred ---------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 011234579999999999984 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=288.96 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=175.8
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..+.|.+.+.||+|.|+.|++|.+..||+.||+|+++...+.. ...+.+.+|+.|.+.|+||||+++++.+...+..||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 3578999999999999999999999999999999998765544 367889999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC---CCcEEEEeccCccccCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~---~~~vkL~DFG~s~~~~~ 826 (905)
|+|++.|++|..-+-.+ ..+++..+..+++||+.+|.|||.+||||||+||.|+|+-+ ...+||+|||++...+
T Consensus 88 vFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999999987666543 44899999999999999999999999999999999999953 3469999999997655
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
+ ....-.++|||.|||||++.. ...+|+|+.|++||-|+.|.+||..
T Consensus 165 ~---------------------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 165 D---------------------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred C---------------------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 1 112346799999999999984 4589999999999999999999965
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=303.26 Aligned_cols=206 Identities=31% Similarity=0.507 Sum_probs=186.8
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
+++..+.|+.-++||+|+||.||-|+...||+.||+|.+.+..+..+......++|..+|.+++.++||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 56778889999999999999999999999999999999988777666777788899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
+|+||..|.||+|.-+|.+.++..|++..++.++.+|+.||.+||+.+||+|||||+|||+|+.|+++|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999999888878899999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
. ......+||.+|||||++.. ....|-|||||+||+|+.|+.||.-
T Consensus 340 g----------------------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 340 G----------------------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred C----------------------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 2 12234589999999999984 3478999999999999999999963
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=309.36 Aligned_cols=202 Identities=32% Similarity=0.464 Sum_probs=174.1
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643334445566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++||+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 9999999999997642 3589999999999999999999999999999999999999999999999999865431110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......+||+.|+|||++.+ ..++|+|||||+||+|++|+.||..
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 158 ------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 01123579999999999863 3489999999999999999999953
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.33 Aligned_cols=198 Identities=31% Similarity=0.568 Sum_probs=171.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCeEEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~lV~ 751 (905)
+|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+.|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588999999999999999999999999999999875444445567788899999999765 6888999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999998764 34899999999999999999999999999999999999999999999999998532100
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 155 -----------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred -----------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 011234579999999999985 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.99 Aligned_cols=202 Identities=22% Similarity=0.407 Sum_probs=182.5
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe-EEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH-VCL 749 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~-~~l 749 (905)
.++|..++++|+|+||.+++++++..+..|++|.+....... .......+|+.+++++.|||||.+++.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 568999999999999999999999999999999998764433 344477899999999999999999999998887 999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||+||+||+|.+.+.++....|+++.+..++.|++.|+.|||++.|+|||||+.|||++.++.|+|.|||+|+..+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999998877789999999999999999999999999999999999999999999999999998865332
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
....+.+|||.||+||++.+ ..++|+|||||++|||++-+++|..
T Consensus 161 --------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 161 --------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred --------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 13457899999999999995 4599999999999999999999964
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=305.02 Aligned_cols=199 Identities=31% Similarity=0.550 Sum_probs=171.5
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+|.+.+.||+|+||.||+|.+..++..||+|++.+...........+..|..++..+ .|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876443444555677788888777 5899999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999998764 34899999999999999999999999999999999999999999999999998542210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 155 -----------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred -----------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 011234579999999999984 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.85 Aligned_cols=201 Identities=27% Similarity=0.397 Sum_probs=180.4
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+=|.+.+.||+|-|+.|-++++.-||..||||++.+..+ +.-....+.+|+.+|+.++|||||++|.+......+|||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 4569999999999999999999999999999999998755 334456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEE-cCCCcEEEEeccCccccCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl-~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
+|+-.+|+|++|+.++. ..+++..+.+++.||+.|+.|||+..+|||||||+|+.+ ..-|-+||.|||++-..
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf----- 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF----- 169 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-----
Confidence 99999999999998874 459999999999999999999999999999999999976 56789999999998442
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCCCchhh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.++....++||+..|.|||++.|. ++.||||||||||.|++|++||..+
T Consensus 170 -----------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 170 -----------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred -----------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 234556788999999999999963 5899999999999999999999864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.95 Aligned_cols=197 Identities=36% Similarity=0.625 Sum_probs=168.4
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCeEEEE
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il---~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
|++++.||+|+||.||+|.+..+++.||+|++++...........+..|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 77899999999999999999999999999999865433344456677776665 456799999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999988754 35899999999999999999999999999999999999999999999999998532110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 155 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 155 ------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred ------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 011235679999999999874 4589999999999999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=311.69 Aligned_cols=227 Identities=34% Similarity=0.527 Sum_probs=179.4
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998754444455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999875 459999999999999999999999999999999999999999999999999987654322100
Q ss_pred CCcchhhhccccCCCCc--ccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNP--VFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
................. ..............||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 00000000000000000 000000112335679999999999984 4599999999999999999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=304.97 Aligned_cols=193 Identities=32% Similarity=0.580 Sum_probs=168.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999876544455566788899999888 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--------- 149 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999998532100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 150 ------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 011234679999999999984 458999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.49 Aligned_cols=193 Identities=38% Similarity=0.651 Sum_probs=168.0
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||+|+||.||+|.+..++..||+|++.+...........+..|+.++..++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998764444555667788999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
+|..++... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999988764 458999999999999999999997 79999999999999999999999999998542110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 150 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred ------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 011224579999999999874 458999999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.38 Aligned_cols=202 Identities=31% Similarity=0.471 Sum_probs=173.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997643333444556788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++|+|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 9999999999997642 358999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCcccccccccc--------CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--------AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--------~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++. ...++|+|||||++|+|++|+.||..
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 157 -----------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred -----------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 01122357999999999985 14589999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=302.03 Aligned_cols=193 Identities=36% Similarity=0.682 Sum_probs=165.5
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999875433344455666777777654 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-------- 150 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-------- 150 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--------
Confidence 9999998764 358999999999999999999999999999999999999999999999999986432110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 151 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~ 197 (316)
T cd05592 151 -------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred -------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence 11234579999999999874 458999999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.96 Aligned_cols=194 Identities=36% Similarity=0.618 Sum_probs=167.6
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999875444445566777899988876 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999988764 34899999999999999999999999999999999999999999999999998542211
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 150 ------------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ------------------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 011234579999999999874 4589999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=302.20 Aligned_cols=199 Identities=32% Similarity=0.557 Sum_probs=170.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999999999999999998654334445567778888988885 577889999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999998764 35999999999999999999999999999999999999999999999999998542210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 155 -----------------------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred -----------------------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 011234579999999999874 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=307.33 Aligned_cols=202 Identities=33% Similarity=0.550 Sum_probs=175.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||+|.+..+++.||+|++++...........+..|+.+++.++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998764434455667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 9999999999998752 3599999999999999999999999999999999999999999999999999865431110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......||+.|+|||++.. ..++|+|||||++|+|++|..||..
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 158 ------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred ------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 01123478999999999862 3589999999999999999999953
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=298.56 Aligned_cols=199 Identities=23% Similarity=0.336 Sum_probs=169.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999875422 12234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 82 FEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred EECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 9999 568888876543 458899999999999999999999999999999999999999999999999985432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+|+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 158 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 -------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred -------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11123468999999999863 3478999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=302.66 Aligned_cols=193 Identities=33% Similarity=0.579 Sum_probs=168.1
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++++...........+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3689999999999999999999999999876544555666788899888776 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999888764 45999999999999999999999999999999999999999999999999998542100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 150 ------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 011234679999999999984 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=306.85 Aligned_cols=205 Identities=20% Similarity=0.276 Sum_probs=175.3
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
..+.+..+...+...||+|.||+||+|.+-+ .||||+++.... .+...+.|++|+.+|++-+|.||+-+.|+|..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4456677788899999999999999999843 499999987643 556889999999999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
.. .||+.+|+|.+|+.+++... ..|.....+.|++||++|+.|||.++|||||||..|||+.++++|||+|||++...
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 76 99999999999999998764 34999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc------CCCCchHHHHHHHHHHHHhCCCCc
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF------AYTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~------~~~~sDiwSlGvil~elltg~~PF 898 (905)
.. | ........--|..-|||||++. .+..+||||||+++|||++|.+||
T Consensus 539 ~~-----------------------w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 TR-----------------------W--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ee-----------------------e--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 21 1 0111122335778899999998 245999999999999999999999
Q ss_pred hh
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 594 si 595 (678)
T KOG0193|consen 594 SI 595 (678)
T ss_pred CC
Confidence 84
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=302.02 Aligned_cols=194 Identities=35% Similarity=0.622 Sum_probs=167.2
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999999999999999999865443444566777888888876 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988764 35899999999999999999999999999999999999999999999999998542100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 150 ------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred ------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 011234579999999999884 4589999999999999999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=303.32 Aligned_cols=199 Identities=38% Similarity=0.622 Sum_probs=169.3
Q ss_pred CeeecccccccCceEEEEEEEc---CCCeEEEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~---~t~~~vavK~~~~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 747 (905)
+|++++.||+|+||.||+|.+. .++..||+|++.+.... .......+..|+.++..+ +|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 47899999999764322 223445678899999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998764 34899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
. .......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 159 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 159 E--------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred C--------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 0 011234579999999999874 348999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=300.94 Aligned_cols=198 Identities=25% Similarity=0.387 Sum_probs=176.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
..|+.++.||+|.||.||+|.+..+++.||+|++... ........+++|+.+|.+++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechh--hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4578889999999999999999999999999999865 34556788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||.||++.++++.. ..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..+..
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN----- 163 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----
Confidence 999999999999764 3358888899999999999999999999999999999999999999999999865431
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......+++|||.|||||++.+ ..++||||||++.|||.+|.+||..
T Consensus 164 ----------------------~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 164 ----------------------TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred ----------------------hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 1223368899999999999984 4599999999999999999999964
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=296.13 Aligned_cols=199 Identities=22% Similarity=0.291 Sum_probs=169.6
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+.+.||.|+||.||+|.+..++..||+|.++... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 568999999999999999999999999999999987542 122234567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+. ++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 82 FEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred EeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 99996 58998887543 357899999999999999999999999999999999999999999999999986432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+|+.|+|||++.+ ..++|+|||||++|+|++|++||..
T Consensus 158 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 158 -------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred -------------------------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01123468999999999863 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=301.99 Aligned_cols=193 Identities=38% Similarity=0.634 Sum_probs=163.9
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333334445555655 45778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--------- 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998542110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 197 (323)
T cd05575 150 ------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (323)
T ss_pred ------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence 011234579999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=303.55 Aligned_cols=207 Identities=25% Similarity=0.354 Sum_probs=175.0
Q ss_pred CccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 664 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
...+.+....+++++.||+|.||.||.|.+..+ ..||+|.++...+ ..+.|.+|+++|++|+|+|||++++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 455667788899999999999999999999433 4799999987633 23567799999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
++.+|||||||+.|+|.++|+......+...+.+.++.|||.||+||+++++|||||-..|||+++++.+||+|||+|+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 88999999999999999999986667799999999999999999999999999999999999999999999999999985
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH-hCCCCch
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF-MEFQPFP 899 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell-tg~~PF~ 899 (905)
...+... .....--...|.|||.+.. +.+|||||||++||||+ .|+.||+
T Consensus 353 ~~d~~Y~--------------------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 353 IGDDEYT--------------------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred cCCCcee--------------------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 4322111 1111122347999999983 56999999999999999 5788886
Q ss_pred hh
Q 002580 900 IL 901 (905)
Q Consensus 900 ~~ 901 (905)
..
T Consensus 407 ~m 408 (468)
T KOG0197|consen 407 GM 408 (468)
T ss_pred CC
Confidence 43
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=295.05 Aligned_cols=200 Identities=21% Similarity=0.283 Sum_probs=170.2
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976422 2334566788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++++.+..+... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 155 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-- 155 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence 99988766655433 24589999999999999999999999999999999999999999999999999865431110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......||+.|+|||++.+ ..++|+|||||++|+|++|++||+.
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 156 ------------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ------------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 11224578999999999874 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=293.95 Aligned_cols=200 Identities=30% Similarity=0.466 Sum_probs=172.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48889999999999999999999999999999976543333344567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 9999999988876545569999999999999999999999999999999999999999999999999986532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+|++.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 157 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 157 ------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred ------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 1123478999999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=302.83 Aligned_cols=206 Identities=24% Similarity=0.324 Sum_probs=168.3
Q ss_pred cccCCCeeecccccccCceEEEEEEEc-----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 741 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 741 (905)
++..++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 456679999999999999999999752 345689999987532 233456788999999999 899999999988
Q ss_pred EeC-CeEEEEEeccCCCCHHHHHhhCC-----------------------------------------------------
Q 002580 742 QTK-THVCLITDYCPGGELFLLLDRQP----------------------------------------------------- 767 (905)
Q Consensus 742 ~~~-~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 767 (905)
... +.+|++||||++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 46899999999999999987532
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhc
Q 002580 768 -------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 840 (905)
Q Consensus 768 -------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~ 840 (905)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 124778888999999999999999999999999999999999999999999998654311110
Q ss_pred cccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 841 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......+++.|+|||++.+ +.++|+|||||+||+|++ |..||+.
T Consensus 231 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 231 ---------------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred ---------------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 01123346788999999874 569999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-33 Score=293.52 Aligned_cols=193 Identities=23% Similarity=0.380 Sum_probs=163.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CeE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----THV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~~ 747 (905)
.|.-.+.+|+|+||.||.+....++..+|||..-... ..-.+|+++|+.++|||||++..+|... -+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5888899999999999999999999999999875431 2234699999999999999999888632 256
Q ss_pred EEEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEeccCcccc
Q 002580 748 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 824 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG~s~~~ 824 (905)
.+||||++ .+|.++++. ..+..++...+.-+..||++||.|||+.|||||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 79999995 699988874 123458888899999999999999999999999999999999976 89999999999876
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
... ....++..|..|.|||.+.| +++.|+||.||++.||+-|++-|+.
T Consensus 177 ~~~----------------------------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 VKG----------------------------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred ccC----------------------------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 422 12346789999999999996 4599999999999999999999975
Q ss_pred h
Q 002580 901 L 901 (905)
Q Consensus 901 ~ 901 (905)
.
T Consensus 229 ~ 229 (364)
T KOG0658|consen 229 D 229 (364)
T ss_pred C
Confidence 4
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=300.97 Aligned_cols=193 Identities=38% Similarity=0.628 Sum_probs=163.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++.+.+..|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999998654333333445555554 57788999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--------- 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---------
Confidence 9999888764 45899999999999999999999999999999999999999999999999998542110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (321)
T cd05603 150 ------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (321)
T ss_pred ------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence 011234579999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=301.23 Aligned_cols=193 Identities=33% Similarity=0.578 Sum_probs=168.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..+ +||||+.+++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3689999999999999999999999999876544455667788999999888 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999988764 35999999999999999999999999999999999999999999999999998542100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||+||+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 150 ------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred ------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 011234679999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=300.74 Aligned_cols=193 Identities=36% Similarity=0.609 Sum_probs=162.2
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999998653322223334444444 56778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--------- 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------- 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---------
Confidence 9999999764 44889999999999999999999999999999999999999999999999998542110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|.+||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 150 ------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred ------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 011234679999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=293.41 Aligned_cols=206 Identities=30% Similarity=0.533 Sum_probs=184.3
Q ss_pred cccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (905)
Q Consensus 666 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 744 (905)
.+.+...+|.++.+||+|+||.|.++..+.|.+.||||++++..+...++++....|-.+|... +-|++++++.+|+.-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3467788999999999999999999999999999999999999888888888888899999876 578999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
+.+|+||||+.||+|...+++-+ .+.+..+..++..|+-||-|||++||++||||.+|||++.+|.+||+|||+++..
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999998754 4999999999999999999999999999999999999999999999999999542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
- -....+.++||||.|+|||++.. ....|.||+||+||||+.|++||..
T Consensus 501 i---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 501 I---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred c---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 1 02234568999999999999984 3477999999999999999999963
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=301.49 Aligned_cols=194 Identities=38% Similarity=0.620 Sum_probs=164.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333444455556655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------- 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------- 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---------
Confidence 9999888764 45899999999999999999999999999999999999999999999999998542100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 150 ------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred ------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 011234579999999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=300.30 Aligned_cols=231 Identities=32% Similarity=0.517 Sum_probs=186.6
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.++...|..++.||-|+||.|+++...+|...||+|.+.+.....++.+..+..|.+||..-+++.||+||..|++++++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 45677899999999999999999999999999999999988777888888999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||+|++||++..+|.+. +.|.+..++.++..+.+|+++.|..|+|||||||+|||||.+|.+||+|||+|+-..-.
T Consensus 705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999999999875 45999999999999999999999999999999999999999999999999998654321
Q ss_pred C-CCCCCcchhhhccccC--------CCCccccc-----c-cccccccccCCcccccccccc--CC-CCchHHHHHHHHH
Q 002580 828 P-QLLLPTTNEKKRRHKG--------QQNPVFMA-----E-PMRASNSFVGTEEYIAPVSDF--AY-TRMTRYNYLILVS 889 (905)
Q Consensus 828 ~-~~~~~~~~~~~~~~~~--------~~~~~~~~-----~-~~~~~~~~~gT~~Y~APE~l~--~~-~~sDiwSlGvil~ 889 (905)
. ...+....+.+...-. ....-++. . .-...-..+||+.|+|||++. |+ ..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1 1111111111000000 00000000 0 001223568999999999998 44 4789999999999
Q ss_pred HHHhCCCCchh
Q 002580 890 KKFMEFQPFPI 900 (905)
Q Consensus 890 elltg~~PF~~ 900 (905)
+|+.|++||-.
T Consensus 863 em~~g~~pf~~ 873 (1034)
T KOG0608|consen 863 EMLVGQPPFLA 873 (1034)
T ss_pred HHhhCCCCccC
Confidence 99999999943
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=302.17 Aligned_cols=193 Identities=23% Similarity=0.379 Sum_probs=168.5
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
+++..+...-++-||.|+.|.||+++. .++.||||.++. .-..+|+.|++|+|+||+.|.++|....+
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCce
Confidence 445555556677899999999999998 578899997642 22347888999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
+|||||||..|-|+.+|+.. ..++......+..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++..+.
T Consensus 187 yCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred eEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999999999874 4588899999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
. .....|+||..|||||++.. +.|.|||||||+||||+||..||..+
T Consensus 265 ~----------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 265 K----------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred h----------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 2 12347899999999999994 67999999999999999999999765
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=291.73 Aligned_cols=194 Identities=29% Similarity=0.474 Sum_probs=166.9
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++|+||++++++|.....+|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998765443444456778899999999999999999999999999999999999999
Q ss_pred HHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 760 FLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 760 ~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
..++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 8887532 23468999999999999999999999999999999999999999999999999986533111
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......||+.|+|||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 152 ------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 152 ------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 11224578999999999984 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=298.58 Aligned_cols=193 Identities=35% Similarity=0.653 Sum_probs=165.1
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..++..||+|++++..............|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999999865433333455667788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 150 ------------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred ------------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 011234679999999999974 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=299.48 Aligned_cols=195 Identities=40% Similarity=0.649 Sum_probs=165.6
Q ss_pred cccccccCceEEEEEEEc---CCCeEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 677 IKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~---~t~~~vavK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
++.||+|+||.||+|.+. .+++.||+|++++.... .......+..|+.+++.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 46889999999864321 22334567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999999764 45889999999999999999999999999999999999999999999999998532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 154 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 154 ----------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred ----------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 011234579999999999974 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=296.55 Aligned_cols=198 Identities=25% Similarity=0.399 Sum_probs=174.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++++.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999987542 3345567899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999999764 3489999999999999999999986 6999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......||+.|+|||++.+ +.++|+|||||++|+|++|+.||.
T Consensus 158 -----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 158 -----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred -----------------------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 1123578999999999984 458999999999999999999995
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=304.63 Aligned_cols=192 Identities=21% Similarity=0.283 Sum_probs=166.7
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+...+|.+++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||++++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 456789999999999999999999999999999996432 34678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
+|||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999 57898888764 348999999999999999999999999999999999999999999999999986422100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||
T Consensus 237 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 237 --------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred --------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 011234679999999999874 45899999999999999999876
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=280.61 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=170.4
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+|+.|--|....+|..||||++.+. ......++.+|++++.++ .|+||++++++|+++..+|||||.|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 5689999999999999999999999999876 345667899999999998 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC---cEEEEeccCccccCCCCCCCCC
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~---~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
|.|...+.++ +.|++.++..+.++|+.||.|||.+||.||||||+|||....+ .+|||||.+..-+.......+.
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999999875 4599999999999999999999999999999999999996544 5899999987543322211100
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCchhhhc
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPILCR 903 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~~~~r 903 (905)
......+-+|+..|||||+... ..++|.||||||||-|+.|.+||..-|+
T Consensus 239 --------------------stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 239 --------------------STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred --------------------CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1112345689999999999872 3589999999999999999999976554
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=296.92 Aligned_cols=193 Identities=35% Similarity=0.662 Sum_probs=164.9
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999875433333445667788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999999764 34889999999999999999999999999999999999999999999999998542110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ +.++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (316)
T cd05619 150 ------------------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred ------------------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 011234579999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=301.79 Aligned_cols=197 Identities=24% Similarity=0.377 Sum_probs=167.9
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
....++|..++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 344678999999999999999999999999999999986542 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+|||||++++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999999998643 23567788899999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~ 899 (905)
........||..|+|||++.. ..++|+|||||++|+|++|+.||.
T Consensus 222 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 222 ---------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ---------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 011234579999999999842 238999999999999999999996
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=315.01 Aligned_cols=212 Identities=25% Similarity=0.289 Sum_probs=174.1
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe---
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS-FQT--- 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~-~~~--- 743 (905)
+...++++.+.|.+|||+.||+|.+...|..||+|.+-.. +....+.+.+|+++|+.|. |+|||.|++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3445678899999999999999999888899999988643 7778899999999999995 9999999993 321
Q ss_pred C---CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCCEEEcCCCcEEEEec
Q 002580 744 K---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 744 ~---~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g--IvHrDLKp~NILl~~~~~vkL~DF 818 (905)
. -.++|+||||.||.|-+++..+....|++.++++|+.+++.|+.+||... |||||||-+||||+.+|.+|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 25789999999999999998765666999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHH
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~ell 892 (905)
|.++-...... ...+.. .....-....|+.|+|||++.- .+|+|||+|||+||.|+
T Consensus 191 GSatt~~~~~~----~~~e~~--------------~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC 252 (738)
T KOG1989|consen 191 GSATTKILSPT----SAQEVN--------------YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC 252 (738)
T ss_pred cccccccCCCc----cHHHHH--------------HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH
Confidence 99864321111 110000 0111122357899999999982 46999999999999999
Q ss_pred hCCCCchhh
Q 002580 893 MEFQPFPIL 901 (905)
Q Consensus 893 tg~~PF~~~ 901 (905)
+...||+.-
T Consensus 253 y~t~PFe~s 261 (738)
T KOG1989|consen 253 YFTTPFEES 261 (738)
T ss_pred HhCCCcCcC
Confidence 999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=299.42 Aligned_cols=199 Identities=19% Similarity=0.304 Sum_probs=166.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CeE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----THV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~~ 747 (905)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233445688999999999999999999988643 358
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||| +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 57899988764 34899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. ........+||+.|+|||++.+ ..++|+|||||++|+|++|++||.
T Consensus 157 ~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 157 TP------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred cC------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 10 0011234579999999999753 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=301.34 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=183.2
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
+....+.|.+.+.||+|.|+.|.++.+..|+..||||++.+... +......+.+|+++|+.++|||||+++.+......
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l-n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL-NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc-ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 34557789999999999999999999999999999999998755 44444558999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
+|+||||+.+|.+++++.+++ +..+..+..++.|++.+++|||+++|||||||.+||||+.+.++||+|||++....
T Consensus 130 lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999999998864 47789999999999999999999999999999999999999999999999996644
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++||++.|.|||++.+ .+.+|+||+|++||.|+.|.+||..
T Consensus 207 ---------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 207 ---------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ---------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 2234568899999999999996 4599999999999999999999973
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=300.19 Aligned_cols=199 Identities=25% Similarity=0.289 Sum_probs=168.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-eEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-HVCL 749 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-~~~l 749 (905)
.++|.....||+|+||.||+|.... +..||||.+....... ...|.+|+.++.+++|||+++|+|||.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 3678888899999999999999854 4889999877542211 345999999999999999999999999988 5999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g---IvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
|+||+++|+|.+++.......++|....+|+.+++.||.|||... |+||||||+|||+|.++++||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999998754327899999999999999999999864 99999999999999999999999999955331
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccc-cCCcccccccccc---CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF-VGTEEYIAPVSDF---AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gT~~Y~APE~l~---~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
. . ...... .||.+|+|||++. -+.++||||||++|+||++|+.|...
T Consensus 230 ~-~--------------------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 230 G-D--------------------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred c-c--------------------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 0 0 001111 7999999999997 35699999999999999999987753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=302.74 Aligned_cols=203 Identities=33% Similarity=0.557 Sum_probs=185.4
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.+...+++++..||-|+||.|-++........+|+|++++..+.+....+.+..|..||..++.|+||++|..|.++.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34567888999999999999999998666667999999998888888888999999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|++||-|-||.|...+... +.|.+..++.++.+++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+..
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 9999999999999999875 4599999999999999999999999999999999999999999999999999988652
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...+.++||||.|.|||++. ...+.|.||||+++|||++|.+||..
T Consensus 573 ---------------------------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 573 ---------------------------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred ---------------------------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 23456899999999999998 35689999999999999999999964
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=296.31 Aligned_cols=193 Identities=35% Similarity=0.618 Sum_probs=167.6
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||+|+||.||+|.+..++..||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876444445566778899999887 799999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999988764 35999999999999999999999999999999999999999999999999998532100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+||+.|+|||++.+ +.++|+|||||++|+|++|..||.
T Consensus 150 ------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~ 197 (318)
T cd05570 150 ------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197 (318)
T ss_pred ------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence 011234579999999999974 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=317.47 Aligned_cols=221 Identities=23% Similarity=0.287 Sum_probs=177.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++.+.||+|+||.||+|.+..+++.||+|++............++.+|+.+++.++||||+++++++.+++..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999765444445567789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 751 TDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
|||++|++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999999986421 123456678889999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
.............. ...+.............+||+.|+|||++.+ +.++|+|||||++|+|++|..||
T Consensus 161 k~i~~~~~~~~~l~---------~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 161 IFKKLEEEDLLDID---------VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred eecccccccccccc---------cccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 76532111000000 0000000111122334679999999999874 45899999999999999999999
Q ss_pred hh
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 232 ~~ 233 (932)
T PRK13184 232 RR 233 (932)
T ss_pred CC
Confidence 53
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=288.22 Aligned_cols=193 Identities=29% Similarity=0.456 Sum_probs=165.8
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||+|+||.||++.+..+|+.||+|.+.............+..|+++++.++||||+++++++..+...|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998764333333344556799999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~ 839 (905)
..++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 988876555568999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......||+.|+|||++.+ +.++|+|||||++|+|++|..||..
T Consensus 150 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 150 -----------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred -----------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 1123468999999999874 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=294.95 Aligned_cols=195 Identities=29% Similarity=0.396 Sum_probs=170.1
Q ss_pred cccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
.+.||+|.||+||-+.++.+|+.||||++.+..+.... ...+.+|+.||+.+.||.||.+...|++.+.+|+|||.+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 36899999999999999999999999999987554443 378899999999999999999999999999999999999 4
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC---CcEEEEeccCccccCCCCCCCCC
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~---~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
|+..+++-....+++++.....++.||+.||.|||-++|+|+||||+|||+.+. -++||||||++++++..+
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----- 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----- 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-----
Confidence 565555555556789999999999999999999999999999999999999653 379999999999876322
Q ss_pred cchhhhccccCCCCcccccccccccccccCCcccccccccc--CCC-CchHHHHHHHHHHHHhCCCCchhh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--AYT-RMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--~~~-~sDiwSlGvil~elltg~~PF~~~ 901 (905)
...+.+|||.|+|||++. ||. .-|+||.|+|+|.-+.|.+||...
T Consensus 722 -----------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 722 -----------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred -----------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 234679999999999998 554 669999999999999999999653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=287.76 Aligned_cols=200 Identities=30% Similarity=0.475 Sum_probs=173.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+..|+.+++.++|+||+.+++.+.+.+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37788899999999999999999999999999876544444444567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|++|++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 9999999999876555568999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......||+.|+|||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 157 ------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 157 ------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred ------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 1123468999999999974 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=286.83 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=173.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|+..+.||.|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++++..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788899999999999999999999999999976544334444567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|..++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 9999999988876555569999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......|++.|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 157 ------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 157 ------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred ------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 1123468999999999874 4589999999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=307.78 Aligned_cols=202 Identities=21% Similarity=0.284 Sum_probs=172.2
Q ss_pred CCCeeecccccccCceEEEEEEEcCC-CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t-~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
...|.+.+.||+|+||.||+|....+ +..+|+|.+... .......+..|+.+++.++||||++++++|...+.+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976533 34445667889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 750 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
||||++|++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999999888642 2346899999999999999999999999999999999999999999999999999754311
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 223 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 223 VS-------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred cc-------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 10 012335679999999999874 4589999999999999999999953
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=304.61 Aligned_cols=199 Identities=30% Similarity=0.385 Sum_probs=170.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------e
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------H 746 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~------~ 746 (905)
.|..-+.||+|+||.||+++++.||+.||||.+++.. .....+...+|+++|++++|+|||+++++=.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4666788999999999999999999999999998753 3445677889999999999999999998765433 4
Q ss_pred EEEEEeccCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEc--CCC--cEEEEeccCc
Q 002580 747 VCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNG--HVSLTDFDLS 821 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~--~~~--~vkL~DFG~s 821 (905)
..+|||||.||+|..++.+- ....+++.+++.++.++..||.|||.+|||||||||.||++- .+| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999999999999863 234699999999999999999999999999999999999984 334 4799999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~P 897 (905)
+-+...+ ...+++||+.|++||++.. ....|.|||||++|+..||..|
T Consensus 172 rel~d~s----------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 172 RELDDNS----------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCCC----------------------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 8755222 3467899999999999983 2378999999999999999999
Q ss_pred chhh
Q 002580 898 FPIL 901 (905)
Q Consensus 898 F~~~ 901 (905)
|...
T Consensus 224 F~p~ 227 (732)
T KOG4250|consen 224 FIPF 227 (732)
T ss_pred CCcC
Confidence 9654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=293.20 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=173.9
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++.+.||.|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++|+||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45678999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999999764 3488999999999999999999985 7999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 158 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -----------------------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1123468999999999974 4589999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=299.47 Aligned_cols=192 Identities=38% Similarity=0.621 Sum_probs=163.1
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
||+|+||.||+|.+..+++.||+|++.+..............|..++..+ +||||+.++++|...+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765433334445556677777665 699999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998542211
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 150 ------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 011234679999999999863 4589999999999999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=282.86 Aligned_cols=196 Identities=24% Similarity=0.379 Sum_probs=177.3
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
-|.++.+||+|+||.||++.++.+|+.+|||.++.. .+.+.+..|+.++++++.++||++|+.|.....+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 378899999999999999999999999999988754 467889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
||..|+..++++.+ .+++++.++..+++..+.||.|||...-+|||||..|||++.+|.+||+|||.+-.+.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999998754 5679999999999999999999999999999999999999999999999999985432
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCcccccccccc--C-CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--A-YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--~-~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.......+..|||.|||||++. | .+++||||||++..||.-|++||..+
T Consensus 181 --------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 181 --------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred --------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 2334456789999999999998 4 56999999999999999999999754
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=298.78 Aligned_cols=193 Identities=26% Similarity=0.369 Sum_probs=174.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
-|.-++.||.|+||.||-+++..+.+.||||.+.-.........+.+..|+..|.+++|||++.+-++|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47788999999999999999999999999999987655566677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|| -|+-.+++.-. .+++.+..+..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.+.+..
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 99 67777877765 3569999999999999999999999999999999999999999999999999986533
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCCc
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~PF 898 (905)
...+|+|||.|||||++.. ..+.||||||+++.+|.-.++|+
T Consensus 178 ------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 178 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred ------------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 2357899999999999982 45999999999999999999995
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=269.65 Aligned_cols=214 Identities=21% Similarity=0.228 Sum_probs=177.9
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--- 744 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--- 744 (905)
.++.++|++.+.||+|||+.||+++...++..||+|.+... ...+.+..++|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 46778999999999999999999999999999999998755 356778899999999999999999998876533
Q ss_pred --CeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCCEEEcCCCcEEEEec
Q 002580 745 --THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 745 --~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~g--IvHrDLKp~NILl~~~~~vkL~DF 818 (905)
...||+++|+..|+|.+.+... .+..+++.+++.|+.+|++||++||+.. +.||||||.|||+++++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 3599999999999999998753 3346999999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHH
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~ell 892 (905)
|.++....--.. . ..+........-.+|..|.|||.+.. +.++|||||||+||.|+
T Consensus 174 GS~~~a~i~i~~---~---------------~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQIEG---S---------------RQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceEeec---h---------------HHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 998653311000 0 00011112223467899999999982 46999999999999999
Q ss_pred hCCCCchhhh
Q 002580 893 MEFQPFPILC 902 (905)
Q Consensus 893 tg~~PF~~~~ 902 (905)
+|..||+...
T Consensus 236 f~~sPfe~~~ 245 (302)
T KOG2345|consen 236 FGESPFERIY 245 (302)
T ss_pred HcCCcchHHh
Confidence 9999998764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=287.64 Aligned_cols=199 Identities=24% Similarity=0.348 Sum_probs=163.9
Q ss_pred CCeeecccccccCceEEEEEEEcC-CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ----- 742 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~-t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~----- 742 (905)
++|++.+.||+|+||.||+|.+.. ++..||+|.+...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 4788999998754322 22233455677777665 6999999999885
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 002580 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 743 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~ 822 (905)
....+++||||+. ++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 2456999999995 699999987655668999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
..... .......||+.|+|||++.+ ..++|+|||||++|+|++|.+||.
T Consensus 159 ~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCC----------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 53211 11234578999999999874 458999999999999999999996
Q ss_pred h
Q 002580 900 I 900 (905)
Q Consensus 900 ~ 900 (905)
.
T Consensus 211 ~ 211 (290)
T cd07862 211 G 211 (290)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=278.66 Aligned_cols=208 Identities=32% Similarity=0.581 Sum_probs=188.7
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 743 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 743 (905)
..+.+..++|.++.+||+|+|++|.+++.++|.+.||+|++++....+..+....+.|..++.+. +||++|-++.+|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 44557788999999999999999999999999999999999999888888888889999998876 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
...+++|.||++||+|.-.++++++ ++++.++.+...|+.||.|||++||++||||.+|+|++..|.+||+|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999999999988887654 99999999999999999999999999999999999999999999999999954
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccCC---CCchHHHHHHHHHHHHhCCCCchh
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY---TRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~---~~sDiwSlGvil~elltg~~PF~~ 900 (905)
-- .+...++++||||.|+|||++.+. ...|.|+||++|+||+.|+.||..
T Consensus 401 ~l---------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GL---------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC---------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 21 234456789999999999999963 378999999999999999999976
Q ss_pred h
Q 002580 901 L 901 (905)
Q Consensus 901 ~ 901 (905)
.
T Consensus 454 v 454 (593)
T KOG0695|consen 454 V 454 (593)
T ss_pred e
Confidence 4
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=296.22 Aligned_cols=195 Identities=22% Similarity=0.354 Sum_probs=165.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 745 (905)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999987542 23344567789999999999999999999986543
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 746 -~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
.+|+||||+. ++|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 5799999995 567666643 3788999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
... .......||+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 174 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 223 (359)
T cd07876 174 CTN----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223 (359)
T ss_pred ccC----------------------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 210 01223578999999999974 458999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=295.89 Aligned_cols=193 Identities=39% Similarity=0.623 Sum_probs=165.4
Q ss_pred ccccccCceEEEEEEE---cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 002580 678 KPLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~---~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 754 (905)
+.||+|+||.||++.+ ..+|+.||+|++.+... .......+..|+.++++++||||+++++++.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999986 35789999999986432 2223456678999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCc
Q 002580 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (905)
Q Consensus 755 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~ 834 (905)
++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------- 151 (318)
T cd05582 81 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------- 151 (318)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-------
Confidence 999999998764 35899999999999999999999999999999999999999999999999998643211
Q ss_pred chhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 152 --------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 152 --------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred --------------------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 011234579999999999874 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=274.50 Aligned_cols=194 Identities=23% Similarity=0.318 Sum_probs=165.2
Q ss_pred CCCeeec-ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----C
Q 002580 671 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----K 744 (905)
Q Consensus 671 ~~~y~i~-~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~----~ 744 (905)
.++|.+- ++||-|-.|.|..|.++.|++.||+|++.-. ....+|+++--.. .|||||.++++|.. .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4566653 6799999999999999999999999987532 4556777764444 79999999998863 4
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC---CCcEEEEeccCc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 821 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~---~~~vkL~DFG~s 821 (905)
.++.+|||+|+||.|+..+..++...|++.++..|++||+.|+.|||+.+|.||||||+|+|... |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 67899999999999999999988889999999999999999999999999999999999999964 457999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
+...... ...+-|.||.|.|||++.. ....|+||+||+||-|++|.+||
T Consensus 212 K~t~~~~----------------------------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 212 KETQEPG----------------------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccCCCc----------------------------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 7643211 2345588999999999983 45789999999999999999999
Q ss_pred hh
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
+-
T Consensus 264 YS 265 (400)
T KOG0604|consen 264 YS 265 (400)
T ss_pred cc
Confidence 74
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=305.59 Aligned_cols=205 Identities=26% Similarity=0.359 Sum_probs=173.8
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--- 745 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--- 745 (905)
...++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999999999999999999976533 4455667889999999999999999988775432
Q ss_pred -----eEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEec
Q 002580 746 -----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 746 -----~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DF 818 (905)
.+++||||+++|+|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 378999999999999998753 2346899999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCC
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~ 895 (905)
|+++....... .......+||+.|+|||++.+ +.++|+|||||++|+|++|+
T Consensus 188 Gls~~~~~~~~-------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 188 GFSKMYAATVS-------------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ccCeecccccc-------------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99865431110 011234679999999999984 45899999999999999999
Q ss_pred CCch
Q 002580 896 QPFP 899 (905)
Q Consensus 896 ~PF~ 899 (905)
.||.
T Consensus 243 ~Pf~ 246 (496)
T PTZ00283 243 RPFD 246 (496)
T ss_pred CCCC
Confidence 9995
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=299.27 Aligned_cols=197 Identities=26% Similarity=0.408 Sum_probs=175.1
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+.|.|+..||.|+||.||++.++.++-..|.|++... .....+.+..||+||..|+||+|+++++.|...+.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4688999999999999999999999999999998744 5677889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||.||-...++-.. ...+++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~----- 182 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS----- 182 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-----
Confidence 999999888877654 35699999999999999999999999999999999999999999999999999865321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+|+|||+|||||+..+ ..++||||||++|.+|..+.+|--
T Consensus 183 ----------------------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 183 ----------------------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred ----------------------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 1123457899999999999984 349999999999999999999964
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=285.36 Aligned_cols=228 Identities=52% Similarity=0.853 Sum_probs=181.2
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|++|.||+|.+..++..||+|.+.+...........+..|+++++.++|+||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765444456677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+.+++|.+++.......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987655679999999999999999999999999999999999999999999999999987654222111
Q ss_pred CCcchhhhccc--cCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
........... ..................+.||..|+|||++.+ ..++|+||||+++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 00000000000 000000000111122345689999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=301.15 Aligned_cols=195 Identities=20% Similarity=0.280 Sum_probs=161.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK----- 744 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~----- 744 (905)
...+|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3468999999999999999999999999999999885431 2235699999999999999999887532
Q ss_pred ---CeEEEEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-cEEEEec
Q 002580 745 ---THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDF 818 (905)
Q Consensus 745 ---~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-~vkL~DF 818 (905)
..+++||||++ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 25789999996 577776653 2235689999999999999999999999999999999999998665 7999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhC
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg 894 (905)
|+|+..... ......+||+.|+|||++.+ ..++|+|||||+||+|++|
T Consensus 216 Gla~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG 267 (440)
T PTZ00036 216 GSAKNLLAG----------------------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267 (440)
T ss_pred ccchhccCC----------------------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999654211 11224578999999999864 3489999999999999999
Q ss_pred CCCchh
Q 002580 895 FQPFPI 900 (905)
Q Consensus 895 ~~PF~~ 900 (905)
.+||..
T Consensus 268 ~~pf~~ 273 (440)
T PTZ00036 268 YPIFSG 273 (440)
T ss_pred CCCCCC
Confidence 999953
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=296.01 Aligned_cols=197 Identities=23% Similarity=0.333 Sum_probs=167.5
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~ 747 (905)
+|++.+.||+|+||.||++.+..+++.||+|.+... .........+.+|+.+++.++|+||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478899999999999999999999999999998654 223344567889999999999999999999998776 79
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+. ++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 6888887653 45899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. .......+|+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 157 ES--------------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred cc--------------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 10 11223468899999999874 347999999999999999999995
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=284.94 Aligned_cols=205 Identities=22% Similarity=0.299 Sum_probs=167.3
Q ss_pred ccCCCeeecccccccCceEEEEEEEcC----------------CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~----------------t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~ 732 (905)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 345789999999999999999998632 34579999987542 344556788999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 002580 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-----------------TKVLKEDAVRFYAAEVVVALEYLHCQGI 795 (905)
Q Consensus 733 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------~~~l~~~~~~~i~~qil~gL~~LH~~gI 795 (905)
||+++++++.+.+..|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986531 1236778889999999999999999999
Q ss_pred eeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC
Q 002580 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA 875 (905)
Q Consensus 796 vHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~ 875 (905)
+||||||+|||++.++.+||+|||++........ ........++..|+|||++.+
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~ 214 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-------------------------YRIQGRAVLPIRWMAWECILM 214 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCce-------------------------eEecCcCCCCccccCHHHHhc
Confidence 9999999999999999999999999865321100 011123356789999999873
Q ss_pred ---CCCchHHHHHHHHHHHHh--CCCCchh
Q 002580 876 ---YTRMTRYNYLILVSKKFM--EFQPFPI 900 (905)
Q Consensus 876 ---~~~sDiwSlGvil~ellt--g~~PF~~ 900 (905)
..++|+|||||++|+|++ +..||..
T Consensus 215 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 215 GKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred CCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 569999999999999986 5677753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=286.34 Aligned_cols=200 Identities=21% Similarity=0.278 Sum_probs=169.1
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..++|.+.+.||+|+||.||+|.+..++..+|+|.++.... ......+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875422 2223456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||||++ ++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred EEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 999996 58888876543 358899999999999999999999999999999999999999999999999985432111
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+|+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 159 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 159 --------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred --------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01123467899999999863 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=312.48 Aligned_cols=203 Identities=22% Similarity=0.347 Sum_probs=170.8
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KT 745 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~ 745 (905)
....++|.+++.||.|+||.||+|.+..++..+|+|++..... .......+..|+.+++.|+||||++++++|.+ ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3456799999999999999999999999999999999876532 34456778899999999999999999998864 45
Q ss_pred eEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeCCCCCCCEEEcC-------
Q 002580 746 HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-------GIIYRDLKPENVLLQG------- 809 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~-------gIvHrDLKp~NILl~~------- 809 (905)
.+|||||||++++|.+++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 799999999999999998753 224599999999999999999999985 4999999999999964
Q ss_pred ----------CCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----
Q 002580 810 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---- 875 (905)
Q Consensus 810 ----------~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---- 875 (905)
.+.+||+|||++...... ......+||+.|+|||++.+
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~----------------------------s~~~s~vGTp~YmAPEvL~ge~~~ 219 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIE----------------------------SMAHSCVGTPYYWSPELLLHETKS 219 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccc----------------------------ccccccCCCccccCHHHHhccCCC
Confidence 235899999998653211 01224579999999999853
Q ss_pred -CCCchHHHHHHHHHHHHhCCCCch
Q 002580 876 -YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 876 -~~~sDiwSlGvil~elltg~~PF~ 899 (905)
..++|||||||+||+|++|..||.
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCC
Confidence 358999999999999999999995
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=293.60 Aligned_cols=195 Identities=21% Similarity=0.357 Sum_probs=166.2
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999987642 2334456778899999999999999999987643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|+||||+. ++|..++.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 35799999995 577777753 2788999999999999999999999999999999999999999999999999653
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
... .......+|+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 177 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 177 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred CCC----------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 211 01234578999999999975 458999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=281.53 Aligned_cols=197 Identities=39% Similarity=0.687 Sum_probs=174.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|++++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997654444455677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999999775 45899999999999999999999999999999999999999999999999998653211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
....++++.|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 155 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred --------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 123468899999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=294.89 Aligned_cols=206 Identities=23% Similarity=0.332 Sum_probs=169.4
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCC-----eEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 741 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~-----~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 741 (905)
.+..++|.+.+.||+|+||.||+|.+..++ ..||+|.++... .......+.+|+.+++.+ +|+||++++++|
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 355678999999999999999999865443 579999997542 233456788999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCC------------------------------------------------------
Q 002580 742 QTKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 767 (905)
Q Consensus 742 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 767 (905)
...+.+|+|||||++|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999986421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 768 --------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 768 --------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
..++++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~---- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence 12477888999999999999999999999999999999999999999999999865321110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
........+++.|+|||++.. +.++|+|||||++|+|++ |..||+.
T Consensus 268 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 268 ---------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred ---------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 001112335678999999873 569999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=287.18 Aligned_cols=204 Identities=21% Similarity=0.319 Sum_probs=169.9
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 747 (905)
++...|+++++||+||.+.||++...+. +.||+|.+... ..+......+.+|+..|.+| .|.+|+++|+|-..++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4567899999999999999999998544 45666655433 34566788899999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
||||||= ..+|..+|.+... .++...++.+..|++.+++++|.+||||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9999976 6799999987533 345458889999999999999999999999999999987 689999999999776533
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------------CCCchHHHHHHHHHHHHh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------------YTRMTRYNYLILVSKKFM 893 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------------~~~sDiwSlGvil~ellt 893 (905)
...+ ...+.+||+.||+||.+.. ..++||||||||||+|++
T Consensus 513 TTsI-------------------------~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 513 TTSI-------------------------VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred ccce-------------------------eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 2221 2345689999999999972 248999999999999999
Q ss_pred CCCCchhhh
Q 002580 894 EFQPFPILC 902 (905)
Q Consensus 894 g~~PF~~~~ 902 (905)
|+.||....
T Consensus 568 gktPf~~~~ 576 (677)
T KOG0596|consen 568 GKTPFGQII 576 (677)
T ss_pred cCCchHHHH
Confidence 999997653
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=292.33 Aligned_cols=196 Identities=21% Similarity=0.361 Sum_probs=166.4
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK----- 744 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~----- 744 (905)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3579999999999999999999999999999999987542 2334456778899999999999999999988643
Q ss_pred -CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 745 -THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 745 -~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
...|+||||++ ++|...+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 35799999995 567776643 388899999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.... .......||+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 169 ~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 169 AGTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred CCCc----------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 3211 01234578999999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=282.55 Aligned_cols=197 Identities=27% Similarity=0.393 Sum_probs=162.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-----K 744 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~-----~ 744 (905)
+|++.+.||+|+||.||+|.+..+++.||+|.++..... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998754221 11223345666666654 79999999998864 3
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..++++|||+. ++|..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999996 58988887655556899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.... ......||+.|+|||++.+ ..++|+|||||++|+|++|.+||.
T Consensus 159 ~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 159 SCQM----------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cCcc----------------------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 3110 1123468999999999874 468999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=291.91 Aligned_cols=194 Identities=25% Similarity=0.377 Sum_probs=166.3
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|.+++.||.|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 468999999999999999999999999999999987542 2223445677899999999999999999987543
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...|++++++ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 8899888754 34899999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. .....+||+.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 169 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred CC------------------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 21 1124578999999999864 358999999999999999999995
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=292.15 Aligned_cols=206 Identities=21% Similarity=0.297 Sum_probs=169.4
Q ss_pred cccCCCeeecccccccCceEEEEEEE-----cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 741 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 741 (905)
.+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.++..+ +||||++++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 35566899999999999999999974 3457789999987542 233456788999999999 899999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCC------------------------------------------------------
Q 002580 742 QTKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 767 (905)
Q Consensus 742 ~~~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 767 (905)
...+..|+|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986532
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 768 -------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 768 -------------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1246788899999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.. .......++..|+|||++.+ ..++|+|||||++|+|++ |..||..
T Consensus 269 ~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 269 NY-------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred cc-------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 10 01112345678999999874 459999999999999997 8999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=272.48 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=174.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|.+.+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 48888999999999999999999999999999875432 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999987655679999999999999999999999999999999999999999999999999986543111
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......|++.|+|||++.. ..++|+|||||++|+|++|+.||..
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 203 (256)
T cd08529 156 -----------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203 (256)
T ss_pred -----------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 11223468899999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=275.90 Aligned_cols=203 Identities=15% Similarity=0.171 Sum_probs=168.7
Q ss_pred ccCCCeeecccccccCceEEEEEEEc---CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~---~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
+...+|++.+.||+|+||.||++.+. ..+..||+|.++... .......+.+|+.++..++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 44568999999999999999999864 346789999987542 3344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
..|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999997643 358999999999999999999999999999999999999999999999999874421
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
... ........++..|+|||.+.+ +.++|+|||||++|++++ |..||..
T Consensus 159 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 159 SEA--------------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccc--------------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 100 001112345678999999874 458999999999999775 9999953
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=279.17 Aligned_cols=190 Identities=17% Similarity=0.134 Sum_probs=163.3
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCeEEEEEec
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDY 753 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~~lV~E~ 753 (905)
..||+|+++.||+|.. +|+.||+|.+.+...........+.+|+.+|.+++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 4689999999999998 789999999986544344445778899999999999999999999876 4578999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
+++|+|.+++... ..+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999999764 3588899999999999999999985 9999999999999999999999999998653211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.....||+.|+|||++.+ +.++|+|||||++|+|++|..||...
T Consensus 177 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 177 -------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred -------------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 112468899999999863 45999999999999999999999743
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=276.16 Aligned_cols=197 Identities=24% Similarity=0.376 Sum_probs=171.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.+++.++||||+++++++...+.+|++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45899999999999999999999999999999998754 223445677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999998764 35899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCcccccccccc------CCCCchHHHHHHHHHHHHhCCCCch
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF------AYTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~------~~~~sDiwSlGvil~elltg~~PF~ 899 (905)
........|++.|+|||++. ...++|+|||||++|+|++|..||.
T Consensus 160 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 160 ------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred ------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 01123457899999999874 2358999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-30 Score=272.60 Aligned_cols=199 Identities=24% Similarity=0.424 Sum_probs=173.5
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||.|+||.||++.+..++..||+|.+.... .....+.+..|+.+++.++|+||+++++++.+++.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986532 23455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999987655566899999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........|++.|+|||++.+ ..++|+||||+++|+|++|..||..
T Consensus 154 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 154 ----------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred ----------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 011224568899999999874 4589999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=290.18 Aligned_cols=207 Identities=23% Similarity=0.275 Sum_probs=170.7
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCC-----CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 740 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t-----~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~ 740 (905)
..+..++|.+++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++.+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 345678999999999999999999987433 3479999987542 3344567889999999996 9999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCC-----------------------------------------------------
Q 002580 741 FQTKTHVCLITDYCPGGELFLLLDRQP----------------------------------------------------- 767 (905)
Q Consensus 741 ~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------------------------------------------- 767 (905)
|...+.+|||||||++|+|.+++..+.
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999886531
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEE
Q 002580 768 -----------------------------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806 (905)
Q Consensus 768 -----------------------------------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NIL 806 (905)
...+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124777888999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHH
Q 002580 807 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYN 883 (905)
Q Consensus 807 l~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwS 883 (905)
++.++.+||+|||++........ ........+++.|+|||.+.+ ..++|+||
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS 324 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN-------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc-------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence 99999999999999865431111 011223457789999999874 45899999
Q ss_pred HHHHHHHHHh-CCCCchh
Q 002580 884 YLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 884 lGvil~ellt-g~~PF~~ 900 (905)
|||++|+|++ |..||..
T Consensus 325 lGvil~ellt~g~~P~~~ 342 (400)
T cd05105 325 YGILLWEIFSLGGTPYPG 342 (400)
T ss_pred HHHHHHHHHHCCCCCCcc
Confidence 9999999996 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=275.33 Aligned_cols=192 Identities=26% Similarity=0.378 Sum_probs=167.2
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36888999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999999986542 3788899999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 149 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 -------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred -------------------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 1224578999999999874 4589999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=273.94 Aligned_cols=198 Identities=23% Similarity=0.341 Sum_probs=170.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 457999999999999999999999999999999987542 23345677899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999999998764 35899999999999999999999999999999999999999999999999998653210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........|++.|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 160 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 160 ------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred ------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 011223568899999998852 3489999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=292.29 Aligned_cols=209 Identities=22% Similarity=0.306 Sum_probs=177.1
Q ss_pred CccccccCCCeeecccccccCceEEEEEEEcCCCe---E-EEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEE
Q 002580 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---Y-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739 (905)
Q Consensus 664 ~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~---~-vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~ 739 (905)
...+++..++-.+.+.||+|+||.||+|.....+. . ||+|..+............+.+|.+++++++||||+++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34456777788888999999999999999865422 3 8999988644556778899999999999999999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEecc
Q 002580 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (905)
Q Consensus 740 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG 819 (905)
+......+++|||+|.||+|.++|+..+. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999998654 58999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCcchhhhccccCCCCcccccccccccc-cccCCccccccccccC---CCCchHHHHHHHHHHHHh-C
Q 002580 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN-SFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-E 894 (905)
Q Consensus 820 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g 894 (905)
+|+... .. .... ..--...|+|||.+.. +.++|||||||++||+++ |
T Consensus 308 Ls~~~~---~~-------------------------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 308 LSRAGS---QY-------------------------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred cccCCc---ce-------------------------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccC
Confidence 986532 00 0011 1113458999999983 579999999999999998 7
Q ss_pred CCCchhh
Q 002580 895 FQPFPIL 901 (905)
Q Consensus 895 ~~PF~~~ 901 (905)
..||+..
T Consensus 360 ~~Py~g~ 366 (474)
T KOG0194|consen 360 AEPYPGM 366 (474)
T ss_pred CCCCCCC
Confidence 8899754
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=274.12 Aligned_cols=202 Identities=23% Similarity=0.331 Sum_probs=174.1
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||+|.+..++..||+|.++............+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999887654445556677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 752 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 752 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||+++++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999999888642 22457899999999999999999999999999999999999999999999999986543110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 161 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred --------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 01123468889999999874 4589999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=271.58 Aligned_cols=203 Identities=24% Similarity=0.325 Sum_probs=172.7
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
++|.+.+.||.|++|.||.|.+..+++.|++|.+....... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 47999999999999999999999999999999987543221 2234578889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
++||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998764 3488999999999999999999999999999999999999999999999999865321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.........+++.|+|||++.+ ..++|+||||+++|+|++|+.||..
T Consensus 160 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 160 ------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ------------------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 0011123568889999999985 3589999999999999999999954
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=291.50 Aligned_cols=194 Identities=22% Similarity=0.327 Sum_probs=165.0
Q ss_pred cCCCeeecccccccCceEEEEEEEc--CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~--~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
...+|.+++.||.|+||.||+|... .++..|++|.+... ....+|+.+|+.++||||++++++|...+.+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3468999999999999999999764 35678999987643 2345799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|++||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 162 ~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 57888888543 45899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. ........||+.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 239 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 239 PD-------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred cc-------------------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 11 011234679999999999984 458999999999999999999994
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=292.61 Aligned_cols=192 Identities=24% Similarity=0.352 Sum_probs=169.3
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCC
Q 002580 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 758 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~ 758 (905)
+||+|+||+||-|++..|....|||-++.. +....+-+..|+.+-++|+|.|||+++|++..++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 589999999999999999999999998754 45566778899999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEc-CCCcEEEEeccCccccCCCCCCCCCcc
Q 002580 759 LFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (905)
Q Consensus 759 L~~~l~~~~~~~l--~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~-~~~~vkL~DFG~s~~~~~~~~~~~~~~ 835 (905)
|.+++...- +++ ++..+-.+.+||+.||+|||++.|||||||-+|+||+ -.|.+||+|||.|+.+..
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--------- 728 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--------- 728 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---------
Confidence 999998643 345 7888999999999999999999999999999999996 589999999999876431
Q ss_pred hhhhccccCCCCcccccccccccccccCCcccccccccc----CC-CCchHHHHHHHHHHHHhCCCCchhh
Q 002580 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF----AY-TRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~----~~-~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
-...+.++.||..|||||++. || .++|||||||++.||.||++||-.+
T Consensus 729 ------------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El 781 (1226)
T KOG4279|consen 729 ------------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL 781 (1226)
T ss_pred ------------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence 112356789999999999998 33 4899999999999999999999654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=276.71 Aligned_cols=205 Identities=22% Similarity=0.335 Sum_probs=171.3
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCC-----eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~-----~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+..++|++.+.||+|+||.||+|.+...+ ..+++|.+... ........+.+|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999986555 68999988744 234455678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~ 809 (905)
.+..|++|||+++++|.+++..... ..+++..+..++.||+.||.|||++|++|+||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999976421 45788899999999999999999999999999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHH
Q 002580 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLI 886 (905)
Q Consensus 810 ~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGv 886 (905)
++.++|+|||++........ ........+++.|+|||.+.. +.++|+|||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-------------------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeecccccc-------------------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 99999999999865321110 011223456889999998863 45899999999
Q ss_pred HHHHHHh-CCCCchh
Q 002580 887 LVSKKFM-EFQPFPI 900 (905)
Q Consensus 887 il~ellt-g~~PF~~ 900 (905)
++|+|++ |..||..
T Consensus 215 il~el~~~g~~p~~~ 229 (283)
T cd05048 215 VLWEIFSYGLQPYYG 229 (283)
T ss_pred HHHHHHcCCCCCCCC
Confidence 9999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=274.25 Aligned_cols=198 Identities=34% Similarity=0.515 Sum_probs=171.2
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|++++.||+|+||+||++.+..+++.||+|++..... .........+|+.+++.++||||+++++++......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987632 222223345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+.+++|.+++... ..++...+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999843 4489999999999999999999999999999999999999999999999999864310
Q ss_pred cchhhhccccCCCCcccccccccccccccCCcccccccccc-C---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF-A---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.........+|+.|+|||++. + ..++|+||||+++|+|++|..||...
T Consensus 151 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 151 --------------------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp --------------------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred --------------------cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 111234567899999999987 2 56999999999999999999999754
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=273.11 Aligned_cols=202 Identities=21% Similarity=0.260 Sum_probs=172.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+...+|.+.+.||+|+||.||+|.+..++..+|+|.+... ......+.+|+.+++.++|+||+++++++..++.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4556799999999999999999999999999999998743 223567888999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999977655568999999999999999999999999999999999999999999999999986543110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......+++.|+|||.+.+ +.++|+|||||++|+|++ |..||+.
T Consensus 159 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 159 Y--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred e--------------------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 0 01112234678999998874 458999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=277.81 Aligned_cols=195 Identities=24% Similarity=0.391 Sum_probs=170.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||++++++|..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 3344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999999765 458999999999999999999998 5999999999999999999999999998854210
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......++++.|+|||.+.+ ..++|+|||||++|+|++|..||.
T Consensus 153 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred -------------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 01124578999999999874 348999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=291.62 Aligned_cols=195 Identities=24% Similarity=0.332 Sum_probs=167.9
Q ss_pred eecccccccCceEEEEEEEcCCCeEEEEEEeecc-cccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--eEEEEE
Q 002580 675 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCLIT 751 (905)
Q Consensus 675 ~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~-~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~--~~~lV~ 751 (905)
+....||+|+|-+||+|.+..+|..||--.++.. ....+...+++..|+.+|+.|+||||+++|++|.+.. .+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 5567899999999999999999988874433322 2345667799999999999999999999999998765 488999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g--IvHrDLKp~NILl~~-~~~vkL~DFG~s~~~~~~~ 828 (905)
|++.+|+|..|+++.+ .++...+..|++||+.||.|||++. |+|||||.+||||+. .|.|||+|+|+|+....+
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 9999999999999864 4899999999999999999999995 999999999999986 589999999999775421
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc--CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+|||.|||||++. .....||||||++|+||+|+.+||..
T Consensus 200 ----------------------------~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 200 ----------------------------HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred ----------------------------ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 123478999999999998 35699999999999999999999964
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=276.13 Aligned_cols=198 Identities=23% Similarity=0.316 Sum_probs=168.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||+|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999999875422 22234567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 753 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|++ ++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 996 68888886543 2568999999999999999999999999999999999999999999999999986432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||.+.+ ..++|+|||||++|+|++|++||.
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 156 ------------------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred ------------------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 01122357889999998864 447999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=296.83 Aligned_cols=193 Identities=19% Similarity=0.281 Sum_probs=159.5
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEEe
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQT 743 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~l~~~~~~ 743 (905)
..++|++++.||+|+||.||+|.+..+++.||||+++... ........|+.+++.+.| .+++.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999999999999999986431 223345567777766644 458889998875
Q ss_pred C-CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCC----------
Q 002580 744 K-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG---------- 811 (905)
Q Consensus 744 ~-~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~---------- 811 (905)
. ..+|+||+++ |++|.+++.+. ..+++..+..|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999998 78899888764 459999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 812 ------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 812 ------~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
.+||+|||.+.... ......+||+.|+|||++.+ ..++|+|
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------cccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 49999999874321 11234689999999999985 4588999
Q ss_pred HHHHHHHHHHhCCCCch
Q 002580 883 NYLILVSKKFMEFQPFP 899 (905)
Q Consensus 883 SlGvil~elltg~~PF~ 899 (905)
||||+||+|++|++||.
T Consensus 330 SlGvil~elltG~~pf~ 346 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYD 346 (467)
T ss_pred HHHHHHHHHHhCCCCCC
Confidence 99999999999999995
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=278.70 Aligned_cols=200 Identities=22% Similarity=0.275 Sum_probs=169.4
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..++|.+.+.||.|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875422 2223456789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||||+. ++|..++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred EEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 999996 68988887643 358899999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||++.+ ..++|+|||||++|+|++|++||..
T Consensus 159 --------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 159 --------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred --------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01123357889999999864 3489999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=275.63 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=172.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+.|++++.||.|+||.||++.+..++..+++|.+... .......+..|+.+++.++|+||+++++++..++.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998754 445567788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|..++.+.. ..+++..+..++.|++.+|.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999999988876543 45899999999999999999999999999999999999999999999999987542211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........+++.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 164 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 164 ------------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred ------------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 011224568889999999852 3479999999999999999999954
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=281.20 Aligned_cols=204 Identities=19% Similarity=0.247 Sum_probs=167.6
Q ss_pred eccccccc--CceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 676 PIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 676 i~~~Lg~G--~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
+++.||+| +|++||++.+..+|+.||+|.+..... .......+.+|+.+++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 789999999999999999999875422 233456677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 999999999976544568999999999999999999999999999999999999999999999998754322110000
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...........++..|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 159 ------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 ------------------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ------------------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 000001123457788999999863 3589999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=272.04 Aligned_cols=201 Identities=21% Similarity=0.297 Sum_probs=170.5
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++++.||+|+||.||++.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 56678999999999999999999974 55679999876432 23467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+++++|.+++.......++...+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999987655668899999999999999999999999999999999999999999999999986543110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......++..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 158 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 158 Y--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred e--------------------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 0 01112345678999999874 348999999999999998 9999953
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=270.34 Aligned_cols=203 Identities=23% Similarity=0.290 Sum_probs=170.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeeccc--ccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 747 (905)
.+|++.+.||+|+||.||.+.+..++..||+|.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 11234456788999999999999999999998763 578
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998764 34788999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .........++..|+|||.+.+ ..++|+|||||++|+|++|+.||..
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 160 CL------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cc------------------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 00 0011223468899999999874 4589999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=280.57 Aligned_cols=193 Identities=23% Similarity=0.331 Sum_probs=156.6
Q ss_pred cccccccCceEEEEEEEc--CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEEEe
Q 002580 677 IKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLITD 752 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~--~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lV~E 752 (905)
.++||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||++++++|.. +..+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 457999999999999975 4678999999875421 2346789999999999999999999864 467899999
Q ss_pred ccCCCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEE----cCCCcEEEEeccCc
Q 002580 753 YCPGGELFLLLDRQP-------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLS 821 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl----~~~~~vkL~DFG~s 821 (905)
|+ +++|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 568888875321 2258899999999999999999999999999999999999 45678999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~P 897 (905)
........ .........||+.|+|||++.+ ..++|+|||||++|+|++|++|
T Consensus 160 ~~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCCc------------------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 76432110 0112234678999999999874 3479999999999999999999
Q ss_pred ch
Q 002580 898 FP 899 (905)
Q Consensus 898 F~ 899 (905)
|.
T Consensus 216 f~ 217 (317)
T cd07868 216 FH 217 (317)
T ss_pred cc
Confidence 95
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=269.78 Aligned_cols=202 Identities=25% Similarity=0.356 Sum_probs=174.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||.|+||.||+|.+..+++.||+|.++............+.+|+++++.++|+||+++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999987654445555678889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 752 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 752 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||+++++|..++... ....+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999998652 23458899999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 161 --------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred --------------------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 01123468889999999874 3489999999999999999999953
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=279.99 Aligned_cols=203 Identities=22% Similarity=0.281 Sum_probs=167.5
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeE----EEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~----vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
+...+|++.+.||+|+||.||+|.+..++.. ||+|.++.. ........+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3456899999999999999999998666553 899988643 2334556788999999999999999999998764
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+++++|+++|+|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999998643 34888899999999999999999999999999999999999999999999999764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
...... .......++..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcc-------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 321110 01112234678999999874 458999999999999997 9999954
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=272.24 Aligned_cols=201 Identities=25% Similarity=0.369 Sum_probs=173.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||.|+||.||++.+..++..+++|.+.............+.+|+.+++.++|+||++++++|..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57899999999999999999999999999999887654444555677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 752 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 752 E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 23458999999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||.+.+ ..++|+||||+++|+|++|..||.
T Consensus 161 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred --------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 01123468899999999864 448999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=291.29 Aligned_cols=193 Identities=23% Similarity=0.277 Sum_probs=164.5
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
...+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|++++|+||+++++++...+..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999995421 235679999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||+++ .++|..++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 238 v~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999 578888886542 3589999999999999999999999999999999999999999999999999865431110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
.......+||+.|+|||++.+ ..++|+|||||+||+|++|..|+
T Consensus 316 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 -------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred -------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 001224579999999999974 45899999999999999987654
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.07 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=171.0
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCeEEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLIT 751 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lV~ 751 (905)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+|++++++.+.. +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875422 33445668889999999999999999998864 45689999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999987555668999999999999999999999999999999999999999999999999986542110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||++.+ +.++|+|||||++|+|++|+.||.
T Consensus 157 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 157 ------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred ------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 11224568899999999874 458999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=275.02 Aligned_cols=214 Identities=35% Similarity=0.544 Sum_probs=174.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||+|+||.||++.+..+++.|++|.+.+...........+.+|+.+++.++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999988654434445667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999765 358999999999999999999999999999999999999999999999999986422111100
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
...... .............++..|+|||.+.. ..++|+|||||++|+|++|..||.
T Consensus 159 ~~~~~~------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 159 LYEGHI------------EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred cccccc------------ccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 000000 00000011123568899999999863 568999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=277.80 Aligned_cols=202 Identities=22% Similarity=0.274 Sum_probs=167.1
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeE--EEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~--vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 745 (905)
+..++|++.+.||+|+||.||+|.+..++.. +++|.++.. ........+.+|+.++.++ +|+||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4567899999999999999999998777754 466665532 2344556788899999999 8999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC
Q 002580 746 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~ 811 (905)
.+|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997542 13578999999999999999999999999999999999999999
Q ss_pred cEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHH
Q 002580 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILV 888 (905)
Q Consensus 812 ~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil 888 (905)
.+||+|||++...... .......++..|+|||.+.+ ..++|+|||||++
T Consensus 162 ~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccchh----------------------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 9999999998431100 00111234668999998873 4689999999999
Q ss_pred HHHHh-CCCCchh
Q 002580 889 SKKFM-EFQPFPI 900 (905)
Q Consensus 889 ~ellt-g~~PF~~ 900 (905)
|+|++ |..||..
T Consensus 214 ~ellt~g~~p~~~ 226 (303)
T cd05088 214 WEIVSLGGTPYCG 226 (303)
T ss_pred HHHHhcCCCCccc
Confidence 99998 9999853
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=273.94 Aligned_cols=199 Identities=24% Similarity=0.398 Sum_probs=172.7
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+++.||.|+||.||++.+..++..+|+|.+... .......+..|+.+++.++|+||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998743 445567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|..++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 81 IEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--- 156 (280)
T ss_pred eeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc---
Confidence 99999999999987643 35899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........+++.|+|||.+.. ..++|+|||||++|+|++|+.||..
T Consensus 157 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 157 ------------------------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred ------------------------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 011224568999999999751 3479999999999999999999954
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=267.16 Aligned_cols=200 Identities=25% Similarity=0.417 Sum_probs=174.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++++.||.|+||.||.+.+..++..+++|.+..... .......+.+|+.++++++|+||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875432 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999876555689999999999999999999999999999999999999999999999999865431110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......+++.|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 157 ------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 157 ------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred ------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 1223568999999999874 4589999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=275.35 Aligned_cols=196 Identities=22% Similarity=0.355 Sum_probs=170.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.+|++.+.||+|+||.||++.+..++..|++|.+.... ......+.+|+.+++.+.|+||++++++|......|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 58999999999999999999999999999999987542 223466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++... .++...+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 999999999998653 47899999999999999999999999999999999999999999999999986432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||..
T Consensus 171 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 171 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred ------------------------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 01123468899999999874 4689999999999999999999953
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-31 Score=315.34 Aligned_cols=205 Identities=25% Similarity=0.366 Sum_probs=176.1
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
-++.-...||.|.||.||.|.+..+|...|+|-++..... ......+.+|..+|..++|||+|++|++=.+.+.++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3566778899999999999999999999999988765332 445567789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||+||+|.+++...+ -.++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+...-+..
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999999999997643 37777788899999999999999999999999999999999999999999997765331111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccCC------CCchHHHHHHHHHHHHhCCCCchhhh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY------TRMTRYNYLILVSKKFMEFQPFPILC 902 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~sDiwSlGvil~elltg~~PF~~~~ 902 (905)
.......+||+.|||||++.+. .+.|||||||++.||+||+.||...-
T Consensus 1392 -----------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1392 -----------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred -----------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 0123467999999999999953 38999999999999999999997653
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=273.12 Aligned_cols=204 Identities=21% Similarity=0.275 Sum_probs=170.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEc-----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+..++|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34568999999999999999999852 34567999988643 34456678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQP-----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~-----------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~ 812 (905)
.+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999997542 124899999999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHH
Q 002580 813 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVS 889 (905)
Q Consensus 813 vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ 889 (905)
++|+|||++........ ........+++.|+|||++.+ ..++|+|||||++|
T Consensus 159 ~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 213 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213 (288)
T ss_pred EEeccCCccccccCCce-------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 99999999865321110 011123346788999999873 45899999999999
Q ss_pred HHHh-CCCCchh
Q 002580 890 KKFM-EFQPFPI 900 (905)
Q Consensus 890 ellt-g~~PF~~ 900 (905)
+|++ |..||..
T Consensus 214 ~l~t~g~~p~~~ 225 (288)
T cd05093 214 EIFTYGKQPWYQ 225 (288)
T ss_pred HHHhCCCCCCCC
Confidence 9998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=282.01 Aligned_cols=206 Identities=25% Similarity=0.340 Sum_probs=167.5
Q ss_pred cccCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 741 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~ 741 (905)
++..++|++.+.||+|+||.||+|.+.. +++.||+|++.... .......+..|+.++.++ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3455689999999999999999997543 45789999987432 233456678899999999 899999999987
Q ss_pred Ee-CCeEEEEEeccCCCCHHHHHhhCCC----------------------------------------------------
Q 002580 742 QT-KTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 768 (905)
Q Consensus 742 ~~-~~~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------- 768 (905)
.. +..++++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 4678999999999999999864321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhcc
Q 002580 769 -------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841 (905)
Q Consensus 769 -------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~ 841 (905)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----------- 229 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----------- 229 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----------
Confidence 25788999999999999999999999999999999999999999999999998654311110
Q ss_pred ccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......++..|+|||++.+ +.++|+|||||+||+|++ |..||..
T Consensus 230 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 230 --------------VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred --------------hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 11123456778999998874 568999999999999997 9999953
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=266.96 Aligned_cols=198 Identities=25% Similarity=0.386 Sum_probs=172.4
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||.|+||.||+|.+..++..+++|++... .......+.+|+.+++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5899999999999999999999989999999999754 2335677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 9999999999987642 35899999999999999999999999999999999999999999999999998653211
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccCC------CCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY------TRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~------~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........++..|+|||.+.+. .++|+|||||++|+|++|..||..
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 155 -----------------------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred -----------------------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 0112235688899999998633 379999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=272.49 Aligned_cols=203 Identities=19% Similarity=0.237 Sum_probs=169.7
Q ss_pred cCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998743 36789999987542 233457888999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc
Q 002580 745 THVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~ 812 (905)
...|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997542 234788899999999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHH
Q 002580 813 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVS 889 (905)
Q Consensus 813 vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ 889 (905)
++|+|||++........ ........+++.|+|||++.+ ..++|+|||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCcc-------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 99999999864321110 011123346789999999874 45899999999999
Q ss_pred HHHh-CCCCch
Q 002580 890 KKFM-EFQPFP 899 (905)
Q Consensus 890 ellt-g~~PF~ 899 (905)
+|++ |..||.
T Consensus 216 e~~~~g~~p~~ 226 (280)
T cd05049 216 EIFTYGKQPWY 226 (280)
T ss_pred HHHhcCCCCCC
Confidence 9998 999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=271.20 Aligned_cols=199 Identities=33% Similarity=0.565 Sum_probs=175.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||.|+||.||+|.+..++..||+|.+.+...........+.+|+.++++++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999987654444567788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+.|++|..++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999999765 458999999999999999999999999999999999999999999999999986543110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
......|+..|+|||.+.. ..++|+||||+++|+|++|..||...
T Consensus 155 ------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 202 (258)
T cd05578 155 ------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202 (258)
T ss_pred ------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence 1123468889999999874 56999999999999999999999753
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=270.64 Aligned_cols=196 Identities=26% Similarity=0.402 Sum_probs=169.4
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|++.+.||.|+||.||++.+..++..+++|.+... .......+.+|+.+++.++|+||++++++|...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 68889999999999999999999999999998654 344566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+++++|..++... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999999887653 245899999999999999999999999999999999999999999999999998543210
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........+++.|+|||++.. ..++|+|||||++|+|++|.+||..
T Consensus 157 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 157 ---------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred ---------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 011234568999999999841 2489999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=270.88 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=168.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC------
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK------ 744 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~------ 744 (905)
+.|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.++..+ +|+||++++++|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46889999999999999999999999999999987542 2235677899999988 799999999998753
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|++|||+.+++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 46899999999999999998755566899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCC
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~ 896 (905)
... ........|++.|+|||++.+ ..++|+|||||++|+|++|..
T Consensus 162 ~~~---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 162 DRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred ccc---------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 211 011234578999999999852 238999999999999999999
Q ss_pred Cchh
Q 002580 897 PFPI 900 (905)
Q Consensus 897 PF~~ 900 (905)
||..
T Consensus 215 p~~~ 218 (272)
T cd06637 215 PLCD 218 (272)
T ss_pred Cccc
Confidence 9953
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=267.72 Aligned_cols=199 Identities=24% Similarity=0.341 Sum_probs=166.4
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
+.++|++.+.||+|+||.||++... .+..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 3467999999999999999999875 456799998764422 23567889999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999999987543 3588999999999999999999999999999999999999999999999999865321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......++..|+|||.+.+ ..++|+||||+++|+|++ |+.||..
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 156 --------------------------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred --------------------------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 01122345678999999874 458999999999999999 8999853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=283.34 Aligned_cols=190 Identities=22% Similarity=0.307 Sum_probs=162.4
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
...+|.+++.||+|+||.||+|.+..++..||+|+..+. ....|+.+++.++|+||+++++++...+..|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345799999999999999999999999999999975433 23458899999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
|||++ .++|.+++... ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99999 56888888654 345899999999999999999999999999999999999999999999999998642211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
.......||+.|+|||++.+ ..++|+|||||++|+|+++..|+
T Consensus 211 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 01124568999999999974 56999999999999999865443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=283.16 Aligned_cols=200 Identities=27% Similarity=0.372 Sum_probs=175.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHH-----HHHHHHHHHHHHhCC---CCCcceEEEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----VHRACAEREILDMLD---HPFVPALYASF 741 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~-----~~~~~~E~~il~~l~---h~nIv~l~~~~ 741 (905)
+...|..++.||.|+||.|++|.++.+...|++|.+.+....-... ...+-.|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999999999999999998865432222 223457999999997 99999999999
Q ss_pred EeCCeEEEEEecc-CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 742 QTKTHVCLITDYC-PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 742 ~~~~~~~lV~E~~-~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
++++++||+||-. +|.+|++++... ..+++.++..|++||+.|+++||++||||||||-+|++++.+|.+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999985 567999999875 4499999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCC
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~ 896 (905)
+......+ ...++||..|.|||++.|. ..-|||++|++||.+++...
T Consensus 717 aa~~ksgp-----------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 717 AAYTKSGP-----------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred hhhhcCCC-----------------------------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 97755332 2468999999999999973 47899999999999999999
Q ss_pred Cchh
Q 002580 897 PFPI 900 (905)
Q Consensus 897 PF~~ 900 (905)
||+.
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9974
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=271.32 Aligned_cols=204 Identities=20% Similarity=0.285 Sum_probs=169.0
Q ss_pred cCCCeeecccccccCceEEEEEEEc----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
..+.|++.+.||+|+||.||+|.+. .++..+++|.+... ........+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4568999999999999999999853 35678999998743 23445567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC
Q 002580 746 HVCLITDYCPGGELFLLLDRQP---------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~---------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~ 810 (905)
..|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999986331 1247888899999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHH
Q 002580 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLIL 887 (905)
Q Consensus 811 ~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvi 887 (905)
+.+||+|||+++....... ........++..|+|||++.+ ..++|+|||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 9999999999865431110 011223446778999999873 458999999999
Q ss_pred HHHHHh-CCCCchh
Q 002580 888 VSKKFM-EFQPFPI 900 (905)
Q Consensus 888 l~ellt-g~~PF~~ 900 (905)
+|+|++ |..||..
T Consensus 216 l~el~~~g~~p~~~ 229 (283)
T cd05090 216 LWEIFSFGLQPYYG 229 (283)
T ss_pred HHHHHcCCCCCCCC
Confidence 999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=270.98 Aligned_cols=198 Identities=22% Similarity=0.321 Sum_probs=168.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875421 2223345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|..++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 999988888776543 3489999999999999999999999999999999999999999999999999865431110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......++..|+|||.+.+ ..++|+||||+++|+|++|..||.
T Consensus 156 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~ 202 (286)
T cd07847 156 -------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202 (286)
T ss_pred -------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 1123457889999999864 348999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=243.50 Aligned_cols=198 Identities=23% Similarity=0.342 Sum_probs=171.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.+|.-.++||+|.||+||++++..+++.||+|.+.... .+........+|+-+|+.++|.||++++++...++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46777889999999999999999999999999987642 23334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||| ..+|..+.... ++.+....++.++.|++.||.|+|++++.||||||.|+||+.+|.+||+|||+++..+.
T Consensus 81 e~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi----- 153 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI----- 153 (292)
T ss_pred HHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC-----
Confidence 999 67899888765 34589999999999999999999999999999999999999999999999999976542
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHH-hCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKF-MEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~ell-tg~~PF~ 899 (905)
+....+..+-|.+|.+|.++.| ++..|+||.||++.|+. .|.+.|+
T Consensus 154 ----------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 154 ----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred ----------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 2233345577999999999995 56899999999999999 5666675
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=266.66 Aligned_cols=201 Identities=24% Similarity=0.320 Sum_probs=169.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++.+.||+|++|.||+|.+. ++..||+|.++.... ....+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999974 457799999875422 2356788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+++++|.+++.......++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999987654568999999999999999999999999999999999999999999999999986643110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. ........+..|+|||.+.+ ..++|+||||+++|+|++ |+.||..
T Consensus 158 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 158 Y--------------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred c--------------------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 0 00111223468999999874 458999999999999999 9999954
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=272.41 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=169.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++++.||+|+||.||++.+..++..||+|.+... ........+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 3689999999999999999999989999999988643 23444567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 752 DYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||+++++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999999887531 2358999999999999999999997 59999999999999999999999999998543210
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---------CCCchHHHHHHHHHHHHhCCCCch
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---------~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 157 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 157 ---------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred ---------------------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 1123457889999999853 348999999999999999999995
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=295.85 Aligned_cols=208 Identities=23% Similarity=0.327 Sum_probs=176.4
Q ss_pred cccCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 742 (905)
.+...+..+.+.||+|.||+||+++... ....||||.++.. .+......|++|++++..++|||||+|+|+|.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 4667788889999999999999998632 3467999999864 34457789999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC
Q 002580 743 TKTHVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (905)
Q Consensus 743 ~~~~~~lV~E~~~gg~L~~~l~~~~------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~ 810 (905)
.++.+|||+|||..|+|.++|.... ..+++..+.+.|+.||+.||.||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999997531 2238889999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHH
Q 002580 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLIL 887 (905)
Q Consensus 811 ~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvi 887 (905)
..|||+|||+++.+....- ++......-..+|||||.+. .+++||||||||+
T Consensus 640 l~VKIsDfGLsRdiYssDY-------------------------Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVv 694 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDY-------------------------YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVV 694 (774)
T ss_pred eEEEecccccchhhhhhhh-------------------------hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhh
Confidence 9999999999987542221 22221223356899999998 3679999999999
Q ss_pred HHHHH-hCCCCchhhh
Q 002580 888 VSKKF-MEFQPFPILC 902 (905)
Q Consensus 888 l~ell-tg~~PF~~~~ 902 (905)
|||++ +|..||+.++
T Consensus 695 LWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 695 LWEIFSYGKQPYYGLS 710 (774)
T ss_pred hhhhhccccCcccccc
Confidence 99999 7999997654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=270.42 Aligned_cols=193 Identities=30% Similarity=0.459 Sum_probs=166.8
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999765443344455667899999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~ 839 (905)
.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99998765456999999999999999999999999999999999999999999999999988543210
Q ss_pred ccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......++..|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 149 ----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 149 ----------------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred ----------------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 01123457889999999874 4489999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=273.29 Aligned_cols=196 Identities=22% Similarity=0.350 Sum_probs=170.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.+|.+.+.||.|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++|+||++++++|..++..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999987542 233466788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999999865 347899999999999999999999999999999999999999999999999986432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+|||||++|++++|..||..
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred ------------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01123468899999999874 3589999999999999999999953
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=269.91 Aligned_cols=205 Identities=16% Similarity=0.163 Sum_probs=167.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+..++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 445789999999999999999998642 35679999886431 23344568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEE
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL 815 (905)
....++||||+++++|.+++..... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999875321 23567888999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH
Q 002580 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 816 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell 892 (905)
+|||++......... .......+++.|+|||++.+ +.++|+|||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDYY-------------------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCccee-------------------------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 999998654321110 01112345788999999874 55899999999999999
Q ss_pred h-CCCCchh
Q 002580 893 M-EFQPFPI 900 (905)
Q Consensus 893 t-g~~PF~~ 900 (905)
+ |..||..
T Consensus 216 ~~~~~p~~~ 224 (277)
T cd05062 216 TLAEQPYQG 224 (277)
T ss_pred cCCCCCCCC
Confidence 8 7889864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=274.82 Aligned_cols=196 Identities=21% Similarity=0.330 Sum_probs=166.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||.|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++|+||+++++++.+.+..|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999875422 22233456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---- 153 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---- 153 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC----
Confidence 995 58888776542 458999999999999999999999999999999999999999999999999986532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCc
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF 898 (905)
.......+++.|+|||++.+ ..++|+|||||++|+|++|..||
T Consensus 154 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 154 -----------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred -----------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 11123457889999999864 45899999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=269.81 Aligned_cols=191 Identities=32% Similarity=0.537 Sum_probs=158.4
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCeEEEEEeccC
Q 002580 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD---MLDHPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~---~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
.||+|+||.||++.+..+++.+|+|.+.+...........+..|..++. ..+||||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654333332333444444433 3479999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcc
Q 002580 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (905)
Q Consensus 756 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~ 835 (905)
+++|.+++..+ ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999998764 35999999999999999999999999999999999999999999999999998543210
Q ss_pred hhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......||+.|+|||.+.. ..++|+|||||++|+|++|..||..
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 151 ---------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred ---------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 0112468999999999862 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=266.53 Aligned_cols=205 Identities=25% Similarity=0.378 Sum_probs=171.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCH------HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR------NKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
+|.+...||.|++|.||+|.+..++..+|+|.+........ .....+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788899999999999999988999999998876433221 233567889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999764 4488999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.... ...........|++.|+|||.+.+ ..++|+|||||++|+|++|+.||..
T Consensus 159 ~~~~---------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 159 NSLS---------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred cccc---------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 1110 000111234568899999999874 4589999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=269.74 Aligned_cols=205 Identities=17% Similarity=0.184 Sum_probs=170.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCC-----CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t-----~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+..++|.+.+.||+|+||.||++.+... +..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 5567899999999999999999998644 4789999986542 23345567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEE
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL 815 (905)
....|+||||+++++|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999987532 123678889999999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH
Q 002580 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 816 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell 892 (905)
+|||+++....... ........++..|+|||.+.. ..++|+|||||++|+++
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred CCcccchhhccCcc-------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence 99999865431111 011223456789999999863 45899999999999999
Q ss_pred h-CCCCchh
Q 002580 893 M-EFQPFPI 900 (905)
Q Consensus 893 t-g~~PF~~ 900 (905)
+ |..||..
T Consensus 216 t~g~~p~~~ 224 (277)
T cd05032 216 TLAEQPYQG 224 (277)
T ss_pred ccCCCCCcc
Confidence 8 9999964
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=302.67 Aligned_cols=415 Identities=11% Similarity=0.072 Sum_probs=290.5
Q ss_pred cceeEEeeeecCCcccccccchHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCC
Q 002580 169 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGT 248 (905)
Q Consensus 169 ~~~~~~~~i~~~~~~~~~l~~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~ 248 (905)
.+.++..||++++..+++|.++++.++.++++++++++++|. +|+|+++|++|++++||+.+|++|+++..+.++..
T Consensus 181 ~~~g~~~DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~ 257 (807)
T PRK13560 181 QVDGFAEDITERKRAEERIDEALHFLQQLLDNIADPAFWKDE---DAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQP 257 (807)
T ss_pred EEEEEEEccchHHHHHHHHHHHHHHHHHHHhhCCCeEEEEcC---CCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcch
Confidence 467888999999999999999999999999999999999998 99999999999999999999999999887776655
Q ss_pred ChHHHHHHHHHHHcCCcEEEEEEEEccCCCeEEEEEEe--eeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhH
Q 002580 249 DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTI--APIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPES 326 (905)
Q Consensus 249 ~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~s~--~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~ 326 (905)
........+..+..++....+...+++||+.+|+++.+ .|+.|.+|.+.+++++++|||++|++|++|+.+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se~~---- 333 (807)
T PRK13560 258 ADDYQEADAAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEKEDM---- 333 (807)
T ss_pred hHHHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHHHHH----
Confidence 44444555666677777888888999999999776654 566799999999999999999999999987642211
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHccCCCCcccc-CCCCcc-cccCCCchhhhhhccccCccCCCCCCCcCCCC-------C
Q 002580 327 LIRYDARQKEMATSSVTELVQAMKKPRSLSES-TNRPPI-IRKSEGGVEEERAGALGRRKSENVPPPRRNSY-------G 397 (905)
Q Consensus 327 l~~~~~~~~~~~~~~~~~l~~al~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~-------~ 397 (905)
+..+++...++...... +....+ +......+++...+++|+......+....... .
T Consensus 334 ---------------l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~ 398 (807)
T PRK13560 334 ---------------LRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWY 398 (807)
T ss_pred ---------------HHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcC
Confidence 12233334433332222 122222 12223356677778888876655443211100 0
Q ss_pred CCc-------------cccccccccccccccccCCccccccccccccCCCCCCCccccchhccCCCCCCCCCCCCCchhh
Q 002580 398 GGC-------------RTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDD 464 (905)
Q Consensus 398 ~~~-------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~e~ 464 (905)
... ......+........++.+...+......+ +....+..........|||++
T Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p-------------~~d~~g~~~~~~~~~~DITer 465 (807)
T PRK13560 399 PDGRPMAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEP-------------LHDADGNIIGAIALLVDITER 465 (807)
T ss_pred CcCCcchhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEee-------------eECCCCCEEEEEEEeehhhhH
Confidence 000 000000111111222333333333332222 111222233334456899999
Q ss_pred HHHHHhhhhcccHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCC--CCcCcCCCCCHHHHHHHHHH
Q 002580 465 KVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAA 542 (905)
Q Consensus 465 k~~e~~~~~~~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~--~~~l~~~~~~~~~~~~~~~~ 542 (905)
|+.|+++++ .+.++++++++++.++.. .+..+.+|.....++||+++++++.. +..+.+|++.......+...
T Consensus 466 k~~E~~L~~---~~~~~e~~~~~i~~~~~~--~~~~~~~~~~~~~~~G~~~~e~~~~~~~~~~~~~p~d~~~~~~~~~~~ 540 (807)
T PRK13560 466 KQVEEQLLL---ANLIVENSPLVLFRWKAE--EGWPVELVSKNITQFGYEPDEFISGKRMFAAIIHPADLEQVAAEVAEF 540 (807)
T ss_pred HHHHHHHHH---HHHHHhcCCceEEEEecC--CCceEEEecchhhhcCCCHHHhhcccchHhhhcChhhHHHHHHHHHHH
Confidence 999999876 467899999999998874 34455666666788999999998643 45678888888777777776
Q ss_pred HHcCC-cEEEEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccCCchhhhHHHHHHHHHHhhhhhh
Q 002580 543 IDNQT-DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNE 621 (905)
Q Consensus 543 l~~g~-~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~~~~~~~~e~~~l~~~~~~~~~~ 621 (905)
+..|. .+..++++.++||..+|+.....|++|.+|.+.+++++++|||++|++|++++ .+.++...++..++|.+.+
T Consensus 541 ~~~g~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~aE~~L~--~a~~~~~~~l~~isHelrn 618 (807)
T PRK13560 541 AAQGVDRFEQEYRILGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHAEEKIK--AALTEKEVLLKEIHHRVKN 618 (807)
T ss_pred HhcCCccceeEEEEEcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHHHHHHH--HHHHHHHHHHHHhHHHHhC
Confidence 66653 57889999999999999999999999999999999999999999999766543 3344555666666666655
Q ss_pred hhhc
Q 002580 622 AVKE 625 (905)
Q Consensus 622 ~~~~ 625 (905)
.+..
T Consensus 619 pL~~ 622 (807)
T PRK13560 619 NLQI 622 (807)
T ss_pred hHHH
Confidence 5443
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=271.67 Aligned_cols=196 Identities=23% Similarity=0.376 Sum_probs=170.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.+|++.+.||.|++|.||++.+..+++.|++|.+... .......+.+|+.+++.++|+||+++++++...+.+|+|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 5799999999999999999999999999999998754 2234567788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|..++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999999988653 48999999999999999999999999999999999999999999999999986532110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred ------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01123468899999999874 4589999999999999999999953
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=267.40 Aligned_cols=200 Identities=23% Similarity=0.316 Sum_probs=166.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++.+.||+|+||.||+|.+..++ .+|+|.+..... ....+.+|+.+++.++|+||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 34568999999999999999999986554 599999875322 2346788999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
+||||+++++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999986544568899999999999999999999999999999999999999999999999986543111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......++..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 157 Y--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred c--------------------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 0 01112346778999998863 458999999999999999 8889854
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=265.62 Aligned_cols=203 Identities=24% Similarity=0.323 Sum_probs=170.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeeccc--ccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 747 (905)
.+|.+.+.||+|+||.||++.+..++..||+|.+.... .........+.+|+.+++.++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999876431 12234556788999999999999999999998764 568
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998764 34889999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .........++..|+|||.+.+ ..++|+|||||++|+|++|+.||..
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 160 CM------------------------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cc------------------------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 00 0011123568999999999874 4589999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.89 Aligned_cols=195 Identities=19% Similarity=0.263 Sum_probs=162.6
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999876432 3445567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
+|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 79 ~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 9999987542 3588999999999999999999999999999999999999999999999999854321000
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.........+..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 150 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 150 -----------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred -----------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 000011123467999999874 458999999999999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=266.36 Aligned_cols=202 Identities=19% Similarity=0.197 Sum_probs=169.5
Q ss_pred cCCCeeecccccccCceEEEEEEEcCC---CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t---~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
..++|++.+.||+|+||.||+|.+..+ ...+|+|.++... .......+..|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 356899999999999999999998644 4579999887542 33445678889999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
.|++|||+++++|.+++.... ..++...+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999999997653 3589999999999999999999999999999999999999999999999999976531
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCch
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~ 899 (905)
.... .......+++.|+|||.+.+ ..++|+||||+++|+|++ |..||.
T Consensus 159 ~~~~-------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 159 SEAT-------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred cccc-------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 1110 00112235678999999874 458999999999999997 999984
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=269.28 Aligned_cols=198 Identities=24% Similarity=0.382 Sum_probs=171.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||.|+||.||+|.+..++..|++|.+..... .......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999876532 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999987643 5699999999999999999999999999999999999999999999999999865431110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......++..|+|||++.+ ..++|+|||||++|+|++|.+||.
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 155 -----------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred -----------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 11123468999999999863 458999999999999999988884
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=271.67 Aligned_cols=199 Identities=24% Similarity=0.301 Sum_probs=167.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4689999999999999999999998999999999875421 11223466899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 99996 59999887653 358999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||++.+ ..++|+||||+++|+|++|..||..
T Consensus 158 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 158 -------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred -------------------------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01112346789999999863 3589999999999999999999953
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=267.99 Aligned_cols=197 Identities=28% Similarity=0.414 Sum_probs=172.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||.|++|.||++.+..++..+|+|.+.... .......+.+|+.+++.++|+||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47899999999999999999999999999999987542 2344566789999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998764 58999999999999999999999999999999999999999999999999986643111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ +.++|+|||||++|+|++|..||..
T Consensus 153 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 153 ------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred ------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 11234568899999999874 4689999999999999999999953
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=272.56 Aligned_cols=205 Identities=22% Similarity=0.299 Sum_probs=171.0
Q ss_pred ccCCCeeecccccccCceEEEEEEEc-----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 742 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 742 (905)
+..++|.+.+.||+|+||.||++.+. .++..+|+|.++... .......+.+|+.+++++ +|+||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 55668999999999999999999852 345689999887542 234456788999999999 7999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 002580 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 743 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~ 822 (905)
..+..|++|||+.+++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999976544458999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCc
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPF 898 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF 898 (905)
........ .......+++.|+|||.+.+ ..++|+|||||++|+|++ |..||
T Consensus 190 ~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~ 244 (302)
T cd05055 190 DIMNDSNY-------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244 (302)
T ss_pred cccCCCce-------------------------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCc
Confidence 54311100 01122346788999999874 458999999999999998 99998
Q ss_pred hh
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 245 ~~ 246 (302)
T cd05055 245 PG 246 (302)
T ss_pred CC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=270.30 Aligned_cols=199 Identities=24% Similarity=0.288 Sum_probs=166.6
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+.+.||+|+||.||+|.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875422 12233567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+. ++|..++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred Eeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 99995 67777765443 347888899999999999999999999999999999999999999999999986432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 158 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 158 -------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred -------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 01123357899999999864 3478999999999999999999963
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=267.99 Aligned_cols=199 Identities=24% Similarity=0.263 Sum_probs=171.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
..+|++.+.||.|+||.||+|.+.. +..+++|.+... .......+..|+.+++.++|+||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3479999999999999999999977 888999998754 233455688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|.+++.......++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999999876556789999999999999999999999999999999999999999999999999865431100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
......++..|+|||.+.. ..++|+||||+++|+|++ |+.||..
T Consensus 160 --------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 160 --------------------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred --------------------------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 1112345678999999873 458999999999999998 8999964
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=246.54 Aligned_cols=205 Identities=24% Similarity=0.351 Sum_probs=170.5
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 743 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~ 743 (905)
.+-.+..+....+..||+|++|.|-+.++..+|...|+|.+.... +....++.++|+++..+. .+|++|++|+.+..
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334555667777889999999999999999999999999998653 345567788899886664 79999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 744 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
.+.++|.||.| ..+|..+... ..+..+++..+-+|+..++.||.|||++ .++|||+||+||||+.+|++||||||.
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999999 5678776553 2345699999999999999999999987 899999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------C-CCchHHHHHHHHHHHHh
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------Y-TRMTRYNYLILVSKKFM 893 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~-~~sDiwSlGvil~ellt 893 (905)
|-.+..+- ..+.-.|-..|||||.+.. | -++|+||||++++||.+
T Consensus 196 sG~L~dSi----------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 196 SGYLVDSI----------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred ceeehhhh----------------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 86543211 1122357789999999982 2 39999999999999999
Q ss_pred CCCCchh
Q 002580 894 EFQPFPI 900 (905)
Q Consensus 894 g~~PF~~ 900 (905)
+++||+.
T Consensus 248 lr~PY~~ 254 (282)
T KOG0984|consen 248 LRFPYES 254 (282)
T ss_pred ccccccc
Confidence 9999963
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=271.54 Aligned_cols=208 Identities=21% Similarity=0.321 Sum_probs=171.4
Q ss_pred cccccCCCeeecccccccCceEEEEEEEcCC-----CeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (905)
Q Consensus 666 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t-----~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 739 (905)
...+..++|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.++..+ +|+||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3456678899999999999999999998644 3789999987542 233456688999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 740 SFQTKTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 740 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
++..++.+|++|||+++++|..++... ....+++..++.++.|++.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999652 234588999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
|++.++.+||+|||++........ ........++..|+|||.+.+ +.++|+|
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999999999875432110 001112234578999998763 4589999
Q ss_pred HHHHHHHHHHh-CCCCchh
Q 002580 883 NYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 883 SlGvil~ellt-g~~PF~~ 900 (905)
||||++|+|++ |..||..
T Consensus 219 slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred ehhhHHHHHhcCCCCCCCC
Confidence 99999999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=270.42 Aligned_cols=203 Identities=21% Similarity=0.259 Sum_probs=168.8
Q ss_pred cCCCeeecccccccCceEEEEEEEc-----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~-----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
...+|.+.+.||+|+||.||+|.+. .++..+++|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999864 34567889987643 234446788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC
Q 002580 745 THVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~ 810 (905)
+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997542 2347889999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHH
Q 002580 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLIL 887 (905)
Q Consensus 811 ~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvi 887 (905)
+.++|+|||++........ ........+++.|+|||.+.+ ..++|+|||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCce-------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 9999999999865431110 011223456789999999874 458999999999
Q ss_pred HHHHHh-CCCCchh
Q 002580 888 VSKKFM-EFQPFPI 900 (905)
Q Consensus 888 l~ellt-g~~PF~~ 900 (905)
+|+|++ |..||..
T Consensus 215 l~el~t~g~~p~~~ 228 (291)
T cd05094 215 LWEIFTYGKQPWFQ 228 (291)
T ss_pred HHHHHhCCCCCCCC
Confidence 999998 9999843
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=265.06 Aligned_cols=203 Identities=24% Similarity=0.313 Sum_probs=170.1
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 747 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~ 747 (905)
.+|.+.+.||+|+||.||++.+..++..|++|.+...... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999999999999999998754321 22345678889999999999999999998875 3678
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
++++||+++++|.+++... ..++...++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999999764 34889999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .........++..|+|||.+.+ +.++|+|||||++|+|++|+.||..
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 160 CM------------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred cc------------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 00 0001123458899999999874 4589999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=266.03 Aligned_cols=198 Identities=23% Similarity=0.319 Sum_probs=165.2
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
..+|++.+.||+|+||.||++.+. ++..+|+|.+.+... ....+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 456899999999999999999885 566799999875432 224577899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999997643 3589999999999999999999999999999999999999999999999999865321100
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......++..|+|||.+.+ ..++|+||||+++|+|++ |..||..
T Consensus 156 -------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 156 -------------------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred -------------------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 00111224567999999874 458999999999999998 8999853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=262.79 Aligned_cols=199 Identities=25% Similarity=0.406 Sum_probs=172.5
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876533 33446778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEeccCccccCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|+++++|.+++.......+++..+..++.+++.+|.|||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 9999999999987555568999999999999999999999999999999999999855 468999999986543110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......+++.|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 157 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 157 -------------------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred -------------------------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 1123468899999999874 4589999999999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=274.57 Aligned_cols=192 Identities=23% Similarity=0.337 Sum_probs=155.3
Q ss_pred ccccccCceEEEEEEEcC--CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCeEEEEEec
Q 002580 678 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLITDY 753 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~--t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~--~~~~~~lV~E~ 753 (905)
..||+|+||.||+|.... ++..||+|.+.... ....+.+|+.+++.++||||+++++++. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 56889999886542 1235678999999999999999999885 35678999999
Q ss_pred cCCCCHHHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEE----cCCCcEEEEeccCcc
Q 002580 754 CPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 822 (905)
Q Consensus 754 ~~gg~L~~~l~~~-------~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl----~~~~~vkL~DFG~s~ 822 (905)
+. ++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5787777532 12348889999999999999999999999999999999999 456789999999997
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCc
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF 898 (905)
....... .........+|+.|+|||++.+ ..++|+|||||++|+|++|.+||
T Consensus 161 ~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCcc------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 6432111 0111234578999999999864 34799999999999999999999
Q ss_pred h
Q 002580 899 P 899 (905)
Q Consensus 899 ~ 899 (905)
.
T Consensus 217 ~ 217 (317)
T cd07867 217 H 217 (317)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=265.09 Aligned_cols=195 Identities=23% Similarity=0.378 Sum_probs=165.3
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCeE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHV 747 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~ 747 (905)
++..+|.+.+.||+|+||.||++.. .+..+++|.+... .....+.+|+.+++.++|+|++++++++. .++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 4567899999999999999999987 4778999988643 23456888999999999999999999764 55679
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|++|||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999998765556889999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.....++..|+|||++.+ ..++|+|||||++|+|++ |+.||..
T Consensus 156 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 156 ------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ------------------------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 112234568999999874 458999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=267.55 Aligned_cols=203 Identities=20% Similarity=0.268 Sum_probs=167.7
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCe----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
+...+|++.+.||+|+||.||+|.+..++. .||+|++... ........+.+|+.++..++|+||+.+++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999877765 4899988654 234445678889999999999999999998875
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...+++++|+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 45789999999999999987642 45899999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
...... .......+++.|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDETE-------------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccce-------------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 321110 00112234678999999874 458999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=266.09 Aligned_cols=199 Identities=20% Similarity=0.297 Sum_probs=166.7
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
+.++|++.+.||+|+||.||.+.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++......|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 34679999999999999999998754 44699998875422 23567889999999999999999999998899999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
+|||+.+++|.+++..... .+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999999999976433 589999999999999999999999999999999999999999999999999865321100
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......++..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 156 --------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 156 --------------------------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred --------------------------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 01112345678999999874 458999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=265.13 Aligned_cols=204 Identities=21% Similarity=0.268 Sum_probs=170.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
+|++.+.||.|+||.||+|.. .+++.+|+|.+..... ........+.+|+++++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999987 5788999998875421 122344668899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
+|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999764 3488999999999999999999999999999999999999999999999999865431111
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. ..........|+..|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 158 ~~---------------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 158 HG---------------------THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred cc---------------------cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 00 00011234568999999999874 4689999999999999999999953
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=267.96 Aligned_cols=203 Identities=19% Similarity=0.274 Sum_probs=165.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCe----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
+..++|++.+.||.|+||.||+|.+..++. .+++|.+... ........+..|+.++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 445689999999999999999999977776 4666766432 12334466778888899999999999999875 4
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...++++||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 56789999999999999997643 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
...... .......++..|+|||.+.+ +.++|+|||||++|++++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 160 YPDDKK-------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCCCcc-------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 311100 01123456778999999873 458999999999999998 9999954
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=268.13 Aligned_cols=204 Identities=20% Similarity=0.254 Sum_probs=169.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEc-----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+...+|.+.++||+|+||.||++... .++..+++|.+... .......+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 44568899999999999999999753 34678999987643 34456678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~-------------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~ 810 (905)
.+..|++|||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 9999999999999999999976431 347889999999999999999999999999999999999999
Q ss_pred CcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHH
Q 002580 811 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLIL 887 (905)
Q Consensus 811 ~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvi 887 (905)
+.+||+|||++........ ........+++.|+|||.+.+ +.++|+|||||+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY-------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVV 213 (280)
T ss_pred CCEEECCCCceeEcCCCce-------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHH
Confidence 9999999999864321100 011123345788999998874 458999999999
Q ss_pred HHHHHh-CCCCchh
Q 002580 888 VSKKFM-EFQPFPI 900 (905)
Q Consensus 888 l~ellt-g~~PF~~ 900 (905)
+|+|++ |.+||..
T Consensus 214 l~el~~~g~~p~~~ 227 (280)
T cd05092 214 LWEIFTYGKQPWYQ 227 (280)
T ss_pred HHHHHcCCCCCCcc
Confidence 999998 9999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=264.49 Aligned_cols=204 Identities=25% Similarity=0.350 Sum_probs=174.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||.|+||.||+|....++..+++|++...... .....+.+|+.+++.++|+||+++++.+...+..|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4799999999999999999999889999999998754322 25677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|++++++|.+++..... ..+++..+..++.|++.||.|||++||+|+||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976432 45899999999999999999999999999999999999999999999999998664422110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.........|+..|+|||++.. ..++|+|||||++|+|++|+.||..
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 159 -----------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred -----------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 0012234578999999999863 4589999999999999999999964
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.84 Aligned_cols=204 Identities=20% Similarity=0.253 Sum_probs=169.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCC---eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~---~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
..++|++.+.||+|+||.||+|.+..++ ..+|+|.++... .......+..|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3568999999999999999999986544 379999887542 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
.|+||||+++++|.+++.... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999997653 4589999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.... ........++..|+|||.+.+ ..++|+|||||++|++++ |..||..
T Consensus 159 ~~~~------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 159 DPEA------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred ccce------------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 1110 001112234568999999874 458999999999999886 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=265.27 Aligned_cols=200 Identities=22% Similarity=0.321 Sum_probs=167.9
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++++.||+|+||.||+|... ++..||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999874 567899999875432 2356788999999999999999999874 56789
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+.+++|.+++.......++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999877655678999999999999999999999999999999999999999999999999985533110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......++..|+|||++.+ ..++|+||||+++|++++ |++||..
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 157 Y--------------------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred c--------------------------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 0 01122345678999999873 458999999999999998 9999963
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=267.35 Aligned_cols=199 Identities=22% Similarity=0.275 Sum_probs=163.2
Q ss_pred Ce-eecccccccCceEEEEEEE----cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 002580 673 HF-RPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KT 745 (905)
Q Consensus 673 ~y-~i~~~Lg~G~~g~V~~~~~----~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~ 745 (905)
+| ++.+.||+|+||.||++.. ..++..+|+|.+.... .......+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 45 9999999999999988653 3567889999987542 22345667889999999999999999998765 34
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+|++|||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 689999999999999998763 38999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
..... ........++..|+|||.+.. ..++|+||||+++|+|++|..||..
T Consensus 159 ~~~~~------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 159 EGHEY------------------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred Ccchh------------------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 21110 001112245667999999873 4599999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=269.90 Aligned_cols=198 Identities=22% Similarity=0.335 Sum_probs=169.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++++.||.|++|.||+|.+..++..||+|.+..... .......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998875422 22234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+. ++|..++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 995 689998877655678999999999999999999999999999999999999999999999999986532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||++.+ ..++|+|||||++|+|+||+.||.
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 155 -----------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred -----------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 01122356889999998874 347999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=270.79 Aligned_cols=198 Identities=25% Similarity=0.324 Sum_probs=169.4
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+++++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 479999999999999999999988999999999876432 2234456788999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|..+.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999998888876543 348999999999999999999999999999999999999999999999999986532111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......++..|+|||++.+ ..++|+||||+++|+|++|++||.
T Consensus 155 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 155 ------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred ------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 11123467899999999874 347999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=267.38 Aligned_cols=205 Identities=18% Similarity=0.266 Sum_probs=168.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+..++|.+.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345689999999999999999999977 7788999987643 223344568889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC---cEEE
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSL 815 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~---~vkL 815 (905)
.+..|+||||++|++|.+++..... ..+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999999976432 2588999999999999999999999999999999999998655 5999
Q ss_pred EeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH
Q 002580 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 816 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell 892 (905)
+|||+++........ ........+..|+|||++.+ ..++|+|||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 161 ADFGMARDIYRASYY-------------------------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ccCccccccCCccce-------------------------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 999998754211100 00112234568999999873 56999999999999999
Q ss_pred h-CCCCchh
Q 002580 893 M-EFQPFPI 900 (905)
Q Consensus 893 t-g~~PF~~ 900 (905)
+ |..||..
T Consensus 216 ~~g~~pf~~ 224 (277)
T cd05036 216 SLGYMPYPG 224 (277)
T ss_pred cCCCCCCCC
Confidence 6 9999964
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=262.86 Aligned_cols=199 Identities=21% Similarity=0.411 Sum_probs=172.3
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||+|+||.||++.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875422 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 9999999999976554568999999999999999999999999999999999999999999999999986532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......|++.|+|||++.+ ..++|+|||||++|+|++|..||.
T Consensus 156 -----------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 156 -----------------------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred -----------------------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 01123457889999999874 458999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=269.42 Aligned_cols=205 Identities=19% Similarity=0.277 Sum_probs=168.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCC-----CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t-----~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
++..+|.+.+.||.|+||.||+|.+..+ +..||+|.+.... .......+..|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456799999999999999999987543 5789999987542 23345668889999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~ 809 (905)
....++++||+.+++|.+++.... ...++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 999999999999999999985321 234788889999999999999999999999999999999999
Q ss_pred CCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHH
Q 002580 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLI 886 (905)
Q Consensus 810 ~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGv 886 (905)
++.+||+|||+++....... ........+++.|+|||.+.+ ..++|+|||||
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-------------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214 (283)
T ss_pred CCceEecccccccccccchh-------------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHH
Confidence 99999999999865321110 011123346789999999863 45899999999
Q ss_pred HHHHHHh-CCCCchh
Q 002580 887 LVSKKFM-EFQPFPI 900 (905)
Q Consensus 887 il~ellt-g~~PF~~ 900 (905)
++|+|++ |..||..
T Consensus 215 ~l~el~~~g~~p~~~ 229 (283)
T cd05091 215 VLWEVFSYGLQPYCG 229 (283)
T ss_pred HHHHHHcCCCCCCCC
Confidence 9999998 8888853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=265.55 Aligned_cols=196 Identities=20% Similarity=0.201 Sum_probs=159.3
Q ss_pred ccccccCceEEEEEEEc--CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 002580 678 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~--~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 345679999876542 22334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 756 GGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 756 gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
+++|.+++.... ....+...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999987532 12456777888999999999999999999999999999999999999999999854321100
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC----------CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----------YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----------~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
........+++.|+|||++.+ ..++|+|||||++|+|++ |..||..
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 156 ----------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred ----------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 011223467889999999863 358999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=270.74 Aligned_cols=198 Identities=24% Similarity=0.338 Sum_probs=168.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+|.+.+.||.|+||.||+|.+..+++.|++|.+...... .......+..|+++++.++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999865432 122344567899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 9999 899999997643 3589999999999999999999999999999999999999999999999999866432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+++.|+|||.+.+ ..++|+|||||++|+|++|.+||.
T Consensus 158 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 158 --------------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred --------------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 1122356789999998853 358999999999999999988875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=267.76 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=169.2
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT------ 743 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~------ 743 (905)
.+.|++.+.||.|+||.||++.+..+++.+|+|++... ......+..|+.++..+ +|+||++++++|..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 46899999999999999999999999999999998653 23345677899999888 79999999999853
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
...+|++|||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 46789999999999999999876556688999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc--------CCCCchHHHHHHHHHHHHhCC
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--------AYTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--------~~~~sDiwSlGvil~elltg~ 895 (905)
.... ........|++.|+|||.+. ...++|+|||||++|+|++|.
T Consensus 171 ~~~~---------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 171 LDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred hhcc---------------------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 3210 01123456899999999975 134899999999999999999
Q ss_pred CCchh
Q 002580 896 QPFPI 900 (905)
Q Consensus 896 ~PF~~ 900 (905)
.||..
T Consensus 224 ~p~~~ 228 (282)
T cd06636 224 PPLCD 228 (282)
T ss_pred CCccc
Confidence 99954
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=255.44 Aligned_cols=200 Identities=25% Similarity=0.351 Sum_probs=168.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 747 (905)
.+.++..++..||.|+.|.|+++..+.+|...|||.+.+. .+..+.++++..++++... ++|+||+.+++|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3455667788899999999999999999999999999875 3566778888888887665 589999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
++.||.| +-.+..++++. .+++++..+-++...++.||.||..+ ||+|||+||+|||+|..|++||||||++-.+..
T Consensus 167 ~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999998 44555566554 46799999999999999999999865 899999999999999999999999999855431
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
+ ...+-..|-+.|||||-+.- .-++|+||||++|+||.||.+||+.
T Consensus 245 S----------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 245 S----------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred c----------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 1 11223468899999999983 2388999999999999999999975
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=265.75 Aligned_cols=197 Identities=21% Similarity=0.239 Sum_probs=157.6
Q ss_pred ccccccCceEEEEEEEcC--CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 002580 678 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~--t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
+.||+|+||.||+|.... ....+++|.+... ........+.+|+.+++.++|+||+++++++......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997533 3457888876543 233345667889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 756 GGELFLLLDRQPT---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 756 gg~L~~~l~~~~~---~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
+++|.+++..... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999999976432 2346778889999999999999999999999999999999999999999999854221100
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC----------CCCchHHHHHHHHHHHHh-CCCCchhh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----------YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----------~~~sDiwSlGvil~ellt-g~~PF~~~ 901 (905)
........+++.|+|||++.. ..++|+|||||++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 001123346778999998741 348999999999999998 88898643
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=271.66 Aligned_cols=205 Identities=21% Similarity=0.300 Sum_probs=167.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEcC-------CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 740 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~-------t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 740 (905)
+..++|.+.+.||+|+||.||++.+.. +...+|+|.+.... .......+..|+.+++.+ +|+||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 445789999999999999999998643 23579999987542 233456788899999999 79999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEE
Q 002580 741 FQTKTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806 (905)
Q Consensus 741 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NIL 806 (905)
+...+..|+||||+++++|.+++..... ..++...++.++.|++.||.|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 9999999999999999999999976421 24788899999999999999999999999999999999
Q ss_pred EcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHH
Q 002580 807 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYN 883 (905)
Q Consensus 807 l~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwS 883 (905)
++.++.+||+|||++........ ........+++.|+|||++.+ ..++|+||
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 227 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227 (307)
T ss_pred EcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHHH
Confidence 99999999999999865321100 001112234578999999874 45899999
Q ss_pred HHHHHHHHHh-CCCCchh
Q 002580 884 YLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 884 lGvil~ellt-g~~PF~~ 900 (905)
|||++|+|++ |..||..
T Consensus 228 lG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 228 FGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred HHHHHHHHHcCCCCCCCc
Confidence 9999999998 8888853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=266.74 Aligned_cols=198 Identities=25% Similarity=0.355 Sum_probs=163.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~i-l~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
++|++.+.||+|+||.||++.+..+|..||+|.++.... .. ....+..|+.+ ++.++||||+++++++..++.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876532 22 23345556654 5667999999999999999999999
Q ss_pred EeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 751 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|||++ ++|.+++... ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99995 6888877642 234689999999999999999999998 9999999999999999999999999998653210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......++..|+|||.+.+ ..++|+|||||++|+|++|+.||..
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 ----------------------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ----------------------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 01122457889999998853 4589999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=265.34 Aligned_cols=203 Identities=20% Similarity=0.293 Sum_probs=170.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
+|+..+.||+|++|.||++.+..++..+|+|.+....... ......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543211 2245678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-~vkL~DFG~s~~~~~~~ 828 (905)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999764 3589999999999999999999999999999999999998776 69999999986543210
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .........++..|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 159 ~~-----------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 159 TG-----------------------AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred cc-----------------------CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 00 0011223568999999999863 4589999999999999999999953
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=268.69 Aligned_cols=204 Identities=22% Similarity=0.318 Sum_probs=170.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCC----------------eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSG----------------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~----------------~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~n 733 (905)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 4568999999999999999999876543 568999987542 2345677889999999999999
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCC
Q 002580 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (905)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~N 804 (905)
|+++++++..++..+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997643 1258999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchH
Q 002580 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTR 881 (905)
Q Consensus 805 ILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDi 881 (905)
|+++.++.++|+|||++........ ........+++.|+|||.+.+ ..++|+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-------------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------eeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 9999999999999999865321110 011223456789999999874 569999
Q ss_pred HHHHHHHHHHHh--CCCCchh
Q 002580 882 YNYLILVSKKFM--EFQPFPI 900 (905)
Q Consensus 882 wSlGvil~ellt--g~~PF~~ 900 (905)
|||||++|+|++ +..||..
T Consensus 216 ~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCC
Confidence 999999999998 6778753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.62 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=166.5
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++|+||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45568999999999999999999875 556799999876432 2346889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999987555568999999999999999999999999999999999999999999999999986532110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......++..|+|||.+.+ ..++|+||||+++|+|++ |..||..
T Consensus 157 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 157 Y--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred c--------------------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 0 01112345678999999864 458999999999999999 8999954
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=267.62 Aligned_cols=206 Identities=16% Similarity=0.170 Sum_probs=167.1
Q ss_pred cccCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 742 (905)
.+..++|++.+.||+|+||.||+|.... .+..||+|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3566789999999999999999997642 35589999876442 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCCHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEE
Q 002580 743 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814 (905)
Q Consensus 743 ~~~~~~lV~E~~~gg~L~~~l~~~~--------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vk 814 (905)
..+..|+||||+++++|.+++.... ...++...+..++.||+.||.|||+++|+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 12346678889999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHH
Q 002580 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKK 891 (905)
Q Consensus 815 L~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~el 891 (905)
|+|||+++....... ........++..|+|||.+.+ +.++|+|||||++|+|
T Consensus 160 L~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCcccccccccc-------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 999999865321110 001112345678999999874 5589999999999999
Q ss_pred Hh-CCCCchh
Q 002580 892 FM-EFQPFPI 900 (905)
Q Consensus 892 lt-g~~PF~~ 900 (905)
++ |..||..
T Consensus 215 ~~~~~~p~~~ 224 (288)
T cd05061 215 TSLAEQPYQG 224 (288)
T ss_pred HhCCCCCCCC
Confidence 98 7889853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=279.98 Aligned_cols=207 Identities=23% Similarity=0.280 Sum_probs=169.6
Q ss_pred ccccCCCeeecccccccCceEEEEEEEc-----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEE
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 740 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~-----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~ 740 (905)
..+..++|.+.+.||+|+||.||+|.+. .++..||+|+++... .......+..|+.+|..+. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 3455678999999999999999999864 345789999997542 2333457889999999997 9999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhhCCC----------------------------------------------------
Q 002580 741 FQTKTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 768 (905)
Q Consensus 741 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------------------------------------------------- 768 (905)
+...+.+|+|||||++|+|.+++.....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999975321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCC
Q 002580 769 --------------------------------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (905)
Q Consensus 769 --------------------------------------------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~N 804 (905)
..++...+..++.||+.||.|||+++|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 235667788899999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchH
Q 002580 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTR 881 (905)
Q Consensus 805 ILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDi 881 (905)
||++.++.+||+|||+++........ .......+++.|+|||.+.+ ..++|+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-------------------------ISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-------------------------ccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 99999999999999998653211110 01123457889999999874 458999
Q ss_pred HHHHHHHHHHHh-CCCCchh
Q 002580 882 YNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 882 wSlGvil~ellt-g~~PF~~ 900 (905)
|||||++|+|++ |..||..
T Consensus 325 wslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCC
Confidence 999999999998 8999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=266.42 Aligned_cols=192 Identities=32% Similarity=0.510 Sum_probs=158.6
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHH---HHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 002580 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~---il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
.||+|+||.||++.+..+++.||+|.+.+...........+..|.. ++....||||+.+++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999999999999999987654332222222333433 3444689999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcc
Q 002580 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (905)
Q Consensus 756 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~ 835 (905)
|++|..++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999988764 45999999999999999999999999999999999999999999999999998543210
Q ss_pred hhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
......|+..|+|||.+.. ..++|+||+||++|+|++|+.||...
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 151 ---------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ---------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 1123468999999999862 35899999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.72 Aligned_cols=208 Identities=26% Similarity=0.388 Sum_probs=176.2
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeeccccc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCC
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML----NRNKVHRACAEREILDMLDHPFVPALYASFQ-TKT 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~----~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~ 745 (905)
.++|-++..||+|+|+.||++.+....+.||||+-...... ..+..+...+|..|-+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 46899999999999999999999999999999986543211 2233456779999999999999999999997 557
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCCEEEc---CCCcEEEEeccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ---GNGHVSLTDFDL 820 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g--IvHrDLKp~NILl~---~~~~vkL~DFG~ 820 (905)
.+|-|+|||+|.+|.-||+.+ +.+++.+++.|+.||+.||.||.... |||=||||.|||+- .-|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999999886 45999999999999999999999874 99999999999994 347899999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc-C------CCCchHHHHHHHHHHHHh
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF-A------YTRMTRYNYLILVSKKFM 893 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~------~~~sDiwSlGvil~ellt 893 (905)
+++....+... ...+..+..+.||.+|++||.+. + +.+.|+||.|||+|..++
T Consensus 620 SKIMdddSy~~--------------------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 620 SKIMDDDSYNS--------------------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred hhhccCCccCc--------------------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 98876443211 12344566789999999999998 2 459999999999999999
Q ss_pred CCCCchh
Q 002580 894 EFQPFPI 900 (905)
Q Consensus 894 g~~PF~~ 900 (905)
|+.||..
T Consensus 680 GrKPFGh 686 (775)
T KOG1151|consen 680 GRKPFGH 686 (775)
T ss_pred cCCCCCC
Confidence 9999974
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=264.98 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=169.6
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT---- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~---- 745 (905)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... .....+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468999999999999999999999899999999987542 2346788999999998 7999999999997644
Q ss_pred --eEEEEEeccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 746 --HVCLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 746 --~~~lV~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
.+|+||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999987533 456899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHh
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFM 893 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~ellt 893 (905)
...... ........|++.|+|||++.. ..++|+|||||+||+|++
T Consensus 161 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 161 AQLDST---------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred eecccc---------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 653211 011223468999999998752 347999999999999999
Q ss_pred CCCCchh
Q 002580 894 EFQPFPI 900 (905)
Q Consensus 894 g~~PF~~ 900 (905)
|+.||..
T Consensus 214 g~~p~~~ 220 (275)
T cd06608 214 GKPPLCD 220 (275)
T ss_pred CCCCccc
Confidence 9999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=268.27 Aligned_cols=198 Identities=24% Similarity=0.413 Sum_probs=172.2
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..++|++++.||+|+||.||++.+..++..||+|++.... .......+.+|+++++.++||||+++++++...+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4568999999999999999999999999999999887542 23445678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
||||+++++|.+++... +.++...+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999999998764 458999999999999999999997 69999999999999999999999999987542100
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+|+..|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 158 ----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 158 ----------------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred ----------------------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 0123468999999999863 4589999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=268.60 Aligned_cols=199 Identities=21% Similarity=0.252 Sum_probs=164.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCe--EEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~--~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 748 (905)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877764 4688877632 2334456788999999999 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEE
Q 002580 749 LITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vk 814 (905)
++|||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 12478899999999999999999999999999999999999999999
Q ss_pred EEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHH
Q 002580 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKK 891 (905)
Q Consensus 815 L~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~el 891 (905)
|+|||++...... ........+..|+|||.+.+ ..++|+|||||++|+|
T Consensus 160 l~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccce----------------------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 9999998431100 00111123457999999874 4589999999999999
Q ss_pred Hh-CCCCchh
Q 002580 892 FM-EFQPFPI 900 (905)
Q Consensus 892 lt-g~~PF~~ 900 (905)
++ |..||..
T Consensus 212 ~t~g~~pf~~ 221 (297)
T cd05089 212 VSLGGTPYCG 221 (297)
T ss_pred HcCCCCCCCC
Confidence 97 9999953
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=261.73 Aligned_cols=196 Identities=25% Similarity=0.375 Sum_probs=171.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||.|+||.||++.+..++..+++|.+.... ....+.+|+++++.++|+||+++++++......|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 58999999999999999999998889999999986531 2577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 78 EYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred ecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 9999999999987543 458999999999999999999999999999999999999999999999999986543111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......++..|+|||++.+ +.++|+||||+++|+|++|+.||..
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 154 ------------------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred ------------------------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01123457889999999874 4589999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=264.21 Aligned_cols=205 Identities=19% Similarity=0.229 Sum_probs=168.9
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCe---EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~---~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.+.|++.+.||+|+||.||+|.+..++. .||+|.+... ........+..|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999876654 6999998754 2344567889999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
++||||+++++|.+++.... ..++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999987643 45899999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.... ..........+..|+|||.+.+ ..++|+|||||++|++++ |..||..
T Consensus 160 ~~~~----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 160 TSDP----------------------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred cccc----------------------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 1100 0000111122467999999874 458999999999999886 9999843
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=261.74 Aligned_cols=194 Identities=20% Similarity=0.276 Sum_probs=160.3
Q ss_pred cccccCceEEEEEEE--cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 679 PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~--~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
.||+|+||.||+|.+ ..++..+|+|+++... ........+..|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4568899999987542 23445677889999999999999999999875 4567999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|.+++... ..+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 9999999764 35899999999999999999999999999999999999999999999999998654322110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
........+++.|+|||.+.. ..++|+|||||++|+|++ |..||..
T Consensus 152 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 152 ------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred ------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 001112245679999998873 448999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=275.37 Aligned_cols=205 Identities=23% Similarity=0.337 Sum_probs=165.9
Q ss_pred ccCCCeeecccccccCceEEEEEEE-----cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 742 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~-----~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~ 742 (905)
+..++|++.+.||+|+||.||+|.+ ..+++.||+|.++... .......+.+|+.++..+ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 5567899999999999999999985 3467899999987542 233456788999999999 6899999999876
Q ss_pred e-CCeEEEEEeccCCCCHHHHHhhCC------------------------------------------------------
Q 002580 743 T-KTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 767 (905)
Q Consensus 743 ~-~~~~~lV~E~~~gg~L~~~l~~~~------------------------------------------------------ 767 (905)
. +..++++||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 457899999999999999986531
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 768 -----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 768 -----------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
...++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 123677888899999999999999999999999999999999999999999998653211110
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+||||+++|+|++ |..||..
T Consensus 236 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 236 -------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred -------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 01112345678999999864 458999999999999996 9999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=269.02 Aligned_cols=204 Identities=22% Similarity=0.326 Sum_probs=167.1
Q ss_pred cCCCeeecccccccCceEEEEEEEcCC--------------CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcc
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGS--------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t--------------~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 735 (905)
..++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456899999999999999999987543 2358999987542 344556788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 736 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
++++++...+..|+||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 12367888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
+++.++.+||+|||++........ ........+++.|+|||++.+ +.++|+|
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 215 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMAWESILLGKFTTASDVW 215 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-------------------------eeccCcCcCceeecChhhhccCCcCchhhHH
Confidence 999999999999999865321100 011122345778999999873 5699999
Q ss_pred HHHHHHHHHHh--CCCCchh
Q 002580 883 NYLILVSKKFM--EFQPFPI 900 (905)
Q Consensus 883 SlGvil~ellt--g~~PF~~ 900 (905)
||||++|+|++ |..||..
T Consensus 216 SlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 216 AFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred HHHHHHHHHHHcCCCCCCcc
Confidence 99999999998 6778864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=289.84 Aligned_cols=200 Identities=20% Similarity=0.233 Sum_probs=155.9
Q ss_pred CCCeeecccccccCceEEEEEEEcCCC-eEEEEE--------------EeecccccCHHHHHHHHHHHHHHHhCCCCCcc
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMK--------------AMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~-~~vavK--------------~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv 735 (905)
.++|++++.||+|+||.||+|...... ...+.| .+.+...........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 578999999999999999998764332 222222 11111112223455678999999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc
Q 002580 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (905)
Q Consensus 736 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~ 812 (905)
++++++...+..|++++++ +++|..++.... ........+..|+.||+.||.|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 567877765421 122345678889999999999999999999999999999999999
Q ss_pred EEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHH
Q 002580 813 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVS 889 (905)
Q Consensus 813 vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ 889 (905)
+||+|||++....... .......+||+.|+|||++.+ ..++|+|||||+||
T Consensus 306 vkL~DFGla~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 306 IVLGDFGTAMPFEKER--------------------------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred EEEEeCCCceecCccc--------------------------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 9999999996543111 011234679999999999984 35899999999999
Q ss_pred HHHhCCCC
Q 002580 890 KKFMEFQP 897 (905)
Q Consensus 890 elltg~~P 897 (905)
+|++|.+|
T Consensus 360 ell~~~~~ 367 (501)
T PHA03210 360 DMLSHDFC 367 (501)
T ss_pred HHHHCCCC
Confidence 99998754
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=269.22 Aligned_cols=199 Identities=19% Similarity=0.257 Sum_probs=169.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 748 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~ 748 (905)
.++|++.+.||.|+||.||+|.+..+++.+++|.++..... ......+.+|+.++..++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45899999999999999999999999999999999755322 22334567899999999999999999998877 8999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 59998887643 358999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||.+.+ ..++|+||||+++|+|++|.+||.
T Consensus 161 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 161 ---------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred ---------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 01123457889999999864 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=262.65 Aligned_cols=192 Identities=37% Similarity=0.629 Sum_probs=168.0
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||.|++|.||+|.+..++..|++|++.+...........+.+|+.+++.++||||+++++++.++...|++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999876544445567889999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~ 839 (905)
.+++.+. ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9999764 348999999999999999999999999999999999999999999999999986543110
Q ss_pred ccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
......+++.|+|||.+.. ..++|+||||+++|+|++|..||...
T Consensus 148 -----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 148 -----------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred -----------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 1123468899999999863 45899999999999999999999643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=262.60 Aligned_cols=201 Identities=23% Similarity=0.317 Sum_probs=170.3
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|.+.+.||.|+||.||++.+. .+..+|+|.+..... ....+..|+.+++.++|+||+++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56789999999999999999999975 457799999875422 3456888999999999999999999999889999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+++++|.+++.......++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999987655568999999999999999999999999999999999999999999999999986543110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
........++..|+|||.+.+ ..++|+|||||++|++++ |+.||..
T Consensus 158 --------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 158 --------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred --------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 000112234568999999874 458999999999999998 9999954
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=268.93 Aligned_cols=205 Identities=21% Similarity=0.306 Sum_probs=168.5
Q ss_pred cccCCCeeecccccccCceEEEEEEEc-------CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-------~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 739 (905)
.+..++|.+.+.||+|+||.||+|... ..+..+|+|.+... ........+.+|+.+++.+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 355678999999999999999999753 23457999988643 1234456788999999999 8999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 740 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 740 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
++......|++|||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999997642 13477888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
+++.++.+||+|||+++........ .......+++.|+|||++.+ ..++|+|
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY-------------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc-------------------------ccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 9999999999999998654311110 01122345678999999874 4589999
Q ss_pred HHHHHHHHHHh-CCCCch
Q 002580 883 NYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 883 SlGvil~ellt-g~~PF~ 899 (905)
|||+++|+|++ |..||.
T Consensus 224 slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred HHHHHHHHHHcCCCCCcc
Confidence 99999999998 788885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=266.36 Aligned_cols=200 Identities=26% Similarity=0.328 Sum_probs=167.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----e
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----T 743 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~-----~ 743 (905)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 4578999999999999999999999999999999876431 1234567899999998 7999999999874 4
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
++.+|+||||+++++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 46799999999999999987632 2345888999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHh
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFM 893 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~ellt 893 (905)
....... .......|++.|+|||++.. ..++|+|||||++|+|++
T Consensus 172 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 172 AQLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred eecccCC---------------------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 6532110 01123468999999998752 348999999999999999
Q ss_pred CCCCchh
Q 002580 894 EFQPFPI 900 (905)
Q Consensus 894 g~~PF~~ 900 (905)
|..||..
T Consensus 225 g~~p~~~ 231 (286)
T cd06638 225 GDPPLAD 231 (286)
T ss_pred CCCCCCC
Confidence 9999854
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=263.14 Aligned_cols=201 Identities=21% Similarity=0.243 Sum_probs=163.9
Q ss_pred eeecccccccCceEEEEEEEcCC---CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe----
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 746 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t---~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---- 746 (905)
|.+.+.||+|+||.||.|....+ +..||+|.++... ........+..|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56788999999999999987643 4789999987542 234456778999999999999999999998865443
Q ss_pred --EEEEEeccCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 747 --VCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 747 --~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
.+++|||+++++|..++... ....+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988543 223589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCC
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQ 896 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~ 896 (905)
++........ .......++..|+|||.+.+ ..++|+|||||++|+|++ |..
T Consensus 160 ~~~~~~~~~~-------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDYY-------------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeeccccccc-------------------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 8654311110 01112234678999999863 458999999999999999 899
Q ss_pred Cchh
Q 002580 897 PFPI 900 (905)
Q Consensus 897 PF~~ 900 (905)
||..
T Consensus 215 p~~~ 218 (273)
T cd05035 215 PYPG 218 (273)
T ss_pred CCCC
Confidence 9854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=264.61 Aligned_cols=203 Identities=22% Similarity=0.284 Sum_probs=168.8
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCe----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
+...+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999876654 58999876542 24455678899999999999999999999887
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 78999999999999999997653 34899999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
...... .......++..|+|||.+.. ..++|+|||||++|++++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 160 DVDEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcccc-------------------------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 311110 00111224578999998863 458999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=267.15 Aligned_cols=199 Identities=20% Similarity=0.274 Sum_probs=167.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865422 2233456778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||++ ++|.+++.......+++..+..++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 9995 68888887655555788899999999999999999999999999999999985 5679999999986533110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||.+.+ ..++|+|||||++|+|++|.+||.
T Consensus 158 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 158 -------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred -------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 01123357889999998863 358999999999999999999995
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=268.04 Aligned_cols=195 Identities=26% Similarity=0.357 Sum_probs=168.6
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
..|.+.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||++++++|.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46999999999999999999999899999999987554444455667889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9996 67777765432 3589999999999999999999999999999999999999999999999999854321
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCcccccccccc------CCCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF------AYTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~------~~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.....+++.|+|||++. ...++|+||||+++|+|++|..||.
T Consensus 168 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 168 --------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred --------------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 12346788999999874 2458999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=260.59 Aligned_cols=198 Identities=25% Similarity=0.365 Sum_probs=170.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ........+.+|+.+++.++|+||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778899999999999999988999999999875422 1234556788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
+||+++++|.+++.+. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999999765 348899999999999999999999999999999999999999999999999986532110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......+++.|+|||.+.. ..++|+|||||++|+|++|+.||..
T Consensus 157 --------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 157 --------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred --------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 1224568899999999863 3489999999999999999999954
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=267.15 Aligned_cols=199 Identities=25% Similarity=0.358 Sum_probs=169.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||+|+||.||+|.+..+++.|++|.++... ........+.+|+++++.++|+||+++++++..++..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999987542 23334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++++.+..+.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999887676655443 3489999999999999999999999999999999999999999999999999865431111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......++..|+|||++.+. .++|+||||+++|+|++|.+||.
T Consensus 156 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred ------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 012245688999999998743 58999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=271.09 Aligned_cols=203 Identities=22% Similarity=0.305 Sum_probs=168.1
Q ss_pred CeeecccccccCceEEEEEEEcC--CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 748 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~--t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~ 748 (905)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999874322233345677899999999999999999999988 8899
Q ss_pred EEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC----CCcEEEEeccCc
Q 002580 749 LITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFDLS 821 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~----~~~vkL~DFG~s 821 (905)
+||||++ ++|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 57777765322 236899999999999999999999999999999999999998 899999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~P 897 (905)
........ ........++++.|+|||++.+ ..++|+|||||++|+|++|++|
T Consensus 160 ~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPLK------------------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCcc------------------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 75432111 0111234578899999998764 3589999999999999999999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 216 ~~~ 218 (316)
T cd07842 216 FKG 218 (316)
T ss_pred CcC
Confidence 964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=260.20 Aligned_cols=202 Identities=25% Similarity=0.436 Sum_probs=173.8
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|.+.+.||+|+||.||++.+..+++.|++|.++.... .......+..|+.+++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999988999999999986533 24567788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~- 156 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM- 156 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-
Confidence 99999999999764 347889999999999999999999999999999999999999999999999986643221100
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........+++.|+|||++.+ ..++|+||||+++|++++|..||..
T Consensus 157 ----------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 157 ----------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred ----------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 000123568899999999873 3489999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=275.49 Aligned_cols=195 Identities=23% Similarity=0.389 Sum_probs=166.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 578999999999999999999999999999999986542 2334455677899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...|+||||+. ++|.+.+... ++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999995 5888887542 889999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.... ......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 169 ~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 169 GTSF----------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred CCCC----------------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 2110 1123468899999999874 458999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=260.72 Aligned_cols=197 Identities=23% Similarity=0.325 Sum_probs=169.2
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++.+.||.|+||.||+|.. .++.+|+|.+.... .....+..|+.+++.++|+||+++++++.+.+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567899999999999999999987 47889999987542 14567889999999999999999999999899999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
+||||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998765456899999999999999999999999999999999999999999999999998653200
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchhh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~~ 901 (905)
......+..|+|||.+.. ..++|+||||+++|++++ |..||...
T Consensus 156 -----------------------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 156 -----------------------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred -----------------------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 011234567999999873 348999999999999997 99998543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=263.70 Aligned_cols=197 Identities=26% Similarity=0.352 Sum_probs=170.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
..|+..+.||.|+||.||.|.+..++..+|+|.+.... .......+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35888899999999999999999899999999987542 2345577889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++|++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......++..|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 156 ------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 156 ------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred ------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 01123468889999999874 4589999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=269.42 Aligned_cols=206 Identities=21% Similarity=0.292 Sum_probs=167.9
Q ss_pred cccCCCeeecccccccCceEEEEEEEcC-------CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-------t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 739 (905)
.+..++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+..|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4456789999999999999999998632 34579999887532 234456788899999999 6999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 740 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 740 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
++...+.+|++|||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999999999999997532 23478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
|++.++.+||+|||+++........ .......+++.|+|||++.+ +.++|+|
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY-------------------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred EEcCCCcEEEccccccccccccccc-------------------------cccccCCCCccccCHHHHccCCcCccchhh
Confidence 9999999999999999654311100 00111234567999999874 4589999
Q ss_pred HHHHHHHHHHh-CCCCchh
Q 002580 883 NYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 883 SlGvil~ellt-g~~PF~~ 900 (905)
||||++|+|++ |..||..
T Consensus 221 slG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 99999999998 8999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=265.09 Aligned_cols=201 Identities=21% Similarity=0.325 Sum_probs=164.4
Q ss_pred CCCeeecccccccCceEEEEEEE----cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~----~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~ 744 (905)
..+|++++.||+|+||.||.+.. ..++..||+|.+... .......+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35899999999999999999974 457889999998654 34455678899999999999999999998753 3
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 57899999999999999997643 34889999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
....... .......++..|+|||++.+ ..++|+|||||++|+|++|..|+.
T Consensus 159 ~~~~~~~------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYY------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcce------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 3211100 00111234456999999874 458999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=262.70 Aligned_cols=205 Identities=19% Similarity=0.222 Sum_probs=168.8
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCe---EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~---~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
+..++|+..+.||+|+||.||+|.+..++. .+++|.+.... .......+..|+.+++.++|+||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345689999999999999999999876554 79999886542 2334567889999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999987643 458999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
..... .........++.|+|||++.+ ..++|+|||||++|++++ |..||..
T Consensus 159 ~~~~~------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 159 DDPEG------------------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred ccccc------------------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 11110 000111223567999999874 458999999999999997 9999953
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=264.20 Aligned_cols=196 Identities=25% Similarity=0.418 Sum_probs=169.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCeEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~~~~~l 749 (905)
.|++.+.||.|+||.||+|.+..++..|++|.+.... .......+.+|+.+++.+. |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888899999999999999999999999999987542 2334567788999999986 9999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
||||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999998653 58999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......|+..|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 156 --------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred --------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 11223468899999999863 4589999999999999999999954
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=262.97 Aligned_cols=201 Identities=22% Similarity=0.257 Sum_probs=162.9
Q ss_pred eeecccccccCceEEEEEEEcCCCe--EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------T 745 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~--~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------~ 745 (905)
|.+.+.||+|+||.||+|.+..++. .+|+|.++.. .........+..|+.+++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999877765 6899988764 23445567888999999999999999999976432 3
Q ss_pred eEEEEEeccCCCCHHHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 746 HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~----~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
..+++|||+.+++|..++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887432 2234889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~P 897 (905)
........ ........+++.|+|||.+.+ +.++|+|||||++|+|++ |..|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 65431110 001122346678999999874 458999999999999999 8999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 215 ~~~ 217 (272)
T cd05075 215 YPG 217 (272)
T ss_pred CCC
Confidence 964
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=261.71 Aligned_cols=200 Identities=24% Similarity=0.314 Sum_probs=165.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|.+...||.|++|.||++.+..++ .+|+|.+..... ....+.+|+.+++.++|+|++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34567999999999999999999986554 589998765421 2356788999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999987555568899999999999999999999999999999999999999999999999986542111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......++..|+|||.+.+ ..++|+||||+++|+|++ |..||..
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 157 Y--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred c--------------------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 0 01112345678999998873 458999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=259.89 Aligned_cols=196 Identities=23% Similarity=0.320 Sum_probs=167.4
Q ss_pred ccccccCceEEEEEEEcCC---CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 002580 678 KPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t---~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 754 (905)
+.||+|+||.||+|.+... +..|++|.++.... ......+..|+.++..++|+||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999765 88999999876532 224678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 755 PGGELFLLLDRQP-------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 755 ~gg~L~~~l~~~~-------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
++++|.+++.... ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999998641 256899999999999999999999999999999999999999999999999999664321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.. ........+++.|+|||.+.. ..++|+|||||++|+|++ |..||..
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 11 011234467889999999874 458999999999999998 6999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=265.06 Aligned_cols=197 Identities=21% Similarity=0.312 Sum_probs=167.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||.|++|.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58899999999999999999999999999999876422 2234556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 753 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|+++ +|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 9974 8888876543 2458999999999999999999999999999999999999999999999999986432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|++||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 155 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 155 ------------------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred ------------------------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11123457889999999864 458999999999999999999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=260.62 Aligned_cols=190 Identities=37% Similarity=0.590 Sum_probs=160.6
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
+.||.|+||.||+|.+..+++.||+|.+.+...........+..|..++. ..+|+||+++++++..++.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57899999999999999999999999987653323333334455555443 45899999999999999999999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999999764 3489999999999999999999999999999999999999999999999998854220
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+++.|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 150 ---------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 150 ---------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred ---------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 123468889999999875 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=265.63 Aligned_cols=201 Identities=21% Similarity=0.276 Sum_probs=165.0
Q ss_pred CeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23568888886542 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 748 CLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~----------------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
|++|||+.+++|.+++.... ...++...+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999986421 13478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
|+++++.+||+|||++......... .......++..|+|||.+.+ ..++|+|
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY-------------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-------------------------hcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 9999999999999998653211110 01122345678999998763 4589999
Q ss_pred HHHHHHHHHHh-CCCCchh
Q 002580 883 NYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 883 SlGvil~ellt-g~~PF~~ 900 (905)
|||+++|+|++ |..||..
T Consensus 214 slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred HHHHHHHHHHhcCCCCCCC
Confidence 99999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=269.81 Aligned_cols=195 Identities=25% Similarity=0.388 Sum_probs=167.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|.....||+|+||.||++.+..++..||||.+... .......+.+|+.+++.++|+||+++++.+...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 455567899999999999999889999999988643 23445668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----- 171 (292)
T cd06658 100 FLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE----- 171 (292)
T ss_pred CCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc-----
Confidence 9999999998854 24889999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........|++.|+|||.+.+ +.++|+||||+++|+|++|..||..
T Consensus 172 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 172 ----------------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred ----------------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 011123568999999999874 5689999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=261.61 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=169.4
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-------RNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~-------~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+....... ....+.+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999998899999999886431111 112356778999999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999765 458999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.... ........++..|+|||.+.. ..++|+||||+++|++++|..||..
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 160 DIYD-------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccc-------------------------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 1100 001234568899999998763 3489999999999999999999953
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=266.18 Aligned_cols=199 Identities=19% Similarity=0.283 Sum_probs=164.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCe----
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH---- 746 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~---- 746 (905)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999886542 12223456778999999995 6999999999887665
Q ss_pred -EEEEEeccCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEEEeccCc
Q 002580 747 -VCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLS 821 (905)
Q Consensus 747 -~~lV~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL~DFG~s 821 (905)
.|++|||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 8888876532 235899999999999999999999999999999999999998 889999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~P 897 (905)
....... .......+++.|+|||++.+ ..++|+||||+++|+|++|..|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSIPV---------------------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCCCc---------------------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 6432110 01112356889999998863 4589999999999999999999
Q ss_pred ch
Q 002580 898 FP 899 (905)
Q Consensus 898 F~ 899 (905)
|.
T Consensus 212 ~~ 213 (295)
T cd07837 212 FP 213 (295)
T ss_pred CC
Confidence 95
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=259.93 Aligned_cols=200 Identities=20% Similarity=0.274 Sum_probs=167.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|.+.+.||+|+||.||++.+. .+..+++|.+... ......+.+|+.+++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 56789999999999999999999864 4556999987643 2234678889999999999999999999887 7889
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+++++|.+++.......++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999987655568888999999999999999999999999999999999999999999999986532111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
. .......++..|+|||++.+ ..++|+|||||++|++++ |..||..
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 157 Y--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred c--------------------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 0 01112235678999999874 458999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=264.90 Aligned_cols=199 Identities=39% Similarity=0.616 Sum_probs=168.0
Q ss_pred CeeecccccccCceEEEEEEEc---CCCeEEEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~---~t~~~vavK~~~~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 747 (905)
+|++.+.||.|+||.||+|.+. .+|..||+|++...... .......+..|+.++..+ +|+||+.++++|..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 47899999998754322 122345677899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999764 35889999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
. ........|+..|+|||.+.+ ..++|+||||+++|+|++|..||.
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 159 E--------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred c--------------------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 0 011123568899999999863 358999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=263.71 Aligned_cols=200 Identities=30% Similarity=0.404 Sum_probs=165.0
Q ss_pred eecccccccCceEEEEEEEc----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 675 RPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 675 ~i~~~Lg~G~~g~V~~~~~~----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+.+.||.|.||.||+|... ..+..|+||.++.. ........+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46688999999999999997 44678999999542 3445578899999999999999999999999988889999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||||++|+|.+++.......++......|+.||+.||.|||+++|+|+||+++||+++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999987456699999999999999999999999999999999999999999999999999866421111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchhh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~~ 901 (905)
........+...|+|||.+.. +.++||||||+++||+++ |+.||...
T Consensus 159 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 ------------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp ------------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011223456779999999873 559999999999999999 78998643
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=259.31 Aligned_cols=195 Identities=22% Similarity=0.289 Sum_probs=163.9
Q ss_pred ccccccCceEEEEEEEcC-CC--eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 002580 678 KPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~-t~--~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 754 (905)
+.||+|++|.||++.+.. .+ ..+|+|.+...... .....+.+|+.++++++|+||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999855 33 36999998875432 556788899999999999999999999988 8999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCc
Q 002580 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (905)
Q Consensus 755 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~ 834 (905)
++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999998754346899999999999999999999999999999999999999999999999998765321110
Q ss_pred chhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCch
Q 002580 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~ 899 (905)
........++..|+|||.+.+ ..++|+|||||++|+|++ |..||.
T Consensus 154 --------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 154 --------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred --------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 011123457789999999874 458999999999999998 999994
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=268.29 Aligned_cols=200 Identities=25% Similarity=0.332 Sum_probs=167.1
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 747 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~ 747 (905)
..++|++.+.||.|+||.||+|.+..+|..||+|.+..... .......+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999875422 112223456799999999999999999998755 568
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 58888887643 45899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
. .......+++.|+|||.+.+ ..++|+|||||++|+|++|.+||.
T Consensus 162 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 162 A---------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred c---------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 1 01122345788999999863 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=265.21 Aligned_cols=200 Identities=21% Similarity=0.309 Sum_probs=165.8
Q ss_pred CCeeecccccccCceEEEEEEE----cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 002580 672 QHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T 745 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~----~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~ 745 (905)
..|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578999999999999999974 4568899999986442 334456788999999999999999999998865 5
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
..++||||++|++|.+++.+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999987643 358999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
..... ........++..|+|||.+.+ +.++|+|||||++|+|+++..|+
T Consensus 161 ~~~~~------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 161 TDKEY------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cCccc------------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 11110 011123456778999999874 45899999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=269.07 Aligned_cols=194 Identities=27% Similarity=0.383 Sum_probs=166.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|.....||.|+||.||++.+..++..||+|.+.... ......+.+|+.++..++||||+++++++..++..|++||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 4555668999999999999998899999999986542 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|..++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~----- 170 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 170 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc-----
Confidence 9999999998755 34899999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
........|++.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 171 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 171 ----------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred ----------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 011224568999999999874 458999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=263.22 Aligned_cols=199 Identities=27% Similarity=0.328 Sum_probs=167.4
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK----- 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~----- 744 (905)
.++|.+.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.++..+ +||||++++++|...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 578999999999999999999999999999999986531 2234567889999988 899999999998753
Q ss_pred CeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 002580 745 THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~ 822 (905)
+..|+||||+++++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 3689999999999999988642 23458999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhC
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg 894 (905)
....... ......|+..|+|||.+.. +.++|+|||||++|+|++|
T Consensus 177 ~~~~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 177 QLTSTRL---------------------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred hcccccc---------------------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 5331100 1123468899999998752 4689999999999999999
Q ss_pred CCCchh
Q 002580 895 FQPFPI 900 (905)
Q Consensus 895 ~~PF~~ 900 (905)
++||..
T Consensus 230 ~~p~~~ 235 (291)
T cd06639 230 DPPLFD 235 (291)
T ss_pred CCCCCC
Confidence 999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=258.86 Aligned_cols=194 Identities=22% Similarity=0.297 Sum_probs=158.3
Q ss_pred cccccCceEEEEEEEc--CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 679 PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~--~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
.||+|+||.||+|.+. .++..+|+|++... ........+.+|+.+++.++|+||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999764 44667999998754 23444567889999999999999999999886 4578999999999
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 9999998754 3458999999999999999999999999999999999999999999999999986543221100
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......+++.|+|||.+.+ +.++|+|||||++|++++ |..||..
T Consensus 153 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 153 -------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred -------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 00111234578999999863 458999999999999996 9999953
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=271.72 Aligned_cols=209 Identities=22% Similarity=0.293 Sum_probs=176.7
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
.++..+...+.++||+|.||.|.+|.-. .+..||+|.++.. ...+....|..|+++|.+|+||||+.++++|..++.
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD--ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcc--cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3566778899999999999999999973 3689999999865 345567889999999999999999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
+|+|+||+++|+|.+++..+....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+..
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999999999887433345556677999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHHHHHHH--hCCCCchhh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLILVSKKF--MEFQPFPIL 901 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvil~ell--tg~~PF~~~ 901 (905)
.+. .+...-.+-...|||||.+. .++++|+|+||++|||++ +...||..+
T Consensus 690 g~y-------------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l 744 (807)
T KOG1094|consen 690 GDY-------------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL 744 (807)
T ss_pred CCc-------------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence 221 12222345567999999998 367999999999999987 568999876
Q ss_pred hc
Q 002580 902 CR 903 (905)
Q Consensus 902 ~r 903 (905)
.+
T Consensus 745 t~ 746 (807)
T KOG1094|consen 745 TD 746 (807)
T ss_pred hH
Confidence 54
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=265.67 Aligned_cols=196 Identities=26% Similarity=0.346 Sum_probs=169.5
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|+..+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 5778889999999999999998899999999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc----
Confidence 9999999998864 348899999999999999999999999999999999999999999999999986532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......++..|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 156 -----------------------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -----------------------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 01123468889999999975 4589999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=259.05 Aligned_cols=199 Identities=25% Similarity=0.413 Sum_probs=173.8
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|.+.+.||.|++|.||+|.+..+++.|++|.+..... ......+..|+..+..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368999999999999999999999999999999876532 145677889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 999999999999865 458999999999999999999999 9999999999999999999999999999865431111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
......++..|+|||.+.. ..++|+||||+++|+|++|..||...
T Consensus 156 --------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 156 --------------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred --------------------------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 1123467889999999874 45899999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=266.07 Aligned_cols=197 Identities=23% Similarity=0.360 Sum_probs=170.3
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+.+.||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999999889999999998643 223346678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
+||+++++|.+++.+. .++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 95 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred EecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 9999999999998753 37889999999999999999999999999999999999999999999999885432111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+|||||++|++++|..||..
T Consensus 170 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 170 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred -------------------------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01123468899999999874 4589999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=264.52 Aligned_cols=195 Identities=25% Similarity=0.363 Sum_probs=168.0
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|...+.||+|+||.||++.+..++..+|+|.+.............+..|+.+++.++|+|++++++++..+...|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48889999999999999999999999999999876544444555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+. ++|.+++... ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 996 5777777554 34589999999999999999999999999999999999999999999999998754221
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCcccccccccc------CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF------AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~------~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....|++.|+|||.+. ...++|+|||||++|+|++|..||..
T Consensus 178 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 178 -------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred -------------------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 12346888999999974 24589999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=265.28 Aligned_cols=203 Identities=23% Similarity=0.325 Sum_probs=165.6
Q ss_pred CCCeeecccccccCceEEEEEEEcC----------------CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCc
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~----------------t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 734 (905)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+... ........+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986532 3457899988754 233445678899999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 735 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
+++++++...+..|++|||+++++|.+++..... ..+++..+..++.||+.||.|||++||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999999876421 2366788999999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
|++.++.++|+|||++........ ........+++.|+|||...+ ..++|+|
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999865421110 001112344678999998763 4589999
Q ss_pred HHHHHHHHHHh--CCCCchh
Q 002580 883 NYLILVSKKFM--EFQPFPI 900 (905)
Q Consensus 883 SlGvil~ellt--g~~PF~~ 900 (905)
||||++|+|++ |..||..
T Consensus 217 SlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred HHHHHHHHHHHhCCCCCccc
Confidence 99999999998 7788853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=262.74 Aligned_cols=197 Identities=25% Similarity=0.420 Sum_probs=171.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+++++.++||||+++++++...+..|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36888999999999999999999999999999987653 2345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||+++++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999998653 568999999999999999999999 99999999999999999999999999998543200
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++..|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 155 --------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred --------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 0111568889999999874 4589999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=261.85 Aligned_cols=199 Identities=27% Similarity=0.425 Sum_probs=168.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 749 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~l 749 (905)
++|...+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46899999999999999999999999999999987542 23455678899999999999999999998865 347899
Q ss_pred EEeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 750 ITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
||||+++++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988764 22345889999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
......++..|+|||.+.+ +.++|+|||||++|+|++|..||...
T Consensus 159 -----------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 -----------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred -----------------------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 0113457889999999874 45899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-28 Score=259.12 Aligned_cols=198 Identities=23% Similarity=0.287 Sum_probs=166.0
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+.+.....||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++..++..++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444445799999999999999999999999988754 3345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l--~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL~DFG~s~~~~~~~ 828 (905)
||+++++|.+++.... ..+ +...+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999987642 224 78888899999999999999999999999999999976 6799999999985432110
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.. ..++|+||||+++|+|++|..||..
T Consensus 164 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 164 ---------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred ---------------------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 01123357899999999853 3589999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=269.97 Aligned_cols=206 Identities=21% Similarity=0.302 Sum_probs=167.6
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCC-------CeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t-------~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 739 (905)
.+...+|++.+.||+|+||.||+|.+... +..+|+|.+... ........+.+|+.+++++ +|+||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 45566899999999999999999986432 246899987743 2334556788999999999 7999999999
Q ss_pred EEEeCCeEEEEEeccCCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCE
Q 002580 740 SFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 740 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NI 805 (905)
++...+.+|++|||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999997532 12467788899999999999999999999999999999
Q ss_pred EEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHH
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 Ll~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiw 882 (905)
|++.++.+||+|||+++....... ........++..|+|||++.+ ..++|+|
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 220 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220 (334)
T ss_pred EEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchhhhH
Confidence 999999999999999865431110 001112234568999999874 4589999
Q ss_pred HHHHHHHHHHh-CCCCchh
Q 002580 883 NYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 883 SlGvil~ellt-g~~PF~~ 900 (905)
||||++|+|++ |..||..
T Consensus 221 slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 221 SFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred HHHHHHHHHHhcCCCCCCC
Confidence 99999999998 8898853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=259.72 Aligned_cols=193 Identities=21% Similarity=0.331 Sum_probs=163.2
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..++|++.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.+++.++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 456899999999999999999875 77889999886431 235678899999999999999999998754 5799
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
+|||+.+++|.+++.......++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998765556899999999999999999999999999999999999999999999999998542210
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
......+..|+|||.+.+ ..++|+|||||++|+|++ |+.||..
T Consensus 154 ----------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 200 (254)
T cd05083 154 ----------------------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200 (254)
T ss_pred ----------------------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 011233567999999873 458999999999999997 9999954
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=257.98 Aligned_cols=200 Identities=25% Similarity=0.438 Sum_probs=170.8
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCeEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLI 750 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~lV 750 (905)
+|.+.+.||.|+||.||++.+..++..+|+|.+..... .......+..|+.+++.++|+||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999876533 34456778899999999999999999998763 4578999
Q ss_pred EeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 751 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH-----~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999998753 2346899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...... ......+++.|+|||.+.. ..++|+||||+++|+|++|..||..
T Consensus 160 ~~~~~~---------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGHDSS---------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccCCcc---------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 431110 1223468999999999874 4589999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=257.22 Aligned_cols=194 Identities=21% Similarity=0.298 Sum_probs=160.2
Q ss_pred ccccccCceEEEEEEEcCCC---eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEecc
Q 002580 678 KPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 754 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~---~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~ 754 (905)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+..|+.+++.+.|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 78999998765332 34567889999999999999999999876 45689999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCc
Q 002580 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (905)
Q Consensus 755 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~ 834 (905)
++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---- 151 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---- 151 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc----
Confidence 9999999998754 5899999999999999999999999999999999999999999999999998654321110
Q ss_pred chhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
........++..|+|||.+.+ ..++|+|||||++|++++ |.+||..
T Consensus 152 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 152 --------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred --------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 001111234568999999874 458999999999999997 9999954
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=271.62 Aligned_cols=199 Identities=20% Similarity=0.343 Sum_probs=165.5
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 745 (905)
.++|.+.+.||+|+||.||+|.+..+|..||+|.+... ........+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 36899999999999999999999999999999998642 1233455677899999999999999999887643 3
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+|+++||+. ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 5899999995 588887754 348999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.... .........||+.|+|||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 158 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 158 PEHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred cccc------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 2110 0011234578999999998753 458999999999999999999994
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=263.10 Aligned_cols=203 Identities=22% Similarity=0.292 Sum_probs=167.5
Q ss_pred cCCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999998753 67889999987542 234456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCC
Q 002580 745 THVCLITDYCPGGELFLLLDRQP--------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 804 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~--------------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~N 804 (905)
...|++|||+++++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997431 1246788899999999999999999999999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchH
Q 002580 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTR 881 (905)
Q Consensus 805 ILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDi 881 (905)
||++.++.++|+|||++........ ........++..|+|||.+.+ ..++|+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------------YKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------------ccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999999999999865321110 001112234668999998874 458999
Q ss_pred HHHHHHHHHHHh-CCCCch
Q 002580 882 YNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 882 wSlGvil~ellt-g~~PF~ 899 (905)
|||||++|+|++ |..||.
T Consensus 216 ~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred HHHHHHHHHHHhCCCCCCC
Confidence 999999999997 888884
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=260.12 Aligned_cols=188 Identities=26% Similarity=0.354 Sum_probs=158.2
Q ss_pred CCeeecccc--cccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 002580 672 QHFRPIKPL--GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 672 ~~y~i~~~L--g~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 748 (905)
++|.+.+.+ |+|+||.||++.+..++..+|+|.+....... .|+.....+ +|+||++++++|...+..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466666666 99999999999999999999999987542211 122222222 7999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-cEEEEeccCccccCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 827 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-~vkL~DFG~s~~~~~~ 827 (905)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999997753 689999999999999999999999999999999999999988 999999999854321
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+++.|+|||++.+ ..++|+||||+++|+|++|..||..
T Consensus 163 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 163 ------------------------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred ------------------------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 112358899999999974 4589999999999999999999963
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=260.45 Aligned_cols=196 Identities=26% Similarity=0.372 Sum_probs=168.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
-|++.+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+.++..++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3778889999999999999998899999999886442 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|..++.. ..++...+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 154 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----
Confidence 9999999999864 34889999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........++..|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 155 ----------------------QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred ----------------------hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 001123468889999999874 4589999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=258.85 Aligned_cols=193 Identities=23% Similarity=0.284 Sum_probs=158.7
Q ss_pred ccccccCceEEEEEEEcCCCe--EEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEEecc
Q 002580 678 KPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYC 754 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~--~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~E~~ 754 (905)
+.||+|+||.||++.+..++. .+++|.++.. ........+..|+.++.++ +||||+++++++...+.+|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999987775 4688877642 2334556788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 755 PGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 755 ~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997542 12478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCC
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQ 896 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~ 896 (905)
+..... .........+..|+|||++.. ..++|+|||||++|+|++ |..
T Consensus 159 ~~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 159 SRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred ccccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 742110 000111234567999999863 458999999999999996 999
Q ss_pred Cchh
Q 002580 897 PFPI 900 (905)
Q Consensus 897 PF~~ 900 (905)
||..
T Consensus 211 pf~~ 214 (270)
T cd05047 211 PYCG 214 (270)
T ss_pred Cccc
Confidence 9953
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=264.76 Aligned_cols=203 Identities=20% Similarity=0.238 Sum_probs=166.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 745 (905)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 5689999999999999999999999999999998865422 1222334567999999999999999999887543
Q ss_pred ---eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 002580 746 ---HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 746 ---~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~ 822 (905)
..|+||||+. ++|..++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4699999995 58888876542 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCc
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF 898 (905)
......... ........++..|+|||.+.+ ..++|+||||+++|+|++|..||
T Consensus 168 ~~~~~~~~~-----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 168 AFSLSKNSK-----------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cccCCcccC-----------------------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 543211100 011123467889999998864 35899999999999999999998
Q ss_pred h
Q 002580 899 P 899 (905)
Q Consensus 899 ~ 899 (905)
.
T Consensus 225 ~ 225 (310)
T cd07865 225 Q 225 (310)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=262.48 Aligned_cols=197 Identities=22% Similarity=0.326 Sum_probs=167.4
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|++.+.||.|++|.||+|.+..+|..||+|++..... .......+.+|+++++.++|+||+++++++.+.+..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6778899999999999999999999999999875422 222335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+ +++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 9 5689999877654468999999999999999999999999999999999999999999999999985432110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......+++.|+|||++.+ ..++|+||||+++|+|++|..||.
T Consensus 154 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 154 ----------------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred ----------------------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 01112246889999998863 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=261.41 Aligned_cols=188 Identities=16% Similarity=0.213 Sum_probs=155.9
Q ss_pred ccccccCceEEEEEEEcCCCe-------EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 678 KPLGSGDTGSVHLVELCGSGQ-------YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~-------~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+.||.|+||.||+|.+..++. .+++|.+... .....+.+..|..+++.+.||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865544 3788877543 233456778899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc--------EEEEeccCcc
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--------VSLTDFDLSC 822 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~--------vkL~DFG~s~ 822 (905)
|||+++++|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999997653 35889999999999999999999999999999999999987664 6999999874
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhC-CCC
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFME-FQP 897 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg-~~P 897 (905)
... ......+++.|+|||.+.+ ..++|+|||||++|+|++| ..|
T Consensus 157 ~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 157 TVL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ccC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 321 1123467889999999874 3489999999999999999 466
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 206 ~~~ 208 (258)
T cd05078 206 LSA 208 (258)
T ss_pred hhh
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=267.49 Aligned_cols=202 Identities=18% Similarity=0.210 Sum_probs=164.3
Q ss_pred cccccc--CceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccC
Q 002580 678 KPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 678 ~~Lg~G--~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
..||.| +||+||++.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875422 33455778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcc
Q 002580 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (905)
Q Consensus 756 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~ 835 (905)
+++|.+++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~---- 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA---- 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc----
Confidence 9999999987655568999999999999999999999999999999999999999999999998653321110000
Q ss_pred hhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...........++..|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 159 ----------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 159 ----------------KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ----------------cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 000011112345678999999864 3589999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=254.42 Aligned_cols=193 Identities=22% Similarity=0.330 Sum_probs=160.5
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||+|+||.||++... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999864 67889999887542 2333456888999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-------- 148 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc--------
Confidence 9999987543 3578999999999999999999999999999999999999999999999999854321100
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
.......+++.|+|||++.+ ..++|+||||+++|++++ |..||..
T Consensus 149 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 149 ------------------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred ------------------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 00112234578999999874 448999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=257.59 Aligned_cols=200 Identities=23% Similarity=0.393 Sum_probs=171.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|.+.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++|+||+++++.+...+..|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999876422 22344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-~vkL~DFG~s~~~~~~~~~~ 831 (905)
|+++++|.+++.......+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 99999999999876555689999999999999999999999999999999999998876 56999999886543111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......|++.|+|||++.. ..++|+||||+++|+|++|..||..
T Consensus 157 ------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 157 ------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred ------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01123458899999998874 4689999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=258.36 Aligned_cols=199 Identities=38% Similarity=0.652 Sum_probs=168.4
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||.|+||.||++.+..+++.+++|.+.............+.+|+.+++.++|+||+++++.+......|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999766444445667888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~ 839 (905)
.+++.+.. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 99998753 589999999999999999999999999999999999999999999999999865332111000
Q ss_pred ccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
...........+++.|+|||.+.. ..++|+||||+++|+|++|..||.
T Consensus 152 ------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~ 202 (265)
T cd05579 152 ------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202 (265)
T ss_pred ------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 000112234568889999999874 458999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=262.10 Aligned_cols=210 Identities=17% Similarity=0.143 Sum_probs=155.9
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCC---CeEEEEEEeecccccCHHHH--------HHHHHHHHHHHhCCCCCcceE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKV--------HRACAEREILDMLDHPFVPAL 737 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t---~~~vavK~~~~~~~~~~~~~--------~~~~~E~~il~~l~h~nIv~l 737 (905)
+..++|.+.+.||+|+||.||+|.+..+ +..+|+|+............ .....+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999998777 66778876443211100000 111223334556789999999
Q ss_pred EEEEEeCC----eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcE
Q 002580 738 YASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 813 (905)
Q Consensus 738 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~v 813 (905)
++++.... ..+++++++ ..++.+.+... ...++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98766443 457888887 45777776553 236788899999999999999999999999999999999999999
Q ss_pred EEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHH
Q 002580 814 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSK 890 (905)
Q Consensus 814 kL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~e 890 (905)
+|+|||+|+......... ...........||+.|+|||++.+ +.++|+|||||+||+
T Consensus 166 ~l~DFGla~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHI--------------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred EEEEcCCceeeccCCccc--------------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999997653211100 000011233579999999999874 458999999999999
Q ss_pred HHhCCCCchhh
Q 002580 891 KFMEFQPFPIL 901 (905)
Q Consensus 891 lltg~~PF~~~ 901 (905)
|++|.+||...
T Consensus 226 l~~g~~P~~~~ 236 (294)
T PHA02882 226 WAGIKLPWKGF 236 (294)
T ss_pred HHhCCCCCCcc
Confidence 99999999754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=264.05 Aligned_cols=203 Identities=19% Similarity=0.268 Sum_probs=165.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCe----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
+..++|+..+.||+|+||.||++.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345689999999999999999999877775 46888876432 233344678899999999999999999988754
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+++++|+++|+|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 5779999999999999987643 34889999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
...... .......++..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKE-------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccc-------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 311110 01122345778999999874 458999999999999997 8999853
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=259.69 Aligned_cols=202 Identities=19% Similarity=0.233 Sum_probs=168.0
Q ss_pred CCCeeecccccccCceEEEEEEEcC-----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~-----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
..+|++++.||.|+||.||+|.... +...+++|.+.... .......+.+|+.++++++|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 34679999876431 2234567889999999999999999999999989
Q ss_pred eEEEEEeccCCCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEec
Q 002580 746 HVCLITDYCPGGELFLLLDRQPT-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~-------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DF 818 (905)
..|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999976541 15899999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-C
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-E 894 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g 894 (905)
|++....... ........++..|+|||.+.+ ..++|+||||+++|+|++ |
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNSE--------------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCccc--------------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9985432110 011123356778999998863 458999999999999998 8
Q ss_pred CCCchh
Q 002580 895 FQPFPI 900 (905)
Q Consensus 895 ~~PF~~ 900 (905)
..||..
T Consensus 216 ~~p~~~ 221 (275)
T cd05046 216 ELPFYG 221 (275)
T ss_pred CCCccc
Confidence 889854
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=255.96 Aligned_cols=198 Identities=20% Similarity=0.309 Sum_probs=165.9
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
...+|++.+.||.|+||.||++.+. .+..+|+|.+..... ....+..|+++++.++||||+++++++......|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3468999999999999999999885 467899998875432 22457789999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 999999999999987643 347899999999999999999999999999999999999999999999999986432110
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCch
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~ 899 (905)
........++..|+|||.+.+ ..++|+||||+++|+|++ |..||.
T Consensus 155 -------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 155 -------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred -------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 001122335678999999874 348999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=261.11 Aligned_cols=220 Identities=31% Similarity=0.478 Sum_probs=178.7
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV 750 (905)
++|.+.+.||+|+||.||++.+..++..|++|++.+...........+..|..+++.+. |+||+++++++..++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998754444555677889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||++++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998753 5999999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
..... ..................+.++..|+|||.+.. ..++|+||||+++|++++|..||..
T Consensus 159 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 159 ESNKG-------DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred ccCCC-------CCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 00000 000000000111223345678999999998874 4489999999999999999999964
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=259.41 Aligned_cols=205 Identities=17% Similarity=0.163 Sum_probs=169.7
Q ss_pred ccCCCeeecccccccCceEEEEEEEcC----CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~----t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~- 743 (905)
+..++|.+.+.||+|+||.||+|.+.. ++..+++|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 3578999987643 244556778899999999999999999998765
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEe
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPT------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~~------~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~D 817 (905)
+...+++++|+++++|.+++..... ..+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5678999999999999999876422 3588999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-
Q 002580 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM- 893 (905)
Q Consensus 818 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt- 893 (905)
||+++........ .......++..|+|||++.+ ..++|+|||||++|++++
T Consensus 161 ~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDYH-------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCceE-------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9998654321110 00112245678999999874 458999999999999998
Q ss_pred CCCCchh
Q 002580 894 EFQPFPI 900 (905)
Q Consensus 894 g~~PF~~ 900 (905)
|+.||..
T Consensus 216 g~~p~~~ 222 (280)
T cd05043 216 GQTPYVE 222 (280)
T ss_pred CCCCcCc
Confidence 9999963
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=259.97 Aligned_cols=187 Identities=16% Similarity=0.174 Sum_probs=153.2
Q ss_pred cccccCceEEEEEEEcCC------------------------CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCc
Q 002580 679 PLGSGDTGSVHLVELCGS------------------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 734 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~~t------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI 734 (905)
.||+|+||.||++....+ ...+++|++... .......+..|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 689999999999875322 235888887643 22334567788999999999999
Q ss_pred ceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC---
Q 002580 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--- 811 (905)
Q Consensus 735 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~--- 811 (905)
+++++++......|+||||+++++|..++... ...+++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999988653 34589999999999999999999999999999999999997543
Q ss_pred ----cEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHH
Q 002580 812 ----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYN 883 (905)
Q Consensus 812 ----~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwS 883 (905)
.+||+|||++..... .....++..|+|||.+.+ ..++|+||
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-------------------------------REERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------ccccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 489999998743210 112356788999998863 45899999
Q ss_pred HHHHHHHHH-hCCCCchh
Q 002580 884 YLILVSKKF-MEFQPFPI 900 (905)
Q Consensus 884 lGvil~ell-tg~~PF~~ 900 (905)
|||++|+++ +|..||..
T Consensus 207 lG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 207 FGTTLLEICFDGEVPLKE 224 (274)
T ss_pred HHHHHHHHHhCCCCCccc
Confidence 999999995 79999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=257.34 Aligned_cols=187 Identities=17% Similarity=0.216 Sum_probs=154.1
Q ss_pred ccccccCceEEEEEEEcC------------CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 678 KPLGSGDTGSVHLVELCG------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~------------t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
+.||+|+||.||++.... ....+++|.+... .......+..|+.++..++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 2235888887643 2334456788899999999999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc-------EEEEec
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------VSLTDF 818 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~-------vkL~DF 818 (905)
..+++|||+++++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998886543 45899999999999999999999999999999999999986664 899999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHH-h
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKF-M 893 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~ell-t 893 (905)
|++.... ......++..|+|||.+.. ..++|+|||||++|+|+ .
T Consensus 157 g~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 157 GIPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 9885422 1123457889999998862 34899999999999997 6
Q ss_pred CCCCch
Q 002580 894 EFQPFP 899 (905)
Q Consensus 894 g~~PF~ 899 (905)
|..||.
T Consensus 206 ~~~p~~ 211 (262)
T cd05077 206 GEIPLK 211 (262)
T ss_pred CCCCCC
Confidence 888885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=255.65 Aligned_cols=204 Identities=24% Similarity=0.340 Sum_probs=168.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCe----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KT 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~ 745 (905)
...|++++.||+|+||.||+|....++. .||+|.++...- ....-....+|+.+++.++||||+.+..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 4579999999999999999997655533 789998875421 11222456789999999999999999998876 78
Q ss_pred eEEEEEeccCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC----CcEEEEec
Q 002580 746 HVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDF 818 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~----~~vkL~DF 818 (905)
.+++++||.+ -+|..+++.+ ..+.++...+..|+.||+.|+.|||++=|+||||||.|||+..+ |.+||+||
T Consensus 102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999995 5888888743 23568999999999999999999999999999999999999877 89999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhC
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg 894 (905)
|++++...+-. +.......+-|.+|.|||.+.| +.+.|+|+.|||+.||++-
T Consensus 181 GlaR~~~~plk------------------------pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 181 GLARLFNNPLK------------------------PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cHHHHhhcccc------------------------ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 99988653322 2223345678999999999995 3488999999999999999
Q ss_pred CCCchh
Q 002580 895 FQPFPI 900 (905)
Q Consensus 895 ~~PF~~ 900 (905)
.+.|.-
T Consensus 237 ~PlF~g 242 (438)
T KOG0666|consen 237 EPLFKG 242 (438)
T ss_pred Cccccc
Confidence 988853
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=267.77 Aligned_cols=194 Identities=25% Similarity=0.382 Sum_probs=164.7
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|.+.+.||+|+||.||++.+..++..||+|.+.+.. ........+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 478999999999999999999999999999999987542 2223345677899999999999999999988643
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 3478888887 8899888764 24899999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. ......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||+
T Consensus 171 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 171 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred cc------------------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 20 1123467889999998764 458999999999999999999995
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=255.02 Aligned_cols=198 Identities=24% Similarity=0.331 Sum_probs=167.4
Q ss_pred eeecccccccCceEEEEEEEcCCC----eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEE
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~----~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
+++.+.||.|+||.||++.+..++ ..+|+|.+.... .......+..|+.++..++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356788999999999999998766 899999986542 22256788899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
+|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999765433389999999999999999999999999999999999999999999999999866432211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCch
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~ 899 (905)
. ......+++.|+|||.+.. ..++|+|||||++|+|++ |.+||.
T Consensus 159 ~--------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 159 Y--------------------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred c--------------------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 0 0001226789999998863 559999999999999998 889986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=257.17 Aligned_cols=202 Identities=20% Similarity=0.245 Sum_probs=165.9
Q ss_pred cCCCeeecccccccCceEEEEEEEcCC---CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t---~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
...+|.+.+.||.|+||.||+|.+... ...+++|.+.... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 456799999999999999999987544 4568999876442 24456678899999999999999999998875 56
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
.|+||||+++++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999997643 3589999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchhh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~~ 901 (905)
... .......+++.|+|||.+.+ ..++|+|||||++|++++ |..||...
T Consensus 160 ~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 160 ESY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ccc--------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 110 01112234568999998863 458999999999999986 99999543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=259.01 Aligned_cols=194 Identities=25% Similarity=0.409 Sum_probs=166.8
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|...+.||.|++|.||++.+..++..+++|.+... .......+.+|+.+++.++|+||+++++++...+..|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567899999999999999889999999988643 23344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.. ..++...+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999999876 34899999999999999999999999999999999999999999999999987543210
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
........|++.|+|||.+.+ ..++|+|||||++|+|++|..||.
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~ 216 (285)
T cd06648 169 ----------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF 216 (285)
T ss_pred ----------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence 011123468899999999874 458999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=269.93 Aligned_cols=201 Identities=23% Similarity=0.369 Sum_probs=167.7
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCeE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHV 747 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~~ 747 (905)
++|.+.+.||.|+||.||+|.+..++..||+|.+..... .......+.+|+.+++.++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999876422 22345667789999999999999999998763 3578
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 99999994 6898888654 34899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
... ........+++..|+|||.+.. ..++|+|||||++|+|++|+.||.
T Consensus 161 ~~~-----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 161 PTE-----------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred CcC-----------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 110 0111234578999999999753 458999999999999999999994
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=289.21 Aligned_cols=206 Identities=20% Similarity=0.295 Sum_probs=173.1
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCe-----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~-----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+.....++...||+|.||.||.|....... .||+|.+++. .+..+...|.+|..+|+.++||||+++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 456678889999999999999999765433 4888888754 567788999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEec
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQP-----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DF 818 (905)
....+|++|||+||+|..+|+..+ ...++....+.++.+|+.|+.||+++++|||||..+|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999999998651 345888999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHHHHHHH-hC
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLILVSKKF-ME 894 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvil~ell-tg 894 (905)
|+|+.+...... .......-...|||||.+. .++++|||||||+|||+| .|
T Consensus 847 GlArDiy~~~yy-------------------------r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYY-------------------------RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchhe-------------------------eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999854322111 0111112335899999998 367999999999999999 57
Q ss_pred CCCchhh
Q 002580 895 FQPFPIL 901 (905)
Q Consensus 895 ~~PF~~~ 901 (905)
..||+..
T Consensus 902 ~~PY~~~ 908 (1025)
T KOG1095|consen 902 ATPYPSR 908 (1025)
T ss_pred CCCCCCc
Confidence 9999753
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=262.52 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=164.6
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~l 749 (905)
.++|...+.||+|+||.||++.+..++..+|+|.+..... ......+..|+.++.++. |+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3567788899999999999999999999999999875422 244567888999999985 9999999999999999999
Q ss_pred EEeccCCCCHHHHH---hhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 750 ITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 750 V~E~~~gg~L~~~l---~~~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
+|||+. ++|.++. .......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999984 4555443 222335699999999999999999999975 99999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCCch
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. .......|++.|+|||++.+ ..++|+|||||++|+|++|+.||.
T Consensus 160 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 DS----------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cC----------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 11 01123358889999999863 348999999999999999999996
Q ss_pred h
Q 002580 900 I 900 (905)
Q Consensus 900 ~ 900 (905)
.
T Consensus 212 ~ 212 (288)
T cd06616 212 K 212 (288)
T ss_pred h
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=259.06 Aligned_cols=198 Identities=24% Similarity=0.376 Sum_probs=172.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+.|.+...||+|++|.||++.+..++..+++|++..... ....+..|+++++.++|+||+++++++...+..|++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4579999999999999999999988899999999975422 456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
+||+++++|.+++.... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999998753 369999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......+++.|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 171 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 171 -------------------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred -------------------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 01123457889999999874 4589999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=267.53 Aligned_cols=202 Identities=24% Similarity=0.362 Sum_probs=167.6
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CeE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THV 747 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~--~~~ 747 (905)
.++|.+.+.||+|+||.||+|.+..++..+|+|.+.+.. ........+.+|+.+++++ +|+||++++++|... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999998899999999886532 2333445677899999999 999999999988643 468
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+. ++|..++... .+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999996 5999888653 5888899999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.... .......+.||+.|+|||.+.+ ..++|+||||+++|+|++|+.||.
T Consensus 161 ~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 161 EENP----------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred cccc----------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 1100 0011234578999999998863 358999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=256.07 Aligned_cols=194 Identities=15% Similarity=0.206 Sum_probs=155.1
Q ss_pred cccccCceEEEEEEEcCC--CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCC
Q 002580 679 PLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~~t--~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~g 756 (905)
.||+|+||.||++..... ...+++|.+... ........+.+|+.+++.++||||+++++++.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC--CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 689999999999975433 234566766543 1234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCc
Q 002580 757 GELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (905)
Q Consensus 757 g~L~~~l~~~~--~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~ 834 (905)
++|.+++.+.. ...++...+..++.||+.||.|||+++++||||||+|||++.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~----- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY----- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh-----
Confidence 99999997642 23466777889999999999999999999999999999999999999999998753211100
Q ss_pred chhhhccccCCCCcccccccccccccccCCccccccccccC----------CCCchHHHHHHHHHHHHh-CCCCch
Q 002580 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----------YTRMTRYNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----------~~~sDiwSlGvil~ellt-g~~PF~ 899 (905)
.......+++..|+|||++.. +.++|+|||||++|+|++ |..||.
T Consensus 155 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 155 --------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred --------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 011224568899999999752 358999999999999996 577884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=258.14 Aligned_cols=193 Identities=24% Similarity=0.388 Sum_probs=161.1
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CeEEEE
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK--THVCLI 750 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~--~~~~lV 750 (905)
|++.+.||+|+||.||++.+..++..||+|.+++... .... .....|+.++.++. |+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999876422 2222 23457888888884 99999999999987 899999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 99996 58888876543 45899999999999999999999999999999999999999 999999999986543111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+++.|+|||.+.. ..++|+|||||++|+|++|..||.
T Consensus 154 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 154 --------------------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred --------------------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 1122457889999997642 458999999999999999999995
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=260.47 Aligned_cols=194 Identities=26% Similarity=0.361 Sum_probs=166.6
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|...+.||+|+||.||+|.+..++..|++|.+.............+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66778899999999999999999999999998765444445556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+. ++|.+++.... ..+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-------- 172 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-------- 172 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--------
Confidence 95 57777776543 458999999999999999999999999999999999999999999999999874321
Q ss_pred cchhhhccccCCCCcccccccccccccccCCcccccccccc------CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF------AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~------~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......|+..|+|||++. ...++|+|||||++|+|++|..||..
T Consensus 173 -----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 173 -----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred -----------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 112346888999999984 24488999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=255.41 Aligned_cols=187 Identities=16% Similarity=0.190 Sum_probs=157.0
Q ss_pred ccccccCceEEEEEEEcCCC----------eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 678 KPLGSGDTGSVHLVELCGSG----------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~----------~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998776 357788765431 115678889999999999999999999888 778
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-------cEEEEeccC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-------HVSLTDFDL 820 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-------~vkL~DFG~ 820 (905)
++||||+++++|.+++..... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999987542 589999999999999999999999999999999999999887 799999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHh-C
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFM-E 894 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~ellt-g 894 (905)
+..... .....++..|+|||++.+ ..++|+|||||++|+|++ |
T Consensus 155 a~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 155 PITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred cccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 865321 112346678999999874 348999999999999999 5
Q ss_pred CCCchhh
Q 002580 895 FQPFPIL 901 (905)
Q Consensus 895 ~~PF~~~ 901 (905)
..||...
T Consensus 204 ~~p~~~~ 210 (259)
T cd05037 204 EEPLSTL 210 (259)
T ss_pred CCCcccC
Confidence 8888544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=267.31 Aligned_cols=194 Identities=25% Similarity=0.368 Sum_probs=166.1
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 745 (905)
.++|++++.||+|+||.||++.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 568999999999999999999999999999999986542 23334456788999999999999999999987653
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 746 -~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
.+|+||+|+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 469999999 7899888764 34899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. ......+++.|+|||.+.+ ..++|+|||||++|+|++|..||.
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 169 DS------------------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cc------------------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 1123457889999999864 358999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=259.26 Aligned_cols=203 Identities=22% Similarity=0.299 Sum_probs=168.2
Q ss_pred CCCeeecccccccCceEEEEEEEc----CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe--C
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~----~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~ 744 (905)
..+|++.+.||+|+||.||++... .++..+|+|.+...... .....+.+|+.+++.+.|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 457889999999999999999864 34789999998765321 356778999999999999999999999877 5
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...+++|||+++++|.+++.... ..++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 68999999999999999997653 24899999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...... ........++..|+|||.+.. ..++|+|||||++|+|++|..||..
T Consensus 160 ~~~~~~------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 160 PEDKDY------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred ccCCcc------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 311110 001112245567999998873 4589999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=286.56 Aligned_cols=151 Identities=39% Similarity=0.653 Sum_probs=139.5
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+++|.+++.||.|+||.||+|.+..+++.||||+++............+..|+.++..++|+||+++++++...+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876555566667889999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
|||+.|++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999999764 3488999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=268.20 Aligned_cols=197 Identities=25% Similarity=0.397 Sum_probs=166.9
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----Ce
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----TH 746 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~~ 746 (905)
++|.+.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999999876422 233345677899999999999999999988644 35
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
.|+++||+ +++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888764 4599999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. .......++..|+|||.+.. ..++|+|||||++|+|++|+.||.
T Consensus 161 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 161 KG---------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred Cc---------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 11 11223467889999998763 459999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=251.95 Aligned_cols=200 Identities=29% Similarity=0.490 Sum_probs=173.6
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|.+.+.||.|+||.||++.+..++..|++|.+..... .......+..|+++++.++|+|++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999998999999999876532 33556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 753 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|+++++|.+++.... ...++...+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999998643 3569999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......|++.|+|||.+.+ ..++|+||+|+++|+|++|..||..
T Consensus 158 -------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 158 -------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred -------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC
Confidence 01223468899999998874 4589999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=250.27 Aligned_cols=197 Identities=29% Similarity=0.454 Sum_probs=172.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|.+.+.||+|++|.||++.+..++..+++|.+..... .....+.+|+.+++.++|+||+++++++..+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 47888999999999999999988999999999876532 355678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999987643 458999999999999999999999999999999999999999999999999986543110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
......++..|+|||.+.+ ..++|+||||+++|+|++|..||...
T Consensus 153 ------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 153 ------------------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred ------------------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 0234568899999999874 45899999999999999999999643
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=258.66 Aligned_cols=197 Identities=23% Similarity=0.334 Sum_probs=167.2
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEEE
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLIT 751 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lV~ 751 (905)
|.+.+.||.|++|.||+|.+..++..+|+|.+.... ........+.+|+.+++.++|+|++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999999999999998653 2333445678899999999999999999999987 8999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||++ ++|..++.... ..+++..++.++.||+.||.|||++|++|+||||+||++++++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9996 58888886542 4689999999999999999999999999999999999999999999999999865432110
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......++..|+|||.+.+ ..++|+||||+++|+|++|+.||.
T Consensus 156 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 156 ------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred ------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 01122356788999998763 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=251.98 Aligned_cols=202 Identities=22% Similarity=0.295 Sum_probs=167.3
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCe
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTH 746 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~~~~ 746 (905)
.|..++.+-+..||.|.||+|++..++.+|+..|||.+.... ...+..+++.|.+...+ -+.||||++|+.....+.
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 456677788899999999999999999999999999998653 34566778888876544 579999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 002580 747 VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~---~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~~~~~vkL~DFG~s~ 822 (905)
.||.||+| ..+|..+.+. -.+..+++..+-.|....+.||.||-.. .|+|||+||+|||++..|.+||||||+|-
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 99999999 5677665542 2345699999999999999999999865 89999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----C-CCchHHHHHHHHHHHHhCCCC
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----Y-TRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~-~~sDiwSlGvil~elltg~~P 897 (905)
.+-.+ ...+--+|-..|||||-+.. | -+||+||||++|||+.||.+|
T Consensus 217 qLv~S----------------------------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 217 QLVDS----------------------------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred hHHHH----------------------------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence 53211 11223467889999999983 2 389999999999999999999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 269 yr~ 271 (361)
T KOG1006|consen 269 YRK 271 (361)
T ss_pred cch
Confidence 953
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=250.20 Aligned_cols=198 Identities=24% Similarity=0.345 Sum_probs=173.2
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|.+.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|++++..++|+|++++++++.+.+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58889999999999999999998999999999987633 23456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999999765 4589999999999999999999999999999999999999999999999999866432111
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++..|+|||.+.+ ..++|+||||+++|+|++|..||..
T Consensus 155 ------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 155 ------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1223468889999999874 4589999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=251.80 Aligned_cols=194 Identities=23% Similarity=0.309 Sum_probs=162.1
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCC
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg 757 (905)
+.||.|+||.||++.+.. ++.|++|.+..... ......+..|+.+++.++|+||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999977 99999998876432 235567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchh
Q 002580 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837 (905)
Q Consensus 758 ~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~ 837 (905)
+|.+++.... ..++...+..++.+++.+|.|||+++++||||||+|||++.++.++|+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999987643 35788999999999999999999999999999999999999999999999998653211000
Q ss_pred hhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCCchh
Q 002580 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~PF~~ 900 (905)
........+..|+|||.+.+ ..++|+|||||++|+|++ |..||..
T Consensus 150 ------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 150 ------------------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ------------------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 00011234567999999873 458999999999999998 8999853
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=261.15 Aligned_cols=195 Identities=19% Similarity=0.287 Sum_probs=168.7
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC--CC----CcceEEEEEEeC
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HP----FVPALYASFQTK 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~--h~----nIv~l~~~~~~~ 744 (905)
.++|.+++.+|+|.||.|..|.+..++..||||+++.- ....+..+-|+++|.++. .| -++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 67899999999999999999999999999999998742 223456678999999983 22 278888899999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC---------------
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--------------- 809 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~--------------- 809 (905)
+++|||+|.+ |.++++++..+...+++...++.|+.|++.+++|||+.+++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 889999999988889999999999999999999999999999999999999831
Q ss_pred -----CCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchH
Q 002580 810 -----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTR 881 (905)
Q Consensus 810 -----~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDi 881 (905)
+..++|+|||.|+... ......+.|..|.|||++.+ +.++|+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgLGwS~pCDv 292 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGLGWSQPCDV 292 (415)
T ss_pred eccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheeccCcCCccCc
Confidence 2248999999996532 11245689999999999994 779999
Q ss_pred HHHHHHHHHHHhCCCCchh
Q 002580 882 YNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 882 wSlGvil~elltg~~PF~~ 900 (905)
||+||||+||++|...|+.
T Consensus 293 WSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 293 WSIGCILVELYTGETLFQT 311 (415)
T ss_pred eeeeeEEEEeeccceeccc
Confidence 9999999999999998863
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=257.46 Aligned_cols=196 Identities=22% Similarity=0.267 Sum_probs=160.8
Q ss_pred ccccccCceEEEEEEEcCCC------eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 678 KPLGSGDTGSVHLVELCGSG------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~------~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+.||+|+||.||+|...... ..+++|.+.+.. .......+.+|+.+++.++||||+++++++...+..|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999886542 2234567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-----cEEEEeccCc
Q 002580 752 DYCPGGELFLLLDRQP-----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFDLS 821 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-----~vkL~DFG~s 821 (905)
||+++++|.+++.... ...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999997532 23478899999999999999999999999999999999999877 8999999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQP 897 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~P 897 (905)
........ ........++..|+|||.+.+ ..++|+|||||++|+|++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 65431110 001112345678999999874 458999999999999998 9999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 214 ~~~ 216 (269)
T cd05044 214 YPA 216 (269)
T ss_pred Ccc
Confidence 863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=261.30 Aligned_cols=196 Identities=21% Similarity=0.239 Sum_probs=161.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHH
Q 002580 684 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763 (905)
Q Consensus 684 ~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 763 (905)
+++.||.+....+++.||+|.+.... ........+..|+.+++.++|+||++++++|...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 45666777777799999999997652 24456678999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhcccc
Q 002580 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843 (905)
Q Consensus 764 ~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~ 843 (905)
.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+..........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------ 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------ 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc------------
Confidence 87555568999999999999999999999999999999999999999999999999886543111100
Q ss_pred CCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 844 GQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...........++..|+|||++.. ..++|+|||||++|+|++|..||..
T Consensus 159 --------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 159 --------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred --------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 001112234567889999999863 3589999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=252.97 Aligned_cols=196 Identities=19% Similarity=0.240 Sum_probs=156.0
Q ss_pred ccccccCceEEEEEEEcC---CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCeEEEEEec
Q 002580 678 KPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHVCLITDY 753 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~---t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~~~~~lV~E~ 753 (905)
+.||+|+||.||+|.+.. .+..+|+|.+... ........+.+|+.+++.++||||+++++++. .++..+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3467999987532 23445677888999999999999999999765 45678999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+.+++|.+++.... ..++...+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999997643 33677788889999999999999999999999999999999999999999998653311100
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhC-CCCch
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFME-FQPFP 899 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg-~~PF~ 899 (905)
.........+++.|+|||.+.+ ..++|+|||||++|+|++| .+||.
T Consensus 155 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 155 --------------------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred --------------------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 0011123346778999998863 4589999999999999994 66665
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=263.50 Aligned_cols=195 Identities=23% Similarity=0.381 Sum_probs=165.8
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCeEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVC 748 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~ 748 (905)
..++|.+.+.||.|+||.||+|.+..++..||+|.+.+.. ........+..|+.+++.++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3568999999999999999999999999999999886542 223344667789999999999999999999875 56799
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++|||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 999999 6789888764 3478888999999999999999999999999999999999999999999999854210
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 161 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 161 ----------------------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred ----------------------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1123467889999998753 458999999999999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=260.73 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=166.9
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT---- 745 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~---- 745 (905)
..++|++.+.||.|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35789999999999999999999999999999999875422 2223345678999999999999999999887654
Q ss_pred ------eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEecc
Q 002580 746 ------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819 (905)
Q Consensus 746 ------~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG 819 (905)
.+|+|+||+++ +|..++... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999965 777777654 3458999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCC
Q 002580 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 820 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~ 895 (905)
++........ .......+++.|+|||.+.+ ..++|+|||||++|+|++|+
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEES--------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCcc--------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9865431110 01112346788999998863 45899999999999999999
Q ss_pred CCchh
Q 002580 896 QPFPI 900 (905)
Q Consensus 896 ~PF~~ 900 (905)
+||..
T Consensus 216 ~~~~~ 220 (302)
T cd07864 216 PIFQA 220 (302)
T ss_pred CCCCC
Confidence 99963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=287.61 Aligned_cols=208 Identities=26% Similarity=0.339 Sum_probs=165.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 743 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------- 743 (905)
..+|+.+..||+||||.||+|+++-+|+.||||.++... .......+.+|+.+|.+|+|||||++|..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 467889999999999999999999999999999998653 55667788999999999999999999864410
Q ss_pred ------------------------------------------------C-------------------------------
Q 002580 744 ------------------------------------------------K------------------------------- 744 (905)
Q Consensus 744 ------------------------------------------------~------------------------------- 744 (905)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 002580 745 ---------------------------------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791 (905)
Q Consensus 745 ---------------------------------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH 791 (905)
-.+||-||||+..+|.+++.++... -....++.++++|+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH
Confidence 1368999999988888888775321 146788999999999999999
Q ss_pred HCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC----CCCCCCCcchhhhccccCCCCcccccccccccccccCCccc
Q 002580 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC----KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEY 867 (905)
Q Consensus 792 ~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y 867 (905)
++|||||||||.|||+++++.|||+|||+++.... ......+.+ ..-..+....+..+||.-|
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~-------------~~~g~~~~~~Ts~VGTalY 781 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFST-------------NRAGSNDGDLTSQVGTALY 781 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccc-------------cccCCCCcccccccceeee
Confidence 99999999999999999999999999999977321 111100000 0011122345678999999
Q ss_pred cccccccC------CCCchHHHHHHHHHHHHhC
Q 002580 868 IAPVSDFA------YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 868 ~APE~l~~------~~~sDiwSlGvil~elltg 894 (905)
+|||++.+ +.|+|+||||+++|||+.-
T Consensus 782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP 814 (1351)
T KOG1035|consen 782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP 814 (1351)
T ss_pred ecHHHhcccccccccchhhhHHHHHHHHHHhcc
Confidence 99999983 3499999999999999964
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=262.98 Aligned_cols=201 Identities=20% Similarity=0.289 Sum_probs=164.3
Q ss_pred CeeecccccccCceEEEEEEEcCC--CeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----KT 745 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t--~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~----~~ 745 (905)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8899999987532 2233355678899999998 59999999987542 24
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+|++++|+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 688999998 47899888654 458999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
..... .........||+.|+|||.+.+ ..++|+|||||++|+|++|.+||..
T Consensus 157 ~~~~~-----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 157 ENPGE-----------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ccccc-----------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 21110 0111234578999999998753 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=258.05 Aligned_cols=193 Identities=25% Similarity=0.387 Sum_probs=165.3
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|.....||+|+||.||++....++..||+|.+... .......+.+|+.+++.++|+||+++++++...+..|++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33446799999999999999999999999987543 233456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----- 170 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 170 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-----
Confidence 999999998754 248899999999999999999999999999999999999999999999999875432110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......|++.|+|||.+.+ ..++|+||||+++|+|++|..||.
T Consensus 171 ----------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 171 ----------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ----------------------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11123468899999999874 458999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=261.09 Aligned_cols=210 Identities=23% Similarity=0.286 Sum_probs=166.9
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|.+.+.||.|+||.||+|.+..+++.+|+|.+....... .....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999987543211 1223567899999999999999999887543
Q ss_pred --CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcc
Q 002580 745 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 745 --~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~ 822 (905)
..+|+||+|+. ++|...+... ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 35799999995 5777776543 3459999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCc
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF 898 (905)
........... + ............+++.|+|||.+.+ ..++|+|||||++|+|++|++||
T Consensus 164 ~~~~~~~~~~~--------------~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPNPKG--------------G--GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCccccc--------------C--CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 64322111000 0 0001112234577899999998763 35899999999999999999998
Q ss_pred h
Q 002580 899 P 899 (905)
Q Consensus 899 ~ 899 (905)
.
T Consensus 228 ~ 228 (311)
T cd07866 228 Q 228 (311)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=249.26 Aligned_cols=201 Identities=26% Similarity=0.347 Sum_probs=174.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CeEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLI 750 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~--~~~~lV 750 (905)
+|.+.+.||+|++|.||+|.+..++..+++|.+..... .......+.+|+.++++++|+||+++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47888999999999999999998999999999876532 245567889999999999999999999999988 899999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999998754 6899999999999999999999999999999999999999999999999998664322110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.......++..|+|||.+.. ..++|+||||+++|+|++|..||...
T Consensus 158 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 158 -------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred -------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01234568899999999874 45899999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=254.40 Aligned_cols=201 Identities=22% Similarity=0.251 Sum_probs=162.1
Q ss_pred eeecccccccCceEEEEEEEc---CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 002580 674 FRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~---~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 745 (905)
|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999864 357899999987653 33445677889999999999999999999886432
Q ss_pred -eEEEEEeccCCCCHHHHHhhCC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 746 -HVCLITDYCPGGELFLLLDRQP----TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 746 -~~~lV~E~~~gg~L~~~l~~~~----~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
..+++++|+.+++|..++.... ...++...+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3578999999999988875321 12478889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh-CCC
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQ 896 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt-g~~ 896 (905)
+........ ........+++.|++||.+.. ..++|+|||||++|+|++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 865431111 001112345678999999873 458999999999999999 899
Q ss_pred Cchh
Q 002580 897 PFPI 900 (905)
Q Consensus 897 PF~~ 900 (905)
||..
T Consensus 215 p~~~ 218 (273)
T cd05074 215 PYAG 218 (273)
T ss_pred CCCC
Confidence 9853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=259.35 Aligned_cols=196 Identities=24% Similarity=0.347 Sum_probs=167.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
..|...+.||.|+||.||++.+..++..+++|.+.............+..|+.+++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 35888899999999999999999999999999987543334445567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 9995 68877775443 4589999999999999999999999999999999999999999999999999854320
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCcccccccccc------CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF------AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~------~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....+++.|+|||.+. ...++|+|||||++|+|++|..||..
T Consensus 168 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 168 --------------------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred --------------------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 12346888999999974 24589999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=254.79 Aligned_cols=197 Identities=22% Similarity=0.339 Sum_probs=164.3
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCe----
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTH---- 746 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~~~~---- 746 (905)
|++.+.||.|+||.||++.+..++..||+|.+..... .......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999988899999999975432 222234556677777665 69999999999988776
Q ss_pred -EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 747 -VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 747 -~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
++++|||+. ++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 589998877554568999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
... ......+++.|+|||.+.+ ..++|+|||||++|+|++|.+||..
T Consensus 159 ~~~----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 159 FEM----------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred CCc----------------------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 110 1122357889999999874 4589999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=257.22 Aligned_cols=199 Identities=38% Similarity=0.600 Sum_probs=167.1
Q ss_pred CeeecccccccCceEEEEEEEc---CCCeEEEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~---~t~~~vavK~~~~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~ 747 (905)
+|.+.+.||+|++|.||++.+. .++..||+|.+++.... .......+..|+.++..+ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999999864 45788999998754322 223345678899999999 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+||||+.+++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998764 34899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. .......|++.|+|||.+.+ ..++|+||||+++|+|++|..||.
T Consensus 159 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 159 EE--------------------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cc--------------------------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 10 11223468899999999863 348999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=256.80 Aligned_cols=196 Identities=27% Similarity=0.412 Sum_probs=166.8
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEe
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~E 752 (905)
|.+.+.||.|++|.||+|....+++.|++|.+..... . .......+|+..+..++ |+||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999988999999999875422 1 12233456888999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~ 832 (905)
|+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 8899998877654568999999999999999999999999999999999999999999999999986532110
Q ss_pred CcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++..|+|||++.. ..++|+||||+++|+|++|++||+.
T Consensus 154 ------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 154 ------------------------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred ------------------------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 1123467889999998853 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=256.84 Aligned_cols=202 Identities=26% Similarity=0.361 Sum_probs=166.6
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 745 (905)
..+..++|.+.+.||+|+||.||+|.+..+++.||+|.+++.. .......+..|+.++..+ .|+||+++++++.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 3456789999999999999999999998889999999997642 222344566677766666 5999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..|++|||+ +++|..++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999998 457777776533 368999999999999999999997 59999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-------CCCchHHHHHHHHHHHHhCCCC
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-------YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~-------~~~sDiwSlGvil~elltg~~P 897 (905)
.... ......+++.|+|||.+.+ ..++|+||||+++|+|++|+.|
T Consensus 166 ~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (296)
T cd06618 166 VDSK----------------------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217 (296)
T ss_pred cCCC----------------------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCC
Confidence 2110 0112357889999999873 3489999999999999999999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 218 ~~~ 220 (296)
T cd06618 218 YKN 220 (296)
T ss_pred CCc
Confidence 964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=250.79 Aligned_cols=197 Identities=27% Similarity=0.426 Sum_probs=170.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+|++.+.||.|+||.||++.+..++..+++|.+..... .......+..|+.+++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58899999999999999999999999999999876533 33445677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 753 YCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 753 ~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
|+++++|..++.+. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999998762 2245889999999999999999999999999999999999999999999999998654311
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+++.|+|||.+.+ ..++|+||||+++|+|++|+.||.
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1112357889999999874 348999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=248.99 Aligned_cols=192 Identities=42% Similarity=0.711 Sum_probs=168.5
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||.|+||.||.+.+..+++.+++|.+.+...........+..|+.+++.++|+||+++++.+..++..|++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999999876555555677888999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~ 839 (905)
.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 99997653 48999999999999999999999999999999999999999999999999986543111
Q ss_pred ccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.......++..|+|||.+.+ ..++|+||||+++|++++|..||..
T Consensus 148 ----------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 148 ----------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred ----------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 11234568889999999874 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=263.83 Aligned_cols=193 Identities=24% Similarity=0.369 Sum_probs=162.4
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.+... .......+.+|+.+++.++|+||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999999999999999999876422 223345678899999999999999999998754
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
...|+|+||+. .+|..++. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 34699999995 57776652 24899999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. ......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 168 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 168 DA------------------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CC------------------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 20 1123467889999999863 348999999999999999999995
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=251.85 Aligned_cols=200 Identities=23% Similarity=0.331 Sum_probs=167.2
Q ss_pred CeeecccccccCceEEEEEEEcC-CCeEEEEEEeecccc-------cCHHHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM-------LNRNKVHRACAEREILDM-LDHPFVPALYASFQT 743 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~-t~~~vavK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~ 743 (905)
+|++.+.||+|+||.||++.+.. ++..+|+|.+..... ........+..|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 688999998864321 123345567788888865 799999999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
++..|++|||+++++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887532 23458999999999999999999996 6899999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCC
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~P 897 (905)
+....... ......|+..|+|||.+.+ ..++|+||||+++|+|++|..|
T Consensus 161 ~~~~~~~~----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQPES----------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccccc----------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 86532110 1224468899999999985 4589999999999999999999
Q ss_pred chh
Q 002580 898 FPI 900 (905)
Q Consensus 898 F~~ 900 (905)
|..
T Consensus 213 ~~~ 215 (269)
T cd08528 213 FYS 215 (269)
T ss_pred ccc
Confidence 854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=263.42 Aligned_cols=199 Identities=22% Similarity=0.346 Sum_probs=169.1
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~ 747 (905)
+|++.+.||.|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999899999999987642 22345567889999999999999999999988765 78
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|++|+|++ ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 58988887643 6999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
... ........+++.|+|||.+.+ ..++|+||||+++|+|++|++||.
T Consensus 157 ~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 157 EDE------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ccc------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 110 011233468899999999874 358999999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=261.38 Aligned_cols=213 Identities=20% Similarity=0.209 Sum_probs=168.0
Q ss_pred CCCee-ecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHH-----------HHHHHHHHHHHHHhCCCCCcceEE
Q 002580 671 LQHFR-PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------KVHRACAEREILDMLDHPFVPALY 738 (905)
Q Consensus 671 ~~~y~-i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~h~nIv~l~ 738 (905)
.++|. +.+.||.|+||.||+|.+..+++.||+|.+......... ....+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35675 457799999999999999999999999998754322100 012467899999999999999999
Q ss_pred EEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEec
Q 002580 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 739 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DF 818 (905)
+++...+..|++|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99999999999999995 6899988764 34899999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhC
Q 002580 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 819 G~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg 894 (905)
|++.....+........ ... ...........+++.|+|||.+.+ ..++|+|||||++|+|++|
T Consensus 164 g~~~~~~~~~~~~~~~~------------~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSK------------DET-MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred cceeecccccccccccc------------ccc-ccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99876542221100000 000 000111223457889999999874 4589999999999999999
Q ss_pred CCCch
Q 002580 895 FQPFP 899 (905)
Q Consensus 895 ~~PF~ 899 (905)
..||.
T Consensus 231 ~~p~~ 235 (335)
T PTZ00024 231 KPLFP 235 (335)
T ss_pred CCCCC
Confidence 99995
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=263.47 Aligned_cols=198 Identities=20% Similarity=0.306 Sum_probs=162.9
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
.++|.+.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999987542 23456678899999999999999999776543
Q ss_pred --------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEE
Q 002580 745 --------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSL 815 (905)
Q Consensus 745 --------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL 815 (905)
...|+||||++ ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35899999996 589888764 34899999999999999999999999999999999999974 567899
Q ss_pred EeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHH
Q 002580 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKK 891 (905)
Q Consensus 816 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~el 891 (905)
+|||++......... ........++..|+|||.+.. ..++|+|||||++|+|
T Consensus 157 ~dfg~~~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 157 GDFGLARIVDPHYSH------------------------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCcccceecCCcccc------------------------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 999998654311000 001122357889999998753 3489999999999999
Q ss_pred HhCCCCch
Q 002580 892 FMEFQPFP 899 (905)
Q Consensus 892 ltg~~PF~ 899 (905)
++|..||.
T Consensus 213 ~~g~~pf~ 220 (342)
T cd07854 213 LTGKPLFA 220 (342)
T ss_pred HhCCCCCC
Confidence 99999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=264.37 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=166.6
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 746 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~---- 746 (905)
.++|.+.+.||+|++|.||+|.+..++..||+|.+.... ........+.+|+.+++.+.|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 568999999999999999999999999999999987542 223344667789999999999999999988876554
Q ss_pred --EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 747 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 747 --~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7799998875 34899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.. ......+++.|+|||.+.+ ..++|+|||||++|+|++|+.||.
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred cc------------------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 21 0123467889999998753 458999999999999999999995
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=253.77 Aligned_cols=196 Identities=24% Similarity=0.388 Sum_probs=167.0
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++.+++..|++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6678899999999999999998999999999876532 223456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+++ +|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 964 8888887643 458999999999999999999999999999999999999999999999999986543111
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCch
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......++..|+|||.+.+ ..++|+||||+++|+|++|+.||+
T Consensus 153 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 153 ----------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred ----------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 01122457889999999864 358999999999999999999994
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=268.69 Aligned_cols=199 Identities=27% Similarity=0.389 Sum_probs=174.3
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----C
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT-----K 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~-----~ 744 (905)
.+.|.+...||.|.+|.||+++.+.+++..|+|++.... ..-+.+..|.++|+.. .|||++.+|++|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 467999999999999999999999999999999987542 2334566788888887 79999999999863 4
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
+.+|||||||.||+.-++++......+.+..+..|++.++.||.+||.+.++|||||-.|||++.++.+||+|||++..+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 68999999999999999998776778999999999999999999999999999999999999999999999999999764
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------CCCchHHHHHHHHHHHHhCCC
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------~~~sDiwSlGvil~elltg~~ 896 (905)
.. ......+++|||.|||||++.. ..++|+||||++..||--|.+
T Consensus 174 ds---------------------------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 174 DS---------------------------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred ec---------------------------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 31 2234467899999999999984 238999999999999999999
Q ss_pred Cchh
Q 002580 897 PFPI 900 (905)
Q Consensus 897 PF~~ 900 (905)
||..
T Consensus 227 Pl~D 230 (953)
T KOG0587|consen 227 PLCD 230 (953)
T ss_pred CccC
Confidence 9864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=246.09 Aligned_cols=178 Identities=25% Similarity=0.294 Sum_probs=150.6
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHH
Q 002580 683 GDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762 (905)
Q Consensus 683 G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 762 (905)
|.+|.||+|.+..+++.||+|.+.+.. ....|...+....||||+++++++...+..|++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999999999999999987542 123344455556799999999999999999999999999999999
Q ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccc
Q 002580 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842 (905)
Q Consensus 763 l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~ 842 (905)
+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---------------- 137 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---------------- 137 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----------------
Confidence 8764 3489999999999999999999999999999999999999999999999998744321
Q ss_pred cCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 843 KGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 843 ~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++..|+|||.+.+ ..++|+||+||++|+|++|..||..
T Consensus 138 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 138 --------------SCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred --------------ccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 0112345678999999863 4589999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=254.92 Aligned_cols=188 Identities=22% Similarity=0.333 Sum_probs=159.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT--- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~~--- 745 (905)
.....+.+.||+|.||.||+|.. +++.||||+++. ...+.+..|.+|++. +.|+||++|+++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 55678889999999999999998 669999999864 356778889888876 48999999998765444
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeCCCCCCCEEEcCCCcEEE
Q 002580 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVSL 815 (905)
Q Consensus 746 -~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~---------gIvHrDLKp~NILl~~~~~vkL 815 (905)
.++||++|.+.|+|.+||+.+ .+++.....|+..+++||+|||.- .|+|||||..|||+.+|++..|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 789999999999999999875 489999999999999999999973 5999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---------CCCchHHHHHH
Q 002580 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---------YTRMTRYNYLI 886 (905)
Q Consensus 816 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---------~~~sDiwSlGv 886 (905)
+|||+|..+.... +....-..+||.+|||||++.+ ..+.||||+|.
T Consensus 358 aDFGLAl~~~p~~-------------------------~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL 412 (534)
T KOG3653|consen 358 ADFGLALRLEPGK-------------------------PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL 412 (534)
T ss_pred eccceeEEecCCC-------------------------CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence 9999997654111 1112234689999999999984 23889999999
Q ss_pred HHHHHHhC
Q 002580 887 LVSKKFME 894 (905)
Q Consensus 887 il~elltg 894 (905)
+|||+++.
T Consensus 413 VLWEi~SR 420 (534)
T KOG3653|consen 413 VLWEIASR 420 (534)
T ss_pred HHHHHHhh
Confidence 99999976
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=251.57 Aligned_cols=197 Identities=24% Similarity=0.344 Sum_probs=167.8
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|++.+.||+|++|.||+|.+..+++.|++|.+.... ........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 667889999999999999999999999999998653 2233345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
++ ++|.+++.+.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 153 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---- 153 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc----
Confidence 96 59999998753 3589999999999999999999999999999999999999999999999999865431110
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++..|+|||.+.+ ..++|+|||||++|++++|.+||..
T Consensus 154 -----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 154 -----------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred -----------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 1122346788999999863 4589999999999999999999953
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=251.05 Aligned_cols=189 Identities=24% Similarity=0.350 Sum_probs=157.4
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT--- 745 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~l~~~~~~~~--- 745 (905)
..+..+.+.||+|.||.||+|.+ -|+.||||++... +...+.+|.+|++. |+|+||+.|++.-..+.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 45678899999999999999999 6789999998743 33456778888766 59999999998755332
Q ss_pred -eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeCCCCCCCEEEcCCCcEEEE
Q 002580 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLT 816 (905)
Q Consensus 746 -~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~--------gIvHrDLKp~NILl~~~~~vkL~ 816 (905)
.+|||++|.+.|+|++||.++ .++.....+++..++.||.|||-. .|.|||||..|||+..+|.+.|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 589999999999999999884 389999999999999999999963 49999999999999999999999
Q ss_pred eccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---------CCCCchHHHHHHH
Q 002580 817 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---------AYTRMTRYNYLIL 887 (905)
Q Consensus 817 DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---------~~~~sDiwSlGvi 887 (905)
|+|+|-........+ ....+..+||..|||||++. .+..+||||||++
T Consensus 359 DLGLAv~h~~~t~~i-----------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTI-----------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred eceeeEEecccCCcc-----------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 999997655332211 11234568999999999997 2568999999999
Q ss_pred HHHHHh
Q 002580 888 VSKKFM 893 (905)
Q Consensus 888 l~ellt 893 (905)
+||+.-
T Consensus 416 lWEiar 421 (513)
T KOG2052|consen 416 LWEIAR 421 (513)
T ss_pred HHHHHH
Confidence 999974
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=258.42 Aligned_cols=207 Identities=20% Similarity=0.242 Sum_probs=178.0
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
..+++...+.....+||-|.||.||.+.++.-.-.||||.++.. .-.++.|+.|..+|+.++|||+|+++++|...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 34456666777888999999999999999988889999998754 34678999999999999999999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|||+|||..|+|.+||.......++.-..+.++.||..|+.||..+++|||||-..|+|+..+..+|++|||++++.
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999999877777888888999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH-hCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF-MEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell-tg~~PF~~ 900 (905)
..+... .....--...|.|||.+.. +-++|+|+|||+|||+. +|-.||+.
T Consensus 416 tgDTYT--------------------------AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTYT--------------------------AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCcee--------------------------cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 533211 0111112357999999985 34999999999999998 68899975
Q ss_pred h
Q 002580 901 L 901 (905)
Q Consensus 901 ~ 901 (905)
+
T Consensus 470 i 470 (1157)
T KOG4278|consen 470 I 470 (1157)
T ss_pred c
Confidence 4
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=268.43 Aligned_cols=206 Identities=21% Similarity=0.277 Sum_probs=177.5
Q ss_pred ccccccCCCeeecccccccCceEEEEEEEcCCC---eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 741 (905)
Q Consensus 665 ~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~---~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~ 741 (905)
-..+++.....+.++||.|.||.||.+..+..+ ..||||.++.. ........|+.|..||-+++||||++|.++.
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV 699 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV 699 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence 344577788899999999999999999987665 46999999865 3556678899999999999999999999999
Q ss_pred EeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 742 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 742 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
.....++||+|||++|+|..+|+.+.. .|+..+...|++.|+.|++||-++|+|||||...|||++.+-.+|++|||++
T Consensus 700 Tks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 700 TKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999999988754 4999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccC--Ccccccccccc---CCCCchHHHHHHHHHHHH-hCC
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG--TEEYIAPVSDF---AYTRMTRYNYLILVSKKF-MEF 895 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--T~~Y~APE~l~---~~~~sDiwSlGvil~ell-tg~ 895 (905)
+.+..++... .++.-| ...|-|||.+. .+.+||+||||++|||.+ +|.
T Consensus 779 Rvledd~~~~--------------------------ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 779 RVLEDDPEAA--------------------------YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred eecccCCCcc--------------------------ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 8876443211 011112 25899999998 366999999999999988 898
Q ss_pred CCch
Q 002580 896 QPFP 899 (905)
Q Consensus 896 ~PF~ 899 (905)
.||=
T Consensus 833 RPYW 836 (996)
T KOG0196|consen 833 RPYW 836 (996)
T ss_pred Cccc
Confidence 8874
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=246.81 Aligned_cols=199 Identities=26% Similarity=0.391 Sum_probs=164.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999888777777776643221 222344567789999999999999999999998999999
Q ss_pred EeccCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 751 TDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
|||+++++|..++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988864 22346899999999999999999999999999999999999974 679999999986543111
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
.......|++.|+|||.+.+ ..++|+||||+++|+|++|..||.
T Consensus 160 ---------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 160 ---------------------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred ---------------------------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 11223457889999999863 448999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=260.85 Aligned_cols=191 Identities=26% Similarity=0.350 Sum_probs=162.6
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEE
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~ 748 (905)
..+.|.+...+|.|+|+.|-.|.+..+++.+++|++.+.. .....|+.++... +||||+++++.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3678999999999999999999999999999999998652 2234466665554 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEE-cCCCcEEEEeccCccccCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl-~~~~~vkL~DFG~s~~~~~~ 827 (905)
+|||++.|+.|.+.+...+. +. ..+..|+.+|+.++.|||++|+|||||||+|||+ ++.|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999988887766432 33 7788899999999999999999999999999999 68999999999999764311
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
...-|-|..|.|||++.. +.++|+||||++||+|++|+.||.-
T Consensus 470 ------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 470 ------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred ------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 123367889999999983 4599999999999999999999964
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=297.64 Aligned_cols=374 Identities=14% Similarity=0.148 Sum_probs=250.6
Q ss_pred CcccccccchHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHH
Q 002580 181 GGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 260 (905)
Q Consensus 181 ~~~~~~l~~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l 260 (905)
+..++.+.++++.++.+++.++++++++|. +|+|+++|++|++++||+.+|++|+++..+.++++.......+...+
T Consensus 272 r~~~~~l~~~e~r~~~l~e~~~~~i~~~d~---dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~~~ 348 (1092)
T PRK09776 272 RAERKHISESETRFRNAMEYSAIGMALVGT---EGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEKLL 348 (1092)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHHHH
Confidence 445566788888999999999999999999 99999999999999999999999999887777776655555555554
Q ss_pred HcC-CcEEEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhHHHHHHHHHHHHHH
Q 002580 261 QNG-QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMAT 339 (905)
Q Consensus 261 ~~g-~~~~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~l~~~~~~~~~~~~ 339 (905)
..+ ..+..+.+..++||+.+|+..+..|+++.+|.+.+++++.+|||++|++|++++...+.
T Consensus 349 ~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~~~----------------- 411 (1092)
T PRK09776 349 SGEINSYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLMER----------------- 411 (1092)
T ss_pred cCCccceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHHHH-----------------
Confidence 443 34678888999999999999999999999999999999999999999999887642111
Q ss_pred HHHHHHHHHccCCCCccc-cCCCCcccccCCCchhhhhhccccCccCC---------CCCCCcCCCCCCC--cccccccc
Q 002580 340 SSVTELVQAMKKPRSLSE-STNRPPIIRKSEGGVEEERAGALGRRKSE---------NVPPPRRNSYGGG--CRTSMQRI 407 (905)
Q Consensus 340 ~~~~~l~~al~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~g~~~~~---------~~~~~~~~~~~~~--~~~~~~~i 407 (905)
...+.++........+ ......++. ...+..|....+ .+.+..+...... ........
T Consensus 412 --~~~~~~~~~~~i~~~d~~~~~~~~n~--------~~~~l~G~~~~~~~~~~~~~~~~~p~d~~~~~~~~~~~~~~~~~ 481 (1092)
T PRK09776 412 --ITLANEAGGIGIWEWDLKPNIISWDK--------RMFELYEIPPHIKPTWQVWYACLHPEDRQRVEKEIRDALQGRSP 481 (1092)
T ss_pred --HHHHHHhcCceEEEEecCCCeEeeCH--------HHHHHhCCCcccCCCHHHHHHhcCHhHHHHHHHHHHHHHhcCCC
Confidence 1112222222211111 111111111 111122221111 0111111000000 00000000
Q ss_pred ccccccccccCCccccccccccccCCCCCCCccccchhccCCCCCCCCCCCCCchhhHHHHHhhhhc-ccHHHHHHhhcc
Q 002580 408 SEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLATTLERIEK 486 (905)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~e~k~~e~~~~~~-~~l~~i~e~~~~ 486 (905)
........++.| ..|....... +....+.........+|||++|+.+++++++ .+++.+++++++
T Consensus 482 ~~~e~r~~~~dG-~~w~~~~~~~-------------~~d~~G~~~~~ig~~~DITerk~~e~~L~~~~~~l~~~l~~~~~ 547 (1092)
T PRK09776 482 FKLEFRIVVKDG-VRHIRALANR-------------VLNKDGEVERLLGINMDMTEVRQLNEALFQEKERLHITLDSIGE 547 (1092)
T ss_pred eeEEEEEEcCCc-eEEEEEeeEE-------------EECCCCCEEEEEeeeeehhHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 111122223334 3333222211 1122233333444568999999988888766 678999999999
Q ss_pred cEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCC--CCHHHHHHHHHHHHcCCc--EEEEEEEEecCCcE
Q 002580 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE--TDPATVRKIRAAIDNQTD--VTVQLINYTKSGKK 562 (905)
Q Consensus 487 ~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~--~~~~~~~~~~~~l~~g~~--~~~e~~~~~kdG~~ 562 (905)
+|+++|. +|+|+++|+++++++||+.+|++|++...+.+.. ........+......+.. +..+....++||..
T Consensus 548 ~i~~~D~---~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~ 624 (1092)
T PRK09776 548 AVVCTDM---AMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGS 624 (1092)
T ss_pred EEEEECC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcE
Confidence 9999999 5569999999999999999999999966554322 222222334444444444 55677788999999
Q ss_pred EEEEEEEeeeecCCCCEEEEEEEeecCcccccccccCCc
Q 002580 563 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIP 601 (905)
Q Consensus 563 ~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~~~ 601 (905)
+|+..+..|++|.+|++.+++++++|||++|+.++++..
T Consensus 625 ~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~L~~ 663 (1092)
T PRK09776 625 YDVHYSITPLSTLDGENIGSVLVIQDVTESRKMLRQLSY 663 (1092)
T ss_pred EEEEEEeeeeecCCCCEEEEEEEEEecchHHHHHHHHHh
Confidence 999999999999999999999999999999997665543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=252.01 Aligned_cols=204 Identities=19% Similarity=0.253 Sum_probs=169.4
Q ss_pred cCCCeeecccccccCceEEEEEEEcCC----CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t----~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
......+.+.||.|.||.||+|....- .--||||..+... +.+..+.|..|..+|+.++||||++++|+|.+ .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 333445667899999999999986332 3358889877643 45568899999999999999999999999975 5
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
..|||||+++-|.|..|++.+. ..++......++.||+.||.|||+..+|||||-..|||+.+...+||+|||+++.+.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 7999999999999999998764 568999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHHHHHHH-hCCCCchhh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLILVSKKF-MEFQPFPIL 901 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvil~ell-tg~~PF~~~ 901 (905)
...-.. .+...-...|||||.+. .++++|+|=|||+|||++ .|..||.+.
T Consensus 543 d~~yYk--------------------------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 543 DDAYYK--------------------------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred ccchhh--------------------------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 332211 01112345799999998 367999999999999998 799999876
Q ss_pred hc
Q 002580 902 CR 903 (905)
Q Consensus 902 ~r 903 (905)
..
T Consensus 597 kN 598 (974)
T KOG4257|consen 597 KN 598 (974)
T ss_pred cc
Confidence 53
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=230.76 Aligned_cols=192 Identities=21% Similarity=0.319 Sum_probs=164.1
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--Ce
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK--TH 746 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~--~~ 746 (905)
+.++|++.+++|+|.++.||.|.+..+++.++||++++- ..+.+.+|+.||..|. ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 357899999999999999999999999999999998753 4577899999999995 99999999998765 46
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEeccCccccC
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 825 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG~s~~~~ 825 (905)
..+|+||+.+.+...+... ++...++.++.+++.||.|||++||+|||+||.|++|+.. -.++|+|+|+|.+..
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7899999988887766543 8888999999999999999999999999999999999864 579999999996643
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHHHhCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~elltg~~PF~~ 900 (905)
... .-+-.+.+..|--||.+..+ ..-|+|||||+|..|++.+-||=.
T Consensus 185 p~~----------------------------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 185 PGK----------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CCc----------------------------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 221 12234677889999999843 478999999999999999999843
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-28 Score=242.87 Aligned_cols=198 Identities=23% Similarity=0.325 Sum_probs=164.7
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----eE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 747 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~~ 747 (905)
+.+.-+.||-|+||.||.+.+..+|+.||+|.+..- ..+-...+++.+|+++|..++|.|++..++..+... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 344557899999999999999999999999988653 344456678899999999999999999988876443 46
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCC
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~ 827 (905)
|+++|+| ..+|..++-.. ..++.+.+..+++||++||+|||+.+|.||||||.|+|++++..+||||||+++....+
T Consensus 133 YV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8889998 56888877553 45888999999999999999999999999999999999999999999999999764422
Q ss_pred CCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. ...+..+-|..|.|||++.| +.+.||||.||++.||+-.+..|..
T Consensus 210 ~~--------------------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 210 DR--------------------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred hh--------------------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 21 12233466889999999995 4589999999999999988888753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-28 Score=240.01 Aligned_cols=205 Identities=20% Similarity=0.258 Sum_probs=167.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----- 743 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----- 743 (905)
...+.|.-...||+|.||.||+|+...+|+.||+|.+--.. ..........+|+++|..++|+|++.++..|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 34567888899999999999999999999999988653210 112233556789999999999999998877642
Q ss_pred ---CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 744 ---KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 744 ---~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
...+|+||.+|+ .+|.-++... ...++...+.+++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+
T Consensus 93 ~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 345999999994 6888888653 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCC
Q 002580 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 821 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~ 896 (905)
++....+..... ..-+..+-|.+|.+||.+.| .++.|+|+.||+|.+|.++.+
T Consensus 171 ar~fs~~~n~~k-----------------------prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 171 ARAFSTSKNVVK-----------------------PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred ccceecccccCC-----------------------CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 977653333211 11234567999999999996 358999999999999999998
Q ss_pred Cch
Q 002580 897 PFP 899 (905)
Q Consensus 897 PF~ 899 (905)
-|.
T Consensus 228 imq 230 (376)
T KOG0669|consen 228 IMQ 230 (376)
T ss_pred ccc
Confidence 774
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=256.30 Aligned_cols=205 Identities=20% Similarity=0.248 Sum_probs=171.0
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCC---CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t---~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
|..++..+.+.||+|.||.|+.+.+... -..||||.+....... ....|.+|+.+|.+|+|+|+++||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 3345677888999999999999988543 2468999998764432 67889999999999999999999999887 7
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccC
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~ 825 (905)
.+.||||+++.|+|.+.|.+.....|.-.....++.||+.||.||.++++|||||-..|+|+-..-.+||+|||+.+.++
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 88999999999999999988666778888999999999999999999999999999999999988899999999998776
Q ss_pred CCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH-hCCCCchh
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF-MEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell-tg~~PF~~ 900 (905)
.....+ .|... .--...|+|||.+.. +.++|+|+|||+||||| +|..||..
T Consensus 264 ~ned~Y------------------vm~p~------rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 264 ENEDMY------------------VMAPQ------RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred CCCcce------------------EecCC------CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 443321 11111 112357999999983 56999999999999999 56888854
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=251.71 Aligned_cols=201 Identities=22% Similarity=0.260 Sum_probs=170.7
Q ss_pred cCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC------CCcceEEEEEEe
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQT 743 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~l~~~~~~ 743 (905)
-.++|.+....|+|-|++|..|.+..-|..||||+|..+. .....-+.|++||++|+. -|++.|+..|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3578999999999999999999999999999999998653 233455689999999952 389999999999
Q ss_pred CCeEEEEEeccCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEeccCc
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLS 821 (905)
Q Consensus 744 ~~~~~lV~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG~s 821 (905)
.+++|||+|-+ ..+|.++|+.-+ +-.+....+..++.|++.||..|-..||+|.||||+|||++.. ..+||||||.|
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 99999999998 789999998643 3468889999999999999999999999999999999999864 57899999998
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
...+.. ..+.+.-+..|.|||++.| ....|+||.||+||||+||+..|
T Consensus 585 ~~~~en-----------------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 585 SFASEN-----------------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cccccc-----------------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 664411 1234456678999999996 45899999999999999999999
Q ss_pred hhhhcc
Q 002580 899 PILCRK 904 (905)
Q Consensus 899 ~~~~r~ 904 (905)
+..+.|
T Consensus 636 pG~TNN 641 (752)
T KOG0670|consen 636 PGRTNN 641 (752)
T ss_pred CCCCcH
Confidence 876543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=264.56 Aligned_cols=199 Identities=17% Similarity=0.183 Sum_probs=143.6
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCC----CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEE---
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS--- 740 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t----~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~--- 740 (905)
.+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..+....+ .+....+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 34678999999999999999999999888 8999999876431 11111111 1122222222222211
Q ss_pred ---EEeCCeEEEEEeccCCCCHHHHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeCC
Q 002580 741 ---FQTKTHVCLITDYCPGGELFLLLDRQPTK------------------VLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799 (905)
Q Consensus 741 ---~~~~~~~~lV~E~~~gg~L~~~l~~~~~~------------------~l~~~~~~~i~~qil~gL~~LH~~gIvHrD 799 (905)
.......++||||+.+++|.+++...... ......+..++.||+.||.|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 23556899999999999999998753210 112344667999999999999999999999
Q ss_pred CCCCCEEEcC-CCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---
Q 002580 800 LKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--- 875 (905)
Q Consensus 800 LKp~NILl~~-~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--- 875 (905)
|||+|||++. ++.+||+|||+|+....... .....+++|+.|+|||.+..
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~--------------------------~~~~~~~~t~~Y~APE~~~~~~~ 334 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGIN--------------------------YIPKEFLLDPRYAAPEQYIMSTQ 334 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccccc--------------------------cCCcccccCCCccChHHhhccCC
Confidence 9999999985 57999999999965431111 11235678999999997642
Q ss_pred ----------------------CCCchHHHHHHHHHHHHhCCCCch
Q 002580 876 ----------------------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 876 ----------------------~~~sDiwSlGvil~elltg~~PF~ 899 (905)
..++|+|||||+||+|+++..|+.
T Consensus 335 ~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 335 TPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred CCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence 124599999999999999887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=239.68 Aligned_cols=141 Identities=29% Similarity=0.442 Sum_probs=125.2
Q ss_pred cCccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-----C---CCc
Q 002580 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----H---PFV 734 (905)
Q Consensus 663 ~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---~nI 734 (905)
+.-|+.|+.++|.+.++||.|-|++||+|.+..+.+.||+|+.+.. ....+....||.+|++++ | .+|
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 3457788889999999999999999999999999999999998753 345567788999999883 3 369
Q ss_pred ceEEEEEEe----CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCCEEEc
Q 002580 735 PALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQ 808 (905)
Q Consensus 735 v~l~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~-gIvHrDLKp~NILl~ 808 (905)
|+|++.|.. +.++|||+|++ |.+|..++.....+.++...+..|++||+.||.|||.. ||||-||||+|||+.
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999974 45899999999 89999999988888899999999999999999999986 999999999999995
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=258.98 Aligned_cols=360 Identities=13% Similarity=0.047 Sum_probs=229.5
Q ss_pred HHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCC-cEEEEEEEEccC
Q 002580 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKKD 276 (905)
Q Consensus 198 le~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~kd 276 (905)
+++++|+++++|. +|+|++||++++.++||+.+|++|+++..+.+++........+...+..+. .+..++....++
T Consensus 2 ~~~~~d~~~~~d~---~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 78 (442)
T TIGR02040 2 LATAADVTLLLDA---EGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPS 78 (442)
T ss_pred CcccCcEEEEECC---CCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCC
Confidence 5778999999999 999999999999999999999999999877777665555566666666654 455565555667
Q ss_pred CCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhHHHHHHHHHHHHHHHHHHHHHHHccCCCCcc
Q 002580 277 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLS 356 (905)
Q Consensus 277 G~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~al~~~~~~~ 356 (905)
|..+|+.++..++.+ +. +++++.+|||++++.+.++......+.. +...-.........+++...++..+.
T Consensus 79 g~~~~~~~~~~~~~~--~~--~~~~i~rDi~~~~~~~~~l~~~~~~~e~-----~~~~l~~~e~r~~~l~e~~~~~i~~~ 149 (442)
T TIGR02040 79 SFELPMRFILVRLGA--DR--GVLALGRDLRAVAELQQQLVAAQQAMER-----DYWTLREMETRYRVVLEVSSDAVLLV 149 (442)
T ss_pred CCccCeEEEEEEeCC--CC--eEEEEecccHHHHHHHHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHhhCCceEEEE
Confidence 777777777666644 22 5788999999988876654221111100 00001111223444555566655554
Q ss_pred c--cCCCCcccccCCCchhhhhhccccCccCCCCCCCcCCCCCCC---ccccccccccccccccccCCcccccccccccc
Q 002580 357 E--STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG---CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKS 431 (905)
Q Consensus 357 ~--~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 431 (905)
. .+....++.......||...+++|+...+.+++......... ...... ..... ......+..... ..+.
T Consensus 150 d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~-~~~~~-~~~~~~~~~~~~--~~~~- 224 (442)
T TIGR02040 150 DMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGS-AAPVR-ILLRRSQKRLLV--VVSV- 224 (442)
T ss_pred ECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCC-CcceE-EEEcCCCeEEEE--EEEE-
Confidence 4 344566677777778889999999988887765433210000 000000 00000 001111111100 0000
Q ss_pred CCCCCCCccccchhccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHc
Q 002580 432 QSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELT 511 (905)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~e~k~~e~~~~~~~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~ 511 (905)
....+.. .......||++++..+++++ .+|+.++++++++|+++|. +|+|++||++|++++
T Consensus 225 -------------~~~~~~~-~~l~~~~dit~~~~~e~~~~--~~~~~l~e~~~d~I~v~D~---~G~I~~~N~a~~~l~ 285 (442)
T TIGR02040 225 -------------FRQDGES-LFLCQLSPAGATQPVGDELS--ENLARLYHEAPDAIVFSDA---DGTIRGANEAFLELT 285 (442)
T ss_pred -------------EEeCCce-EEEEEEcccchhhhhhHHHH--HHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHh
Confidence 0000000 00112467788876665443 2589999999999999999 556999999999999
Q ss_pred CCC-hhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCc
Q 002580 512 EYS-REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (905)
Q Consensus 512 Gys-~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DIT 590 (905)
||+ .++++|++...+.++.... ....+......|.....+..+.++||+.+|+.+++.|+.+.++ ..++++++|||
T Consensus 286 G~~~~~~l~G~~~~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDIT 362 (442)
T TIGR02040 286 DSSSLEAVRGRTLDRWLGRGGVD-LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGER--PLIVLVIRDIS 362 (442)
T ss_pred CCCChHHHcCCCHHHHhCCCccc-HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCc--eEEEEEEecch
Confidence 997 5789999976555433221 1222333334555556777888999999999999999987544 46889999999
Q ss_pred cccccc
Q 002580 591 EHLEPL 596 (905)
Q Consensus 591 erk~~e 596 (905)
+||+++
T Consensus 363 eR~~~~ 368 (442)
T TIGR02040 363 RRLTMR 368 (442)
T ss_pred hhccCC
Confidence 999964
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-26 Score=229.66 Aligned_cols=193 Identities=22% Similarity=0.277 Sum_probs=159.3
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEE-EEEeCCeEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA-SFQTKTHVC 748 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~-~~~~~~~~~ 748 (905)
.+.|.+.+.||+|.||.+.+|.++.++..+++|.+++.. .....|.+|...--.| .|.||+.-|+ .|+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 467999999999999999999999999999999988653 3456677787654445 5889998776 477888999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEc--CCCcEEEEeccCccccCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~--~~~~vkL~DFG~s~~~~~ 826 (905)
+++||++-|+|.+-+.. ..+-+.....++.|+++||.|||++++||||||.+||||- +...+||||||.++..+.
T Consensus 99 F~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999999877654 3488889999999999999999999999999999999994 234899999999876441
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc--------CCCCchHHHHHHHHHHHHhCCCCc
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--------AYTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--------~~~~sDiwSlGvil~elltg~~PF 898 (905)
.- .-.-.+..|.+||.+. ..+.+|+|.||+++|..+||.+||
T Consensus 176 tV------------------------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 176 TV------------------------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred ee------------------------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 11 0112456799998876 356899999999999999999999
Q ss_pred hh
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 226 Qk 227 (378)
T KOG1345|consen 226 QK 227 (378)
T ss_pred hh
Confidence 74
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=223.85 Aligned_cols=198 Identities=33% Similarity=0.502 Sum_probs=169.0
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
|.+.+.||.|++|.||++.+..++..+++|.+...... .....+.+|++.+..++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56778999999999999999888999999998865322 2567888999999999999999999999998999999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCC
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~ 833 (905)
+++++|.+++...... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 9999999999864321 7889999999999999999999999999999999999999999999999986543111
Q ss_pred cchhhhccccCCCCcccccccccccccccCCccccccccc-c---CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSD-F---AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l-~---~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
........++..|++||.+ . ...++|+|+||+++|+|++|+.||..
T Consensus 153 ---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 ---------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0012345678899999998 3 23489999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=249.11 Aligned_cols=206 Identities=17% Similarity=0.175 Sum_probs=151.8
Q ss_pred cccCCCeeecccccccCceEEEEEEEc----------------CCCeEEEEEEeecccccCHH-----------HHHHHH
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELC----------------GSGQYFAMKAMDKGVMLNRN-----------KVHRAC 720 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~----------------~t~~~vavK~~~~~~~~~~~-----------~~~~~~ 720 (905)
.+..++|.+.++||+|+||.||++... ..++.||||.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 466889999999999999999999752 23567999998643111000 112234
Q ss_pred HHHHHHHhCCCCCc-----ceEEEEEEe--------CCeEEEEEeccCCCCHHHHHhhCC--------------------
Q 002580 721 AEREILDMLDHPFV-----PALYASFQT--------KTHVCLITDYCPGGELFLLLDRQP-------------------- 767 (905)
Q Consensus 721 ~E~~il~~l~h~nI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~~-------------------- 767 (905)
.|+..+.+++|.++ ++++++|.. .+..++||||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 56667777766544 566666642 356899999999999999986421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCC
Q 002580 768 --TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845 (905)
Q Consensus 768 --~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~ 845 (905)
...+++..+..++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------------- 364 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---------------- 364 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc----------------
Confidence 11235667888999999999999999999999999999999999999999999854321100
Q ss_pred CCcccccccccccccccCCccccccccccCC-------------------------CCchHHHHHHHHHHHHhCCC-Cch
Q 002580 846 QNPVFMAEPMRASNSFVGTEEYIAPVSDFAY-------------------------TRMTRYNYLILVSKKFMEFQ-PFP 899 (905)
Q Consensus 846 ~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-------------------------~~sDiwSlGvil~elltg~~-PF~ 899 (905)
.......+|+.|+|||.+... .+.|+||+||++|+|++|.. ||.
T Consensus 365 ----------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 365 ----------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ----------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 001122458899999987521 14699999999999999986 775
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=276.99 Aligned_cols=183 Identities=19% Similarity=0.309 Sum_probs=154.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|.....||+|+||.||+|.+..++..||+|.+..... ....|++++++++||||++++++|.+.+..|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 45667789999999999999988999999998864321 11245788999999999999999999999999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH---CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH---~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~ 829 (905)
|+++++|.+++.. +++..+..|+.||+.||.||| +.+|+||||||+||+++.++..++. ||......
T Consensus 764 y~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~---- 833 (968)
T PLN00113 764 YIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC---- 833 (968)
T ss_pred CCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----
Confidence 9999999999953 788999999999999999999 6699999999999999998888775 66542211
Q ss_pred CCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
......+|+.|+|||++.+ ..++|||||||++|||++|+.||.
T Consensus 834 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 834 ---------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ---------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 0112367899999999874 459999999999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=231.13 Aligned_cols=195 Identities=21% Similarity=0.336 Sum_probs=168.3
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 744 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~------ 744 (905)
..+|.-++.+|.|.. .|..+.+.-+++.+|+|.+... ..+.....+..+|..++..++|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 457888999999999 8888999889999999988766 44455567788999999999999999999999744
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|+|||+| ..+|...+.. .+....+..|+.|+++|++|||+.||+||||||+||++..++.+||+|||++...
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3589999999 6789888863 2788999999999999999999999999999999999999999999999999543
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.. .-..+.++.|..|.|||++.+ ....||||+||++.||++|+..|+.
T Consensus 169 ~~----------------------------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 169 DT----------------------------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG 219 (369)
T ss_pred Cc----------------------------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence 21 113456789999999999985 3489999999999999999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=251.98 Aligned_cols=195 Identities=22% Similarity=0.258 Sum_probs=158.6
Q ss_pred eeecccccccCceE-EEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCeEEEEE
Q 002580 674 FRPIKPLGSGDTGS-VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 674 y~i~~~Lg~G~~g~-V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
|...+.+|.|+.|+ ||+|.. .|+.||||.+-.. ......+|+..|+.- .||||+++|+.-.+....||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44556788998865 689988 7889999987543 446778999999988 6999999999989999999999
Q ss_pred eccCCCCHHHHHhhCC-C-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC---C--CcEEEEeccCcccc
Q 002580 752 DYCPGGELFLLLDRQP-T-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---N--GHVSLTDFDLSCLT 824 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~-~-~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~---~--~~vkL~DFG~s~~~ 824 (905)
|+| ..+|.+++.... . ........+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+|+..
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 689999998731 1 11111345678899999999999999999999999999975 3 37899999999987
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhC-CCCchh
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFME-FQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg-~~PF~~ 900 (905)
...... .....+..||-+|+|||++.. ..+.|||||||++|+.++| .+||..
T Consensus 662 ~~~~sS------------------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 662 AGGKSS------------------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCCcch------------------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 644332 223456789999999999994 4588999999999999988 999975
Q ss_pred h
Q 002580 901 L 901 (905)
Q Consensus 901 ~ 901 (905)
.
T Consensus 718 ~ 718 (903)
T KOG1027|consen 718 S 718 (903)
T ss_pred h
Confidence 4
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=232.67 Aligned_cols=221 Identities=21% Similarity=0.257 Sum_probs=170.0
Q ss_pred cCCCeeecccccccCceEEEEEEEcC---CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (905)
Q Consensus 670 ~~~~y~i~~~Lg~G~~g~V~~~~~~~---t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 745 (905)
..+.|.++.+||.|.|++||++.+.. ..+.||+|.+... ....++..|+++|..+ .+.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 35679999999999999999999887 7889999988654 2446789999999998 6999999999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEEEeccCcccc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLT 824 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL~DFG~s~~~ 824 (905)
.+++||||++.....+++.. ++...+..+++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||++...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999998888765 778899999999999999999999999999999999975 567899999999721
Q ss_pred CCCC------C----CCCC-cch-hhhccccCCCCcccccc-----cccccccccCCccccccccccC----CCCchHHH
Q 002580 825 SCKP------Q----LLLP-TTN-EKKRRHKGQQNPVFMAE-----PMRASNSFVGTEEYIAPVSDFA----YTRMTRYN 883 (905)
Q Consensus 825 ~~~~------~----~~~~-~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwS 883 (905)
.... . ...+ ... ....+..+...|.-... .-.......||++|.|||++.. ++++|+||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1100 0 0000 000 00000111111111110 1112235689999999999994 56999999
Q ss_pred HHHHHHHHHhCCCCchh
Q 002580 884 YLILVSKKFMEFQPFPI 900 (905)
Q Consensus 884 lGvil~elltg~~PF~~ 900 (905)
.|+|++-++++.+||--
T Consensus 264 ~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccceeehhhcccccccc
Confidence 99999999999999843
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=220.06 Aligned_cols=185 Identities=37% Similarity=0.616 Sum_probs=160.4
Q ss_pred CceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHH
Q 002580 684 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763 (905)
Q Consensus 684 ~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 763 (905)
+||.||+|.+..+++.+++|++........ ...+.+|+..++.++|+||+++++++......++++||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999876533221 578889999999999999999999999999999999999999999998
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhcccc
Q 002580 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843 (905)
Q Consensus 764 ~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~ 843 (905)
..... ++...+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 76433 8899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 844 GQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 844 ~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
......++..|++||.+.+ ..++|+||||+++|++++|..||..
T Consensus 142 -------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 142 -------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred -------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1224467889999999863 4599999999999999999999965
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-25 Score=246.34 Aligned_cols=195 Identities=26% Similarity=0.382 Sum_probs=172.8
Q ss_pred CCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.++..+|.|+||.||+++++.+++..|+|+++.. ...+...++.|+-+++.++||||+.+++.|...+.+++.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 35899999999999999999999999999999999854 445667788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCC
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~ 830 (905)
||||.||+|.+...- ..++++.++..+++..+.||+|||++|-+|||||-.|||+++.|.+||.|||.+..+..
T Consensus 91 MEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita---- 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA---- 164 (829)
T ss_pred EEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh----
Confidence 999999999988754 46799999999999999999999999999999999999999999999999999866431
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCcccccccccc-----C-CCCchHHHHHHHHHHHHhCCCC
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF-----A-YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-----~-~~~sDiwSlGvil~elltg~~P 897 (905)
......++.|||.|||||+-. + ...+|+|++|+...|+---++|
T Consensus 165 -----------------------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp 214 (829)
T KOG0576|consen 165 -----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP 214 (829)
T ss_pred -----------------------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence 122345789999999999987 3 4599999999999998776666
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=258.21 Aligned_cols=381 Identities=10% Similarity=0.055 Sum_probs=255.1
Q ss_pred cccccccchHHHH-HHHHHhhccceEEEeCCCCCCcE--EEcCHHHHHHcCCChhhhcCCC--CcccCCCCCChHHH---
Q 002580 182 GKEKGLPRVSDIV-KDALSTFQQTFVVSDATKPDYPI--MYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPEDV--- 253 (905)
Q Consensus 182 ~~~~~l~~~~~~l-~~ile~~~~~i~i~D~~~~dG~I--~~~N~a~~~l~Gys~eEliG~~--~~~l~~~~~~~~~~--- 253 (905)
..+..+....+.+ +.+++++|+++++.+. +.+|.+ .+++++...++||...++++.. +..+.+|++....+
T Consensus 57 ~~~~~l~~~~e~~~r~l~~~~p~~i~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~p~d~~~~~~~~ 135 (807)
T PRK13560 57 IAEAEAQDCREQCERNLKANIPGGMFLFAL-DGDGTFSFPSLLDANGELAAIAKHDLMADKGLLAMLIGGDDGDFFFANP 135 (807)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCceEEEEEE-cCccccccceeeccchhHHHhcCcccCCccchhhhhcCCCcchhhhhCh
Confidence 3556666666777 9999999999999886 234443 3478888888999888877643 23455666554433
Q ss_pred ----HHHHHHHHcCCcEEEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhHHHH
Q 002580 254 ----AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIR 329 (905)
Q Consensus 254 ----~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~l~~ 329 (905)
+.+..++..+.....+++.+++||+ |+.....|.++++|.+ .++|+++|||++|++|++|+..+
T Consensus 136 ~~~~~~~~~~~~~~~~~~~e~r~~~~dg~--~~~~~~~~~~~~~g~~-~~~g~~~DIT~rk~ae~~l~~~~--------- 203 (807)
T PRK13560 136 FRSAETIAMALQSDDWQEEEGHFRCGDGR--FIDCCLRFERHAHADD-QVDGFAEDITERKRAEERIDEAL--------- 203 (807)
T ss_pred hhHHHHHHHHhccCcccceEEEEEeCCcc--EEEEEeeeeecCCCce-EEEEEEEccchHHHHHHHHHHHH---------
Confidence 2333444455666788888999996 6667788999988886 68999999999999998875321
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCC-ccccCCCCcccccCCCchhhhhhccccCccCCCCCCCcCCCCCCC--ccccccc
Q 002580 330 YDARQKEMATSSVTELVQAMKKPRS-LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG--CRTSMQR 406 (905)
Q Consensus 330 ~~~~~~~~~~~~~~~l~~al~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~--~~~~~~~ 406 (905)
..+..+++...+... ...++....++......+|++.++++|+...++.++...+..... .......
T Consensus 204 ----------~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (807)
T PRK13560 204 ----------HFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKFDADG 273 (807)
T ss_pred ----------HHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHhccCC
Confidence 112233444444322 234556666777777888999999999999888776443321100 0000011
Q ss_pred cccccccccccCCccccccccccccCCCCCCCccccchhccCCCCCCCCCCCCCchhhHHHHHhhhhc-ccHHHHHHhhc
Q 002580 407 ISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLATTLERIE 485 (905)
Q Consensus 407 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~e~k~~e~~~~~~-~~l~~i~e~~~ 485 (905)
...+.....++.|...+.....+.. .+....+.........+||+++|..|++++++ .+|+.++++++
T Consensus 274 ~~~~e~~~~~~dG~~~~~~~~~~~~-----------~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se~~l~~l~~~~~ 342 (807)
T PRK13560 274 SQIIEAEFQNKDGRTRPVDVIFNHA-----------EFDDKENHCAGLVGAITDISGRRAAERELLEKEDMLRAIIEAAP 342 (807)
T ss_pred ceEEEEEEEcCCCCEEEEEEEecce-----------EEEcCCCCEEEEEEEEEechHHHHHHHHHHHHHHHHHHHHHhCc
Confidence 1122233445555555433221111 01111122222233458999999999998876 67899999999
Q ss_pred ccEEEEcCCCCCCCeEee-CHHHHHHcCCChhhhcCCCCCcCcCCCCCHH---------------H--HHHHHHHHHcCC
Q 002580 486 KNFVITDPRLPDNPIIFA-SDSFLELTEYSREEILGRNCRFLQGPETDPA---------------T--VRKIRAAIDNQT 547 (905)
Q Consensus 486 ~~i~i~D~~g~dg~I~~v-N~a~~~l~Gys~eEliGk~~~~l~~~~~~~~---------------~--~~~~~~~l~~g~ 547 (905)
++|+++|. +|.++++ |+++++++||+.+|++|++...+.+...... . ...+...+..+.
T Consensus 343 ~~i~~~d~---~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (807)
T PRK13560 343 IAAIGLDA---DGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDACPMAKTIKGGK 419 (807)
T ss_pred ccEEEEcC---CCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcchhhhhhHHHHHhcCC
Confidence 99999999 5559987 6788889999999999998654433221111 0 011233355555
Q ss_pred cEE-EEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccC
Q 002580 548 DVT-VQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 599 (905)
Q Consensus 548 ~~~-~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~ 599 (905)
.+. .++.+.+++|..+|+.+...|++|.+|.+++++++++|||++|++|+++
T Consensus 420 ~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~~E~~L 472 (807)
T PRK13560 420 IFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQVEEQL 472 (807)
T ss_pred cccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHHHHHHH
Confidence 543 4778889999999999999999999999999999999999999965443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=246.03 Aligned_cols=207 Identities=24% Similarity=0.347 Sum_probs=170.2
Q ss_pred cccccCCCeeecccccccCceEEEEEEEcC-------CCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceE
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 737 (905)
Q Consensus 666 ~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~-------t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l 737 (905)
..++..++..+.+.||+|.||.|+++.... ....||||.++... ...+...+..|+++|+.+ .|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 345666677778899999999999997531 14579999988653 336778899999999998 69999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCC
Q 002580 738 YASFQTKTHVCLITDYCPGGELFLLLDRQP------------T--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 803 (905)
Q Consensus 738 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~--~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~ 803 (905)
++++...+.+++|+||+..|+|..++...+ . ..++......++.||+.|++||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998754 0 13888999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccC--CccccccccccC---CCC
Q 002580 804 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG--TEEYIAPVSDFA---YTR 878 (905)
Q Consensus 804 NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g--T~~Y~APE~l~~---~~~ 878 (905)
|||+..+..+||+|||+++......... .....+ ...|||||.+.. +.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~--------------------------~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYR--------------------------TKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceE--------------------------ecCCCCccceeecCHHHhccCccccc
Confidence 9999999999999999997644222110 001112 235999999984 569
Q ss_pred chHHHHHHHHHHHH-hCCCCchh
Q 002580 879 MTRYNYLILVSKKF-MEFQPFPI 900 (905)
Q Consensus 879 sDiwSlGvil~ell-tg~~PF~~ 900 (905)
+|+||||++|||++ .|..||+.
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999 67899975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.5e-24 Score=240.16 Aligned_cols=199 Identities=21% Similarity=0.224 Sum_probs=163.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCe----EEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~----~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
..+..++||+|+||+||++.+...|+ +||+|++... ........+..|+-+|..++|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34556889999999999998865554 6888887654 23445677889999999999999999999998765 88
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
||++|+++|+|.++++.++ ..+-....+.|..||++||.|||.+++|||||-..|||+..-..+||.|||+++....+.
T Consensus 774 lvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999999998764 458888889999999999999999999999999999999999999999999998876443
Q ss_pred CCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---CCCCchHHHHHHHHHHHH-hCCCCchh
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---AYTRMTRYNYLILVSKKF-MEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---~~~~sDiwSlGvil~ell-tg~~PF~~ 900 (905)
..... ....-.+.|||-|.+. ...++|||||||++||++ +|..||..
T Consensus 853 ~ey~~-------------------------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 853 KEYSA-------------------------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred ccccc-------------------------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 32110 0111235789999887 355999999999999999 68888754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=224.01 Aligned_cols=174 Identities=22% Similarity=0.178 Sum_probs=132.6
Q ss_pred ccCCCeeecccccccCceEEEEEEEcC-CCeEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCcce-EEEEEEeC
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPA-LYASFQTK 744 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~-t~~~vavK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~-l~~~~~~~ 744 (905)
...++|.+.+.||+|+||+||+|.+.. +++.+|||.+..... ........+.+|+++|+.++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 346789999999999999999999876 678889998753311 12334567899999999999999885 5432
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC-CCCCEEEcCCCcEEEEeccCccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDL-Kp~NILl~~~~~vkL~DFG~s~~ 823 (905)
+..|+|||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 468999999999999632 11 11 1457889999999999999999999 99999999999999999999987
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF 874 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~ 874 (905)
........ .+. ....-...++++.|+|||.+.
T Consensus 162 ~~~~~~~~------------------~~~-~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALY------------------RIA-AYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchh------------------hhh-hhhhhhhhhccCccCCcccCC
Confidence 64322111 000 001113567899999999998
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=201.28 Aligned_cols=208 Identities=22% Similarity=0.236 Sum_probs=173.6
Q ss_pred ccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT 745 (905)
Q Consensus 667 ~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~ 745 (905)
..+..++|.++++||+|+||.+|++....+|..||||+-.... ....+..|..+...|+ ...|+.+..++....
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 3466789999999999999999999999999999999865432 2345677888998886 468899999999999
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC---CCcEEEEeccCcc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSC 822 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~---~~~vkL~DFG~s~ 822 (905)
+-.+||+++ |.+|.+++.-. ...|+..+++.++-|++.-++|+|.++++||||||+|+|+.- ...+.|+|||+|+
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred cceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 999999999 89999988754 345999999999999999999999999999999999999853 3579999999998
Q ss_pred ccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCch
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~ 899 (905)
........ ...+........||..|.+=-...+ +.+.|+-|+|.+|.++.-|..||.
T Consensus 163 ky~d~~t~--------------------~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 163 KYRDIRTR--------------------QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred hhcccccc--------------------ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 76532211 1234556667899999999877774 558899999999999999999997
Q ss_pred hh
Q 002580 900 IL 901 (905)
Q Consensus 900 ~~ 901 (905)
.+
T Consensus 223 gl 224 (341)
T KOG1163|consen 223 GL 224 (341)
T ss_pred cc
Confidence 54
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-21 Score=198.78 Aligned_cols=182 Identities=35% Similarity=0.550 Sum_probs=155.8
Q ss_pred ccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCH
Q 002580 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 759 (905)
Q Consensus 680 Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L 759 (905)
||.|.+|.||++....+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 346788999999999999999999999998999999999999999
Q ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-CCcEEEEeccCccccCCCCCCCCCcchhh
Q 002580 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838 (905)
Q Consensus 760 ~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-~~~vkL~DFG~s~~~~~~~~~~~~~~~~~ 838 (905)
.+++.... ..++...+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 34889999999999999999999999999999999999998 89999999999865431110
Q ss_pred hccccCCCCcccccccccccccccCCccccccccccCC----CCchHHHHHHHHHHH
Q 002580 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY----TRMTRYNYLILVSKK 891 (905)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~----~~sDiwSlGvil~el 891 (905)
......+...|++||.+... .+.|+|++|++++++
T Consensus 149 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 ------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 12234578899999998754 689999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=205.68 Aligned_cols=207 Identities=21% Similarity=0.254 Sum_probs=174.7
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCe
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 746 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~~ 746 (905)
.+..-+|++.++||+|+||.++.+.+.-+++.||||.-+.. ....++.-|....+.| ..++|+.+|-+.+++.+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~ 98 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY 98 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence 34556899999999999999999999999999999976543 2345677788888887 57999999999999999
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-----CcEEEEeccCc
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFDLS 821 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-----~~vkL~DFG~s 821 (905)
-.||+|++ |.+|.+++.-++ ..|+.+.+..++.|++.-++|+|++.+|+|||||+|+||..- ..+.|+|||++
T Consensus 99 NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99999999 899999988664 459999999999999999999999999999999999999643 36899999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
+....+.... ..+.....+..||..||+=....| +.+-|+-|||-++++++-|.+||
T Consensus 177 K~YrDp~Tkq--------------------HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW 236 (449)
T KOG1165|consen 177 KEYRDPKTKQ--------------------HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 236 (449)
T ss_pred hhhcCccccc--------------------cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence 8765433221 234556667889999999888886 45789999999999999999999
Q ss_pred hhh
Q 002580 899 PIL 901 (905)
Q Consensus 899 ~~~ 901 (905)
..+
T Consensus 237 QGL 239 (449)
T KOG1165|consen 237 QGL 239 (449)
T ss_pred ccc
Confidence 654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-21 Score=213.41 Aligned_cols=209 Identities=23% Similarity=0.239 Sum_probs=166.6
Q ss_pred CeeecccccccCceEEEEEEEcCCC-eEEEEEEeecccccCHHHHHHHHHHHHHHHhCC----CCCcceEEEEE-EeCCe
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----HPFVPALYASF-QTKTH 746 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~-~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~----h~nIv~l~~~~-~~~~~ 746 (905)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+........ ...+..|..++..+. .++++.+++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997774 678999876542111 115677888888886 36899999999 57889
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-----CcEEEEeccCc
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFDLS 821 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-----~~vkL~DFG~s 821 (905)
.|+||+.+ |.+|.++....+...++..++..|+.|++.+|.+||+.|++||||||+|+++... ..+.|+|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999877766789999999999999999999999999999999999999754 46999999999
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCc
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF 898 (905)
+......... . ....+-.....+.||..|+++.+..+ ..+.|+||++.++.+++.|..||
T Consensus 175 r~~~~~~~~~-----~------------~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 175 RRFKYVGDSG-----G------------NLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred ccccccCCCC-----c------------ccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 7322110000 0 00001111245779999999999986 45889999999999999999999
Q ss_pred hhhh
Q 002580 899 PILC 902 (905)
Q Consensus 899 ~~~~ 902 (905)
....
T Consensus 238 ~~~~ 241 (322)
T KOG1164|consen 238 EALE 241 (322)
T ss_pred cccc
Confidence 6554
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-21 Score=237.02 Aligned_cols=240 Identities=20% Similarity=0.316 Sum_probs=195.3
Q ss_pred HHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCC----cE
Q 002580 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SY 266 (905)
Q Consensus 191 ~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~----~~ 266 (905)
...+..+++.++++++++|. +|+|++||++|++++||+++|++|+++..+.+++........+......+. .+
T Consensus 11 ~~~~~~~le~~~~~i~~~d~---~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (799)
T PRK11359 11 DGIFFPALEQNMMGAVLINE---NDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGM 87 (799)
T ss_pred hhhHHHHHHhhcCcEEEEcC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCcccccc
Confidence 34567789999999999998 999999999999999999999999998877776655544444554444433 24
Q ss_pred EEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhHHHHHHHHHHHHHHHHHHHHH
Q 002580 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELV 346 (905)
Q Consensus 267 ~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~ 346 (905)
..+++.+++||+.+|+.++..|+. .+|.. +++++.+|||++++.+++++.
T Consensus 88 ~~e~~~~~~dG~~~~v~~~~~~~~-~~g~~-~~~~~~~DiT~~~~~~~~~~~---------------------------- 137 (799)
T PRK11359 88 SRELQLEKKDGSKIWTRFALSKVS-AEGKV-YYLALVRDASVEMAQKEQTRQ---------------------------- 137 (799)
T ss_pred ceeeEEecCCcCEEEEEEEeeeec-cCCce-EEEEEEeeccchhhhHHHHHH----------------------------
Confidence 457888899999999999998874 45554 578999999987655433210
Q ss_pred HHccCCCCccccCCCCcccccCCCchhhhhhccccCccCCCCCCCcCCCCCCCccccccccccccccccccCCccccccc
Q 002580 347 QAMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGL 426 (905)
Q Consensus 347 ~al~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 426 (905)
T Consensus 138 -------------------------------------------------------------------------------- 137 (799)
T PRK11359 138 -------------------------------------------------------------------------------- 137 (799)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccCCCCCCCccccchhccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhhcccEEEEcCCCCCCCeEeeCHH
Q 002580 427 IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDS 506 (905)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~e~k~~e~~~~~~~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a 506 (905)
+..++++++++++++|. +|+++++|++
T Consensus 138 --------------------------------------------------~~~~~~~~~~~i~~~d~---~g~i~~~N~~ 164 (799)
T PRK11359 138 --------------------------------------------------LIIAVDHLDRPVIVLDP---ERRIVQCNRA 164 (799)
T ss_pred --------------------------------------------------HHHHHhcCCCcEEEEcC---CCcEEEEChh
Confidence 45678999999999999 5669999999
Q ss_pred HHHHcCCChhhhcCCCCCcCc-CCCCCHHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEE
Q 002580 507 FLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585 (905)
Q Consensus 507 ~~~l~Gys~eEliGk~~~~l~-~~~~~~~~~~~~~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i 585 (905)
+++++||+.++++|++...+. ++.........+...+..+..+..+.+..+++|..+|+.++..|+.|.+|.+.+++++
T Consensus 165 ~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~ 244 (799)
T PRK11359 165 FTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMT 244 (799)
T ss_pred hHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEE
Confidence 999999999999999876554 4555555666667777777778888899999999999999999999999999999999
Q ss_pred eecCccccccc
Q 002580 586 QLDGSEHLEPL 596 (905)
Q Consensus 586 ~~DITerk~~e 596 (905)
++|||++|+.+
T Consensus 245 ~~DITerk~~e 255 (799)
T PRK11359 245 FSDITEERQIR 255 (799)
T ss_pred eehhhhHHHHH
Confidence 99999999853
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=230.40 Aligned_cols=245 Identities=20% Similarity=0.304 Sum_probs=191.7
Q ss_pred HHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEE
Q 002580 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270 (905)
Q Consensus 191 ~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (905)
.+.++.++++++++++++|. +|+++++|++|++++||++++++|++...+.++.........+++.+..+..+..++
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKL 79 (494)
T ss_pred hHHHHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCccccee
Confidence 35789999999999999999 999999999999999999999999987766666666677788888888888888888
Q ss_pred EEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhHHHHHHHHHHHHHHHHHHHHHHHcc
Q 002580 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 350 (905)
Q Consensus 271 ~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~al~ 350 (905)
..++++|..+|+..++.|+++.+|.+.+++++++|||++++++++++..
T Consensus 80 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~------------------------------- 128 (494)
T TIGR02938 80 LNRRKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ------------------------------- 128 (494)
T ss_pred eccCCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH-------------------------------
Confidence 8889999999999999999999999999999999999999988775320
Q ss_pred CCCCccccCCCCcccccCCCchhhhhhccccCccCCCCCCCcCCCCCCCccccccccccccccccccCCccccccccccc
Q 002580 351 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRK 430 (905)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 430 (905)
T Consensus 129 -------------------------------------------------------------------------------- 128 (494)
T TIGR02938 129 -------------------------------------------------------------------------------- 128 (494)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cCCCCCCCccccchhccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHH
Q 002580 431 SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLEL 510 (905)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~di~e~k~~e~~~~~~~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l 510 (905)
+ ..|+.++++++++++++|. +|.++++|++|+++
T Consensus 129 -------------------------------------~------~~~~~~~~~~~~~i~~~d~---~~~i~~~N~~~~~~ 162 (494)
T TIGR02938 129 -------------------------------------K------LLIESVVDAAPVAFVLLDP---TGRVILDNQEYKKL 162 (494)
T ss_pred -------------------------------------H------HHHHHHHhcccceEEEEcC---CCCEEEechhHHHh
Confidence 0 1168899999999999999 56699999999999
Q ss_pred cCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcE-EEEEEEEecCCc-EEEEEEEEeeeecCCCCE---------
Q 002580 511 TEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDV-TVQLINYTKSGK-KFWNLFHLQPMRDQKGEV--------- 579 (905)
Q Consensus 511 ~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~-~~e~~~~~kdG~-~~wv~~~~~pi~d~~G~i--------- 579 (905)
+|+...+..+.....+.+++..... ......+..+ ..+......+|. .+|+.....|+.+..|.+
T Consensus 163 ~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (494)
T TIGR02938 163 ATDLRVKEPAHTVLDLLREAWREAL----AENWPQQLAFSNREARFDRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQ 238 (494)
T ss_pred hchhhhhHHHHHHHHHhhHHhhhhh----hhcchhhhccccceeeeccCCCceeeEEEecCceEEeecchhhheeccCCC
Confidence 9999888777654444433322221 1111111122 223444455555 789998888887766554
Q ss_pred EEEEEEeecCcccccccccC
Q 002580 580 QYFIGVQLDGSEHLEPLRNS 599 (905)
Q Consensus 580 ~~~i~i~~DITerk~~e~~~ 599 (905)
.+++++++|||++|++++++
T Consensus 239 ~~~~~~~~DITe~k~~ee~l 258 (494)
T TIGR02938 239 PYLLLTIADISNLREEQERA 258 (494)
T ss_pred chheehHHHHHHHHHHHHHH
Confidence 34567899999999976544
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=189.27 Aligned_cols=142 Identities=16% Similarity=0.167 Sum_probs=110.4
Q ss_pred cccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHH-----------------------HHHHHHHHHHHHhCCCCC
Q 002580 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----------------------VHRACAEREILDMLDHPF 733 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~-----------------------~~~~~~E~~il~~l~h~n 733 (905)
...||+|+||.||+|.+. +|+.||+|+++......... ......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 89999999998653211110 122345999999998887
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeCCCCCCCEEEcCCCc
Q 002580 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPENVLLQGNGH 812 (905)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~L-H~~gIvHrDLKp~NILl~~~~~ 812 (905)
+...+.+... ..+|||||++|+++....... ..++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7544433222 238999999887776543332 4588999999999999999999 799999999999999998 578
Q ss_pred EEEEeccCcccc
Q 002580 813 VSLTDFDLSCLT 824 (905)
Q Consensus 813 vkL~DFG~s~~~ 824 (905)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-19 Score=192.72 Aligned_cols=204 Identities=32% Similarity=0.458 Sum_probs=168.9
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCeEEEEEe
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~l~~~~~~~~~~~lV~E 752 (905)
|.+.+.||.|+|+.||.+.+. ..+++|.+.............+.+|+.++..+.|+ +|+.+++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778889999999999999996 77899999876544444567889999999999988 79999999988888899999
Q ss_pred ccCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC-cEEEEeccCccccCCCCCC
Q 002580 753 YCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~-~vkL~DFG~s~~~~~~~~~ 830 (905)
++.+++|.+++..... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765431 2589999999999999999999999999999999999999988 7999999998643321110
Q ss_pred CCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.. ........+||..|+|||.+.+ ....|+||+|++++++++|..||...
T Consensus 159 ~~---------------------~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 159 SS---------------------IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred cc---------------------ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 00 0012456789999999999864 34889999999999999999997654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=187.42 Aligned_cols=143 Identities=17% Similarity=0.189 Sum_probs=117.9
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDMLDHPFVPALYASFQ 742 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~------~~~E~~il~~l~h~nIv~l~~~~~ 742 (905)
+-.++|++++.||.|+||.||++.. ++..+|+|++.......+..... +.+|+..+.++.|++|+.+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4467999999999999999999765 46689999998765444444444 578999999999999999998866
Q ss_pred eC--------CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEE
Q 002580 743 TK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814 (905)
Q Consensus 743 ~~--------~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vk 814 (905)
.. +..+|+|||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+| ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 43 35899999999999987732 333 2456899999999999999999999999999988 99
Q ss_pred EEeccCcccc
Q 002580 815 LTDFDLSCLT 824 (905)
Q Consensus 815 L~DFG~s~~~ 824 (905)
|+|||.+...
T Consensus 175 liDfg~~~~~ 184 (232)
T PRK10359 175 IIDLSGKRCT 184 (232)
T ss_pred EEECCCcccc
Confidence 9999987543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=189.02 Aligned_cols=207 Identities=15% Similarity=0.117 Sum_probs=160.3
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCC-----eEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~-----~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 742 (905)
.+...++++...+-+|.||.||.|.+++.. +.+-+|.++.. ..+-....+..|.-.+..+.|||+..+.+++.
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 344567888999999999999999765432 23445555432 34456677888888888889999999999876
Q ss_pred e-CCeEEEEEeccCCCCHHHHHhhC------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEE
Q 002580 743 T-KTHVCLITDYCPGGELFLLLDRQ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815 (905)
Q Consensus 743 ~-~~~~~lV~E~~~gg~L~~~l~~~------~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL 815 (905)
. ....++++.++.-|+|..++... ....++..+...++.|++.|+.|||++||||.||-..|.+|++.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 4 46788899999889999999832 2234667778889999999999999999999999999999999999999
Q ss_pred EeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHH
Q 002580 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKF 892 (905)
Q Consensus 816 ~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ell 892 (905)
+|-.+++.+=...-.. .....-....||+||.+.. +.++|+||||++||||+
T Consensus 438 tDsaLSRDLFP~DYhc-------------------------LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHC-------------------------LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred ccchhccccCcccccc-------------------------cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 9999987643221111 1111123458999999983 56999999999999999
Q ss_pred -hCCCCchhh
Q 002580 893 -MEFQPFPIL 901 (905)
Q Consensus 893 -tg~~PF~~~ 901 (905)
.|+.||..+
T Consensus 493 tlg~~PyaeI 502 (563)
T KOG1024|consen 493 TLGKLPYAEI 502 (563)
T ss_pred hcCCCCcccc
Confidence 588898653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=180.92 Aligned_cols=142 Identities=18% Similarity=0.155 Sum_probs=112.0
Q ss_pred cccccccCceEEEEEEEcCCCeEEEEEEeecccccCH-----------------------HHHHHHHHHHHHHHhCCCCC
Q 002580 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----------------------NKVHRACAEREILDMLDHPF 733 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~il~~l~h~n 733 (905)
.+.||+|++|.||+|.+. +|+.||||++........ .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999987531100 00223457899999999998
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCCHHHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCC
Q 002580 734 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 811 (905)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~ 811 (905)
+.....+.... .||||||++|+++... +.. ..++...+..++.|++.+|.+||+ +||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 75544433332 4899999988755433 332 347888999999999999999999 9999999999999999 89
Q ss_pred cEEEEeccCccccC
Q 002580 812 HVSLTDFDLSCLTS 825 (905)
Q Consensus 812 ~vkL~DFG~s~~~~ 825 (905)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-20 Score=228.50 Aligned_cols=171 Identities=15% Similarity=0.130 Sum_probs=115.4
Q ss_pred CCC-CCcceEEEEE-------EeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC
Q 002580 729 LDH-PFVPALYASF-------QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800 (905)
Q Consensus 729 l~h-~nIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDL 800 (905)
+.| +||..++++| .....++++|||+ +++|.+++... ...+++..+..|+.||+.||.|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 4666777766 2334678888988 77999999753 345999999999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccC--------CCCcccccccccccccccCCcccccccc
Q 002580 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG--------QQNPVFMAEPMRASNSFVGTEEYIAPVS 872 (905)
Q Consensus 801 Kp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~gT~~Y~APE~ 872 (905)
||+||||+..|.+|++|||++...................+... .................+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999998877888888777654322111000000000000000 0000000000011123578999999999
Q ss_pred ccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 873 DFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 873 l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
+.+ ..++|||||||+||||++|.+||...
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 874 56999999999999999999998743
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=174.23 Aligned_cols=195 Identities=20% Similarity=0.167 Sum_probs=137.1
Q ss_pred eecccccccCceEEEEEEEcCCCeEEEEEEeecccccC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEe
Q 002580 675 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 675 ~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~-~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.+...|++|+||+||.+.. .+..++.+.+....... .-....+.+|+++|++|. |++|++++++ +..|++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3556899999999997776 66777777665432211 112235789999999995 5889999886 45799999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC-CCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDL-Kp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||++..........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999998654321 1 1346789999999999999999999 7999999999999999999997543211100
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccCC-----CCchHHHHHHHHHHHHhCCCCc
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY-----TRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~-----~~sDiwSlGvil~elltg~~PF 898 (905)
..-.....+ .. ...-...++.|++|+.-... ...+.++.|+.+|.++|+..|+
T Consensus 150 -r~L~~rDl~------------~l-lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 150 -RLLAREDLR------------HL-LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred -HHHHHHHHH------------HH-HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 000000000 00 00112367888999776532 3557789999999999999886
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-20 Score=206.83 Aligned_cols=188 Identities=37% Similarity=0.531 Sum_probs=161.0
Q ss_pred cccccCceEEEEEEE---cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEEEEEecc
Q 002580 679 PLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYC 754 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~---~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV~E~~ 754 (905)
.+|+|.||.|+++.. ...+..||+|++++......... ....|..++..++ ||++++++..|+.+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998764 34578899999988755444443 5667888888886 999999999999999999999999
Q ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCc
Q 002580 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834 (905)
Q Consensus 755 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~ 834 (905)
.||.|+..+... ..+.+.....+...++.+++++|+.+|+|||+|++||+++.+|.+++.|||+++..-
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v--------- 148 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV--------- 148 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH---------
Confidence 999999888664 347888888889999999999999999999999999999999999999999986532
Q ss_pred chhhhccccCCCCcccccccccccccccCCcccccccccc-CCCCchHHHHHHHHHHHHhCCCCchh
Q 002580 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF-AYTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~-~~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
.....|||..|||||++. +....|.||||+++|+|++|..||..
T Consensus 149 ----------------------~~~~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 149 ----------------------KEKIACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----------------------hhhhcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 011129999999999999 57799999999999999999999965
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.2e-18 Score=173.97 Aligned_cols=137 Identities=23% Similarity=0.255 Sum_probs=107.4
Q ss_pred ecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---eE
Q 002580 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-----DHPFVPALYASFQTKT---HV 747 (905)
Q Consensus 676 i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~l~~~~~~~~---~~ 747 (905)
-.+.||+|+||.||. ++.++.. +||++.... ......+.+|+.+++.+ .||||+++|+++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 346899999999995 7667665 689886532 22346789999999999 5799999999999873 44
Q ss_pred E-EEEec--cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeCCCCCCCEEEcC----CCcEEEEe-c
Q 002580 748 C-LITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL-EYLHCQGIIYRDLKPENVLLQG----NGHVSLTD-F 818 (905)
Q Consensus 748 ~-lV~E~--~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL-~~LH~~gIvHrDLKp~NILl~~----~~~vkL~D-F 818 (905)
+ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+| |
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 78999 5579999999663 25655 35577888777 8999999999999999999974 34799999 5
Q ss_pred cCccc
Q 002580 819 DLSCL 823 (905)
Q Consensus 819 G~s~~ 823 (905)
|....
T Consensus 155 G~~~~ 159 (210)
T PRK10345 155 GESTF 159 (210)
T ss_pred CCcce
Confidence 55433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-19 Score=210.55 Aligned_cols=203 Identities=23% Similarity=0.322 Sum_probs=157.8
Q ss_pred eecccccccCceEEEEEEEcCCCeEEEEEEeec---ccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 675 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK---GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 675 ~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~---~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.....+|.|.+|.|+.+........++.|.+.. ...........+..|+-+-..+.|+|++..+..+.+....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456678999999888888876666666665442 11111222222556666677789999887776666555555559
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|||++ +|+.++... ..+....+..++.|++.|++|||+.||.||||||+|+++..+|.+||+|||.+......-.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e-- 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE-- 475 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc--
Confidence 99999 999999875 3488899999999999999999999999999999999999999999999999865432111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC----CCCchHHHHHHHHHHHHhCCCCchhhhc
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPILCR 903 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~~~r 903 (905)
........++|+..|+|||++.+ -...|+||.|++++.|++|++||....+
T Consensus 476 ---------------------~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~ 530 (601)
T KOG0590|consen 476 ---------------------KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKK 530 (601)
T ss_pred ---------------------hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccc
Confidence 11234567899999999999985 2388999999999999999999987654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-17 Score=172.46 Aligned_cols=146 Identities=20% Similarity=0.144 Sum_probs=114.2
Q ss_pred CeeecccccccCceEEEEEE-EcCCCeEEEEEEeecccccC-------------------HH--HHHHHHHHHHHHHhCC
Q 002580 673 HFRPIKPLGSGDTGSVHLVE-LCGSGQYFAMKAMDKGVMLN-------------------RN--KVHRACAEREILDMLD 730 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~-~~~t~~~vavK~~~~~~~~~-------------------~~--~~~~~~~E~~il~~l~ 730 (905)
.|.+.+.||+|++|.||+|. +..+|+.||+|++....... .. ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999999 66789999999987642110 00 1134568999999997
Q ss_pred CC--CcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeCCCCCCCEEE
Q 002580 731 HP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLL 807 (905)
Q Consensus 731 h~--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g-IvHrDLKp~NILl 807 (905)
+. .+++++.. ...++||||++|.+|....... ..+....+..++.||+.+|.+||++| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34555543 2358999999988887654322 33566677889999999999999999 9999999999999
Q ss_pred cCCCcEEEEeccCccccC
Q 002580 808 QGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 808 ~~~~~vkL~DFG~s~~~~ 825 (905)
+ ++.++|+|||.+....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987544
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-17 Score=198.87 Aligned_cols=195 Identities=21% Similarity=0.276 Sum_probs=154.7
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC---CCCcceEEEEEEeC
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTK 744 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~l~~~~~~~ 744 (905)
++....|.|-+.||+|+||+||+|.... |+.||+|+-++..... |.-=.+++.+|+ -+.|..++..+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4556789999999999999999999976 9999999877653222 111122333333 24556666666677
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEc-------CCCcEEEEe
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-------GNGHVSLTD 817 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~-------~~~~vkL~D 817 (905)
+..++|++|.+-|+|.+++. ..+.+++..++.+..|++.-+++||..+|||+||||+|+||. ..-.++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 78899999999999999997 456799999999999999999999999999999999999994 233699999
Q ss_pred ccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhC
Q 002580 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 818 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg 894 (905)
||.+..... ..........++|-.+-.+|+..| ....|.|.|+.+++.|++|
T Consensus 845 fG~siDm~l-------------------------fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 845 FGRSIDMKL-------------------------FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred cccceeeeE-------------------------cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 999865431 112234456789999999999995 5699999999999999999
Q ss_pred CC
Q 002580 895 FQ 896 (905)
Q Consensus 895 ~~ 896 (905)
++
T Consensus 900 ~y 901 (974)
T KOG1166|consen 900 KY 901 (974)
T ss_pred HH
Confidence 74
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-17 Score=174.75 Aligned_cols=208 Identities=19% Similarity=0.223 Sum_probs=145.5
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCe-----------------------------------EEEEEEeecccccC
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----------------------------------YFAMKAMDKGVMLN 712 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~-----------------------------------~vavK~~~~~~~~~ 712 (905)
.|.+++|.+...||+|....||.+.....|. +.|||.+-.-...+
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 4678899999999999999999987643221 24555543221111
Q ss_pred --HHHHHHHHHHHH-------H-------HH-------h-CCCCCcceEEEEEEe-------------------------
Q 002580 713 --RNKVHRACAERE-------I-------LD-------M-LDHPFVPALYASFQT------------------------- 743 (905)
Q Consensus 713 --~~~~~~~~~E~~-------i-------l~-------~-l~h~nIv~l~~~~~~------------------------- 743 (905)
....+...+|.- . .+ + -+|||||.+..+|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 011111112210 0 01 1 269999999887743
Q ss_pred --CCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEE--cCCC--cEEEEe
Q 002580 744 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNG--HVSLTD 817 (905)
Q Consensus 744 --~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl--~~~~--~vkL~D 817 (905)
...+|+||..+ ..+|..++..+. .+......|+.|+++|+.|||.+||.|||||.+|||+ ++|+ .+.|+|
T Consensus 313 g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 313 GEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred CCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 23489999988 579999997643 6777788899999999999999999999999999998 4444 578999
Q ss_pred ccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc---------CCCCchHHHHHHHH
Q 002580 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF---------AYTRMTRYNYLILV 888 (905)
Q Consensus 818 FG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~---------~~~~sDiwSlGvil 888 (905)
||+|--... ..... +.....-..-|+..-||||+.. .|.++|.|+.|.+.
T Consensus 389 FGCcLAd~~-hGlql--------------------py~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Gala 447 (598)
T KOG4158|consen 389 FGCCLADDN-HGLQL--------------------PYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALA 447 (598)
T ss_pred cceeeeccc-ccccc--------------------ccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhH
Confidence 998743211 01110 0111122345777889999987 36799999999999
Q ss_pred HHHHhCCCCchh
Q 002580 889 SKKFMEFQPFPI 900 (905)
Q Consensus 889 ~elltg~~PF~~ 900 (905)
||++....||+.
T Consensus 448 YEIfg~~NPFY~ 459 (598)
T KOG4158|consen 448 YEIFGRSNPFYK 459 (598)
T ss_pred HHHhccCCcccc
Confidence 999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.1e-17 Score=163.83 Aligned_cols=103 Identities=19% Similarity=0.171 Sum_probs=88.6
Q ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcch
Q 002580 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836 (905)
Q Consensus 757 g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~ 836 (905)
|+|.+++... ...+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899999764 345999999999999999999999998 999999999999999 999865321
Q ss_pred hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchh
Q 002580 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~ 900 (905)
....||+.|||||++.+ ..++|||||||++|+|++|..||..
T Consensus 62 ----------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 62 ----------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ----------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 11258899999999974 4589999999999999999999964
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.3e-16 Score=162.17 Aligned_cols=137 Identities=21% Similarity=0.233 Sum_probs=114.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCH-----HHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~-----~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
+.||+|++|.||+|.. .|..+++|.......... .....+.+|+.++..+.|++|+....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 677899998664332221 123457789999999999998877777777788999999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
|++|++|.+++... .. ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998653 12 7788999999999999999999999999999999 78999999999865
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.66 E-value=3e-16 Score=167.23 Aligned_cols=198 Identities=18% Similarity=0.193 Sum_probs=128.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC----------CCCcceEEEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----------HPFVPALYASFQ 742 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~----------h~nIv~l~~~~~ 742 (905)
.+.....||.|+++.||.+++..|++.+|+|++...........+.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4677889999999999999999999999999987655444455666666654443322 112222223221
Q ss_pred ---------eC---C-----eEEEEEeccCCCCHHHHHhh---CCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC
Q 002580 743 ---------TK---T-----HVCLITDYCPGGELFLLLDR---QPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800 (905)
Q Consensus 743 ---------~~---~-----~~~lV~E~~~gg~L~~~l~~---~~~~--~l~~~~~~~i~~qil~gL~~LH~~gIvHrDL 800 (905)
.. . +.+++|+-+ .++|..++.- .... .+.......+..|+++.+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 246788887 5788777542 1111 1223333456689999999999999999999
Q ss_pred CCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC-----
Q 002580 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----- 875 (905)
Q Consensus 801 Kp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~----- 875 (905)
||+|++++.+|.++|+||+.....+.. ......+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~------------------------------~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR------------------------------YRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE------------------------------EEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce------------------------------eeccCCCcccCChhhhhhhcccC
Confidence 999999999999999999876443210 000223467888887642
Q ss_pred ------CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 876 ------YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 876 ------~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
+.+.|.|+||+++|.|.+|..||...
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 33779999999999999999999754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.6e-16 Score=158.03 Aligned_cols=133 Identities=18% Similarity=0.197 Sum_probs=107.5
Q ss_pred cccccCceEEEEEEEcCCCeEEEEEEeecccccC-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEec
Q 002580 679 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 679 ~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
.||+|+||.||++.. ++..+++|......... .....++.+|+.++..+.|+++.....++...+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 479999999999985 67789999865432211 11235677899999999888765555555566678999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875421 1 6789999999999999999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-15 Score=138.22 Aligned_cols=104 Identities=26% Similarity=0.564 Sum_probs=96.6
Q ss_pred ccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEEEEEccCCCeEE
Q 002580 202 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 281 (905)
Q Consensus 202 ~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 281 (905)
|++++++|. +|+|+++|++|++++||++++++|+++..+.++.........+.+.+..+..+..++..++++|+.+|
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999 99999999999999999999999999998888877888899999999999999999999999999999
Q ss_pred EEEEeeeeecCCCCEEEEEEEEeccch
Q 002580 282 NLLTIAPIKDDEGKVLKFIGMQVEVSK 308 (905)
Q Consensus 282 ~~~s~~pi~d~~G~v~~~v~~~~DITe 308 (905)
++++++|+.+++|++.+++++++|||+
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=157.32 Aligned_cols=140 Identities=21% Similarity=0.152 Sum_probs=109.0
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCH-------------------HHHHHHHHHHHHHHhCCCC-
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-------------------NKVHRACAEREILDMLDHP- 732 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~il~~l~h~- 732 (905)
.|.+.+.||+|+||.||++... +|+.+|+|++........ ........|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3788899999999999999874 799999998765321000 0112356788888888777
Q ss_pred -CcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC
Q 002580 733 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (905)
Q Consensus 733 -nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~ 811 (905)
.++..++ ....+++|||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4555554 2456899999999998765321 23456888999999999999999999999999999999
Q ss_pred cEEEEeccCccccC
Q 002580 812 HVSLTDFDLSCLTS 825 (905)
Q Consensus 812 ~vkL~DFG~s~~~~ 825 (905)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.64 E-value=2e-15 Score=137.32 Aligned_cols=104 Identities=29% Similarity=0.492 Sum_probs=96.0
Q ss_pred cccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEEecCCcEEE
Q 002580 485 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564 (905)
Q Consensus 485 ~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~~kdG~~~w 564 (905)
|++++++|. +|+|++||++|++++||++++++|+++..+.+++......+.+.+.+..+..+..+..+.+++|+.+|
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999 56699999999999999999999999998988888888889999999999999999999999999999
Q ss_pred EEEEEeeeecCCCCEEEEEEEeecCcc
Q 002580 565 NLFHLQPMRDQKGEVQYFIGVQLDGSE 591 (905)
Q Consensus 565 v~~~~~pi~d~~G~i~~~i~i~~DITe 591 (905)
+.+++.|+.+++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-15 Score=178.39 Aligned_cols=140 Identities=21% Similarity=0.227 Sum_probs=112.5
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeeccccc-----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCe
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
..|...+.||+|+||.||++.+... .+++|........ .......+.+|+.++..++|++++..+.++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3456788999999999999987443 3444443222111 11234568899999999999999988877777778
Q ss_pred EEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 747 ~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
.++||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999998875 245688999999999999999999999999999 5789999999999764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-16 Score=160.69 Aligned_cols=198 Identities=16% Similarity=0.250 Sum_probs=160.3
Q ss_pred cccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeE
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.++.....++.+|...-.|..|++++. |..++.|+++..... ...-..|..|.-.|+-+.||||+.+++.|....++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 355667778888999999999999994 455777887755332 22335677888889889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCCEEEcCCCcEEEE--eccCccc
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLT--DFDLSCL 823 (905)
Q Consensus 748 ~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g--IvHrDLKp~NILl~~~~~vkL~--DFG~s~~ 823 (905)
.++..||+-|+|+.++........+..++..++.+++.|+.|||+.. |.---|....++||++.+.+|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf- 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF- 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence 99999999999999999887777888999999999999999999985 4445788999999998877653 333321
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC------CCCchHHHHHHHHHHHHhCCCC
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~------~~~sDiwSlGvil~elltg~~P 897 (905)
+.......|.||+||.+.. -..+|+|||+++||||.|...|
T Consensus 342 ---------------------------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 342 ---------------------------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred ---------------------------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccc
Confidence 1223356789999999984 2489999999999999999999
Q ss_pred chhhh
Q 002580 898 FPILC 902 (905)
Q Consensus 898 F~~~~ 902 (905)
|....
T Consensus 389 fadls 393 (448)
T KOG0195|consen 389 FADLS 393 (448)
T ss_pred cccCC
Confidence 97653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.2e-16 Score=183.42 Aligned_cols=175 Identities=33% Similarity=0.459 Sum_probs=123.3
Q ss_pred CCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
.+|..++.|..|+||.||.++++.+.+.+|+|+-+.+ + +.+- ++.....|+++
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l--------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L--------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc-h--------hhhc--cccccCCccee----------------
Confidence 5789999999999999999999999999999653322 1 1100 33333444443
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
|+....++..+. ++- +++.+++|||+.||+|||+||+|.+|..-|.+|+.|||++++........
T Consensus 136 -----gDc~tllk~~g~--lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP--LPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccCCC--Ccc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 455555554322 332 22778999999999999999999999999999999999997754222111
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCcccccccccc--CC-CCchHHHHHHHHHHHHhCCCCchh
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--AY-TRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--~~-~~sDiwSlGvil~elltg~~PF~~ 900 (905)
....-..+ +. ........||||.|+|||++. || ...|.|++|+|+|+++-|..||-.
T Consensus 201 l~eg~I~k-----------~t-~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG 260 (1205)
T KOG0606|consen 201 LKEGHIEK-----------DT-HEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 260 (1205)
T ss_pred hhhcchHH-----------HH-HHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence 11100000 00 112344679999999999998 44 488999999999999999999843
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.9e-15 Score=149.16 Aligned_cols=139 Identities=20% Similarity=0.219 Sum_probs=100.2
Q ss_pred cccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHH---------------------HHHHHHHHHHhCCCC--C
Q 002580 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---------------------RACAEREILDMLDHP--F 733 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~il~~l~h~--n 733 (905)
.+.||+|+||.||+|.+. +++.||+|++............ ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999986 7899999998764221111111 113566666666443 3
Q ss_pred cceEEEEEEeCCeEEEEEeccCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCCEEEcCCC
Q 002580 734 VPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG 811 (905)
Q Consensus 734 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~gIvHrDLKp~NILl~~~~ 811 (905)
+++++++ ...++||||++++++.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 5555553 24689999998854321 121110 1 15678899999999999999 9999999999999999 89
Q ss_pred cEEEEeccCccccC
Q 002580 812 HVSLTDFDLSCLTS 825 (905)
Q Consensus 812 ~vkL~DFG~s~~~~ 825 (905)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.9e-16 Score=180.59 Aligned_cols=203 Identities=21% Similarity=0.232 Sum_probs=150.9
Q ss_pred CeeecccccccCceEEEEEEEcCCCeEEEEEEeeccc-ccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEE
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 673 ~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~-~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+|...+.||.+.|=+|.+|++. .|. +++|++-+.. ...-....+...|++ ...+++||++.+.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888899999999999999984 344 8999987653 122233344445555 56679999999988877788889999
Q ss_pred eccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCC
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~ 831 (905)
+|. -.+|++.+..++. +...+.+.|+.||+.||..||..||+|||||.+||||++-+=+.|+||..-+...
T Consensus 101 qyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY------ 171 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY------ 171 (1431)
T ss_pred HHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc------
Confidence 998 5699999876543 7778888899999999999999999999999999999998889999998653322
Q ss_pred CCcchhhhccccCCCCcccccccccccccccCCccccccccccC--------------CCCchHHHHHHHHHHHHh-CCC
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------------YTRMTRYNYLILVSKKFM-EFQ 896 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------------~~~sDiwSlGvil~ellt-g~~ 896 (905)
.|.++.... .|+.+. ...-.-|+|||-+.. .++.||||+||++.||++ |++
T Consensus 172 LPeDNPadf--------~fFFDT------SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 172 LPEDNPADF--------TFFFDT------SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred CCCCCcccc--------eEEEec------CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 111111100 111111 111235999998862 248899999999999996 588
Q ss_pred Cchhh
Q 002580 897 PFPIL 901 (905)
Q Consensus 897 PF~~~ 901 (905)
||...
T Consensus 238 lF~LS 242 (1431)
T KOG1240|consen 238 LFTLS 242 (1431)
T ss_pred cccHH
Confidence 89753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.7e-14 Score=150.24 Aligned_cols=137 Identities=23% Similarity=0.344 Sum_probs=104.1
Q ss_pred ccc-ccCceEEEEEEEcCCCeEEEEEEeecccc----------cCHHHHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC-
Q 002580 679 PLG-SGDTGSVHLVELCGSGQYFAMKAMDKGVM----------LNRNKVHRACAEREILDMLDHPFV--PALYASFQTK- 744 (905)
Q Consensus 679 ~Lg-~G~~g~V~~~~~~~t~~~vavK~~~~~~~----------~~~~~~~~~~~E~~il~~l~h~nI--v~l~~~~~~~- 744 (905)
.|| .|+.|+||.+.. .+..++||.+..... ........+.+|+.++..+.|++| +..+++....
T Consensus 38 ~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 455 677778888776 377899998864321 111234567889999999988775 6777764432
Q ss_pred C---eEEEEEeccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccC
Q 002580 745 T---HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820 (905)
Q Consensus 745 ~---~~~lV~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~ 820 (905)
. ..++|||+++| .+|.+++... .+++.. +.+|+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 23599999997 6898888652 355443 56899999999999999999999999999989999999999
Q ss_pred cccc
Q 002580 821 SCLT 824 (905)
Q Consensus 821 s~~~ 824 (905)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8664
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.7e-14 Score=127.91 Aligned_cols=110 Identities=24% Similarity=0.365 Sum_probs=99.9
Q ss_pred HHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEEEEEccCC
Q 002580 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDG 277 (905)
Q Consensus 198 le~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 277 (905)
|++++++++++|. +|+|+++|+++++++|++.++++|+++..+.++.........+.+++..+.....+..... +|
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999 9999999999999999999999999999888887777888889999998888777666655 99
Q ss_pred CeEEEEEEeeeeecCCCCEEEEEEEEeccchhhH
Q 002580 278 TPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311 (905)
Q Consensus 278 ~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~ 311 (905)
...|+.+++.|++|.+|++.|++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999885
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.6e-14 Score=129.17 Aligned_cols=110 Identities=26% Similarity=0.364 Sum_probs=99.4
Q ss_pred HHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEEecCC
Q 002580 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 560 (905)
Q Consensus 481 ~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~~kdG 560 (905)
|++++++++++|. +|+|+++|+++++++|++.++++|+++..++++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999 6669999999999999999999999988888888888888888889888888777766655 99
Q ss_pred cEEEEEEEEeeeecCCCCEEEEEEEeecCccccc
Q 002580 561 KKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594 (905)
Q Consensus 561 ~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~ 594 (905)
..+|+.+++.|++|.+|++.|++++++|||++||
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=134.15 Aligned_cols=132 Identities=23% Similarity=0.245 Sum_probs=110.7
Q ss_pred ecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCeEEEEEec
Q 002580 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 676 i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
+++.||.|.++.||++.... ..+++|....... ...+..|+.++..+.| .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45679999999999999843 6799998865421 4567889999999976 5899999988888899999999
Q ss_pred cCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 754 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~---gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
++|..+..+ +......++.+++.+|.+||.. +++|+||+|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988777543 4455667789999999999985 699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=126.36 Aligned_cols=112 Identities=21% Similarity=0.385 Sum_probs=96.2
Q ss_pred HHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEE-EE
Q 002580 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG-RL 270 (905)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~-e~ 270 (905)
+.+++++++++++++++|. +|+|+++|++|++++||+.++++|+++..+.++++.......+.+.+..+..... ..
T Consensus 1 e~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEV 77 (113)
T ss_dssp HHHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEE
T ss_pred CHHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEE
Confidence 4688999999999999998 9999999999999999999999999998777766655677888888888776554 33
Q ss_pred EEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEecc
Q 002580 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306 (905)
Q Consensus 271 ~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DI 306 (905)
....++|..+|+.++.+|+++.+|++.+++++++||
T Consensus 78 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 78 RFRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 333469999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=127.03 Aligned_cols=111 Identities=23% Similarity=0.357 Sum_probs=95.0
Q ss_pred cHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEE-EEE
Q 002580 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTV-QLI 554 (905)
Q Consensus 476 ~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~-e~~ 554 (905)
+|+.++++++++++++|. +|+|+|+|++++++|||+.++++|++...++++++.......+...+..+..... +..
T Consensus 2 ~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T PF00989_consen 2 RYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVR 78 (113)
T ss_dssp HHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEE
T ss_pred HHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEE
Confidence 489999999999999998 5669999999999999999999999998888887766677778888877776444 444
Q ss_pred EEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecC
Q 002580 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 589 (905)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DI 589 (905)
...++|+.+|+.+..+|+++.+|.+.+++++++||
T Consensus 79 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 79 FRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 44569999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=5.3e-13 Score=159.00 Aligned_cols=148 Identities=39% Similarity=0.698 Sum_probs=123.8
Q ss_pred ccHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEE
Q 002580 475 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 554 (905)
Q Consensus 475 ~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~ 554 (905)
..|+.++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..+..+++
T Consensus 30 ~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (540)
T PRK13557 30 DIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEIL 109 (540)
T ss_pred HHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEEE
Confidence 34899999999999999976667889999999999999999999999988888888888888888888888888888999
Q ss_pred EEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccCCchhhhHHHHHHHHHHhhhhhhh
Q 002580 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 622 (905)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~~~~~~~~e~~~l~~~~~~~~~~~ 622 (905)
..++||+.+|+.++..|+++.+|.+++++++.+|||++++.+++.........+..++..+++.+...
T Consensus 110 ~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~~~~~~l~~~~~~i~h~l~~p 177 (540)
T PRK13557 110 NYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQAQKMEALGQLTGGIAHDFNNL 177 (540)
T ss_pred EEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHHHHHHHhhhhhhhhhHHhhhH
Confidence 89999999999999999999999999999999999999987655443333333444444444444433
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-12 Score=145.80 Aligned_cols=120 Identities=45% Similarity=0.839 Sum_probs=108.7
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~ 556 (905)
|+.++++++++|+++|..+.+|.|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..+....
T Consensus 45 ~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 124 (361)
T PRK13559 45 FEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVELLNY 124 (361)
T ss_pred HHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEEEEE
Confidence 78899999999999998665677999999999999999999999998777777777777777788888888888899999
Q ss_pred ecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCccccccc
Q 002580 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596 (905)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e 596 (905)
++||..+|+.++..|+++.+|.+.+++++++|||++|+.+
T Consensus 125 ~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e 164 (361)
T PRK13559 125 RKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVR 164 (361)
T ss_pred cCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhH
Confidence 9999999999999999999999999999999999999854
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.8e-14 Score=170.66 Aligned_cols=208 Identities=21% Similarity=0.279 Sum_probs=165.0
Q ss_pred CCCeeecccccccCceEEEEEEEcCC-CeEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCeEE
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 748 (905)
Q Consensus 671 ~~~y~i~~~Lg~G~~g~V~~~~~~~t-~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~ 748 (905)
...|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... ...........|..+-+.+. |.|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 34688888999999999998887433 4556667665442 23334455556777777775 999999999999999999
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCCCCEEEcCCC-cEEEEeccCccccCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 826 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH-~~gIvHrDLKp~NILl~~~~-~vkL~DFG~s~~~~~ 826 (905)
++++|..|++++..+........+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .+++.|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999998883222224677788889999999999999 99999999999999999999 999999999976542
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccC-CccccccccccC----CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG-TEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-T~~Y~APE~l~~----~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
.. .........+| ++.|+|||...+ ....|+||+|+++.-+++|..|+...
T Consensus 178 ~~------------------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 KN------------------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cC------------------------CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 10 11122334577 999999999997 67999999999999999999999766
Q ss_pred hc
Q 002580 902 CR 903 (905)
Q Consensus 902 ~r 903 (905)
.+
T Consensus 234 ~~ 235 (601)
T KOG0590|consen 234 SR 235 (601)
T ss_pred cc
Confidence 54
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.4e-12 Score=162.73 Aligned_cols=158 Identities=13% Similarity=0.124 Sum_probs=129.0
Q ss_pred CCchhhHHHHHhhhhc-ccHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHH
Q 002580 459 PDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 537 (905)
Q Consensus 459 ~di~e~k~~e~~~~~~-~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~ 537 (905)
.++.++++.+++++.+ ..++.++++++++|+++|. +|+|+++|+++++++||+.++++|++...+++++.......
T Consensus 138 ~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~ 214 (779)
T PRK11091 138 NEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIE 214 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHH
Confidence 4677777777766655 5689999999999999999 56699999999999999999999999888888776666666
Q ss_pred HHHHHHHcCCcEEEEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccCCchhhhHHHHHHHHHHhh
Q 002580 538 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAE 617 (905)
Q Consensus 538 ~~~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~~~~~~~~e~~~l~~~~~~ 617 (905)
.....+..+..+..+....++||+.+|+.++..|+++.+|.+.|++++++|||++|++++++. ...++....+..++|
T Consensus 215 ~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~--~a~~~~~~~~a~isH 292 (779)
T PRK11091 215 TDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALE--KASRDKTTFISTISH 292 (779)
T ss_pred HHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHH--HHHHHHHHHHHHhhH
Confidence 677777888889999999999999999999999999999999999999999999999654432 222333444455555
Q ss_pred hhhh
Q 002580 618 NVNE 621 (905)
Q Consensus 618 ~~~~ 621 (905)
.+..
T Consensus 293 elrt 296 (779)
T PRK11091 293 ELRT 296 (779)
T ss_pred hhcC
Confidence 5443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.2e-14 Score=155.58 Aligned_cols=125 Identities=20% Similarity=0.318 Sum_probs=103.7
Q ss_pred CeEEEEEeccCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 745 THVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
.++||.|++|...+|.+++.+. .....+......++.|++.|++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4689999999999999999743 33456777888999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHh
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM 893 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~ellt 893 (905)
....+.. .......+..+||..||+||.+.+ ..++||||||++|+||++
T Consensus 406 ~~~~~~~---------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETV---------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcc---------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 4432211 112334456789999999999995 459999999999999998
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.8e-12 Score=151.63 Aligned_cols=130 Identities=38% Similarity=0.762 Sum_probs=118.6
Q ss_pred chHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEE
Q 002580 189 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 268 (905)
Q Consensus 189 ~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 268 (905)
..+..|..++++++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..+..
T Consensus 27 ~~~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (540)
T PRK13557 27 HRSDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIAT 106 (540)
T ss_pred hhhHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceE
Confidence 44678999999999999999976668999999999999999999999999998888777777788889999999988888
Q ss_pred EEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhc
Q 002580 269 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 318 (905)
Q Consensus 269 e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~ 318 (905)
++..++++|+.+|+.+++.|+++.+|.+.+++++.+|||++++++++++.
T Consensus 107 ~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~ 156 (540)
T PRK13557 107 EILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQ 156 (540)
T ss_pred EEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHH
Confidence 88889999999999999999999999999999999999999999877653
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.8e-12 Score=143.10 Aligned_cols=127 Identities=40% Similarity=0.763 Sum_probs=112.6
Q ss_pred hHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEE
Q 002580 190 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGR 269 (905)
Q Consensus 190 ~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 269 (905)
+...++.+++.++++++++|..+.+|+|+++|++|++++||+.+|++|+++..+.++.........++..+..+..+..+
T Consensus 41 ~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e 120 (361)
T PRK13559 41 SGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVE 120 (361)
T ss_pred hhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEE
Confidence 35567889999999999999755578999999999999999999999999887776666666777788888888888889
Q ss_pred EEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHh
Q 002580 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 316 (905)
Q Consensus 270 ~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l 316 (905)
...+++||..+|+.+++.|+++.+|.+.+++++++|||++|++|+..
T Consensus 121 ~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~ 167 (361)
T PRK13559 121 LLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALE 167 (361)
T ss_pred EEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHH
Confidence 99999999999999999999999999999999999999999887554
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.3e-12 Score=162.81 Aligned_cols=143 Identities=13% Similarity=0.118 Sum_probs=127.6
Q ss_pred EeeeecCCcccccccchHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHH
Q 002580 174 SGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDV 253 (905)
Q Consensus 174 ~~~i~~~~~~~~~l~~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~ 253 (905)
..++.+++..+.++...++.++.++++++++++++|. +|+|+++|++|++++||+.++++|+++..+++++......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 3456667777888899999999999999999999999 9999999999999999999999999988777776666666
Q ss_pred HHHHHHHHcCCcEEEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcC
Q 002580 254 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 319 (905)
Q Consensus 254 ~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~ 319 (905)
......+..+..+..+....++||..+|+.++..|+++.+|.+.|++++++|||++|++|++++..
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~a 279 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEKA 279 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHHH
Confidence 667777888888888888899999999999999999999999999999999999999999887653
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.8e-12 Score=161.98 Aligned_cols=190 Identities=12% Similarity=0.116 Sum_probs=146.7
Q ss_pred cccccCCCCCccceeeccCCCCCCCCCCccccCCCC-cceeEEeeeecCCcccccccchHHHHHHHHHhhccceEEEeCC
Q 002580 133 VLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSN-NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDAT 211 (905)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~l~~~~~~l~~ile~~~~~i~i~D~~ 211 (905)
.++....+| .+|+.....-..+. .+.. .+.++..||++++..++++.+.++.++.++++++++++++|.
T Consensus 485 e~r~~~~dG-~~w~~~~~~~~~d~--------~G~~~~~ig~~~DITerk~~e~~L~~~~~~l~~~l~~~~~~i~~~D~- 554 (1092)
T PRK09776 485 EFRIVVKDG-VRHIRALANRVLNK--------DGEVERLLGINMDMTEVRQLNEALFQEKERLHITLDSIGEAVVCTDM- 554 (1092)
T ss_pred EEEEEcCCc-eEEEEEeeEEEECC--------CCCEEEEEeeeeehhHHHHHHHHHHHHHHHHHHHHhccccEEEEECC-
Confidence 344555677 77775443321211 1222 467888999999999999999999999999999999999999
Q ss_pred CCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCC--CCChHHHHHHHHHHHcCCc--EEEEEEEEccCCCeEEEEEEee
Q 002580 212 KPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA--GTDPEDVAKIRETLQNGQS--YCGRLLNYKKDGTPFWNLLTIA 287 (905)
Q Consensus 212 ~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~--~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~~~w~~~s~~ 287 (905)
+|+|+++|+++++++||+.+|++|+++..+.+. .........+......+.. ...+...+++||..+|++.+..
T Consensus 555 --~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~~~~ 632 (1092)
T PRK09776 555 --AMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVHYSIT 632 (1092)
T ss_pred --CCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEEEEee
Confidence 999999999999999999999999997644332 2222333335555554443 4566777899999999999999
Q ss_pred eeecCCCCEEEEEEEEeccchhhHHHHHhhc-----CCCCChhHHHHHHHHH
Q 002580 288 PIKDDEGKVLKFIGMQVEVSKHTEGAKDKML-----RPNGLPESLIRYDARQ 334 (905)
Q Consensus 288 pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~-----~~~~l~~~l~~~~~~~ 334 (905)
|+++.+|++.+++++.+|||++|+.|++|+. ..++|++|....+...
T Consensus 633 pi~~~~g~~~g~v~~~~DITe~k~~e~~L~~~a~~D~lTgl~nr~~f~~~l~ 684 (1092)
T PRK09776 633 PLSTLDGENIGSVLVIQDVTESRKMLRQLSYSASHDALTHLANRASFEKQLR 684 (1092)
T ss_pred eeecCCCCEEEEEEEEEecchHHHHHHHHHhhcCCCcccCCccHHHHHHHHH
Confidence 9999999999999999999999999998864 4678888765555443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-12 Score=148.63 Aligned_cols=152 Identities=22% Similarity=0.282 Sum_probs=124.6
Q ss_pred HHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eeCCCCCCC
Q 002580 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-IYRDLKPEN 804 (905)
Q Consensus 726 l~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gI-vHrDLKp~N 804 (905)
|+.+.|.|+.++++.+.++...++|.+||.-|+|.+.+... ...++..-...++++|+.||.|||...| .|+.|++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 35678999999999999999999999999999999999874 3447777888899999999999999866 999999999
Q ss_pred EEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC---------
Q 002580 805 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------- 875 (905)
Q Consensus 805 ILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--------- 875 (905)
.+++....+||+|||+.......... .......-..-|.|||.+.+
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~-------------------------~~~~~~~~~~lw~aPellr~~~~~~~~~~ 134 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEP-------------------------EAHHPIRKALLWTAPELLRGALSQSLESA 134 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccc-------------------------cccchhHHHHhccCHHHhccccccccccc
Confidence 99999999999999998664320000 00011123457999999984
Q ss_pred -CCCchHHHHHHHHHHHHhCCCCchhhhc
Q 002580 876 -YTRMTRYNYLILVSKKFMEFQPFPILCR 903 (905)
Q Consensus 876 -~~~sDiwSlGvil~elltg~~PF~~~~r 903 (905)
..+.|+||||++++|+++...||.....
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~ 163 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNL 163 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccc
Confidence 3479999999999999999999987544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-12 Score=147.94 Aligned_cols=188 Identities=21% Similarity=0.245 Sum_probs=115.5
Q ss_pred CCCchhhhcccccccCCCCCCCCCCchhhHHhhcCccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeeccc
Q 002580 630 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709 (905)
Q Consensus 630 n~~p~~~~~~~s~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~ 709 (905)
.+-|+++...-++.....|+.+.......+...+..+..-....|. .+.||.|++|+||+|+. .+|+.||||+.++..
T Consensus 76 dllp~~~~~~L~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i 153 (437)
T TIGR01982 76 DLLPADIAEELSLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGI 153 (437)
T ss_pred ccCCHHHHHHHHHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEe-cCCCEEEEEeeCCCc
Confidence 3445666555555444444333222222333333222211122333 36799999999999997 478999999987652
Q ss_pred ccCHH---------------------------H----HH------HHHHHHHHHHhC----C-CCC--cceEEEEEEeCC
Q 002580 710 MLNRN---------------------------K----VH------RACAEREILDML----D-HPF--VPALYASFQTKT 745 (905)
Q Consensus 710 ~~~~~---------------------------~----~~------~~~~E~~il~~l----~-h~n--Iv~l~~~~~~~~ 745 (905)
...-. . .. .+.+|...+.++ . +++ |+++|.. ...
T Consensus 154 ~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~~~ 231 (437)
T TIGR01982 154 EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWD--RTS 231 (437)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehh--hcC
Confidence 11000 0 00 233455555544 2 333 3344432 234
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV-ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~-gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
..+|||||++|++|.++...... ... ...++.+++. .+..+|..|++|+|+||.||+++.+|.++|+|||++...
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 57999999999999887653211 122 2345555555 478899999999999999999999999999999999765
Q ss_pred C
Q 002580 825 S 825 (905)
Q Consensus 825 ~ 825 (905)
.
T Consensus 308 ~ 308 (437)
T TIGR01982 308 S 308 (437)
T ss_pred C
Confidence 4
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=4e-13 Score=156.10 Aligned_cols=187 Identities=17% Similarity=0.212 Sum_probs=111.8
Q ss_pred CCchhhhcccccccCCCCCCCCCCchhhHHhhcCccccccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccc
Q 002580 631 LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 710 (905)
Q Consensus 631 ~~p~~~~~~~s~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~ 710 (905)
+-|+++...-++.....|+.+.......+...+..+..-....|.. +.||+|++|+||.|+...+|+.||||++.+...
T Consensus 79 llP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~ 157 (537)
T PRK04750 79 LFPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDIL 157 (537)
T ss_pred cCCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchH
Confidence 3455655544444443333222222223333333322222456776 789999999999999988899999999986521
Q ss_pred c--------------------------C-H----HHHHH------HHHHHHHHHhC----CCCCcceEEEEEE-eCCeEE
Q 002580 711 L--------------------------N-R----NKVHR------ACAEREILDML----DHPFVPALYASFQ-TKTHVC 748 (905)
Q Consensus 711 ~--------------------------~-~----~~~~~------~~~E~~il~~l----~h~nIv~l~~~~~-~~~~~~ 748 (905)
. + . +.... +.+|...+.++ .+.+.+.+-.+|. .....+
T Consensus 158 ~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~V 237 (537)
T PRK04750 158 PVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETV 237 (537)
T ss_pred HHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCce
Confidence 0 0 0 11111 23444444443 2333333333332 234678
Q ss_pred EEEeccCCCCHHHHH--hhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC----cEEEEeccC
Q 002580 749 LITDYCPGGELFLLL--DRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDL 820 (905)
Q Consensus 749 lV~E~~~gg~L~~~l--~~~~~--~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~----~vkL~DFG~ 820 (905)
|||||++|+.+.++. ...+. ..+.+..+..++.| ++..|++|+|+||.||+++.+| .++++|||+
T Consensus 238 LvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGi 310 (537)
T PRK04750 238 MVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGI 310 (537)
T ss_pred EEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecce
Confidence 999999999997753 22210 01333333334444 4468999999999999999888 999999999
Q ss_pred ccccC
Q 002580 821 SCLTS 825 (905)
Q Consensus 821 s~~~~ 825 (905)
+..++
T Consensus 311 vg~l~ 315 (537)
T PRK04750 311 VGSLN 315 (537)
T ss_pred EEECC
Confidence 87654
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.3e-11 Score=148.11 Aligned_cols=154 Identities=14% Similarity=0.174 Sum_probs=121.5
Q ss_pred ecCCcccccccchHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcc-cCCCCCChHHHHHH
Q 002580 178 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKI 256 (905)
Q Consensus 178 ~~~~~~~~~l~~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~-l~~~~~~~~~~~~i 256 (905)
.|.......+......++.+++.++++|+++|. +|+|+++|++|++++||+.+|++|+++.. +.++.........+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~ 173 (663)
T PRK10060 97 HDTPSVARDLSHGLSFAEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNI 173 (663)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHH
Confidence 333334444555566788899999999999999 99999999999999999999999999764 44555455566778
Q ss_pred HHHHHcCCcEEEEEEEEccCCCeEEEEEEeeeeecCCCC-EEEEEEEEeccchhhHHHHHhhc-----CCCCChhHHHHH
Q 002580 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK-VLKFIGMQVEVSKHTEGAKDKML-----RPNGLPESLIRY 330 (905)
Q Consensus 257 ~~~l~~g~~~~~e~~~~~kdG~~~w~~~s~~pi~d~~G~-v~~~v~~~~DITe~k~~E~~l~~-----~~~~l~~~l~~~ 330 (905)
+..+..+..|.++++.++++|..+|...... +.+..|. ..+++++.+|||++++++++++. .+++|+||....
T Consensus 174 ~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~-~~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~LTGL~NR~~f~ 252 (663)
T PRK10060 174 RGFFRSGNAYEVERWIKTRKGQRLFLFRNKF-VHSGSGKNEIFLICSGTDITEERRAQERLRILANTDSITGLPNRNAIQ 252 (663)
T ss_pred HHHHhcCCceEEEEEEEeCCCCEEEEEeeeE-EEcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCccCCCcCHHHHH
Confidence 8888889999999999999999999876544 4444554 46788999999999999988765 578888887666
Q ss_pred HHHHH
Q 002580 331 DARQK 335 (905)
Q Consensus 331 ~~~~~ 335 (905)
+....
T Consensus 253 ~~l~~ 257 (663)
T PRK10060 253 ELIDH 257 (663)
T ss_pred HHHHH
Confidence 65544
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.6e-11 Score=146.36 Aligned_cols=128 Identities=39% Similarity=0.742 Sum_probs=115.1
Q ss_pred HHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEEE
Q 002580 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLL 271 (905)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 271 (905)
..++.+++.++.++++.|..+++|+|+|+|++|++++||+.++++|+++..+.++.........++..+..+..+..++.
T Consensus 148 r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 227 (665)
T PRK13558 148 RLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELR 227 (665)
T ss_pred HHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEE
Confidence 34577999999999999865568999999999999999999999999988777777666777778888888888999999
Q ss_pred EEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcC
Q 002580 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 319 (905)
Q Consensus 272 ~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~ 319 (905)
.+++||..+|+.++..|+++.+|.+.+++++.+|||++|++|++++..
T Consensus 228 ~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~~ 275 (665)
T PRK13558 228 NYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQRE 275 (665)
T ss_pred EECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999988753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.5e-11 Score=119.03 Aligned_cols=139 Identities=15% Similarity=0.118 Sum_probs=101.9
Q ss_pred cccccccCceEEEEEEEcC------CCeEEEEEEeecccc--c-----------------CHHHHHHH----HHHHHHHH
Q 002580 677 IKPLGSGDTGSVHLVELCG------SGQYFAMKAMDKGVM--L-----------------NRNKVHRA----CAEREILD 727 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~------t~~~vavK~~~~~~~--~-----------------~~~~~~~~----~~E~~il~ 727 (905)
...||.|.-+.||.|.... .+..+|+|+++.... . ..+....+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357899999864320 0 01112233 38999999
Q ss_pred hCC--CCCcceEEEEEEeCCeEEEEEeccCCCCHHH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeCCCCCC
Q 002580 728 MLD--HPFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPE 803 (905)
Q Consensus 728 ~l~--h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~l~~~~~~~l~~~~~~~i~~qil~gL~~L-H~~gIvHrDLKp~ 803 (905)
++. .-+++.++++ ...+|||||+.+..+.. .++. ..++......++.+++.+|..| |..||||+||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 985 3577888865 45789999996644422 2222 2355566777889999999998 8999999999999
Q ss_pred CEEEcCCCcEEEEeccCccc
Q 002580 804 NVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 804 NILl~~~~~vkL~DFG~s~~ 823 (905)
|||++ ++.++|+|||.+..
T Consensus 155 NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HEEEE-CCcEEEEECCCcee
Confidence 99997 57899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.9e-11 Score=143.45 Aligned_cols=123 Identities=40% Similarity=0.741 Sum_probs=109.8
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~ 556 (905)
++.++++++++++++|..+.+|.|+|+|+++++++||++++++|+++..+.+++........+...+..+..+..+++.+
T Consensus 150 ~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 229 (665)
T PRK13558 150 KERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELRNY 229 (665)
T ss_pred HHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 46789999999999986545677999999999999999999999998888877777777777788888888899999999
Q ss_pred ecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccC
Q 002580 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNS 599 (905)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~ 599 (905)
++||..+|+.++..|+++.+|.+.+++++++|||++|++++++
T Consensus 230 ~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L 272 (665)
T PRK13558 230 RKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELAL 272 (665)
T ss_pred CCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHH
Confidence 9999999999999999999999999999999999999975543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.2e-11 Score=118.17 Aligned_cols=128 Identities=24% Similarity=0.306 Sum_probs=95.9
Q ss_pred cccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCeEEEEEeccC
Q 002580 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lV~E~~~ 755 (905)
++.|+.|.++.||++.. .+..|++|+...... ....+..|+.+++.+.+.+ +++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 35688999999999987 477899998765421 1224567888888885444 456665543 34579999999
Q ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeCCCCCCCEEEcCCCcEEEEeccCccc
Q 002580 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-----IYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 756 gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gI-----vHrDLKp~NILl~~~~~vkL~DFG~s~~ 823 (905)
|.++... . . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887543 0 1 112356789999999999985 9999999999999 67899999999854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-10 Score=134.99 Aligned_cols=125 Identities=18% Similarity=0.142 Sum_probs=93.2
Q ss_pred HHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCC-hhhhcCCCCcccCCCCCChHHHHHHHHHHH-cCCcEEEE
Q 002580 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYT-SKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-NGQSYCGR 269 (905)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys-~eEliG~~~~~l~~~~~~~~~~~~i~~~l~-~g~~~~~e 269 (905)
+.++.++++++++|+++|. +|+|+++|++|++++||+ .++++|+++..+.++... ....+...+. .|.....+
T Consensus 252 ~~~~~l~e~~~d~I~v~D~---~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~--~~~~~~~~~~~~g~~~~~~ 326 (442)
T TIGR02040 252 ENLARLYHEAPDAIVFSDA---DGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV--DLRVLLSNVRRTGQVRLYA 326 (442)
T ss_pred HHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc--cHHHHHHHHhhcCceEEEE
Confidence 3689999999999999999 999999999999999997 578999997644432221 1233333343 34444456
Q ss_pred EEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChh
Q 002580 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPE 325 (905)
Q Consensus 270 ~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~ 325 (905)
....++||+.+|++++..|+.+.++ ..++++++|||++++.+. ....+.|+.
T Consensus 327 ~~~~~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~~~~~--~~~~~~l~~ 378 (442)
T TIGR02040 327 TTLTGEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRLTMRD--VPATGVLPR 378 (442)
T ss_pred EEEEcCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhccCCC--CCCcccchh
Confidence 6678999999999999999986554 358889999999988853 333344443
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-10 Score=132.15 Aligned_cols=168 Identities=14% Similarity=0.139 Sum_probs=129.4
Q ss_pred EEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCC
Q 002580 690 LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 769 (905)
Q Consensus 690 ~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~ 769 (905)
.+..+.++.++.+..++... ........+-++.|+.++||||+++++.++..+.+|||+|.+ ..|..+++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh---
Confidence 45666778888888887552 234556677888899999999999999999999999999998 4788888763
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCc
Q 002580 770 VLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848 (905)
Q Consensus 770 ~l~~~~~~~i~~qil~gL~~LH-~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (905)
....+...+.||+.||.||| +.+++|++|..+.|+++..|..||++|-+++.......
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------------------- 160 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------------------- 160 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------------------
Confidence 45667778899999999998 56899999999999999999999999998754321110
Q ss_pred ccccccccccccccCCccccccccccCC-CCchHHHHHHHHHHHHhC
Q 002580 849 VFMAEPMRASNSFVGTEEYIAPVSDFAY-TRMTRYNYLILVSKKFME 894 (905)
Q Consensus 849 ~~~~~~~~~~~~~~gT~~Y~APE~l~~~-~~sDiwSlGvil~elltg 894 (905)
......--..|..|+.+..+ -..|.|-|||++++++.|
T Consensus 161 --------~~~~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 --------PAKSLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --------ccccchhhhcccChhhcCccccchhhhhHHHHHHHHhCc
Confidence 00111122346667665532 367999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-10 Score=111.32 Aligned_cols=147 Identities=19% Similarity=0.198 Sum_probs=110.7
Q ss_pred ecccccccCceEEEEEEEcCCCeEEEEEEeeccc-----ccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEE
Q 002580 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-----MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 676 i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+..|-+|+-+.|+.+.+ .|+.+.||.-.... +...-...+..+|+.+|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 456788999999999988 78888888543322 22233456778999999988654554444446666777899
Q ss_pred EeccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCC---cEEEEeccCcccc
Q 002580 751 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 824 (905)
Q Consensus 751 ~E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~---~vkL~DFG~s~~~ 824 (905)
|||++| .++.+++...-...........++++|-..+.-||..+|||+||..+||++.+++ .+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999977 4788888765444444445578899999999999999999999999999997665 3589999998654
|
|
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.9e-11 Score=143.54 Aligned_cols=119 Identities=16% Similarity=0.157 Sum_probs=96.9
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcC-cCCCCCHHHHHHHHHHHHcCCcEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL-QGPETDPATVRKIRAAIDNQTDVTVQLIN 555 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l-~~~~~~~~~~~~~~~~l~~g~~~~~e~~~ 555 (905)
++.++++++++|+++|. +|+|+++|++|++++||+.+|++|++...+ .++++.......+...+..+..+..|.++
T Consensus 113 ~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 113 AEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 57889999999999999 566999999999999999999999996544 45555555666777778888899999999
Q ss_pred EecCCcEEEEEEEEeeeecCCC-CEEEEEEEeecCcccccccccC
Q 002580 556 YTKSGKKFWNLFHLQPMRDQKG-EVQYFIGVQLDGSEHLEPLRNS 599 (905)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G-~i~~~i~i~~DITerk~~e~~~ 599 (905)
.+++|..+|+.....+ .+..| ...+++++.+|||++|+.++++
T Consensus 190 ~~~~G~~~~~~~~~~~-~~~~g~~~~~~i~~~~DITe~k~~e~~l 233 (663)
T PRK10060 190 KTRKGQRLFLFRNKFV-HSGSGKNEIFLICSGTDITEERRAQERL 233 (663)
T ss_pred EeCCCCEEEEEeeeEE-EcCCCCceEEEEEEEEechHHHHHHHHH
Confidence 9999999998766544 44444 4467889999999999865443
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.7e-11 Score=137.96 Aligned_cols=118 Identities=25% Similarity=0.435 Sum_probs=105.9
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~ 556 (905)
|+.++++++++++++|. +|+++++|+++++++||++++++|++...+.++.......+.+...+..+..+..+....
T Consensus 6 ~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 6 YRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred HHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 89999999999999999 555999999999999999999999987777777667777777778888888888888889
Q ss_pred ecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccc
Q 002580 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597 (905)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~ 597 (905)
+++|+.+|+.....|+++.+|.+.+++++++|||++|++++
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~ 123 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQ 123 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHH
Confidence 99999999999999999999999999999999999998543
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.4e-10 Score=100.05 Aligned_cols=120 Identities=20% Similarity=0.409 Sum_probs=97.2
Q ss_pred HHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcC-CcEEEEE
Q 002580 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG-QSYCGRL 270 (905)
Q Consensus 192 ~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g-~~~~~e~ 270 (905)
..++.+++.++++++++|. +|.++++|+++++++|++.++++|+++..+.++.........+...+..+ ......+
T Consensus 3 ~~~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEER 79 (124)
T ss_pred hHHHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEe
Confidence 4578899999999999998 99999999999999999999999998776666555555555555555533 2233445
Q ss_pred EEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHH
Q 002580 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 315 (905)
Q Consensus 271 ~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~ 315 (905)
....++|..+|+..+..|+. .+|...+++++..|||++++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 80 RVRRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred eeEcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 55588999999999999998 788899999999999999988754
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.2e-10 Score=108.70 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=101.3
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHH-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEEEEEe
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
..+++|+-+.+|.+.. -|..+++|.-.++..-.+. -..+..+|..++..+.--.|+..+-++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999866 3445777764443332222 23566789999998865555555545566777889999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCcccc
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~ 824 (905)
|++|..|.+++... ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999999888764 134566777778899999999999999999998654 999999999754
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.3e-10 Score=140.92 Aligned_cols=142 Identities=14% Similarity=0.178 Sum_probs=117.9
Q ss_pred cceeEEeeeecCCcccccccchHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCccc-CCCC
Q 002580 169 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFL-QGAG 247 (905)
Q Consensus 169 ~~~~~~~~i~~~~~~~~~l~~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l-~~~~ 247 (905)
.+.++..||++++.. .+....+..+++.++++++++|. +|+++++|+++++++||+.++++|+++..+ .++.
T Consensus 117 ~~~~~~~DiT~~~~~----~~~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~ 189 (799)
T PRK11359 117 YYLALVRDASVEMAQ----KEQTRQLIIAVDHLDRPVIVLDP---ERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPE 189 (799)
T ss_pred EEEEEEeeccchhhh----HHHHHHHHHHHhcCCCcEEEEcC---CCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCC
Confidence 455677888866433 33445667789999999999998 999999999999999999999999997744 4445
Q ss_pred CChHHHHHHHHHHHcCCcEEEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 002580 248 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (905)
Q Consensus 248 ~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~ 317 (905)
........++..+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++.+|||+++++++..+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~ 259 (799)
T PRK11359 190 FPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEG 259 (799)
T ss_pred CcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHH
Confidence 5555666677777778888888888999999999999999999999999999999999999998876543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.3e-11 Score=134.48 Aligned_cols=204 Identities=20% Similarity=0.142 Sum_probs=158.6
Q ss_pred cCCCeeecccccc--cCceEEEEEEE--cCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 002580 670 NLQHFRPIKPLGS--GDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 744 (905)
Q Consensus 670 ~~~~y~i~~~Lg~--G~~g~V~~~~~--~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~ 744 (905)
....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .........-.+|+.-...+ .|+|.++.+..+...
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccC
Confidence 3456777888999 99999999988 888999999974432 11222223344566555666 489999999999999
Q ss_pred CeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEecc
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV----ALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFD 819 (905)
Q Consensus 745 ~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~----gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG 819 (905)
+..|+-+|+| +.+|..+.... ...++...++.++.+... ||.++|+.+++|-|+||.||++..+ ...+++|||
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred Ccceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 9999999999 67888877643 344788899999999999 9999999999999999999999998 889999999
Q ss_pred CccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccC--CCCchHHHHHHHHHHHHhCCCC
Q 002580 820 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--YTRMTRYNYLILVSKKFMEFQP 897 (905)
Q Consensus 820 ~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~--~~~sDiwSlGvil~elltg~~P 897 (905)
+...++...... .........|...|++||...+ ....|+|++|.++.+..++..+
T Consensus 269 ~v~~i~~~~~~~----------------------~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 269 LVSKISDGNFSS----------------------VFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred eeEEccCCcccc----------------------ceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccc
Confidence 987765332211 0011112257778999999995 5589999999999999988766
Q ss_pred c
Q 002580 898 F 898 (905)
Q Consensus 898 F 898 (905)
+
T Consensus 327 ~ 327 (524)
T KOG0601|consen 327 P 327 (524)
T ss_pred c
Confidence 5
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.7e-11 Score=140.87 Aligned_cols=231 Identities=24% Similarity=0.306 Sum_probs=165.4
Q ss_pred ccCCCeeecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCeEE
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
...+.+.+.+.+-+|.++.++.+.-..+|...++|+..+......+..+....+-.++-...+|.++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45678888899999999999999988888777877766543333333444444444444445676666655566778899
Q ss_pred EEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCCCC
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~ 828 (905)
++++|+.+++|...++..+ +.+..-++.++..+..+++|||...+.|+|++|.|+++..+|..++.|||........+
T Consensus 881 L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999999987753 46777777788889999999999999999999999999999999999999654443321
Q ss_pred CCCCCc--ch--hhhccccCCCCcccccccccccccccCCccccccccccC---CCCchHHHHHHHHHHHHhCCCCchhh
Q 002580 829 QLLLPT--TN--EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 829 ~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~---~~~sDiwSlGvil~elltg~~PF~~~ 901 (905)
...-.. .+ -..+-......+..............||+.|.+||.+.+ ....|.|++|+++++.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 111000 00 000000011111111222344566789999999999984 56889999999999999999999654
|
|
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.4e-10 Score=99.38 Aligned_cols=86 Identities=29% Similarity=0.408 Sum_probs=74.4
Q ss_pred eEeeCHHHHHHcCCChhhhcCCC----CCcCcCCCCCHHHHHHHHH-HHHcCCcEEEEEEEEecCCcEEEEEEEEeeeec
Q 002580 500 IIFASDSFLELTEYSREEILGRN----CRFLQGPETDPATVRKIRA-AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD 574 (905)
Q Consensus 500 I~~vN~a~~~l~Gys~eEliGk~----~~~l~~~~~~~~~~~~~~~-~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d 574 (905)
|+|||+++++++||+++++ |.. +..++||++.....+.+.. ....+..+..+++++++||+.+|+..+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 6678999999999999999 778888999999999999999999999999999
Q ss_pred CCCCEEEEEEEe
Q 002580 575 QKGEVQYFIGVQ 586 (905)
Q Consensus 575 ~~G~i~~~i~i~ 586 (905)
.+|.++.++|++
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999974
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=97.67 Aligned_cols=116 Identities=22% Similarity=0.361 Sum_probs=94.9
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcC-CcEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLIN 555 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g-~~~~~e~~~ 555 (905)
++.++++++++++++|. ++.++++|+++++++|++.++++|++...+.++.........+...+..+ .....+..+
T Consensus 5 ~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (124)
T TIGR00229 5 YRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRV 81 (124)
T ss_pred HHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeee
Confidence 78899999999999999 55599999999999999999999998777777766665555555555533 234445555
Q ss_pred EecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCccccccc
Q 002580 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596 (905)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e 596 (905)
..++|..+|+..+..|+. .+|...++++++.|||++++.+
T Consensus 82 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~ 121 (124)
T TIGR00229 82 RRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAE 121 (124)
T ss_pred EcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHH
Confidence 688999999999999998 7888999999999999998843
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=96.79 Aligned_cols=86 Identities=28% Similarity=0.453 Sum_probs=73.6
Q ss_pred EEEcCHHHHHHcCCChhhhcCCC----CcccCCCCCChHHHHHHHH-HHHcCCcEEEEEEEEccCCCeEEEEEEeeeeec
Q 002580 217 IMYASAGFFKMTGYTSKEVVGRN----CRFLQGAGTDPEDVAKIRE-TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKD 291 (905)
Q Consensus 217 I~~~N~a~~~l~Gys~eEliG~~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~w~~~s~~pi~d 291 (905)
|+|+|++|++++||+++++ |.. +..+.+|++.......+.. .+..+..+..+++.+++||+.+|++.+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 5577888988889999999 788888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 002580 292 DEGKVLKFIGMQ 303 (905)
Q Consensus 292 ~~G~v~~~v~~~ 303 (905)
.+|++.+++|++
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999974
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.1e-09 Score=109.41 Aligned_cols=140 Identities=24% Similarity=0.320 Sum_probs=103.7
Q ss_pred ccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CeEEEEEe
Q 002580 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTK---THVCLITD 752 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~l~~~~~~~---~~~~lV~E 752 (905)
+.|+.|.++.||++.... |..|++|........ .....+..|..+++.+.+ .++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998743 578999987654211 124567889999999865 4467888776653 36789999
Q ss_pred ccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------------- 792 (905)
Q Consensus 753 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~---------------------------------------- 792 (905)
|++|.++...+.. ..++......++.+++..|..||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999888665421 125666666667777777777763
Q ss_pred ----------------CCCeeCCCCCCCEEEcC--CCcEEEEeccCccc
Q 002580 793 ----------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCL 823 (905)
Q Consensus 793 ----------------~gIvHrDLKp~NILl~~--~~~vkL~DFG~s~~ 823 (905)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.9e-08 Score=106.53 Aligned_cols=135 Identities=19% Similarity=0.063 Sum_probs=95.9
Q ss_pred EEEEEEEcCCCeEEEEEEeecccccC--------HHHHHHHHHHHHHHHhCCCCC--cceEEEEEEe-----CCeEEEEE
Q 002580 687 SVHLVELCGSGQYFAMKAMDKGVMLN--------RNKVHRACAEREILDMLDHPF--VPALYASFQT-----KTHVCLIT 751 (905)
Q Consensus 687 ~V~~~~~~~t~~~vavK~~~~~~~~~--------~~~~~~~~~E~~il~~l~h~n--Iv~l~~~~~~-----~~~~~lV~ 751 (905)
.|+.+.. .|+.|.||......... ......+.+|...+..|...+ ++.++.++.. ....+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555554 56788899764332100 011124678888888874333 3445555543 23578999
Q ss_pred eccCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcC-------CCcEEEEeccCccc
Q 002580 752 DYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTDFDLSCL 823 (905)
Q Consensus 752 E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~-------~~~vkL~DFG~s~~ 823 (905)
|++++. +|.+++........+......++.+++..+.-||..||+|+||+++|||++. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 8999886432334566777889999999999999999999999999999975 46899999998854
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.1e-08 Score=81.84 Aligned_cols=102 Identities=25% Similarity=0.477 Sum_probs=86.8
Q ss_pred ccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEEEEEccCCCeEE
Q 002580 202 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 281 (905)
Q Consensus 202 ~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 281 (905)
+++++++|. +|.++++|+++++++|++.++++|+++..+.++.........+...+..+.....++.....+|...|
T Consensus 2 ~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (103)
T cd00130 2 PDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVIW 78 (103)
T ss_pred CceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEEE
Confidence 578889988 99999999999999999999999999876666666556666666666666667778888888899999
Q ss_pred EEEEeeeeecCCCCEEEEEEEEecc
Q 002580 282 NLLTIAPIKDDEGKVLKFIGMQVEV 306 (905)
Q Consensus 282 ~~~s~~pi~d~~G~v~~~v~~~~DI 306 (905)
+.....++.+..|...+++++.+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 79 VLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEecCCCCEEEEEEEEecC
Confidence 9999999999889999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.4e-09 Score=115.53 Aligned_cols=137 Identities=13% Similarity=0.158 Sum_probs=99.1
Q ss_pred cHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEE
Q 002580 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555 (905)
Q Consensus 476 ~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~ 555 (905)
.++.++++++++++++|. +|+|+++|+++++++||+.++++|+++..+.+... .....+...+..+..+..+...
T Consensus 8 ~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 82 (348)
T PRK11073 8 DAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNEVT 82 (348)
T ss_pred hHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccceE
Confidence 478999999999999999 56699999999999999999999999877765432 2223445566666655544455
Q ss_pred EecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccCCchhhhHHHHHHHHHHhhhhhhh
Q 002580 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 622 (905)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~~~~~~~~e~~~l~~~~~~~~~~~ 622 (905)
..+||+.+|+.++..|+. . .+++..++|||++++.++++..+........++..++|.+...
T Consensus 83 ~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~~~~~~~~~~~~~~~iaHelr~p 144 (348)
T PRK11073 83 LVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQLQHAQQVAARDLVRGLAHEIKNP 144 (348)
T ss_pred EEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHHHHHHHHHHHHHHHhhhHhhcCh
Confidence 678999999999999997 2 2467779999999886554443333333344444455554443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-09 Score=122.18 Aligned_cols=196 Identities=18% Similarity=0.222 Sum_probs=146.1
Q ss_pred cccCCCeeecccccccCceEEEEEEEc-CCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (905)
Q Consensus 668 ~~~~~~y~i~~~Lg~G~~g~V~~~~~~-~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 745 (905)
.....+|..+..||.|.|+.|+.+... .++..|++|.+.+.......+. .-..|+.+...+ .|.+++.++..|....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccc
Confidence 345678999999999999999998765 6788999998877644333332 233455555555 5889999888888888
Q ss_pred eEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCC-CcEEEEeccCcccc
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 824 (905)
Q Consensus 746 ~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~-~~vkL~DFG~s~~~ 824 (905)
..|+-.|||+++++.....- ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||+.+-.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 88899999999887655522 2347778888999999999999999999999999999999876 78899999987432
Q ss_pred CCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccc-cccccc----CCCCchHHHHHHHHHHHHhCCC
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI-APVSDF----AYTRMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~-APE~l~----~~~~sDiwSlGvil~elltg~~ 896 (905)
.-. ...+.+.-.++ .+|++. ...+.|+||||..+++.+++..
T Consensus 418 ~~~------------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 418 AFS------------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cee------------------------------cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 100 11122333444 244444 3459999999999999998754
|
|
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.3e-08 Score=81.10 Aligned_cols=103 Identities=28% Similarity=0.453 Sum_probs=87.9
Q ss_pred hcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEEecCCcEE
Q 002580 484 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 563 (905)
Q Consensus 484 ~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~~kdG~~~ 563 (905)
++++++++|. ++.++++|+++++++|++.++++|+....+.++.........+......+.....+......+|..+
T Consensus 1 ~~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3578999999 5559999999999999999999999977777777776666666666666667778888888999999
Q ss_pred EEEEEEeeeecCCCCEEEEEEEeecC
Q 002580 564 WNLFHLQPMRDQKGEVQYFIGVQLDG 589 (905)
Q Consensus 564 wv~~~~~pi~d~~G~i~~~i~i~~DI 589 (905)
|+.+...++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999999888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.1e-08 Score=101.51 Aligned_cols=128 Identities=23% Similarity=0.209 Sum_probs=83.4
Q ss_pred EEEEEEEcCCCeEEEEEEeeccccc-----------------------CHHHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 002580 687 SVHLVELCGSGQYFAMKAMDKGVML-----------------------NRNKVHRACAEREILDMLDHP--FVPALYASF 741 (905)
Q Consensus 687 ~V~~~~~~~t~~~vavK~~~~~~~~-----------------------~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~ 741 (905)
.||.|.. ..|..+|+|+....... .........+|...|..+..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 46779999998753100 001124567899999999755 578887653
Q ss_pred EeCCeEEEEEeccC--CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeCCCCCCCEEEcCCCcEEEEec
Q 002580 742 QTKTHVCLITDYCP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY-LHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 742 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~-LH~~gIvHrDLKp~NILl~~~~~vkL~DF 818 (905)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 3479999997 65565544322 2234456677788885555 579999999999999999977 9999999
Q ss_pred cCcccc
Q 002580 819 DLSCLT 824 (905)
Q Consensus 819 G~s~~~ 824 (905)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.3e-09 Score=109.20 Aligned_cols=149 Identities=20% Similarity=0.254 Sum_probs=110.9
Q ss_pred HHHHhCCCCCcceEEEEEEeCC-----eEEEEEeccCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 002580 724 EILDMLDHPFVPALYASFQTKT-----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-- 794 (905)
Q Consensus 724 ~il~~l~h~nIv~l~~~~~~~~-----~~~lV~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~g-- 794 (905)
..|-++.|.||++++.|+.+.. ...+++||+..|+|..+|++. ..+.+......+++.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3455667999999999987654 488999999999999999863 2345778888899999999999999985
Q ss_pred CeeCCCCCCCEEEcCCCcEEEEeccCccccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc
Q 002580 795 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF 874 (905)
Q Consensus 795 IvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~ 874 (905)
|+|+++..+-|++..+|-+||.--....... + +.........-..+-++|.|||.-.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~--------s---------------~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP--------S---------------VNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccch--------h---------------hhhhhHhhhhccccCCccccCCcCc
Confidence 9999999999999999988874322111110 0 0000001112234678999999876
Q ss_pred ---CCCCchHHHHHHHHHHHHhCC
Q 002580 875 ---AYTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 875 ---~~~~sDiwSlGvil~elltg~ 895 (905)
....+|||+||+..++|..+.
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHhe
Confidence 356999999999999998764
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.1e-08 Score=110.57 Aligned_cols=221 Identities=19% Similarity=0.214 Sum_probs=152.1
Q ss_pred HHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEEEEEcc
Q 002580 196 DALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKK 275 (905)
Q Consensus 196 ~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~k 275 (905)
.+++.++++++++|. ...|.++|..+..+++-....++|+++..+.+...-.... .+..+........+
T Consensus 5 ~~l~~~~~~~~vi~~---~~~~~~~~~~a~~~~~~~~~~~i~~~~~~i~~~~~~~~v~--------~~~~~~~~~~~~~~ 73 (560)
T COG3829 5 GILKSILDGPVVIDK---NTGIDVANALALAKRQKNAEAVIGRPLREILETLGMERVE--------QSRDKELTERLKLK 73 (560)
T ss_pred hhhhhcccceEEEEc---CCceeeechHHHHhhhcceEEEecccceeeccccCcceee--------ccCccceeeeeecc
Confidence 478999999999998 7789999999999999999999999887655443222111 22222222222233
Q ss_pred CCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhcCCCCChhHHHHHHHHHHHHHHHHHHHHHHHccCCCCc
Q 002580 276 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 355 (905)
Q Consensus 276 dG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~~~~~l~~~l~~~~~~~~~~~~~~~~~l~~al~~~~~~ 355 (905)
+ . -..+..-++.++.|+++|+++++.|+++....-.+. +
T Consensus 74 -~-~-~~~~~~~~~~~~~~~~~g~~~~~~~~~e~~~~~~~~----------------------------l---------- 112 (560)
T COG3829 74 -V-K-RIVVVGKTPVDEQGRVVGVLEVFLDISEALELIEEN----------------------------L---------- 112 (560)
T ss_pred -c-e-eEEEcCCceeecCCceeeeehhhhhhHHHHHHHHHH----------------------------H----------
Confidence 3 2 223344455678899999999999999844322111 0
Q ss_pred cccCCCCcccccCCCchhhhhhccccCccCCCCCCCcCCCCCCCccccccccccccccccccCCccccccccccccCCCC
Q 002580 356 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTD 435 (905)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (905)
T Consensus 113 -------------------------------------------------------------------------------- 112 (560)
T COG3829 113 -------------------------------------------------------------------------------- 112 (560)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCccccchhccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCCh
Q 002580 436 DHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSR 515 (905)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~di~e~k~~e~~~~~~~~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~ 515 (905)
..+ ...|+.+++.+.++++++|. +|.++++|+++..++|++.
T Consensus 113 ------------------------------~~~-----~~~l~~il~~~~~~l~vvD~---~G~~i~~N~~~~~~~gl~~ 154 (560)
T COG3829 113 ------------------------------RQL-----RQRLEAILDSIDDGLLVVDE---DGIIIYYNKAYAKLLGLSP 154 (560)
T ss_pred ------------------------------HHH-----HHHHHHHHhhccCceEEEcC---CCcEEEEcHHHHHHhCCCH
Confidence 000 01178999999999999999 5559999999999999999
Q ss_pred hhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccc
Q 002580 516 EEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595 (905)
Q Consensus 516 eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~ 595 (905)
++++|++...+...... .....++..+++.......+. |... ..+..|+. .+|.+.|.+++.+|+++-+..
T Consensus 155 e~~~gk~~~~v~~~~~~----s~~l~vl~~~kp~~~~~~~~~--~~~~--i~~~~pv~-~~g~l~G~v~~~~~~~~l~~l 225 (560)
T COG3829 155 EEVLGKHLLDVVSAGED----STLLEVLRTGKPIRDVVQTYN--GNKI--IVNVAPVY-ADGQLIGVVGISKDVSELERL 225 (560)
T ss_pred HHHcCCcHHHHHhccCC----ceehhhhhcCCcceeeeeeec--CCce--eEeeccEe-cCCcEEEEEEeecchHHHHHH
Confidence 99999986666411111 123456777777554443332 2222 45566776 467999999999999998764
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.3e-08 Score=119.22 Aligned_cols=141 Identities=16% Similarity=0.139 Sum_probs=106.6
Q ss_pred cHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCc-EEEEEE
Q 002580 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLI 554 (905)
Q Consensus 476 ~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~-~~~e~~ 554 (905)
.++.++++++++++++|. +|.|+++|+++++++||++++++|++...+.++.. .....+...+..+.. ...+..
T Consensus 263 ~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 337 (607)
T PRK11360 263 LNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTEHVDLEIS 337 (607)
T ss_pred HHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCCccceEEE
Confidence 368899999999999999 55599999999999999999999999777766542 233344555555443 445667
Q ss_pred EEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccccccCCchhhhHHHHHHHHHHhhhhhhh
Q 002580 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 622 (905)
Q Consensus 555 ~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e~~~~~~~~~~e~~~l~~~~~~~~~~~ 622 (905)
+.+++|..+ +.++..|++|.+|.+.+++++++|||++++.+++.......+.+..++..+.+.+...
T Consensus 338 ~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~~l~~~~~~~~hel~~~ 404 (607)
T PRK11360 338 FPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLAALGELVAGVAHEIRNP 404 (607)
T ss_pred EEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhH
Confidence 778888876 8899999999999999999999999999997665544433334444444555544443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.3e-08 Score=106.43 Aligned_cols=167 Identities=16% Similarity=0.182 Sum_probs=127.9
Q ss_pred ceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCeEEEEEeccCC-CCH
Q 002580 685 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----TKTHVCLITDYCPG-GEL 759 (905)
Q Consensus 685 ~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~----~~~~~~lV~E~~~g-g~L 759 (905)
..+.|+|....+|..|++|.++.......+ ....-++.++++.|+|||++.++|. .+..+++|++|+++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 457899999999999999999543222221 2223466899999999999999887 34579999999986 578
Q ss_pred HHHHhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCccccCC
Q 002580 760 FLLLDRQP-------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 760 ~~~l~~~~-------------~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s~~~~~ 826 (905)
.++.-... +...++..+|.++.||..||.++|+.|+..+-|.|.+||++.+.+++|+..|....+-.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 77654321 22367899999999999999999999999999999999999988999988777643221
Q ss_pred CCCCCCCcchhhhccccCCCCcccccccccccccccCCccccccccccCCCCchHHHHHHHHHHHHhCC
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAYTRMTRYNYLILVSKKFMEF 895 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~~~~~sDiwSlGvil~elltg~ 895 (905)
++ -+-+....+-|.=.||.+++-|.||.
T Consensus 446 d~-----------------------------------------~~~le~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DP-----------------------------------------TEPLESQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC-----------------------------------------CcchhHHhhhhHHHHHHHHHHHhhcc
Confidence 10 12344556788889999999999983
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.72 E-value=5.3e-08 Score=108.00 Aligned_cols=113 Identities=14% Similarity=0.114 Sum_probs=88.6
Q ss_pred chHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEE
Q 002580 189 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 268 (905)
Q Consensus 189 ~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 268 (905)
...+.++.++++++++++++|. +|+|+++|++|++++||++++++|+++..+..+ ..++..+..+.. ..
T Consensus 3 ~~~~~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~-------~~~~~~l~~~~~-~~ 71 (333)
T TIGR02966 3 ALLSRFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRH-------PEFVEYLAAGRF-SE 71 (333)
T ss_pred hHHHHHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccC-------HHHHHHHHhccc-CC
Confidence 4567789999999999999999 999999999999999999999999997755432 123444444332 22
Q ss_pred EEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 002580 269 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (905)
Q Consensus 269 e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~ 317 (905)
......++|..+|+.+.+.|+.+.+ ++++++|||++++.++..+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~ 115 (333)
T TIGR02966 72 PLELPSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRR 115 (333)
T ss_pred CeEeecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHH
Confidence 3445568899999999999987643 6788999999998876643
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.9e-08 Score=108.83 Aligned_cols=120 Identities=27% Similarity=0.608 Sum_probs=104.4
Q ss_pred HHHHHHhh---cccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCC--CCcCcCCCCCHHHHHHHHHHHHcCCcEEE
Q 002580 477 LATTLERI---EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 551 (905)
Q Consensus 477 l~~i~e~~---~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~--~~~l~~~~~~~~~~~~~~~~l~~g~~~~~ 551 (905)
|+.++..+ ...+++.+++-.|+.|+|+|+.||++.||.+.|++.++ +.+.+++-.+....+.+++.+++-+.-.+
T Consensus 16 LENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~qf 95 (971)
T KOG0501|consen 16 LENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQF 95 (971)
T ss_pred HHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcce
Confidence 55565433 34555556666688999999999999999999999998 45677888888889999999999999899
Q ss_pred EEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCccccccc
Q 002580 552 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596 (905)
Q Consensus 552 e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e 596 (905)
|+-++.|+.+.+|+.+.+.||+++...++.|+..+.|||..||+.
T Consensus 96 EillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQPi 140 (971)
T KOG0501|consen 96 EILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQPI 140 (971)
T ss_pred eeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCCC
Confidence 999999999999999999999999999999999999999999973
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.5e-08 Score=108.22 Aligned_cols=117 Identities=17% Similarity=0.213 Sum_probs=93.0
Q ss_pred HHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEE
Q 002580 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270 (905)
Q Consensus 191 ~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (905)
...+++++++++++++++|. +|+|+++|+++++++||+.++++|+++..+.+... .....+...+..+..+....
T Consensus 6 ~~~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 80 (348)
T PRK11073 6 LPDAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNE 80 (348)
T ss_pred cchHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccc
Confidence 34678999999999999999 99999999999999999999999999886665432 22344556666666655545
Q ss_pred EEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhh
Q 002580 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 317 (905)
Q Consensus 271 ~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~ 317 (905)
..+.+||..+|+.++..|+. . .+++..++|||++++.++++.
T Consensus 81 ~~~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~ 122 (348)
T PRK11073 81 VTLVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQL 122 (348)
T ss_pred eEEEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHH
Confidence 55678999999999999986 2 246677999999998877653
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.67 E-value=6.8e-08 Score=107.13 Aligned_cols=104 Identities=11% Similarity=0.041 Sum_probs=80.9
Q ss_pred cHHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEE
Q 002580 476 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555 (905)
Q Consensus 476 ~l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~ 555 (905)
+|+.++++++++|+++|. +|.|+++|++|++++||++++++|++...+.+++ . +...+..+.. .....+
T Consensus 7 ~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---~----~~~~l~~~~~-~~~~~~ 75 (333)
T TIGR02966 7 RFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRHP---E----FVEYLAAGRF-SEPLEL 75 (333)
T ss_pred HHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccCH---H----HHHHHHhccc-CCCeEe
Confidence 389999999999999999 5559999999999999999999999977665432 2 2333333322 233555
Q ss_pred EecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCcccccc
Q 002580 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 595 (905)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~ 595 (905)
..++|..+|+.+...|+.+.. ++++++|||++++.
T Consensus 76 ~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~ 110 (333)
T TIGR02966 76 PSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRL 110 (333)
T ss_pred ecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHH
Confidence 568899999999999997642 67889999998874
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=113.46 Aligned_cols=127 Identities=13% Similarity=0.118 Sum_probs=103.8
Q ss_pred cccchHHHHHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCc
Q 002580 186 GLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 265 (905)
Q Consensus 186 ~l~~~~~~l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~ 265 (905)
.+......++.+++.++++++++|. +|+|+++|+++++++||+.++++|+++..+.++.. .....+...+..+..
T Consensus 256 ~l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~ 330 (607)
T PRK11360 256 ALRETRSLNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTE 330 (607)
T ss_pred HHHHHHHHHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCC
Confidence 4455566778899999999999998 99999999999999999999999999887666432 234455556665554
Q ss_pred E-EEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHHHhhc
Q 002580 266 Y-CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 318 (905)
Q Consensus 266 ~-~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~~l~~ 318 (905)
. ..++...+++|..+ +.++..|+.+.+|++.+++++.+|||+++++|++++.
T Consensus 331 ~~~~~~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~ 383 (607)
T PRK11360 331 HVDLEISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVAR 383 (607)
T ss_pred ccceEEEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHH
Confidence 3 34566677888776 8899999999999999999999999999999988764
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.8e-08 Score=87.72 Aligned_cols=106 Identities=15% Similarity=0.275 Sum_probs=75.1
Q ss_pred HHHHHHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCcccCCCCCChHHHHHHHHHHHcCCcEEEEEEEE
Q 002580 194 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 273 (905)
Q Consensus 194 l~~ile~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 273 (905)
|..+|++++.+++++|. +++|.++|+++.++++... ..+|+++..+.++. .......+.+.+..|+....+...
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~-~~~~l~~~i~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPL-SYPNLKKIIEQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HH-HHHHHHHHHHHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCcc-chHHHHHHHHHHHcCCCceEEEEe-
Confidence 56789999999999999 9999999999999999775 55799998887663 333444455666667653333333
Q ss_pred ccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccc
Q 002580 274 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307 (905)
Q Consensus 274 ~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DIT 307 (905)
.++|. |+.+++.|++|.+|+..|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 34554 667899999999999999999999998
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.5e-07 Score=90.48 Aligned_cols=141 Identities=14% Similarity=0.150 Sum_probs=102.9
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEeeccc---ccCHHHHHHHHHHHHHHHhCCCC--CcceEEEEEEeC----CeEEEEE
Q 002580 681 GSGDTGSVHLVELCGSGQYFAMKAMDKGV---MLNRNKVHRACAEREILDMLDHP--FVPALYASFQTK----THVCLIT 751 (905)
Q Consensus 681 g~G~~g~V~~~~~~~t~~~vavK~~~~~~---~~~~~~~~~~~~E~~il~~l~h~--nIv~l~~~~~~~----~~~~lV~ 751 (905)
|.||.+.|+.... .|..|-+|.-.... ...+.....+.+|+..|..|... .++++..+.... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6788889998776 33357778654221 11133556788999999888432 255555222211 2478999
Q ss_pred eccCC-CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc--EEEEeccCccc
Q 002580 752 DYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCL 823 (905)
Q Consensus 752 E~~~g-g~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~--vkL~DFG~s~~ 823 (905)
|-+.| .+|.+++....-.+.+......++.+|+..+.-||+.|+.|+|+-+.|||++.+|. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 58988886644445677777889999999999999999999999999999987677 99999987754
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.5e-07 Score=86.57 Aligned_cols=106 Identities=20% Similarity=0.301 Sum_probs=73.5
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~ 556 (905)
|..++++++.++.++|. +++|.|.|+++.++|+... ..+|++...+.++...+... .+.+.+..|+....+...
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~~~~l~-~~i~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPLSYPNLK-KIIEQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HHHHHHHH-HHHHHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCccchHHHH-HHHHHHHcCCCceEEEEe-
Confidence 46789999999999999 5669999999999999764 56899988887664333333 344555566653333333
Q ss_pred ecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCc
Q 002580 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (905)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DIT 590 (905)
..+|. |+.+...|++|++|+..|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35555 567899999999999999999999998
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.1e-07 Score=96.86 Aligned_cols=138 Identities=21% Similarity=0.182 Sum_probs=103.5
Q ss_pred eeecccccccCceEEEEEEEcCCCeEEEEEEeecccc-----------------cC--HHHHHHHHHHHHHHHhCCCC--
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-----------------LN--RNKVHRACAEREILDMLDHP-- 732 (905)
Q Consensus 674 y~i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~-----------------~~--~~~~~~~~~E~~il~~l~h~-- 732 (905)
+.+...||-|.-|.||.|.+. .|..+|+|.-..... .+ .-......+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345678999999999999985 688899997543210 00 01123456899999998655
Q ss_pred CcceEEEEEEeCCeEEEEEeccCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCc
Q 002580 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 812 (905)
Q Consensus 733 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~ 812 (905)
.|++.+++ +..++||||++|..|...- ++......++..|+.-+.-+-..||||+|+++=||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 78887764 6788999999987775432 234445556677777777777899999999999999999999
Q ss_pred EEEEeccCccc
Q 002580 813 VSLTDFDLSCL 823 (905)
Q Consensus 813 vkL~DFG~s~~ 823 (905)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999987643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=7.2e-07 Score=92.52 Aligned_cols=107 Identities=27% Similarity=0.288 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHhCCCC--CcceEEEEEEeC----CeEEEEEeccCCC-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHH
Q 002580 716 VHRACAEREILDMLDHP--FVPALYASFQTK----THVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788 (905)
Q Consensus 716 ~~~~~~E~~il~~l~h~--nIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~~~l~~~~~~~i~~qil~gL~ 788 (905)
.....+|...+..|..- .++..+++.... ...++|+|++++. +|.+++..... .+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34677888887777433 356666666543 2468999999874 79999876332 566777889999999999
Q ss_pred HHHHCCCeeCCCCCCCEEEcCCC---cEEEEeccCcccc
Q 002580 789 YLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 824 (905)
Q Consensus 789 ~LH~~gIvHrDLKp~NILl~~~~---~vkL~DFG~s~~~ 824 (905)
-||.+||+|+|+++.|||++.++ .+.|+||+.+...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999999877 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.1e-07 Score=86.85 Aligned_cols=105 Identities=21% Similarity=0.297 Sum_probs=74.6
Q ss_pred HHhhccceEEEeCCCCCCcEEEcCHHHHHHcCCChhhh-cCCCCcccC---------CCCCChHHHHHHHHHHHcCCcEE
Q 002580 198 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV-VGRNCRFLQ---------GAGTDPEDVAKIRETLQNGQSYC 267 (905)
Q Consensus 198 le~~~~~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEl-iG~~~~~l~---------~~~~~~~~~~~i~~~l~~g~~~~ 267 (905)
|+++++|+++.|. +|+++++|++|.+++|++.+.+ .|.++..+. ++.............+.......
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4788999999999 9999999999999999999998 788865322 11222233333333344444433
Q ss_pred EEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHHHH
Q 002580 268 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 314 (905)
Q Consensus 268 ~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~E~ 314 (905)
.+. ...||. |++++..|+. +| |+|.++.|||+++++|+
T Consensus 78 ~~~--~~~dgr--~l~~~~~~~~--~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 78 FEL--RLPDGR--WLEVRAQPLP--DG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred eEE--ECCCCE--EEEEEeEECC--CC---CEEEEEEeCCHHHHhcC
Confidence 333 457775 6678888884 45 47889999999998874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.6e-07 Score=97.80 Aligned_cols=189 Identities=17% Similarity=0.214 Sum_probs=128.6
Q ss_pred ecccccccCceEEEEEEEcCCCeEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCcce--------EEEEEEeCCe
Q 002580 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA--------LYASFQTKTH 746 (905)
Q Consensus 676 i~~~Lg~G~~g~V~~~~~~~t~~~vavK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~--------l~~~~~~~~~ 746 (905)
+...||+|+-+.+|-.-.. ...+.|++.+....... . ....|... .||-+.. +++- .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a---q---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA---Q---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHH---H---HHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 4567999999999965442 22456888765322111 1 12223332 4554322 1111 12233
Q ss_pred EEEEEeccCCCC-HHHHHh----hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCCEEEcCCCcEEEEeccCc
Q 002580 747 VCLITDYCPGGE-LFLLLD----RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 747 ~~lV~E~~~gg~-L~~~l~----~~~~~~l~~~~~~~i~~qil~gL~~LH~~gIvHrDLKp~NILl~~~~~vkL~DFG~s 821 (905)
+.++|..+.|.. ...++. ++....+.+.-....++.|+.+..-||..|.+-+|+.++|+|+++++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 788999987753 333332 223345678888999999999999999999999999999999999999999985432
Q ss_pred cccCCCCCCCCCcchhhhccccCCCCcccccccccccccccCCcccccccccc--------CCCCchHHHHHHHHHHHHh
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDF--------AYTRMTRYNYLILVSKKFM 893 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gT~~Y~APE~l~--------~~~~sDiwSlGvil~ellt 893 (905)
.+. .+......-+|.+.|.+||... .....|-|.||+++|++++
T Consensus 165 qi~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 165 QIN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred eec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 211 1122233457899999999877 2458899999999999998
Q ss_pred C-CCCchhhh
Q 002580 894 E-FQPFPILC 902 (905)
Q Consensus 894 g-~~PF~~~~ 902 (905)
| ++||..+.
T Consensus 217 ggrHPysGI~ 226 (637)
T COG4248 217 GGRHPYSGIP 226 (637)
T ss_pred cCCCCCCccc
Confidence 8 99997653
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.5e-07 Score=102.64 Aligned_cols=121 Identities=31% Similarity=0.634 Sum_probs=102.4
Q ss_pred HHHHHHHHhhc--c-ceEEEeCCCCCCcEEEcCHHHHHHcCCChhhhcCCCCc--ccCCCCCChHHHHHHHHHHHcCCcE
Q 002580 192 DIVKDALSTFQ--Q-TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSY 266 (905)
Q Consensus 192 ~~l~~ile~~~--~-~i~i~D~~~~dG~I~~~N~a~~~l~Gys~eEliG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~ 266 (905)
..|+.++..+. | .+++.++.--|..|+|+|+.||++.||.+.|+..+++. +.+++..+......+++++.+.+.-
T Consensus 14 TFLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~ 93 (971)
T KOG0501|consen 14 TFLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETN 93 (971)
T ss_pred hHHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhc
Confidence 44555665554 3 33333333337889999999999999999999998854 7778888889999999999999999
Q ss_pred EEEEEEEccCCCeEEEEEEeeeeecCCCCEEEEEEEEeccchhhHH
Q 002580 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 312 (905)
Q Consensus 267 ~~e~~~~~kdG~~~w~~~s~~pi~d~~G~v~~~v~~~~DITe~k~~ 312 (905)
+.|+..++|+-.++|+.+.+.||+++...++-|++.++|||..|+-
T Consensus 94 qfEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 94 QFEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred ceeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 9999999999999999999999999999999999999999988764
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.2e-07 Score=86.66 Aligned_cols=104 Identities=23% Similarity=0.315 Sum_probs=74.1
Q ss_pred HHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhh-cCCCCCcCc---------CCCCCHHHHHHHHHHHHcCCcEE
Q 002580 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEI-LGRNCRFLQ---------GPETDPATVRKIRAAIDNQTDVT 550 (905)
Q Consensus 481 ~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEl-iGk~~~~l~---------~~~~~~~~~~~~~~~l~~g~~~~ 550 (905)
+++++.||+++|. +++++++|++|.+++|++.+.+ .|.++..++ .+.....................
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4689999999999 6669999999999999999998 788754432 22333333444444444444443
Q ss_pred EEEEEEecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCccccccc
Q 002580 551 VQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596 (905)
Q Consensus 551 ~e~~~~~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~~e 596 (905)
.+ ....||+ |+.++..|+ ++| |++.++.|||+++++|
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E 114 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAE 114 (115)
T ss_pred eE--EECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhc
Confidence 43 3567887 567888888 456 5778999999999964
|
|
| >PRK11388 DNA-binding transcriptional regulator DhaR; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.2e-06 Score=104.29 Aligned_cols=107 Identities=16% Similarity=0.207 Sum_probs=78.2
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHHHHHHHHHHHHcCCcEEEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 556 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~~~~~~~~~l~~g~~~~~e~~~~ 556 (905)
+..+++++.++|+++|. +|+|+++|+++++++|++.++++|++...+++.. ..+..++..+..+.......
T Consensus 205 ~~~il~~~~~gVl~vD~---~G~I~~~N~aa~~llg~s~~~l~G~~i~~l~~~~------~~l~~vl~~~~~~~~~~~~l 275 (638)
T PRK11388 205 LNALLESMDDGVIAWDE---QGNLQFLNAQAARLLRLDATASQGRAITELLTLP------AVLQQAIKQAHPLKHVEVTF 275 (638)
T ss_pred HHHHHhccCCcEEEECC---CCeEehhhHHHHHHhCcCHHHHCCCcHHHHhccc------hHHHHHHhcCCceeeEEEEE
Confidence 56688999999999999 5669999999999999999999999976665321 12344556666544333333
Q ss_pred ecCCcEEEEEEEEeeeecCCCCEEEEEEEeecCccccc
Q 002580 557 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594 (905)
Q Consensus 557 ~kdG~~~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~ 594 (905)
..+|..+++.++..|+.+..| .+++.+.+|++..++
T Consensus 276 ~~~g~~~~~~v~~~Pi~~~~g--~~~v~~l~~~~~~~~ 311 (638)
T PRK11388 276 ESQGQFIDAVITLKPIIEGQG--TSFILLLHPVEQMRQ 311 (638)
T ss_pred ecCCceEEEEEEEEeecccCc--eEEEEEehhhHHHHH
Confidence 456777889999999975445 346666788877544
|
|
| >COG2202 AtoS FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-05 Score=79.19 Aligned_cols=114 Identities=28% Similarity=0.372 Sum_probs=86.8
Q ss_pred HHHHHHhhcccEEEEcCCCCCCCeEeeCHHHHHHcCCChhhhcCCCCCcCcCCCCCHH--HHHHHHHHHHcCCcEEEEEE
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA--TVRKIRAAIDNQTDVTVQLI 554 (905)
Q Consensus 477 l~~i~e~~~~~i~i~D~~g~dg~I~~vN~a~~~l~Gys~eEliGk~~~~l~~~~~~~~--~~~~~~~~l~~g~~~~~e~~ 554 (905)
++.++++.+++++++|. ++.++++|+++++++||+..+.++.....+........ .................+..
T Consensus 114 ~~~~~~~~~~~~~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (232)
T COG2202 114 LRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEYR 190 (232)
T ss_pred HHHHHhhCCceEEEEeC---CCCEEEeCHHHHHHhCCChHHhcCCChhheEecCCCchhhHHHHHHhhccCCCCcceEEE
Confidence 67889999999999999 55699999999999999988888877555443333221 11122222333445778888
Q ss_pred EEecCCcE-EEEEEEEeeeecCCCCEEEEEEEeecCccccc
Q 002580 555 NYTKSGKK-FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594 (905)
Q Consensus 555 ~~~kdG~~-~wv~~~~~pi~d~~G~i~~~i~i~~DITerk~ 594 (905)
...++|.. .|+.....+..+ .|.+..+.+...|+|++++
T Consensus 191 ~~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~ 230 (232)
T COG2202 191 VRRKDGERVRWILSRISPVRD-DGEIVGVVGIARDITERKQ 230 (232)
T ss_pred EEecCCCEEEEEEeeeeEecC-CCceEEEEEEEechHHHhh
Confidence 99999996 888888877765 7899999999999999887
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 905 | ||||
| 2v1a_A | 144 | N- And C-Terminal Helices Of Oat Lov2 (404-546) Are | 2e-67 | ||
| 2v0u_A | 146 | N- And C-terminal Helices Of Oat Lov2 (404-546) Are | 2e-67 | ||
| 2wkp_A | 332 | Structure Of A Photoactivatable Rac1 Containing Lov | 6e-67 | ||
| 2wkq_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 6e-66 | ||
| 2wkr_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 9e-66 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 1e-63 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 3e-25 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 6e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 3e-26 | ||
| 4eep_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 7e-55 | ||
| 4eer_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 6e-54 | ||
| 4ees_A | 115 | Crystal Structure Of Ilov Length = 115 | 4e-52 | ||
| 4eeu_A | 118 | Crystal Structure Of Philov2.1 Length = 118 | 5e-48 | ||
| 1g28_A | 104 | Structure Of A Flavin-Binding Domain, Lov2, From Th | 2e-40 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 1e-35 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-33 | ||
| 3ulf_A | 170 | The Light State Structure Of The Blue-light Photore | 1e-32 | ||
| 3ue6_A | 166 | The Dark Structure Of The Blue-light Photoreceptor | 1e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-32 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-31 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-30 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-29 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-29 | ||
| 3t50_A | 128 | X-Ray Structure Of The Lov Domain From The Lov-Hk S | 3e-29 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-29 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-29 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-28 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-28 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-27 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-27 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-27 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-27 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-26 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-26 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-26 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-26 | ||
| 2pr5_A | 132 | Structural Basis For Light-dependent Signaling In T | 7e-26 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-26 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-24 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-24 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-24 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-24 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 4e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 5e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-22 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-22 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-20 | ||
| 3rh8_B | 148 | Crystal Structure Of The Light-State Dimer Of Funga | 2e-20 | ||
| 3hjk_A | 154 | 2.0 Angstrom Structure Of The Ile74val Variant Of V | 2e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-20 | ||
| 3is2_B | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 3hji_A | 154 | 1.8 Angstrom Crystal Structure Of The I74v:i85v Var | 3e-20 | ||
| 3is2_A | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 2pd8_A | 149 | 1.8 Angstrom Crystal Structure Of The Cys71ser Muta | 3e-20 | ||
| 2pd7_A | 149 | 2.0 Angstrom Crystal Structure Of The Fungal Blue-L | 4e-20 | ||
| 3d72_A | 149 | 1.65 Angstrom Crystal Structure Of The Cys71val Var | 4e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-08 | ||
| 2l0w_A | 138 | Solution Nmr Structure Of The N-Terminal Pas Domain | 5e-08 | ||
| 2l4r_A | 135 | Nmr Solution Structure Of The N-Terminal Pas Domain | 5e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-08 | ||
| 2l1m_A | 150 | Solution Structure Of The Eag Domain Of The Herg (K | 6e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 2gj3_A | 120 | Crystal Structure Of The Fad-Containing Pas Domain | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 1byw_A | 110 | Structure Of The N-Terminal Domain Of The Human-Erg | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 9e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-04 |
| >pdb|2V1A|A Chain A, N- And C-Terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-Induced Signal Transduction (Room Temperature (293k) Dark Structure Of Lov2 (404-546)) Length = 144 | Back alignment and structure |
|
| >pdb|2V0U|A Chain A, N- And C-terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-induced Signal Transduction (cryo Dark Structure Of Lov2 (404-546)) Length = 146 | Back alignment and structure |
|
| >pdb|2WKP|A Chain A, Structure Of A Photoactivatable Rac1 Containing Lov2 Wildtype Length = 332 | Back alignment and structure |
|
| >pdb|2WKQ|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450a Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2WKR|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450m Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|4EEP|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 Length = 115 | Back alignment and structure |
|
| >pdb|4EER|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 C426a Mutant Length = 115 | Back alignment and structure |
|
| >pdb|4EES|A Chain A, Crystal Structure Of Ilov Length = 115 | Back alignment and structure |
|
| >pdb|4EEU|A Chain A, Crystal Structure Of Philov2.1 Length = 118 | Back alignment and structure |
|
| >pdb|1G28|A Chain A, Structure Of A Flavin-Binding Domain, Lov2, From The Chimeric PhytochromePHOTOTROPIN PHOTORECEPTOR PHY3 Length = 104 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ULF|A Chain A, The Light State Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 170 | Back alignment and structure |
|
| >pdb|3UE6|A Chain A, The Dark Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 166 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3T50|A Chain A, X-Ray Structure Of The Lov Domain From The Lov-Hk Sensory Protein From Brucella Abortus (Dark State). Length = 128 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2PR5|A Chain A, Structural Basis For Light-dependent Signaling In The Dimeric Lov Photosensor Ytva (dark Structure) Length = 132 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3RH8|B Chain B, Crystal Structure Of The Light-State Dimer Of Fungal Blue-Light Photoreceptor Vivid Length = 148 | Back alignment and structure |
|
| >pdb|3HJK|A Chain A, 2.0 Angstrom Structure Of The Ile74val Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IS2|B Chain B, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3HJI|A Chain A, 1.8 Angstrom Crystal Structure Of The I74v:i85v Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3IS2|A Chain A, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|2PD8|A Chain A, 1.8 Angstrom Crystal Structure Of The Cys71ser Mutant Of Vivid Length = 149 | Back alignment and structure |
|
| >pdb|2PD7|A Chain A, 2.0 Angstrom Crystal Structure Of The Fungal Blue-Light Photoreceptor Vivid Length = 149 | Back alignment and structure |
|
| >pdb|3D72|A Chain A, 1.65 Angstrom Crystal Structure Of The Cys71val Variant In The Fungal Photoreceptor Vvd Length = 149 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2L0W|A Chain A, Solution Nmr Structure Of The N-Terminal Pas Domain Of Herg Potassium Channel Length = 138 | Back alignment and structure |
|
| >pdb|2L4R|A Chain A, Nmr Solution Structure Of The N-Terminal Pas Domain Of Herg Length = 135 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2L1M|A Chain A, Solution Structure Of The Eag Domain Of The Herg (Kv11.1) K+ Channel Length = 150 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2GJ3|A Chain A, Crystal Structure Of The Fad-Containing Pas Domain Of The Protein Nifl From Azotobacter Vinelandii. Length = 120 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1BYW|A Chain A, Structure Of The N-Terminal Domain Of The Human-Erg Potassium Channel Length = 110 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 905 | |||
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 1e-65 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 4e-40 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 8e-65 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 5e-54 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-64 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-62 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 3e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 1e-56 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 9e-61 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-60 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-60 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 1e-59 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 9e-55 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-59 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 7e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 4e-54 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-58 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 4e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 9e-56 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 7e-58 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-58 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-58 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-57 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-57 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-57 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-56 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-56 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 4e-56 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 8e-56 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 1e-55 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 4e-54 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 3e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 8e-53 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 8e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 8e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 4e-52 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 3e-53 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 3e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 2e-52 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 5e-53 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 3e-50 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 9e-52 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 5e-49 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-47 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-47 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 8e-41 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-40 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-40 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-38 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-38 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-38 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-37 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-35 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-35 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-35 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-33 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-33 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-32 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-32 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-32 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-32 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-32 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-32 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-31 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-31 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-31 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-31 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-31 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-30 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-30 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-30 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-30 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-30 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-30 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-30 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-30 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-30 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-30 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-30 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 5e-30 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-30 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 6e-30 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-29 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-29 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-29 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-29 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-29 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-29 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-29 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-29 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-29 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-29 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-29 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-29 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-28 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-28 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-28 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-27 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-26 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-26 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-26 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-25 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-25 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-25 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-24 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-24 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-24 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-24 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-23 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 2e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-22 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 2e-19 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-23 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-23 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-06 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 5e-23 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-23 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-22 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-22 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-22 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-22 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-22 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 8e-22 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-21 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-21 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-21 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 6e-21 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 6e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 4e-16 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-20 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-20 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-20 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 8e-20 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-17 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-19 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 6e-19 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-19 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-18 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-18 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-18 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-16 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-16 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-14 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-13 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-13 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-13 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 7e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-12 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-12 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-12 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 5e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 7e-10 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-12 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 8e-12 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-12 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 9e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-11 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-11 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-11 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-11 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-11 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-11 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 4e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-11 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-11 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-11 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-10 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-10 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-10 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-10 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-10 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-10 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-10 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-10 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-10 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 7e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-10 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 8e-10 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 9e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-09 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-09 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-09 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-09 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-09 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-09 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-09 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 9e-09 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-08 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-08 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-08 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-08 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-08 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-08 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 5e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 7e-05 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-08 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-08 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-08 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-08 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 6e-08 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 8e-08 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 1e-07 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 4e-05 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 2e-07 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 4e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 5e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 3e-04 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 7e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 8e-07 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 5e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 2e-05 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 6e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-06 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-06 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 9e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-05 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-05 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-05 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-05 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 2e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 4e-05 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-05 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 2e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 3e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 4e-04 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 3e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 2e-04 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-05 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-04 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-04 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-04 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-04 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 9e-04 |
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 120/236 (50%), Positives = 150/236 (63%), Gaps = 15/236 (6%)
Query: 468 QKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ 527
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRN RFLQ
Sbjct: 4 SHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQ 63
Query: 528 GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQL 587
GPETD ATVRKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQL
Sbjct: 64 GPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL 123
Query: 588 DGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPK 647
DG+EH+ +++ + + + A+ + + + D + L +++ P
Sbjct: 124 DGTEHVRDAAEREGVMLIKKTAENIDEAAKELIK-CVVVGDGAVGKTCLLISYTTNAFPG 182
Query: 648 PHRKDSPPW-KAIQKILDSGEQINLQ--------HFRPIKPLGSGDTGSVHLVELC 694
+ + ++ G+ +NL + ++PL T + +C
Sbjct: 183 EYI--PTVFDNYSANVMVDGKPVNLGLWDTAGLEDYDRLRPLSYPQT---DVFLIC 233
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 48/130 (36%), Positives = 76/130 (58%)
Query: 188 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 247
+ L ++ FV++D PD PI++AS F ++T Y+ +E++GRN RFLQG
Sbjct: 7 HHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPE 66
Query: 248 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
TD V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ +
Sbjct: 67 TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 126
Query: 308 KHTEGAKDKM 317
+H A ++
Sbjct: 127 EHVRDAAERE 136
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 8e-65
Identities = 123/150 (82%), Positives = 133/150 (88%), Gaps = 7/150 (4%)
Query: 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 536
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRNCRFLQGPETD ATV
Sbjct: 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATV 63
Query: 537 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 596
RKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH+
Sbjct: 64 RKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-- 121
Query: 597 RNSIPEATAEESEKLVKQTAENVNEAVKEL 626
+A E L+K+TAEN++EA KEL
Sbjct: 122 -----DAAEREGVMLIKKTAENIDEAAKEL 146
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-54
Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 251
+ + L ++ FV++D PD PI++AS F ++T Y+ +E++GRNCRFLQG TD
Sbjct: 2 EFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRA 61
Query: 252 DVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ ++H
Sbjct: 62 TVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 121
Query: 312 GAKDKMLRPNGLPESLIRYDARQKEMATSSVTEL 345
A ++ E ++ E + EL
Sbjct: 122 DAAER--------EGVMLIKKTA-ENIDEAAKEL 146
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-64
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
+ + F+ K LG G +V L + + +A+K ++K ++ NKV ER+++
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 84
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
LDHPF LY +FQ + Y GEL + + E RFY AE+V A
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 142
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
LEYLH +GII+RDLKPEN+LL + H+ +TDF K +L +++ R
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-----AK---VLSPESKQAR------ 188
Query: 847 NPVFMAEPMRASNSFVGTEEYIAP 870
+NSFVGT +Y++P
Sbjct: 189 -----------ANSFVGTAQYVSP 201
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-62
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 29/203 (14%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + + +K +G G G V LV + + +AMK + K M+ R+ ER+I+
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RFY AEVV+AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLAL 181
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+ +H G I+RD+KP+N+LL +GH+ L DF K +G
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----------------MKMNKEGMVR 225
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
++ VGT +YI+P
Sbjct: 226 ----------CDTAVGTPDYISP 238
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-62
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 27/203 (13%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ F +K +G G V +V++ +GQ +AMK M+K ML R +V ER++L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
D ++ L+ +FQ + ++ L+ +Y GG+L LL + + + + RFY AE+V+A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAI 175
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
+ +H G ++RD+KP+N+LL GH+ L DF K R G
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC----------------LKLRADGTVR 219
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
S VGT +Y++P
Sbjct: 220 ----------SLVAVGTPDYLSP 232
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-62
Identities = 97/130 (74%), Positives = 112/130 (86%)
Query: 187 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246
PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGRNCRFLQG
Sbjct: 1 FPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGP 60
Query: 247 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +KFIGMQVEV
Sbjct: 61 DTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEV 120
Query: 307 SKHTEGAKDK 316
SK+TEG DK
Sbjct: 121 SKYTEGVNDK 130
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-56
Identities = 53/127 (41%), Positives = 79/127 (62%)
Query: 472 RKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET 531
R +L T L +++ FV++D P PI++AS F +T YS +EI+GRNCRFLQGP+T
Sbjct: 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDT 62
Query: 532 DPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
D V KIR + N +L+NY K G FWNL + P++D +G FIG+Q++ S+
Sbjct: 63 DKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSK 122
Query: 592 HLEPLRN 598
+ E + +
Sbjct: 123 YTEGVND 129
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 9e-61
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 27/204 (13%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
+++ + F +K +G G G V +V+L + + FAMK ++K ML R + ER++L
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
D ++ L+ +FQ ++ L+ DY GG+L LL + + L E+ RFY AE+V+A
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIA 187
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
++ +H ++RD+KP+N+L+ NGH+ L DF C
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS-----CLK------------------ 224
Query: 847 NPVFMAEPMRASNSFVGTEEYIAP 870
M + S+ VGT +YI+P
Sbjct: 225 ---LMEDGTVQSSVAVGTPDYISP 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-60
Identities = 75/214 (35%), Positives = 111/214 (51%), Gaps = 31/214 (14%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
HPF+ AL +FQT +C + +Y GGELF L R+ +V E+ RFY AE+V AL
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYLH + ++YRD+K EN++L +GH+ +TDF L CK +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGI----------------- 156
Query: 848 PVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+F GT EY+AP + D Y R
Sbjct: 157 -----SDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-60
Identities = 77/225 (34%), Positives = 116/225 (51%), Gaps = 35/225 (15%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKV 716
+ + E+ + F +K LG G G V LV+ + Q +AMK + K + R++V
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 717 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 776
ER+IL ++HPF+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V
Sbjct: 72 R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
+FY AE+ +AL++LH GIIYRDLKPEN+LL GH+ LTDF L K +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKK- 182
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+ SF GT EY+AP V+ +T+
Sbjct: 183 ---------------------AYSFCGTVEYMAPEVVNRRGHTQS 206
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-59
Identities = 96/113 (84%), Positives = 103/113 (91%)
Query: 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540
E IEKNFVITDPRLPDNPIIFASD FLELTEYSREEILGRN RFLQGPETD ATV+KIR
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIR 62
Query: 541 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 593
AI +Q + TVQLINYTKSGKKFWNL HLQP+RDQKGE+QYFIGVQLDGS+H+
Sbjct: 63 DAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 9e-55
Identities = 47/113 (41%), Positives = 76/113 (67%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
+ ++ FV++D PD PI++AS GF ++T Y+ +E++GRN RFLQG TD V KI
Sbjct: 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKI 61
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
R+ +++ + +L+NY K G FWNLL + P++D +G++ FIG+Q++ S H
Sbjct: 62 RDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-59
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 30/209 (14%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 721
+ D E +N HF ++ +G G G V +V+ + + +AMK M+K + RN+V
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
E +I+ L+HPF+ L+ SFQ + + ++ D GG+L L + KE+ V+ +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
E+V+AL+YL Q II+RD+KP+N+LL +GHV +TDF++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-----AA-------------- 163
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
M + GT+ Y+AP
Sbjct: 164 ---------MLPRETQITTMAGTKPYMAP 183
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-59
Identities = 78/226 (34%), Positives = 112/226 (49%), Gaps = 35/226 (15%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK- 715
+ E+I + F ++ LG G G V V +G+ FAMK + K +++ K
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
AER IL+ + HPF+ L +FQT + LI +Y GGELF+ L+R+ + ED
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDT 122
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
FY AE+ +AL +LH +GIIYRDLKPEN++L GHV LTDF L CK
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-----CK-------- 169
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+ + ++F GT EY+AP + + R
Sbjct: 170 -------------ESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRA 201
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-59
Identities = 67/155 (43%), Positives = 91/155 (58%), Gaps = 3/155 (1%)
Query: 443 EIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIF 502
+I + + ++ S +++ + L L+ ++NFVITD LPDNPI++
Sbjct: 6 SLIAQCSPEADTLLTDNPSKANRILEDPDYS---LVKALQMAQQNFVITDASLPDNPIVY 62
Query: 503 ASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 562
AS FL LT YS ++ILGRNCRFLQGPETDP V KIR AI D +V L+NY + G
Sbjct: 63 ASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTT 122
Query: 563 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 597
FWNLF + +RD KG + ++GVQ SE L
Sbjct: 123 FWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLL 157
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-54
Identities = 56/143 (39%), Positives = 84/143 (58%)
Query: 169 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT 228
+ + + + L + AL QQ FV++DA+ PD PI+YAS GF +T
Sbjct: 12 SPEADTLLTDNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLT 71
Query: 229 GYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAP 288
GY+ +++GRNCRFLQG TDP V KIR + G LLNY++DGT FWNL +A
Sbjct: 72 GYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAG 131
Query: 289 IKDDEGKVLKFIGMQVEVSKHTE 311
++D +G ++ ++G+Q +VS+
Sbjct: 132 LRDSKGNIVNYVGVQSKVSEDYA 154
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 3e-58
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
++ ++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 725 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
+L + +HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
++ L++LH +GI+YRDLK +N+LL +GH+ + DF + CK +L
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLGDAK-------- 174
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+N+F GT +YIAP + Y
Sbjct: 175 --------------TNTFCGTPDYIAPEILLGQKYNHS 198
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-58
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 32/203 (15%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+ +LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
++ HPF+ ++ +FQ + +I DY GGELF LL + + +FYAAEV +AL
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLAL 119
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
EYLH + IIYRDLKPEN+LL NGH+ +TDF K
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AK-------------------- 154
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
+ + GT +YIAP
Sbjct: 155 -----YVPDVTYTLCGTPDYIAP 172
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-58
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 260
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-56
Identities = 49/102 (48%), Positives = 66/102 (64%)
Query: 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 546
FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 5 TFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKG 64
Query: 547 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 65 EACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 7e-58
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 32/218 (14%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + + LQ F ++ +G G V LV L + + +AMK + K ++ + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 725 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
+ + +HPF+ L++ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 119
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+AL YLH +GIIYRDLK +NVLL GH+ LTD+ + CK L
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGL------------- 161
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
P +++F GT YIAP + Y
Sbjct: 162 ---------RPGDTTSTFCGTPNYIAPEILRGEDYGFS 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-58
Identities = 76/233 (32%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709
P + I S F +K +G G G V L ++A+K + K
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 710 MLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+L + + +ER +L + HPF+ L+ SFQT + + DY GGELF L R+
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-- 133
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
+ E RFYAAE+ AL YLH I+YRDLKPEN+LL GH+ LTDF L CK
Sbjct: 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-----CKE 188
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+ +T +++F GT EY+AP + Y R
Sbjct: 189 NIEHNST----------------------TSTFCGTPEYLAPEVLHKQPYDRT 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 9e-58
Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ +++ L F + LG G G V L E G+ + +A+K + K V++ + V E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 725 ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
+L + PF+ L++ FQT + + +Y GG+L + + KE FYAAE+
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ L +L +GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVT-------- 177
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+ +F GT +YIAP ++ Y +
Sbjct: 178 --------------TKTFCGTPDYIAPEIIAYQPYGKS 201
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-57
Identities = 76/211 (36%), Positives = 112/211 (53%), Gaps = 33/211 (15%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-VHRAC 720
E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 721 AEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ + E V+ Y
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIY 164
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF L K
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-----SK------------ 207
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
F+A+ + F GT EY+AP
Sbjct: 208 ---------EFVADETERAYDFCGTIEYMAP 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-57
Identities = 68/218 (31%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
S ++ + +F I+ LG G G V L + +G +A+K + K V+L + V E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 725 IL-DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
IL +HPF+ L+ FQT + + ++ GG+L + + + E RFYAAE+
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ AL +LH +GIIYRDLK +NVLL GH L DF + CK + T
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVT-------- 180
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+ +F GT +YIAP + + Y
Sbjct: 181 --------------TATFCGTPDYIAPEILQEMLYGPA 204
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-57
Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 32/256 (12%)
Query: 627 PDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTG 686
+ N ++ ++ + + LQ F ++ +G G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 687 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 745
V LV L + + +AM+ + K ++ + + E+ + +HPF+ L++ FQT++
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYRDLK +NV
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
LL GH+ LTD+ + CK L P +++F GT
Sbjct: 185 LLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTTSTFCGTP 217
Query: 866 EYIAP--VSDFAYTRM 879
YIAP + Y
Sbjct: 218 NYIAPEILRGEDYGFS 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-56
Identities = 84/269 (31%), Positives = 125/269 (46%), Gaps = 33/269 (12%)
Query: 614 QTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQH 673
+T E E + + A P +S + + ++ +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
F +K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ AL SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE 267
Query: 794 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
++YRDLK EN++L +GH+ +TDF L CK + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGAT----------------- 305
Query: 853 EPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+F GT EY+AP + D Y R
Sbjct: 306 -----MKTFCGTPEYLAPEVLEDNDYGRA 329
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-56
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
S L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
IL ++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
+ EYLH +IYRDLKPEN+L+ G++ +TDF K
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AK----------------- 189
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + GT E +AP
Sbjct: 190 --------RVKGRTWTLCGTPEALAP 207
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-56
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 37/286 (12%)
Query: 598 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 657
+ + V + + + + P L + + WK
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQ-PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWK 175
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 717
++ + + F + LG G G V ++ +G+ +A K ++K + R
Sbjct: 176 WLEA-----QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 718 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDA 775
A E++IL + F+ +L +F+TKT +CL+ GG++ + + +E
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
FY A++V LE+LH + IIYRDLKPENVLL +G+V ++D L+
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE------------ 338
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
A + + GT ++AP + Y
Sbjct: 339 --------------LKAGQTKT-KGYAGTPGFMAPELLLGEEYDFS 369
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 8e-56
Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 42/293 (14%)
Query: 596 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV-VHPKPHRKDSP 654
+N + + ++ +Q N + +++ P +L E H + V P DS
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 655 ------PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
WK +++ + + FR + LG G G V ++ +G+ +A K ++K
Sbjct: 166 YFNRFLQWKWLER-----QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+ R A E++IL+ ++ FV +L +++TK +CL+ GG+L +
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
E FYAAE+ LE LH + I+YRDLKPEN+LL +GH+ ++D L
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-----AVH 335
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAYTRM 879
+ E VGT Y+AP V + YT
Sbjct: 336 ----------------------VPEGQTI-KGRVGTVGYMAPEVVKNERYTFS 365
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 427 IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEK 486
+GR DD D G D P + D +V + + + +E
Sbjct: 21 MGRDLYDDDDKDHP----FTMGQDRPIDGSGAPGADDTRVEVQPPAQ--WVLDLIEASPI 74
Query: 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 546
V++DPRL DNP+I + +F +LT YS EE +GRNCRFL G T+P KIR +
Sbjct: 75 ASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREH 134
Query: 547 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAE 606
V V+++NY K G F N + P+ D E+ YF+G Q++ + +
Sbjct: 135 KPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNM-----GMARR 189
Query: 607 ESEKLVKQTAENVNEAVKELPDANLTPEDLWAN----------HSKVVHPKPHRKDSP 654
E + +T V L + L +++ A H +V K + K S
Sbjct: 190 ERAAEMLKTLSPRQLEVTTLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSA 247
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-54
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 147 VARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFV 206
+ R DD P T ++ + D + + V D + V
Sbjct: 21 MGRDLYDDDDKDHPFTMGQDRPIDGSGAPGADDT---RVEVQPPAQWVLDLIEASPIASV 77
Query: 207 VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 266
VSD D P++ + F +TGY+ +E VGRNCRFL G+GT+P KIR+ ++ +
Sbjct: 78 VSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPV 137
Query: 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLP-- 324
+LNYKKDGTPF N + +API DD+ ++L F+G QVEV
Sbjct: 138 LVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLK 197
Query: 325 ---------ESLIRYDARQKEMA 338
+L+ R KE+A
Sbjct: 198 TLSPRQLEVTTLVASGLRNKEVA 220
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-55
Identities = 54/114 (47%), Positives = 77/114 (67%)
Query: 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540
E +IT+P LPDNPI+FA+ +FL+LT Y +E++GRNCRFLQG TDPA VR I+
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIK 62
Query: 541 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 594
+AI + + + +INY KSG+ FWN H+ P+ + G +Q+F+ QLD + L
Sbjct: 63 SAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-53
Identities = 43/113 (38%), Positives = 67/113 (59%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
A ++++ PD PI++A+ F K+TGY + EV+GRNCRFLQG GTDP V I
Sbjct: 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAI 61
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
+ + + ++NYKK G FWN L I+P+ + G++ F+ Q++V+
Sbjct: 62 KSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLE 114
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 8e-55
Identities = 75/363 (20%), Positives = 142/363 (39%), Gaps = 41/363 (11%)
Query: 529 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
P K++ D +++ + S WN +++ + + + +
Sbjct: 189 PNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDW 248
Query: 589 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPED---------LWAN 639
S+ +E + V + +++ E + + PE +
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
K + + + + +++ L F + LG G G V L E G+ +
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368
Query: 700 FAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGE 758
+A+K + K V++ + V E+ +L + PF+ L++ FQT + + +Y GG+
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 759 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
L + + KE FYAAE+ + L +L +GIIYRDLK +NV+L GH+ + DF
Sbjct: 429 LMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP--VSDFAY 876
+ CK + T + +F GT +YIAP ++ Y
Sbjct: 487 GM-----CKENIWDGVT----------------------TKTFCGTPDYIAPEIIAYQPY 519
Query: 877 TRM 879
+
Sbjct: 520 GKS 522
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-55
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 467 RQKEMRKGIDLATTLERIEK---NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR-- 521
R + L T + + E F+I + R+ + +I+ +D F EL YSR E++ R
Sbjct: 8 RGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPC 67
Query: 522 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 581
C FL GP T +I A+ + V++ Y K G F L + P++++ G V
Sbjct: 68 TCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIM 127
Query: 582 FIGVQLDGSE 591
FI E
Sbjct: 128 FILNFEVVME 137
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-52
Identities = 32/118 (27%), Positives = 59/118 (50%), Gaps = 2/118 (1%)
Query: 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTD 249
D + + F++++A + ++Y + GF ++ GY+ EV+ R C FL G T
Sbjct: 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQ 78
Query: 250 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
A+I + L + + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 79 RRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 136
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 3/135 (2%)
Query: 460 DSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEIL 519
V + L + ++ V+ + D +I+ + +F LT YSR+EIL
Sbjct: 13 GLVPRGSHMINAQL---LQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEIL 69
Query: 520 GRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 579
++CRFLQG + D +IR A+ L NY K G FWN + P++ +
Sbjct: 70 YQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQR 129
Query: 580 QYFIGVQLDGSEHLE 594
YFIG+Q D S +E
Sbjct: 130 TYFIGIQKDVSRQVE 144
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-53
Identities = 42/115 (36%), Positives = 66/115 (57%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
+ VV++ D ++Y +A F +TGY+ E++ ++CRFLQG D A+I
Sbjct: 30 MVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARI 89
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
R+ + G+ L NY+KDG+ FWN L+I P+K D + FIG+Q +VS+ E
Sbjct: 90 RKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE 144
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-53
Identities = 68/275 (24%), Positives = 119/275 (43%), Gaps = 38/275 (13%)
Query: 601 PEATAEESEKLVKQTAENVNEAVKELPDANLTP--EDLWANHSKVVHPKPHRKDSPPWKA 658
+ S+ ++ ++ + K++P P E++ N V K D
Sbjct: 118 LACSHPFSKSAIEHVQGHLVK--KQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFC 175
Query: 659 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
K ++ + + F + +G G G V+ +G+ +AMK +DK + +
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 719 ACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
A ER +L ++ D PF+ + +F T + I D GG+L L + V E
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAD 293
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+RFYAAE+++ LE++H + ++YRDLKP N+LL +GHV ++D L+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------------- 339
Query: 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K + ++ VGT Y+AP
Sbjct: 340 ---CDFSKKK------------PHASVGTHGYMAP 359
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 2/107 (1%)
Query: 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAID 544
F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALL 62
Query: 545 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 63 GAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETL 260
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-53
Identities = 58/128 (45%), Positives = 80/128 (62%), Gaps = 5/128 (3%)
Query: 481 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540
L+ + VITDP L DNPI++ + F+++T Y EEILG+NCRFLQG TDPA V IR
Sbjct: 5 LDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIR 64
Query: 541 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL---EPLR 597
A+ N+ VTVQ+ NY K G FWN ++ PM + YF+G+Q D ++ + L
Sbjct: 65 TALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEI--EDKTYFVGIQNDITKQKEYEKLLE 122
Query: 598 NSIPEATA 605
+S+ E TA
Sbjct: 123 DSLTEITA 130
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 3e-50
Identities = 49/115 (42%), Positives = 73/115 (63%), Gaps = 2/115 (1%)
Query: 197 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 256
L + V++D D PI+Y + GF +MTGY ++E++G+NCRFLQG TDP +V I
Sbjct: 4 MLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNI 63
Query: 257 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
R LQN + ++ NYKKDGT FWN L I P++ ++ F+G+Q +++K E
Sbjct: 64 RTALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIEDKTY--FVGIQNDITKQKE 116
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-52
Identities = 48/141 (34%), Positives = 76/141 (53%), Gaps = 26/141 (18%)
Query: 474 GIDLATTLERI--EKN-------------FVITDPRLPDNPIIFASDSFLELTEYSREEI 518
G D+ L +I N ++ D + D PI++AS++FL +T YS E+
Sbjct: 9 GYDIMGYLIQIMNRPNPQVELGPVDTSVALILCDLKQKDTPIVYASEAFLYMTGYSNAEV 68
Query: 519 LGRNCRFLQGPE-----------TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 567
LGRNCRFLQ P+ D T+ +R AID +V V+++N+ K+G++F N
Sbjct: 69 LGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFL 128
Query: 568 HLQPMRDQKGEVQYFIGVQLD 588
+ P+RD+ GE +Y +G Q +
Sbjct: 129 TMIPVRDETGEYRYSMGFQCE 149
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-49
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 205 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG-----------TDPEDV 253
++ D + D PI+YAS F MTGY++ EV+GRNCRFLQ D +
Sbjct: 38 LILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTI 97
Query: 254 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 305
+R+ + ++N+KK+G F N LT+ P++D+ G+ +G Q E
Sbjct: 98 NTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 53/168 (31%), Positives = 74/168 (44%), Gaps = 5/168 (2%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
Q L+ F +PLG G G+V+L S A+K + K + H+ E EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + LY F T V LI +Y P G ++ L + E Y E+ AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 122
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
Y H + +I+RD+KPEN+LL G + + DF S P
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTDL 167
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-47
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 31/203 (15%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+ + F +PLG G G+V+L + A+K + K + H+ E EI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + +Y F + + L+ ++ P GEL+ L + E + E+ AL
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADAL 127
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
Y H + +I+RD+KPEN+L+ G + + DF S RR
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA------------PSLRRR----- 170
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
+ GT +Y+ P
Sbjct: 171 ------------TMCGTLDYLPP 181
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-41
Identities = 39/221 (17%), Positives = 85/221 (38%), Gaps = 44/221 (19%)
Query: 634 EDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVEL 693
+D+ +N+S +++ + K+ + + +R I+ L G + L E
Sbjct: 7 KDILSNYSNLIYLNKYVKE--------------KDKYINDYRIIRTLNQGKFNKIILCE- 51
Query: 694 CGSGQYFAMKAMDKGVMLNRNKVHRACA--------------EREILDMLDHPFVPALYA 739
+++A+K +K ++ + ++ E +I+ + + +
Sbjct: 52 -KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 740 SFQTKTHVCLITDYCPGGELF------LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
V +I +Y + +LD+ T + ++ V+ + Y+H +
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 794 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCL-------TSC 826
I +RD+KP N+L+ NG V L+DF S S
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 52/245 (21%), Positives = 85/245 (34%), Gaps = 35/245 (14%)
Query: 630 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKIL---DSGEQINLQHFRPIKPLGSGDTG 686
+L E+L+ + P+ + +Q E Q F+ + LG G G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 687 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 745
V V G+ +A+K +++ AE + HP L +++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ L T+ C G L + L E V Y + ++AL +LH QG+++ D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 865
L G L DF L V + G
Sbjct: 189 FLGPRGRCKLGDFGLL---------------------------VELGTAGAG-EVQEGDP 220
Query: 866 EYIAP 870
Y+AP
Sbjct: 221 RYMAP 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 31/213 (14%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
F I LG G G V +Y+A+K + K+ +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN 60
Query: 731 HPFVPALYASFQ-------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 777
H +V YA++ K+ + + +YC G L+ L+ + + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYW 119
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+++ AL Y+H QGII+RDLKP N+ + + +V + DF L+ N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------------KNV 166
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + + + S +GT Y+A
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 1/161 (0%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ F+ LG G V+ E +G A+K +DK M V R E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + LY F+ +V L+ + C GE+ L + K E+ R + +++ + YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYL 128
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
H GI++RDL N+LL N ++ + DF L+ +
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 4/200 (2%)
Query: 632 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 691
P D V +PP K I ++L + + + + LG G +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR--SRRRYVRGRFLGKGGFAKCFEI 60
Query: 692 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751
+ + FA K + K ++L ++ + E I L H V + F+ V ++
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811
+ C L L R+ K L E R+Y ++V+ +YLH +I+RDLK N+ L +
Sbjct: 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 812 HVSLTDFDLSCLTSCKPQLL 831
V + DF L+ +
Sbjct: 179 EVKIGDFGLATKVEYDGERK 198
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-38
Identities = 45/227 (19%), Positives = 102/227 (44%), Gaps = 33/227 (14%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H + ++ +++ + ++ +G G G LV+ G+ + +K
Sbjct: 1 MHHHHHHS-----SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK 55
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 763
++ M ++ + + E +L + HP + SF+ + ++ DYC GG+LF +
Sbjct: 56 EINISRMSSKER-EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
+ Q + +ED + + ++ +AL+++H + I++RD+K +N+ L +G V L DF ++ +
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ +L + +GT Y++P
Sbjct: 175 LNSTVELA---------------------------RACIGTPYYLSP 194
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 2/162 (1%)
Query: 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 729
+ + + + LG G + + + FA K + K ++L ++ + E I L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
H V + F+ V ++ + C L L R+ K L E R+Y ++V+ +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 130
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
LH +I+RDLK N+ L + V + DF L+ +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 37/211 (17%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
+ + + LG G T +V +G FA+K + L V E E+L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 727 DMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 783
L+H + L+A + T H LI ++CP G L+ +L + L E +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 839
V + +L GI++R++KP N++ G LTDF +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------------------ 163
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ ++ S GTEEY+ P
Sbjct: 164 ---RELEDDEQFV-------SLYGTEEYLHP 184
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 37/213 (17%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + + LG G T +V +G FA+K + L V E E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 725 ILDMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAA 781
+L L+H + L+A + T H LI ++CP G L+ +L + L E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNE 837
+VV + +L GI++R++KP N++ G LTDF +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------- 163
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ ++ S GTEEY+ P
Sbjct: 164 -----RELEDDEQF-------VSLYGTEEYLHP 184
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 32/227 (14%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
P P KA++ + L +FR K +G G V+ G A+K +
Sbjct: 9 QGPPVPQFQPQKALRPDMGYNT---LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 706 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-- 763
+++ E ++L L+HP V YASF + ++ + G+L ++
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 764 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
++ +++ E V Y ++ ALE++H + +++RD+KP NV + G V L D L
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
S K +S VGT Y++P
Sbjct: 186 FSSKTTAA---------------------------HSLVGTPYYMSP 205
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 49/209 (23%), Positives = 83/209 (39%), Gaps = 27/209 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
I+ +H+ I+ LG G V LVE G ++A+K + +R + R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 728 MLDHPFVPALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAA 781
+ +HP + L A + L+ + G L+ ++R K L ED + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
+ LE +H +G +RDLKP N+LL G L D S + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG-----SMNQACIHVEGSRQ--- 193
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
A ++ + T Y AP
Sbjct: 194 ----------ALTLQDWAAQRCTISYRAP 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 40/216 (18%), Positives = 74/216 (34%), Gaps = 51/216 (23%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
F+ I+ +GSG G V + G+ + +K + N K R E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLD 62
Query: 731 HPFVPALYASFQ----------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
H + + + + ++C G L ++++ + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
++ ++Y+H + +I RDLKP N+ L V + DF L L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--------SLKN 174
Query: 835 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
++ GT Y++P
Sbjct: 175 DGKRT--------------------RSKGTLRYMSP 190
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 37/209 (17%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+ + + +G+G G + G+ K +D G M K +E +L L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 731 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVA 786
HP + Y +T + ++ +YC GG+L ++ + + L E+ V ++ +A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 787 LEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
L+ H +++RDLKP NV L G +V L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-------------------- 163
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + A +FVGT Y++P
Sbjct: 164 -RILNHDTSFA------KTFVGTPYYMSP 185
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 44/209 (21%), Positives = 76/209 (36%), Gaps = 40/209 (19%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDML 729
+ + +G G V +GQ FA+K +D + + +RE I ML
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAVRFYAAEVV 784
HP + L ++ + + ++ ++ G +L V E Y +++
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLC---FEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 785 VALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
AL Y H II+RD+KP VLL + V L F ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-------------------- 180
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + E + VGT ++AP
Sbjct: 181 -------IQLGESGLVAGGRVGTPHFMAP 202
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 10/168 (5%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
++ + H+ LG G G V + E +G A+K +++ + + + V + E + L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ HP + LY T T ++ +Y GGELF + + ++E R +++ A
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL--------TSC 826
++Y H +++RDLKPENVLL + + + DF LS + TSC
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 8/176 (4%)
Query: 652 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 711
+ PP + L + E Q + + PLGSG G V + +K + K +L
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 712 NRNKVHRACAER-----EILDMLDHPFVPALYASFQTKTHVCLITD-YCPGGELFLLLDR 765
+ + IL ++H + + F+ + L+ + + G +LF +DR
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
P L E + ++V A+ YL + II+RD+K EN+++ + + L DF +
Sbjct: 124 HPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 38/251 (15%), Positives = 75/251 (29%), Gaps = 49/251 (19%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINL--QHFRPIKPLGSGDTGSVHLVE-----L 693
S + P ++ W+ + + L + LG G V+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 694 CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753
+ Q F +K N + + E L Y++ + L+ +
Sbjct: 92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148
Query: 754 CPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG- 809
G L ++ P KV+ + V +A ++ +E +H II+ D+KP+N +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208
Query: 810 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 859
+ ++L D S P + +F
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFP-----------------KGTIF--------T 243
Query: 860 SFVGTEEYIAP 870
+ T +
Sbjct: 244 AKCETSGFQCV 254
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 729
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 788
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL-LLPTT 835
YLH GI +RD+KPEN+LL ++ ++DF L+ + + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAE 722
+ EQ ++ ++R +K +G G+ V L +G+ A+K +DK + + K+ R E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---E 64
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
I+ +L+HP + L+ +T+ + LI +Y GGE+F L +KE R +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQ 122
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL--------TSC 826
+V A++Y H + I++RDLK EN+LL + ++ + DF S C
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 37/197 (18%)
Query: 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-- 721
SG+ + L + +G G G V L Y+AMK + K ++ + R
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 722 -------------------EREI--LDMLDHPFVPALY--ASFQTKTHVCLITDYCPGGE 758
+EI L LDHP V L + H+ ++ + G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 759 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ + +P L ED RFY +++ +EYLH Q II+RD+KP N+L+ +GH+ + DF
Sbjct: 125 VMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 819 DLSCL---------TSC 826
+S +
Sbjct: 182 GVSNEFKGSDALLSNTV 198
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 32/214 (14%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 729
L F PI+ LG G G V + +A+K + L R KV R E + L L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 730 DHPFVPALYASFQTKT------------HVCLITDYCPGGELFLLLDRQPTKVLKEDA-V 776
+HP + + ++ K ++ + C L ++ + T +E +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 836
++ A+E+LH +G+++RDLKP N+ + V + DF L +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDE 172
Query: 837 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
E++ VGT+ Y++P
Sbjct: 173 EEQTVLTPMPAYARH-------TGQVGTKLYMSP 199
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 38/217 (17%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHR 718
++ L I+ F + LGSG G VHLVE SG +K ++K + ++
Sbjct: 11 RENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 719 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDAV 776
E E+L LDHP + ++ F+ ++ ++ + C GGEL ++ + K L E V
Sbjct: 70 ---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLP 833
+++ AL Y H Q ++++DLKPEN+L Q + + + DF L+
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------------ 174
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ S + GT Y+AP
Sbjct: 175 ---------------ELF-KSDEHSTNAAGTALYMAP 195
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 38/203 (18%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
Q++ +G G G V + G+ A K + K + + ++ + E EI+ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 790
P + LY +F+ T + L+ + C GGELF +R K +E +V+ A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 791 HCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H + +RDLKPEN L + S L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-------------------------- 156
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
+P + + VGT Y++P
Sbjct: 157 -ARF-KPGKMMRTKVGTPYYVSP 177
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 9/168 (5%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 729
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 788
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL-LLPTT 835
YLH GI +RD+KPEN+LL ++ ++DF L+ + + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 57/229 (24%), Positives = 87/229 (37%), Gaps = 46/229 (20%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 709
R + P S +++ P + LG G + V + + +A+K +D
Sbjct: 2 RDAALPGS------HSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG 54
Query: 710 MLNRNKVH----RACAERE--ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
+ + R +E IL + HP + L +++T T L+ D GELF
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-- 112
Query: 763 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
D KV L E R ++ + LH I++RDLKPEN+LL + ++ LTDF S
Sbjct: 113 -DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
C P L GT Y+AP
Sbjct: 172 CQ--LDPGEKLREV--------------------------CGTPSYLAP 192
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 49/197 (24%), Positives = 80/197 (40%), Gaps = 38/197 (19%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
+ LGSG G VH +G+ F K ++ L++ V E I++ L HP + L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 795
+ +F+ K + LI ++ GGELF DR + + E V Y + L+++H I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 796 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
++ D+KPEN++ + V + DF L+
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT----------------------------KLN 202
Query: 854 PMRASNSFVGTEEYIAP 870
P T E+ AP
Sbjct: 203 PDEIVKVTTATAEFAAP 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 37/233 (15%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H S E N + K LG G V +GQ +A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 704 AMDKGVMLNRNKVHRACAERE--ILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELF 760
+ K R + RA E +L++ P V L+ ++ + + LI +Y GGE+F
Sbjct: 61 FLKKR---RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 761 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTD 817
L + +++ E+ V +++ + YLH I++ DLKP+N+LL G + + D
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
F +S +R +GT EY+AP
Sbjct: 178 FGMS--RKIGHA-----------------------CELR---EIMGTPEYLAP 202
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
++ + LG G G V L + +GQ A+K + K + + E ++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 790
P + LY F+ K + L+ + GGELF D K E +V+ + Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 791 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSC 822
H I++RDLKPEN+LL+ + ++ + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 45/229 (19%), Positives = 85/229 (37%), Gaps = 34/229 (14%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H S + + + +K +GSG + V V L Q +A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQS-MSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIK 58
Query: 704 AMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASFQTKTHVCLITDYCPGGELFL 761
++ + + E L+ L + LY T ++ ++ + +L
Sbjct: 59 YVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L ++ K + + Y ++ A+ +H GI++ DLKP N L+ +G + L DF ++
Sbjct: 117 WLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ P T + +S VGT Y+ P
Sbjct: 174 -------NQMQPDTTSVVK------------------DSQVGTVNYMPP 197
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 39/201 (19%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 734
+ LGSG V G+G+ +A K + K + + R V R ERE IL + HP +
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 793
L+ F+ KT V LI + GGELF D K L ED + +++ + YLH +
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 794 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
I + DLKPEN++L N + L DF ++ +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--HKIEAG-------------------- 165
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
+ + GT E++AP
Sbjct: 166 ---NEFK---NIFGTPEFVAP 180
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 62/286 (21%), Positives = 110/286 (38%), Gaps = 47/286 (16%)
Query: 589 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 648
G+E+L S + + + + +P + L + P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 649 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
HR + A+ + + LG G G VH E +G A K +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKT---------EILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
M ++ +V E +++ LDH + LY +F++K + L+ +Y GGELF DR
Sbjct: 126 GMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF---DRIID 179
Query: 769 K--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLT 824
+ L E + ++ + ++H I++ DLKPEN+L + + + DF L+
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA--- 236
Query: 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
RR+K + E ++ GT E++AP
Sbjct: 237 ---------------RRYKPR-------EKLK---VNFGTPEFLAP 257
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 39/207 (18%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH-RACAERE--ILDM 728
+ + LGSG V +G +A K + K + R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVAL 787
+ H V L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 788 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + GT E++AP
Sbjct: 173 ---------VEFK---NIFGTPEFVAP 187
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 726
++ + H+ LG G G V + + +G A+K +++ + + + V + E + L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ HP + LY T + + ++ +Y GGELF + + L E R +++
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL--------TSC 826
++Y H +++RDLKPENVLL + + + DF LS + TSC
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 52/269 (19%), Positives = 87/269 (32%), Gaps = 68/269 (25%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 703
+H H + + S ++ + + +G G G V + + A+K
Sbjct: 1 MHHHHHHSSGR--ENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 704 AMDKGVMLNRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF- 760
M+K + N + E ++ L HP + LY ++ + ++CL+ + C GG L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 761 -------------------------------------LLLDRQPTKVLKEDAVRFYAAEV 783
V +E + ++
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 841
AL YLH QGI +RD+KPEN L + + L DF LS K+
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS----------------KEFY 221
Query: 842 HKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
M GT ++AP
Sbjct: 222 KLNNGEYYGMTT-------KAGTPYFVAP 243
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 48/198 (24%), Positives = 74/198 (37%), Gaps = 31/198 (15%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 736
LG G V + Q +A+K ++K R++V R E E+L H V
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
L F+ + L+ + GG + + E +V AL++LH +GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 796 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
+RDLKPEN+L + VS + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG-----------------SGIKLNGDCSPIST 175
Query: 853 EPMRASNSFVGTEEYIAP 870
+ + G+ EY+AP
Sbjct: 176 PELL---TPCGSAEYMAP 190
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 54/281 (19%), Positives = 102/281 (36%), Gaps = 51/281 (18%)
Query: 594 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 653
+P + P + K ++ +V+E K + + + +
Sbjct: 92 KPCEPTAPVLIPGDERK--RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 654 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
+ D E+ LG+G G VH V +G FA K + ++
Sbjct: 150 IKHDHVLDHYDIHEE-----------LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 714 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VL 771
V + E + + +L HP + L+ +F+ + +I ++ GGELF ++ + +
Sbjct: 199 ETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNKM 252
Query: 772 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQ 829
ED Y +V L ++H ++ DLKPEN++ + + L DF L+
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA------- 305
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+P ++ GT E+ AP
Sbjct: 306 ---------------------HLDPKQSVKVTTGTAEFAAP 325
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 25/168 (14%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN----KVHRACAEREILDMLDHPF 733
LG G G V V + A+K + K + V + E ++L L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67
Query: 734 VPALY--ASFQTKTHVCLITDYCPGG--ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
V L + K + ++ +YC G E+ D P K Y +++ LEY
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-----------CLTSC 826
LH QGI+++D+KP N+LL G + ++ ++ C TS
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 39/207 (18%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK-GVMLNRNKVHRACAERE--ILDM 728
+ + LGSG V +G +A K + K +R V R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVAL 787
+ HP + L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 788 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + GT E++AP
Sbjct: 173 ---------VEFK---NIFGTPEFVAP 187
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 54/201 (26%), Positives = 80/201 (39%), Gaps = 39/201 (19%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 734
+ LGSG V +G +A K + K + R V R ERE IL + HP V
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 793
L+ ++ KT V LI + GGELF D K L E+ + +++ + YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 794 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
I + DLKPEN++L + + DF L+
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFG-------------------- 171
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
+ + GT E++AP
Sbjct: 172 ---NEFK---NIFGTPEFVAP 186
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 36/203 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + LG G G V + + Q +A+K ++K N++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 790
P + L+ + + ++ + GGELF D K E +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 791 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-------------------------- 171
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
+ +GT YIAP
Sbjct: 172 -TCF-QQNTKMKDRIGTAYYIAP 192
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 14/236 (5%)
Query: 598 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 657
N E L E ++ L D +L A K+ +P ++ ++
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 658 AIQKILDSGEQINLQHFRPI----KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 713
++ + + + F +G G + V +G FA+K M+
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 714 NKVHRACAER-----EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 767
+ E IL + HP + L S+++ + + L+ D GELF D
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF---DYLT 192
Query: 768 TKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
KV L E R ++ A+ +LH I++RDLKPEN+LL N + L+DF SC
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 43/197 (21%), Positives = 79/197 (40%), Gaps = 39/197 (19%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
+ LG G+ G VH S + + K + ++ V + E IL++ H + L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARHRNILHL 66
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 795
+ SF++ + +I ++ G ++F +R T L E + Y +V AL++LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 796 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+ D++PEN++ Q + + + +F + KP +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPG-----------------------D 158
Query: 854 PMRASNSFVGTEEYIAP 870
R EY AP
Sbjct: 159 NFR---LLFTAPEYYAP 172
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 729
++ + LG G V +G FA K ++ + R+ K+ R E I L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 788
HP + L+ S Q ++ L+ D GGELF + + E +++ ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIA 119
Query: 789 YLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
Y H GI++R+LKPEN+LL V L DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA------------------------ 155
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAP 870
+ + A + F GT Y++P
Sbjct: 156 ---IEV-NDSEAWHGFAGTPGYLSP 176
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 16/177 (9%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA 719
LD + + +K +GSG+ G L+ + + A+K +++G V R
Sbjct: 8 TGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQR- 65
Query: 720 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 779
E L HP + T TH+ +I +Y GGEL+ + ED RF+
Sbjct: 66 --EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFF 121
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCL--------TSC 826
+++ + Y H I +RDLK EN LL G+ + + DF S ++
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F ++ LGSG V LV+ +G+ FA+K + K + + E +L + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 790
+ L +++ TH L+ GGELF DR + E +V+ A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF---DRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 791 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 821
H GI++RDLKPEN+L N + +TDF LS
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 33/205 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+ + + +K +GSG + V V L Q +A+K ++ + + E L+
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLN 62
Query: 728 MLDHP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
L + LY T ++ ++ + +L L ++ K + + Y ++
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLE 119
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
A+ +H GI++ DLKP N L+ +G + L DF ++ + +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA------------------NQMQPD 160
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAP 870
V +S VGT Y+ P
Sbjct: 161 TTSVVK-------DSQVGTVNYMPP 178
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 40/205 (19%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 729
+ + + LG G G V + + Q +A+K ++K N++ + R E E+L L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKL 78
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALE 788
DHP + L+ + + ++ + GGELF D K E +V +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 789 YLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
Y+H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--------------------- 174
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAP 870
+ +GT YIAP
Sbjct: 175 -------QQNTKMKDRIGTAYYIAP 192
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 59/241 (24%), Positives = 93/241 (38%), Gaps = 48/241 (19%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINL--------QHFRPIKPLGSGDTGSVHLVELCG 695
+H H Q L + + + + ++ +K LGSG G V L
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 696 SGQYFAMKAMDKGVMLNRN--KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753
+ A+K + K + + K+ E +L +LDHP + LY F+ K + L+ +
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 754 CPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---G 809
GGELF D E +V+ + YLH I++RDLKPEN+LL+
Sbjct: 118 YKGGELF---DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
+ + + DF LS + E + +GT YIA
Sbjct: 175 DALIKIVDFGLSA----------------------------VFENQKKMKERLGTAYYIA 206
Query: 870 P 870
P
Sbjct: 207 P 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 41/232 (17%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
H + + ++++ + + ++ + LG G V +G FA K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 705 MDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
++ + R K+ R E I L HP + L+ S Q ++ L+ D GGELF
Sbjct: 62 INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-- 116
Query: 763 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDF 818
+ + E +++ ++ Y H GI++R+LKPEN+LL V L DF
Sbjct: 117 -EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 819 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
L+ + + A + F GT Y++P
Sbjct: 176 GLA---------------------------IEV-NDSEAWHGFAGTPGYLSP 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 55/172 (31%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
+ + ++ + + LG G G V L + Q A+K + + ++ + R ERE
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV--ERE 59
Query: 725 I--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
I L +L HP + LY T T + ++ +Y GGELF + + K + ED R + +
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQ 116
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL--------TSC 826
++ A+EY H I++RDLKPEN+LL N +V + DF LS + TSC
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-29
Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 24/200 (12%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPI-------KPLGSGDTGSVHLVELCGS 696
+H H Q I + + I + LGSG G V L +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 697 GQYFAMKAMDKGVMLNRNKVHRACA----------EREILDMLDHPFVPALYASFQTKTH 746
A+K + K E +L LDHP + L+ F+ K +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 747 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
L+T++ GGELF ++ E +++ + YLH I++RD+KPEN+
Sbjct: 121 FYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 806 LLQ---GNGHVSLTDFDLSC 822
LL+ ++ + DF LS
Sbjct: 178 LLENKNSLLNIKIVDFGLSS 197
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-29
Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 40/208 (19%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + LG+G G V +G+ A+K + L+ R C E +I+ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHP 72
Query: 733 FVPALYASFQTKTHV------CLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVV 785
V + + L +YC GG+L L + LKE +R +++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
AL YLH II+RDLKPEN++LQ + D + L
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELC---------- 180
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP 870
FVGT +Y+AP
Sbjct: 181 ----------------TEFVGTLQYLAP 192
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 726
+ K LGSG G V L + + A+K + K + A EIL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVV 785
L+HP + + F + ++ + GGELF D+ LKE + Y ++++
Sbjct: 70 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 786 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 821
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 47/203 (23%), Positives = 79/203 (38%), Gaps = 35/203 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ ++ + LG G V +GQ +A ++ L+ + E I +L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 790
P + L+ S + H LI D GGELF + + E +++ A+ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF---EDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 791 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 847
H G+++R+LKPEN+LL V L DF L+
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-------------------------- 160
Query: 848 PVFMAEPMRASNSFVGTEEYIAP 870
+ + +A F GT Y++P
Sbjct: 161 -IEVEGEQQAWFGFAGTPGYLSP 182
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 48/198 (24%), Positives = 72/198 (36%), Gaps = 41/198 (20%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPA 736
KPLG G S Q FA+K + K E L + + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
L+ F + H L+ + GGELF +R + K E + ++V A+ ++H G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 796 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
++RDLKPEN+L + DF + R K N
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA-------------------RLKPPDNQPLK- 167
Query: 853 EPMRASNSFVGTEEYIAP 870
+ T Y AP
Sbjct: 168 -------TPCFTLHYAAP 178
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 41/208 (19%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 726
+ K LGSG G V L + + A++ + K + A EIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVV 785
L+HP + + F + ++ + GGELF D+ K LKE + Y ++++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 250
Query: 786 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 289
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K M + GT Y+AP
Sbjct: 290 KILGETSLM-------RTLCGTPTYLAP 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-28
Identities = 47/249 (18%), Positives = 90/249 (36%), Gaps = 34/249 (13%)
Query: 624 KELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG 683
+P + E A + P KA + + + + +K +GSG
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANEC-ISVKGRIYSILKQIGSG 67
Query: 684 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASF 741
+ V V L Q +A+K ++ + + E L+ L + LY
Sbjct: 68 GSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 742 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 801
T ++ ++ + +L L ++ K + + Y ++ A+ +H GI++ DLK
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 802 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 861
P N L+ +G + L DF ++ + P T + +S
Sbjct: 183 PANFLIV-DGMLKLIDFGIA-------NQMQPDTTSVVK------------------DSQ 216
Query: 862 VGTEEYIAP 870
VG Y+ P
Sbjct: 217 VGAVNYMPP 225
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 40/197 (20%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G T V+ + G+ + +A+K + K E +L L HP + L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGII 796
F+T T + L+ + GGELF DR K E +++ A+ YLH GI+
Sbjct: 114 KEIFETPTEISLVLELVTGGELF---DRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 797 YRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 853
+RDLKPEN+L + + + DF LS + + Q+L+ T
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKT------------------- 209
Query: 854 PMRASNSFVGTEEYIAP 870
GT Y AP
Sbjct: 210 -------VCGTPGYCAP 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 14/174 (8%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ R + L G V+ + GSG+ +A+K + + + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMK 80
Query: 728 ML-DHPFVPALYASFQTKTH--------VCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
L HP + ++ L+T+ C G + L + L D V
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 779 YAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
+ A++++H Q II+RDLK EN+LL G + L DF + S P
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 46/224 (20%), Positives = 78/224 (34%), Gaps = 43/224 (19%)
Query: 653 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 712
+ +I + L + + +G G + FA+K +DK +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----S 58
Query: 713 RNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKV 770
+ E EIL HP + L + +V ++T+ GGEL D+ K
Sbjct: 59 KRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL---DKILRQKF 112
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSC 826
E + +EYLH QG+++RDLKP N+L + + DF +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA----- 167
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K+ R + + P T ++AP
Sbjct: 168 -----------KQLRAENG----LLMTP-------CYTANFVAP 189
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 33/154 (21%), Positives = 63/154 (40%), Gaps = 8/154 (5%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LD 727
F ++ +GSG+ GSV G +A+K K + V A RE+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVDEQNALREVYAHAV 66
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVV 785
+ H V ++++ H+ + +YC GG L + + KE ++ +V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
L Y+H +++ D+KP N+ + + +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 48/235 (20%), Positives = 86/235 (36%), Gaps = 33/235 (14%)
Query: 637 WANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGS 696
+ + + P+ + K +D + + +G G G VH ++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 697 GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756
G A+K + V E L P + LY + + V + + G
Sbjct: 83 GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSL 815
G L L+ + L ED +Y + + LEYLH + I++ D+K +NVLL +G +L
Sbjct: 135 GSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 816 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
DF + P + + + + GTE ++AP
Sbjct: 193 CDFGHA----------------------LCLQPDGLGKSLLTGDYIPGTETHMAP 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 42/197 (21%), Positives = 74/197 (37%), Gaps = 18/197 (9%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 705
+PP + +R LG G G+V A+K +
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 706 DKGVMLNRNKVHRACA-EREI--LDMLD----HPFVPALYASFQTKTHVCLITDY-CPGG 757
+ +L + + + E+ L + HP V L F+T+ L+ + P
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLT 816
+LF + + L E R + +VV A+++ H +G+++RD+K EN+L+ G L
Sbjct: 125 DLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 817 DFDLSCL-------TSC 826
DF L
Sbjct: 183 DFGSGALLHDEPYTDFD 199
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 43/200 (21%), Positives = 79/200 (39%), Gaps = 16/200 (8%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
S +V H A + ++ ++ LGSG GSV+
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 701 AMKAMDKGVMLNRNKV-HRACAEREI--LDMLDH--PFVPALYASFQTKTHVCLITDYC- 754
A+K ++K + + ++ + E+ L + V L F+ LI +
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHV 813
P +LF + + L+E+ R + +V+ A+ + H G+++RD+K EN+L+ N G +
Sbjct: 132 PVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 814 SLTDFDLSCL-------TSC 826
L DF L
Sbjct: 190 KLIDFGSGALLKDTVYTDFD 209
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 27/175 (15%), Positives = 54/175 (30%), Gaps = 31/175 (17%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 726
LG D + +G+ F + N + + E L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 727 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 768
D++ P + + + +++ + +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 769 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 41/206 (19%), Positives = 68/206 (33%), Gaps = 55/206 (26%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFV 734
+ LG G G V +GQ A+K + A +E+ P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYD----------SPKARQEVDHHWQASGGPHI 84
Query: 735 PALYASFQTKTH----VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 787
+ ++ H + +I + GGELF R + + E ++ A+
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
++LH I +RD+KPEN+L + LTDF + K
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---------------------KE 180
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAP 870
+ T Y+AP
Sbjct: 181 TTQNALQ--------TPCYTPYYVAP 198
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 35/260 (13%), Positives = 73/260 (28%), Gaps = 51/260 (19%)
Query: 592 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK 651
H+E + + + E E + E + E + +W +++ +
Sbjct: 3 HMEAGDSFMRDLLKREEELIGYCREEALKEPAAMV---EAVTATVWPQNAETTVDSLLSQ 59
Query: 652 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 711
+ + ++PL GD V LV + FA+K G
Sbjct: 60 GE------------------RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 712 NRNKVHRACAEREILDMLDHPFVPALYASFQ--------------------------TKT 745
+R+++ R L +
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 746 HVCLITDYCPG--GELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 801
+ L+ LF LD A+ A+++ L +G+++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221
Query: 802 PENVLLQGNGHVSLTDFDLS 821
P+N+ + +G + L D
Sbjct: 222 PDNLFIMPDGRLMLGDVSAL 241
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 45/239 (18%), Positives = 78/239 (32%), Gaps = 54/239 (22%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
P P + P + + I + + LG G G V + + + FA+K
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 705 MDKGVMLNRNKVHRACAEREI---LDMLDHPFVPALYASFQT----KTHVCLITDYCPGG 757
+ A RE+ P + + ++ + + ++ + GG
Sbjct: 95 LQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144
Query: 758 ELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814
ELF R + + E + A++YLH I +RD+KPEN+L +
Sbjct: 145 ELF---SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 815 ---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
LTDF + T+ L + T Y+AP
Sbjct: 202 ILKLTDFGFAKETTSHNSL----------------------------TTPCYTPYYVAP 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 37/230 (16%), Positives = 87/230 (37%), Gaps = 32/230 (13%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAM 702
H H ++ ++ + L G + + +G G D +V+L +G+Y +
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGG-----CYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57
Query: 703 KAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELF 760
+ ++ + + + E+ +HP + A+F + ++T + G
Sbjct: 58 RRIN---LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 761 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
L+ + E A+ + V+ AL+Y+H G ++R +K ++L+ +G V L+
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 821 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + + +R+ P V +++P
Sbjct: 175 NL------SM----ISHGQRQRVVHDFP----------KYSVKVLPWLSP 204
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 37/223 (16%)
Query: 652 DSPPWKAIQKILDSGE---QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
D K ++ L + ++ F I LG+G+ G V V SG A K +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-- 67
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+ + ++ E ++L + P++ Y +F + + + ++ GG L +L +
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--A 125
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
+ E + + V+ L YL + I++RD+KP N+L+ G + L DF +S
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------ 179
Query: 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
GQ + + M NSFVGT Y++P
Sbjct: 180 ----------------GQ-----LIDSMA--NSFVGTRSYMSP 199
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + LG G G V+ + +G A K ++ + ++ E EIL DH
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDH 75
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P++ L ++ + ++ ++CPGG + ++ + L E ++ +++ AL +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH 134
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+ II+RDLK NVL+ G + L DF +S + ++R
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA------KN----LKTLQKR---------- 174
Query: 852 AEPMRASNSFVGTEEYIAP-VSDFAYTRMTRYNY 884
+SF+GT ++AP V + T Y+Y
Sbjct: 175 -------DSFIGTPYWMAPEVVMCETMKDTPYDY 201
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 26/156 (16%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFV 734
+ LG G G V + + + FA+K + A RE+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHI 73
Query: 735 PALYASFQT----KTHVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 787
+ ++ + + ++ + GGELF R + + E + A+
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 788 EYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDL 820
+YLH I +RD+KPEN+L N + LTDF
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 33/206 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-L 726
++ PI LG G G V + SGQ A+K + +N + R + +I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISM 60
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+D PF Y + + V + + + F + + ED + A +V
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 786 ALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
ALE+LH + +I+RD+KP NVL+ G V + DF +S G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS----------------------G 158
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + + A + G + Y+AP
Sbjct: 159 Y-----LVDDV-AKDIDAGCKPYMAP 178
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 50/232 (21%), Positives = 81/232 (34%), Gaps = 44/232 (18%)
Query: 662 ILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 718
L G Q + + +GSG G V + +G A+K M + NK
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEEN 67
Query: 719 ACAEREI---LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
++ L D P++ + +F T T V + + L ++ + E
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPIPERI 125
Query: 776 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLP 833
+ +V AL YL + G+I+RD+KP N+LL G + L DF +S L
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------- 177
Query: 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP-VSDFAYTRMTRYNY 884
+A + G Y+AP D Y+
Sbjct: 178 ---------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDI 208
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 27/101 (26%), Positives = 51/101 (50%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270
T I+YA+ F ++ Y +E+VG++ R + + + T+ G + G
Sbjct: 5 TDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEF 64
Query: 271 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 311
N +KDGT +W TI P+ D+ GK ++I ++ +++ E
Sbjct: 65 CNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKE 105
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 37/186 (19%), Positives = 75/186 (40%), Gaps = 15/186 (8%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
ITD I++A+D+F ++ Y REE++G++ R + A +R + I
Sbjct: 3 SITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNI 59
Query: 549 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE------HLEPLRNSIPE 602
+ N K G ++W + P+ D G+ + +I ++ D + L L+ ++
Sbjct: 60 WQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKEAEAQLARLKQAMDA 119
Query: 603 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW-ANHSKVVHPKPHRKDSPPWKAIQK 661
+ N A+ + + +L + S + P D A+Q+
Sbjct: 120 NSEMILLTDRAGRIIYANPALCRF--SGMAEGELLGQSPSILDSP---LADQETLAAMQE 174
Query: 662 ILDSGE 667
L +G+
Sbjct: 175 ALQAGQ 180
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-22
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 270
T I+YA+ + +G E++G++ L D E +A ++E LQ GQ + GRL
Sbjct: 127 TDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRL 186
Query: 271 LNYKK------DGTPFWNLLTIAPIKDDEGKVLKFIGMQ 303
LN ++ D +W ++ PI D ++ ++ +Q
Sbjct: 187 LNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 21/128 (16%), Positives = 53/128 (41%), Gaps = 9/128 (7%)
Query: 467 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 526
+++ + L ++ + ++TD II+A+ + + + E+LG++ L
Sbjct: 103 QKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSIL 159
Query: 527 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK------FWNLFHLQPMRDQKGEVQ 580
P D T+ ++ A+ + +L+N ++G +W P+ +
Sbjct: 160 DSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLV 219
Query: 581 YFIGVQLD 588
++ +Q D
Sbjct: 220 GYVQIQHD 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 36/211 (17%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
IN + + +GSG T V + A+K ++ L + + +EI M
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAM 67
Query: 729 --LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFYA 780
HP + + Y SF K + L+ GG + ++ + VL E +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKK 839
EV+ LEYLH G I+RD+K N+LL +G V + DF +S L + T K
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-----GDITRNKV 182
Query: 840 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
R +FVGT ++AP
Sbjct: 183 R------------------KTFVGTPCWMAP 195
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 30/224 (13%), Positives = 58/224 (25%), Gaps = 57/224 (25%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 726
LG D + +G+ F + N + + E L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 727 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 768
D++ P + + + +++ + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 769 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 259
Query: 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
A + E A
Sbjct: 260 ----------------------RDGASAVSPIGRGFAPPETTAE 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 41/213 (19%), Positives = 71/213 (33%), Gaps = 39/213 (18%)
Query: 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 723
S + F P LG G G++ + + A+K + A E
Sbjct: 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILP------ECFSFADREV 68
Query: 724 EILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
++L D HP V + + + + + + C L ++ Q +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQ 126
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNE 837
L +LH I++RDLKP N+L+ ++DF L
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC---------------- 170
Query: 838 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K+ G+ + + GTE +IAP
Sbjct: 171 -KKLAVGRHSFSRR-------SGVPGTEGWIAP 195
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 29/201 (14%), Positives = 68/201 (33%), Gaps = 17/201 (8%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+H ++ + + + ++ D + + + + + +D
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFS 119
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 789
K ++ + C L ++R+ + + ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH +G+++RDLKP N+ + V + DF L + E++
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEEEQTVLTPM---- 227
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
VGT+ Y++P
Sbjct: 228 ---PAYATHTGQVGTKLYMSP 245
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 729
L F PI+ +G G G V + +A+K + L R KV R E + L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 61
Query: 730 DHPFVPALYASFQTKTHVCLITDYC 754
+HP + + ++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 45/193 (23%), Positives = 76/193 (39%), Gaps = 32/193 (16%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
LG G G V+ + A+K + + E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 740 SFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYR 798
SF + + + PGG L LL + + E + FY +++ L+YLH I++R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 799 DLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
D+K +NVL+ +G + ++DF S KR +A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----------------KR----------LAGINPC 179
Query: 858 SNSFVGTEEYIAP 870
+ +F GT +Y+AP
Sbjct: 180 TETFTGTLQYMAP 192
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 36/201 (17%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--L 729
+ F ++ +G G G V + + A+K +D L + ++EI +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
D P+V Y S+ T + +I +Y GG LL+ L E + E++ L+Y
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDY 134
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 849
LH + I+RD+K NVLL +G V L DF ++ QL T+ + +R
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QL----TDTQIKR-------- 176
Query: 850 FMAEPMRASNSFVGTEEYIAP 870
N+FVGT ++AP
Sbjct: 177 ---------NTFVGTPFWMAP 188
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 35/207 (16%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+G G TG V L SG+ A+K MD + + + E I+ H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQH 101
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
V +Y S+ + ++ ++ GG L ++ + L E+ + V+ AL YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH 158
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
QG+I+RD+K +++LL +G V L+DF Q+ + + +R
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QI----SKDVPKR---------- 198
Query: 852 AEPMRASNSFVGTEEYIAP--VSDFAY 876
S VGT ++AP +S Y
Sbjct: 199 -------KSLVGTPYWMAPEVISRSLY 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 32/157 (20%), Positives = 62/157 (39%), Gaps = 10/157 (6%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 725
+ + + +G G GSV+ + SGQ A+K + ++ + ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 726 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAE 782
+ D P++ Y + + + + V+ E+ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 783 VVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDF 818
V AL +L II+RD+KP N+LL +G++ L DF
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 650 RKDSPPWKAIQKILDSGEQIN-LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 708
+ +PP + ++K+ + + F ++ LG G GSV+ +GQ A+K +
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63
Query: 709 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 768
+ + E I+ D P V Y S+ T + ++ +YC G + ++ +
Sbjct: 64 ---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN- 119
Query: 769 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828
K L ED + + LEYLH I+RD+K N+LL GH L DF ++
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG------ 173
Query: 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
QL T+ +R N+ +GT ++AP
Sbjct: 174 QL----TDTMAKR-----------------NTVIGTPFWMAP 194
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 45/199 (22%), Positives = 86/199 (43%), Gaps = 33/199 (16%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + +G G +G+V+ +GQ A++ M+ + + K E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + S+ + ++ +Y GG L ++ + E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+I+RD+K +N+LL +G V LTDF Q+ T E+ +R
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QI----TPEQSKR---------- 173
Query: 852 AEPMRASNSFVGTEEYIAP 870
++ VGT ++AP
Sbjct: 174 -------STMVGTPYWMAP 185
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-22
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 50/227 (22%)
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
+ + EQ K LG G +G+V G+ A+K M + A E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI------DFCDIALME 58
Query: 723 REILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 776
++L D HP V Y S T + + + C L L++ + K+ KE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 777 RFYAAEVVVALEYLHCQGIIYRDLKPENVLL-------------QGNGHVSLTDFDLSCL 823
++ + +LH II+RDLKP+N+L+ N + ++DF L
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-- 175
Query: 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
K+ GQ + N+ GT + AP
Sbjct: 176 ---------------KKLDSGQSS------FRTNLNNPSGTSGWRAP 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 17/202 (8%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+ LG G G V +G+ MK + + + + E +++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRC 63
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L+HP V + IT+Y GG L ++ ++ V F A ++ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMA 122
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
YLH II+RDL N L++ N +V + DF L+ L+ + + + P
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------LMVDEKTQPEGLRSLKKP 174
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
+ + VG ++AP
Sbjct: 175 DR-----KKRYTVVGNPYWMAP 191
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 14/168 (8%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE--RE-- 724
+ K +G G G VH L A+K++ G ++ E RE
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
I+ L+HP + LY ++ ++ P G+L+ L + + +R ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 785 VALEYLHCQG--IIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTS 825
+ +EY+ Q I++RDL+ N+ L + DF LS +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 38/206 (18%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLD 730
F ++ +G+G G V+ +GQ A+K MD + ++ E +L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 731 HPFVPALYASFQTKTHVC------LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
H + Y +F K L+ ++C G + L+ LKE+ + + E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
L +LH +I+RD+K +NVLL N V L DF +S QL RR
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL----DRTVGRR--- 186
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAP 870
N+F+GT ++AP
Sbjct: 187 --------------NTFIGTPYWMAP 198
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 39/179 (21%), Positives = 70/179 (39%), Gaps = 13/179 (7%)
Query: 650 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMD 706
+ + D E I + +GSG G+V+ G++ A+K ++
Sbjct: 3 KGHHHHHHGSRDAADDWE-IPDGQITVGQRIGSGSFGTVYK------GKWHGDVAVKMLN 55
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
++ E +L H + T + ++T +C G L+ L
Sbjct: 56 VTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
TK + + A + ++YLH + II+RDLK N+ L + V + DF L+ S
Sbjct: 114 ETKFEMKKLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 42/174 (24%), Positives = 68/174 (39%), Gaps = 4/174 (2%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
P R S + ++ + + F ++ +G G G+V+ + + A+K
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDD--PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 705 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 764
M + K E L L HP + + L+ +YC G LL
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 146
Query: 765 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
+ K L+E + + L YLH +I+RD+K N+LL G V L DF
Sbjct: 147 HK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 14/166 (8%)
Query: 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 724
S I+ + + +G G G V + + A+K + + ++ E
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELR 53
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 783
L ++HP + LY + VCL+ +Y GG L+ +L +P + +
Sbjct: 54 QLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 784 VVALEYLHC---QGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTS 825
+ YLH + +I+RDLKP N+LL G V + DF +C
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 6e-21
Identities = 29/92 (31%), Positives = 51/92 (55%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+YA+ F +TGY S+EV+G+N L T + L + + G L+N +KD
Sbjct: 27 ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVNRRKD 86
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
T + LT+AP+ ++ G+ + ++GM + S+
Sbjct: 87 KTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-16
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 5/116 (4%)
Query: 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 536
T+E ITD I++A+ +F +T Y EE+LG+N L T
Sbjct: 7 FRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVY 63
Query: 537 RKIRAAIDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ + + Q + L+N K + + P+ ++ GE Y++G+ D SE
Sbjct: 64 QALWGRL-AQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 22/180 (12%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 739
+G G +V+ + A + L +++ R E E+L L HP + Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 740 SF----QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG- 794
S+ + K + L+T+ G L L R KV+K +R + +++ L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 795 -IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 852
II+RDLK +N+ + G G V + D L+ L + G P FMA
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----------KRASFAKAVIG--TPEFMA 198
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 52/236 (22%), Positives = 85/236 (36%), Gaps = 35/236 (14%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQ--INLQHFRPIKPLGSGDTGSVHLVELCGSG 697
H HP + G+ I + +G+G G+VH E G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-- 60
Query: 698 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 757
A+K + + +V+ E I+ L HP + + ++ ++T+Y G
Sbjct: 61 SDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 758 ELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVS 814
L+ LL + L E A +V + YLH + I++R+LK N+L+ V
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 815 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ DF LS A +S S GT E++AP
Sbjct: 180 VCDFGLSR---------------------------LKASTFLSSKSAAGTPEWMAP 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 34/205 (16%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREI 725
I + + +G G G V+ G++ A++ +D N +++ E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY------HGRWHGEVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
H V + + H+ +IT C G L+ ++ R VL + R A E+V
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVK 141
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ YLH +GI+++DLK +NV NG V +TDF L + +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI---------------SGVLQAG 185
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAP 870
+ + G ++AP
Sbjct: 186 RREDKLRIQ-------NGWLCHLAP 203
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 16/86 (18%), Positives = 37/86 (43%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+ + G + GY+ ++ +G+ L G +++ ++N + G + KD
Sbjct: 29 IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRMLHKD 88
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGM 302
G W PI + +++ +G+
Sbjct: 89 GHIGWIESMCVPIYGENYQMVGALGI 114
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 3e-17
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 3/103 (2%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
V+TD II + L YS+E+ +G+ L P ++ +A++NQ
Sbjct: 21 VVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGK 77
Query: 549 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
T ++ K G W P+ + ++ +G+ D ++
Sbjct: 78 WTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITK 120
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 51/208 (24%), Positives = 81/208 (38%), Gaps = 48/208 (23%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 734
+ +G G G V + G + A+K + + + E EI ML H +
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTVMLRHENI 98
Query: 735 PALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
A+ T T + L++DY G LF L+R V E ++ A L +L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKL-ALSTASGLAHL 155
Query: 791 HCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 842
H + I +RDLK +N+L++ NG + D L+ RH
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------------------VRH 197
Query: 843 KGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + + A N VGT+ Y+AP
Sbjct: 198 DSATDTIDI-----APNHRVGTKRYMAP 220
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 28/169 (16%), Positives = 59/169 (34%), Gaps = 7/169 (4%)
Query: 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 722
++ I+ + + L +G + G +K + + K E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVR-DWSTRKSRDFNEE 57
Query: 723 REILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
L + HP V + + Q+ H LIT + P G L+ +L V+ + +A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 781 AEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
++ + +LH I L +V++ + ++ D+
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 17/171 (9%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREIL 726
+I+ + +G G G V+ G A+KA + ++ E ++
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 727 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 786
ML HP + AL + ++CL+ ++ GG L +L + + D + +A ++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 787 LEYLHCQG---IIYRDLKPENVLL--------QGNGHVSLTDFDLSCLTSC 826
+ YLH + II+RDLK N+L+ N + +TDF L+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 47/219 (21%), Positives = 75/219 (34%), Gaps = 55/219 (25%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 725
I L + +G G G V G + A+K + + E E+
Sbjct: 8 RDITLL-----ECVGKGRYGEVWRGSWQG--ENVAVK------IFSSRDEKSWFRETELY 54
Query: 726 -LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
ML H F+ + S + T + LIT Y G L+ L +R
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRI-V 111
Query: 781 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLL 831
+ L +LH + I +RDLK +N+L++ NG + D L+ + + QL
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ VGT+ Y+AP
Sbjct: 172 VGNNPR------------------------VGTKRYMAP 186
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 47/218 (21%), Positives = 78/218 (35%), Gaps = 46/218 (21%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--L 726
++L + + ++ +G G G+V+ L + A+K NR E+ I +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFIN---EKNIYRV 61
Query: 727 DMLDHPFVPALYA-----SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
+++H + + + L+ +Y P G L L + A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 782 EVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
V L YLH + I +RDL NVL++ +G ++DF LS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--------- 169
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
V E A+ S VGT Y+AP
Sbjct: 170 ----------LTGNRLVRPGEEDNAAISEVGTIRYMAP 197
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 47/218 (21%), Positives = 83/218 (38%), Gaps = 48/218 (22%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 725
++ + + +K +G G G V + + G + A+K V + E EI
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVK-----VFFTTEE-ASWFRETEIY 83
Query: 726 -LDMLDHPFVPALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
++ H + A+ + T + LITDY G L+ L + + ++ A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL-A 140
Query: 781 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832
V L +LH + I +RDLK +N+L++ NG + D L+
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----------- 189
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ N V + N+ VGT+ Y+ P
Sbjct: 190 -------VKFISDTNEVDI-----PPNTRVGTKRYMPP 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 1e-16
Identities = 44/211 (20%), Positives = 75/211 (35%), Gaps = 25/211 (11%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR--ACAER 723
G+ N + I+ LG G +V L ++ AMK ++ + + A E
Sbjct: 32 GDLFN-GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEI 84
Query: 724 EILDML-----DHP---FVPALYASFQTK----THVCLITDYCPGGE-LFLLLDRQPTKV 770
+L + + P V L F+ TH+C++ + G L + + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQG 142
Query: 771 LKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
L V+ +V+ L+YLH + II+ D+KPEN+LL N +
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 860
+ V EP A
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 42/219 (19%), Positives = 71/219 (32%), Gaps = 52/219 (23%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 725
+ ++ G G V +L +Y A+K ++ E E+
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQ---DKQSWQN---EYEVYS 71
Query: 726 LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
L + H F+ A + LIT + G L L + + + A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 782 EVVVALEYLHCQ----------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831
+ L YLH I +RD+K +NVLL+ N + DF L+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---------- 178
Query: 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + ++ + VGT Y+AP
Sbjct: 179 --------LKFEAGKSAGDT-------HGQVGTRRYMAP 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 80.3 bits (197), Expect = 2e-15
Identities = 114/691 (16%), Positives = 190/691 (27%), Gaps = 232/691 (33%)
Query: 195 KDALSTFQQTFV-------VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 247
KD LS F+ FV V D K I+ + +E+
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKS---IL------------SKEEI------------ 51
Query: 248 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ + ++ + + RL FW LL+ K +E V KF+
Sbjct: 52 ---DHIIMSKDAVS--GTL--RL---------FWTLLS----KQEEM-VQKFVE------ 84
Query: 308 KHTEGAKDKMLRPN-GLPESLIRYDARQKEMATSSVTELVQAMKK-PRSLSE-STNRPPI 364
++LR N S I+ + RQ M T E + + ++ + +R
Sbjct: 85 --------EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 365 IRKSEGGVEEERA-------GALGRRKS-------ENVPPPRRNSYG------GGCRTSM 404
K + E R G LG K+ + + + C +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 405 QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDERPDS 461
+ + QK + I S DH S I +
Sbjct: 197 TVL-----EMLQK-----LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 462 ---VDDKVRQKEMRKGID-----LATTLERIEKNFVITDPRLPDNPIIFASDSFLE-LTE 512
+ + V+ + + L TT + +TD + D LT
Sbjct: 247 LLVLLN-VQNAKAWNAFNLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 513 YSREEILGR--NCRFLQGPE----TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 566
+ +L + +CR P T+P + I +I + G W+
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI--------------RDGLATWDN 346
Query: 567 FHLQPMRDQKGEVQYFIGVQLDGSEHLEP--LRNS------------IPEAT-------- 604
+ D+ + I L LEP R IP
Sbjct: 347 W-KHVNCDKLTTI---IESSL---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 605 -AEESE----KLVKQT--AENVNEAVKELPDANL----TPEDLWANHSKVVHPKPHRKDS 653
+ KL K + + E+ +P L E+ +A H +V K
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 654 PPWKAIQKILDSGEQIN--LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 711
I LD H +G HL + + M V L
Sbjct: 460 DSDDLIPPYLD-----QYFYSH------IGH------HLKN-IEHPERMTLFRM---VFL 498
Query: 712 N----RNKVHRA----CAEREILDML-DHPFVPALYASFQTKTH------VCLITDYCPG 756
+ K+ A IL+ L F Y + V I D+ P
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDNDPKYERLVNAILDFLPK 554
Query: 757 GELFLLLDR----------QPTKVLKEDAVR 777
E L+ + + + E+A +
Sbjct: 555 IEENLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 45/281 (16%), Positives = 92/281 (32%), Gaps = 78/281 (27%)
Query: 563 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 622
FW L + Q+ VQ F+ E L + E +Q +
Sbjct: 68 FWTL-----LSKQEEMVQKFVE------EVLRINYKFLMSPIKTEQ----RQPSMMTRMY 112
Query: 623 VKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPL-- 680
+++ + L+ N ++V K + P+ +++ L RP K +
Sbjct: 113 IEQR-------DRLY-NDNQVF-AKYNVSRLQPYLKLRQ--------ALLELRPAKNVLI 155
Query: 681 -GSGDTG-SVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPAL 737
G +G + +++C S Y MD + LN + +L+ML L
Sbjct: 156 DGVLGSGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNS---PETVLEMLQ-----KL 205
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
++ + + + ++ + R ++ Y +C ++
Sbjct: 206 LYQIDP--------NWTSRSDHSSNI-KLRIHSIQAELRRLLKSK-----PYENCL-LVL 250
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+++ F+LSC ++LL TT K
Sbjct: 251 LNVQNAKAW---------NAFNLSC------KILL-TTRFK 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 7/149 (4%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
+ I +G G G V +GQ A+K K + + V + A REI L L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + L F+ K + L+ +YC + LDR + + E V+ + + A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH 119
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
I+RD+KPEN+L+ + + L DF
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 34/176 (19%), Positives = 62/176 (35%), Gaps = 12/176 (6%)
Query: 646 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL---VELCGSGQYFAM 702
+P R+ S P +Q L G +I +R + G L + A+
Sbjct: 7 REPDRESSAPPDDVQ--LVPGARIANGRYRLLIFHGGVPPLQFWQALDTAL---DRQVAL 61
Query: 703 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
+D +L + + + L +D P V + T+ ++ ++ GG L +
Sbjct: 62 TFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV 121
Query: 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
D P+ A+R + A + H G+ P V + +G V L
Sbjct: 122 ADTSPSP---VGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 35/190 (18%), Positives = 72/190 (37%), Gaps = 6/190 (3%)
Query: 632 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 691
+ L + P + +A+ K D +N + + +G G+ G V
Sbjct: 77 SIPLLIDHLLSTQQPLTKKSGVVLHRAVPK--DKWV-LNHEDLVLGEQIGRGNFGEVFSG 133
Query: 692 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751
L A+K+ + + + + E IL HP + L K + ++
Sbjct: 134 RLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811
+ GG+ L + ++ + ++ + +EYL + I+RDL N L+
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 812 HVSLTDFDLS 821
+ ++DF +S
Sbjct: 251 VLKISDFGMS 260
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 27/101 (26%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 723 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
REI L L+HP + L T+ + L+ ++ +L +D + ++ Y
Sbjct: 51 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYL 109
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ L + H +++RDLKP+N+L+ G + L DF L+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 42/203 (20%), Positives = 80/203 (39%), Gaps = 39/203 (19%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
+R + +GSG G ++L +G+ A+K + K + E +I M+
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 732 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+P + + ++ + G +LF R+ + LK V A +++ +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFS--LK--TVLLLADQMISRI 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 844
EY+H + I+RD+KP+N L+ V + DF L+ + + +H
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK----------KYRDARTHQHI- 167
Query: 845 QQNPVFMAEPMRASNSFVGTEEY 867
P R + + GT Y
Sbjct: 168 ---------PYRENKNLTGTARY 181
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 15/191 (7%)
Query: 639 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG--- 695
+H + + + + D + +H + ++ LG G+ GSV +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 696 -SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA--SFQTKTHVCLITD 752
+G+ A+K + + R E EIL L H + + ++ LI +
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 753 YCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810
Y P G L +L ++ + + + Y +++ +EYL + I+RDL N+L++
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 811 GHVSLTDFDLS 821
V + DF L+
Sbjct: 182 NRVKIGDFGLT 192
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 41/160 (25%)
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKV 770
A AER+ L + HP + ++ + ++ +Y G L ++
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---- 178
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
L Y E++ AL YLH G++Y DLKPEN++L + L D
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGA---------- 227
Query: 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + GT + AP
Sbjct: 228 ---------------------VSRINSFGYLYGTPGFQAP 246
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 14/162 (8%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAER 723
Q +H + ++ LG G+ GSV + +G+ A+K + + R E
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EI 62
Query: 724 EILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY 779
EIL L H + + ++ LI +Y P G L +L ++ + + + Y
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQY 119
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ +EYL + I+RDL N+L++ V + DF L+
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 7/150 (4%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 731
+ + +G G G V +G+ A+K K + + +K+ + A REI L L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+ L + K L+ ++ + L+ P L V+ Y +++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH 141
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
II+RD+KPEN+L+ +G V L DF +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDK--GVMLNRNKVHRACAEREI- 725
++ + + LG G +V+ + + A+K ++ G A RE+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVS 52
Query: 726 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
L L H + L+ T+ + L+ +Y +L LD + V+ + +++
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLL 110
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L Y H Q +++RDLKP+N+L+ G + L DF L+
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 4/103 (3%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
REI L L H + LY TK + L+ ++ +L LLD L+ +
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKS 104
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++ + Y H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
K+ P K PW+ +I + + K LG+G G V + +
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAW------EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-V 215
Query: 701 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF 760
A+K M G M V AE ++ L H + L+A TK + +IT++ G L
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLL 270
Query: 761 -LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
L + +K + F +A++ + ++ + I+RDL+ N+L+ + + DF
Sbjct: 271 DFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 820 LS 821
L+
Sbjct: 330 LA 331
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 6/176 (3%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
P K + P ++ LG G G V+ A+K +
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDR 765
+ M +V E ++ + HP + L + +IT++ G L L +
Sbjct: 255 EDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+V + A ++ A+EYL + I+R+L N L+ N V + DF LS
Sbjct: 311 NRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 39/204 (19%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 65
Query: 732 PFVPALYASFQTKTHVCLITDYCPG---GELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
+P +Y Q H L+ D G +L L R+ + +K V A +++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFS--VK--TVAMAAKQMLARVQ 120
Query: 789 YLHCQGIIYRDLKPENVLL-QGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+H + ++YRD+KP+N L+ + N + + DF + K R
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----------------KFYRDP 164
Query: 844 GQQNPVFMAEPMRASNSFVGTEEY 867
+ + P R + GT Y
Sbjct: 165 VTKQHI----PYREKKNLSGTARY 184
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 5e-12
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAK-IRETLQNGQSYCGRLLNYKK 275
I + + +++GR+ L + + E + + I + SY + +
Sbjct: 24 IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83
Query: 276 DGTPFWNLLTIAPIKDDEGKVLKFIGM 302
G FW +T + D + +
Sbjct: 84 GGELFWCHVTGRAL-DRTAPLAAGVWT 109
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 7e-10
Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 2/95 (2%)
Query: 495 LPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQL 553
D I +D + +R +++GR+ L + +I +
Sbjct: 19 SRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDR 78
Query: 554 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
I G+ FW + + D+ + + D
Sbjct: 79 IMKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 7e-12
Identities = 29/101 (28%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 723 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
REI L L HP + +L ++ + L+ ++ +L +LD T L++ ++ Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL 125
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ + + H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 37/183 (20%), Positives = 73/183 (39%), Gaps = 29/183 (15%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-ACAERE 724
GE + ++ LG G +V L + + + AMK ++ A E +
Sbjct: 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIK 67
Query: 725 ILDML-----------DHPFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTK 769
+L + + L F K HV ++ + G L L+ + +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 770 VLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLL------QGNGHVSLTDFDLSC 822
+ V+ + ++++ L+Y+H + GII+ D+KPENVL+ + + + D +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 823 LTS 825
Sbjct: 187 WYD 189
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 720
+ + + + + +K +G G G V Q+ A+K ++ N + HR A
Sbjct: 88 VQVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAA 141
Query: 721 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
E IL+ L + + +F + H+C+ + L+ L+ + +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIH-MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 774 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSC 822
VR +A ++ L+ LH II+ DLKPEN+LL+ G + + DF SC
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 9e-12
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A REI L L HP + L +F K+++ L+ D+ +L +++ L ++
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKA 116
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
Y + LEYLH I++RDLKP N+LL NG + L DF L
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-12
Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 11/192 (5%)
Query: 634 EDLWANHSKVVHPKPHRKDSPPWK---AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 690
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 226 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 285
Query: 691 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 286 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 751 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 398
Query: 810 NGHVSLTDFDLS 821
N + DF L+
Sbjct: 399 NLVCKVADFGLA 410
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 9e-12
Identities = 28/103 (27%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A REI L L H + L+ + + L+ ++C +L D L + V+
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKS 105
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +++ L + H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 43/192 (22%), Positives = 76/192 (39%), Gaps = 11/192 (5%)
Query: 634 EDLWANHSKVVHPKPHRKDSPPW---KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 690
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 143 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 202
Query: 691 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 203 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 751 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 315
Query: 810 NGHVSLTDFDLS 821
N + DF L+
Sbjct: 316 NLVCKVADFGLA 327
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 720
I+ +GE+ + +G G G V ++ A+K ++ N+ A
Sbjct: 45 IVKNGEKWM-DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQ 98
Query: 721 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 773
E +L+++ + V L F + H+CL+ + L+ LL + +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVH-LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 774 DAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL--QGNGHVSLTDFDLSC 822
+ R +A ++ AL +L II+ DLKPEN+LL + + DF SC
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 729
+ ++ + P+GSG GSV +G A+K K ++ +H RE+ L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 730 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
H V L S + V L+T G +L ++ Q L +D V+F ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 141
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ L+Y+H II+RDLKP N+ + + + + DF L+
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 36/154 (23%), Positives = 67/154 (43%), Gaps = 17/154 (11%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-D 730
++ ++ LG G V + + +K +L K + E +IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRG 89
Query: 731 HPFVPALYA---SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
P + L ++T L+ ++ + L L + +RFY E++ AL
Sbjct: 90 GPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 788 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDL 820
+Y H GI++RD+KP NV++ + + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 17/164 (10%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 721
+ + I+ LG G G V L G A+K++ + G +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----K 72
Query: 722 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
E EIL L H + + + LI ++ P G L +L + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 129
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YA ++ ++YL + ++RDL NVL++ V + DF L+
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 15/185 (8%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 720
G +N F I+ +G G G V L + + +Y+A+K V+ N K R A
Sbjct: 26 SWKKGMLLN-NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAK 79
Query: 721 AEREILDML------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
E +IL + ++ V + F H+CLI + G L+ ++ R +
Sbjct: 80 IEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 834
++ Y E++ AL YL + + DLKPEN+LL K Q+
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 835 TNEKK 839
+ K
Sbjct: 198 STGIK 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 7/107 (6%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKED 774
A REI + L H + LY T+ + L+ ++ +L +D + L+ +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
V+++ +++ L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 14/161 (8%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAERE 724
+H + I LG G+ GSV L G A+K + + R E +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQ 76
Query: 725 ILDMLDHPFVPALYA-SFQTKTH-VCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
IL L F+ S+ + L+ +Y P G L FL ++ L + Y+
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYS 133
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ +EYL + ++RDL N+L++ HV + DF L+
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 40/251 (15%), Positives = 79/251 (31%), Gaps = 42/251 (16%)
Query: 639 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCG 695
+HS V + L +G + + ++ + G ++
Sbjct: 6 HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTS 65
Query: 696 SG--------QYFAMK--AMDKGVMLNRNKVHRACAEREI-----LDMLDHPFVPALYAS 740
+ Q F++K A D + +N RA ++ L +P
Sbjct: 66 TLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF 125
Query: 741 -FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 799
+ L+ G L LD P VL E +V A ++ ALE+LH ++ +
Sbjct: 126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 800 LKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 857
+ EN+ + + V+L + + + G+ +
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFA----------------FRYCPSGKHVA----YVEGS 224
Query: 858 SNSFVGTEEYI 868
+ G E+I
Sbjct: 225 RSPHEGDLEFI 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 15/172 (8%)
Query: 655 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML 711
P +++ ++ + + L ++ LG G G V E A+K + V+
Sbjct: 7 PLQSLTCLIGE-KDLRL-----LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 712 NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTK 769
+ E + LDH + LY + ++T+ P G L L R+
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQG 116
Query: 770 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ YA +V + YL + I+RDL N+LL V + DF L
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 11/108 (10%)
Query: 723 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 772
RE+ L+ +HP V L + + V L+ ++ +L LD+ P L
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
+ ++ + + L++LH I++RDLKPEN+L+ G V L DF L
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 35/191 (18%), Positives = 69/191 (36%), Gaps = 22/191 (11%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 704
H H + + + + + + +G G G V + A+K
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK 59
Query: 705 MDKGVMLNRNKVHRACAEREI--LDMLDHP--------FVPALYASFQTKTHVCLITDYC 754
+ ++ + REI L H + V ++ D
Sbjct: 60 ISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLM 112
Query: 755 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 814
+L+ LL Q L D + ++ +++ L+Y+H +++RDLKP N+LL +
Sbjct: 113 -ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168
Query: 815 LTDFDLSCLTS 825
+ DF L+ +
Sbjct: 169 ICDFGLARVAD 179
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 46/189 (24%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 642 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQ---HFRPIKPLGSGDTGSVHLVELCGSGQ 698
+D K + G+ + + K +G+G G V+ +LC SG+
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 699 YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------HVCLITD 752
A+K K V+ ++ +R E +I+ LDH + L F + ++ L+ D
Sbjct: 81 LVAIK---K-VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 753 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 810
Y P ++ + + L V+ Y ++ +L Y+H GI +RD+KP+N+LL +
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192
Query: 811 -GHVSLTDF 818
+ L DF
Sbjct: 193 TAVLKLCDF 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 28/108 (25%), Positives = 57/108 (52%), Gaps = 11/108 (10%)
Query: 723 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 772
RE+ L+ +HP V L+ + +T + L+ ++ +L LD+ P +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
+ ++ +++ L++LH +++RDLKP+N+L+ +G + L DF L
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 41/164 (25%), Positives = 63/164 (38%), Gaps = 19/164 (11%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 721
+ ++ + I+ LG G G V L + A+KA+ D G
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----Q 82
Query: 722 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
E +IL L H + + L+ +Y P G L +L L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---- 138
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+A ++ + YLH Q I+RDL NVLL + V + DF L+
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 722
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + YL + +++RDL NVL++ HV +TDF L+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 36/155 (23%), Positives = 61/155 (39%), Gaps = 6/155 (3%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ LG G G V+ A+K + + M +V E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVA 786
+ HP + L + +IT++ G L L + +V + A ++ A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSA 123
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+EYL + I+RDL N L+ N V + DF LS
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 21/159 (13%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
+FR K +G G+ G + L + + +Y A+K + +++ + E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 732 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+P +Y + ++ + G +LF L DR + LK V A +++ +
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFS--LK--TVLMIAIQLISRM 118
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLS 821
EY+H + +IYRD+KPEN L+ G+ + + DF L+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 42/184 (22%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 642 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 701
+++ PK + SG +N++ + ++ +G G+ G V L G Y
Sbjct: 166 RLIKPKVMEGTVAAQDEFYR---SGWALNMKELKLLQTIGKGEFGDVML------GDYRG 216
Query: 702 MKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL 759
K K + + +A AE ++ L H + L + K + ++T+Y G L
Sbjct: 217 NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 760 --FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
+L R + + + ++F + +V A+EYL ++RDL NVL+ + ++D
Sbjct: 275 VDYLR-SRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 818 FDLS 821
F L+
Sbjct: 333 FGLT 336
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 39/199 (19%), Positives = 77/199 (38%), Gaps = 31/199 (15%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DH 731
FR + +GSG G ++L + + A+K + + K + E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+P + + L+ D G L L + K+ + + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFVH 120
Query: 792 CQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+ ++RD+KP+N L+ V + DF L+ + +H
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----------KYRDTSTHQHI----- 165
Query: 849 VFMAEPMRASNSFVGTEEY 867
P R + + GT Y
Sbjct: 166 -----PYRENKNLTGTARY 179
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 729
+R ++P+GSG G+V +G A+K + + ++++ A RE+ L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 730 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
H V L + T L+ + G +L L+ + L ED ++F ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ L Y+H GII+RDLKP N+ + + + + DF L+
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 43/245 (17%), Positives = 79/245 (32%), Gaps = 44/245 (17%)
Query: 645 HPKPHRKDSPPWKAIQKI-LDSGEQINL---QHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
H Q + G+ ++ + K +GSG G ++L +
Sbjct: 6 HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD 65
Query: 701 AMKAM-----DKGVMLNRNKV-HRACAEREILDM-----LDHPFVPALYAS----FQTKT 745
A + + G + + K R + I LD+ +P Y S F+ ++
Sbjct: 66 ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
+ ++ + G +L + + T V ++ LEY+H ++ D+K N+
Sbjct: 126 YRFMVMERL-GIDLQKISGQNGTFKKS--TVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 806 LL-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 863
LL N V L D+ LS + G G
Sbjct: 183 LLGYKNPDQVYLADYGLS----------------YRYCPNGNHKQY----QENPRKGHNG 222
Query: 864 TEEYI 868
T E+
Sbjct: 223 TIEFT 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 45/181 (24%), Positives = 84/181 (46%), Gaps = 19/181 (10%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
P + K + +GEQ + + K +G+G G V +L S + A+K
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAKLVESDE-VAIK--- 70
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH------VCLITDYCPGGELF 760
K V+ ++ +R E +I+ ++ HP V L A F + + L+ +Y P ++
Sbjct: 71 K-VLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 761 LLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTD 817
+ + + ++ Y +++ +L Y+H GI +RD+KP+N+LL G + L D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 818 F 818
F
Sbjct: 186 F 186
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 32/142 (22%), Positives = 54/142 (38%), Gaps = 28/142 (19%)
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L P V ++ + + + G +L +L RQ + AV ++ AL+
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVA-IVRQIGSALD 148
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
H G +RD+KPEN+L+ + L DF ++ T+
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----------------------- 185
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
E + + VGT Y+AP
Sbjct: 186 ---DEKLTQLGNTVGTLYYMAP 204
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 30/145 (20%), Positives = 61/145 (42%), Gaps = 2/145 (1%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
++ + LG G +V+L E A+KA+ + R E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 734 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ ++ + L+ +Y G L ++ L D + +++ +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM 130
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDF 818
I++RD+KP+N+L+ N + + DF
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 6/185 (3%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
K+ P+ + + + + +I K +GSGD+G V L GQ
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 700 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 756
A+KA+ G + + +E I+ DHP + L ++T+Y
Sbjct: 77 DVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 757 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 816
G L L + V V + YL G ++RDL NVL+ N ++
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 817 DFDLS 821
DF LS
Sbjct: 194 DFGLS 198
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 45/244 (18%), Positives = 84/244 (34%), Gaps = 44/244 (18%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINL---QHFRPIKPLGSGDTGSVHLVEL-----CGSGQ 698
+ S + + + GE I ++ P+G G G ++L ++ GS
Sbjct: 7 AQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDA 66
Query: 699 YFAMKAM--DKGVMLNRNKVHRACAEREILDM------LDHPFVPALYAS----FQTKTH 746
+K D G + K ++ A+ E + L + VP + S K++
Sbjct: 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY 126
Query: 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806
+I D G +L + + + V + ++ LEY+H ++ D+K N+L
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 807 L-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 864
L N V L D+ L+ + +G GT
Sbjct: 185 LNYKNPDQVYLVDYGLA----------------YRYCPEGVHKAY----AADPKRCHDGT 224
Query: 865 EEYI 868
E+
Sbjct: 225 IEFT 228
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 34/158 (21%), Positives = 72/158 (45%), Gaps = 16/158 (10%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 729
+ + +GSG GSV SG+ A+K + + ++++ A RE+ L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 730 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
H V L +S + L+ + +L ++ E+ +++ ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLK---FSEEKIQYLVYQM 135
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ L+Y+H G+++RDLKP N+ + + + + DF L+
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 21/176 (11%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KP +D W ++ + + ++ LG+G G V + G + A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK 46
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-DR 765
+G M + AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSMSPDAFL----AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP 101
Query: 766 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
K+ + AA++ + ++ + I+RDL+ N+L+ + DF L+
Sbjct: 102 SGIKLTINKLLDM-AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 35/166 (21%), Positives = 68/166 (40%), Gaps = 22/166 (13%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREI 725
+ + + SG G+V + G A+K + V + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 726 --LDMLDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
L+ HP FV + + L+T+ +L ++ V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELM-RTDLAQVI-HDQRIVISPQH 135
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++++ +++ L LH G+++RDL P N+LL N +++ DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 36/168 (21%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 729 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
++H + +L + + V L+ + L ++ + L + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QME---LDHERMSYLLYQ 172
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
++ +++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 35/167 (20%), Positives = 72/167 (43%), Gaps = 21/167 (12%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 718
I SG+ ++ + + LG G G V VE G++ A+K ++ N ++
Sbjct: 5 ICQSGDVLS-ARYEIVDTLGEGAFGKV--VECIDHKAGGRHVAVK-----IVKNVDRYCE 56
Query: 719 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
A +E ++L+ L V + F+ H+C++ + G + +
Sbjct: 57 AARSEIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP 114
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
+ D +R A ++ ++ +LH + + DLKPEN+L + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 34/148 (22%), Positives = 61/148 (41%), Gaps = 10/148 (6%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LGSG+ G+V A+K + + AE ++ LD+P++
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 81
Query: 736 ALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 793
+ L+ + G L +L +R +K+ + +V + ++YL
Sbjct: 82 RMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 136
Query: 794 GIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++RDL NVLL + ++DF LS
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 38/192 (19%), Positives = 73/192 (38%), Gaps = 7/192 (3%)
Query: 633 PEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKP-LGSGDTGSVHLV 691
P + + P P+ +++ D + + LG G+ GSV
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 692 ELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749
+ A+K + +G + E +I+ LD+P++ L + L
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRLIG-VCQAEALML 412
Query: 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
+ + GG L L + + V +V + ++YL + ++R+L NVLL
Sbjct: 413 VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 810 NGHVSLTDFDLS 821
+ ++DF LS
Sbjct: 472 RHYAKISDFGLS 483
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 21/167 (12%)
Query: 662 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 718
+ G+ + + + + LG G G V VE A+K ++ N K
Sbjct: 10 VCRIGDWLQ-ERYEIVGNLGEGTFGKV--VECLDHARGKSQVALK-----IIRNVGKYRE 61
Query: 719 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
A E +L + V + F H+C+ + G F L +
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP 119
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
VR A ++ AL +LH + + DLKPEN+L + +L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 722
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + YL + +++RDL NVL++ HV +TDF L+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 25/107 (23%), Positives = 49/107 (45%), Gaps = 10/107 (9%)
Query: 721 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 778
A RE+ L L H + L + + LI +Y +L +D+ P + ++
Sbjct: 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKS 136
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLL-----QGNGHVSLTDFDL 820
+ +++ + + H + ++RDLKP+N+LL + + DF L
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 6/154 (3%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
I+ ++ +GSG G VHL + A+K + +G M E E++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMM 58
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + LY + +CL+T++ G L L Q E + +V +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGM 117
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
YL +I+RDL N L+ N + ++DF ++
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 38/178 (21%), Positives = 71/178 (39%), Gaps = 21/178 (11%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
F+ LG G G V +G+ A+K ++ + REI L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PF--DKPLFALRTLREIKILKH 65
Query: 729 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
H P + +F V +I + +L ++ Q L +D ++++
Sbjct: 66 FKHENIITIFNIQRPDSFENFN---EVYIIQELM-QTDLHRVISTQM---LSDDHIQYFI 118
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+ + A++ LH +I+RDLKP N+L+ N + + DF L+ + T ++
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 47/241 (19%), Positives = 84/241 (34%), Gaps = 22/241 (9%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
S+ + + S A S QI + +G+G G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 701 AMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 758
A+K + + + + + REI L+ L+H V + + + D E
Sbjct: 82 AIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVL-------DIVIPKDVEKFDE 131
Query: 759 LFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809
L+++L+ + L E ++ ++V ++Y+H GI++RDLKP N L+
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191
Query: 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 869
+ V + DF L+ + R V T Y A
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 870 P 870
P
Sbjct: 252 P 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 24/94 (25%), Positives = 42/94 (44%), Gaps = 6/94 (6%)
Query: 729 LDHPFVPALY----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
L+HP + A+Y A ++ +Y G L ++ + + A+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADAC 126
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818
AL + H GII+RD+KP N+++ V + DF
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 12/110 (10%)
Query: 721 AEREI--LDMLDHPFVPALY--------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 770
A REI L +L H V L + K + L+ D+C +L LL K
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK- 120
Query: 771 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
++ ++ L Y+H I++RD+K NVL+ +G + L DF L
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 41/167 (24%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 657 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 716
A + SG +N++ + ++ +G G+ G V L + G A+K + +
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVK------CIKNDAT 57
Query: 717 HRA-CAEREILDMLDHPFVPALYAS-FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 774
+A AE ++ L H + L + K + ++T+Y G L L + VL D
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 775 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ ++ +V A+EYL ++RDL NVL+ + ++DF L+
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 36/168 (21%), Positives = 76/168 (45%), Gaps = 16/168 (9%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 729 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
++H + L S + V ++ + L ++ + L + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QME---LDHERMSYLLYQ 135
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
++ +++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 45/206 (21%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---D 727
L+ + +K LG G G V +G+ A+K K +N REI+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 728 MLDHPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ H + L + V L+ DY +L ++ L+ ++ +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIK 120
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKKRRHKG 844
++YLH G+++RD+KP N+LL HV + DF LS + + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 845 QQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + + +V T Y AP
Sbjct: 181 DDDQPILTD-------YVATRWYRAP 199
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 37/186 (19%), Positives = 68/186 (36%), Gaps = 11/186 (5%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
++ ++ + P Q +L +I+ K +G+G+ G V+ L S
Sbjct: 16 TTENLYFQGAMGSDPN----QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK 71
Query: 700 F----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755
A+K + G + E I+ H + L + +IT+Y
Sbjct: 72 KEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129
Query: 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 815
G L L + + V + ++YL ++RDL N+L+ N +
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGM-LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 188
Query: 816 TDFDLS 821
+DF LS
Sbjct: 189 SDFGLS 194
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 36/167 (21%), Positives = 67/167 (40%), Gaps = 31/167 (18%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV--HRACAEREI--- 725
+ F+ + G G G+V L + +G A+K KV RE+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----------KVIQDPRFRNRELQIM 70
Query: 726 --LDMLDHPFVPALYASFQTKTH-------VCLITDYCPGGELFLLLDRQPTK--VLKED 774
L +L HP + L + F T + ++ +Y P L +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 775 AVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL-QGNGHVSLTDF 818
++ + +++ ++ LH + +RD+KP NVL+ + +G + L DF
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 37/161 (22%), Positives = 62/161 (38%), Gaps = 16/161 (9%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACAE 722
R +K LGSG G+VH G+ +K + G +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT----DH 65
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 780
+ LDH + L + + L+T Y P G L + RQ L + +
Sbjct: 66 MLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWG 121
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + YL G+++R+L NVLL+ V + DF ++
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 11/159 (6%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 724
+I + + +G G G VH A+K + + + E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEAL 68
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 782
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 69 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQ 124
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
++ +G G G V+L + + A+K +++ + + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNR 81
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFY 779
L ++ LY + + D EL+++L+ + L E+ ++
Sbjct: 82 LKSDYIIRLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134
Query: 780 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++ ++H GII+RDLKP N LL + V + DF L+
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 13/160 (8%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML-NRNKVHRACAER 723
I + + LG G G V+ A+K K L N+ K E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EA 64
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAA 781
I+ LDHP + L + +I + P GEL +L + LK + Y+
Sbjct: 65 VIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSL 120
Query: 782 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ A+ YL ++RD+ N+L+ V L DF LS
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 6/154 (3%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + +K LGSG G V L + G A+K + +G M E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMM 58
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L HP + Y + + ++T+Y G L L + + +V +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGM 117
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+L I+RDL N L+ + V ++DF ++
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 19/155 (12%)
Query: 677 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 729
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 83
Query: 730 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 786
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 140
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++YL + ++RDL N +L V + DF L+
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 22/180 (12%)
Query: 652 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKG 708
DS ++ +L E++ + +G G G V+ E Q A+K
Sbjct: 4 DSALLAEVKDVLIPHERVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQCAIK----- 55
Query: 709 VMLNRNKVHRACA----EREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FL 761
L+R + E ++ L+HP V AL + ++ Y G+L F+
Sbjct: 56 -SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 762 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ V +D + F +V +EYL Q ++RDL N +L + V + DF L+
Sbjct: 115 RSPQRNPTV--KDLISF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 41/159 (25%), Positives = 64/159 (40%), Gaps = 11/159 (6%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 724
+I + + +G G G VH A+K + + + E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE--KFLQEAL 443
Query: 725 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 782
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQ 499
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 33/164 (20%), Positives = 66/164 (40%), Gaps = 18/164 (10%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 728
+ +KPLG G G V + A+K K ++ + A REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---K--IVLTDPQSVKHALREIKIIRR 64
Query: 729 LDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRF 778
LDH + ++ + ++++ + T L E+ R
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 779 YAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLS 821
+ +++ L+Y+H +++RDLKP N+ + + + + DF L+
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 21/169 (12%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAER 723
+Q L + LG G+ GSV +L F A+K + ++ + + E
Sbjct: 23 QQFTL-----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREA 76
Query: 724 EILDMLDHPFVPALYA------SFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLK 772
+ DHP V L + +I + G+L FLL R P +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ VRF ++ +EYL + I+RDL N +L + V + DF LS
Sbjct: 137 QTLVRF-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-08
Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 1/88 (1%)
Query: 501 IFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 560
+ S + E +ILG + + PE R + + + G
Sbjct: 26 LAVSRRWREDYGLGDGDILGMSHYDI-FPEIGEEWKSVHRRGLAGEVIRVEEDCFVRADG 84
Query: 561 KKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
+ W + ++P + +G V + D
Sbjct: 85 RTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 17/93 (18%)
Query: 218 MYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD----PEDVAKIRET----LQNGQSYCGR 269
+ S + + G +++G + PE + + L
Sbjct: 26 LAVSRRWREDYGLGDGDILGM---------SHYDIFPEIGEEWKSVHRRGLAGEVIRVEE 76
Query: 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 302
+ DG W + P + EG+V +
Sbjct: 77 DCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIF 109
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 26/169 (15%), Positives = 54/169 (31%), Gaps = 19/169 (11%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF-------AMKAMDKGVMLNRNKVHRAC 720
+I + + LG G + G Y +K +DK
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-- 61
Query: 721 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 780
++ L H + Y L+ ++ G L L + + + A
Sbjct: 62 -AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-A 119
Query: 781 AEVVVALEYLHCQGIIYRDLKPENVLLQG--------NGHVSLTDFDLS 821
++ A+ +L +I+ ++ +N+LL + L+D +S
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 5e-08
Identities = 39/154 (25%), Positives = 67/154 (43%), Gaps = 6/154 (3%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
+I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMM 74
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
L H + LY + + +IT+Y G L L + + + +V A+
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAM 133
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
EYL + ++RDL N L+ G V ++DF LS
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 35/145 (24%), Positives = 63/145 (43%), Gaps = 8/145 (5%)
Query: 680 LGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPA 736
LG G+ GSV + A+K + +G E +I+ LD+P++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVR 74
Query: 737 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 796
L Q + + L+ + GG L L + ++ + +V + ++YL + +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFV 132
Query: 797 YRDLKPENVLLQGNGHVSLTDFDLS 821
+RDL NVLL + ++DF LS
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 35/155 (22%), Positives = 65/155 (41%), Gaps = 19/155 (12%)
Query: 677 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 729
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 147
Query: 730 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 786
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 204
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+++L + ++RDL N +L V + DF L+
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 39/179 (21%), Positives = 69/179 (38%), Gaps = 12/179 (6%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMK 703
PH + P Q + + ++++ + K +G+G+ G V L + A+K
Sbjct: 24 DPHTFEDP----TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 704 AMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 762
+ G R E I+ DHP + L V ++T+Y G L
Sbjct: 80 TLKVGYTEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 763 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L + + V + ++YL G ++RDL N+L+ N ++DF L
Sbjct: 137 LRKHDAQFTVIQLVGM-LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 41/193 (21%), Positives = 74/193 (38%), Gaps = 47/193 (24%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
G + + + + K LG+G G V V SG+ FA+K K V+ + +R E +I
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---K-VLQDPRYKNR---ELDI 53
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGG--------------------------EL 759
+ +LDH + L F T P L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 760 FLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806
++++ P + + + + Y ++ A+ ++H GI +RD+KP+N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 807 LQGN-GHVSLTDF 818
+ + L DF
Sbjct: 174 VNSKDNTLKLCDF 186
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I YA+ + ++K +V ++ Q D+A + + LQ+GQS + + D
Sbjct: 29 IRYANPAAELLFSQSAKRIVEQSLS--QLIQHASLDLALLTQPLQSGQSITDSDVTFVVD 86
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
G P +T++PI +L
Sbjct: 87 GRPLMLEVTVSPITWQRQLML 107
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 14/92 (15%), Positives = 35/92 (38%), Gaps = 7/92 (7%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNC-RFLQGPETDPATVRKIRAAIDNQT 547
+I D I +A+ + L S + I+ ++ + +Q D A + + +
Sbjct: 21 LILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL---LTQPLQSGQ 74
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 579
+T + + G+ + P+ Q+ +
Sbjct: 75 SITDSDVTFVVDGRPLMLEVTVSPITWQRQLM 106
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-07
Identities = 13/93 (13%), Positives = 28/93 (30%), Gaps = 12/93 (12%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCGR 269
+ + + GYT E + + L + D +L G+
Sbjct: 29 AEGHYLDVNPAICSAIGYTRDEFLALDWGVL----SRGVDSGWAAASLARIVGGEPLREE 84
Query: 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 302
+ ++G L+ + D K +G+
Sbjct: 85 RTVWTRNGDQLTVELSAHLLPDG-----KILGI 112
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 10/86 (11%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 559
+ + + Y+R+E L + L + + + + + +T++
Sbjct: 33 YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSGWAAASLARIVGGEP-LREERTVWTRN 91
Query: 560 GKKFWNLFHLQPMRDQKGEVQYFIGV 585
G + + D K +G+
Sbjct: 92 GDQLTVELSAHLLPDGK-----ILGI 112
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 19/139 (13%)
Query: 695 GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH--VCLITD 752
+ +A+K ++ + AC E +L L HP V +L F + V L+ D
Sbjct: 46 KDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100
Query: 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEV-------VVALEYLHCQGIIYRDLKPENV 805
Y +L+ ++ + V+ V + + YLH +++RDLKP N+
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 159
Query: 806 LLQG----NGHVSLTDFDL 820
L+ G G V + D
Sbjct: 160 LVMGEGPERGRVKIADMGF 178
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-07
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG---R 269
+ I+Y SA GY E++G + ED + N R
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTF----LHEEDQFLVESYFYNEHHLMPCTFR 72
Query: 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308
+ KKD T W + + + + I ++++V +
Sbjct: 73 FI--KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 15/96 (15%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555
+ II+ S + Y + E++G + E D V + T + I
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE-DQFLVESYFYNEHHLMPCTFRFI- 74
Query: 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
K W ++ + + + I +++ E
Sbjct: 75 -KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 15/98 (15%), Positives = 26/98 (26%), Gaps = 6/98 (6%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
+ D D I + F Y E+LGR+ D V+ +
Sbjct: 30 IDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDE 85
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
+ + + G HL F+ +
Sbjct: 86 RRKFEGLYERRDGSTMSVEVHLLRFNL--EGEDRFLAI 121
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 8e-07
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I + F GY EV+GR+ D EDV + L ++D
Sbjct: 39 ICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDERRKFEGLYERRD 97
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
G+ + + +
Sbjct: 98 GSTMSVEVHLLRFNLEGEDRF 118
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 20/195 (10%)
Query: 640 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 699
H R ++ ++ + L K LG G+ GSV L
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLIL-----GKILGEGEFGSVMEGNLKQEDGT 61
Query: 700 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-----SFQTKTHVCLIT 751
A+K M ++ ++ +E + HP V L S Q +I
Sbjct: 62 SLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 752 DYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 806
+ G+L +LL R P + + ++F ++ + +EYL + ++RDL N +
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF-MVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 807 LQGNGHVSLTDFDLS 821
L+ + V + DF LS
Sbjct: 180 LRDDMTVCVADFGLS 194
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 12/98 (12%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
+I + + +++A+ + + Y+ EE++ + + A KI A +
Sbjct: 12 ILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGK 67
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
++ L K G + + +
Sbjct: 68 KESLPLSLEKKEGTSIPAKARIWQGKW--HNEPCLFAI 103
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
++YA+ K GYT +E++ + + + + KI L G+ L KK+
Sbjct: 21 LLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGKKESLPLSLEKKE 79
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
GT I K L
Sbjct: 80 GTSIPAKARIWQGKWHNEPCL 100
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 39/165 (23%), Positives = 61/165 (36%), Gaps = 24/165 (14%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQH 76
Query: 732 PFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR----------- 777
+ Y + ++ +Y G+L FL +L + R
Sbjct: 77 EHIVKFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 778 -FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
A+++ + YL Q ++RDL N L+ N V + DF +S
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 41/170 (24%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 729
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 94
Query: 730 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 778
H + L + + +I +Y G L +L R P D R
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 779 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 50/196 (25%), Positives = 75/196 (38%), Gaps = 29/196 (14%)
Query: 645 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AM 702
H H + P I +LD I Q +G G+ G V + G A+
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDW-NDIKFQ-----DVIGEGNFGQVLKARIKKDGLRMDAAI 57
Query: 703 KAMDKGVMLNRNKVHRA-CAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL- 759
K M + HR E E+L L HP + L + + + ++ L +Y P G L
Sbjct: 58 KRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 760 -FLLLDRQPTKVLK-------------EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805
FL R + + F AA+V ++YL + I+RDL N+
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNI 173
Query: 806 LLQGNGHVSLTDFDLS 821
L+ N + DF LS
Sbjct: 174 LVGENYVAKIADFGLS 189
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 9e-06
Identities = 38/164 (23%), Positives = 59/164 (35%), Gaps = 23/164 (14%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
LG G G V L E A+KA+ + R R E E+L ML H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQH 102
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKEDAVR 777
+ + + ++ +Y G+L FL D P + +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 778 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
A++V + YL ++RDL N L+ V + DF +S
Sbjct: 163 V-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 17/35 (48%), Positives = 23/35 (65%)
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L YLH + II+RD+K N+LL N +TDF +S
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 29/116 (25%), Positives = 46/116 (39%), Gaps = 16/116 (13%)
Query: 722 EREILDMLD-HPFVPALY-ASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
E +IL + H V L A + + +I ++C G L +L R K
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 778 F------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 29/159 (18%), Positives = 56/159 (35%), Gaps = 17/159 (10%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
+ LG G G V+ G + A+K +++ + R + E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASVMKEFN 86
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR------FYAAE 782
V L +I + G+L +L R A A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ + YL+ ++RDL N ++ + V + DF ++
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 41/170 (24%), Positives = 65/170 (38%), Gaps = 30/170 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 729
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 140
Query: 730 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 778
H + L + + +I +Y G L +L R P D R
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 779 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 39/170 (22%), Positives = 63/170 (37%), Gaps = 30/170 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 729
KPLG G G V L E G + + V ML + E+++ D++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLSDLISEMEMM 128
Query: 730 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 778
H + L + + +I +Y G L +L R P +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 779 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 27/122 (22%), Positives = 47/122 (38%), Gaps = 22/122 (18%)
Query: 722 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF- 778
E +L ++HP V LY + + LI +Y G L FL R+
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 779 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
+A ++ ++YL +++RDL N+L+ + ++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 820 LS 821
LS
Sbjct: 196 LS 197
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 488 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 547
+ ++ +D+ +TEYSRE++L N + + D I +
Sbjct: 26 SFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKN 77
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
+ T + ++SG+ F L + DQ+ +
Sbjct: 78 NYTFKTRYRSQSGRIFLVEMSLTFLEDQERR--FSCVF 113
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 12/81 (14%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
+Y + +MT Y+ ++++ N + + D + E ++ +Y + +
Sbjct: 35 FLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKNNYTFKTRYRSQS 89
Query: 277 GTPFWNLLTIAPIKDDEGKVL 297
G F +++ ++D E +
Sbjct: 90 GRIFLVEMSLTFLEDQERRFS 110
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 34/148 (22%), Positives = 58/148 (39%), Gaps = 14/148 (9%)
Query: 680 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALY 738
+G G G V+ + + A+K + V + ++ + E +++ H + L
Sbjct: 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 739 ASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKED-AVRFY----AAEVVVALEYLHC 792
+CL+ Y P G L L T L +R AA + +LH
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRCKIAQGAAN---GINFLHE 151
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDL 820
I+RD+K N+LL ++DF L
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCG--RLL 271
++ ++ + + G + ++ FL G PED +++T+Q +G+S R+
Sbjct: 34 VLVINSAYEDIWGRSVAKLRENPHDFLNG--IHPEDRELMKDTMQSLMDGESADVECRVN 91
Query: 272 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 301
+ W + PI +D G+ ++ G
Sbjct: 92 A--TEEYQRWVWIQGEPITNDAGETVRVAG 119
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 6/86 (6%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 559
I+ + S + ++G+ + E + ++A++N T +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTATRSE---DAVG 97
Query: 560 GKKFWNLFHLQPMRDQKGEVQYFIGV 585
G+ + N + P+ + F V
Sbjct: 98 GRHYHNQYI--PVDSH-RKSDTFQLV 120
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 217 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 276
I+ + G +VG+ + + + + + ++NG +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTA---TRSEDAVG 97
Query: 277 GTPFWNLLTIAPIKDDEGKVLKFIGM 302
G + N P+ D K F +
Sbjct: 98 GRHYHN--QYIPV-DSHRKSDTFQLV 120
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 16/99 (16%), Positives = 28/99 (28%), Gaps = 12/99 (12%)
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRK-IRAAIDNQTDVTVQ 552
I F +FL+ E L + D + + + +T+
Sbjct: 24 GQATIRFRPPAFLKT--LVSEHAGTTRLNTLSMIHHD-DRHMLSNAYSKLREAKHSLTLV 80
Query: 553 LINY---TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
Y T GK W H++ G G+ +
Sbjct: 81 ---YRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCE 116
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 12/95 (12%), Positives = 21/95 (22%), Gaps = 12/95 (12%)
Query: 213 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ----NGQSYCG 268
I + F K N + +D + S
Sbjct: 24 GQATIRFRPPAFLKTLVSEHAGTTRLNTL----SMIHHDDRHMLSNAYSKLREAKHSLTL 79
Query: 269 --RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 301
R++ +G W + D+G G
Sbjct: 80 VYRIVT--PEGKLHWIEDHMRSSFSDDGLFSGIDG 112
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 23/165 (13%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
++ LG G V+ L G A+K + R + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRARLQ 70
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF---------- 778
HP V L + +I YC G+L FL++ + V D R
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 779 --YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
A++ +EYL ++++DL NVL+ +V ++D L
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 21/161 (13%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 91
Query: 731 HPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEV 783
H + S Q+ ++ + GG+L FL R QP+ + D + A ++
Sbjct: 92 HQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDI 149
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLS 821
+YL I+RD+ N LL G + DF ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 36/173 (20%), Positives = 60/173 (34%), Gaps = 31/173 (17%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
++ +G G G V G Y A+K + + + + R E ++ D
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAEFD 108
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY--------- 779
+P + L +CL+ +Y G+L FL T +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 780 -----------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 27/118 (22%), Positives = 46/118 (38%), Gaps = 17/118 (14%)
Query: 721 AEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 777
+E ++L L +H + L + +IT+YC G+L FL R K
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 778 F--------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ +V + +L + I+RDL N+LL + DF L+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 33/160 (20%), Positives = 58/160 (36%), Gaps = 19/160 (11%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 730
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 132
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEVV 784
H + ++ + GG+L FL R QP+ + D + A ++
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDIA 191
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLS 821
+YL I+RD+ N LL G + DF ++
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 2e-04
Identities = 40/159 (25%), Positives = 57/159 (35%), Gaps = 22/159 (13%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA----CAEREILDML 729
F LG G G V+ L G A+K L + E E++ M
Sbjct: 32 FSNKNILGRGGFGKVYKGRL-ADGTLVAVK------RLKEERTQGGELQFQTEVEMISMA 84
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFY----AAEVV 784
H + L T T L+ Y G + L +R ++ + R +A
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 785 VALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDL 820
L YLH II+RD+K N+LL + DF L
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 15/114 (13%)
Query: 722 EREILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLK------ 772
E +I+ L H + L + V +IT+YC G+L FL + +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 773 -----EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
D + F +++V + +L + I+RD+ NVLL + DF L+
Sbjct: 159 STASTRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 12/125 (9%), Positives = 40/125 (32%), Gaps = 9/125 (7%)
Query: 500 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN-----QTDVTVQLI 554
+ + ++ + + +G+ R + + ++ +Q
Sbjct: 60 FVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWRLQTD 117
Query: 555 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQ 614
++ + F + P R G ++ + D + + + + EA EE + +
Sbjct: 118 YDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAA--EARVEELSERYRN 175
Query: 615 TAENV 619
++
Sbjct: 176 VRDSA 180
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 905 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-32 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-31 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-30 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-28 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-25 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-24 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-24 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-23 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 4e-23 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 5e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-16 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 5e-16 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 8e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 7e-07 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 7e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 7e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 4e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 9e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 3e-04 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 0.001 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 0.001 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-39
Identities = 51/152 (33%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+ F +PLG G G+V+L S A+K + K + H+ E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + LY F T V LI +Y P G ++ L + E Y E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
H + +I+RD+KPEN+LL G + + DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 9e-39
Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 4/150 (2%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ I LG G G V+ + + A K +D + ++ E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ L +F + ++ ++ ++C GG + ++ + L E ++ + + AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
II+RDLK N+L +G + L DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSA 158
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 58/163 (35%), Positives = 87/163 (53%), Gaps = 2/163 (1%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
F+ K LG G +V L + + +A+K ++K ++ NKV ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
F LY +FQ + Y GEL + + E RFY AE+V ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+GII+RDLKPEN+LL + H+ +TDF + + S + + +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 34/204 (16%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ F I LG+G+ G V V SG A K + + ++ E ++L
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ P++ Y +F + + + ++ GG L +L + + E + + V+ L
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 788 EYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
YL I++RD+KP N+L+ G + L DF +S
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------------------- 155
Query: 847 NPVFMAEPMRASNSFVGTEEYIAP 870
+NSFVGT Y++P
Sbjct: 156 -------IDSMANSFVGTRSYMSP 172
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 6e-38
Identities = 48/199 (24%), Positives = 75/199 (37%), Gaps = 33/199 (16%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + + L+ +YC G LL + K L+E + + L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 851
+I+RD+K N+LL G V L DF + +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------------------- 164
Query: 852 AEPMRASNSFVGTEEYIAP 870
M +NSFVGT ++AP
Sbjct: 165 ---MAPANSFVGTPYWMAP 180
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 29/200 (14%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ + ++ LG G G V L + + A+K +D ++ + E I ML+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
H V Y + L +YC GGELF ++ + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H GI +RD+KPEN+LL ++ ++DF L+ + +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--------------------- 158
Query: 851 MAEPMRASNSFVGTEEYIAP 870
R N GT Y+AP
Sbjct: 159 ----ERLLNKMCGTLPYVAP 174
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (350), Expect = 2e-36
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 6/154 (3%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ ++ LGSG G VH +G+ F K ++ L++ V E I++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLH 84
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L+ +F+ K + LI ++ GGELF + + K + E V Y + L+++
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 791 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSC 822
H I++ D+KPEN++ + V + DF L+
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 177
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (350), Expect = 2e-36
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 6/157 (3%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L H+ + LG+G G VH V +G FA K + ++ V + E + + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L+ +F+ + +I ++ GGELF + + K + ED Y +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 791 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTS 825
H ++ DLKPEN++ + + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (351), Expect = 2e-36
Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 5/160 (3%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+ + F + +G G G V+ +G+ +AMK +DK + + A ER +L +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 729 L---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ D PF+ + +F T + I D GG+L L + E +RFYAAE+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIIL 118
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
LE++H + ++YRDLKP N+LL +GHV ++D L+C S
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (332), Expect = 7e-35
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK------VHRACAEREI 725
+++ P + LG G + V + + +A+K +D + + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 726 LDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
L + HP + L +++T T L+ D GELF L + T L E R ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
+ LH I++RDLKPEN+LL + ++ LTDF SC
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (333), Expect = 1e-34
Identities = 65/155 (41%), Positives = 95/155 (61%), Gaps = 2/155 (1%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HPF+ ++ +FQ + +I DY GGELF LL + +FYAAEV +ALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYL 120
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
H + IIYRDLKPEN+LL NGH+ +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-34
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ + +G+G G + G+ K +D G M + +E +L L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 734 VPALYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEY 789
+ Y +T T + ++ +YC GG+L ++ + + + L E+ V ++ +AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 790 LHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
H + +++RDLKP NV L G +V L DF L+ +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-34
Identities = 35/155 (22%), Positives = 69/155 (44%), Gaps = 6/155 (3%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+ + + +G G +G+V+ +GQ A++ M+ + + E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
P + S+ + ++ +Y GG L ++ E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH 133
Query: 792 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
+I+RD+K +N+LL +G V LTDF +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-33
Identities = 62/155 (40%), Positives = 92/155 (59%), Gaps = 2/155 (1%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
+ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
HPF+ AL +FQT +C + +Y GGELF L R+ E+ RFY AE+V ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
YLH + ++YRD+K EN++L +GH+ +TDF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-33
Identities = 53/152 (34%), Positives = 88/152 (57%), Gaps = 3/152 (1%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-L 729
++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
+HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+++ L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
LH +GI+YRDLK +N+LL +GH+ + DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-32
Identities = 58/155 (37%), Positives = 89/155 (57%), Gaps = 2/155 (1%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+ IL
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
EYLH +IYRDLKPEN+L+ G++ +TDF +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 1e-32
Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 6/157 (3%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I + +GSG G+V+ + G A+K ++ ++ E +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
H + + T + ++T +C G L+ L TK + + A + ++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
YLH + II+RDLK N+ L + V + DF L+ + S
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 1e-32
Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 43/218 (19%)
Query: 656 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 715
WK + I D + LG+G V L E + + A+K + K + K
Sbjct: 1 WKQAEDIRD--------IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGK 50
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
E +L + HP + AL +++ H+ LI GGELF + + E
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 108
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLL 832
+V+ A++YLH GI++RDLKPEN+L + + ++DF LS +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME-------- 160
Query: 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+P ++ GT Y+AP
Sbjct: 161 --------------------DPGSVLSTACGTPGYVAP 178
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 67/167 (40%), Positives = 99/167 (59%), Gaps = 7/167 (4%)
Query: 661 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-V 716
+ E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 717 HRACAEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822
V+ Y E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-32
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 8/161 (4%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
G +N++ + ++ +G G+ G V L + G A+K + AE +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-----DATAQAFLAEASV 53
Query: 726 LDMLDHPFVPALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
+ L H + L + K + ++T+Y G L L + VL D + ++ +V
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
A+EYL ++RDL NVL+ + ++DF L+ S
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-32
Identities = 33/160 (20%), Positives = 68/160 (42%), Gaps = 7/160 (4%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + LG G+ G VH S + + K + E IL++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 733 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ L+ SF++ + +I ++ G ++F ++ + L E + Y +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 793 QGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQL 830
I + D++PEN++ Q + + + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 8e-32
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
G + + + +G G +V+ + A + L +++ R E E+
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEM 61
Query: 726 LDMLDHPFVPALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 781
L L HP + Y S+++ K + L+T+ G L L R KV+K +R +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCR 119
Query: 782 EVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
+++ L++LH + II+RDLK +N+ + G G V + D L+ L
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--------------- 164
Query: 839 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 870
+ + + +GT E++AP
Sbjct: 165 --------------KRASFAKAVIGTPEFMAP 182
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 6/157 (3%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L H + LY + + +IT+Y G L L + + + +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
YL + ++RDL N L+ G V ++DF LS
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (307), Expect = 2e-31
Identities = 35/158 (22%), Positives = 63/158 (39%), Gaps = 4/158 (2%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ LG G G V+ A+K + + + +V E ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 68
Query: 728 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
+ HP + L + +IT++ G L L + + + + A ++ A+
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
EYL + I+RDL N L+ N V + DF LS L +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (305), Expect = 3e-31
Identities = 38/202 (18%), Positives = 78/202 (38%), Gaps = 30/202 (14%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + LG G VHL + A+K + + + + R E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 733 FVPALYASFQTKTH----VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
+ A+Y + + +T ++ +Y G L ++ + + A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+ H GII+RD+KP N+++ V + DF ++ +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN------------------- 166
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
+ + + +GT +Y++P
Sbjct: 167 -----SVTQTAAVIGTAQYLSP 183
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 7e-31
Identities = 41/177 (23%), Positives = 75/177 (42%), Gaps = 19/177 (10%)
Query: 647 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 706
KP +D W ++ + + ++ LG+G G V + G A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK 46
Query: 707 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 766
+G M AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSM----SPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTP 101
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
L + + AA++ + ++ + I+RDL+ N+L+ + DF L+ L
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 8e-31
Identities = 45/216 (20%), Positives = 72/216 (33%), Gaps = 13/216 (6%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
I + R ++ LG G G V E G A+K + V+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ LDH + LY T + ++T+ P G L L + + YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 845
+ YL + I+RDL N+LL V + DF L LP ++ + +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR--------ALPQNDDHYVMQEHR 174
Query: 846 QNPVFMAEPMRASNSFVGTEEYIAPVSDFAYTRMTR 881
+ P P + T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-30
Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 6/158 (3%)
Query: 680 LGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737
LG G+ GSV A+K + +G + E +I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 738 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 797
Q + + L+ + GG L L + + V +V + ++YL + ++
Sbjct: 75 IGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 798 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
RDL NVLL + ++DF LS +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 1e-29
Identities = 37/160 (23%), Positives = 66/160 (41%), Gaps = 6/160 (3%)
Query: 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAER 723
++I++ + + +G+G+ G V L G+ + A+K + G + +E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEA 78
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
I+ DHP V L T V +IT++ G L RQ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGI 137
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
++YL ++RDL N+L+ N ++DF LS
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-29
Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 736
+ LG G G V + + + FA+K + R E E+ P +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 737 LYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 792
+ ++ + + ++ + GGELF + + + E + A++YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 793 QGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTS 825
I +RD+KPEN+L + N + LTDF + T+
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-29
Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 29/194 (14%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAER 723
++ K LGSG G V G + A+K + + + ++ +E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSEL 91
Query: 724 EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK------------- 769
+++ L H + L + + LI +YC G+L L + K
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 770 --------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
VL + + +A +V +E+L + ++RDL NVL+ V + DF L+
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 822 CLTSCKPQLLLPTT 835
++
Sbjct: 212 RDIMSDSNYVVRGN 225
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 4/148 (2%)
Query: 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 734
+ LG G +V+ + Q A+K + G A RE +L L HP +
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 735 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 794
L +F K+++ L+ D+ ++ D VL ++ Y + LEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 795 IIYRDLKPENVLLQGNGHVSLTDFDLSC 822
I++RDLKP N+LL NG + L DF L+
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK 148
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 36/195 (18%), Positives = 69/195 (35%), Gaps = 30/195 (15%)
Query: 678 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 735
K LGSG+ G+V + A+K + + AE ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 795
+ + ++ L+ + G L L + +K+ + +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 796 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 855
++RDL NVLL + ++DF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------------------------YY 164
Query: 856 RASNSFVGTEEYIAP 870
+A ++ AP
Sbjct: 165 KAQTHGKWPVKWYAP 179
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-28
Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 6/155 (3%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I+ ++ +GSG G VHL + A+K + +G M + + E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE----EAEVMMK 56
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L HP + LY + +CL+ ++ G L R + + + +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
YL +I+RDL N L+ N + ++DF ++
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-28
Identities = 37/197 (18%), Positives = 68/197 (34%), Gaps = 24/197 (12%)
Query: 660 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRN 714
Q D + K LG+G G V G + A+K + +
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLT 68
Query: 715 KVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ------- 766
+ +E ++L L +H + L + +IT+YC G+L L R+
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 767 ---------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 817
L + + ++ +V + +L + I+RDL N+LL + D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 818 FDLSCLTSCKPQLLLPT 834
F L+ ++
Sbjct: 189 FGLARDIKNDSNYVVKG 205
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 6/157 (3%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 728
I + R LG G G V + G+ + A+K + G M E +++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 729 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
L H + LYA ++ + ++T+Y G L L + K L+ + AA++ +
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
Y+ ++RDL+ N+L+ N + DF L+ L
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 6e-27
Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 7/159 (4%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---RACAEREILDML 729
++ LGSG GSV+ A+K ++K + + ++ R E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 730 D--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
V L F+ LI + + + L+E+ R + +V+ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 788 EYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTS 825
+ H G+++RD+K EN+L+ N G + L DF L
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAERE--ILDML 729
++ + LGSG V +G +A K + K +R V R ERE IL +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 730 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
HP V L+ ++ KT V LI + GGELF L + + L E+ + +++ + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 790 LHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLTS 825
LH I + DLKPEN++L + + DF L+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-26
Identities = 35/169 (20%), Positives = 62/169 (36%), Gaps = 15/169 (8%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 727
++ + +G G+ G V + G +++ E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 728 ML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQPTKVLK 772
L HP + L + + + ++ L +Y P G L L L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 773 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
+ +AA+V ++YL + I+RDL N+L+ N + DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 733
+ K +G+G G V+ +LC SG+ A+K + + E +I+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 734 VPALYASFQT------KTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVA 786
+ L F + + ++ L+ DY P + + + L V+ Y ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 787 LEYLHCQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTS 825
L Y+H GI +RD+KP+N+LL + V L DF +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 36/194 (18%), Positives = 76/194 (39%), Gaps = 12/194 (6%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+++F+ ++ +G G G V+ +G+ A+K + A E +L L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
HP + L T+ + L+ ++ L +D + ++ Y +++ L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H +++RDLKP+N+L+ G + L DF L+ + +
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----------VPVRTYTHEVVTLWY 168
Query: 851 MAEPMRASNSFVGT 864
A + + T
Sbjct: 169 RAPEILLGCKYYST 182
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (273), Expect = 1e-26
Identities = 38/189 (20%), Positives = 75/189 (39%), Gaps = 18/189 (9%)
Query: 641 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 700
++V + W +++ G N ++ ++ LG G V + +
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWG---NQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 701 AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH--VCLITDYCPGG 757
+K + K + E +IL+ L P + L + L+ ++
Sbjct: 64 VVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 758 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLT 816
+ L L + +RFY E++ AL+Y H GI++RD+KP NV++ + + L
Sbjct: 118 DFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 817 DFDLSCLTS 825
D+ L+
Sbjct: 173 DWGLAEFYH 181
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (269), Expect = 2e-26
Identities = 38/212 (17%), Positives = 79/212 (37%), Gaps = 14/212 (6%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
++ + ++ +G G G V+ + G+ FA+K + + E IL L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE-KEDEGIPSTTIREISILKELK 58
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
H + LY TK + L+ ++ LL + L+ + + +++ + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 850
H + +++RDLKP+N+L+ G + + DF L+ ++ +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFG----------IPVRKYTHEIVTLWY 166
Query: 851 MAEPMRASNSFVGTEEYIAPVSDFAYTRMTRY 882
A + + T I V +
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-26
Identities = 35/187 (18%), Positives = 72/187 (38%), Gaps = 16/187 (8%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + +G G G V + A+K + ++ R E +IL H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 66
Query: 733 FVPALYASFQTKTHV----CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 788
+ + + T + + G +L+ LL Q L D + ++ +++ L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 789 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
Y+H +++RDLKP N+LL + + DF L+ ++ P + +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA-------RVADPDHDHTGFLTEYVATR 176
Query: 849 VFMAEPM 855
+ A +
Sbjct: 177 WYRAPEI 183
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 40/158 (25%), Positives = 62/158 (39%), Gaps = 7/158 (4%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
I + + +G G G VH A+K + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALT 61
Query: 726 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 785
+ DHP + L T+ V +I + C GEL L + L ++ YA ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 786 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-26
Identities = 31/155 (20%), Positives = 68/155 (43%), Gaps = 3/155 (1%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
+Q + ++ +G G G+V + + + A+K + + A E +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 731 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 790
H + L+ + + L+ ++C L + V+ + +++ L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 791 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-26
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 11/157 (7%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+ + +G G G V +GQ A+K + A E +IL +L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHE 69
Query: 733 FVPALYASFQTKT--------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
V L +TK + L+ D+C LL + ++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
L Y+H I++RD+K NVL+ +G + L DF L+
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 164
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 105 bits (263), Expect = 1e-25
Identities = 35/204 (17%), Positives = 69/204 (33%), Gaps = 33/204 (16%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 731
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+P +Y Q H L+ D LL + V A +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 792 CQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 846
+ ++YRD+KP+N L+ + + + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR--------------------D 158
Query: 847 NPVFMAEPMRASNSFVGTEEYIAP 870
P R + GT Y++
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSI 182
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 10/168 (5%)
Query: 658 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-- 715
A+ +IL E F+ IK LGSG G+V+ G+ + K + +
Sbjct: 1 ALLRILKETE------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54
Query: 716 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
E ++ +D+P V L T T LIT P G L + +
Sbjct: 55 NKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQY 112
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823
+ + ++ + YL + +++RDL NVL++ HV +TDF L+ L
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 2e-25
Identities = 33/195 (16%), Positives = 58/195 (29%), Gaps = 29/195 (14%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 722
+ + ++ +G G G V G A+K + + + + E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66
Query: 723 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---------------- 766
++ D+P + L +CL+ +Y G+L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 767 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 820
L A +V + YL + ++RDL N L+ N V + DF L
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 821 SCLTSCKPQLLLPTT 835
S
Sbjct: 187 SRNIYSADYYKADGN 201
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (261), Expect = 6e-25
Identities = 33/166 (19%), Positives = 73/166 (43%), Gaps = 12/166 (7%)
Query: 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 730
L+ ++ +KP+GSG G V + A+K + + N+ RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 731 HPFVPALYASFQTK------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 784
H + +L F + V L+ + ++ + + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 785 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830
+++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (257), Expect = 8e-25
Identities = 37/202 (18%), Positives = 74/202 (36%), Gaps = 31/202 (15%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
+R + +GSG G ++L +G+ A+K + + K + E +I M+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGG 62
Query: 733 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
+P + + ++ + L ++ V A +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 792 CQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 848
+ I+RD+KP+N L+ V + DF L+ K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--------------------KYRDAR 160
Query: 849 VFMAEPMRASNSFVGTEEYIAP 870
P R + + GT Y +
Sbjct: 161 THQHIPYRENKNLTGTARYASI 182
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-24
Identities = 37/163 (22%), Positives = 73/163 (44%), Gaps = 11/163 (6%)
Query: 672 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML- 729
Q + + +G G G V +L G++ A+K + E +L L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65
Query: 730 --DHPFVPALYASFQT-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
+HP V L+ +T + L+ ++ L D+ P + + ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQ 124
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 167
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 97.2 bits (241), Expect = 1e-24
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 260
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 1e-24
Identities = 49/105 (46%), Positives = 67/105 (63%)
Query: 484 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAI 543
+ FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 544 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 1e-24
Identities = 47/221 (21%), Positives = 77/221 (34%), Gaps = 48/221 (21%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVP 735
+ +G G G V + G+ A+K + + + E EI L H +
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVK------IFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 736 ALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 791
A+ T T + L++DY G LF L+R + + + A L +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLH 117
Query: 792 CQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 843
+ I +RDLK +N+L++ NG + D L+ +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------ 165
Query: 844 GQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAYTRMTRYNY 884
A N VGT+ Y+AP M +
Sbjct: 166 -----------DIAPNHRVGTKRYMAPEVLDDSINMKHFES 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-24
Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 23/189 (12%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 722
+ + KPLG G G V + G + + A+K + +G + ++ + E
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--E 66
Query: 723 REILDMLDHPF--VPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-------------- 766
+IL + H V L A + + +I ++C G L L +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826
L + + Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 827 KPQLLLPTT 835
P +
Sbjct: 187 DPDYVRKGD 195
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-24
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 3/158 (1%)
Query: 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 731
+R ++P+GSG G+V +G A+K + + + RA E +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 732 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 789
V L F + TD+ L + L ED ++F +++ L Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 790 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827
+H GII+RDLKP N+ + + + + DF L+ +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 2e-23
Identities = 39/179 (21%), Positives = 63/179 (35%), Gaps = 24/179 (13%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACA 721
+ KPLG G G V L E G A+K + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLIS 67
Query: 722 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQ 766
E E++ M+ H + L + + +I +Y G L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 767 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825
P + L + A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 92.3 bits (228), Expect = 4e-23
Identities = 75/103 (72%), Positives = 86/103 (83%)
Query: 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN 545
K+FVITDPRLPDNPIIFASD FLELTEY+REE+LG NCRFLQG TD V+ IR A+
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 546 QTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588
Q DVTVQ++NYTK G+ FWNLFHLQ MRD+ G+VQYFIGVQ +
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 86.5 bits (213), Expect = 5e-21
Identities = 46/104 (44%), Positives = 69/104 (66%)
Query: 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN 262
++FV++D PD PI++AS F ++T YT +EV+G NCRFLQG GTD + V IR+ ++
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 263 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306
+ ++LNY K G FWNL + ++D+ G V FIG+Q E+
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQEM 104
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 5e-23
Identities = 35/175 (20%), Positives = 63/175 (36%), Gaps = 7/175 (4%)
Query: 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAER 723
+I+ K +G+G+ G V+ L S A+K + G + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 783
I+ H + L + +IT+Y G R+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 784 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 838
++YL ++RDL N+L+ N ++DF LS + P+ T+ K
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 3e-22
Identities = 26/180 (14%), Positives = 54/180 (30%), Gaps = 15/180 (8%)
Query: 669 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAER 723
+ + + LG G G V+ G A+K +++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 74
Query: 724 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------DRQPTKVLKEDA 775
++ + V L +I + G+L L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 776 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835
+ A E+ + YL+ ++RDL N ++ + V + DF ++
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 7e-22
Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 9/162 (5%)
Query: 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 732
++ + P+GSG GSV +G A+K + + + R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 733 FVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 787
V L F + + + G +L ++ Q L +D V+F +++ L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 788 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829
+Y+H II+RDLKP N+ + + + + DF L+ T +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 2e-21
Identities = 37/184 (20%), Positives = 79/184 (42%), Gaps = 10/184 (5%)
Query: 644 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYF 700
VH + +A+Q ++ + + HF + +G G G V+ L G +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIV-HFNEV--IGRGHFGCVYHGTLLDNDGKKIHC 58
Query: 701 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY-ASFQTKTHVCLITDYCPGGEL 759
A+K++++ + + +V + E I+ HP V +L +++ ++ Y G+L
Sbjct: 59 AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 760 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 819
+ + +D + F +V +++L + ++RDL N +L V + DF
Sbjct: 117 RNFIRNETHNPTVKDLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 820 LSCL 823
L+
Sbjct: 176 LARD 179
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.9 bits (193), Expect = 4e-16
Identities = 33/174 (18%), Positives = 68/174 (39%), Gaps = 12/174 (6%)
Query: 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 725
GE + ++ LG G +V L + + + AMK + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 726 -------LDMLDHPFVPALYASFQTKT---HVCLITDYCPGGELFLLLDRQPTKVLKEDA 775
D + + L F K ++ G L L+ + + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 776 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCK 827
V+ + ++++ L+Y+H + GII+ D+KPENVL++ L ++ L +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (177), Expect = 5e-16
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC--RFLQGPETDPATVRKIRAAI 543
+ F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 544 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 591
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 8e-13
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETL 260
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 261 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 2e-13
Identities = 25/159 (15%), Positives = 46/159 (28%), Gaps = 30/159 (18%)
Query: 678 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-KVHRACAERE------------ 724
K +G G +V +K G + K R +
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 725 --ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 782
L L VP +YA ++ + ++ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVLDM 111
Query: 783 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821
++ + + +GI++ DL NVL+ G + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW-IIDFPQS 149
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 46.3 bits (108), Expect = 7e-07
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 9/108 (8%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKI----RAAID 544
++ D I S + L +S E +G+N L I +
Sbjct: 4 IVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDP 60
Query: 545 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592
+ + + + G F + M+ G YF G D +EH
Sbjct: 61 HIIGIGRIVTGKRRDGTTFPMHLSIGEMQS--GGEPYFTGFVRDLTEH 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 43.6 bits (101), Expect = 7e-06
Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI----RETLQNGQSY 266
I S ++ G++ E +G+N L + I + +
Sbjct: 6 IDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGI 65
Query: 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309
+ ++DGT F L+I ++ F G ++++H
Sbjct: 66 GRIVTGKRRDGTTFPMHLSIGEMQSGGEPY--FTGFVRDLTEH 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 44.3 bits (103), Expect = 7e-06
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 211 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SY 266
+ D I+ +A + GY +EV+G+N R L E ++ + G+
Sbjct: 32 SATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGI 91
Query: 267 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307
+ +KDG+ F L + ++ + F G +++
Sbjct: 92 DRVVSGQRKDGSTFPMKLAVGEMRSGGERF--FTGFIRDLT 130
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 42.3 bits (98), Expect = 4e-05
Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 13/129 (10%)
Query: 464 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 523
D VR ++ L + L+ + V++ D I+ + + + Y+ EE++G+N
Sbjct: 9 DVVRARDAH----LRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNL 61
Query: 524 RFLQG----PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 579
R L E D R + + + K G F + MR G
Sbjct: 62 RILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRS--GGE 119
Query: 580 QYFIGVQLD 588
++F G D
Sbjct: 120 RFFTGFIRD 128
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (94), Expect = 9e-05
Identities = 15/101 (14%), Positives = 34/101 (33%), Gaps = 8/101 (7%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 548
D + I+ A+D L YS ++++G+ ++
Sbjct: 12 FTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGH 69
Query: 549 VTV----QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 585
V + ++SG+K ++ MR ++ + V
Sbjct: 70 AAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRL--CCVVV 108
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 3e-04
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 1/97 (1%)
Query: 496 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 555
D + D EL Y EE+LGR+ + + V+ Q
Sbjct: 14 MDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRM 73
Query: 556 YTKSGKKFWNLFHLQPMRDQK-GEVQYFIGVQLDGSE 591
K G W + + + + Q + V SE
Sbjct: 74 LAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLSE 110
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (85), Expect = 0.001
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 3/107 (2%)
Query: 202 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ 261
+TF+ D Y ++ GY +E++GR+ A +
Sbjct: 5 SKTFLSR--HSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCT 62
Query: 262 NGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVS 307
GQ G+ K G W I + + + + +S
Sbjct: 63 KGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLS 109
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 37.4 bits (86), Expect = 0.001
Identities = 12/96 (12%), Positives = 25/96 (26%), Gaps = 5/96 (5%)
Query: 489 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR-KIRAAIDNQT 547
+ D I + + L+ E ++GRN P T+ + + + T
Sbjct: 17 IQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT 73
Query: 548 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 583
+ +Q F+
Sbjct: 74 LDARFDFVFDFQMAPVRVQIRMQNAGVP-DRYWIFV 108
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 905 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.9 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.87 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.85 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.83 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.83 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.82 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.81 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.78 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.72 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.72 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.66 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.66 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.65 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.64 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.56 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.53 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.51 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.48 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.39 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.39 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 99.14 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 99.07 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.85 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 97.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.03 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 95.24 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 95.18 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 94.93 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 93.74 | |
| d3c2wa3 | 113 | Bacteriophytochrome BphP {Pseudomonas aeruginosa [ | 84.36 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.37 Aligned_cols=203 Identities=35% Similarity=0.635 Sum_probs=181.1
Q ss_pred CCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 45899043244454685599999990799299999930664358778999999999999579999652789998289499
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++++.||+|+||.||+|+++.+|..||+|++.+...........+.+|+.+|+.++||||+.+++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 84474289889831768499999998999899999981565449799999999999998679998877876403564211
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99961699998899963899999999999999999999999998998407889998898089919999036866458788
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~ 828 (905)
+|||||+||+|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|+......
T Consensus 82 iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred CCEECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 1000357986055553256--77599999999999652113431596224647778476589988882056520035678
Q ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 87788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
......+||+.|+|||++.+ ..++|+|||||++|+|++|++||..
T Consensus 160 ---------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 160 ---------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp ---------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------------------CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCC
T ss_conf ---------------------------620551008899666650489888333102230678899878999999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.87 Aligned_cols=197 Identities=22% Similarity=0.343 Sum_probs=175.7
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++++.||+|+||.||+|.+..+|..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 10538878981285829999999899989999998430172---799999999999867999880585779889998999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
||||+||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 96 mEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EEECCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--
T ss_conf 9703798089886415---99999999999999999999998797226776888688789968642515641321366--
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
......+||+.|+|||++.+ +.++|+|||||++|+|++|..||..
T Consensus 171 -------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 171 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp -------------------------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCC
T ss_conf -------------------------644444447773682664479988012031372999998048899899
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.81 Aligned_cols=200 Identities=29% Similarity=0.444 Sum_probs=178.1
Q ss_pred CCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 58990432444546855999999907992999999306643587789999999999995799996527899982894999
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..++|++.+.||+|+||.||+|+++.++..||+|.+.+...........+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 15376998898517785899999989994999999816885676899999999999985688888859999998999899
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99616999988999638999999999999999999999999989984078899988980899199990368664587888
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~ 829 (905)
|||||+||+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|......
T Consensus 84 vmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred EEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC--
T ss_conf 985047985898875048--9999999999999999999999889465220234414668998711555633544888--
Q ss_pred CCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 7788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.....+||+.|||||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 160 ---------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 160 ---------------------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp ---------------------------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ---------------------------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf ---------------------------52355788763499997589989314404675999998329999888
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.69 Aligned_cols=204 Identities=33% Similarity=0.541 Sum_probs=179.5
Q ss_pred CCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 58990432444546855999999907992999999306643587789999999999995799996527899982894999
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
..++|++++.||+|+||.||+|+++.++..||+|++.+...........+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 99877898898508790999999989997999999865775577789999999999987688886179999998998899
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99616999988999638999999999999999999999999989984078899988980899199990368664587888
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~ 829 (905)
|||||+||+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|..+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC
T ss_conf 997048987777653159--999999999999999999762165088476774123668885388603210242256776
Q ss_pred CCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 7788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......+||+.|||||++.+ +.++|+|||||++|+|++|..||..
T Consensus 164 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 164 -------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp -------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------------------------CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCC
T ss_conf -------------------------4333555677552584400268989666230456999998038899899
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.58 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=177.0
Q ss_pred CCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 45899043244454685599999990799299999930664358778999999999999579999652789998289499
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
+..++|++++.||+|+||.||+|+++.+|..||+|.+.... .......+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 87568889789712778099999998999699999987540--9789999999999998679999994999999899999
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99961699998899963899999999999999999999999998-99840788999889808991999903686645878
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~ 827 (905)
+|||||+||+|.+++.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.+|.+||+|||+|.....
T Consensus 81 iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC-
T ss_conf 9997679986899874249--9999999999999999999999859997144577994687899899954877625678-
Q ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 887788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
....+.+||+.|+|||++.+ +.++|+||+||++|+|++|+.||..
T Consensus 158 ----------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 ----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp ----------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ----------------------------CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf ----------------------------862111377141194687589989488899899999999988899899
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=325.76 Aligned_cols=198 Identities=38% Similarity=0.710 Sum_probs=177.6
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+++|++++.||+|+||.||+|+++.+|..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
||||+||+|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|.....
T Consensus 83 mE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEECCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECC----
T ss_conf 65037863223432222--111007999999998765541247677055681050386899889831752167124----
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.....+||+.|||||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 157 --------------------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 157 --------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp --------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --------------------------CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC
T ss_conf --------------------------56434576343599998389998043046533368999759899999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=325.57 Aligned_cols=198 Identities=33% Similarity=0.583 Sum_probs=177.8
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++++.||+|+||.||+|+++.+|..||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444322222322
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
|||+.||+|..++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred CCCCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC----
T ss_conf 22334662266675158--989999999999999989999859986176799993607789788610103332256----
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.....+||+.|||||++.+ +.++|+|||||++|+|++|..||..
T Consensus 194 --------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 194 --------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp --------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf --------------------------66433676356788997179988533114500789999758899899
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=322.46 Aligned_cols=195 Identities=26% Similarity=0.356 Sum_probs=175.1
Q ss_pred CEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 90432444546855999999907992999999306643587789999999999995799996527899982894999996
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 752 (905)
Q Consensus 673 ~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E 752 (905)
.|+.++.||+|+||.||+|++..++..||+|.+.............+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred CCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 16999988999638999999999999999999999999989984078899988980899199990368664587888778
Q 002580 753 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 832 (905)
Q Consensus 753 ~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~~~ 832 (905)
||++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC-------
T ss_conf 06999457899737--999999999999999999999986897666788421798799978984436533467-------
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 8620110024688996422344555665657866234433468------9984387899999999919999365
Q 002580 833 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.....+||+.|||||++.+ +.++|+|||||++|+|++|..||..
T Consensus 167 ------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp ------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ------------------------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf ------------------------78731347663688998346788867214545589999999878899999
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.74 Aligned_cols=202 Identities=25% Similarity=0.360 Sum_probs=176.5
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++++.||+|+||.||+|.++.+|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 7460899897217480999999999997999999845664--12799999999999857998884696540467436798
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|........
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 158 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 8645898089997537--9999999999999999999999975983575468997887899879832314224046886-
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---C-CCCHHHHHHHHHHHHHHCCCCCHHH
Q ss_conf 788620110024688996422344555665657866234433468---9-9843878999999999199993654
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---Y-TRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~-~~~D~~SlG~il~el~~g~~Pf~~~ 901 (905)
.......+||+.|||||++.+ + .++|+|||||++|+|++|+.||...
T Consensus 159 ------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 159 ------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp ------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ------------------------CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCC
T ss_conf ------------------------531113255747428728618999997101617379999998299788889
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=324.21 Aligned_cols=200 Identities=30% Similarity=0.493 Sum_probs=171.9
Q ss_pred CCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHH---HHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 5899043244454685599999990799299999930664358778999999---9999995799996527899982894
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 670 ~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~---E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
..++|++++.||+|+||.||+|++..+|..||+|++.+...........+.+ ++.+++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99999616999988999638999999999999999999999999989984078899988980899199990368664587
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~ 826 (905)
+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.+|.+||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf 89999914898389998732--5532789999999999999999977962204442216785889679822010233378
Q ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 8887788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
. .....+||+.|+|||++.. ..++|+|||||++|+|++|+.||..
T Consensus 160 ~-----------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 160 K-----------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp S-----------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred C-----------------------------CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf 8-----------------------------643311345542168760389998441046778999999859998888
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=319.47 Aligned_cols=198 Identities=25% Similarity=0.371 Sum_probs=175.3
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++++.||+|+||.||+|+++.+|..||+|.+... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 65758988984076819999998899989999998452---431699999999999867997999299999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCC
Q ss_conf 9616999988999638999999999999999999999999989984078899988980--89919999036866458788
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~--~~g~vkL~DFGla~~~~~~~ 828 (905)
||||+||+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++ .++.+||+|||+|..+...
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EECCCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC-
T ss_conf 98579988999997623-7899999999999999999999756976000154673641688986999545210442565-
Q ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 87788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......||+.|||||++.+ ..++|+|||||++|+|++|..||..
T Consensus 180 ---------------------------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 180 ---------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp ---------------------------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ---------------------------CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf ---------------------------432000686242188997589987267655465999999859899899
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=319.38 Aligned_cols=198 Identities=24% Similarity=0.309 Sum_probs=175.1
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++++.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 403599899931778299999998999799999988726---46799999999999867997989199999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCC
Q ss_conf 9616999988999638999999999999999999999999989984078899988980--89919999036866458788
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~--~~g~vkL~DFGla~~~~~~~ 828 (905)
||||+||+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EECCCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC-
T ss_conf 9828998088889863-89989999999999999999999977926513144553113467884899525630343788-
Q ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 87788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 183 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 183 ---------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp ---------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ---------------------------CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf ---------------------------720100476453489997479989763338989999999968899899
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.06 Aligned_cols=198 Identities=26% Similarity=0.350 Sum_probs=174.6
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.+.|++.+.||+|+||.||+|+++.++..||+|.+.+.... .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 66669988994065839999999999989999998157731--2899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCC
Q ss_conf 9616999988999638999999999999999999999999989984078899988980---8991999903686645878
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~---~~g~vkL~DFGla~~~~~~ 827 (905)
||||+||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+. .++.+||+|||+|......
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf 8526898488865303--67887899999999999987524130556870463001104688824998315435872589
Q ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 887788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
......+||+.|||||++.+ +.++|+|||||++|+|++|..||..
T Consensus 164 ----------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 164 ----------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp -------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ----------------------------CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf ----------------------------704400328422591887379998078734515999999859799999
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.09 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=174.4
Q ss_pred CCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 99043244454685599999990799299999930664358778999999999999579999652789998289499999
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 751 (905)
Q Consensus 672 ~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~ 751 (905)
+.|++++.||+|+||.||+|++..++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37598479930778199999999999399999987289---999999999999998679999884988980099589999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61699998899963899999999999999999999999998998407889998898089919999036866458788877
Q 002580 752 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 831 (905)
Q Consensus 752 E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~~ 831 (905)
|||+||+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|......
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred ECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC----
T ss_conf 627998188999862-899999999999999999999999889887140700314878999899716123035778----
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--------CCCCHHHHHHHHHHHHHHCCCCCHHH
Q ss_conf 88620110024688996422344555665657866234433468--------99843878999999999199993654
Q 002580 832 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--------YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~D~~SlG~il~el~~g~~Pf~~~ 901 (905)
.......+||+.|+|||++.+ ..++|+|||||++|+|++|..||...
T Consensus 164 -----------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 164 -----------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp -----------------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----------------------CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf -----------------------6410010256264799998320257888880665787899999982088999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.59 Aligned_cols=197 Identities=24% Similarity=0.363 Sum_probs=171.9
Q ss_pred CCE-EECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE----CCE
Q ss_conf 990-432444546855999999907992999999306643587789999999999995799996527899982----894
Q 002580 672 QHF-RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTH 746 (905)
Q Consensus 672 ~~y-~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~----~~~ 746 (905)
++| ++.++||+|+||.||+|.+..++..||+|.+..... .......+.+|++++++++||||+++++++.+ ...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCE
T ss_conf 8778851697008284999999999995999999851227-989999999999999857999850699998403345888
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CEECCCCCCCEEEC-CCCCEEEEECCCCCC
Q ss_conf 999996169999889996389999999999999999999999999899--84078899988980-899199990368664
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLSCL 823 (905)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~g--iiHrDLkp~NIli~-~~g~vkL~DFGla~~ 823 (905)
+|+|||||+||+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEE
T ss_conf 99999578989489997513--5546999999999999999999978997996876743511667999889800576542
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 5878887788620110024688996422344555665657866234433468--9984387899999999919999365
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
... ......+||+.|||||++.+ +.++|+|||||++|+|++|+.||..
T Consensus 165 ~~~-----------------------------~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 165 KRA-----------------------------SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp CCT-----------------------------TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC-----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf 368-----------------------------76677553813008988478999867110079999999878899987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=312.56 Aligned_cols=201 Identities=32% Similarity=0.616 Sum_probs=175.0
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEE
Q ss_conf 899043244454685599999990799299999930664358778999999999999-5799996527899982894999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~l~~~~~~~~~~~l 749 (905)
.++|.+++.||+|+||.||+|.++.+++.||+|++.+...........+..|..++. .++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99616999988999638999999999999999999999999989984078899988980899199990368664587888
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~ 829 (905)
|||||+||+|.+++.... .+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++.......
T Consensus 81 vmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~- 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEECCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCC-
T ss_conf 775037980899864047--89999999999999999999986893403476540444489963015553023235665-
Q ss_pred CCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 7788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
......+||+.|+|||++.+ ..++|+|||||++|+|++|+.||..
T Consensus 158 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 158 --------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp --------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf --------------------------334545787776899998279988323201122789898738899999
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.35 Aligned_cols=200 Identities=25% Similarity=0.322 Sum_probs=175.9
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 899043244454685599999990799299999930664358---77899999999999957999965278999828949
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.++|++++.||+|+||.||+|+++.+|..||+|++.+..... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC----CEEEEECCCCCC
Q ss_conf 9999616999988999638999999999999999999999999989984078899988980899----199990368664
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 823 (905)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g----~vkL~DFGla~~ 823 (905)
|+|||||+||+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEECCCCCCCCCHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf 99998677864310010356--4215578999999999987666254221133301279825898666469643344210
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 5878887788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.... .......||+.|+|||++.+ +.++|+|||||++|+|++|..||..
T Consensus 167 ~~~~----------------------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 167 IDFG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp CTTS----------------------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCC----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
T ss_conf 5777----------------------------631224777743099998189999766522140999999708899889
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.53 Aligned_cols=202 Identities=24% Similarity=0.438 Sum_probs=176.0
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEE
Q ss_conf 8990432444546855999999907992999999306643587789999999999995799996527899982--89499
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVC 748 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~--~~~~~ 748 (905)
.++|++++.||+|+||.||+|+++.+|..||+|.+..... +......+.+|+.++++++||||+++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 3337996798308891999999999997999999874657-979999999999999977899982489999917899899
Q ss_pred EEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 999616999988999638--9999999999999999999999999899-----840788999889808991999903686
Q 002580 749 LITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 749 lV~E~~~ggsL~~~l~~~--~~~~l~~~~~~~i~~qil~gL~~LH~~g-----iiHrDLkp~NIli~~~g~vkL~DFGla 821 (905)
+|||||+||+|.+++.+. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 645878887788620110024688996422344555665657866234433468---99843878999999999199993
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf 898 (905)
....... ......+||+.|||||++.+ +.++|+|||||++|+|++|+.||
T Consensus 162 ~~~~~~~---------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 162 RILNHDT---------------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EECCCCC---------------------------CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 3224577---------------------------7556677882327999983999993898875278999980188998
Q ss_pred HH
Q ss_conf 65
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 215 ~~ 216 (269)
T d2java1 215 TA 216 (269)
T ss_dssp CC
T ss_pred CC
T ss_conf 99
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=312.95 Aligned_cols=203 Identities=20% Similarity=0.204 Sum_probs=177.5
Q ss_pred CCCCCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 44445899043244454685599999990799299999930664358778999999999999579999652789998289
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 666 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
.+++..++|++.+.||+|+||.||+|.+..++..||+|.++... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCCCCEECCCCCEEECC
T ss_conf 51745799398659820888089999999999699999977761----03999999999998679998826775274578
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 49999961699998899963899999999999999999999999998998407889998898089919999036866458
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~ 825 (905)
.+|+|||||++|+|..++.......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 54787631467606777530355415799999999999997888987893057604576899899928983244546537
Q ss_pred CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 78887788620110024688996422344555665657866234433468---99843878999999999199993
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf 898 (905)
.... .......|++.|+|||++.+ +.++|+||||+++|+|++|..||
T Consensus 167 ~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 167 GDTY--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp SSSS--------------------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCC--------------------------EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCC
T ss_conf 8872--------------------------2103556654666927872799981043021789999998679988
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.19 Aligned_cols=194 Identities=22% Similarity=0.309 Sum_probs=168.4
Q ss_pred CCCEEECC-CCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEE----C
Q ss_conf 89904324-44546855999999907992999999306643587789999999999995-799996527899982----8
Q 002580 671 LQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT----K 744 (905)
Q Consensus 671 ~~~y~~~~-~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~-l~h~nIv~l~~~~~~----~ 744 (905)
.++|.++. .||+|+||.||+|++..++..||+|++... ..+.+|+.++.+ ++||||++++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
T ss_conf 148798107965454869999998899989999998974--------779999999998669999782989995034689
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC---CCCEEEEECCCC
Q ss_conf 94999996169999889996389999999999999999999999999899840788999889808---991999903686
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 821 (905)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~---~g~vkL~DFGla 821 (905)
..+|+|||||+||+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++. .+.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 78999997789984999998627877579999999999999999999769864441002201135555663113545512
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 645878887788620110024688996422344555665657866234433468---99843878999999999199993
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf 898 (905)
+...... .....+||+.|||||++.+ +.++|+|||||++|+|++|+.||
T Consensus 162 ~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 162 KETTSHN----------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp EECCCCC----------------------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred EECCCCC----------------------------CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 3336888----------------------------643226775637927774898888888876451677886588998
Q ss_pred HH
Q ss_conf 65
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 214 ~~ 215 (335)
T d2ozaa1 214 YS 215 (335)
T ss_dssp EE
T ss_pred CC
T ss_conf 89
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.56 Aligned_cols=205 Identities=19% Similarity=0.246 Sum_probs=173.8
Q ss_pred CCCCCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 44445899043244454685599999990799299999930664358778999999999999579999652789998289
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 666 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
+|.+..++|.+.+.||+|+||.||+|+.. ..||+|.+.... .+......+.+|+.++.+++||||+++++++. .+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CC
T ss_conf 71315451899889830788589999999---989999997346-99899999999999998479987864567971-55
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 49999961699998899963899999999999999999999999998998407889998898089919999036866458
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~ 825 (905)
.+|+|||||+||+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 8999996589988899985235-789999999999999999888750999516147899798189978875002213335
Q ss_pred CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHCCCCCH
Q ss_conf 78887788620110024688996422344555665657866234433468------998438789999999991999936
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA------YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~~D~~SlG~il~el~~g~~Pf~ 899 (905)
.... ........||+.|||||++.+ +.++|+||||+++|||++|+.||.
T Consensus 156 ~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 156 RWSG-------------------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCC-------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 5677-------------------------631256655743179999950568999953151635999999997889989
Q ss_pred HH
Q ss_conf 54
Q 002580 900 IL 901 (905)
Q Consensus 900 ~~ 901 (905)
..
T Consensus 211 ~~ 212 (276)
T d1uwha_ 211 NI 212 (276)
T ss_dssp TC
T ss_pred CC
T ss_conf 98
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.74 Aligned_cols=197 Identities=21% Similarity=0.289 Sum_probs=173.5
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|.+++.||+|+||.||+|.++.++..||+|.++... .....+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 010588789831778399999998999699999975786----6599999999999857997989098999889988999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC--CCCEEEEECCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808--9919999036866458788
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~--~g~vkL~DFGla~~~~~~~ 828 (905)
||||+|++|.+++...+ ..+++.++..++.||+.||.|||++||+||||||+|||++. .+.+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC-
T ss_conf 95389980889987538-9999999999999999999999876997513554443443788518997644111003467-
Q ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 87788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......||+.|+|||.+.+ ..++|+|||||++|+|++|..||..
T Consensus 158 ---------------------------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 158 ---------------------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp ---------------------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ---------------------------CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCC
T ss_conf ---------------------------753212233222340210487778401130279999999828999999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.66 Aligned_cols=209 Identities=22% Similarity=0.321 Sum_probs=175.9
Q ss_pred CCCCCCCCEEECCCCCCCCCEEEEEEEECCCCE-----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 444458990432444546855999999907992-----9999993066435877899999999999957-9999652789
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 739 (905)
Q Consensus 666 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~-----~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~ 739 (905)
.+++..++|++.+.||+|+||.||+|++..++. .||+|.+.... .......+.+|+.++.++ +||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 4657789939701983078819999998578855420499999966335--87899999999999997158996868778
Q ss_pred EEEECCEEEEEEECCCCCCHHHHHHHCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEEC
Q ss_conf 99828949999961699998899963899---------------------999999999999999999999998998407
Q 002580 740 SFQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYR 798 (905)
Q Consensus 740 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------~~l~~~~~~~i~~qil~gL~~LH~~giiHr 798 (905)
++.+.+.+|+|||||+||+|.+++..... ..+++..+..++.|++.||.|||+++|+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
T ss_conf 88629958999972799959999986257775102210000122200125778999999999999999999973990505
Q ss_pred CCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---
Q ss_conf 88999889808991999903686645878887788620110024688996422344555665657866234433468---
Q 002580 799 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA--- 875 (905)
Q Consensus 799 DLkp~NIli~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--- 875 (905)
||||+|||++.++.+||+|||+|+........ .......||+.|||||++.+
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-------------------------VVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-------------------------EEETTEEECGGGCCHHHHHHCCC
T ss_pred CCCHHCCCCCCCCEEEEEECCCCCCCCCCCCE-------------------------EEECCCCCCCCCCCHHHHCCCCC
T ss_conf 27032144345982898514222204577861-------------------------56234357876578388727999
Q ss_pred CCCCHHHHHHHHHHHHHH-CCCCCHHH
Q ss_conf 998438789999999991-99993654
Q 002580 876 YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 876 ~~~~D~~SlG~il~el~~-g~~Pf~~~ 901 (905)
+.++|+|||||++|||++ |..||...
T Consensus 244 ~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 244 TIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CCCEECCCHHHHHHHHHHCCCCCCCCC
T ss_conf 963303000399999983899999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=304.48 Aligned_cols=204 Identities=21% Similarity=0.293 Sum_probs=179.0
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----E
Q ss_conf 899043244454685599999990799299999930664358778999999999999579999652789998289----4
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 746 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----~ 746 (905)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+....+......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99999616999988999638999999999999999999999999989984078899988980899199990368664587
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~ 826 (905)
+|+|||||+|++|..++.... .+++..+..++.||+.||.|||+++++||||||+|||++.++..+|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEEHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf 999997788987101120358--999999999999999999999857952763467556657543201003444322123
Q ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 8887788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.... .......+||+.|+|||++.+ +.++|+|||||++|+|++|.+||..
T Consensus 164 ~~~~------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 164 SGNS------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp ---------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCC------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCC
T ss_conf 5443------------------------3334642576243699998399999663202652899999769799899
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=301.56 Aligned_cols=201 Identities=25% Similarity=0.330 Sum_probs=176.8
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC------HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 899043244454685599999990799299999930664358------778999999999999579-9996527899982
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREILDMLD-HPFVPALYASFQT 743 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~ 743 (905)
.++|++.+.||+|+||+||+|++..++..||+|++.+..... ......+.+|+.+++.+. ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89499999616999988999638999999999999999999999999989984078899988980899199990368664
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
++.+|+|||||+||+|.+++..+. .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf 760599997689866899998659--999999999999999999999875994323462548986899838712403167
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---------CCCCHHHHHHHHHHHHHHC
Q ss_conf 5878887788620110024688996422344555665657866234433468---------9984387899999999919
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---------YTRMTRYNYLILVSKKFME 894 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---------~~~~D~~SlG~il~el~~g 894 (905)
+... ......+||+.|+|||.+.+ +.++|+||+||++|+|++|
T Consensus 160 ~~~~----------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 160 LDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCC----------------------------CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCC
T ss_conf 2688----------------------------721345246788898886053445678899233185656023103228
Q ss_pred CCCCHHH
Q ss_conf 9993654
Q 002580 895 FQPFPIL 901 (905)
Q Consensus 895 ~~Pf~~~ 901 (905)
..||...
T Consensus 212 ~~Pf~~~ 218 (277)
T d1phka_ 212 SPPFWHR 218 (277)
T ss_dssp SCSSCCS
T ss_pred CCCCCCC
T ss_conf 8898899
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=306.05 Aligned_cols=209 Identities=20% Similarity=0.246 Sum_probs=176.4
Q ss_pred CCCCCCEEECCCCCCCCCEEEEEEEECCCCE---EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 4458990432444546855999999907992---9999993066435877899999999999957999965278999828
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 744 (905)
Q Consensus 668 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~---~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~ 744 (905)
.+..++|++.+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|+.+|++++||||+++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 20800427856980278829999999579978899999997844--5989999999999999857998886189999628
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 94999996169999889996389999999999999999999999999899840788999889808991999903686645
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~ 824 (905)
+.+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEECCCCCCEEEECCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 87799997227985300210456-79999999999999999889885279835761504489889991998884431575
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHH
Q ss_conf 878887788620110024688996422344555665657866234433468---998438789999999991-9999365
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~ 900 (905)
....... .........||+.|||||++.+ +.++|+|||||++|||++ |..||..
T Consensus 179 ~~~~~~~----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 179 EDDTSDP----------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ---------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCCCC----------------------EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 6777765----------------------365025666883003878883699786121445357899998679999999
Q ss_pred H
Q ss_conf 4
Q 002580 901 L 901 (905)
Q Consensus 901 ~ 901 (905)
.
T Consensus 237 ~ 237 (299)
T d1jpaa_ 237 M 237 (299)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.24 Aligned_cols=201 Identities=21% Similarity=0.317 Sum_probs=173.7
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
.++|++++.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999776517723768099999999999799999980222-5758999999999999867998388744533224320378
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
||||. +++..++.......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|.......
T Consensus 80 ~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-- 156 (298)
T d1gz8a_ 80 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 156 (298)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred EEECC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC--
T ss_conf 86237-744555442025688889999999999999998652889921357114011346762103578613436886--
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......||+.|+|||++.. ..++|+||||+++|+|++|+.||..
T Consensus 157 -------------------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 157 -------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp -------------------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -------------------------CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf -------------------------4100103652154112213665777422103333134279668799898
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.89 Aligned_cols=206 Identities=20% Similarity=0.293 Sum_probs=173.2
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 07644445899043244454685599999990799299999930664358778999999999999579999652789998
Q 002580 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (905)
Q Consensus 663 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 742 (905)
.+..+.+..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++.+++||||+++++++.
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEC
T ss_conf 98770038899388679810798289999999-999999999864768----8899999999998679998857873104
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 28949999961699998899963899999999999999999999999998998407889998898089919999036866
Q 002580 743 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~ 822 (905)
+ +.+|+|||||++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred C-CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEE
T ss_conf 5-976999995789828888751478988788999999999999999974895467564225156202440423410147
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCC-CCC
Q ss_conf 45878887788620110024688996422344555665657866234433468---99843878999999999199-993
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEF-QPF 898 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~-~Pf 898 (905)
....... .......||+.|||||++.+ +.++|+||||+++|||++|. +||
T Consensus 158 ~~~~~~~--------------------------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 158 LIEDNEY--------------------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECSSSCE--------------------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ECCCCCC--------------------------CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 7358864--------------------------42035677444458289837999824564525799999996898888
Q ss_pred HH
Q ss_conf 65
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 212 ~~ 213 (272)
T d1qpca_ 212 PG 213 (272)
T ss_dssp TT
T ss_pred CC
T ss_conf 88
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.86 Aligned_cols=203 Identities=21% Similarity=0.285 Sum_probs=170.9
Q ss_pred CCCEEECC-CCCCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 89904324-44546855999999907--9929999993066435877899999999999957999965278999828949
Q 002580 671 LQHFRPIK-PLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 747 (905)
Q Consensus 671 ~~~y~~~~-~Lg~G~~g~V~~~~~~~--tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~ 747 (905)
.++|.+.+ +||+|+||.||+|.++. ++..||+|.+... ........+.+|+.++++++||||+++++++.. +.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEE
T ss_conf 44718878487306080999999960897689999998820--397899999999999986799888068656036-807
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99996169999889996389999999999999999999999999899840788999889808991999903686645878
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~ 827 (905)
|+|||||+||+|.+++... ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+|+.+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 9999807899689975212-569999999999999999878998688105767646604546885420331342115543
Q ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHHH
Q ss_conf 887788620110024688996422344555665657866234433468---998438789999999991-99993654
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~~ 901 (905)
... ........||+.|+|||++.. +.++|+||||+++|||++ |..||...
T Consensus 163 ~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 163 DSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp SCE------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCC------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf 432------------------------113562113743358688727999954123220178999993899999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=302.52 Aligned_cols=196 Identities=27% Similarity=0.344 Sum_probs=166.7
Q ss_pred ECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 3244454685599999990799299999930664358--77899999999999957999965278999828949999961
Q 002580 676 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 753 (905)
Q Consensus 676 ~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~ 753 (905)
.++.||+|+||+||+|++..+|+.||+|.+....... ......+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 69999889996389999999999999999999999999899840788999889808991999903686645878887788
Q 002580 754 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 833 (905)
Q Consensus 754 ~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~~~~ 833 (905)
|.|+++..+... ...+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~----- 154 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----- 154 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-----
T ss_pred HCCHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC-----
T ss_conf 345077655412--6677899999999999999988631635503577625885377841146576100057875-----
Q ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 834 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
......+||+.|+|||++.. +.++|+|||||++|+|++|.+||..
T Consensus 155 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 155 ----------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp ----------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ----------------------CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCC
T ss_conf ----------------------5433020473336399972677888056436304289999859699999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.29 Aligned_cols=200 Identities=21% Similarity=0.306 Sum_probs=171.0
Q ss_pred CCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 45899043244454685599999990799299999930664358778999999999999579999652789998289499
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 748 (905)
Q Consensus 669 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~ 748 (905)
++.++|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++||||+++++++...+.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEE
T ss_conf 89699588889820888299999988-999999999878867----6899999999999668997565352431599337
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99961699998899963899999999999999999999999998998407889998898089919999036866458788
Q 002580 749 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 828 (905)
Q Consensus 749 lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~ 828 (905)
+|||||++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 999836999189975201-3478899999999999998776531643104431532666688776865532100236887
Q ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHH
Q ss_conf 87788620110024688996422344555665657866234433468---998438789999999991-9999365
Q 002580 829 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~ 900 (905)
. .......||+.|+|||++.+ +.++|+||||+++|||++ |.+||..
T Consensus 156 ~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 156 Y--------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred C--------------------------EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC
T ss_conf 3--------------------------3504300176667857860799984033210599999998789888778
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=292.84 Aligned_cols=205 Identities=18% Similarity=0.177 Sum_probs=173.1
Q ss_pred CCCCCCEEECCCCCCCCCEEEEEEEECCCC----EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 445899043244454685599999990799----2999999306643587789999999999995799996527899982
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 668 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg----~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
++..+.|...+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 5788996861598117790999999968998787999999988445--96899999999999985689878323677833
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89499999616999988999638999999999999999999999999989984078899988980899199990368664
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
.+.+++|||||.++++.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCEEEEEEECCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 880389997213574022210234-5420899999999999854121212342576564427888998499845510300
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCH
Q ss_conf 5878887788620110024688996422344555665657866234433468---998438789999999991999936
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~ 899 (905)
....... ........||+.|||||++.+ +.++|+||||+++|||+++..||.
T Consensus 160 ~~~~~~~------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 160 LEDDPEA------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCCCCC------------------------CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 3578765------------------------267426777734348888704999973556344898999996798865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.92 Aligned_cols=196 Identities=20% Similarity=0.273 Sum_probs=165.9
Q ss_pred CCCCCCCCEEEEEEEEC--CCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
Q ss_conf 44454685599999990--7992999999306643587789999999999995799996527899982894999996169
Q 002580 678 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 678 ~~Lg~G~~g~V~~~~~~--~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
++||+|+||.||+|.+. .++..||+|.+.... .+......+.+|+.++++++||||+++++++.. +..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 99988999638999999999999999999999999989984078899988980899199990368664587888778862
Q 002580 756 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 835 (905)
Q Consensus 756 ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~~~~~~ 835 (905)
+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+........
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~----- 163 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----- 163 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-----
T ss_pred CCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC-----
T ss_conf 89689997522--57899999999999999976687479556777611310235675123413453313432344-----
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHHH
Q ss_conf 0110024688996422344555665657866234433468---998438789999999991-99993654
Q 002580 836 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~~ 901 (905)
........||+.|||||++.+ +.++|+||||+++|||++ |..||...
T Consensus 164 -------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~ 214 (277)
T d1xbba_ 164 -------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214 (277)
T ss_dssp -------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred -------------------CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCC
T ss_conf -------------------322445677842039166537999843443034031328965899999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.58 Aligned_cols=200 Identities=24% Similarity=0.243 Sum_probs=169.7
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHH---HHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
Q ss_conf 89904324445468559999999079929999993066435877---8999999999999579--999652789998289
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN---KVHRACAEREILDMLD--HPFVPALYASFQTKT 745 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~ 745 (905)
.++|++.+.||+|+||.||+|++..+|..||+|.+.+....... ....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC-CCCEEEEECCCCCC
Q ss_conf 49999961699-99889996389999999999999999999999999899840788999889808-99199990368664
Q 002580 746 HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCL 823 (905)
Q Consensus 746 ~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~-~g~vkL~DFGla~~ 823 (905)
.+|+||||+.+ +++.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf 6899998336862289998615--89999999999999999999998779755667611147744788489775465353
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---C-CCCHHHHHHHHHHHHHHCCCCCH
Q ss_conf 5878887788620110024688996422344555665657866234433468---9-98438789999999991999936
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---Y-TRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~-~~~D~~SlG~il~el~~g~~Pf~ 899 (905)
.... .....+||+.|+|||++.+ + .++|+|||||++|+|++|..||.
T Consensus 161 ~~~~-----------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 161 LKDT-----------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CCSS-----------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCC-----------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCC
T ss_conf 2444-----------------------------55665658774799998489978865332554034536756889988
Q ss_pred HH
Q ss_conf 54
Q 002580 900 IL 901 (905)
Q Consensus 900 ~~ 901 (905)
..
T Consensus 212 ~~ 213 (273)
T d1xwsa_ 212 HD 213 (273)
T ss_dssp SH
T ss_pred CC
T ss_conf 73
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=291.73 Aligned_cols=195 Identities=24% Similarity=0.357 Sum_probs=172.3
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 899043244454685599999990799299999930664358778999999999999579999652789998289-----
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 745 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~----- 745 (905)
.++|++++.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 771899889801778199999999999899999985222-5969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf -4999996169999889996389999999999999999999999999899840788999889808991999903686645
Q 002580 746 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 746 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~ 824 (905)
.+|+||||| +.+|..+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECC-CCCHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC
T ss_conf 1599998405-52189998740---2269999999999999999987378764566851111210012211343102206
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 878887788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.. ......||+.|+|||++.+ ..++|+||+||++|+|++|.+||..
T Consensus 172 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 172 DS------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CS------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC------------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCC
T ss_conf 87------------------------------631024553335889981787899650103003899999978699888
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=288.89 Aligned_cols=200 Identities=21% Similarity=0.293 Sum_probs=173.6
Q ss_pred CCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 58990432444546855999999907992999999306643587789999999999995799996527899982894999
Q 002580 670 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 749 (905)
Q Consensus 670 ~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~l 749 (905)
+.++|++.++||+|+||.||+|++ .++..||+|.+++... ....+.+|+.++.+++||||+++++++.+++.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
T ss_conf 969979968982078839999998-8998999999874757----78999999999996689860158899850781699
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99616999988999638999999999999999999999999989984078899988980899199990368664587888
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 829 (905)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~ 829 (905)
||||+++|+|..++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++........
T Consensus 77 v~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEECCCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 997048993888641024-6776899999999999999987546843466541358876998479886144202357872
Q ss_pred CCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHHH
Q ss_conf 7788620110024688996422344555665657866234433468---998438789999999991-99993654
Q 002580 830 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~~ 901 (905)
.......||+.|+|||++.. +.++|+||||+++|||++ |+.||...
T Consensus 156 --------------------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 156 --------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp --------------------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred --------------------------EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCC
T ss_conf --------------------------25246578877578078637998852103364324673975599998899
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=290.11 Aligned_cols=202 Identities=22% Similarity=0.283 Sum_probs=169.7
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCE----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 8990432444546855999999907992----999999306643587789999999999995799996527899982894
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 746 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~----~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~ 746 (905)
..+|++++.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.++++++||||+++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-C
T ss_conf 8999783198208992999999958998898999999965134--979999999999999867998881589999619-8
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99999616999988999638999999999999999999999999989984078899988980899199990368664587
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~ 826 (905)
.+++++++.+++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 36999842687401011133-45799999999999999999999876950476212031167998758602552223354
Q ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHHH
Q ss_conf 8887788620110024688996422344555665657866234433468---998438789999999991-99993654
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~~ 901 (905)
.... .......||+.|+|||++.+ +.++|+||||+++|||++ |.+||...
T Consensus 164 ~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~ 217 (317)
T d1xkka_ 164 EEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217 (317)
T ss_dssp TCC---------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred CCCC-------------------------CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 4453-------------------------22365105864467088746999835654407999999997799999999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=288.47 Aligned_cols=199 Identities=22% Similarity=0.316 Sum_probs=168.8
Q ss_pred CCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----E
Q ss_conf 99043244454685599999990799299999930664358778999999999999579999652789998289-----4
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----H 746 (905)
Q Consensus 672 ~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~-----~ 746 (905)
.+|++++.||+|+||.||+|.+..+|..||+|.+.+.. .......+.+|+.+|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 98599789940648099999999999499999980310--9589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99999616999988999638999999999999999999999999989984078899988980899199990368664587
Q 002580 747 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 826 (905)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~ 826 (905)
+|++++ +.|++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 86 ~~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEE-ECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 999996-2598656644058---999999999999999999999978986777876437887999778754570565047
Q ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 8887788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.... .......+||+.|+|||++.. ..++|+||+|+++|+|++|..||..
T Consensus 162 ~~~~------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 162 DHDH------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp GGCB------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCC------------------------CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCC
T ss_conf 7764------------------------10101102652000387860478887410100467013377669799788
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=289.44 Aligned_cols=205 Identities=22% Similarity=0.278 Sum_probs=173.5
Q ss_pred CCCCCCCEEECCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 444589904324445468559999999079---92999999306643587789999999999995799996527899982
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 667 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~t---g~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+++..++|++.+.||+|+||.||+|.+..+ +..+|+|.+... ........+.+|+.++++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf 976889969877993078829999999369964499999993656--68799999999999998689999856988995-
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89499999616999988999638999999999999999999999999989984078899988980899199990368664
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
.+.+|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+|+.
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred CCEEEEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 374799998406980776542247-8999999999999998775230226744141026553206789678765034213
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCH
Q ss_conf 5878887788620110024688996422344555665657866234433468---998438789999999991-999936
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFP 899 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~ 899 (905)
...... .......||+.|+|||++.+ ..++|+||||+++|||++ |.+||.
T Consensus 158 ~~~~~~--------------------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 158 MEDSTY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCCC--------------------------EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 367762--------------------------330540058310326675169988745244424789999826999988
Q ss_pred HH
Q ss_conf 54
Q 002580 900 IL 901 (905)
Q Consensus 900 ~~ 901 (905)
..
T Consensus 212 ~~ 213 (273)
T d1mp8a_ 212 GV 213 (273)
T ss_dssp TC
T ss_pred CC
T ss_conf 89
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=291.52 Aligned_cols=204 Identities=21% Similarity=0.277 Sum_probs=171.7
Q ss_pred CCCCCCCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 76444458990432444546855999999907992999999306643587789999999999995799996527899982
Q 002580 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 743 (905)
Q Consensus 664 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~ 743 (905)
+..+.+..++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ....+.+|+.++++++|+||+++++++.+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCEECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 756074779979846993079809999999999-9999999880448----88999999999986666788689999823
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 89499999616999988999638999999999999999999999999989984078899988980899199990368664
Q 002580 744 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 744 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
+.+|+|||||++|+|..++.......+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+|+.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHH
T ss_conf -9759999944799435420000355305999999999999999987541143353123079998999299844255542
Q ss_pred CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCH
Q ss_conf 5878887788620110024688996422344555665657866234433468---998438789999999991999936
Q 002580 824 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~ 899 (905)
...... .......||+.|+|||++.. +.++|+||||+++|||++|..||.
T Consensus 163 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~ 215 (285)
T d1fmka3 163 IEDNEY--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215 (285)
T ss_dssp ---------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCCCC--------------------------EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCC
T ss_conf 568873--------------------------35245455665458089837998917741323589999986899999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=286.94 Aligned_cols=193 Identities=24% Similarity=0.349 Sum_probs=161.0
Q ss_pred CEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------CCE
Q ss_conf 90432444546855999999907992999999306643587789999999999995799996527899982------894
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KTH 746 (905)
Q Consensus 673 ~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~~~ 746 (905)
+|+.++.||+|+||+||+|++..+|+.||+|.+..... ...+|+.++++++|+||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 76751698217683999999999997999999881606-------89999999986689898738789974476577318
Q ss_pred EEEEEECCCCCCHHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 9999961699998899963-8999999999999999999999999989984078899988980899-1999903686645
Q 002580 747 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLT 824 (905)
Q Consensus 747 ~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g-~vkL~DFGla~~~ 824 (905)
+|+|||||+++.+..+... .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 99998416886078888631036899999999999999999999986687645788603787358971167336605440
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 878887788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
... ......+||+.|+|||.+.+ ..++|+||+||++|+|++|..||..
T Consensus 174 ~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 174 VRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CTT----------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred CCC----------------------------CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCC
T ss_conf 477----------------------------6532002555556827764046888210002465277855028799898
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=287.13 Aligned_cols=200 Identities=23% Similarity=0.310 Sum_probs=163.3
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCC-CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEE---
Q ss_conf 89904324445468559999999079-929999993066435877899999999999957---99996527899982---
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT--- 743 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~t-g~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l---~h~nIv~l~~~~~~--- 743 (905)
.++|++++.||+|+||.||+|++..+ ++.||+|.+...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 589798889921558699999998889989999998023245-1679999999999998742589880236632214666
Q ss_pred --CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf --894999996169999889996389999999999999999999999999899840788999889808991999903686
Q 002580 744 --KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 744 --~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla 821 (905)
...+|+++|||.++.+.... ......+++..+..++.|++.||.|||+++|+||||||+|||++..+.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCCEEEEEEEECCCCCHHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHH
T ss_conf 6674699999740587144444-303789998999999999999999997588983579862789858997542100010
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 645878887788620110024688996422344555665657866234433468---99843878999999999199993
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf 898 (905)
...... .......||+.|+|||++.+ +.++|+||+||++|+|++|..||
T Consensus 164 ~~~~~~----------------------------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCCGG----------------------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHHCCC----------------------------CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCC
T ss_conf 110023----------------------------4577765485114831001798881110003289999998787998
Q ss_pred HH
Q ss_conf 65
Q 002580 899 PI 900 (905)
Q Consensus 899 ~~ 900 (905)
..
T Consensus 216 ~~ 217 (305)
T d1blxa_ 216 RG 217 (305)
T ss_dssp CC
T ss_pred CC
T ss_conf 99
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=286.26 Aligned_cols=203 Identities=21% Similarity=0.236 Sum_probs=170.2
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-------
Q ss_conf 8990432444546855999999907992999999306643587789999999999995799996527899982-------
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 743 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------- 743 (905)
.++|++++.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+|+.++|+||+.+++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 2798899997227482999999989997999999842224-637899999999999983599966067654024654444
Q ss_pred -CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf -8949999961699998899963899999999999999999999999998998407889998898089919999036866
Q 002580 744 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 822 (905)
Q Consensus 744 -~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~ 822 (905)
.+.+|++||||.++.+..+... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf 57638999853578741012220--3443308999999999999988522998856767222036689968763135002
Q ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 45878887788620110024688996422344555665657866234433468----99843878999999999199993
Q 002580 823 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf 898 (905)
........ ........+||+.|+|||++.+ +.++|+||+||++|+|++|+.||
T Consensus 166 ~~~~~~~~-----------------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 166 AFSLAKNS-----------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ECCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ECCCCCCC-----------------------CCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCC
T ss_conf 23554443-----------------------2113566024978742899707999891787006786466174487998
Q ss_pred H
Q ss_conf 6
Q 002580 899 P 899 (905)
Q Consensus 899 ~ 899 (905)
.
T Consensus 223 ~ 223 (318)
T d3blha1 223 Q 223 (318)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=285.72 Aligned_cols=208 Identities=22% Similarity=0.319 Sum_probs=170.6
Q ss_pred CCCCCCCEEECCCCCCCCCEEEEEEEECCC-----CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEE
Q ss_conf 444589904324445468559999999079-----929999993066435877899999999999957-99996527899
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 740 (905)
Q Consensus 667 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~t-----g~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~ 740 (905)
+.+..++|++.+.||+|+||.||+|.+..+ ++.||+|.+.... .......+..|..++.++ .|+||+.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 261679979844984167839999998677755578399999986001--717899999999998861499849974115
Q ss_pred EEE-CCEEEEEEECCCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCE
Q ss_conf 982-894999996169999889996389--------------99999999999999999999999989984078899988
Q 002580 741 FQT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 805 (905)
Q Consensus 741 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NI 805 (905)
+.. ...+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
T ss_conf 40479757999984589929999985366666532220233214689999999999999999988737971786773106
Q ss_pred EECCCCCEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHH
Q ss_conf 9808991999903686645878887788620110024688996422344555665657866234433468---9984387
Q 002580 806 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRY 882 (905)
Q Consensus 806 li~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~ 882 (905)
|++.++.+||+|||+|+........ .......||+.|+|||++.+ +.++|+|
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDY-------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp EECGGGCEEECC------CCSCTTS-------------------------CCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred EECCCCCEEECCCCCHHHCCCCCCC-------------------------CCCCCEEECCCCCCHHHHHCCCCCCCCCEE
T ss_conf 5779982898457520011356652-------------------------224751667210203686468899663221
Q ss_pred HHHHHHHHHHHC-CCCCHHH
Q ss_conf 899999999919-9993654
Q 002580 883 NYLILVSKKFME-FQPFPIL 901 (905)
Q Consensus 883 SlG~il~el~~g-~~Pf~~~ 901 (905)
||||++|+|+++ .+||...
T Consensus 221 S~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTC
T ss_pred EHHHHHHHHHHCCCCCCCCC
T ss_conf 36789999986889999899
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=285.67 Aligned_cols=191 Identities=20% Similarity=0.304 Sum_probs=165.3
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE--CCEE
Q ss_conf 899043244454685599999990799299999930664358778999999999999579-9996527899982--8949
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQT--KTHV 747 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~--~~~~ 747 (905)
.++|++++.||.|+||.||+|+++.+++.||+|++++. ....+.+|+.+|..+. ||||+++++++.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCE
T ss_conf 86718978983174819999998899979999998889------999999999999851579987679999981687712
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 9999616999988999638999999999999999999999999989984078899988980899-199990368664587
Q 002580 748 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 826 (905)
Q Consensus 748 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g-~vkL~DFGla~~~~~ 826 (905)
|+|||||.+++|..+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEEEECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 6888631798589974-----68999999999999999998876433443456441237748998366415654266468
Q ss_pred CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 8887788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 827 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
. ......+||+.|+|||++.+ +.++|+||+||++|+|++|..||..
T Consensus 183 ~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 183 G----------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp T----------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred C----------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
T ss_conf 8----------------------------7444322486424761026888888452323354555876048899988
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=287.77 Aligned_cols=199 Identities=21% Similarity=0.274 Sum_probs=171.4
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+++|+++++||+|+||.||+|++. +|..||+|.+..... .......+.+|+.+++.++||||+++++++...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 999634318722778189999968-999999999812326-858999999999999867998687660120467731589
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
++++.++.+..+.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|.......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEHHHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC--
T ss_conf 9740045678998604--775144568999999999998605748826787750568689978732366430114676--
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......|++.|+|||.+.+ ..++|+||||+++|+|++|+.||..
T Consensus 155 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 155 -------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -------------------------CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCC
T ss_conf -------------------------5410102431101378871788888410021117589999779799898
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=283.94 Aligned_cols=210 Identities=22% Similarity=0.311 Sum_probs=178.2
Q ss_pred CCCCCCCCCCEEECCCCCCCCCEEEEEEEECCCC-------EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCC
Q ss_conf 7644445899043244454685599999990799-------29999993066435877899999999999957-999965
Q 002580 664 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 735 (905)
Q Consensus 664 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg-------~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv 735 (905)
.+.+.+..++|.+.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|...+.++ +||||+
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEE
T ss_conf 97672258996970098516782899999857875556675499999988112--8688999999999999813999697
Q ss_pred EEEEEEEECCEEEEEEECCCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCC
Q ss_conf 27899982894999996169999889996389--------------9999999999999999999999998998407889
Q 002580 736 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 801 (905)
Q Consensus 736 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLk 801 (905)
++++++.+++.+|+|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++++|||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ECCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEEC
T ss_conf 34652201886899997369990999998606776432223345743467999999999999999987663797863022
Q ss_pred CCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCC
Q ss_conf 99889808991999903686645878887788620110024688996422344555665657866234433468---998
Q 002580 802 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTR 878 (905)
Q Consensus 802 p~NIli~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~ 878 (905)
|+|||++.++.+||+|||++........ ........||+.|+|||++.. +.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~l~~~~y~~k 217 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQ 217 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCT-------------------------TCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred CCCEEECCCCCEEECCCHHHCCCCCCCC-------------------------CCCCCCCCCCHHHHHHHHHCCCCCCCH
T ss_conf 1022454789767622111011355555-------------------------431466788846632667517988825
Q ss_pred CHHHHHHHHHHHHHH-CCCCCHH
Q ss_conf 438789999999991-9999365
Q 002580 879 MTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 879 ~D~~SlG~il~el~~-g~~Pf~~ 900 (905)
+|+||||+++|+|++ |.+||..
T Consensus 218 ~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 218 SDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 55477588888740179898999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=284.05 Aligned_cols=195 Identities=22% Similarity=0.359 Sum_probs=169.8
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------C
Q ss_conf 8990432444546855999999907992999999306643587789999999999995799996527899982------8
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 744 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~------~ 744 (905)
.++|++++.||+|+||+||+|.+..+|..||+|++.+.. .+......+.+|+.++++++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 377599889621758599999999999899999988233-6979999999999999864898764899897025643457
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 94999996169999889996389999999999999999999999999899840788999889808991999903686645
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~ 824 (905)
..+|+|||||.+ ++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||++...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CEEEEEEECCCH-HHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCC
T ss_conf 626999841446-7787650----38999999999999999998865221124567763211365443132010232114
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCH
Q ss_conf 878887788620110024688996422344555665657866234433468---998438789999999991999936
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFP 899 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~ 899 (905)
... ......+||+.|+|||++.+ +.++|+||+||++|+|++|+.||.
T Consensus 170 ~~~----------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 170 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCC----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCC
T ss_conf 666----------------------------55332214655558133147777877433356625789865989988
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=288.65 Aligned_cols=207 Identities=37% Similarity=0.599 Sum_probs=175.4
Q ss_pred CCCCCCCEEECCCCCCCCCEEEEEEEEC---CCCEEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCCCEEEEEE
Q ss_conf 4445899043244454685599999990---79929999993066435-87789999999999995799-9965278999
Q 002580 667 EQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDH-PFVPALYASF 741 (905)
Q Consensus 667 ~~~~~~~y~~~~~Lg~G~~g~V~~~~~~---~tg~~~AiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~ 741 (905)
+.+..++|++++.||+|+||.||+|++. .+|+.||+|.+.+.... +......+.+|+.++++++| |||+++++++
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred CCCCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 53451025999898328783999999876588794899999836772101689999999999998646798399962000
Q ss_pred EECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 82894999996169999889996389999999999999999999999999899840788999889808991999903686
Q 002580 742 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 821 (905)
Q Consensus 742 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla 821 (905)
.+...+|++||||.+++|.+++.... .+.+..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred CCCCCEEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 24873001231234117999987304--5437888888999999998851499896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCHHHHHHHHHHHHHHCCC
Q ss_conf 645878887788620110024688996422344555665657866234433468-----998438789999999991999
Q 002580 822 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA-----YTRMTRYNYLILVSKKFMEFQ 896 (905)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~D~~SlG~il~el~~g~~ 896 (905)
..+.... ........|++.|+|||.+.+ +.++|+|||||+||+|++|..
T Consensus 177 ~~~~~~~--------------------------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 177 KEFVADE--------------------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp EECCGGG--------------------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred HHHCCCC--------------------------CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 2203444--------------------------43221222333331068760577688713251777799999976899
Q ss_pred CCHHH
Q ss_conf 93654
Q 002580 897 PFPIL 901 (905)
Q Consensus 897 Pf~~~ 901 (905)
||...
T Consensus 231 PF~~~ 235 (322)
T d1vzoa_ 231 PFTVD 235 (322)
T ss_dssp TTSCT
T ss_pred CCCCC
T ss_conf 98888
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=281.66 Aligned_cols=203 Identities=19% Similarity=0.220 Sum_probs=171.6
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEEE
Q ss_conf 8990432444546855999999907992999999306643587789999999999995799-996527899982894999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVCL 749 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~l~~~~~~~~~~~l 749 (905)
.++|++.+.||+|+||.||+|++..+|..||+|+++.... ...+..|+..+..+.| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
T ss_conf 9806997998417882999999988997999999750258-----29999999999996489998779999601881179
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC-----CCCEEEEECCCCCCC
Q ss_conf 996169999889996389999999999999999999999999899840788999889808-----991999903686645
Q 002580 750 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-----NGHVSLTDFDLSCLT 824 (905)
Q Consensus 750 V~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~-----~g~vkL~DFGla~~~ 824 (905)
||||| +++|.+++.... ..++...+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+..
T Consensus 79 vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEC-CCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 99964-888799997520-3110689999999999999999977966266771315234754344795687236605771
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 878887788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
....... ..+.......+||+.|||||++.+ +.++|+||||+++|+|++|..||..
T Consensus 157 ~~~~~~~--------------------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 157 RDPVTKQ--------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp BCTTTCC--------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CCCCCCC--------------------CEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 4676654--------------------1110246762775102679896488888699989831999999869876788
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=284.06 Aligned_cols=196 Identities=23% Similarity=0.344 Sum_probs=169.0
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----C
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828-----9
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 745 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~-----~ 745 (905)
.++|++++.||+|+||+||+|++..+|+.||+|++.+.. .+......+.+|+.+++.++|+||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 987188889831788399999999999799999988200-2868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 49999961699998899963899999999999999999999999998998407889998898089919999036866458
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~ 825 (905)
..+++++++.|++|.+++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred CEEEEEEEECCCCHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC
T ss_conf 649999962588623200224---53099999999999999999973887651667763345543220013210001257
Q ss_pred CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 78887788620110024688996422344555665657866234433468----9984387899999999919999365
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
.......||+.|+|||++.+ ..++|+|||||++|+|++|..||..
T Consensus 173 ------------------------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~ 221 (348)
T d2gfsa1 173 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221 (348)
T ss_dssp ------------------------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------------------------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
T ss_conf ------------------------------5444434543555835533775678551243205899999768899788
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=284.43 Aligned_cols=202 Identities=22% Similarity=0.274 Sum_probs=171.7
Q ss_pred CCCCCEEECCCCCCCCCEEEEEEEECCCCEE--EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECC
Q ss_conf 4589904324445468559999999079929--999993066435877899999999999957-9999652789998289
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~--~AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~~~~~~~~ 745 (905)
++.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred CCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC
T ss_conf 687996887798207882899999989996999999997823--385799999999999986228998836788884187
Q ss_pred EEEEEEECCCCCCHHHHHHHC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCC
Q ss_conf 499999616999988999638--------------999999999999999999999999989984078899988980899
Q 002580 746 HVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 811 (905)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g 811 (905)
.+|+|||||+||+|.+++... ....+++..+..++.||+.||.|||+++++||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCC
T ss_conf 36999980289869999864035555512310123457899999999999999998766308954555052048986887
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHH
Q ss_conf 1999903686645878887788620110024688996422344555665657866234433468---9984387899999
Q 002580 812 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILV 888 (905)
Q Consensus 812 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il 888 (905)
.+||+|||+|+..... .......||..|+|||.+.. +.++|+||||+++
T Consensus 165 ~~kl~DfG~a~~~~~~----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil 216 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216 (309)
T ss_dssp CEEECCTTCEESSCEE----------------------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CEEECCCCCCCCCCCC----------------------------CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHH
T ss_conf 6387434432244422----------------------------345530137755553875269999622153138899
Q ss_pred HHHHHCC-CCCHH
Q ss_conf 9999199-99365
Q 002580 889 SKKFMEF-QPFPI 900 (905)
Q Consensus 889 ~el~~g~-~Pf~~ 900 (905)
|+|++|. +||..
T Consensus 217 ~ell~~~~~p~~~ 229 (309)
T d1fvra_ 217 WEIVSLGGTPYCG 229 (309)
T ss_dssp HHHHTTSCCTTTT
T ss_pred HHHHHCCCCCCCC
T ss_conf 9998368999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=283.35 Aligned_cols=207 Identities=20% Similarity=0.254 Sum_probs=174.7
Q ss_pred CCCCCCEEECCCCCCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 4458990432444546855999999907-----99299999930664358778999999999999579999652789998
Q 002580 668 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 742 (905)
Q Consensus 668 ~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-----tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~ 742 (905)
++..++|++.+.||+|+||.||+|++.. ++..||+|.+... ........+.+|+.++++++||||+.+++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH--CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 3898893886798207883999999888765778829999998821--08579999999999999668997655246660
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCC
Q ss_conf 2894999996169999889996389----------------------999999999999999999999999899840788
Q 002580 743 TKTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 800 (905)
Q Consensus 743 ~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDL 800 (905)
..+..+++|||+++|+|.+++.... ...++...+..++.|++.||.|||+++++||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578685488
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CC
Q ss_conf 999889808991999903686645878887788620110024688996422344555665657866234433468---99
Q 002580 801 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YT 877 (905)
Q Consensus 801 kp~NIli~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~ 877 (905)
||+|||++.++.+||+|||+|+....... ........||+.|+|||++.+ +.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADY-------------------------YKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC-------------------------BC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCC-------------------------CCCCCCCCCCCCCCCHHHHCCCCCCH
T ss_conf 40116898999289833144211367764-------------------------11157777676767989972688980
Q ss_pred CCHHHHHHHHHHHHHHCC-CCCHHH
Q ss_conf 843878999999999199-993654
Q 002580 878 RMTRYNYLILVSKKFMEF-QPFPIL 901 (905)
Q Consensus 878 ~~D~~SlG~il~el~~g~-~Pf~~~ 901 (905)
++|+||||+++|||++|. +||...
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred HHHHCCCHHHHHHHHCCCCCCCCCC
T ss_conf 5630252362999980689999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=286.79 Aligned_cols=207 Identities=22% Similarity=0.254 Sum_probs=174.4
Q ss_pred CCCCCEEECCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 4589904324445468559999999079---9299999930664358778999999999999579999652789998289
Q 002580 669 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 745 (905)
Q Consensus 669 ~~~~~y~~~~~Lg~G~~g~V~~~~~~~t---g~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~ 745 (905)
+..++|++++.||+|+||.||+|+.... ...||+|.+.+...........+.+|+.++++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf 864891997898038883999999988999079999999983555798999999999999986899998789877740-1
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 49999961699998899963899999999999999999999999998998407889998898089919999036866458
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 825 (905)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~ 825 (905)
.+++|||||++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CHHEEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 0011465423861254442126-899999999999999999987521787520566888156556543325611555303
Q ss_pred CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHHH
Q ss_conf 78887788620110024688996422344555665657866234433468---998438789999999991-99993654
Q 002580 826 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPIL 901 (905)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~~ 901 (905)
..... ........|+..|+|||++.+ +.++|+||||+++|||++ |..||...
T Consensus 163 ~~~~~------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDDH------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CCE------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCC------------------------CEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 58875------------------------265476325731079999837999942156614899999996899999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=281.26 Aligned_cols=209 Identities=21% Similarity=0.275 Sum_probs=176.6
Q ss_pred CCCCCCCCCEEECCCCCCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 644445899043244454685599999990-----79929999993066435877899999999999957-999965278
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 738 (905)
Q Consensus 665 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~-----~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~l~ 738 (905)
..+.+..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.++..+ +||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 02637789969854982068829999998066447788699999987424--8779999999999987626999887899
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCC
Q ss_conf 99982894999996169999889996389----------------99999999999999999999999989984078899
Q 002580 739 ASFQTKTHVCLITDYCPGGELFLLLDRQP----------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKP 802 (905)
Q Consensus 739 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp 802 (905)
+++.+.+.+|++||||++|+|.+++.... ...+++..+..++.||+.||.|||+++++||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCC
Q ss_conf 9889808991999903686645878887788620110024688996422344555665657866234433468---9984
Q 002580 803 ENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRM 879 (905)
Q Consensus 803 ~NIli~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~ 879 (905)
+||+++.++.++|+|||+++........ .......||+.|+|||++.. +.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNY-------------------------VVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS-------------------------EECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCCCCC-------------------------EEEEECCCCHHHCCHHHHCCCCCCCCC
T ss_conf 2100002575210234010233678861-------------------------586201359687677886179999740
Q ss_pred HHHHHHHHHHHHHH-CCCCCHH
Q ss_conf 38789999999991-9999365
Q 002580 880 TRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 880 D~~SlG~il~el~~-g~~Pf~~ 900 (905)
|+||||+++|+|++ |.+||..
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCCHHHHHHHHHHCCCCCCCC
T ss_conf 0102589999998589988778
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=279.16 Aligned_cols=198 Identities=19% Similarity=0.278 Sum_probs=174.4
Q ss_pred CCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89904324445468559999999079929999993066435877899999999999957999965278999828949999
Q 002580 671 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 671 ~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~~~~~~lV 750 (905)
+++|++++.||+|+||.||+|++..++..||+|+++... ........+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999786269712868199999999999699999980321-7868999999999999856757888213544444311588
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
++++.+++|..++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||.|........
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred EEECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC-
T ss_conf 6302332221121235--6540367899999999998774339986001467612113378266520460110468875-
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 788620110024688996422344555665657866234433468----99843878999999999199993
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA----YTRMTRYNYLILVSKKFMEFQPF 898 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~~D~~SlG~il~el~~g~~Pf 898 (905)
......+++.|+|||++.. ..++|+|||||++|+|++|..||
T Consensus 157 --------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 202 (292)
T d1unla_ 157 --------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp --------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred --------------------------CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCC
T ss_conf --------------------------1001034431014667506988880444026541889985189999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=287.43 Aligned_cols=200 Identities=23% Similarity=0.368 Sum_probs=173.1
Q ss_pred CCCCCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE-EC
Q ss_conf 44445899043244454685599999990799299999930664358778999999999999579999652789998-28
Q 002580 666 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TK 744 (905)
Q Consensus 666 ~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~-~~ 744 (905)
||.+..++|++++.||.|+||.||+|.+ .|..||+|.++.. .....+.+|+.++++++||||+++++++. ..
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCCCCHHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9955789948857982079808999999--9909999998857-----77999999999998678989854987887238
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 94999996169999889996389999999999999999999999999899840788999889808991999903686645
Q 002580 745 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 824 (905)
Q Consensus 745 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~ 824 (905)
+.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++...
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEEC
T ss_conf 92899996369998999987457888899999999999985232113376553666567601468997763245600344
Q ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHH-CCCCCHH
Q ss_conf 878887788620110024688996422344555665657866234433468---998438789999999991-9999365
Q 002580 825 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFM-EFQPFPI 900 (905)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~-g~~Pf~~ 900 (905)
... .....+|..|+|||++.+ +.++|+||||+++|||++ |.+||..
T Consensus 154 ~~~------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 154 SST------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CCC------------------------------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 787------------------------------76556664677817872798885887775799999999789999999
Q ss_pred HH
Q ss_conf 43
Q 002580 901 LC 902 (905)
Q Consensus 901 ~~ 902 (905)
..
T Consensus 204 ~~ 205 (262)
T d1byga_ 204 IP 205 (262)
T ss_dssp SC
T ss_pred CC
T ss_conf 99
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-44 Score=274.49 Aligned_cols=203 Identities=20% Similarity=0.243 Sum_probs=166.3
Q ss_pred CCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEEEEE
Q ss_conf 99043244454685599999990799299999930664358778999999999999579999-65278999828949999
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLI 750 (905)
Q Consensus 672 ~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~l~~~~~~~~~~~lV 750 (905)
++|++.+.||+|+||.||+|++..+|+.||+|++..... ...+..|+++++.++|++ |+.++.++...+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 889996898507880999999988998999999721005-----888999999999703899601799999519877899
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC---CCCEEEEECCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808---991999903686645878
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCK 827 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~---~g~vkL~DFGla~~~~~~ 827 (905)
|||| +++|...+... ...+++..+..++.|++.||.|||+++|+||||||+|||++. +..++|+|||+|+.+...
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEC-CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf 9873-87133324430-688768999999999999999999799442667876606433577761565046751342554
Q ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHHH
Q ss_conf 887788620110024688996422344555665657866234433468---99843878999999999199993654
Q 002580 828 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~~ 901 (905)
.... ..........+||+.|||||++.+ +.++|+|||||++|+|++|..||...
T Consensus 160 ~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~ 216 (299)
T d1ckia_ 160 RTHQ--------------------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216 (299)
T ss_dssp TTCC--------------------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCC--------------------CEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCC
T ss_conf 4554--------------------10001357767873532999991899898321886177899998498766553
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=279.88 Aligned_cols=211 Identities=15% Similarity=0.147 Sum_probs=177.2
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEE
Q ss_conf 076444458990432444546855999999907-----992999999306643587789999999999995799996527
Q 002580 663 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 737 (905)
Q Consensus 663 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~-----tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l 737 (905)
++..+.+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.++++++||||+.+
T Consensus 11 ~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 11 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred CCCCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEE
T ss_conf 861004268991883598207881899999878644778968999998701--286899999999999997699988412
Q ss_pred EEEEEECCEEEEEEECCCCCCHHHHHHHC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECC
Q ss_conf 89998289499999616999988999638--------9999999999999999999999999899840788999889808
Q 002580 738 YASFQTKTHVCLITDYCPGGELFLLLDRQ--------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 809 (905)
Q Consensus 738 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~ 809 (905)
++++...+..++|||||++|+|.+++... ....++...+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EEEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECC
T ss_conf 54784288106777604899889998750332113444688799999999999999999876479654328677540359
Q ss_pred CCCEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHH
Q ss_conf 991999903686645878887788620110024688996422344555665657866234433468---99843878999
Q 002580 810 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLI 886 (905)
Q Consensus 810 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~ 886 (905)
++.+||+|||+|+....... ........||+.|+|||++.+ ..++|+||||+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGC-------------------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CCEEEEEECCCCEECCCCCC-------------------------EEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHH
T ss_conf 96499942454202357763-------------------------03134023163237888873699883334443789
Q ss_pred HHHHHHHC-CCCCHH
Q ss_conf 99999919-999365
Q 002580 887 LVSKKFME-FQPFPI 900 (905)
Q Consensus 887 il~el~~g-~~Pf~~ 900 (905)
++|||++| ..||..
T Consensus 224 il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 224 VLWEIATLAEQPYQG 238 (308)
T ss_dssp HHHHHHHTSCCTTTT
T ss_pred HHHHHHHCCCCCCCC
T ss_conf 999999689999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=276.72 Aligned_cols=195 Identities=24% Similarity=0.271 Sum_probs=160.4
Q ss_pred CCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHH--HHHHHCCCCCCCEEEEEEEECC----
Q ss_conf 9904324445468559999999079929999993066435877899999999--9999579999652789998289----
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER--EILDMLDHPFVPALYASFQTKT---- 745 (905)
Q Consensus 672 ~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~--~il~~l~h~nIv~l~~~~~~~~---- 745 (905)
.+|.+.+.||+|+||.||+|++ +|..||+|.+... ......+|. ..+.+++||||+++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
T ss_conf 6899988982078819999999--9989999998720------0467999999999962799868326889983798604
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEECCCCCCCEEECCCCCEEEEE
Q ss_conf 49999961699998899963899999999999999999999999998--------9984078899988980899199990
Q 002580 746 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC--------QGIIYRDLKPENVLLQGNGHVSLTD 817 (905)
Q Consensus 746 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~--------~giiHrDLkp~NIli~~~g~vkL~D 817 (905)
.+|+|||||++|+|.+++.+. .+++.....++.|++.||.|+|. ++|+||||||+|||++.++.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 899999646698989998658---99989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---------CCCHHHHHHHHH
Q ss_conf 36866458788877886201100246889964223445556656578662344334689---------984387899999
Q 002580 818 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFAY---------TRMTRYNYLILV 888 (905)
Q Consensus 818 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---------~~~D~~SlG~il 888 (905)
||++.......... .......+||+.|+|||++.+. .++|+|||||+|
T Consensus 152 FGl~~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 152 LGLAVRHDSATDTI-----------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp CTTCEEEETTTTEE-----------------------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCCE-----------------------ECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 38662346777620-----------------------0135525035476782210565454677767501220159999
Q ss_pred HHHHHCCCCCHH
Q ss_conf 999919999365
Q 002580 889 SKKFMEFQPFPI 900 (905)
Q Consensus 889 ~el~~g~~Pf~~ 900 (905)
|||++|..||..
T Consensus 209 ~el~tg~~~~~~ 220 (303)
T d1vjya_ 209 WEIARRCSIGGI 220 (303)
T ss_dssp HHHHHTBCBTTB
T ss_pred HHHHHCCCCCCC
T ss_conf 999628998876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=271.77 Aligned_cols=200 Identities=18% Similarity=0.164 Sum_probs=166.9
Q ss_pred EECCCCCCCCCEEEEEEEECCCC---EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEE
Q ss_conf 43244454685599999990799---2999999306643587789999999999995799996527899982-8949999
Q 002580 675 RPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLI 750 (905)
Q Consensus 675 ~~~~~Lg~G~~g~V~~~~~~~tg---~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~l~~~~~~-~~~~~lV 750 (905)
...+.||+|+||+||+|.+..++ ..||+|.++.. .+......+.+|+.++++++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 2666981368809999999779987999999998843--69789999999999998678999867867898069943899
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96169999889996389999999999999999999999999899840788999889808991999903686645878887
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 830 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DFGla~~~~~~~~~ 830 (905)
||||++++|.+++... ...++...+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEECCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 9874067414421013-454048999999999887652003367625776687576779998899106523225566555
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHCCCCCHH
Q ss_conf 788620110024688996422344555665657866234433468---9984387899999999919999365
Q 002580 831 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMTRYNYLILVSKKFMEFQPFPI 900 (905)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D~~SlG~il~el~~g~~Pf~~ 900 (905)
. ........||..|+|||.+.. ..++|+||||+++|||++|..||..
T Consensus 187 ~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 187 S-----------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp C-----------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred C-----------------------CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 3-----------------------1002565556455676887437999745746619999999978999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-39 Score=244.03 Aligned_cols=203 Identities=20% Similarity=0.257 Sum_probs=164.2
Q ss_pred CCCCCCCCCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCC
Q ss_conf 644445899043244454685599999990799299999930664358778999999999999579-----------999
Q 002580 665 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HPF 733 (905)
Q Consensus 665 ~~~~~~~~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------h~n 733 (905)
.|+.+..++|++++.||.|+||+||+|++..+|+.||+|++.+. ......+.+|+.+++.+. |+|
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCC
T ss_conf 88884478579989975077818999999999979999998343----13368999999999984014555554227676
Q ss_pred CCEEEEEEE--ECCEEEEEEECCCCC-CHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEECC
Q ss_conf 652789998--289499999616999-98899963899999999999999999999999998-99840788999889808
Q 002580 734 VPALYASFQ--TKTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQG 809 (905)
Q Consensus 734 Iv~l~~~~~--~~~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~-~giiHrDLkp~NIli~~ 809 (905)
|+.+++++. .....++++.++..+ .............+++..+..++.|++.||.|||+ .||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred EEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC
T ss_conf 47899876312565202343200035420000012234678689999999999999888764058646567705705630
Q ss_pred CC------CEEEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCH
Q ss_conf 99------1999903686645878887788620110024688996422344555665657866234433468---99843
Q 002580 810 NG------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPVSDFA---YTRMT 880 (905)
Q Consensus 810 ~g------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~~D 880 (905)
++ .++|+|||.+..... .....+||+.|+|||++.. +.++|
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 211 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDE------------------------------HYTNSIQTREYRSPEVLLGAPWGCGAD 211 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTB------------------------------CCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred CCCCCCCCEEEEEECCCCCCCCC------------------------------CCCCCCCCCCCCCHHHCCCCCCCCCCC
T ss_conf 57656443056753144212344------------------------------542236652105713214667776432
Q ss_pred HHHHHHHHHHHHHCCCCCHHH
Q ss_conf 878999999999199993654
Q 002580 881 RYNYLILVSKKFMEFQPFPIL 901 (905)
Q Consensus 881 ~~SlG~il~el~~g~~Pf~~~ 901 (905)
+||+|+++++|++|+.||...
T Consensus 212 iwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---
T ss_pred CCCHHHHHHHHHHCCCCCCCC
T ss_conf 012378999998788998987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.2e-24 Score=158.36 Aligned_cols=137 Identities=19% Similarity=0.146 Sum_probs=105.9
Q ss_pred EEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCC---------------CHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 04324445468559999999079929999993066435---------------877899999999999957999965278
Q 002580 674 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---------------NRNKVHRACAEREILDMLDHPFVPALY 738 (905)
Q Consensus 674 y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~h~nIv~l~ 738 (905)
+.+.++||.|+||.||+|.+ .+|..||+|++...... ..........|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 02277802485659999997-99999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 99982894999996169999889996389999999999999999999999999899840788999889808991999903
Q 002580 739 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 818 (905)
Q Consensus 739 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~giiHrDLkp~NIli~~~g~vkL~DF 818 (905)
++.. .+++|||+++..+.. ++......++.|++.++.|||++|++||||||+|||++.+ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EECC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEEC
T ss_conf 8628----889999504565420---------0157899999999999999826888983689036114289-8999877
Q ss_pred CCCCCCC
Q ss_conf 6866458
Q 002580 819 DLSCLTS 825 (905)
Q Consensus 819 Gla~~~~ 825 (905)
|.|....
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCCCCCC
T ss_conf 8843089
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.90 E-value=6.9e-23 Score=148.06 Aligned_cols=108 Identities=60% Similarity=1.139 Sum_probs=98.4
Q ss_pred HCCCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEECCCCCEE
Q ss_conf 12546999277899867873778899809991322499976667999996899999999975991999999971599769
Q 002580 201 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 280 (905)
Q Consensus 201 ~~~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 280 (905)
+.++++++|+..|||+|+|+|++|++++||+++|++|+++.++.+++........+++.+..++.+.+++..++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEEEECCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCEEE
T ss_conf 66569999598998969999589999888699998587300311355787784223457653985031278870688399
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCH
Q ss_conf 9998754566699998999999964405
Q 002580 281 WNLLTIAPIKDDEGKVLKFIGMQVEVSK 308 (905)
Q Consensus 281 w~~~s~~pi~d~~G~~~~~v~~~~DITe 308 (905)
|++++++|++|++|++.+++++.+|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
T ss_conf 9998998899999999999999997799
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.87 E-value=1.9e-21 Score=139.58 Aligned_cols=108 Identities=45% Similarity=0.912 Sum_probs=101.1
Q ss_pred HCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 03649999389999995851788899829992322699987676999997899999999973994999999980289399
Q 002580 484 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 563 (905)
Q Consensus 484 a~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~~~~~e~~~~~kdG~~~ 563 (905)
+.++++++|+..+||+|+|||++|++++||+++|++|+++..+.+++..+...+.+.+.+..+..+.+|+.+++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEEEECCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCEEE
T ss_conf 66569999598998969999589999888699998587300311355787784223457653985031278870688399
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCC
Q ss_conf 9999993100599998999998406865
Q 002580 564 WNLFHLQPMRDQKGEVQYFIGVQLDGSE 591 (905)
Q Consensus 564 wv~~~~~pi~d~~G~v~~~igi~rDITe 591 (905)
|+++++.|++|++|++.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
T ss_conf 9998998899999999999999997799
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.6e-20 Score=134.20 Aligned_cols=107 Identities=29% Similarity=0.579 Sum_probs=89.7
Q ss_pred CCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEECCCCCEE
Q ss_conf 546999277899867873778899809991322499976--667999996899999999975991999999971599769
Q 002580 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 280 (905)
Q Consensus 203 ~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 280 (905)
..++|+|+..+|+.|+|+|++|++++||+++|++|+++. ++.+++........++..+..++.+..+++.++++|+.+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CEEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCCCCCCEEEHEECCCCCCCCHHHCCCCCCCCEEEEEECCCCEE
T ss_conf 61999759899998999948999985998889533674311210100000000010000001211111000220132201
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCHH
Q ss_conf 99987545666999989999999644053
Q 002580 281 WNLLTIAPIKDDEGKVLKFIGMQVEVSKH 309 (905)
Q Consensus 281 w~~~s~~pi~d~~G~~~~~v~~~~DITe~ 309 (905)
|++++++|++|++|++.+++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCCC
T ss_conf 12336778998999999999999978899
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.83 E-value=5.1e-20 Score=131.24 Aligned_cols=103 Identities=45% Similarity=0.866 Sum_probs=87.4
Q ss_pred CEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEECCCCCEEEEE
Q ss_conf 46999277899867873778899809991322499976667999996899999999975991999999971599769999
Q 002580 204 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNL 283 (905)
Q Consensus 204 ~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~ 283 (905)
.++++|+..+||+|+|+|++|++++||+.+|++|+++..+.++.........++..+..+..+.++++.+++||+.+|++
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEECCCCCCCHHHHHHHHHHHHCCCEEEEEEEEEECCCCEEEEE
T ss_conf 59998599998989999689999888698997786210010110016777642356525963576899996055428988
Q ss_pred EEEEEEECCCCCEEEEEEEEECC
Q ss_conf 87545666999989999999644
Q 002580 284 LTIAPIKDDEGKVLKFIGMQVEV 306 (905)
Q Consensus 284 ~s~~pi~d~~G~~~~~v~~~~DI 306 (905)
+++.|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEECC
T ss_conf 78888999999999999999829
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=8.7e-20 Score=129.88 Aligned_cols=107 Identities=30% Similarity=0.527 Sum_probs=97.8
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCC--CCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 6499993899999958517888998299923226999876--76999997899999999973994999999980289399
Q 002580 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF--LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 563 (905)
Q Consensus 486 ~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~--l~~~~~~~~~~~~~~~~~~~g~~~~~e~~~~~kdG~~~ 563 (905)
..++++|+++.|++|+|+|++|++++||+.+|++|+++.. +.+++........+..++..+..+..+++.++++|..+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CEEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCCCCCCEEEHEECCCCCCCCHHHCCCCCCCCEEEEEECCCCEE
T ss_conf 61999759899998999948999985998889533674311210100000000010000001211111000220132201
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCCC
Q ss_conf 99999931005999989999984068655
Q 002580 564 WNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592 (905)
Q Consensus 564 wv~~~~~pi~d~~G~v~~~igi~rDITer 592 (905)
|+.++.+|++|++|++++++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCCC
T ss_conf 12336778998999999999999978899
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.82 E-value=1.5e-19 Score=128.51 Aligned_cols=124 Identities=17% Similarity=0.231 Sum_probs=101.7
Q ss_pred HHHHHHHHHHHHC-CCHHHHHHHHCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 1069999966204-649999986036499993899999958517888998299923226999876769999978999999
Q 002580 462 VDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 540 (905)
Q Consensus 462 ~e~~~~e~~~~~~-~~l~~i~e~a~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~ 540 (905)
++.++.|++++++ .+|+.++++++++|+++|. +|+|++||+++++++||+++|++|+++..++++.........+.
T Consensus 2 s~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~ 78 (130)
T d1ew0a_ 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCEEEEEEC---CCCEEEEHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 769999999999999999999719772999908---96499878887775169988962875223333102677889999
Q ss_pred HHHHCCCC----EEEEEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 99973994----999999980289399999999310059999899999840686
Q 002580 541 AAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (905)
Q Consensus 541 ~~~~~g~~----~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rDIT 590 (905)
..+..+.. ...++...++||+.+|++++++|+.++++ ..++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEEEEEECCE--EEEEEEEEECC
T ss_conf 99971887544410158898589979999999999997993--89999999787
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.81 E-value=4.3e-19 Score=125.85 Aligned_cols=103 Identities=72% Similarity=1.188 Sum_probs=97.6
Q ss_pred CEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 49999389999995851788899829992322699987676999997899999999973994999999980289399999
Q 002580 487 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 566 (905)
Q Consensus 487 ~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~~~~~e~~~~~kdG~~~wv~ 566 (905)
.++++|+..+|++|+|+|++|++++||+.+|++|+++..+.+++......+.+...+..+..+.+|++++++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEECCCCCCCHHHHHHHHHHHHCCCEEEEEEEEEECCCCEEEEE
T ss_conf 59998599998989999689999888698997786210010110016777642356525963576899996055428988
Q ss_pred EEEEEEECCCCCEEEEEEEEECC
Q ss_conf 99931005999989999984068
Q 002580 567 FHLQPMRDQKGEVQYFIGVQLDG 589 (905)
Q Consensus 567 ~~~~pi~d~~G~v~~~igi~rDI 589 (905)
+++.|++|++|++++++++++||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEECC
T ss_conf 78888999999999999999829
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.78 E-value=2.4e-19 Score=127.28 Aligned_cols=122 Identities=21% Similarity=0.272 Sum_probs=104.2
Q ss_pred CCCCCCCCCHHHHHHHHHHHHCCCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 76411321308999999996125469992778998678737788998099913224999766679999968999999999
Q 002580 181 GGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 260 (905)
Q Consensus 181 ~~~e~~l~~~~~~l~~~le~~~~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l 260 (905)
.+.+..|..+++.++.++++++++++++|. +|+|+++|++|++++||+++|++|+++..+.++.........+...+
T Consensus 5 ~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~ 81 (130)
T d1ew0a_ 5 LETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYM 81 (130)
T ss_dssp HHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCCCEEEEEEC---CCCEEEEHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 999999999999999999719772999908---96499878887775169988962875223333102677889999999
Q ss_pred HCCCC----EEEEEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 75991----999999971599769999875456669999899999996440
Q 002580 261 QNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 307 (905)
Q Consensus 261 ~~g~~----~~~e~~~~~kdG~~~w~~~s~~pi~d~~G~~~~~v~~~~DIT 307 (905)
..+.. ...++...++||..+|++++++|+.+.++ ..++++++|||
T Consensus 82 ~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 82 ATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHCCCCCCCCEEEEEEECCCCCEEEEEEEEEEEEECCE--EEEEEEEEECC
T ss_conf 71887544410158898589979999999999997993--89999999787
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=9.6e-18 Score=117.91 Aligned_cols=97 Identities=16% Similarity=0.186 Sum_probs=48.3
Q ss_pred CCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEECCCCCEEEEEEEEEEEECC-
Q ss_conf 9867873778899809991322499976667999996899999999975991999999971599769999875456669-
Q 002580 214 DYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDD- 292 (905)
Q Consensus 214 dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~s~~pi~d~- 292 (905)
+|+|+|+|+++++++||+++|++|+++..+.++++.......+...+..+..+..+++.+++||+.+|++++.+|++|+
T Consensus 15 dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~~~~~~~~~~~ 94 (114)
T d1p97a_ 15 DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLETQGTVIYNPR 94 (114)
T ss_dssp TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEEEEEEEEECTT
T ss_pred CCCEEEECHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCEEECCEEEEEECCCCEEEEEEEEEEEECC
T ss_conf 99599998799977499713055200000000012431100100001111100011000000476517999988999689
Q ss_pred CCCEEEEEEEEECCCHHH
Q ss_conf 999899999996440536
Q 002580 293 EGKVLKFIGMQVEVSKHT 310 (905)
Q Consensus 293 ~G~~~~~v~~~~DITe~k 310 (905)
+|++.+++++.+|||++|
T Consensus 95 ~~~~~~ii~~~~dite~k 112 (114)
T d1p97a_ 95 NLQPQCIMCVNYVLSEIE 112 (114)
T ss_dssp TCSEEEEEEEEEEEEEEE
T ss_pred CCCEEEEEEEEEECCHHH
T ss_conf 998999999999897242
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=9.3e-18 Score=118.01 Aligned_cols=107 Identities=18% Similarity=0.134 Sum_probs=94.6
Q ss_pred CCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEE
Q ss_conf 36499993899999958517888998299923226999876769999978999999999739949999999802893999
Q 002580 485 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564 (905)
Q Consensus 485 ~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~~~~~e~~~~~kdG~~~w 564 (905)
+..|+..|. ||+|+|+|+++++++||+.+|++|+++..+++|++.....+.....+..+..+..+++++++||+.+|
T Consensus 6 ~~fi~r~~~---dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~w 82 (114)
T d1p97a_ 6 KTFLSRHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVW 82 (114)
T ss_dssp EEEEEEECT---TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEE
T ss_pred CEEEEEECC---CCCEEEECHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCEEECCEEEEEECCCCEE
T ss_conf 779999979---99599998799977499713055200000000012431100100001111100011000000476517
Q ss_pred EEEEEEEEECC-CCCEEEEEEEEECCCCCCC
Q ss_conf 99999310059-9998999998406865533
Q 002580 565 NLFHLQPMRDQ-KGEVQYFIGVQLDGSEHLE 594 (905)
Q Consensus 565 v~~~~~pi~d~-~G~v~~~igi~rDITerk~ 594 (905)
+.++..|++|+ +|.+.+++++.+||||+|+
T Consensus 83 v~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 83 LETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCHHHC
T ss_conf 9999889996899989999999998972423
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.66 E-value=3.9e-16 Score=108.51 Aligned_cols=107 Identities=23% Similarity=0.392 Sum_probs=54.6
Q ss_pred HHHHHHHHCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC----CEEEE
Q ss_conf 99999860364999938999999585178889982999232269998767699999789999999997399----49999
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT----DVTVQ 552 (905)
Q Consensus 477 l~~i~e~a~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~----~~~~e 552 (905)
|..++++++++|+++|. +|+|+++|+++++++||+.+|++|++...+.++................+. ....+
T Consensus 3 ~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 79 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 79 (113)
T ss_dssp HHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CE
T ss_pred HHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 89998708471899929---999999861686652013666537520003321111110000011001243200110002
Q ss_pred EEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEEC
Q ss_conf 999802893999999993100599998999998406
Q 002580 553 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 588 (905)
Q Consensus 553 ~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rD 588 (905)
...+++||+.+|+++++.|+.+++| ..++++++|
T Consensus 80 ~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 80 LQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred EEECCCCCEEEEEEEEEEEEEECCE--EEEEEEEEC
T ss_conf 4410245416999999999998990--899999999
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.66 E-value=4.8e-16 Score=107.95 Aligned_cols=108 Identities=21% Similarity=0.348 Sum_probs=87.3
Q ss_pred HHHHHHHHHCCCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC----CEEE
Q ss_conf 999999961254699927789986787377889980999132249997666799999689999999997599----1999
Q 002580 193 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SYCG 268 (905)
Q Consensus 193 ~l~~~le~~~~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~----~~~~ 268 (905)
.|.++++.++++|+++|. +|+|+++|++|++++||+++|++|+++..+.+..........+...+..+. ....
T Consensus 2 ~~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T d1v9ya_ 2 IFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 78 (113)
T ss_dssp CHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------C
T ss_pred HHHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 789998708471899929---99999986168665201366653752000332111111000001100124320011000
Q ss_pred EEEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEC
Q ss_conf 9999715997699998754566699998999999964
Q 002580 269 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 305 (905)
Q Consensus 269 e~~~~~kdG~~~w~~~s~~pi~d~~G~~~~~v~~~~D 305 (905)
+...++|||+.+|++++++|+.+++|. +++++++|
T Consensus 79 e~~~~~~dG~~~~v~~~~~~i~~~~~~--~~~~v~rD 113 (113)
T d1v9ya_ 79 ELQLEKKDGSKIWTRFALSKVSAEGKV--YYLALVRD 113 (113)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTEE--EEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEEEEEEECCEE--EEEEEEEC
T ss_conf 244102454169999999999989908--99999999
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.65 E-value=6.3e-16 Score=107.27 Aligned_cols=101 Identities=18% Similarity=0.245 Sum_probs=62.6
Q ss_pred CCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEECCCCC
Q ss_conf 546999277899867873778899809991322499976667999996899999999975991----9999999715997
Q 002580 203 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKKDGT 278 (905)
Q Consensus 203 ~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~ 278 (905)
+||+++|. +|+|+++|++|++++||+++|++|+++..+.++.........+...+..+.. +..++..+++||+
T Consensus 1 dgi~~~D~---~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECC---CCCEEEECHHHHHHHHHCHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEEEEEECCCE
T ss_conf 98999979---993997738999876434186618974224221210001122234443023211111100013301436
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEECCCH
Q ss_conf 699998754566699998999999964405
Q 002580 279 PFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 308 (905)
Q Consensus 279 ~~w~~~s~~pi~d~~G~~~~~v~~~~DITe 308 (905)
.+|++++++|+.++++ .+++++++||||
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE 105 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTE 105 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHH
T ss_pred EEEEEEEEEEEEECCE--EEEEEEEEECCC
T ss_conf 9988899999997993--799999996889
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.64 E-value=4.8e-16 Score=107.99 Aligned_cols=102 Identities=19% Similarity=0.218 Sum_probs=83.9
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEEECCCC
Q ss_conf 649999389999995851788899829992322699987676999997899999999973994----9999999802893
Q 002580 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINYTKSGK 561 (905)
Q Consensus 486 ~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~~----~~~e~~~~~kdG~ 561 (905)
|||+++|.+ |+|+++|+++++++||+.+|++|++...++++.............+..... ...+...+++||+
T Consensus 1 dgi~~~D~~---G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDGH---GIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEETT---SBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECCC---CCEEEECHHHHHHHHHCHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEEEEEECCCE
T ss_conf 989999799---93997738999876434186618974224221210001122234443023211111100013301436
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEECCCCC
Q ss_conf 9999999931005999989999984068655
Q 002580 562 KFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 592 (905)
Q Consensus 562 ~~wv~~~~~pi~d~~G~v~~~igi~rDITer 592 (905)
.+|++++++|+.++++ .+++++++||||.
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCE--EEEEEEEEECCCC
T ss_conf 9988899999997993--7999999968898
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.56 E-value=9.6e-15 Score=100.36 Aligned_cols=106 Identities=12% Similarity=0.066 Sum_probs=62.0
Q ss_pred HHHHHHHHCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCC-CCCHHHHHHHHHHHHCCCCEEEEEEE
Q ss_conf 99999860364999938999999585178889982999232269998767699-99978999999999739949999999
Q 002580 477 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGP-ETDPATVRKIRAAIDNQTDVTVQLIN 555 (905)
Q Consensus 477 l~~i~e~a~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~-~~~~~~~~~~~~~~~~g~~~~~e~~~ 555 (905)
+..+++++|+|++++|. +|+|+++|+++++++||+++|++|+++..+++| +....+...+.+.+..|.....+...
T Consensus 19 ~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 95 (125)
T d1nwza_ 19 DDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEYT 95 (125)
T ss_dssp CHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEEE
T ss_pred HHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCHHHCCCCHHHHHHEEEECEEEEECCCCCEEEEEE
T ss_conf 99998578752999908---998999817999762456276639977772695666100200000021047754588887
Q ss_pred EECCCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 8028939999999931005999989999984068
Q 002580 556 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 589 (905)
Q Consensus 556 ~~kdG~~~wv~~~~~pi~d~~G~v~~~igi~rDI 589 (905)
.+++|..+|+.+++.++.+ |+-+ ..+++||
T Consensus 96 ~~~~G~~~~v~v~l~~~~~--g~~~--~v~V~di 125 (125)
T d1nwza_ 96 FDYQMTPTKVKVHMKKALS--GDSY--WVFVKRV 125 (125)
T ss_dssp ECTTSCCEEEEEEEEECSS--SSEE--EEEEEEC
T ss_pred ECCCCCEEEEEEEEEEECC--CCEE--EEEEEEC
T ss_conf 4037947999999999469--9989--9999989
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.53 E-value=5.7e-14 Score=95.84 Aligned_cols=109 Identities=18% Similarity=0.144 Sum_probs=89.2
Q ss_pred HHHHHHHHHHHCCCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCEEEE
Q ss_conf 899999999612546999277899867873778899809991322499976-6679999968999999999759919999
Q 002580 191 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR-FLQGAGTDPEDVAKIRETLQNGQSYCGR 269 (905)
Q Consensus 191 ~~~l~~~le~~~~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~-~l~~~~~~~~~~~~i~~~l~~g~~~~~e 269 (905)
+..+..++|++++|++++|. +|+|+++|++|++++||+++|++|+++. .+.|+.........+.+.+..|.....+
T Consensus 16 ~~~~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~ 92 (125)
T d1nwza_ 16 AKMDDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMF 92 (125)
T ss_dssp TTCCHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEE
T ss_pred HHHHHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCHHHCCCCHHHHHHEEEECEEEEECCCCCEEE
T ss_conf 99999998578752999908---998999817999762456276639977772695666100200000021047754588
Q ss_pred EEEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 9997159976999987545666999989999999644
Q 002580 270 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306 (905)
Q Consensus 270 ~~~~~kdG~~~w~~~s~~pi~d~~G~~~~~v~~~~DI 306 (905)
....+++|..+|+++++.+.. +|.-. ..+++||
T Consensus 93 ~~~~~~~G~~~~v~v~l~~~~--~g~~~--~v~V~di 125 (125)
T d1nwza_ 93 EYTFDYQMTPTKVKVHMKKAL--SGDSY--WVFVKRV 125 (125)
T ss_dssp EEEECTTSCCEEEEEEEEECS--SSSEE--EEEEEEC
T ss_pred EEEECCCCCEEEEEEEEEEEC--CCCEE--EEEEEEC
T ss_conf 887403794799999999946--99989--9999989
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.51 E-value=5.2e-14 Score=96.06 Aligned_cols=92 Identities=12% Similarity=0.009 Sum_probs=40.9
Q ss_pred HHHHHHHCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCEEEEEEEE
Q ss_conf 99998603649999389999995851788899829992322699987676-99999789999999997399499999998
Q 002580 478 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLINY 556 (905)
Q Consensus 478 ~~i~e~a~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~-~~~~~~~~~~~~~~~~~~g~~~~~e~~~~ 556 (905)
.++++++|++|+++|. +|+|++||+++++++||+++|++|+++..++ |+...+.+...+.+.+..|..........
T Consensus 6 ~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~l 82 (110)
T d1mzua_ 6 TAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFVF 82 (110)
T ss_dssp CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEEE
T ss_pred HHHHHCCCCEEEEECC---CCCEEEEHHHHHHHHCCCHHHHCCCCHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 9998478937999969---9999985778999886799998599789964986466899999999986556574137999
Q ss_pred ECCCCEEEEEEEEEEE
Q ss_conf 0289399999999310
Q 002580 557 TKSGKKFWNLFHLQPM 572 (905)
Q Consensus 557 ~kdG~~~wv~~~~~pi 572 (905)
+++|..+++++++.+.
T Consensus 83 ~~~G~~~~v~v~~~~~ 98 (110)
T d1mzua_ 83 DFQMAPVRVQIRMQNA 98 (110)
T ss_dssp ECSSCEEEEEEEEEEC
T ss_pred ECCCCEEEEEEEEEEE
T ss_conf 3079638999999993
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.48 E-value=1.5e-13 Score=93.40 Aligned_cols=101 Identities=10% Similarity=0.056 Sum_probs=82.7
Q ss_pred HHHHHHHHHHCCCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCEEEEE
Q ss_conf 99999999612546999277899867873778899809991322499976-66799999689999999997599199999
Q 002580 192 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR-FLQGAGTDPEDVAKIRETLQNGQSYCGRL 270 (905)
Q Consensus 192 ~~l~~~le~~~~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~-~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 270 (905)
..+.+++|+++++++++|. +|+|+++|+++++|+||+++|++|+++. .+.|+.........+.+.+.+|......-
T Consensus 3 ~~~~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 79 (110)
T d1mzua_ 3 GMGTAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFD 79 (110)
T ss_dssp ---CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEE
T ss_pred CHHHHHHHCCCCEEEEECC---CCCEEEEHHHHHHHHCCCHHHHCCCCHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 2779998478937999969---9999985778999886799998599789964986466899999999986556574137
Q ss_pred EEECCCCCEEEEEEEEEEEECCCCCEE
Q ss_conf 997159976999987545666999989
Q 002580 271 LNYKKDGTPFWNLLTIAPIKDDEGKVL 297 (905)
Q Consensus 271 ~~~~kdG~~~w~~~s~~pi~d~~G~~~ 297 (905)
...+++|..++++++..+.. .|...
T Consensus 80 ~~l~~~G~~~~v~v~~~~~~--~~~~~ 104 (110)
T d1mzua_ 80 FVFDFQMAPVRVQIRMQNAG--VPDRY 104 (110)
T ss_dssp EEEECSSCEEEEEEEEEECS--STTEE
T ss_pred EEEECCCCEEEEEEEEEEEC--CCCEE
T ss_conf 99930796389999999934--79989
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=6.4e-14 Score=95.54 Aligned_cols=103 Identities=13% Similarity=0.164 Sum_probs=48.0
Q ss_pred HHCCCEEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEECC
Q ss_conf 612546999277899867873778899809991322499976667999996899999999975991----9999999715
Q 002580 200 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKK 275 (905)
Q Consensus 200 ~~~~~i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~k 275 (905)
.+.++|+++|.. +|.|+++|+++++++||+++|++|+++..+.++.........+...+..+.. +..++...++
T Consensus 6 ~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 83 (114)
T d1ll8a_ 6 EFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISR 83 (114)
T ss_dssp TTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECCT
T ss_pred HCCCEEEEEECC--CCEEEEECHHHHHHHCCCHHHHCCCCEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEECC
T ss_conf 009689999999--999999778999754689789839972214281049999999999985677731003678888804
Q ss_pred CCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 9976999987545666999989999999644
Q 002580 276 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 306 (905)
Q Consensus 276 dG~~~w~~~s~~pi~d~~G~~~~~v~~~~DI 306 (905)
+|+.+|++++++++..+ |... ++++.+||
T Consensus 84 ~G~~~pvevs~~~i~~~-~~~~-~l~vi~dV 112 (114)
T d1ll8a_ 84 SGEKIPVSVWMKRMRQE-RRLC-CVVVLEPV 112 (114)
T ss_dssp TCCCEEEECCEECCBSS-SSBE-EEEEEEEC
T ss_pred CCCEEEEEEEEEEEEEC-CEEE-EEEEEEEC
T ss_conf 99199999999999999-9679-99999977
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=8.5e-14 Score=94.81 Aligned_cols=105 Identities=14% Similarity=0.168 Sum_probs=83.3
Q ss_pred HHHCCCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEEE
Q ss_conf 8603649999389999995851788899829992322699987676999997899999999973994----999999980
Q 002580 482 ERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINYT 557 (905)
Q Consensus 482 e~a~~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~~----~~~e~~~~~ 557 (905)
+...++|+++|.+ +|.|+++|++++++|||+.+|++|++...++++++.......+...+..+.. ...+...++
T Consensus 5 ~~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (114)
T d1ll8a_ 5 PEFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIIS 82 (114)
T ss_dssp TTTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECC
T ss_pred HHCCCEEEEEECC--CCEEEEECHHHHHHHCCCHHHHCCCCEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEC
T ss_conf 1009689999999--99999977899975468978983997221428104999999999998567773100367888880
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 289399999999310059999899999840686
Q 002580 558 KSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 590 (905)
Q Consensus 558 kdG~~~wv~~~~~pi~d~~G~v~~~igi~rDIT 590 (905)
++|+.+|++++++++..+ |+. .++++.+||+
T Consensus 83 ~~G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 83 RSGEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp TTCCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred CCCCEEEEEEEEEEEEEC-CEE-EEEEEEEECC
T ss_conf 499199999999999999-967-9999999775
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.14 E-value=1.4e-11 Score=81.83 Aligned_cols=94 Identities=12% Similarity=0.074 Sum_probs=58.2
Q ss_pred EEEECCCCCCCEEECCHHHHHHCCCCH-HHHCCCCCCCCCCCCCCH--HHHHHHHHHHHCCCCEEEEEEEECCCCCEEEE
Q ss_conf 999277899867873778899809991-322499976667999996--89999999997599199999997159976999
Q 002580 206 VVSDATKPDYPIMYASAGFFKMTGYTS-KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWN 282 (905)
Q Consensus 206 ~iiD~~~~dG~Il~~N~af~~l~Gys~-~EiiG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~ 282 (905)
.-.|. +|+|+++|+++.+++||.+ +|++|+++..+++|++.. .........+..|.....+++.++|||+.+|+
T Consensus 6 trh~~---~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv 82 (109)
T d1oj5a_ 6 TKQDT---TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSA 82 (109)
T ss_dssp EEECT---TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEE
T ss_pred EEECC---CCEEEEECHHHHHHHHCCCHHHHCCCCHHHEECCCCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCEEEE
T ss_conf 99879---962999987896675337878985975988498013327776678998873022230556440236838999
Q ss_pred EEEEEEEECCCCCEE-EEEEE
Q ss_conf 987545666999989-99999
Q 002580 283 LLTIAPIKDDEGKVL-KFIGM 302 (905)
Q Consensus 283 ~~s~~pi~d~~G~~~-~~v~~ 302 (905)
+.+..+++|+.|... +++++
T Consensus 83 ~t~~~~~~~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 83 HTRCKLCYPQSPDMQPFIMGI 103 (109)
T ss_dssp EEEEEEECC----CCCEEEEE
T ss_pred EEEEEEEECCCCCCCCEEEEE
T ss_conf 999999999999963589999
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.07 E-value=4.1e-11 Score=79.10 Aligned_cols=95 Identities=12% Similarity=0.133 Sum_probs=76.0
Q ss_pred EEEECCCCCCCCEEEECHHHHHHCCCCH-HHHCCCCCCCCCCCCCCHH--HHHHHHHHHHCCCCEEEEEEEEECCCCEEE
Q ss_conf 9999389999995851788899829992-3226999876769999978--999999999739949999999802893999
Q 002580 488 FVITDPRLPDNPIIFASDSFLELTEYSR-EEILGRNCRFLQGPETDPA--TVRKIRAAIDNQTDVTVQLINYTKSGKKFW 564 (905)
Q Consensus 488 i~v~D~~g~dg~Iv~vN~a~~~l~Gys~-eEiiG~~~~~l~~~~~~~~--~~~~~~~~~~~g~~~~~e~~~~~kdG~~~w 564 (905)
+.-.|. +|+|+++|+++++++||.+ +|++|+++..++||++.+. ...........|.....++++++|||+.+|
T Consensus 5 ~trh~~---~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vW 81 (109)
T d1oj5a_ 5 MTKQDT---TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 81 (109)
T ss_dssp EEEECT---TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred EEEECC---CCEEEEECHHHHHHHHCCCHHHHCCCCHHHEECCCCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCEEE
T ss_conf 999879---96299998789667533787898597598849801332777667899887302223055644023683899
Q ss_pred EEEEEEEEECCCCCE-EEEEEE
Q ss_conf 999993100599998-999998
Q 002580 565 NLFHLQPMRDQKGEV-QYFIGV 585 (905)
Q Consensus 565 v~~~~~pi~d~~G~v-~~~igi 585 (905)
+..+..+++|+.|+. ..++|+
T Consensus 82 v~t~~~~~~~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 82 AHTRCKLCYPQSPDMQPFIMGI 103 (109)
T ss_dssp EEEEEEEECC----CCCEEEEE
T ss_pred EEEEEEEEECCCCCCCCEEEEE
T ss_conf 9999999999999963589999
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.95 E-value=6.6e-09 Score=66.18 Aligned_cols=140 Identities=12% Similarity=0.057 Sum_probs=92.3
Q ss_pred CCEEECCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEEEE
Q ss_conf 99043244454685599999990799299999930664358778999999999999579-99965278999828949999
Q 002580 672 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 750 (905)
Q Consensus 672 ~~y~~~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~~~~~lV 750 (905)
..|+..+..+.++.+.||++.. .+..+++|........ ....+.+|...+..+. +-.+++++.....++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCC---CHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEE
T ss_conf 3527997678998771899990--8986999984887653---2556999999999876069987289997508964999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------
Q ss_conf 9616999988999638999999999999999999999999989-------------------------------------
Q 002580 751 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ------------------------------------- 793 (905)
Q Consensus 751 ~E~~~ggsL~~~l~~~~~~~l~~~~~~~i~~qil~gL~~LH~~------------------------------------- 793 (905)
|++++|.++....... ... ..++.++...+..||+.
T Consensus 89 ~~~l~G~~~~~~~~~~----~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEECCCCCCCCCCCCC----CCH---HHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 9860433435433440----269---999998999999985568421435764465655577899877655554303323
Q ss_pred ----------------------CCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ----------------------984078899988980899199990368664
Q 002580 794 ----------------------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 794 ----------------------giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
.++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 2005799999999844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.62 E-value=2.2e-07 Score=57.31 Aligned_cols=80 Identities=15% Similarity=0.120 Sum_probs=53.1
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC----HHHHHHHHHHHHHHHHCC-C--CCCCEEEEEEEECCEEEE
Q ss_conf 244454685599999990799299999930664358----778999999999999579-9--996527899982894999
Q 002580 677 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLD-H--PFVPALYASFQTKTHVCL 749 (905)
Q Consensus 677 ~~~Lg~G~~g~V~~~~~~~tg~~~AiK~i~~~~~~~----~~~~~~~~~E~~il~~l~-h--~nIv~l~~~~~~~~~~~l 749 (905)
.+.+|.|....||++.+..++..+++|.-.+..... .....+...|..+|..+. + ..++.++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCC
Q ss_conf 996169999
Q 002580 750 ITDYCPGGE 758 (905)
Q Consensus 750 V~E~~~ggs 758 (905)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEECCCCCC
T ss_conf 871357765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.53 E-value=3.5e-07 Score=56.07 Aligned_cols=138 Identities=14% Similarity=0.092 Sum_probs=80.8
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCEEEEEEECCC
Q ss_conf 4454685-599999990799299999930664358778999999999999579--9996527899982894999996169
Q 002580 679 PLGSGDT-GSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCP 755 (905)
Q Consensus 679 ~Lg~G~~-g~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~l~~~~~~~~~~~lV~E~~~ 755 (905)
.+..|.. +.||++.. ..+..+++|....... ..+..|...++.+. .-.+++++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCCH------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEE
T ss_conf 7678654775899993-8987899995896677------68999999999998659998861322245661599987441
Q ss_pred CCCHHH--------------HHHH-CC----CCCC--CHHHHHHHHH--------------------HHHHHHHHHHHC-
Q ss_conf 999889--------------9963-89----9999--9999999999--------------------999999999989-
Q 002580 756 GGELFL--------------LLDR-QP----TKVL--KEDAVRFYAA--------------------EVVVALEYLHCQ- 793 (905)
Q Consensus 756 ggsL~~--------------~l~~-~~----~~~l--~~~~~~~i~~--------------------qil~gL~~LH~~- 793 (905)
|.++.. .+.+ .. ...+ .......-.. .....+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 35543221268999999999999873688544887554124688999999875411011340112137999999998718
Q ss_pred ------CCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ------984078899988980899199990368664
Q 002580 794 ------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 794 ------giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 765795678678887635773796589998533265
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.85 E-value=4.4e-05 Score=43.78 Aligned_cols=77 Identities=21% Similarity=0.333 Sum_probs=49.9
Q ss_pred CEEECCCCCCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEEC
Q ss_conf 90432444546855999999907-------99299999930664358778999999999999579-99965278999828
Q 002580 673 HFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTK 744 (905)
Q Consensus 673 ~y~~~~~Lg~G~~g~V~~~~~~~-------tg~~~AiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~l~~~~~~~ 744 (905)
.+.+ ++|..|-.-.+|++.... ....+.+++.... . ......+|..+++.+. +.-.+++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----E-TESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred CEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC----C-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC-
T ss_conf 1699-99178533434899968877544578981799965996----1-165899999999999757999808998189-
Q ss_pred CEEEEEEECCCCCCH
Q ss_conf 949999961699998
Q 002580 745 THVCLITDYCPGGEL 759 (905)
Q Consensus 745 ~~~~lV~E~~~ggsL 759 (905)
++|++|++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---CEEEEEECCCCC
T ss_conf ---569997345548
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=97.34 E-value=8.6e-05 Score=42.07 Aligned_cols=33 Identities=15% Similarity=0.054 Sum_probs=19.5
Q ss_pred CCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCC
Q ss_conf 986787377889980999132249997666799
Q 002580 214 DYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246 (905)
Q Consensus 214 dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~ 246 (905)
+|+|+|++++...++|+++++++|+++..++++
T Consensus 27 d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~ 59 (114)
T d2oola2 27 DLRIASVSANVEDLLRQPPASLLNVPIAHYLTA 59 (114)
T ss_dssp TCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCH
T ss_pred CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCH
T ss_conf 998999948889984889288759988996899
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00091 Score=36.09 Aligned_cols=28 Identities=21% Similarity=0.199 Sum_probs=23.2
Q ss_pred CCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 984078899988980899199990368664
Q 002580 794 GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 794 giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
++||+|+.+.|||+++ + ..++||+-|..
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred EEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 2024788804287838-9-35886520146
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=97.31 E-value=9.3e-05 Score=41.88 Aligned_cols=77 Identities=13% Similarity=0.144 Sum_probs=48.6
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC---EEEEEEEEECC-CC
Q ss_conf 649999389999995851788899829992322699987676999997899999999973994---99999998028-93
Q 002580 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD---VTVQLINYTKS-GK 561 (905)
Q Consensus 486 ~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~~---~~~e~~~~~kd-G~ 561 (905)
..++++|.. +++|++++++..+++|+++++++|++...++++++... +++.+..... ..........+ |.
T Consensus 18 G~Llvld~~--d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~~~~----i~~~l~~~~~~~~~~~~~~~~~~~~~~ 91 (114)
T d2oola2 18 GYLFVVSET--DLRIASVSANVEDLLRQPPASLLNVPIAHYLTAASAAR----LTHALHGGDPAAINPIRLDVVTPDGER 91 (114)
T ss_dssp SEEEEECTT--TCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHHHHH----HHHHHCC----CCCSEEEEEEETTEEE
T ss_pred CEEEEEECC--CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHHHHH----HHHHHHCCCCCCCCCEEEEEECCCCCE
T ss_conf 189999889--99899994888998488928875998899689989999----999874279444787899975279986
Q ss_pred EEEEEEE
Q ss_conf 9999999
Q 002580 562 KFWNLFH 568 (905)
Q Consensus 562 ~~wv~~~ 568 (905)
.+++.+.
T Consensus 92 ~~~~~~H 98 (114)
T d2oola2 92 AFNGILH 98 (114)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
T ss_conf 8999999
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.03 E-value=0.0042 Score=32.20 Aligned_cols=31 Identities=35% Similarity=0.620 Sum_probs=27.4
Q ss_pred CCCEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9984078899988980899199990368664
Q 002580 793 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 823 (905)
Q Consensus 793 ~giiHrDLkp~NIli~~~g~vkL~DFGla~~ 823 (905)
.|+||+|+.+.|++++.+...-++||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 5033378636564020454126742221236
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=95.24 E-value=0.024 Score=27.79 Aligned_cols=32 Identities=13% Similarity=0.053 Sum_probs=20.7
Q ss_pred CCCEEECCHHHHHHCCCCHHHHCCCCCCCCCC
Q ss_conf 98678737788998099913224999766679
Q 002580 214 DYPIMYASAGFFKMTGYTSKEVVGRNCRFLQG 245 (905)
Q Consensus 214 dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~ 245 (905)
+++|+.++.+...++|+++++++|+++..+++
T Consensus 45 ~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~ 76 (127)
T d2o9ca2 45 SGEVLQMSLNAATFLGQEPTVLRGQTLAALLP 76 (127)
T ss_dssp TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCT
T ss_pred CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCC
T ss_conf 99799987898998387968984999899888
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=95.18 E-value=0.0089 Score=30.26 Aligned_cols=33 Identities=21% Similarity=0.274 Sum_probs=16.0
Q ss_pred CCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCC
Q ss_conf 986787377889980999132249997666799
Q 002580 214 DYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 246 (905)
Q Consensus 214 dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~ 246 (905)
+++|+.++.+...++|+++++++|+++..++++
T Consensus 36 ~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~ 68 (127)
T d2veaa3 36 DLTISQISANCTGILGRSPEDLLGRTLGEVFDS 68 (127)
T ss_dssp TTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBC
T ss_pred CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCH
T ss_conf 998999857989884859699839998898798
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=94.93 E-value=0.011 Score=29.66 Aligned_cols=81 Identities=17% Similarity=0.086 Sum_probs=48.7
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHH-HHHCCCCEEEEEEEEECCCCEEE
Q ss_conf 64999938999999585178889982999232269998767699999789999999-99739949999999802893999
Q 002580 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRA-AIDNQTDVTVQLINYTKSGKKFW 564 (905)
Q Consensus 486 ~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~-~~~~g~~~~~e~~~~~kdG~~~w 564 (905)
-.++++|.. +++|+.++....+++|.++++++|++...++.++........+.. ......+.....+....++..|+
T Consensus 27 G~LLald~~--~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~~~~l~~~l~~~~~~~~~p~~~~~~~~~~~~~~fd 104 (127)
T d2veaa3 27 GLVVVLQEP--DLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQIDPIQSRLTAGQISSLNPSKLWARVMGDDFVIFD 104 (127)
T ss_dssp SEEEEEETT--TTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC--------CCCTTHHHHSSEEEEEECC--CEEEEE
T ss_pred EEEEEEECC--CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHHHHHHHHHHHCCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 689999889--998999857989884859699839998898798999999998642675557977999873489973799
Q ss_pred EEEE
Q ss_conf 9999
Q 002580 565 NLFH 568 (905)
Q Consensus 565 v~~~ 568 (905)
+.+.
T Consensus 105 ~~~H 108 (127)
T d2veaa3 105 GVFH 108 (127)
T ss_dssp EEEE
T ss_pred EEEE
T ss_conf 9999
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=93.74 E-value=0.042 Score=26.31 Aligned_cols=78 Identities=9% Similarity=-0.009 Sum_probs=49.5
Q ss_pred CCEEEECCCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC--CEEEEEEEEECCCCEE
Q ss_conf 64999938999999585178889982999232269998767699999789999999997399--4999999980289399
Q 002580 486 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT--DVTVQLINYTKSGKKF 563 (905)
Q Consensus 486 ~~i~v~D~~g~dg~Iv~vN~a~~~l~Gys~eEiiG~~~~~l~~~~~~~~~~~~~~~~~~~g~--~~~~e~~~~~kdG~~~ 563 (905)
-.++++|.. ++.|+.++....+++|++.++++|++...+++.. . ..+...+.... ...........+|..+
T Consensus 36 G~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~f 108 (127)
T d2o9ca2 36 GALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-W----PALQAALPPGCPDALQYRATLDWPAAGHL 108 (127)
T ss_dssp SEEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-H----HHHHHHSCTTCCTTCCEEEEECCSSSSEE
T ss_pred EEEEEEECC--CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHH-H----HHHHHHHHHCCCCCCCCEEEEECCCCCEE
T ss_conf 489999889--9979998789899838796898499989988888-9----99999865358632223035406899369
Q ss_pred EEEEEEE
Q ss_conf 9999993
Q 002580 564 WNLFHLQ 570 (905)
Q Consensus 564 wv~~~~~ 570 (905)
|+.+..+
T Consensus 109 ~~~~Hrs 115 (127)
T d2o9ca2 109 SLTVHRV 115 (127)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
T ss_conf 9999997
|
| >d3c2wa3 d.110.3.9 (A:5-117) Bacteriophytochrome BphP {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Pseudomonas aeruginosa [TaxId: 287]
Probab=84.36 E-value=0.71 Score=19.14 Aligned_cols=72 Identities=17% Similarity=0.143 Sum_probs=33.7
Q ss_pred EEEEECCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEECCCCCEEEEEE
Q ss_conf 69992778998678737788998099913224999766679999968999999999759919999999715997699998
Q 002580 205 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLL 284 (905)
Q Consensus 205 i~iiD~~~~dG~Il~~N~af~~l~Gys~~EiiG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~ 284 (905)
++++|. ++.|+.++.+...++|++++ .+|+....+.. ......+...+........... .+.+|..||+-+
T Consensus 25 LLald~---~~~I~~~S~N~~~~lg~~~~-~L~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~d~~~ 95 (113)
T d3c2wa3 25 LVTLRA---DGMVLAASENIQALLGFVAS-PGSYLTQEQVG----PEVLRMLEEGLTGNGPWSNSVE-TRIGEHLFDVIG 95 (113)
T ss_dssp EEEECT---TSBEEEEETTHHHHTSSCCC-TTCBCCHHHHH----HHHHHHHHHHHSCSSCCCCEEE-ECCSSSCEEEEE
T ss_pred EEEECC---CCEEEEECCCHHHHHCCCHH-HHCCCHHHHHC----HHHHHHHHHHHHCCCCCEEEEE-ECCCCEEEEEEE
T ss_conf 999869---97099981798988398856-74542787758----7999999866302898356789-636993799999
Q ss_pred E
Q ss_conf 7
Q 002580 285 T 285 (905)
Q Consensus 285 s 285 (905)
+
T Consensus 96 H 96 (113)
T d3c2wa3 96 H 96 (113)
T ss_dssp E
T ss_pred E
T ss_conf 9
|